PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sakala, C; Newburn, M				Sakala, Carol; Newburn, Mary			Meeting needs of childbearing women and newborn infants through strengthened midwifery	LANCET			English	Editorial Material							HEALTH		[Sakala, Carol] Natl Partnership Women & Families, Childbirth Connect Programs, Washington, DC 20009 USA; [Newburn, Mary] NCT, London W3 6NH, England		Sakala, C (corresponding author), Natl Partnership Women & Families, Childbirth Connect Programs, Washington, DC 20009 USA.	csakala@nationalpartnership.org						Bell AF, 2014, J MIDWIFERY WOM HEAL, V59, P35, DOI 10.1111/jmwh.12101; Buckley S., 2014, HORMONAL PHYSL CHILD; Care Quality Commission, NAT FIND 2013 SURV W; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Csaba G, 2011, CLIN EPIGENETICS, V2, P187, DOI 10.1007/s13148-011-0024-8; Dahlen HG, 2013, MED HYPOTHESES, V80, P656, DOI 10.1016/j.mehy.2013.01.017; Declercq ER, 2013, LISTENING MOTHERS IL; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Halfon N, 2014, MATERN CHILD HLTH J, V18, P344, DOI 10.1007/s10995-013-1346-2; International Confederation of Midwives, 2010, ESS COMP BAS MIDW PR; Kriebel D, 2001, AM J PUBLIC HEALTH, V91, P1351, DOI 10.2105/AJPH.91.9.1351; Olza-Fernandez I, 2014, FRONT NEUROENDOCRIN, V35, P459, DOI 10.1016/j.yfrne.2014.03.007; Renfrew MJ, 2014, LANCET; UNFPA, 2014, STAT WORLDS MIDW 201	14	26	26	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					E39	E40		10.1016/S0140-6736(14)60856-4	http://dx.doi.org/10.1016/S0140-6736(14)60856-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965817				2022-12-28	WOS:000342630600001
J	Russell, SJ; El-Khatib, FH; Sinha, M; Magyar, KL; McKeon, K; Goergen, LG; Balliro, C; Hillard, MA; Nathan, DM; Damiano, ER				Russell, Steven J.; El-Khatib, Firas H.; Sinha, Manasi; Magyar, Kendra L.; McKeon, Katherine; Goergen, Laura G.; Balliro, Courtney; Hillard, Mallory A.; Nathan, David M.; Damiano, Edward R.			Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOOP INSULIN DELIVERY; ARTIFICIAL PANCREAS; SEVERE HYPOGLYCEMIA; GLUCOSE CONTROL; ADOLESCENTS; ADULTS; KETOACIDOSIS; FEASIBILITY; SYSTEM; YOUTH	BACKGROUND The safety and effectiveness of automated glycemic management have not been tested in multiday studies under unrestricted outpatient conditions. METHODS In two random-order, crossover studies with similar but distinct designs, we compared glycemic control with a wearable, bihormonal, automated, "bionic" pancreas (bionic-pancreas period) with glycemic control with an insulin pump (control period) for 5 days in 20 adults and 32 adolescents with type 1 diabetes mellitus. The automatically adaptive algorithm of the bionic pancreas received data from a continuous glucose monitor to control subcutaneous delivery of insulin and glucagon. RESULTS Among the adults, the mean plasma glucose level over the 5-day bionic-pancreas period was 138 mg per deciliter (7.7 mmol per liter), and the mean percentage of time with a low glucose level (<70 mg per deciliter [3.9 mmol per liter]) was 4.8%. After 1 day of automatic adaptation by the bionic pancreas, the mean (+/- SD) glucose level on continuous monitoring was lower than the mean level during the control period (133 +/- 13 vs. 159 +/- 30 mg per deciliter [7.4 +/- 0.7 vs. 8.8 +/- 1.7 mmol per liter], P<0.001) and the percentage of time with a low glucose reading was lower (4.1% vs. 7.3%, P = 0.01). Among the adolescents, the mean plasma glucose level was also lower during the bionic-pancreas period than during the control period (138 +/- 18 vs. 157 +/- 27 mg per deciliter [7.7 +/- 1.0 vs. 8.7 +/- 1.5 mmol per liter], P = 0.004), but the percentage of time with a low plasma glucose reading was similar during the two periods (6.1% and 7.6%, respectively; P = 0.23). The mean frequency of interventions for hypoglycemia among the adolescents was lower during the bionic-pancreas period than during the control period (one per 1.6 days vs. one per 0.8 days, P<0.001). CONCLUSIONS As compared with an insulin pump, a wearable, automated, bihormonal, bionic pancreas improved mean glycemic levels, with less frequent hypoglycemic episodes, among both adults and adolescents with type 1 diabetes mellitus.	[Russell, Steven J.; Magyar, Kendra L.; Goergen, Laura G.; Balliro, Courtney; Hillard, Mallory A.; Nathan, David M.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Russell, Steven J.; Sinha, Manasi; Magyar, Kendra L.; Goergen, Laura G.; Balliro, Courtney; Hillard, Mallory A.; Nathan, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Russell, Steven J.; Sinha, Manasi; Magyar, Kendra L.; Goergen, Laura G.; Balliro, Courtney; Hillard, Mallory A.; Nathan, David M.] Harvard Univ, Sch Med, Boston, MA USA; [El-Khatib, Firas H.; McKeon, Katherine; Damiano, Edward R.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University	Damiano, ER (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	edamiano@bu.edu			National Institute of Diabetes and Digestive and Kidney Diseases and others; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085633, R01DK097657] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases and others; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; ClinicalTrials.gov numbers, NCT01762059 and NCT01833988.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; [Anonymous], 2013, DEXCOM G4 PLATINUM C; Atlas E, 2010, DIABETES CARE, V33, P1072, DOI 10.2337/dc09-1830; Beck RW, 2012, J CLIN ENDOCR METAB, V97, P4383, DOI 10.1210/jc.2012-1561; Burdick J, 2004, PEDIATRICS, V113, pE221, DOI 10.1542/peds.113.3.e221; Castle JR, 2010, DIABETES CARE, V33, P1282, DOI 10.2337/dc09-2254; Cengiz E, 2013, PEDIATR DIABETES, V14, P447, DOI 10.1111/pedi.12030; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; El Youssef Joseph, 2011, J Diabetes Sci Technol, V5, P1312; El-Khatib FH, 2014, J CLIN ENDOCR METAB, V99, P1701, DOI 10.1210/jc.2013-4151; El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619; Elleri D, 2013, DIABETES CARE, V36, P838, DOI 10.2337/dc12-0816; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Hovorka R, 2014, DIABETES CARE, V37, P1204, DOI 10.2337/dc13-2644; Kovatchev BP, 2013, DIABETES CARE, V36, P1851, DOI 10.2337/dc12-1965; Kudva YC, 2014, DIABETES CARE, V37, P1184, DOI 10.2337/dc13-2066; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; MOLNAR GD, 1972, DIABETOLOGIA, V8, P342, DOI 10.1007/BF01218495; Murphy HR, 2012, DIABETES CARE, V35, P191; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nathan DM, 2009, DIABETES CARE, V32, P207; Olinder AL, 2009, PEDIATR DIABETES, V10, P142, DOI 10.1111/j.1399-5448.2008.00462.x; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Phillip M, 2013, NEW ENGL J MED, V368, P824, DOI 10.1056/NEJMoa1206881; Renard E, 2010, DIABETES CARE, V33, P121, DOI 10.2337/dc09-1080; Ruiz Jessica L, 2012, J Diabetes Sci Technol, V6, P1123; Russell SJ, 2012, DIABETES CARE, V35, P2148, DOI 10.2337/dc12-0071; SERVICE FJ, 1980, DIABETES CARE, V3, P58, DOI 10.2337/diacare.3.1.58; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steil GM, 2006, DIABETES, V55, P3344, DOI 10.2337/db06-0419; Steil GM, 2011, J CLIN ENDOCR METAB, V96, P1402, DOI 10.1210/jc.2010-2578; Weinstock RS, 2013, J CLIN ENDOCR METAB, V98, P3411, DOI 10.1210/jc.2013-1589; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967; Weinzimer SA, 2012, DIABETES CARE, V35, P1994, DOI 10.2337/dc12-0330; Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959	37	373	385	9	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					313	325		10.1056/NEJMoa1314474	http://dx.doi.org/10.1056/NEJMoa1314474			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	24931572	Green Accepted			2022-12-28	WOS:000339339800008
J	Legro, RS; Brzyski, RG; Diamond, MP; Coutifaris, C; Schlaff, WD; Casson, P; Christman, GM; Huang, H; Yan, QS; Alvero, R; Haisenleder, DJ; Barnhart, KT; Bates, GW; Usadi, R; Lucidi, S; Baker, V; Trussell, JC; Krawetz, SA; Snyder, P; Ohl, D; Santoro, N; Eisenberg, E; Zhang, H				Legro, Richard S.; Brzyski, Robert G.; Diamond, Michael P.; Coutifaris, Christos; Schlaff, William D.; Casson, Peter; Christman, Gregory M.; Huang, Hao; Yan, Qingshang; Alvero, Ruben; Haisenleder, Daniel J.; Barnhart, Kurt T.; Bates, G. Wright; Usadi, Rebecca; Lucidi, Scott; Baker, Valerie; Trussell, J. C.; Krawetz, Stephen A.; Snyder, Peter; Ohl, Dana; Santoro, Nanette; Eisenberg, Esther; Zhang, Heping		NICHD Reproductive Med Network	Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AROMATASE INHIBITORS; DOUBLE-BLIND; LIVE-BIRTH; PHASE-II; WOMEN; ANASTROZOLE; MULTICENTER; PREGNANCY; METFORMIN; OVULATION	Background Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes. Methods In this double-blind, multicenter trial, we randomly assigned 750 women, in a 1: 1 ratio, to receive letrozole or clomiphene for up to five treatment cycles, with visits to determine ovulation and pregnancy, followed by tracking of pregnancies. The polycystic ovary syndrome was defined according to modified Rotterdam criteria (anovulation with either hyperandrogenism or polycystic ovaries). Participants were 18 to 40 years of age, had at least one patent fallopian tube and a normal uterine cavity, and had a male partner with a sperm concentration of at least 14 million per milliliter; the women and their partners agreed to have regular intercourse with the intent of conception during the study. The primary outcome was live birth during the treatment period. Results Women who received letrozole had more cumulative live births than those who received clomiphene (103 of 374 [27.5%] vs. 72 of 376 [19.1%], P = 0.007; rate ratio for live birth, 1.44; 95% confidence interval, 1.10 to 1.87) without significant differences in overall congenital anomalies, though there were four major congenital anomalies in the letrozole group versus one in the clomiphene group (P = 0.65). The cumulative ovulation rate was higher with letrozole than with clomiphene (834 of 1352 treatment cycles [61.7%] vs. 688 of 1425 treatment cycles [48.3%], P<0.001). There were no significant between-group differences in pregnancy loss (49 of 154 pregnancies in the letrozole group [31.8%] and 30 of 103 pregnancies in the clomiphene group [29.1%]) or twin pregnancy (3.4% and 7.4%, respectively). Clomiphene was associated with a higher incidence of hot flushes, and letrozole was associated with higher incidences of fatigue and dizziness. Rates of other adverse events were similar in the two treatment groups. Conclusions As compared with clomiphene, letrozole was associated with higher live-birth and ovulation rates among infertile women with the polycystic ovary syndrome.	[Legro, Richard S.] Penn State Univ, Dept Obstet & Gynecol, Hershey, PA USA; [Brzyski, Robert G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Diamond, Michael P.] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Diamond, Michael P.; Krawetz, Stephen A.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Coutifaris, Christos; Barnhart, Kurt T.; Snyder, Peter] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Schlaff, William D.; Alvero, Ruben; Santoro, Nanette] Univ Colorado, Dept Obstet & Gynecol, Aurora, CO USA; [Casson, Peter] Univ Vermont, Dept Obstet & Gynecol, Burlington, VT 05405 USA; [Christman, Gregory M.; Ohl, Dana] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Huang, Hao; Yan, Qingshang; Zhang, Heping] Yale Univ, Dept Biostat, Sch Publ Hlth, New Haven, CT USA; [Haisenleder, Daniel J.] Univ Virginia, Ctr Res Reprod, Ligand Core Lab, Charlottesville, VA USA; [Bates, G. Wright] Univ Alabama Birmingham, Birmingham, AL USA; [Usadi, Rebecca] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Lucidi, Scott] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Baker, Valerie] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Trussell, J. C.] SUNY Upstate Med Univ, Syracuse, NY USA; [Eisenberg, Esther] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Fertil & Infertil Branch, Rockville, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; University of Texas Health San Antonio; University System of Georgia; Augusta University; Wayne State University; University of Pennsylvania; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Vermont; University of Michigan System; University of Michigan; Yale University; University of Virginia; University of Alabama System; University of Alabama Birmingham; Carolinas Medical Center; Virginia Commonwealth University; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Legro, RS (corresponding author), Penn State Coll Med, MS Hershey Med Ctr, Dept Obstet & Gynecol, 500 Univ Dr,H103, Hershey, PA 17033 USA.	rsl1@psu.edu	Huang, Huang/AAN-5671-2020; krawetz, stephen/GQQ-3308-2022	Diamond, Michael/0000-0001-6353-4489; Legro, Richard/0000-0001-9927-7584	NICHD [U10 HD27049, U10 HD38992, U10HD055925, U10 HD39005, U10 HD38998, U10 HD055936, U10 HD055942, U10 HD055944, U54-HD29834]; National Center for Research Resources; National Center for Advancing Translational Sciences through an NIH [UL1 TR000127]; Ferring Pharmaceuticals; AstraZeneca; Euroscreen; EMD Serono; Bayer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027049, U10HD055936, U10HD039005, U10HD038998, U10HD055925, U10HD055942, U10HD055944, U10HD038992, P50HD028934] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences through an NIH; Ferring Pharmaceuticals(Ferring Pharmaceuticals); AstraZeneca(AstraZeneca); Euroscreen; EMD Serono; Bayer(Bayer AG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants from the NICHD (U10 HD27049, to Dr. Coutifaris; U10 HD38992, to Dr. Legro; U10HD055925, to Dr. Zhang; U10 HD39005, to Dr. Diamond; U10 HD38998, to Dr. Schlaff; U10 HD055936, to Dr. Christman; U10 HD055942, to Dr. Brzyski; and U10 HD055944, to Dr. Casson; and U54-HD29834, to the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core of the Specialized Cooperative Centers Program in Reproduction and Infertility Research); and by the National Center for Research Resources and the National Center for Advancing Translational Sciences through an NIH grant (UL1 TR000127) to Pennsylvania State University.; Dr. Legro reports receiving consulting fees from Ferring Pharmaceuticals, AstraZeneca, and Euroscreen. Dr. Diamond reports receiving consulting fees from EMD Serono and serving on the board of directors of and owning stock in Advanced Reproductive Care. Dr. Santoro reports receiving grant support from Bayer and holding stock options in MenoGeniX. No other potential conflict of interest relevant to this article was reported.	Anderson K, 2010, COCHRANE DB SYST REV, V4; Azim AA, 2007, J CLIN ENDOCR METAB, V92, P2197, DOI 10.1210/jc.2007-0247; Azziz R, 2001, J CLIN ENDOCR METAB, V86, P1626, DOI 10.1210/jc.86.4.1626; Casper RF, 2006, J CLIN ENDOCR METAB, V91, P760, DOI 10.1210/jc.2005-1923; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Diamond MP, 2012, OBSTET GYNECOL, V119, P902, DOI 10.1097/AOG.0b013e31824da35c; Geisler J, 2011, BRIT J CANCER, V104, P1059, DOI 10.1038/bjc.2011.58; Kamphuis EI, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g252; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 2014, FERTIL STERIL, V101, P258, DOI 10.1016/j.fertnstert.2013.08.056; Legro RS, 2012, CONTEMP CLIN TRIALS, V33, P470, DOI 10.1016/j.cct.2011.12.005; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5305, DOI 10.1210/jc.2010-1123; Malloch L, 2013, FERTIL STERIL, V100, P1740, DOI 10.1016/j.fertnstert.2013.08.040; Misso ML, 2012, HUM REPROD UPDATE, V18, P301, DOI 10.1093/humupd/dms003; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Morin-Papunen L, 2012, J CLIN ENDOCR METAB, V97, P1492, DOI 10.1210/jc.2011-3061; Rausch ME, 2009, J CLIN ENDOCR METAB, V94, P3458, DOI 10.1210/jc.2009-0545; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Tarlatzis BC, 2008, FERTIL STERIL, V89, P505, DOI 10.1016/j.fertnstert.2007.09.041; Tredway D, 2011, FERTIL STERIL, V95, P1725, DOI 10.1016/j.fertnstert.2010.11.068; Tredway D, 2011, FERTIL STERIL, V95, P1720, DOI 10.1016/j.fertnstert.2010.12.064; Zain MM, 2009, FERTIL STERIL, V91, P514, DOI 10.1016/j.fertnstert.2007.12.002	24	306	336	4	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					119	129		10.1056/NEJMoa1313517	http://dx.doi.org/10.1056/NEJMoa1313517			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006718	Green Published, Green Accepted			2022-12-28	WOS:000338645500008
J	Mitchinson, A				Mitchinson, Andrew			CLIMATE SCIENCE City heat	NATURE			English	Editorial Material																		Zhao L, 2014, NATURE, V511, P216, DOI 10.1038/nature13462	1	0	0	1	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					163	163		10.1038/511163a	http://dx.doi.org/10.1038/511163a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SP	25008518				2022-12-28	WOS:000349549100021
J	Kumar, B; Swee, M				Kumar, Bharat; Swee, Melissa			Aldosterone-Renin Ratio in the Assessment of Primary Aldosteronism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kumar, Bharat] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; [Swee, Melissa] Univ Nebraska, Dept Internal Med, Omaha, NE 68182 USA	University of Kentucky; University of Nebraska System	Kumar, B (corresponding author), Univ Kentucky, Dept Internal Med, Charles T Wethington Bldg,Room 306, Lexington, KY 40536 USA.	bharat.kumar@uky.edu	Swee, Melissa/AAV-2489-2021; Swee, Melissa/AAC-7410-2021	Swee, Melissa/0000-0002-1591-0862; Kumar, Bharat/0000-0002-4245-521X				Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Montori VM, 2002, ENDOCRIN METAB CLIN, V31, P619, DOI 10.1016/S0889-8529(02)00013-0; Tomaschitz A, 2010, HORM METAB RES, V42, P382, DOI 10.1055/s-0030-1248326; Young WF, 2007, CLIN ENDOCRINOL, V66, P607, DOI 10.1111/j.1365-2265.2007.02775.x	4	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					184	185		10.1001/jama.2014.64	http://dx.doi.org/10.1001/jama.2014.64			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005657				2022-12-28	WOS:000338511200026
J	Chinthapalli, K				Chinthapalli, Krishna			ALZHEIMER'S DISEASE Alzheimer's disease: still a perplexing problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TASK-FORCE; FOLLOW-UP; DEMENTIA; THERAPY; BETA; ASSOCIATION; DIAGNOSIS; MUTATION; TRIALS; TAU		Royal Surrey Cty Hosp, Guildford, Surrey, England	Royal Surrey County Hospital	Chinthapalli, K (corresponding author), Royal Surrey Cty Hosp, Guildford, Surrey, England.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Aisen PS, 2011, ARCH MED SCI, V7, P102, DOI 10.5114/aoms.2011.20612; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Booth P, 2008, STANDPOINT       NOV; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Cameron D., 2014, GIRL SUMMIT SPEECH; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; DEAKIN JFW, 1983, BRIT MED J, V287, P1323, DOI 10.1136/bmj.287.6402.1323; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Ferrer I, 2012, PROG NEUROBIOL, V97, P38, DOI 10.1016/j.pneurobio.2012.03.005; Fineberg NA, 2013, J PSYCHOPHARMACOL, V27, P761, DOI 10.1177/0269881113495118; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; HARRISON PJ, 1986, J ROY SOC MED, V79, P347, DOI 10.1177/014107688607900612; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7529; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Muller U, 2013, LANCET NEUROL, V12, P129, DOI 10.1016/S1474-4422(12)70307-1; Nygaard HB, 2013, CLIN THER, V35, P1480, DOI 10.1016/j.clinthera.2013.09.009; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Strassnig Martin, 2005, Psychiatry (Edgmont), V2, P30; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; Welge V, 2009, J NEURAL TRANSM, V116, P203, DOI 10.1007/s00702-008-0177-6; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0; Wischik CM, 2014, BIOCHEM PHARMACOL, V88, P529, DOI 10.1016/j.bcp.2013.12.008; Zetterberg H, 2014, EXPERT REV NEUROTHER, V14, P621, DOI 10.1586/14737175.2014.915740	48	2	4	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4433	10.1136/bmj.g4433	http://dx.doi.org/10.1136/bmj.g4433			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005430				2022-12-28	WOS:000338993300008
J	Sheikh, A; Jha, A; Cresswell, K; Greaves, F; Bates, DW				Sheikh, Aziz; Jha, Ashish; Cresswell, Kathrin; Greaves, Felix; Bates, David W.			Adoption of electronic health records in UK hospitals: lessons from the USA	LANCET			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, eHlth Res Grp, Edinburgh EH8 9AG, Midlothian, Scotland; [Sheikh, Aziz; Bates, David W.] Harvard Univ, Sch Med, Boston, MA USA; [Jha, Ashish; Greaves, Felix; Bates, David W.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Cresswell, Kathrin] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Sheikh, Aziz; Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Edinburgh; Harvard University; Brigham & Women's Hospital	Sheikh, A (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, eHlth Res Grp, Edinburgh EH8 9AG, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Greaves, Felix/AAL-5891-2021; Bates, David/AAE-7283-2019; Greaves, Felix/A-1324-2012	Sheikh, Aziz/0000-0001-7022-3056; Greaves, Felix/0000-0001-9393-3122; Greaves, Felix/0000-0001-9393-3122	National Institute for Health Research [ACF-2009-21-030] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2011, LANCET, V378, P542; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Blumenthal D, 2012, LANCET, V380, P1352, DOI 10.1016/S0140-6736(12)60956-8; Blumenthal D, 2011, NEW ENGL J MED, V365, P2323, DOI 10.1056/NEJMsr1110507; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Department of Health, 2002, DEL 21 CENT IT SUPP; DesRoches CM, 2013, HEALTH AFFAIR, V32, P1478, DOI 10.1377/hlthaff.2013.0308; Sheikh A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6054; The White House, 2004, TRANSF HLTH CARE; US Department of Health and Human Services, 2014, US UK WORK STRENTH U	10	33	33	2	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					8	9		10.1016/S0140-6736(14)61099-0	http://dx.doi.org/10.1016/S0140-6736(14)61099-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24998803				2022-12-28	WOS:000338919600007
J	Azzolin, L; Panciera, T; Soligo, S; Enzo, E; Bicciato, S; Dupont, S; Bresolin, S; Frasson, C; Basso, G; Guzzardo, V; Fassina, A; Cordenonsi, M; Piccolo, S				Azzolin, Luca; Panciera, Tito; Soligo, Sandra; Enzo, Elena; Bicciato, Silvio; Dupont, Sirio; Bresolin, Silvia; Frasson, Chiara; Basso, Giuseppe; Guzzardo, Vincenza; Fassina, Ambrogio; Cordenonsi, Michelangelo; Piccolo, Stefano			YAP/TAZ Incorporation in the beta-Catenin Destruction Complex Orchestrates the Wnt Response	CELL			English	Article							CELL SELF-RENEWAL; HIPPO SIGNALING PATHWAY; INTESTINAL REGENERATION; DIFFERENTIATION; INHIBITION; TAZ; TUMORIGENESIS; DISEASE; KINASE; GROWTH	The Hippo transducers YAP/TAZ have been shown to play positive, as well as negative, roles in Wnt signaling, but the underlying mechanisms remain unclear. Here, we provide biochemical, functional, and genetic evidence that YAP and TAZ are integral components of the beta-catenin destruction complex that serves as cytoplasmic sink for YAP/TAZ. In Wnt-ON cells, YAP/TAZ are physically dislodged from the destruction complex, allowing their nuclear accumulation and activation of Wnt/YAP/TAZ-dependent biological effects. YAP/TAZ are required for intestinal crypt overgrowth induced by APC deficiency and for crypt regeneration ex vivo. In Wnt-OFF cells, YAP/TAZ are essential for beta-TrCP recruitment to the complex and b-catenin inactivation. In Wnt-ON cells, release of YAP/TAZ from the complex is instrumental for Wnt/beta-catenin signaling. In line, the beta-catenin-dependent maintenance of ES cells in an undifferentiated state is sustained by loss of YAP/TAZ. This work reveals an unprecedented signaling framework relevant for organ size control, regeneration, and tumor suppression.	[Azzolin, Luca; Panciera, Tito; Soligo, Sandra; Enzo, Elena; Dupont, Sirio; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Mol Med, I-35126 Padua, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Ctr Genome Res, Dept Biomed Sci, I-41100 Modena, Italy; [Bresolin, Silvia; Frasson, Chiara; Basso, Giuseppe] Univ Padua, Dept Paediat, I-35128 Padua, Italy; [Guzzardo, Vincenza; Fassina, Ambrogio] Univ Padua, Sch Med, Dept Med, I-35126 Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua; University of Padua	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Mol Med, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Bicciato, Silvio/C-9825-2009; Cordenonsi, Michelangelo/K-7692-2016; Azzolin, Luca/K-8012-2016; BICCIATO, Silvio/J-4466-2019; Bresolin, Silvia/K-6576-2016; Dupont, Sirio/AAP-8133-2021	Bicciato, Silvio/0000-0002-1944-7078; Cordenonsi, Michelangelo/0000-0002-8253-5724; Azzolin, Luca/0000-0002-2425-6153; BICCIATO, Silvio/0000-0002-1944-7078; Bresolin, Silvia/0000-0001-7677-7084; PICCOLO, STEFANO/0000-0002-2037-0004; Dupont, Sirio/0000-0002-6869-1966; Enzo, Elena/0000-0001-9768-6368; BASSO, GIUSEPPE/0000-0002-2634-9302; Panciera, Tito/0000-0002-9272-5716	"Young Italian Researchers'' grant from the Italian Welfare Ministry; AIRC-MFAG; Fondazione Citta della Speranza Grant; AIRC Special Program Molecular Clinical Oncology "5 per mille''; Epigenetics Flagship project CNR-Miur; HSFP; Excellence-IIT	"Young Italian Researchers'' grant from the Italian Welfare Ministry; AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza Grant; AIRC Special Program Molecular Clinical Oncology "5 per mille''(Fondazione AIRC per la ricerca sul cancro); Epigenetics Flagship project CNR-Miur; HSFP; Excellence-IIT	We thank O. Wessely and Francesca Zanconato for comments; E. Batlle for training with crypt cultures; G. Martello and A. Smith for reagents and suggestions with ES experiments. We are indebted to the following colleagues for generously sharing transgenic mice: A. Clarke (APC fl/fl), D. J. Pan (YAP fl/fl), J. Miyazaki (CAG-Cre), and Sylvie Robine (Villin-CreERT2). We thank Lorenza Ronzani and the transgenic core facility (CFCM-San Raffaele) for TAZ conditional knockout. Axin plasmid was deposited by F. Costantini in Addgene. This work is supported by a "Young Italian Researchers'' grant from the Italian Welfare Ministry and AIRC-MFAG to M. C.; from Fondazione Citta della Speranza Grant to G. B.; from AIRC Special Program Molecular Clinical Oncology "5 per mille'' to S. P. and S. B.; from a donation in memoriam of Liana Simonutti; and from HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S. P.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Buske P, 2012, FEBS J, V279, P3475, DOI 10.1111/j.1742-4658.2012.08646.x; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cordero JB, 2012, ACTA PHYSIOL, V204, P137, DOI 10.1111/j.1748-1716.2011.02288.x; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Roman AKS, 2014, STEM CELL REP, V2, P127, DOI 10.1016/j.stemcr.2013.12.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	686	709	5	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					157	170		10.1016/j.cell.2014.06.013	http://dx.doi.org/10.1016/j.cell.2014.06.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24976009	Bronze			2022-12-28	WOS:000340943100015
J	Derex, M; Beugin, MP; Godelle, B; Raymond, M				Derex, Maxime; Beugin, Marie-Pauline; Godelle, Bernard; Raymond, Michel			Group size and cultural complexity Reply	NATURE			English	Letter							DEMOGRAPHY		[Derex, Maxime; Beugin, Marie-Pauline; Godelle, Bernard; Raymond, Michel] Univ Montpellier 2, F-34095 Montpellier 5, France; [Raymond, Michel] CNRS, Inst Evolutionary Sci, CC 065, F-34095 Montpellier, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Derex, M (corresponding author), Univ Montpellier 2, Pl Eugene Bataillon, F-34095 Montpellier 5, France.	maxime.derex@gmail.com		Derex, Maxime/0000-0002-1512-6496; Raymond, Michel/0000-0002-1714-6984				Andersson C, 2014, NATURE, V511, pE1, DOI 10.1038/nature13411; Derex M, 2013, NATURE, V503, P389, DOI 10.1038/nature12774; Fisher R. A., 1946, Statistical methods for research workers.; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Kempe M., EVOL HUM BE IN PRESS; Mesoudi A., 2011, CULTURAL EVOLUTION D; Mesoudi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018239; Muthukrishna M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2511; Richerson P. J, 2005, NOT GENES ALONE; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014	10	1	1	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					E2	E2		10.1038/nature13412	http://dx.doi.org/10.1038/nature13412			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990756				2022-12-28	WOS:000338199400002
J	Thiagarajan, N; Subhas, AV; Southon, JR; Eiler, JM; Adkins, JF				Thiagarajan, Nivedita; Subhas, Adam V.; Southon, John R.; Eiler, John M.; Adkins, Jess F.			Abrupt pre-Bolling-Allerod warming and circulation changes in the deep ocean	NATURE			English	Article							ATLANTIC THERMOHALINE CIRCULATION; WESTERN NORTH-ATLANTIC; OVERTURNING CIRCULATION; SURFACE TEMPERATURES; LAST DEGLACIATION; SOUTHERN-OCEAN; YOUNGER DRYAS; RAPID CHANGES; SEA CORALS; HULU CAVE	Several large and rapid changes in atmospheric temperature and the partial pressure of carbon dioxide in the atmosphere(1)-probably linked to changes in deep ocean circulation(2)-occurred during the last deglaciation. The abrupt temperature rise in the Northern Hemisphere and the restart of the Atlantic meridional overturning circulation at the start of the Bolling-Allerod interstadial, 14,700 years ago, are among the most dramatic deglacial events(3), but their underlying physical causes are not known. Here we show that the release of heat from warm waters in the deep North Atlantic Ocean probably triggered the Bolling-Allerod warming and reinvigoration of the Atlantic meridional overturning circulation. Our results are based on coupled radiocarbon and uranium-series dates, along with clumped isotope temperature estimates, from water column profiles of fossil deep-sea corals in a limited area of the western North Atlantic. We find that during Heinrich stadial 1 (the cool period immediately before the Bolling-Allerod interstadial), the deep ocean was about three degrees Celsius warmer than shallower waters above. This reversal of the ocean's usual thermal stratification pre-dates the Bolling-Allerod warming and must have been associated with increased salinity at depth to preserve the static stability of the water column. The depleted radiocarbon content of the warm and salty water mass implies a long-term disconnect from rapid surface exchanges, and, although uncertainties remain, is most consistent with a Southern Ocean source. The Heinrich stadial 1 ocean profile is distinct from the modern water column, that for the Last Glacial Maximum and that for the Younger Dryas, suggesting that the patterns we observe are a unique feature of the deglacial climate system. Our observations indicate that the deep ocean influenced dramatic Northern Hemisphere warming by storing heat at depth that preconditioned the system for a subsequent abrupt overturning event during the Bolling-Allerod interstadial.	[Thiagarajan, Nivedita; Subhas, Adam V.; Eiler, John M.; Adkins, Jess F.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Southon, John R.] Univ Calif Irvine, Earth Syst Sci Dept, Irvine, CA 92697 USA	California Institute of Technology; University of California System; University of California Irvine	Thiagarajan, N (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	nivedita@gps.caltech.edu	Adkins, Jess/GYI-8778-2022	Subhas, Adam/0000-0002-7688-6624				Adkins JF, 2013, PALEOCEANOGRAPHY, V28, P539, DOI 10.1002/palo.20046; Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; Adkins JF, 2005, QUATERNARY SCI REV, V24, P581, DOI 10.1016/j.quascirev.2004.11.005; Adkins JF, 2002, RADIOCARBON, V44, P567, DOI 10.1017/S0033822200031921; Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Akitomo K, 1999, J GEOPHYS RES-OCEANS, V104, P5225, DOI 10.1029/1998JC900058; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Barker S, 2010, NAT GEOSCI, V3, P567, DOI [10.1038/ngeo921, 10.1038/NGEO921]; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Came RE, 2007, NATURE, V449, P198, DOI 10.1038/nature06085; Came RE, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001450; Cheng H, 2000, GEOCHIM COSMOCHIM AC, V64, P2401, DOI 10.1016/S0016-7037(99)00422-6; Chiessi CM, 2008, GEOLOGY, V36, P919, DOI 10.1130/G24979A.1; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Cleroux C, 2011, QUATERNARY SCI REV, V30, P1875, DOI 10.1016/j.quascirev.2011.04.015; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; De Pol-Holz R, 2010, NAT GEOSCI, V3, P192, DOI 10.1038/NGEO745; Denbo DW, 1996, J GEOPHYS RES-OCEANS, V101, P1095, DOI 10.1029/95JC02828; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Dokken TM, 1999, NATURE, V401, P458, DOI 10.1038/46753; Dwyer G. S., 2000, GEOCHEM GEOPHY GEOSY, V1, P1028, DOI [DOI 10.1029/2000GC000046, 10.1029/2000GC000046]; Eltgroth SF, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001192; Emile-Geay J, 2009, OCEAN SCI, V5, P203, DOI 10.5194/os-5-203-2009; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Gherardi JM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001696; Gherardi JM, 2005, EARTH PLANET SC LETT, V240, P710, DOI 10.1016/j.epsl.2005.09.061; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Huntington KW, 2009, J MASS SPECTROM, V44, P1318, DOI 10.1002/jms.1614; Keigwin LD, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001029; Kiefer T, 2005, QUATERNARY SCI REV, V24, P1063, DOI 10.1016/j.quascirev.2004.02.021; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Kwon EY, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002211; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Lund DC, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001938; Marchal O, 2008, J PHYS OCEANOGR, V38, P2014, DOI 10.1175/2008JPO3895.1; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; McCulloch M, 2010, EARTH PLANET SC LETT, V298, P143, DOI 10.1016/j.epsl.2010.07.036; MCDOUGALL TJ, 1987, J GEOPHYS RES-OCEANS, V92, P5448, DOI 10.1029/JC092iC05p05448; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Oppo D. W., 2012, NATURE ED KNOWL, V3, P1; Pahnke K, 2008, NAT GEOSCI, V1, P870, DOI 10.1038/ngeo360; Passey BH, 2010, P NATL ACAD SCI USA, V107, P11245, DOI 10.1073/pnas.1001824107; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rasmussen TL, 1996, GEOLOGY, V24, P937, DOI 10.1130/0091-7613(1996)024<0937:CCITFS>2.3.CO;2; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Rickaby REM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000858; Robinson LF, 2007, B MAR SCI, V81, P371; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Rogerson M, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002931; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Saenko OA, 2003, J CLIMATE, V16, P2797, DOI 10.1175/1520-0442(2003)016<2797:OTLBTT>2.0.CO;2; Shaffer G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020968; Siani G, 2001, SCIENCE, V294, P1917, DOI 10.1126/science.1063649; Skinner LC, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001338; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Tessin AC, 2013, PALEOCEANOGRAPHY, V28, P296, DOI 10.1002/palo.20026; Thiagarajan N, 2013, PALEOCEANOGRAPHY, V28, P227, DOI 10.1002/palo.20023; Thiagarajan N, 2011, GEOCHIM COSMOCHIM AC, V75, P4416, DOI 10.1016/j.gca.2011.05.004; Thornalley DJR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001833; Tripati A, 2008, GEOCHIM COSMOCHIM AC, V72, pA956; Waelbroeck C, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002007; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Xie RFC, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002337	71	74	76	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					75	U409		10.1038/nature13472	http://dx.doi.org/10.1038/nature13472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990748				2022-12-28	WOS:000338199400038
J	Walters, S; Valliani, T; Przemioslo, R; Rooney, N				Walters, Sarah; Valliani, Talal; Przemioslo, Robert; Rooney, Nicholas			Whipple's disease: an unexpected finding in a peripheral lymph node biopsy	LANCET			English	Editorial Material									[Walters, Sarah; Valliani, Talal; Przemioslo, Robert] Frenchay Hosp, Dept Gastroenterol & Hepatol, Bristol BS16 1LE, South Glouceste, England; [Rooney, Nicholas] Southmead Hosp, Dept Pathol, Bristol, Avon, England	Southmead Hospital	Przemioslo, R (corresponding author), Frenchay Hosp, Frenchay Pk Rd, Bristol BS16 1LE, South Glouceste, England.	robert.przemioslo@nbt.nhs.uk						Alkan S, 2001, AM J CLIN PATHOL, V116, P898; Conly J M, 2001, Can J Infect Dis, V12, P133; Dobbins 3rd WO, 1987, WHIPPLES DIS; Durand DV, 1997, MEDICINE, V76, P170, DOI 10.1097/00005792-199705000-00003; Marin M, 2007, J CLIN MICROBIOL, V45, P2078, DOI 10.1128/JCM.00096-07	5	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2268	2268		10.1016/S0140-6736(14)61043-6	http://dx.doi.org/10.1016/S0140-6736(14)61043-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24976328				2022-12-28	WOS:000338657600032
J	Leadlay, PF				Leadlay, Peter F.			STRUCTURAL BIOLOGY Enzyme assembly line pictured	NATURE			English	Editorial Material							FATTY-ACID SYNTHASE; POLYKETIDE SYNTHASE; MODULE		Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Leadlay, PF (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	leadlay@mole.bio.cam.ac.uk		Leadlay, Peter/0000-0002-3247-509X				Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Dutta S, 2014, NATURE, V510, P512, DOI 10.1038/nature13423; Edwards AL, 2014, J MOL BIOL, V426, P2229, DOI 10.1016/j.jmb.2014.03.015; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Whicher JR, 2014, NATURE, V510, P560, DOI 10.1038/nature13409	9	4	4	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					482	483		10.1038/nature13505	http://dx.doi.org/10.1038/nature13505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965648				2022-12-28	WOS:000337806300036
J	Rosi, G; Sorrentino, F; Cacciapuoti, L; Prevedelli, M; Tino, GM				Rosi, G.; Sorrentino, F.; Cacciapuoti, L.; Prevedelli, M.; Tino, G. M.			Precision measurement of the Newtonian gravitational constant using cold atoms	NATURE			English	Article							TORSION BALANCE; INTERFEROMETRY; GRAVITY; ACCELERATION	About 300 experiments have tried to determine the value of the Newtonian gravitational constant, G, so far, but large discrepancies in the results have made it impossible to know its value precisely'. The weakness of the gravitational interaction and the impossibility of shielding the effects of gravity make it very difficult to measure G while keeping systematic effects under control. Most previous experiments performed were based on the torsion pendulum or torsion balance scheme as in the experiment by Cavendish(2) in 1798, and in all cases macroscopic masses were used. Here we report the precise determination of G using laser-cooled atoms and quantum interferometry. We obtain the value G = 6.67191(99) X 10(-11) m(3) kg(-1) s(-2) with a relative uncertainty of 150 parts per million (the combined standard uncertainty is given in parentheses). Our value differs by 1.5 combined standard deviations from the current recommended value of the Committee on Data for Science and Technology(3). A conceptually different experiment such as ours helps to identify the systematic errors that have proved elusive in previous experiments, thus improving the confidence in the value of G. There is no definitive relationship between G and the other fundamental constants, and there is no theoretical prediction for its value, against which to test experimental results. Improving the precision with which we know G has not only a pure metrological interest, but is also important because of the key role that G has in theories of gravitation, cosmology, particle physics and astrophysics and in geophysical models.	[Rosi, G.; Sorrentino, F.; Tino, G. M.] Univ Florence, INFN Sez Firenze, Dipartimento Fis Astron, I-50019 Sesto Fiorentino, Italy; [Rosi, G.; Sorrentino, F.; Tino, G. M.] Univ Florence, INFN Sez Firenze, LENS, I-50019 Sesto Fiorentino, Italy; [Cacciapuoti, L.] European Space Agcy, NL-2200 AG Noordwijk, Netherlands; [Prevedelli, M.] Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy	Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; European Space Agency; University of Bologna	Tino, GM (corresponding author), Univ Florence, INFN Sez Firenze, Dipartimento Fis Astron, Via Sansone 1, I-50019 Sesto Fiorentino, Italy.	guglielmo.tino@fi.infn.it	Prevedelli, Marco/ABG-2216-2021; Sorrentino, Fiodor/X-8942-2019; Sorrentino, Fiodor/M-6662-2016	Prevedelli, Marco/0000-0002-3136-2392; Sorrentino, Fiodor/0000-0002-9605-9829; Sorrentino, Fiodor/0000-0002-9605-9829; Tino, Guglielmo M./0000-0002-7944-9825; Cacciapuoti, Luigi/0000-0002-5628-8766	INFN (MAGIA experiment)	INFN (MAGIA experiment)	G.M.T. acknowledges discussions with M. A. Kasevich and J. Faller and useful suggestions by A. Peters in the initial phase of the experiment. We are grateful to A. Cecchetti and B. Dulach for the design of the source mass support and to A. Peuto, A. Malengo, and S. Pettorruso for density tests on the tungsten masses. We thank D. Wiersma for a critical reading of the manuscript. This work was supported by INFN (MAGIA experiment).	Amelino-Camelia G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.171302; Antoine C, 2003, PHYS LETT A, V306, P277, DOI 10.1016/S0375-9601(02)01625-0; Armstrong TR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.201101; Bagley CH, 1997, PHYS REV LETT, V78, P3047, DOI 10.1103/PhysRevLett.78.3047; Bertoldi A, 2006, EUR PHYS J D, V40, P271, DOI 10.1140/epjd/e2006-00212-2; Cavendish H., 1798, PHILOS T ROYAL SOC L, V88, P469, DOI [DOI 10.1098/RSTL.1798.0022, 10.1098/RSTL.1798]; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; de Angelis M, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/2/022001; Dimopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.111102; Ferrari G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.060402; Fixler JB, 2007, SCIENCE, V315, P74, DOI 10.1126/science.1135459; Foster GT, 2002, OPT LETT, V27, P951, DOI 10.1364/OL.27.000951; Gundlach JH, 2000, PHYS REV LETT, V85, P2869, DOI 10.1103/PhysRevLett.85.2869; Gustavson TL, 2000, CLASSICAL QUANT GRAV, V17, P2385, DOI 10.1088/0264-9381/17/12/311; Hu ZK, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.127505; Johnson DMS., 2009, P INT SCH PHYS ENR F, P411; Karagioz OV, 1996, MEAS TECH+, V39, P979, DOI 10.1007/BF02377461; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; Kasevich M. A., 2014, ATOM INTERFEROMETRY; Kleinevoss U., 2002, THESIS U WUPPERTAL; Lamporesi G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050801; Lamporesi G, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2751090; Lan SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.090402; Louchet-Chauvet A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065025; Luo J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.240801; LUTHER GG, 1982, PHYS REV LETT, V48, P121, DOI 10.1103/PhysRevLett.48.121; McGuirk JM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033608; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Parks HV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.110801; Peters A, 1999, NATURE, V400, P849, DOI 10.1038/23655; Poli N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038501; Quinn T, 2000, NATURE, V408, P919, DOI 10.1038/35050187; Quinn T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.101102; Quinn TJ, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.111101; Schlamminger S, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.082001; Sorrentino F, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023607; Sorrentino F, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/095009; Sorrentino F, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013409; Stellmer S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263003; STOREY P, 1994, J PHYS II, V4, P1999, DOI 10.1051/jp2:1994103; Tino GM, 2013, NUCL PHYS B-PROC SUP, V243, P203, DOI 10.1016/j.nuclphysbps.2013.09.023; Tino GM, 2011, GEN RELAT GRAVIT, V43, P1901, DOI 10.1007/s10714-011-1196-4; Tu LC, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.022001	43	367	378	5	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					518	+		10.1038/nature13433	http://dx.doi.org/10.1038/nature13433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965653	Green Submitted			2022-12-28	WOS:000337806300042
J	Yang, F; Wang, X; Zhang, DQ; Yang, J; Luo, D; Xu, ZW; Wei, JK; Wang, JQ; Xu, Z; Peng, F; Li, XM; Li, RM; Li, YL; Li, MH; Bai, XD; Ding, F; Li, Y				Yang, Feng; Wang, Xiao; Zhang, Daqi; Yang, Juan; Luo, Da; Xu, Ziwei; Wei, Jiake; Wang, Jian-Qiang; Xu, Zhi; Peng, Fei; Li, Xuemei; Li, Ruoming; Li, Yilun; Li, Meihui; Bai, Xuedong; Ding, Feng; Li, Yan			Chirality-specific growth of single-walled carbon nanotubes on solid alloy catalysts	NATURE			English	Article							MOLECULAR NANOCLUSTERS; SELECTIVE GROWTH; NANOPARTICLES; DIAMETER; DYNAMICS; ANGLE	Carbon nanotubes have many material properties that make them attractive for applications(1,2). In the context of nanoelectronics(3), interest has focused on single-walled carbon nanotubes(4) (SWNTs) because slight changes in tube diameter and wrapping angle, defined by the chirality indices (n,m), will shift their electrical conductivity from one characteristic of a metallic state to one characteristic of a semiconducting state, and will also change the bandgap. However, this structure-function relationship can be fully exploited only with structurally pure SWNTs. Solution-based separation methods(5) yield tubes within a narrow structure range, but the ultimate goal of producing just one type of SWNT by controlling its structure during growth has proved to be a considerable challenge over the last two decades(6-9). Such efforts aim to optimize the composition(6,10-17) or shape(18-21) of the catalyst particles that are used in the chemical vapour deposition synthesis process to decompose the carbon feedstock and influence SWNT nucleation and growth(22-25). This approach resulted in the highest reported proportion, 55 per cent, of single-chirality SWNTs in an as-grown sample(11). Here we show that SWNTs of a single chirality, (12, 6), can be produced directly with an abundance higher than 92 per cent when using tungsten-based bimetallic alloy nanocrystals as catalysts. These, unlike other catalysts used so far, have such high melting points that they maintain their crystalline structure during the chemical vapour deposition process. This feature seems crucial because experiment and simulation both suggest that the highly selective growth of (12, 6) SWNTs is the result of a good structural match between the carbon atom arrangement around the nanotube circumference and the arrangement of the catalytically active atoms in one of the planes of the nanocrystal catalyst. We anticipate that using high-melting-point alloy nanocrystals with optimized structures as catalysts paves the way for total chirality control in SWNT growth and will thus promote the development of SWNT applications.	[Yang, Feng; Wang, Xiao; Zhang, Daqi; Yang, Juan; Luo, Da; Peng, Fei; Li, Ruoming; Li, Yilun; Li, Meihui; Li, Yan] Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Phys & Chem Nanodevices, State Key Lab Rare Earth Mat Chem & Applicat,Coll, Beijing 100871, Peoples R China; [Xu, Ziwei; Ding, Feng] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China; [Wei, Jiake; Xu, Zhi; Bai, Xuedong] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Wang, Jian-Qiang] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai 201204, Peoples R China; [Li, Xuemei] Peking Univ, Electron Microscopy Lab, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Hong Kong Polytechnic University; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Peking University	Li, Y (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Phys & Chem Nanodevices, State Key Lab Rare Earth Mat Chem & Applicat,Coll, Beijing 100871, Peoples R China.	yanli@pku.edu.cn	DING, FENG/D-5938-2011; Yang, Feng/O-4424-2019; Yang, Feng/K-4358-2014; Luo, Da/ABW-0504-2022; Li, Yan/D-5497-2009; Wei, Jiake/ABH-9015-2020; Luo, Da/AFX-4147-2022; Yang, Juan/F-5220-2010; Wang, Xiao/AAL-8698-2020; Yang, Feng/GRT-0056-2022; Wang, Jian-Qiang/P-5345-2014; Li, Yilun/I-5873-2019; Xu, Zhi/B-8078-2014	DING, FENG/0000-0001-9153-9279; Yang, Feng/0000-0002-3637-814X; Luo, Da/0000-0002-9128-6782; Li, Yan/0000-0002-3828-8340; Luo, Da/0000-0002-9128-6782; Yang, Juan/0000-0001-5502-9351; Wang, Xiao/0000-0002-4251-9412; Yang, Feng/0000-0002-3637-814X; Wang, Jian-Qiang/0000-0003-4123-7592; Li, Yilun/0000-0002-0750-2228; Xu, Zhi/0000-0002-0761-4764	MoST [2011CB933003]; NSFC of China [21125103, 91333105, 21321001, 11179011, 21273189]; Hong Kong GRF research grant [G-YX4Q]	MoST; NSFC of China(National Natural Science Foundation of China (NSFC)); Hong Kong GRF research grant	We thank S. Iijima, S. Maruyama and J. Liu for advice on the manuscript; K. Lu, Y. Wang, E. Wang and S. Yao for discussions on catalyst preparation and properties; D. P. Nackashi, J. Ju, Y. Li and Protochips Inc. for in situ TEM measurements; H. Xu, H. Yang, K. Jiang and S. Wang for Raman measurements. This research was financially supported by MoST (project 2011CB933003), the NSFC of China (projects 21125103,91333105, 21321001, 11179011 and 21273189) and a Hong Kong GRF research grant (G-YX4Q).	An L, 2002, J AM CHEM SOC, V124, P13688, DOI 10.1021/ja0274958; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Chen YB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3205; Chiang WH, 2009, NAT MATER, V8, P882, DOI [10.1038/nmat2531, 10.1038/NMAT2531]; Chu HB, 2009, J AM CHEM SOC, V131, P14310, DOI 10.1021/ja9035972; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Ding F, 2009, P NATL ACAD SCI USA, V106, P2506, DOI 10.1073/pnas.0811946106; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Harutyunyan AR, 2009, SCIENCE, V326, P116, DOI 10.1126/science.1177599; He MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01460; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Hofmann S, 2007, NANO LETT, V7, P602, DOI 10.1021/nl0624824; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Koziol KKK, 2010, CHEM MATER, V22, P4904, DOI 10.1021/cm100916m; Li XL, 2007, J AM CHEM SOC, V129, P15770, DOI 10.1021/ja077886s; Li Y, 2010, ADV MATER, V22, P1508, DOI 10.1002/adma.200904366; Liu BL, 2012, CHEM COMMUN, V48, P2409, DOI 10.1039/c2cc16491d; Liu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2205; Lolli G, 2006, J PHYS CHEM B, V110, P2108, DOI 10.1021/jp056095e; Naumov AV, 2009, NANO LETT, V9, P3203, DOI 10.1021/nl9014342; Peng F, 2013, CHINESE SCI BULL, V58, P433, DOI 10.1007/s11434-012-5588-y; Raty JY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.096103; Reich S, 2006, CHEM PHYS LETT, V421, P469, DOI 10.1016/j.cplett.2006.01.110; Shibuta Y, 2003, CHEM PHYS LETT, V382, P381, DOI 10.1016/j.cplett.2003.10.080; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Wang H, 2013, ACS NANO, V7, P614, DOI 10.1021/nn3047633; Yao S, 2010, DALTON T, V39, P3884, DOI 10.1039/b921261b; Zhou WW, 2006, NANO LETT, V6, P2987, DOI 10.1021/nl061871v	30	563	586	46	1060	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					522	+		10.1038/nature13434	http://dx.doi.org/10.1038/nature13434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965654				2022-12-28	WOS:000337806300043
J	Ben-Johny, M; Yang, PS; Niu, J; Yang, WJ; Joshi-Mukherjee, R; Yue, DT				Ben-Johny, Manu; Yang, Philemon S.; Niu, Jacqueline; Yang, Wanjun; Joshi-Mukherjee, Rosy; Yue, David T.			Conservation of Ca2+/Calmodulin Regulation across Na and Ca2+ Channels	CELL			English	Article							CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; EF-HAND; CALMODULIN-BINDING; CALCIUM REGULATION; CA(V)1.3 CHANNELS; SKELETAL-MUSCLE; C-TERMINUS; MOTIF; DETERMINANTS	Voltage-gated Na and Ca2+ channels comprise distinct ion channel superfamilies, yet the carboxy tails of these channels exhibit high homology, hinting at a long-shared and purposeful module. For different Ca2+ channels, carboxyl-tail interactions with calmodulin do elaborate robust and similar forms of Ca2+ regulation. However, Na channels have only shown subtler Ca2+ modulation that differs among reports, challenging attempts at unified understanding. Here, by rapid Ca2+ photorelease onto Na channels, we reset this view of Na channel regulation. For cardiac-muscle channels (Na(V)1.5), reported effects from which most mechanistic proposals derive, we observe no Ca2+ modulation. Conversely, for skeletal-muscle channels (Na(V)1.4), we uncover fast Ca2+ regulation eerily similar to that of Ca2+ channels. Channelopathic myotonia mutations halve Na(V)1.4 Ca2+ regulation, and transplanting the Na(V)1.4 carboxy tail onto Ca2+ channels recapitulates Ca2+ regulation. Thus, we argue for the persistence and physiological relevance of an ancient Ca2+ regulatory module across Na and Ca2+ channels.	[Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@jhmi.edu		Ben-Johny, Manu/0000-0002-5645-0815; Joshi-Mukherjee, Rosy/0000-0003-0162-1004	NINDS; NIMH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073874] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Gordon Tomaselli, King-Wai Yau, Paul Adams, and members of the Ca<SUP>2+</SUP> signals lab for comments. Michael Tadross helped construct and advised on the use of the flash photolysis setup. We thank Dr. Yi Chen-Izu for the generous loan of a flash photolysis system and Drs. Manfred Grabner and Bernhard Flucher for GLT cells. This work was supported by grants from the NINDS (to D.T.Y.) and NIMH (M.B.J.).	Adams P. J., 2007, V45, P215; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; BENJOHNY M, 2012, BIOPHYS J, V102, pA125; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081063; Biswas S, 2009, CIRC RES, V104, P870, DOI 10.1161/CIRCRESAHA.108.193565; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Cannon SC, 1997, NEUROMUSCULAR DISORD, V7, P241, DOI 10.1016/S0960-8966(97)00430-6; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Clausen T, 2011, EXP PHYSIOL, V96, P356, DOI 10.1113/expphysiol.2010.054999; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Herzog RI, 2003, J NEUROSCI, V23, P8261; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kubota T, 2009, MUSCLE NERVE, V39, P666, DOI 10.1002/mus.21155; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; PRESTON RR, 1991, ANNU REV PHYSIOL, V53, P309, DOI 10.1146/annurev.ph.53.030191.001521; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tadross MR, 2013, P NATL ACAD SCI USA, V110, P15794, DOI 10.1073/pnas.1313898110; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Van Petegem F, 2012, BIOPHYS J, V103, P2243, DOI 10.1016/j.bpj.2012.10.020; Wagner Stefan, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS26, DOI 10.1111/j.1540-8167.2006.00382.x; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Wu FF, 2005, J PHYSIOL-LONDON, V565, P371, DOI 10.1113/jphysiol.2005.082909; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	64	71	73	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1657	1670		10.1016/j.cell.2014.04.035	http://dx.doi.org/10.1016/j.cell.2014.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949975	Bronze, Green Accepted			2022-12-28	WOS:000340941900019
J	Lee, EB; Fleischmann, R; Hall, S; Wilkinson, B; Bradley, JD; Gruben, D; Koncz, T; Krishnaswami, S; Wallenstein, GV; Zang, CB; Zwillich, SH; van Vollenhoven, RF				Lee, Eun Bong; Fleischmann, Roy; Hall, Stephen; Wilkinson, Bethanie; Bradley, John D.; Gruben, David; Koncz, Tamas; Krishnaswami, Sriram; Wallenstein, Gene V.; Zang, Chuanbo; Zwillich, Samuel H.; van Vollenhoven, Ronald F.		ORAL Start Investigators	Tofacitinib versus Methotrexate in Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; COMBINATION THERAPY; PLUS METHOTREXATE; JOINT DAMAGE; DOUBLE-BLIND; ETANERCEPT; DISEASE; RECOMMENDATIONS; ADALIMUMAB; CP-690,550	Background Methotrexate is the most frequently used first-line antirheumatic drug. We report the findings of a phase 3 study of monotherapy with tofacitinib, an oral Janus kinase inhibitor, as compared with methotrexate monotherapy in patients with rheumatoid arthritis who had not previously received methotrexate or therapeutic doses of methotrexate. Methods We randomly assigned 958 patients to receive 5 mg or 10 mg of tofacitinib twice daily or methotrexate at a dose that was incrementally increased to 20 mg per week over 8 weeks; 956 patients received a study drug. The coprimary end points at month 6 were the mean change from baseline in the van der Heijde modified total Sharp score (which ranges from 0 to 448, with higher scores indicating greater structural joint damage) and the proportion of patients with an American College of Rheumatology (ACR) 70 response (>= 70% reduction in the number of both tender and swollen joints and >= 70% improvement in three of five other criteria: the patient's assessment of pain, level of disability, C-reactive protein level or erythrocyte sedimentation rate, global assessment of disease by the patient, and global assessment of disease by the physician). Results Mean changes in the modified total Sharp score from baseline to month 6 were significantly smaller in the tofacitinib groups than in the methotrexate group, but changes were modest in all three groups (0.2 points in the 5-mg tofacitinib group and <0.1 point in the 10-mg tofacitinib group, as compared with 0.8 points in the methotrexate group [ P<0.001 for both comparisons]). Among the patients receiving tofacitinib, 25.5% in the 5-mg group and 37.7% in the 10-mg group had an ACR 70 response at month 6, as compared with 12.0% of patients in the methotrexate group (P<0.001 for both comparisons). Herpes zoster developed in 31 of 770 patients who received tofacitinib (4.0%) and in 2 of 186 patients who received methotrexate (1.1%). Confirmed cases of cancer (including three cases of lymphoma) developed in 5 patients who received tofacitinib and in 1 patient who received methotrexate. Tofacitinib was associated with increases in creatinine levels and in low-density and high-density lipoprotein cholesterol levels. Conclusions In patients who had not previously received methotrexate or therapeutic doses of methotrexate, tofacitinib monotherapy was superior to methotrexate in reducing signs and symptoms of rheumatoid arthritis and inhibiting the progression of structural joint damage. The benefits of tofacitinib need to be considered in the context of the risks of adverse events.	[Lee, Eun Bong] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Fleischmann, Roy] Metroplex Clin Res Ctr, Dallas, TX USA; [Hall, Stephen] Cabrini Hlth, Melbourne, Vic, Australia; [Hall, Stephen] Monash Univ, Melbourne, Vic 3004, Australia; [Wilkinson, Bethanie; Bradley, John D.; Gruben, David; Krishnaswami, Sriram; Wallenstein, Gene V.; Zang, Chuanbo; Zwillich, Samuel H.] Pfizer Inc, Groton, CT 06340 USA; [Koncz, Tamas] Pfizer, New York, NY USA; [van Vollenhoven, Ronald F.] Karolinska Inst, Stockholm, Sweden	Seoul National University (SNU); Metroplex Clinical Research Center; Cabrini Health; Monash University; Pfizer; Pfizer; Karolinska Institutet	Wilkinson, B (corresponding author), Pfizer Inc, 445 Eastern Point Rd,Bldg 98,MS 8260-2517, Groton, CT 06340 USA.	bethanie.wilkinson@pfizer.com	Maslyanskiy, Alexey L/G-7691-2018; van Vollenhoven, Ronald/ABE-1244-2021; Fernandez-Nebro, Antonio/K-7628-2012	Maslyanskiy, Alexey L/0000-0003-2427-4148; Fernandez-Nebro, Antonio/0000-0002-2962-9844; Gonzalez, Carlos M./0000-0001-5511-8274; Glogowska-Szelag, Joanna/0000-0003-0949-322X	Pfizer	Pfizer(Pfizer)	Funded by Pfizer; ORAL Start ClinicalTrials.gov number, NCT01039688.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Bruynesteyn K, 2002, ARTHRITIS RHEUM-US, V46, P913, DOI 10.1002/art.10190; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Emery P, 2000, RHEUMATOLOGY, V39, P655, DOI 10.1093/rheumatology/39.6.655; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2011, ARTHRITIS RHEUM-US, V63, P1200, DOI 10.1002/art.30263; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Isaacs JD, 2012, ANN RHEUM DIS SS672, V71, pS672; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Maradit-Kremers H, 2006, J RHEUMATOL, V33, P248; McInnes IB, 2014, ANN RHEUM DIS, V73, P124, DOI 10.1136/annrheumdis-2012-202442; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; O'Dell JR, 2004, NEW ENGL J MED, V350, P2591, DOI 10.1056/NEJMra040226; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2011, ANN RHEUM DIS, V70, P1519; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; Tak PP, 2011, ANN RHEUM DIS, V70, P39, DOI 10.1136/ard.2010.137703; TUGWELL P, 1995, NEW ENGL J MED, V333, P137, DOI 10.1056/NEJM199507203330301; van der Heijde D, 2006, ANN RHEUM DIS, V65, P328, DOI 10.1136/ard.2005.035709; van der Heijde D, 2002, ARTHRIT RHEUM-ARTHR, V47, P215, DOI 10.1002/art.10181; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; van Vollenhoven RF, 2013, NEW ENGL J MED, V369, P293; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121	34	496	525	4	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2377	2386		10.1056/NEJMoa1310476	http://dx.doi.org/10.1056/NEJMoa1310476			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24941177	Green Published			2022-12-28	WOS:000337353000006
J	Andersen, NN; Pasternak, B; Basit, S; Andersson, M; Svanstrom, H; Caspersen, S; Munkholm, P; Hviid, A; Jess, T				Andersen, Nynne Nyboe; Pasternak, Bjorn; Basit, Saima; Andersson, Mikael; Svanstrom, Henrik; Caspersen, Sarah; Munkholm, Pia; Hviid, Anders; Jess, Tine			Association Between Tumor Necrosis Factor-alpha Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONMELANOMA SKIN CANCERS; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INFLIXIMAB; THERAPY; MALIGNANCIES; METAANALYSIS; MAINTENANCE; COHORT	IMPORTANCE A Cochrane review and network meta-analysis concluded that there is need for more research on adverse effects, including cancer, after treatment with tumor necrosis factor a (TNF-alpha) antagonists and that national registries and large databases would provide relevant sources of data to evaluate these effects. OBJECTIVE To investigate whether patients with inflammatory bowel disease (IBD) exposed to TNF-alpha antagonists were at increased risk of developing cancer. DESIGN, SETTING, AND PARTICIPANTS Nationwide register-based cohort study in Denmark, 1999-2012. Participants were 56 146 patients 15 years or older with IBD identified in the National Patient Registry, of whom 4553 (8.1%) were exposed to TNF-alpha antagonists. Cancer cases were identified in the Danish Cancer Registry. MAIN OUTCOMES AND MEASURES Rate ratios (RRs) for incident cancer (overall and site-specific) comparing TNF-alpha antagonist users and nonusers, estimated using Poisson regression adjusted for age, calendar year, disease duration, propensity scores, and use of other IBD medications. RESULTS During 489 433 person-years of follow-up (median, 9.3 years [interquartile range, 4.2-14.0]), 81 of 4553 patients exposed to TNF-alpha antagonists (1.8%) (median follow-up, 3.7 years [interquartile range, 1.8-6.0]) and 3465 of 51 593 unexposed patients (6.7%) developed cancer, yielding a fully adjusted RR of 1.07 (95% CI, 0.85-1.36). There was no significantly increased risk of cancer by TNF-alpha antagonist exposure. No site-specific cancers were in significant excess in fully adjusted models. [GRAPHICS] CONCLUSIONS AND RELEVANCE In this Danish nationwide study, exposure to TNF-alpha antagonists among patients with IBD was not associated with an increased risk of cancer over a median follow-up of 3.7 years among those exposed. An increased risk associated with longer-term accumulated doses and follow-up cannot be excluded.	[Andersen, Nynne Nyboe; Pasternak, Bjorn; Basit, Saima; Andersson, Mikael; Svanstrom, Henrik; Hviid, Anders; Jess, Tine] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Caspersen, Sarah; Munkholm, Pia] Herlev Univ Hosp, Gastroenterol Unit, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital	Andersen, NN (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nyna@ssi.dk	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012; Andersen, Nynne Nyboe/I-1043-2019; Munkholm, Pia/ABD-2432-2021	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466; Andersen, Nynne Nyboe/0000-0003-0874-0356; 	Lundbeck Foundation [R83-A7812]; Danish Cancer Society [R40-A1737-11-S2]; Crohn's & Colitis Association of Denmark; Danish Council of Independent Research [09-066323]	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Crohn's & Colitis Association of Denmark; Danish Council of Independent Research(Det Frie Forskningsrad (DFF))	This study was supported by grants from the Lundbeck Foundation (R83-A7812), the Danish Cancer Society (R40-A1737-11-S2), and the Crohn's & Colitis Association of Denmark. Dr Jess holds a Female Research Leader grant (09-066323) from the Danish Council of Independent Research.	Andersen TF, 1999, DAN MED BULL, V46, P263; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Caspersen S, 2008, CLIN GASTROENTEROL H, V6, P1212, DOI 10.1016/j.cgh.2008.05.010; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Fidder H, 2009, GUT, V58, P501, DOI 10.1136/gut.2008.163642; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Haynes K, 2013, ARTHRITIS RHEUM-US, V65, P48, DOI 10.1002/art.37740; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1051, DOI 10.1038/ajg.2012.89; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Moulis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048991; Osterman MT, 2014, GASTROENTEROLOGY, V146, P941, DOI 10.1053/j.gastro.2013.12.025; Pasternak B, 2013, AM J EPIDEMIOL, V177, P1296, DOI 10.1093/aje/kws375; Pedersen CB, 2006, DAN MED BULL, V53, P441; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Setshedi M, 2012, J GASTROEN HEPATOL, V27, P385, DOI 10.1111/j.1440-1746.2011.06865.x; Singh H, 2011, GASTROENTEROLOGY, V141, P1612, DOI 10.1053/j.gastro.2011.07.039; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Storm HH, 1997, DAN MED BULL, V44, P535; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; van Schaik FDM, 2011, CLIN GASTROENTEROL H, V9, P449, DOI 10.1016/j.cgh.2011.01.021; Williams CJM, 2014, ALIMENT PHARM THER, V39, P447, DOI 10.1111/apt.12624	31	161	163	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2406	2413		10.1001/jama.2014.5613	http://dx.doi.org/10.1001/jama.2014.5613			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938563	Bronze			2022-12-28	WOS:000337301500021
J	Brito, JP; Hay, ID; Morris, JC				Brito, Juan P.; Hay, Ian D.; Morris, John C.			Low risk papillary thyroid cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LYMPH-NODE DISSECTION; POSTOPERATIVE THYROGLOBULIN LEVELS; PERCUTANEOUS ETHANOL INJECTION; CENTRAL NECK DISSECTION; RADIOACTIVE IODINE; LASER-ABLATION; BRAF MUTATION; THYROTROPIN SUPPRESSION; INCREASING INCIDENCE; DISEASE PROGRESSION	Thyroid cancer is one of the fastest growing diagnoses; more cases of thyroid cancer are found every year than all leukemias and cancers of the liver, pancreas, and stomach. Most of these incident cases are papillary in origin and are both small and localized. Patients with these small localized papillary thyroid cancers have a 99% survival rate at 20 years. In view of the excellent prognosis of these tumors, they have been denoted as low risk. The incidence of these low risk thyroid cancers is growing, probably because of the use of imaging technologies capable of exposing a large reservoir of subclinical disease. Despite their excellent prognosis, these subclinical low risk cancers are often treated aggressively. Although surgery is traditionally viewed as the cornerstone treatment for these tumors, there is less agreement about the extent of surgery (lobectomy v near total thyroidectomy) and whether prophylactic central neck dissection for removal of lymph nodes is needed. Many of these tumors are treated with radioactive iodine ablation and thyrotropin suppressive therapy, which-although effective for more aggressive forms of thyroid cancer-have not been shown to be of benefit in the management of these lesions. This review offers an evidence based approach to managing low risk papillary thyroid cancer. It also looks at the future of promising alternative surgical techniques, non-surgical minimally localized invasive therapies (ethanol ablation and laser ablation), and active surveillance, all of which form part of a more individualized treatment approach for low risk papillary thyroid tumors.	[Brito, Juan P.; Hay, Ian D.; Morris, John C.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA; [Brito, Juan P.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Morris, JC (corresponding author), Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA.	Morris.John@mayo.edu						American Cancer Society, CANC FACTS FIG 2012; [Anonymous], 1937, Br Med J, V1, P460; Bauer DC, 2007, AM J MED, V120, P343, DOI 10.1016/j.amjmed.2006.04.034; Bilimoria KY, 2007, ANN SURG, V246, P375, DOI 10.1097/SLA.0b013e31814697d9; Bilimoria KY, 2007, ANN SURG, V246, P81; BLAHD WH, 1960, CANCER-AM CANCER SOC, V13, P745, DOI 10.1002/1097-0142(196007/08)13:4<745::AID-CNCR2820130416>3.0.CO;2-J; Brabant G, 2008, J CLIN ENDOCR METAB, V93, P1167, DOI 10.1210/jc.2007-2228; Braunstein GD, 2012, ENDOCR UPDAT, P45, DOI 10.1007/978-1-4614-0875-8_3; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Brito JP, 2013, THYROID, V23, P449, DOI 10.1089/thy.2012.0156; CADY B, 1988, SURGERY, V104, P947; Cappola AR, 2013, JAMA-J AM MED ASSOC, V309, P1529, DOI 10.1001/jama.2013.3620; Carling T, 2012, THYROID, V22, P237, DOI 10.1089/thy.2011.0317; Castagna MG, 2011, EUR J ENDOCRINOL, V165, P441, DOI 10.1530/EJE-11-0466; Clark OH, 2006, SURGERY, V140, P1005; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cooper DS, 1998, THYROID, V8, P737, DOI 10.1089/thy.1998.8.737; Curado MP, 2007, IARC SCI PUBLICATION, VIX; Dal Maso L, 2009, CANCER CAUSE CONTROL, V20, P75, DOI 10.1007/s10552-008-9219-5; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Dean D S, 2000, Cancer Control, V7, P229; Dralle H, 2008, SURGERY, V144, P987; Durante C, 2012, J CLIN ENDOCR METAB, V97, P2748, DOI 10.1210/jc.2012-1123; Edge SB, 2010, AJCC CANC STAGING MA, P87; Farkas EA, 2002, AM SURGEON, V68, P678; Farkas EA, 2002, AM SURGEON, V68, P82; Ferlay J, 2010, IARC CANCERBASE; Fuller CW, 2014, LARYNGOSCOPE, V124, P346, DOI 10.1002/lary.24406; Gouveia C, 2013, JAMA OTOLARYNGOL, V139, P1164, DOI 10.1001/jamaoto.2013.4501; Gulben K, 2008, LANGENBECK ARCH SURG, V393, P25, DOI 10.1007/s00423-007-0213-2; Guglielmi R, 2004, THYROID, V14, P125, DOI 10.1089/105072504322880364; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; HARACH HR, 1985, CANCER, V56, P531, DOI DOI 10.1002/1097-0142(19850801)56:3!; Harris PE, 2002, CLIN MED, V2, P144, DOI 10.7861/clinmedicine.2-2-144; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; Hay ID, 2013, SURGERY, V154, P1448, DOI 10.1016/j.surg.2013.07.007; Hay ID, 2008, SURGERY, V144, P980, DOI 10.1016/j.surg.2008.08.035; HAY ID, 1993, SURGERY, V114, P1050; HAY ID, 1987, SURGERY, V102, P1088; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Hay ID, 2013, THYROID S1, V23; Haymart MR, 2011, JAMA-J AM MED ASSOC, V306, P721, DOI 10.1001/jama.2011.1139; Henry JF, 1998, LANGENBECK ARCH SURG, V383, P167, DOI 10.1007/s004230050111; Hughes DT, 2010, SURGERY, V148, P1100, DOI 10.1016/j.surg.2010.09.019; Hughes DT, 2010, SURGERY, V148, P006; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Ito Y, 2014, WORLD J SURG, V38, P679, DOI 10.1007/s00268-013-2223-2; Ito Y, 2014, THYROID, V24, P27, DOI 10.1089/thy.2013.0367; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jeon MJ, 2014, EUR J ENDOCRINOL, V170, P23, DOI 10.1530/EJE-13-0524; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kung AWC, 1996, J CLIN ENDOCR METAB, V81, P1232, DOI 10.1210/jc.81.3.1232; Kweon SS, 2013, JPN J CLIN ONCOL, V43, P1039, DOI 10.1093/jjco/hyt102; Lang BHH, 2013, THYROID, V23, P1087, DOI 10.1089/thy.2012.0608; Lee TJ, 2012, J KOREAN MED SCI, V27, P1491, DOI 10.3346/jkms.2012.27.12.1491; Lewis BD, 2002, AM J ROENTGENOL, V178, P699, DOI 10.2214/ajr.178.3.1780699; Machens A, 2002, WORLD J SURG, V26, P22; Malone MK, 2014, THYROID, V24, P314, DOI 10.1089/thy.2012.0651; MARTINEZTELLO FJ, 1993, CANCER-AM CANCER SOC, V71, P4022, DOI 10.1002/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O; McGriff NJ, 2002, ANN MED, V34, P554, DOI 10.1080/078538902321117760; McIver B, 2001, SURGERY, V130, P1028, DOI 10.1067/msy.2001.118266; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Mendelsohn AH, 2010, ARCH OTOLARYNGOL, V136, P1055, DOI 10.1001/archoto.2010.181; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Negri E, 1999, CANCER CAUSE CONTROL, V10, P131, DOI 10.1023/A:1008851613024; Pace MD, 2013, THYROID S1, V23; Pacella CM, 2000, RADIOLOGY, V217, P673, DOI 10.1148/radiology.217.3.r00dc09673; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Palestini N, 2008, LANGENBECK ARCH SURG, V393, P693, DOI 10.1007/s00423-008-0360-0; Papini E, 2011, THYROID, V21, P917, DOI 10.1089/thy.2010.0447; Pitoia F, 2013, THYROID, V23, P1401, DOI 10.1089/thy.2013.0011; Pitoia F, 2009, ARQ BRAS ENDOCRINOL, V53, P884, DOI 10.1590/S0004-27302009000700014; Pujol P, 1996, J CLIN ENDOCR METAB, V81, P4318, DOI 10.1210/jc.81.12.4318; Reiner L, 1942, SCIENCE, V96, P362, DOI 10.1126/science.96.2494.362; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Robenshtok E, 2012, J CLIN ENDOCR METAB, V97, P2706, DOI 10.1210/jc.2012-1553; Roh JL, 2007, ANN SURG, V245, P604, DOI 10.1097/01.sla.0000250451.59685.67; Roh JL, 2009, CANCER-AM CANCER SOC, V115, P251, DOI 10.1002/cncr.24027; Rondeau G, 2011, THYROID, V21, P845, DOI 10.1089/thy.2011.0011; Ross JA, 1996, CANCER, V77, P201, DOI 10.1002/(SICI)1097-0142(19960101)77:1<201::AID-CNCR32>3.0.CO;2-7; Roti E, 2008, EUR J ENDOCRINOL, V159, P659, DOI 10.1530/EJE-07-0896; Rouxel A, 2004, J CLIN ENDOCR METAB, V89, P5362, DOI 10.1210/jc.2003-032004; Sacks W, 2010, THYROID, V20, P1235, DOI 10.1089/thy.2009.0455; SALVESEN H, 1991, ACTA CHIR-EUR J SURG, V157, P521; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Schvartz C, 2012, J CLIN ENDOCR METAB, V97, P1526, DOI 10.1210/jc.2011-2512; Sgourakis G, 2008, THYROID, V18, P721, DOI 10.1089/thy.2008.0028; Shaha AR, 1997, ANN SURG ONCOL, V4, P328, DOI 10.1007/BF02303583; Shin JE, 2013, CURR OPIN ONCOL, V25, P14, DOI 10.1097/CCO.0b013e32835a583d; Sugitani I, 2010, WORLD J SURG, V34, P1222, DOI 10.1007/s00268-009-0359-x; Sywak M, 2006, SURGERY, V140, P1000, DOI 10.1016/j.surg.2006.08.001; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Tisell LE, 1996, WORLD J SURG, V20, P854, DOI 10.1007/s002689900130; Toubeau M, 2004, J NUCL MED, V45, P988; Tufano RP, 2012, MEDICINE, V91, P274, DOI 10.1097/MD.0b013e31826a9c71; Valcavi R, 2013, THYROID, V23, P1578, DOI 10.1089/thy.2013.0279; Van den Bruel A, 2013, J CLIN ENDOCR METAB, V98, P4063, DOI 10.1210/jc.2013-1705; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Xing MZ, 2013, LANCET, V381, P1058, DOI 10.1016/S0140-6736(13)60109-9; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Zetoune T, 2010, ANN SURG ONCOL, V17, P3287, DOI 10.1245/s10434-010-1137-6	103	91	100	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g3045	10.1136/bmj.g3045	http://dx.doi.org/10.1136/bmj.g3045			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24935445				2022-12-28	WOS:000337804300009
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED How to undermine general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], GREAT VAL PET INS	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g4061	10.1136/bmj.g4061	http://dx.doi.org/10.1136/bmj.g4061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24934620				2022-12-28	WOS:000337804300011
J	Resing, JA; Barrett, PM				Resing, Joseph A.; Barrett, Pamela M.			OCEAN CHEMISTRY Fingerprints of a trace nutrient	NATURE			English	Editorial Material							IRON; CYCLE		[Resing, Joseph A.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98115 USA; [Resing, Joseph A.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Barrett, Pamela M.] Univ Washington, Dept Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Resing, JA (corresponding author), Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98115 USA.	resing@uw.edu; barrettp@uw.edu	Resing, Joseph A/J-6110-2017	Resing, Joseph A/0000-0002-7334-4176; Barrett, Pamela/0000-0003-3405-5328	Division Of Ocean Sciences [1260376] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Baker AR, 2010, MAR CHEM, V120, P4, DOI 10.1016/j.marchem.2008.09.003; Bennett SA, 2008, EARTH PLANET SC LETT, V270, P157, DOI 10.1016/j.epsl.2008.01.048; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Conway TM, 2014, NATURE, V511, P212, DOI 10.1038/nature13482; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Kohfeld KE, 2009, GEOPHYS MONOGR SER, V187, P251, DOI 10.1029/2008GM000845; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002541; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Sedwick PN, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001586; Tagliabue A, 2014, GEOPHYS RES LETT, V41, P920, DOI 10.1002/2013GL059059; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Ziegler M, 2013, NAT GEOSCI, V6, P457, DOI [10.1038/NGEO1782, 10.1038/ngeo1782]	13	0	0	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					164	165		10.1038/nature13513	http://dx.doi.org/10.1038/nature13513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008519				2022-12-28	WOS:000338649800032
J	Murad, MH; Montori, VM; Ioannidis, JPA; Jaeschke, R; Devereaux, PJ; Prasad, K; Neumann, I; Carrasco-Labra, A; Agoritsas, T; Hatala, R; Meade, MO; Wyer, P; Cook, DJ; Guyatt, G				Murad, Mohammad Hassan; Montori, Victor M.; Ioannidis, John P. A.; Jaeschke, Roman; Devereaux, P. J.; Prasad, Kameshwar; Neumann, Ignacio; Carrasco-Labra, Alonso; Agoritsas, Thomas; Hatala, Rose; Meade, Maureen O.; Wyer, Peter; Cook, Deborah J.; Guyatt, Gordon			How to Read a Systematic Review and Meta-analysis and Apply the Results to Patient Care Users' Guides to the Medical Literature	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIALS; MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE; PUBLICATION BIAS; RISK PATIENTS; QUALITY; GRADE; PREVENTION; BISOPROLOL; REGISTRIES	Clinical decisions should be based on the totality of the best evidence and not the results of individual studies. When clinicians apply the results of a systematic review or meta-analysis to patient care, they should start by evaluating the credibility of the methods of the systematic review, ie, the extent to which these methods have likely protected against misleading results. Credibility depends on whether the review addressed a sensible clinical question; included an exhaustive literature search; demonstrated reproducibility of the selection and assessment of studies; and presented results in a useful manner. For reviews that are sufficiently credible, clinicians must decide on the degree of confidence in the estimates that the evidence warrants (quality of evidence). Confidence depends on the risk of bias in the body of evidence; the precision and consistency of the results; whether the results directly apply to the patient of interest; and the likelihood of reporting bias. Shared decision making requires understanding of the estimates of magnitude of beneficial and harmful effects, and confidence in those estimates.	[Murad, Mohammad Hassan] Mayo Clin, Div Prevent Med, Rochester, MN 55905 USA; [Murad, Mohammad Hassan; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Montori, Victor M.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Jaeschke, Roman; Devereaux, P. J.; Cook, Deborah J.; Guyatt, Gordon] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Jaeschke, Roman; Devereaux, P. J.; Carrasco-Labra, Alonso; Agoritsas, Thomas; Meade, Maureen O.; Cook, Deborah J.; Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Devereaux, P. J.; Cook, Deborah J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Prasad, Kameshwar] All India Inst Med Sci, New Delhi, India; [Neumann, Ignacio] Pontificia Univ Catolica Chile, Sch Med, Dept Internal Med, Santiago, Chile; [Carrasco-Labra, Alonso] Univ Chile, Fac Dent, Evidence Based Dent Unit, Santiago, Chile; [Hatala, Rose] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Wyer, Peter] Columbia Univ, Med Ctr, New York, NY USA	Mayo Clinic; Mayo Clinic; Stanford University; Stanford University; Stanford University; Stanford University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; All India Institute of Medical Sciences (AIIMS) New Delhi; Pontificia Universidad Catolica de Chile; Universidad de Chile; University of British Columbia; Columbia University	Murad, MH (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	murad.mohammad@mayo.edu	Carrasco-Labra, Alonso/ABF-9555-2020; Neumann, Ignacio/ABB-5013-2020; Ioannidis, John P. A./G-9836-2011; Agoritsas, Thomas/F-4321-2014; Devereaux, PJ/AAY-1757-2021; Devereaux, PJ/AAF-2862-2019; Murad, M. Hassan/AAW-4367-2020	Carrasco-Labra, Alonso/0000-0003-3546-3526; Agoritsas, Thomas/0000-0002-6182-9969; Devereaux, PJ/0000-0003-2935-637X; Murad, Mohammad Hassan/0000-0001-5502-5975; Montori, Victor/0000-0003-0595-2898	Laura and John Arnold Foundation; Swiss National Science Foundation [PBGEP3-142251]	Laura and John Arnold Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Murad and Montori receive funding from several non-for-profit organizations to conduct systematic reviews and meta-analysis. The Meta-Research Innovation Center at Stanford (METRICS), directed by Dr Ioannidis, is funded by a grant from the Laura and John Arnold Foundation. Dr Agoritsas was financially supported by Fellowship for Prospective Researchers Grant No. PBGEP3-142251 from the Swiss National Science Foundation. Dr Cook is a Research Chair of the Canadian Institutes of Health Research.	Alkin M., 2004, EVALUATION ROOTS TRA, P91; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 2011, COCHRANE HDB SYSTEMA; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Boissel JP, 1997, FUNDAM CLIN PHARM, V11, P281, DOI 10.1111/j.1472-8206.1997.tb00197.x; Bouri S, 2014, HEART, V100, P456, DOI 10.1136/heartjnl-2013-304262; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Dickersin K, 2012, JAMA-J AM MED ASSOC, V307, P1861, DOI 10.1001/jama.2012.4230; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 2003, Health Technol Assess, V7, P1; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2012, CHEST, V141, pE185S, DOI 10.1378/chest.11-2289; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; Jacobs AK, 2013, CIRCULATION, V127, P268, DOI 10.1161/CIR.0b013e31827e8e5f; Johnston Bradley C, 2013, Health Qual Life Outcomes, V11, P211, DOI 10.1186/1477-7525-11-211; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lacasse Y, 2007, Eura Medicophys, V43, P475; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P706, DOI 10.1001/archsurg.2009.150; McDonagh MS, 2013, J CLIN EPIDEMIOL, V66, P1071, DOI 10.1016/j.jclinepi.2013.05.006; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Murad MH, 2013, JAMA-J AM MED ASSOC, V309, P2217, DOI 10.1001/jama.2013.5616; Murad MH, 2011, J CLIN EPIDEMIOL, V64, P743, DOI 10.1016/j.jclinepi.2010.08.005; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Murad MH, 2009, J CLIN EPIDEMIOL, V62, P865, DOI 10.1016/j.jclinepi.2008.11.005; Navarese EP, 2014, AM J CARDIOL, V113, P1753, DOI 10.1016/j.amjcard.2014.02.034; Odgaard-Jensen J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub3; Oxford Centre for Evidence-based Medicine (OECBM) Levels of Evidence Working Group, 2011, OECBM 2011 LEV EV; OXMAN AD, 1994, BMJ-BRIT MED J, V309, P648, DOI 10.1136/bmj.309.6955.648; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Saquib N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4313; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; US Preventive Services Task Force (USPSTF), GRAD DEF	52	272	280	2	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					171	179		10.1001/jama.2014.5559	http://dx.doi.org/10.1001/jama.2014.5559			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005654				2022-12-28	WOS:000338511200023
J	Brenguier, F; Campillo, M; Takeda, T; Aoki, Y; Shapiro, NM; Briand, X; Emoto, K; Miyake, H				Brenguier, F.; Campillo, M.; Takeda, T.; Aoki, Y.; Shapiro, N. M.; Briand, X.; Emoto, K.; Miyake, H.			Mapping pressurized volcanic fluids from induced crustal seismic velocity drops	SCIENCE			English	Article							TOHOKU EARTHQUAKE; FAULT; AFTERSHOCKS; SUBSIDENCE; ROCKS	Volcanic eruptions are caused by the release of pressure that has accumulated due to hot volcanic fluids at depth. Here, we show that the extent of the regions affected by pressurized fluids can be imaged through the measurement of their response to transient stress perturbations. We used records of seismic noise from the Japanese Hi-net seismic network to measure the crustal seismic velocity changes below volcanic regions caused by the 2011 moment magnitude (M-w) 9.0 Tohoku-Oki earthquake. We interpret coseismic crustal seismic velocity reductions as related to the mechanical weakening of the pressurized crust by the dynamic stress associated with the seismic waves. We suggest, therefore, that mapping seismic velocity susceptibility to dynamic stress perturbations can be used for the imaging and characterization of volcanic systems.	[Brenguier, F.; Campillo, M.; Briand, X.] Univ Grenoble 1, CNRS, Inst Sci Terre, F-38041 Grenoble, France; [Takeda, T.; Emoto, K.] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki, Japan; [Aoki, Y.; Miyake, H.] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; [Shapiro, N. M.] CNRS UMR7154, Sorbonne Paris Cite, Inst Phys Globe Paris, F-75238 Paris 5, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; National Research Institute for Earth Science & Disaster Resilience; University of Tokyo; UDICE-French Research Universities; Universite Paris Cite	Brenguier, F (corresponding author), Univ Grenoble 1, CNRS, Inst Sci Terre, F-38041 Grenoble, France.	florent.brenguier@ujf-grenoble.fr	Aoki, Yosuke/I-8801-2019; Brenguier, Florent/E-4843-2017; Campillo, Michel/K-6231-2012; Shapiro, Nikolai M/G-1049-2010; Campillo, Michel/AAC-5666-2019	Aoki, Yosuke/0000-0002-2539-4144; Brenguier, Florent/0000-0001-8684-7613; Campillo, Michel/0000-0001-6971-4499; Shapiro, Nikolai M/0000-0002-0144-723X; Campillo, Michel/0000-0001-6971-4499	Rhone-Alpes region [CPER07_13 CIRA]; France Grilles; CNRS MASTODONS program; French National Research Agency [2011-JAPN-006-NAMAZU]; Japan Science and Technology Agency [2011-JAPN-006-NAMAZU]; European Union through the projects European Research Council [227507, FP7 RI283542]; Grants-in-Aid for Scientific Research [25800244] Funding Source: KAKEN	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); France Grilles; CNRS MASTODONS program; French National Research Agency(French National Research Agency (ANR)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); European Union through the projects European Research Council; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	All of the seismological data used in this study are archived at the Japanese National Research Institute for Earth Science and Disaster Prevention (NIED) (www.hinet.bosai.go.jp/?LANG=en and www.kyoshin.bosai.go.jp/). The seismological data used in this study are available upon request at the NIED data center. We thank Geospatial Information Authority of Japan for access to Global Navigation Satellite System data. All of the computations in this study were performed using the High-Performance Computing (CIMENT) infrastructure (https://ciment.ujf-grenoble.fr), which is supported by the Rhone-Alpes region (GRANT CPER07_13 CIRA: www.ci-ra.org), France Grilles (www.france-grilles.fr), and the CNRS MASTODONS program. We acknowledge the French National Research Agency and the Japan Science and Technology Agency for funding support (project 2011-JAPN-006-NAMAZU). We received support from the European Union through the projects European Research Council advanced grant 227507 "Whisper" and FP7 RI283542 "VERCE." We thank T. Nishimura, P. Johnson, G. Olivier, G. Hillers, C. Jaupart, and T. Lecocq for useful discussions.	Adams LH, 1923, J FRANKL INST, V195, P475, DOI 10.1016/S0016-0032(23)90314-5; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Gomberg J, 1996, B SEISMOL SOC AM, V86, P212; Hirose F, 2011, EARTH PLANETS SPACE, V63, P513, DOI 10.5047/eps.2011.05.019; Husen S, 2004, GEOLOGY, V32, P537, DOI 10.1130/G20381.1; Husen S, 2004, J VOLCANOL GEOTH RES, V131, P397, DOI 10.1016/S0377-0273(03)00416-5; Lees JM, 2007, J VOLCANOL GEOTH RES, V167, P37, DOI 10.1016/j.jvolgeores.2007.06.008; LOCKNER DA, 1977, J GEOPHYS RES, V82, P5374, DOI 10.1029/JB082i033p05374; Pollitz FF, 2012, NATURE, V490, P250, DOI 10.1038/nature11504; Pritchard ME, 2013, NAT GEOSCI, V6, P632, DOI [10.1038/ngeo1855, 10.1038/NGEO1855]; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Shapiro SA, 2003, GEOPHYSICS, V68, P482, DOI 10.1190/1.1567215; Takada Y, 2013, NAT GEOSCI, V6, P637, DOI [10.1038/ngeo1857, 10.1038/NGEO1857]; Wegler U, 2007, GEOPHYS J INT, V168, P1029, DOI 10.1111/j.1365-246X.2006.03284.x; Yukutake Y, 2011, EARTH PLANETS SPACE, V63, P737, DOI 10.5047/eps.2011.05.004; Zhao DP, 2002, PHYS EARTH PLANET IN, V132, P249, DOI 10.1016/S0031-9201(02)00082-1; Zigone D, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009160; Zinszner B, 1997, J GEOPHYS RES-SOL EA, V102, P8105, DOI 10.1029/96JB03225	18	165	170	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					80	82		10.1126/science.1254073	http://dx.doi.org/10.1126/science.1254073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994652				2022-12-28	WOS:000338284400054
J	Li, Y; Calvo, SE; Gutman, R; Liu, JS; Mootha, VK				Li, Yang; Calvo, Sarah E.; Gutman, Roee; Liu, Jun S.; Mootha, Vamsi K.			Expansion of Biological Pathways Based on Evolutionary Inference	CELL			English	Article							MITOCHONDRIAL CALCIUM UNIPORTER; PROTEOMIC ANALYSIS; COMPLEX; PROTEIN; GENES; GENOMICS; DISEASE; IDENTIFICATION; PREDICTION; TRANSPORT	The availability of diverse genomes makes it possible to predict gene function based on shared evolutionary history. This approach can be challenging, however, for pathways whose components do not exhibit a shared history but rather consist of distinct "evolutionary modules." We introduce a computational algorithm, clustering by inferred models of evolution (CLIME), which inputs a eukaryotic species tree, homology matrix, and pathway (gene set) of interest. CLIME partitions the gene set into disjoint evolutionary modules, simultaneously learning the number of modules and a tree-based evolutionary history that defines each module. CLIME then expands each module by scanning the genome for new components that likely arose under the inferred evolutionary model. Application of CLIME to similar to 1,000 annotated human pathways and to the proteomes of yeast, red algae, and malaria reveals unanticipated evolutionary modularity and coevolving components. CLIME is freely available and should become increasingly powerful with the growing wealth of eukaryotic genomes.	[Li, Yang; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Li, Yang; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Li, Yang; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02141 USA; [Gutman, Roee] Brown Univ, Dept Biostat, Providence, RI 02912 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Brown University; Harvard University; Harvard Medical School	Liu, JS (corresponding author), Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu; vamsi@hms.harvard.edu	Gutman, Roee/J-2355-2014; /AAD-1516-2020	Gutman, Roee/0000-0001-7095-3016; 	NIH [GM0077465]; National Science Foundations [DMS-1007762, IIS-1017967]; Shenzhen Special Fund for Strategic Emerging Industry grant [ZD201111080127A]; Investigator of the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1007762] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundations(National Science Foundation (NSF)); Shenzhen Special Fund for Strategic Emerging Industry grant; Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Jagesh Shah for curation of cilia-related genes and Eran Mick and Daniel Arlow for manuscript feedback. This work was supported in part by grants from the NIH (GM0077465 to V.K.M.), National Science Foundations (DMS-1007762 and IIS-1017967 to J.S.L.), and the Shenzhen Special Fund for Strategic Emerging Industry grant (ZD201111080127A to J.S.L.). V.K.M. is an Investigator of the Howard Hughes Medical Institute.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; DORFMAN BZ, 1969, GENETICS, V61, P377; DOVEY HF, 1984, MOL BIOCHEM PARASIT, V11, P157, DOI 10.1016/0166-6851(84)90062-8; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Gabaldon T, 2005, EVOL BIOINFORM, V1, P51; Glazko GV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r32; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jamerson M, 2012, MICROBIOL-SGM, V158, P791, DOI 10.1099/mic.0.055020-0; Jim K, 2004, GENOME RES, V14, P109; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Liu J.S., 2008, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Smith JC, 2005, J PROTEOME RES, V4, P909, DOI 10.1021/pr050013h; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Zhou Y, 2006, J MOL BIOL, V359, P1150, DOI 10.1016/j.jmb.2006.04.011	45	71	73	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					213	225		10.1016/j.cell.2014.05.034	http://dx.doi.org/10.1016/j.cell.2014.05.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995987	Bronze, Green Accepted			2022-12-28	WOS:000340943100019
J	Qiao, S; Luo, QS; Zhao, Y; Zhang, XJC; Huang, YH				Qiao, Shuai; Luo, Qingshan; Zhao, Yan; Zhang, Xuejun Cai; Huang, Yihua			Structural basis for lipopolysaccharide insertion in the bacterial outer membrane	NATURE			English	Article							FUNCTIONAL-ANALYSIS; PROTEIN COMPLEX; CELL-ENVELOPE; TRANSPORT; IDENTIFICATION; MUTAGENESIS; BIOGENESIS; EXPORT; PLUG; LPTD	One of the fundamental properties of biological membranes is the asymmetric distribution of membrane lipids. In Gram-negative bacteria, the outer leaflet of the outer membrane is composed predominantly of lipopolysaccharides (LPS)(1). The export of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane, through the periplasm to the surfac(2)e. Of the seven Lpt proteins, the LptD-LptE complex is responsible for inserting LPS into the external leaflet of the outer membrane(3,4). Here we report the crystal structure of the similar to 110-kilodalton membrane protein complex LptD-LptE from Shigella flexneri at 2.4 angstrom resolution. The structure reveals an unprecedented two-protein plug-and-barrel architecture with LptE embedded into a 26-stranded beta-barrel formed by LptD. Importantly, the secondary structures of the first two beta-strands are distorted by two proline residues, weakening their interactions with neighbouring beta-strands and creating a potential portal on the barrel wall that could allow lateral diffusion of LPS into the outer membrane. The crystal structure of the LptD-LptE complex opens the door to new antibiotic strategies targeting the bacterial outer membrane.	[Qiao, Shuai; Luo, Qingshan; Zhao, Yan; Zhang, Xuejun Cai; Huang, Yihua] Chinese Acad Sci, Inst Biophys, Natl Ctr Prot Sci Beijing, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Qiao, Shuai; Luo, Qingshan] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Zhao, Yan] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, YH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Ctr Prot Sci Beijing, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	yihuahuang@sun5.ibp.ac.cn		Qiao, Shuai/0000-0002-9573-8774	Ministry of Science and Technology [2012CB917302, 2013CB910603]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB080203]; National Natural Science Foundation of China [31170698]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Y. Shan for discussions, H. Wu, J. Deisenhofer, Y. Jiang, N. Huang, Z. Zhou, G. Li, Z. Liu and members of the Huang group for critically reading the manuscript. The diffraction data were collected at the Shanghai Synchrotron Radiation Facility (SSRF, China) and Beijing Synchrotron Radiation Facility of China (BSRF, China). This work was supported by grants from the Ministry of Science and Technology (2012CB917302 and 2013CB910603 to Y.H.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB080203 to Y.H. and X.C.Z.) and the National Natural Science Foundation of China (31170698 to Y.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; DeLano W. L., 2009, 238 ACS NAT M, V238; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Grabowicz M, 2013, J BACTERIOL, V195, P1327, DOI 10.1128/JB.02142-12; Khan MA, 2009, BIOCHEMISTRY-US, V48, P9745, DOI 10.1021/bi9013566; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	30	169	176	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					108	U523		10.1038/nature13484	http://dx.doi.org/10.1038/nature13484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990751				2022-12-28	WOS:000338199400046
J	Mak, KF; McGill, KL; Park, J; McEuen, PL				Mak, K. F.; McGill, K. L.; Park, J.; McEuen, P. L.			The valley Hall effect in MoS2 transistors	SCIENCE			English	Article							MONOLAYER; POLARIZATION	Electrons in two-dimensional crystals with a honeycomb lattice structure possess a valley degree of freedom (DOF) in addition to charge and spin. These systems are predicted to exhibit an anomalous Hall effect whose sign depends on the valley index. Here, we report the observation of this so-called valley Hall effect (VHE). Monolayer MoS2 transistors are illuminated with circularly polarized light, which preferentially excites electrons into a specific valley, causing a finite anomalous Hall voltage whose sign is controlled by the helicity of the light. No anomalous Hall effect is observed in bilayer devices, which have crystal inversion symmetry. Our observation of the VHE opens up new possibilities for using the valley DOF as an information carrier in next-generation electronics and optoelectronics.	[Mak, K. F.; Park, J.; McEuen, P. L.] Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA; [Mak, K. F.; McGill, K. L.; McEuen, P. L.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Park, J.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Mak, KF (corresponding author), Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA.	km627@cornell.edu; plm23@cornell.edu	McGill, Kathryn/N-4438-2013; Mak, Kin Fai/E-9004-2015; Park, Jiwoong/C-2327-2013	McGill, Kathryn/0000-0002-8841-6910; Mak, Kin Fai/0000-0002-5768-199X; 	Kavli Institute at Cornell for Nanoscale Science; Cornell Center for Materials Research [National Science Foundation (NSF)] [DMR-1120296]; Air Force Office of Scientific Research [FA9550-10-1-0410]; Nano-Material Technology Development Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2012M3A7B4049887]; NSF [ECCS-0335765]; NSF Integrative Graduate Education and Research Traineeship program [DGE-0654193]; NSF Graduate Research Fellowship Program [DGE-1144153]	Kavli Institute at Cornell for Nanoscale Science; Cornell Center for Materials Research [National Science Foundation (NSF)](National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Nano-Material Technology Development Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; NSF(National Science Foundation (NSF)); NSF Integrative Graduate Education and Research Traineeship program(National Science Foundation (NSF)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	We thank D. C. Ralph for his insightful suggestions and J. W. Kevek for technical support. We also thank J. Shan for many fruitful discussions and Y. You for private communications regarding the optical data on monolayer MoS<INF>2</INF>. This research was supported by the Kavli Institute at Cornell for Nanoscale Science and the Cornell Center for Materials Research [National Science Foundation (NSF) DMR-1120296]. Additional funding was provided by the Air Force Office of Scientific Research (FA9550-10-1-0410) and the Nano-Material Technology Development Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (2012M3A7B4049887). Device fabrication was performed at the Cornell NanoScale Science and Technology Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by NSF (grant ECCS-0335765). K. L. M. acknowledges support from the NSF Integrative Graduate Education and Research Traineeship program (DGE-0654193) and the NSF Graduate Research Fellowship Program (DGE-1144153).	Akhmerov AR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.157003; Baugher BWH, 2013, NANO LETT, V13, P4212, DOI 10.1021/nl401916s; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cheiwchanchamnangij T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205302; Engel HA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.166605; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kioseoglou G, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768299; Li X, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066803; Lopez-Sanchez O, 2013, NAT NANOTECHNOL, V8, P497, DOI [10.1038/NNANO.2013.100, 10.1038/nnano.2013.100]; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Rycerz A, 2007, NAT PHYS, V3, P172, DOI 10.1038/nphys547; Sallen G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.081301; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; van der Pauw LJ, 1958, PHILLIPS TECHNICAL R, V20, P220, DOI DOI 10.4236/JMP.2013.411179; Wu SF, 2013, NAT PHYS, V9, P149, DOI 10.1038/nphys2524; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Wunderlich J, 2010, SCIENCE, V330, P1801, DOI 10.1126/science.1195816; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; Yao W, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235406; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329	29	1237	1251	60	956	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1489	1492		10.1126/science.1250140	http://dx.doi.org/10.1126/science.1250140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970080	Green Submitted			2022-12-28	WOS:000337889900043
J	Glaser, A; Barak, B; Goldston, RJ				Glaser, Alexander; Barak, Boaz; Goldston, Robert J.			A zero-knowledge protocol for nuclear warhead verification	NATURE			English	Article							DOSIMETRY	The verification of nuclear warheads for arms control involves a paradox: international inspectors will have to gain high confidence in the authenticity of submitted items while learning nothing about them. Proposed inspection systems featuring 'information barriers', designed to hide measurements stored in electronic systems, are at risk of tampering and snooping. Here we show the viability of a fundamentally new approach to nuclear warhead verification that incorporates a zero-knowledge protocol, which is designed in such a way that sensitive information is never measured and so does not need to be hidden. We interrogate submitted items with energetic neutrons, making, in effect, differential measurements of both neutron transmission and emission. Calculations for scenarios in which material is diverted from a test object show that a high degree of discrimination can be achieved while revealing zero information. Our ideas for a physical zero-knowledge system could have applications beyond the context of nuclear disarmament. The proposed technique suggests a way to perform comparisons or computations on personal or confidential data without measuring the data in the first place.	[Glaser, Alexander] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Barak, Boaz] Microsoft Res, Cambridge, MA 02142 USA; [Goldston, Robert J.] Princeton Univ, Princeton Plasma Phys Lab, Princeton, NJ 08540 USA	Princeton University; Microsoft; Princeton University; United States Department of Energy (DOE); Princeton Plasma Physics Laboratory	Glaser, A (corresponding author), Princeton Univ, Dept Mech & Aerosp Engn, Olden St, Princeton, NJ 08544 USA.	aglaser@princeton.edu			Global Zero; US Department of State; Princeton Plasma Physics Laboratory (DOE) [DE-AC02-09CH11466]	Global Zero; US Department of State; Princeton Plasma Physics Laboratory (DOE)(United States Department of Energy (DOE))	This project was supported by Global Zero and the US Department of State, the Princeton Plasma Physics Laboratory (DOE contract DE-AC02-09CH11466) and in-kind contributions from Microsoft Research New England. We thank D. Dobkin, F. d'Errico, J. Fuller, D. MacArthur, J. Mihalczo, S. Philippe and M. Walker for discussions and feedback. We thank S. Philippe (Princeton University) for graphics in Fig. 2. All simulations were run on Princeton University's High Performance Cluster.	Allen K., 2013, P ESARDA 35 ANN M IS; Anderson Brian, 2012, VERIFICATION NUCL WE; [Anonymous], 2005, GEN MONT CARL N PART; Bleuel D. L., 2012, REV SCI INSTRUM, V83; Chazelle B, 2007, NATURE, V446, P992, DOI 10.1038/446992a; Comley C., 2000, CONFIDENCE SECURITY; d'Errico F, 2001, NUCL INSTRUM METH B, V184, P229, DOI 10.1016/S0168-583X(01)00730-3; d'Errico F, 1998, PHYS MED BIOL, V43, P1147, DOI 10.1088/0031-9155/43/5/007; d'Errico F, 2008, RADIAT MEAS, V43, P432, DOI 10.1016/j.radmeas.2008.02.011; Fuller J., 2010, CULTIVATING CONFIDEN; Fuller J., 2010, ARMS CONTROL TODAY, V40, P19; Goldreich O., 1987, 19 ANN ACM S THEOR C, P218; GOLDWASSER S, 1989, SIAM J COMPUT, V18, P186, DOI 10.1137/0218012; Hall J., 2001, SCI TECHNOL REV, P4; Lindell Y., 2008, J PRIVACY CONFIDENT, V2008, P197, DOI DOI 10.29012/JPC.V1I1.566; Naor M., P CRYPTO 20 IN PRESS; Roquemore A. L., 1993, 15 IEEE NPSS S FUS E, P114; Spears D., 2001, TECHNOLOGY R D ARMS	18	41	43	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					497	502		10.1038/nature13457	http://dx.doi.org/10.1038/nature13457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965650	Green Submitted			2022-12-28	WOS:000337806300038
J	Hakim, AM				Hakim, Antoine M.			PERSPECTIVE Silent, but preventable, perils	NATURE			English	Editorial Material							VASCULAR DEMENTIA; STROKE		[Hakim, Antoine M.] Ottawa Hosp, Res Inst, Canadian Stroke Network, Ottawa, ON, Canada; [Hakim, Antoine M.] Ottawa Hosp, Res Inst, Neurosci Res Program, Ottawa, ON, Canada; [Hakim, Antoine M.] Univ Ottawa Canada, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Hakim, AM (corresponding author), Ottawa Hosp, Res Inst, Canadian Stroke Network, Ottawa, ON, Canada.	ahakim@ohri.ca						Aguero-Torres H, 2006, DEMENT GERIATR COGN, V22, P244, DOI 10.1159/000094973; [Anonymous], 2010, POP PROJ CAN PROV TE; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Neltner JH, 2014, BRAIN, V137, P255, DOI 10.1093/brain/awt318; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pergola P. E., 2014, AM J HYPERTENS; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278	9	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S12	S12		10.1038/510S12a	http://dx.doi.org/10.1038/510S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964022	Bronze			2022-12-28	WOS:000337806300008
J	Leslie, T; Mikhail, A; Mayan, I; Cundill, B; Anwar, M; Bakhtash, SH; Mohammed, N; Rahman, H; Zekria, R; Whitty, CJM; Rowland, M				Leslie, Toby; Mikhail, Amy; Mayan, Ismail; Cundill, Bonnie; Anwar, Mohammed; Bakhtash, Sayed Habib; Mohammed, Nader; Rahman, Habib; Zekria, Rohullah; Whitty, Christopher J. M.; Rowland, Mark			Rapid diagnostic tests to improve treatment of malaria and other febrile illnesses: patient randomised effectiveness trial in primary care clinics in Afghanistan	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REAL-TIME PCR; TANZANIA; MICROSCOPY; TRANSMISSION; IMPACT; LEVEL; AREA	Objective To assess the impact of rapid diagnostic tests on the diagnostic accuracy and treatment of malaria and non-severe fever in an Asian setting. Design Patient randomised trial in primary level clinics. Setting Two areas of Afghanistan where Plasmodium vivax and Plasmodium falciparum are endemic; one area with moderate transmission (eastern region) and one with low transmission (northern region). Participants 5794 patients of all ages with suspected malaria enrolled by 80 clinicians in 22 clinics. Interventions Malaria rapid diagnostic tests were compared with clinical diagnosis where no parasite diagnostic test was available, longer established field microscopy, and recently introduced microscopy. Main outcome measures Proportion of patients appropriately treated with an antimalarial, defined as patients with P vivax who received chloroquine, patients with P falciparum who received artemisinin based combination therapy, and patients with no malaria parasites who did not receive an antimalarial. Secondary outcomes included diagnostic test accuracy and the proportion of patients negative for malaria who received antibiotics and antimalarials. Results In the low transmission area, comparing rapid diagnostic tests with clinical diagnosis, 65% (212/325) versus 12% (40/321) of febrile patients were appropriately treated for malaria (adjusted odds ratio 92.7, 95% confidence interval 12.4 to 694.1, P<0.001). The proportion of patients who were negative for malaria and received an antibiotic was 57% (185/325) in the rapid diagnostic test arm compared with 14% (46/321) in the clinical diagnosis arm (16.9, 3.8 to 75.4, P<0.001). In the comparison of rapid diagnostic test with microscopy in the moderate transmission area, 83.6% (1696/2028) versus 76.3% (1512/1983) of patients were appropriately treated for malaria (1.70, 1.30 to 2.23, P<0.001). A higher proportion of P falciparum cases received appropriate treatment with artemisinin based combination therapy when malaria was diagnosed by rapid diagnostic test (82%, 58/71 v 32%, 24/76; 9.2, 3.88 to 21.66, P<0.001). Conclusions In South and central Asian regions of low to moderate malaria transmission where clinics lack capacity for diagnosis with rapid diagnostic tests or microscopy, the introduction of the tests should be considered to improve clinical care, reduce the overuse of antimalarials, and improve disease surveillance.	[Leslie, Toby; Mikhail, Amy; Cundill, Bonnie; Whitty, Christopher J. M.; Rowland, Mark] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Leslie, Toby; Mikhail, Amy; Mayan, Ismail; Rahman, Habib; Zekria, Rohullah] Hlth Protect & Res Org, Kabul, Afghanistan; [Anwar, Mohammed; Mohammed, Nader] HealthNet TPO, Kabul, Afghanistan; [Bakhtash, Sayed Habib] Merlin, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Leslie, T (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	toby.leslie@lshtm.ac.uk		Mikhail, Amy Frances Wahid/0000-0003-3414-2173; Whitty, Christopher/0000-0002-6076-5027; Cundill, Bonnie/0000-0002-3648-820X	Bill and Melinda Gates Foundation; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Bill and Melinda Gates Foundation though a grant to the ACT Consortium at the London School of Hygiene & Tropical Medicine. The funding source played no role in the design, conduct, analysis or interpretation of the results.	[Anonymous], BMJ; [Anonymous], 2011, UN ACC MAL DIAGN TES; [Anonymous], APPL MIXED MODELS ME; Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandramohan D, 2001, TROP MED INT HEALTH, V6, P505, DOI 10.1046/j.1365-3156.2001.00739.x; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Leslie T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4389; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Mikhail AFW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-169; Moonasar D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-74; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199; Reyburn H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-4; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Reynolds J, 2013, QUAL HEALTH RES, V23, P579, DOI 10.1177/1049732312470761; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; Wallace MR, 2002, CLIN INFECT DIS, V34, pS171, DOI 10.1086/340704; WHO, 2012, WORLD MALARIA REPORT 2012, P1	26	21	22	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2014	348								g3730	10.1136/bmj.g3730	http://dx.doi.org/10.1136/bmj.g3730			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LH	24948695	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000337805800001
J	Wang, T; Sha, HY; Ji, DM; Zhang, HL; Chen, DW; Cao, YX; Zhu, JH				Wang, Tian; Sha, Hongying; Ji, Dongmei; Zhang, Helen L.; Chen, Dawei; Cao, Yunxia; Zhu, Jianhong			Polar Body Genome Transfer for Preventing the Transmission of Inherited Mitochondrial Diseases	CELL			English	Article							MOUSE EMBRYOS; PREIMPLANTATION EMBRYOS; POINT MUTATIONS; MTDNA MUTATIONS; HUMAN OOCYTES; DIGITAL PCR; DNA; METHYLATION; SEGREGATION; BODIES	Inherited mtDNA diseases transmit maternally and cause severe phenotypes. Currently, there is no effective therapy or genetic screens for these diseases; however, nuclear genome transfer between patients' and healthy eggs to replace mutant mtDNAs holds promises. Considering that a polar body contains few mitochondria and shares the same genomic material as an oocyte, we perform polar body transfer to prevent the transmission of mtDNA variants. We compare the effects of different types of germline genome transfer, including spindle-chromosome transfer, pronuclear transfer, and first and second polar body transfer, in mice. Reconstructed embryos support normal fertilization and produce live offspring. Importantly, genetic analysis confirms that the F1 generation from polar body transfer possesses minimal donor mtDNA carryover compared to the F1 generation from other procedures. Moreover, the mtDNA genotype remains stable in F2 progeny after polar body transfer. Our preclinical model demonstrates polar body transfer has great potential to prevent inherited mtDNA diseases.	[Wang, Tian; Sha, Hongying; Zhu, Jianhong] Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, Dept Neurobiol, Shanghai 200032, Peoples R China; [Wang, Tian; Sha, Hongying; Zhu, Jianhong] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200032, Peoples R China; [Ji, Dongmei; Chen, Dawei; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Dept Obstet & Gynecol, Hefei 230022, Peoples R China; [Zhang, Helen L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Fudan University; Fudan University; Anhui Medical University; Harvard University; Harvard Medical School	Sha, HY (corresponding author), Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, Dept Neurobiol, Shanghai 200032, Peoples R China.	shahongying@fudan.edu.cn; jzhu@fudan.edu.cn	Wang, Tian/AAX-8754-2021; Chen, Dawei/V-4296-2019	Chen, Dawei/0000-0002-8201-0549	National Basic Research Program of China [2010CB945500, 2012CB966304, 2012CB944704]; Shanghai Municipality Project [11JC1401000]; National NSF [81271003]; Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship) [2011S06]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipality Project; National NSF(National Natural Science Foundation of China (NSFC)); Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship)	We are grateful to Dr. Bin Lai (Fudan) for assisting confocal analysis, Yimin Tian (Shanghai Geneland Biotech) for help with pyrosequencing, and Drs. Hongkui Deng (Peking University), Dangsheng Li (SIBCB), and Alastair Murchie (Fudan) for critical reading of the manuscript. This study was supported by grants from National Basic Research Program of China (2010CB945500 to J.Z., 2012CB966304 to H.S., 2012CB944704 to Y.C.), Shanghai Municipality Project (11JC1401000 to H.S.), National NSF grant (81271003 to J.Z.) and Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship 2011S06 to T.W.).	Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639; BIEBER FR, 1981, SCIENCE, V213, P775, DOI 10.1126/science.7196086; Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232; Christopikou D, 2013, HUM REPROD, V28, P1426, DOI 10.1093/humrep/det053; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FDA: Cellular Tissue and Gene Therapies Advisory Committee, 2014, BRIEF DOC OOC MOD AS; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; HFEA, 2012, MIT PUBL CONS 2012 M; Hino T, 2013, J ASSIST REPROD GEN, V30, P91, DOI 10.1007/s10815-012-9899-3; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; HOULISTON E, 1988, DEVELOPMENT, V102, P271; HUTCHISO.CA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Link J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003261; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Lorthongpanich C, 2013, SCIENCE, V341, P1110, DOI 10.1126/science.1240617; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Meirelles FV, 1997, GENETICS, V145, P445; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; Wakayama T, 1997, J REPROD FERTIL, V110, P263, DOI 10.1530/jrf.0.1100263; Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190	48	105	120	8	101	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1591	1604		10.1016/j.cell.2014.04.042	http://dx.doi.org/10.1016/j.cell.2014.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949971	Bronze			2022-12-28	WOS:000340941900014
J	Chua, KP; Sommers, BD				Chua, Kao-Ping; Sommers, Benjamin D.			Changes in Health and Medical Spending Among Young Adults Under Health Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							AFFORDABLE CARE ACT; INSURANCE-COVERAGE		[Chua, Kao-Ping] Harvard Univ, Harvard PhD Program Hlth Policy, Cambridge, MA 02138 USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Chua, KP (corresponding author), Harvard PhD Program Hlth Policy, 14 Story St, Cambridge, MA 02138 USA.	kao-ping.chua@childrens.harvard.edu		Chua, Kao-Ping/0000-0002-4081-272X				Agency for Health Care Research and Quality, MEPS HC 147 2011 FUL; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; Mulcahy A, 2013, NEW ENGL J MED, V368, P2105, DOI 10.1056/NEJMsa1212779; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913	6	82	83	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2437	2439		10.1001/jama.2014.2202	http://dx.doi.org/10.1001/jama.2014.2202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938568	Bronze			2022-12-28	WOS:000337301500026
J	Fortescue, EB				Fortescue, Elizabeth B.			Keeping the Pace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONGENITAL HEART-DISEASE		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fortescue, EB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	efortescue@verizon.net						Arne HW, 2002, NY TIMES; Fortescue EB, 2005, J INTERV CARD ELECTR, V14, P27, DOI 10.1007/s10840-005-3797-x; Fortescue EB, 2004, HEART RHYTHM, V1, P150, DOI 10.1016/j.hrthm.2004.02.020; Moss AJ, 2003, JAMA-J AM MED ASSOC, V289, P2041, DOI 10.1001/jama.289.16.2041; Sears SF, 2009, J CARDIOVASC ELECTR, V20, P1297, DOI 10.1111/j.1540-8167.2009.01526.x	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2383	2384		10.1001/jama.2014.4962	http://dx.doi.org/10.1001/jama.2014.4962			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938560				2022-12-28	WOS:000337301500017
J	Gyldenlove, M; Rorvig, S; Skov, L; Hansen, D				Gyldenlove, Mette; Rorvig, Sara; Skov, Lone; Hansen, Ditte			Severe hypercalcaemia, nephrocalcinosis, and multiple paraffinomas caused by paraffin oil injections in a young bodybuilder	LANCET			English	Editorial Material									[Gyldenlove, Mette; Skov, Lone] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Copenhagen, Denmark; [Rorvig, Sara] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Hansen, Ditte] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Gyldenlove, M (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, DK-2900 Hellerup, Denmark.	mette.gyldenloeve@regionh.dk	Skov, Lone/W-3575-2018	Hansen, Ditte/0000-0003-4929-7901; Skov, Lone/0000-0002-4784-9680				El MM, 2010, ENDOCR PRACT, V16, P102; MOORE B, 1946, BRIT J IND MED, V3, P250; Moraitis AG, 2013, ENDOCR PRACT, V19, pE50, DOI 10.4158/EP12092.CR; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	4	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2098	2098		10.1016/S0140-6736(14)60806-0	http://dx.doi.org/10.1016/S0140-6736(14)60806-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24931692				2022-12-28	WOS:000337292400030
J	Holloman, B				Holloman, Bill			Robin Holliday 1932-2014 Obituary	CELL			English	Biographical-Item									Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University	Holloman, B (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	wkhollo@med.cornell.edu						HOLLIDAY R, PUBLICATION LIST	1	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1001	1003		10.1016/j.cell.2014.05.005	http://dx.doi.org/10.1016/j.cell.2014.05.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24983099	Bronze			2022-12-28	WOS:000336437200001
J	Bingel, U				Bingel, Ulrike			Avoiding Nocebo Effects to Optimize Treatment Outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, D-45147 Essen, Germany	University of Duisburg Essen	Bingel, U (corresponding author), Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany.	ulrike.bingel@uk-essen.de						Benedetti F, 2014, PAIN, V155, P921, DOI 10.1016/j.pain.2014.01.016; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Rief W, 2006, ARCH INTERN MED, V166, P155, DOI 10.1001/archinte.166.2.155; Varelmann D, 2010, ANESTH ANALG, V110, P868, DOI 10.1213/ANE.0b013e3181cc5727	9	113	114	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					693	694		10.1001/jama.2014.8342	http://dx.doi.org/10.1001/jama.2014.8342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25003609				2022-12-28	WOS:000340438700013
J	Rayment, M; Asboe, D; Sullivan, AK				Rayment, Michael; Asboe, David; Sullivan, Ann K.			HIV testing and management of newly diagnosed HIV	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTIRETROVIRAL THERAPY; ASSOCIATION GUIDELINES; SEXUAL TRANSMISSION; INFECTION; RISK; COHORT; ADULTS; MEN		[Rayment, Michael] Homerton Univ Hosp NHS Fdn Trust, Homerton Sexual Hlth Serv, London E9 6SR, England; [Asboe, David; Sullivan, Ann K.] Chelsea & Westminster Hosp NHS Fdn Trust, Directorate HIV GU Med, London, England	Imperial College London	Rayment, M (corresponding author), Homerton Univ Hosp NHS Fdn Trust, Homerton Sexual Hlth Serv, London E9 6SR, England.	michaelrayment@nhs.net						Anderson M, 2010, AIDS CARE, V22, P1493, DOI 10.1080/09540121.2010.482125; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Berry JM, 2009, DIS COLON RECTUM, V52, P239, DOI 10.1007/DCR.0b013e31819793d9; British HIV Association, 2013, HIV TRANSM LAW WORK; British HIV Association, 2008, GUID HIV TEST; British HIV Association British Association for Sexual Health and HIV. Joint National Audit of the British HIV Association and the British Society for Sexual Health and HIV, 2013, HIV PARTN NOT PROC O; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Czoski-Murray C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14530; Damery S, 2013, BRIT J GEN PRACT, V63, pE370, DOI 10.3399/bjgp13X668159; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Ferreira A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002843.pub2; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Geretti AM, 2008, HIV MED, V9, P795, DOI 10.1111/j.1468-1293.2008.00637.x; Health Protection Agency, HIV UK 2013 REP; Hult JR, 2009, AIDS CARE, V21, P185, DOI 10.1080/09540120802017602; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; May M., 2014, AIDS; Moore AL, 2002, AIDS, V16, P927, DOI 10.1097/00002030-200204120-00014; Murphy G, 2008, EURO SURVEILL, V13; Myers T, 2007, AIDS CARE, V19, P1013, DOI 10.1080/09540120701294260; National Institute for Health and Care Excellence, 2011, INCR UPT HIV TEST BL; National Institute for Health and Care Excellence, 2011, INCR UPT HIV TEST ME; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Sabin CA, 2000, J ACQ IMMUN DEF SYND, V23, P172; Sharrocks K, 2012, INT J STD AIDS, V23, P540, DOI 10.1258/ijsa.2012.011450; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]	35	8	8	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4275	10.1136/bmj.g4275	http://dx.doi.org/10.1136/bmj.g4275			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005147				2022-12-28	WOS:000338993300003
J	Fee, E				Fee, Elizabeth			Information on a global scale: the National Library of Medicine	LANCET			English	Editorial Material									Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Fee, E (corresponding author), Natl Lib Med, Bethesda, MD 20894 USA.	feee@mail.nih.gov							0	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					21	22		10.1016/S0140-6736(14)61118-1	http://dx.doi.org/10.1016/S0140-6736(14)61118-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	25003181				2022-12-28	WOS:000338919600011
J	Schuchat, A; Tappero, J; Blandford, J				Schuchat, Anne; Tappero, Jordan; Blandford, John			Global health and the US Centers for Disease Control and Prevention	LANCET			English	Editorial Material							A H7N9 VIRUS; PUBLIC-HEALTH; HUMAN INFECTION; INFLUENZA; HIV; SURVEILLANCE; CHOLERA; PEPFAR		[Schuchat, Anne; Tappero, Jordan; Blandford, John] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Schuchat, A (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Mailstop A-27,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	ASchuchat@cdc.gov						Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P933; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927; Centers for Disease Control and Prevention, 2013, CDC GLOB HLTH STRAT; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V46, P1245; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cherutich Peter, 2012, Morbidity and Mortality Weekly Report, V61, P957; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; El-Sadr WM, 2012, JAIDS-J ACQ IMM DEF, V60, pS96, DOI 10.1097/QAI.0b013e31825eb27b; Fischer JE, 2013, BIOSECUR BIOTERROR, V11, P153, DOI 10.1089/bsp.2013.0030; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ijaz K, 2012, EMERG INFECT DIS, V18, P1054, DOI 10.3201/eid1807.120487; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kruk ME, 2012, HEALTH AFFAIR, V31, P1478, DOI 10.1377/hlthaff.2012.0197; Magloire R., 2010, Morbidity and Mortality Weekly Report, V59, P939; Ministere de la Sante Publique et de la Population, 2014, MIN SANT PUBL POP DA; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827; Thomas AG, 2012, J ACQ IMMUN DEF SYND, V60, P88; UNAIDS, UNAIDS REP GLOB AIDS; US President's Emergency Plan for AIDS Relief (PEPFAR), 2013, 2013 PREFAR RES; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035; Vertefeuille JF, 2013, LANCET, V381, P517, DOI 10.1016/S0140-6736(13)60051-3; Waldman RJ, 2013, NEW ENGL J MED, V368, P592, DOI 10.1056/NEJMp1214179; Walldorf JA, 2012, AIDS, V26, P1431, DOI 10.1097/QAD.0b013e328352d032; WHO/UNICEF, 2015, JOINT MON PROGR WAT	32	8	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					98	101		10.1016/S0140-6736(14)60570-5	http://dx.doi.org/10.1016/S0140-6736(14)60570-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24998008	Green Published, Bronze			2022-12-28	WOS:000338919600031
J	Sydeman, WJ; Garcia-Reyes, M; Schoeman, DS; Rykaczewski, RR; Thompson, SA; Black, BA; Bograd, SJ				Sydeman, W. J.; Garcia-Reyes, M.; Schoeman, D. S.; Rykaczewski, R. R.; Thompson, S. A.; Black, B. A.; Bograd, S. J.			Climate change and wind intensification in coastal upwelling ecosystems	SCIENCE			English	Article							CALIFORNIA CURRENT; TRENDS; FUTURE	In 1990, Andrew Bakun proposed that increasing greenhouse gas concentrations would force intensification of upwelling-favorable winds in eastern boundary current systems that contribute substantial services to society. Because there is considerable disagreement about whether contemporary wind trends support Bakun's hypothesis, we performed a meta-analysis of the literature on upwelling-favorable wind intensification. The preponderance of published analyses suggests that winds have intensified in the California, Benguela, and Humboldt upwelling systems and weakened in the Iberian system over time scales ranging up to 60 years; wind change is equivocal in the Canary system. Stronger intensification signals are observed at higher latitudes, consistent with the warming pattern associated with climate change. Overall, reported changes in coastal winds, although subtle and spatially variable, support Bakun's hypothesis of upwelling intensification in eastern boundary current systems.	[Sydeman, W. J.; Garcia-Reyes, M.; Thompson, S. A.] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA; [Schoeman, D. S.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld 4558, Australia; [Rykaczewski, R. R.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Rykaczewski, R. R.] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; [Thompson, S. A.] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA; [Black, B. A.] Univ Texas Richardson, Inst Marine Sci, Port Aransas, TX 78373 USA; [Bograd, S. J.] NOAA, Environm Res Div, Southwest Fisheries Sci Ctr, Pacific Grove, CA 93950 USA	University of the Sunshine Coast; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Dallas; National Oceanic Atmospheric Admin (NOAA) - USA	Sydeman, WJ (corresponding author), Farallon Inst Adv Ecosyst Res, Suite Q,101 H St, Petaluma, CA 94952 USA.	wsydeman@comcast.net	Bograd, Steven/AAA-4824-2021; Rykaczewski, Ryan/A-8625-2016; Black, Bryan/A-7057-2009	Rykaczewski, Ryan/0000-0001-8893-872X; Black, Bryan/0000-0001-6851-257X; Schoeman, David/0000-0003-1258-0885	NSF [1130125]; NOAA's Environmental Research Division; Australian Research Council's Collaborative Research Network; Directorate For Geosciences [1026607] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NOAA's Environmental Research Division; Australian Research Council's Collaborative Research Network(Australian Research Council); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support for this study was provided by NSF award no. 1130125, NOAA's Environmental Research Division, and donors to the Farallon Institute. D.S. was supported by the Australian Research Council's Collaborative Research Network. The data reported in this paper are tabulated in the supplementary materials; electronic files of the tabulated data are available upon request from the senior author and at www.faralloninstitute.org.	BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Baumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067596; Black BA, 2011, GLOBAL CHANGE BIOL, V17, P2536, DOI 10.1111/j.1365-2486.2011.02422.x; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Botsford LW, 2006, DEEP-SEA RES PT II, V53, P3116, DOI 10.1016/j.dsr2.2006.07.011; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Hakkinen S, 2011, SCIENCE, V334, P655, DOI 10.1126/science.1205683; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Kahru M, 2012, DEEP-SEA RES PT II, V77-80, P89, DOI 10.1016/j.dsr2.2012.04.007; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Schroeder ID, 2009, MAR ECOL PROG SER, V393, P211, DOI 10.3354/meps08103; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Solomon S., 2007, PHYS SCI BASIS WORKI; Thomas BR, 2008, INT J CLIMATOL, V28, P747, DOI 10.1002/joc.1570; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270	25	334	348	16	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					77	80		10.1126/science.1251635	http://dx.doi.org/10.1126/science.1251635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994651				2022-12-28	WOS:000338284400053
J	Kryazhimskiy, S; Rice, DP; Jerison, ER; Desai, MM				Kryazhimskiy, Sergey; Rice, Daniel P.; Jerison, Elizabeth R.; Desai, Michael M.			Global epistasis makes adaptation predictable despite sequence-level stochasticity	SCIENCE			English	Article							BENEFICIAL MUTATIONS; ESCHERICHIA-COLI; CLONAL INTERFERENCE; EVOLUTION; POPULATIONS; EVOLVABILITY; RATES	Epistatic interactions between mutations can make evolutionary trajectories contingent on the chance occurrence of initial mutations. We used experimental evolution in Saccharomyces cerevisiae to quantify this contingency, finding differences in adaptability among 64 closely related genotypes. Despite these differences, sequencing of 104 evolved clones showed that initial genotype did not constrain future mutational trajectories. Instead, reconstructed combinations of mutations revealed a pattern of diminishing-returns epistasis: Beneficial mutations have consistently smaller effects in fitter backgrounds. Taken together, these results show that beneficial mutations affecting a variety of biological processes are globally coupled; they interact strongly, but only through their combined effect on fitness. As a consequence, fitness evolution follows a predictable trajectory even though sequence-level adaptation is stochastic.	[Kryazhimskiy, Sergey; Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Jerison, Elizabeth R.; Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kryazhimskiy, Sergey; Rice, Daniel P.; Jerison, Elizabeth R.; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Kryazhimskiy, S (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	skryazhi@oeb.harvard.edu; mdesai@oeb.harvard.edu	Kryazhimskiy, Sergey/AAV-1258-2020	Kryazhimskiy, Sergey/0000-0001-9128-8705; Jerison, Elizabeth/0000-0003-3793-8839; Desai, Michael/0000-0002-9581-1150	Burroughs Wellcome Foundation; NSF graduate research fellowships; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Harvard Milton Fund; NSF [PHY 1313638]; NIH [GM104239]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104239] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1313638] Funding Source: National Science Foundation	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NSF graduate research fellowships(National Science Foundation (NSF)); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Harvard Milton Fund; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Murray, Q. Justman, B. Good, D. van Dyken, M. McDonald for useful discussions; A. Subramaniam, G. Lang, M. Muller, and J. Koschwanez for experimental advice and strains; and P. Rogers and C. Daly for technical support. Supported by the Burroughs Wellcome Foundation (S.K.), NSF graduate research fellowships (D.P.R., E.R.J.), and the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Harvard Milton Fund, NSF grant PHY 1313638, and NIH grant GM104239 (M.M.D.). Sequence data have been deposited to GenBank under BioProject identifier PRJNA242140.	Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bollback JP, 2007, MOL BIOL EVOL, V24, P1397, DOI 10.1093/molbev/msm056; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Gould S. J., 1989, WONDERFUL LIFE; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Perfeito L, 2014, EVOLUTION, V68, P150, DOI 10.1111/evo.12234; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	20	223	225	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1519	1522		10.1126/science.1250939	http://dx.doi.org/10.1126/science.1250939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970088	Green Submitted, Green Accepted			2022-12-28	WOS:000337889900051
J	Monk, J; Palsson, BO				Monk, Jonathan; Palsson, Bernhard O.			Predicting microbial growth	SCIENCE			English	Editorial Material									[Monk, Jonathan; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA	University of California System; University of California San Diego	Monk, J (corresponding author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA.	palsson@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Monk, Jonathan M./0000-0002-3895-8949				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barua D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000970; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deutschbauer A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002385; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846	12	31	31	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1448	1449		10.1126/science.1253388	http://dx.doi.org/10.1126/science.1253388			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970063				2022-12-28	WOS:000337889900019
J	Kampinga, HH				Kampinga, Harm H.			A cell death avenue evolved from a life-saving path	SCIENCE			English	Editorial Material							PROTEINS; APOPTOSIS; HSP70; YEAST; YCA1		Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands	University of Groningen	Kampinga, HH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands.	h.h.kampinga@umcg.nl		Kampinga, Harm/0000-0002-8966-8466				Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hill SM, 2014, SCIENCE, V344, P1389, DOI 10.1126/science.1252634; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468	11	2	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1341	1342		10.1126/science.1256084	http://dx.doi.org/10.1126/science.1256084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948721				2022-12-28	WOS:000337531700018
J	Kotler, S; Akerman, N; Navon, N; Glickman, Y; Ozeri, R				Kotler, Shlomi; Akerman, Nitzan; Navon, Nir; Glickman, Yinnon; Ozeri, Roee			Measurement of the magnetic interaction between two bound electrons of two separate ions	NATURE			English	Article							TRAPPED IONS; SPIN; ENTANGLEMENT; STATES; FORCE	Electrons have an intrinsic, indivisible, magnetic dipole aligned with their internal angular momentum (spin). The magnetic interaction between two electronic spins can therefore impose a change in their orientation. Similar dipolar magnetic interactions exist between other spin systems and have been studied experimentally. Examples include the interaction between an electron and its nucleus and the interaction between several multi-electron spin complexes(1-5). The challenge in observing such interactions for two electrons is twofold. First, at the atomic scale, where the coupling is relatively large, it is often dominated by the much larger Coulomb exchange counterpart(1). Second, on scales that are substantially larger than the atomic, the magnetic coupling is very weak and can be well below the ambient magnetic noise. Here we report the measurement of the magnetic interaction between the two ground-state spin-1/2 valence electrons of two Sr-88(+) ions, cotrapped in an electric Paul trap. We varied the ion separation, d, between 2.18 and 2.76 micrometres and measured the electrons' weak, millihertz-scale, magnetic interaction as a function of distance, in the presence of magnetic noise that was six orders of magnitude larger than the magnetic fields the electrons apply on each other. The cooperative spin dynamics was kept coherent for 15 seconds, during which spin entanglement was generated, as verified by a negative measured value of -0.16 for the swap entanglement witness. The sensitivity necessary for this measurement was provided by restricting the spin evolution to a decoherence-free subspace that is immune to collective magnetic field noise. Our measurements show a d(-3.0(4)) distance dependence for the coupling, consistent with the inverse-cube law.	[Kotler, Shlomi; Akerman, Nitzan; Navon, Nir; Glickman, Yinnon; Ozeri, Roee] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kotler, S (corresponding author), NIST, Phys Measurement Lab, Boulder, CO 80305 USA.	shlomi.kotler@weizmann.ac.il	Kotler, Shlomi/I-4393-2014	Kotler, Shlomi/0000-0002-0191-5777; Navon, Nir/0000-0002-8917-3463	Israeli Science Foundation; Crown Photonics Center; German-Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation); Crown Photonics Center; German-Israeli Science Foundation(German-Israeli Foundation for Scientific Research and Development)	We thank J. Avron for discussions on the entanglement witness. We acknowledge support by the Israeli Science Foundation, the Crown Photonics Center, the German-Israeli Science Foundation and M. Kushner Schnur, Mexico.	Akerman N, 2012, APPL PHYS B-LASERS O, V107, P1167, DOI 10.1007/s00340-011-4807-6; Arrad G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150801; Biercuk MJ, 2010, NAT NANOTECHNOL, V5, P646, DOI [10.1038/NNANO.2010.165, 10.1038/nnano.2010.165]; Breit G, 1928, NATURE, V122, P649, DOI 10.1038/122649a0; Budker D., 2004, ATOMIC PHYS EXPLORAT, P1; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Dolde F, 2013, NAT PHYS, V9, P139, DOI 10.1038/nphys2545; Dur W, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.080801; Grinolds MS, 2013, NAT PHYS, V9, P215, DOI [10.1038/NPHYS2543, 10.1038/nphys2543]; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Keselman A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073027; Kessler EM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150802; Kotler S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.110503; Kotler S, 2011, NATURE, V473, P61, DOI 10.1038/nature10010; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; MOODY JE, 1984, PHYS REV D, V30, P130, DOI 10.1103/PhysRevD.30.130; Navon N., 2013, PREPRINT; Navon N, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.073001; Ozeri R., 2013, PREPRINT; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schmidt-Kaler F, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/53001; Stuhler J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.150406; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; Warring U, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.173002	30	44	44	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					376	380		10.1038/nature13403	http://dx.doi.org/10.1038/nature13403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24943952	Green Submitted			2022-12-28	WOS:000337350200030
J	Sharma, M; Perera, K				Sharma, Mukul; Perera, Kanjana			In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION; ANTICOAGULATION; THERAPY; RISK		[Sharma, Mukul; Perera, Kanjana] McMaster Univ, Hamilton, ON, Canada	McMaster University	Sharma, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Sharma, Mukul/0000-0002-6119-342X				Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Goodman SG, 2014, J AM COLL CARDIOL, V63, P891, DOI 10.1016/j.jacc.2013.11.013; Gross CP, 2003, CLIN THER, V25, P1750, DOI 10.1016/S0149-2918(03)80167-4; Sellers MB, 2011, AM HEART J, V161, P241, DOI 10.1016/j.ahj.2010.11.002	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC7	10.7326/0003-4819-160-12-201406170-02007	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935513				2022-12-28	WOS:000337374900007
J	Watts, G				Watts, Geoff			Douglas Leonard Coleman Obituary	LANCET			English	Biographical-Item																		COLEMAN D, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1966	1966		10.1016/S0140-6736(14)60946-6	http://dx.doi.org/10.1016/S0140-6736(14)60946-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24936629	Bronze			2022-12-28	WOS:000336848200015
J	Harms, MJ; Thornton, JW				Harms, Michael J.; Thornton, Joseph W.			Historical contingency and its biophysical basis in glucocorticoid receptor evolution	NATURE			English	Article							MOLECULAR-DYNAMICS METHOD; LIGAND-BINDING DOMAIN; DIRECTED EVOLUTION; KEY INNOVATION; FORCE-FIELD; PROTEIN; MUTATIONS; SIMULATIONS; RESISTANCE; EPISTASIS	Understanding how chance historical events shape evolutionary processes is a central goal of evolutionary biology(1-7). Direct insights into the extent and causes of evolutionary contingency have been limited to experimental systems(7-9), because it is difficult to know what happened in the deep past and to characterize other paths that evolution could have followed. Here we combine ancestral protein reconstruction, directed evolution and biophysical analysis to explore alternative 'might-have-been' trajectories during the ancient evolution of a novel protein function. We previously found that the evolution of cortisol specificity in the ancestral glucocorticoid receptor (GR) was contingent on permissive substitutions, which had no apparent effect on receptor function but were necessary for GR to tolerate the large-effect mutations that caused the shift in specificity(6). Here we show that alternative mutations that could have permitted the historical function-switching substitutions are extremely rare in the ensemble of genotypes accessible to the ancestral GR. In a library of thousands of variants of the ancestral protein, we recovered historical permissive substitutions but no alternative permissive genotypes. Using biophysical analysis, we found that permissive mutations must satisfy at least three physical requirements-they must stabilize specific local elements of the protein structure, maintain the correct energetic balance between functional conformations, and be compatible with the ancestral and derived structures-thus revealing why permissive mutations are rare. These findings demonstrate that GR evolution depended strongly on improbable, non-deterministic events, and this contingency arose from intrinsic biophysical properties of the protein.	[Harms, Michael J.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Harms, Michael J.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Harms, Michael J.; Thornton, Joseph W.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Harms, Michael J.; Thornton, Joseph W.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Thornton, Joseph W.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon; University of Oregon; University of Chicago; University of Chicago; University of Oregon	Thornton, JW (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	joet1@uchicago.edu	Thornton, Joseph/GSN-4190-2022	Harms, Michael/0000-0002-0241-4122	National Institutes of Health (NIH) [F32-GM090650, NIH R01-GM081592, R01-GM104397]; NSF [IOB-0546906]; Howard Hughes Medical Institute Early Career Scientist award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081592, R01GM104397] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute Early Career Scientist award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bridgham, members of the Thornton laboratory, and B. Buckley McAllister for technical assistance and fruitful discussions. We thank M. Stallcup for sharing plasmids and the University of Oregon ACISS cluster for computing resources (National Science Foundation (NSF) OCI-0960354). This work was supported by National Institutes of Health (NIH) F32-GM090650 (M.J.H.), NIH R01-GM081592 (J.W.T.) and R01-GM104397 (J.W.T.), NSF IOB-0546906 (J.W.T.) and a Howard Hughes Medical Institute Early Career Scientist award (J.W.T.).	Beatty J, 2006, J PHILOS, V103, P336, DOI 10.5840/jphil2006103716; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bledsoe RK, 2004, VITAM HORM, V68, P49; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; Chen ZL, 2004, J BIOL CHEM, V279, P33855, DOI 10.1074/jbc.M402118200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Field SF, 2010, MOL BIOL EVOL, V27, P225, DOI 10.1093/molbev/msp230; Fisher, 1958, GENETICAL THEORY NAT; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Gould S. J., 1990, WONDERFUL LIFE BURGE; Granovsky A. A., FIREFLY VERSION 7 1; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Monod J., 1972, CHANCE NECESSITY ESS; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Morris S. C., 2000, CRUCIBLE CREATION BU; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	48	102	103	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					203	+		10.1038/nature13410	http://dx.doi.org/10.1038/nature13410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	24930765	Green Accepted			2022-12-28	WOS:000340200700034
J	Langley, RG; Elewski, BE; Lebwohl, M; Reich, K; Griffiths, CEM; Papp, K; Puig, L; Nakagawa, H; Spelman, L; Sigurgeirsson, B; Rivas, E; Tsai, TF; Wasel, N; Tyring, S; Salko, T; Hampele, I; Notter, M; Karpov, A; Helou, S; Papavassilis, C				Langley, Richard G.; Elewski, Boni E.; Lebwohl, Mark; Reich, Kristian; Griffiths, Christopher E. M.; Papp, Kim; Puig, Lluis; Nakagawa, Hidemi; Spelman, Lynda; Sigurgeirsson, Bardur; Rivas, Enrique; Tsai, Tsen-Fang; Wasel, Norman; Tyring, Stephen; Salko, Thomas; Hampele, Isabelle; Notter, Marianne; Karpov, Alexander; Helou, Silvia; Papavassilis, Charis		ERASURE Study Grp; FIXTURE Study Grp	Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELLS; DOUBLE-BLIND; INTERLEUKIN-17; PATHOGENESIS; MECHANISMS; DISTINCT; DISEASE; LINEAGE; LIFE	BACKGROUND Interleukin-17A is considered to be central to the pathogenesis of psoriasis. We evaluated secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis. METHODS In two phase 3, double-blind, 52-week trials, ERASURE (Efficacy of Response and Safety of Two Fixed Secukinumab Regimens in Psoriasis) and FIXTURE (Full Year Investigative Examination of Secukinumab vs. Etanercept Using Two Dosing Regimens to Determine Efficacy in Psoriasis), we randomly assigned 738 patients (in the ERASURE study) and 1306 patients (in the FIXTURE study) to subcutaneous secukinumab at a dose of 300 mg or 150 mg (administered once weekly for 5 weeks, then every 4 weeks), placebo, or (in the FIXTURE study only) etanercept at a dose of 50 mg (administered twice weekly for 12 weeks, then once weekly). The objective of each study was to show the superiority of secukinumab over placebo at week 12 with respect to the proportion of patients who had a reduction of 75% or more from baseline in the psoriasis area-and-severity index score (PASI 75) and a score of 0 (clear) or 1 (almost clear) on a 5-point modified investigator's global assessment (coprimary end points). RESULTS The proportion of patients who met the criterion for PASI 75 at week 12 was higher with each secukinumab dose than with placebo or etanercept: in the ERASURE study, the rates were 81.6% with 300 mg of secukinumab, 71.6% with 150 mg of secukinumab, and 4.5% with placebo; in the FIXTURE study, the rates were 77.1% with 300 mg of secukinumab, 67.0% with 150 mg of secukinumab, 44.0% with etanercept, and 4.9% with placebo (P<0.001 for each secukinumab dose vs. comparators). The proportion of patients with a response of 0 or 1 on the modified investigator's global assessment at week 12 was higher with each secukinumab dose than with placebo or etanercept: in the ERASURE study, the rates were 65.3% with 300 mg of secukinumab, 51.2% with 150 mg of secukinumab, and 2.4% with placebo; in the FIXTURE study, the rates were 62.5% with 300 mg of secukinumab, 51.1% with 150 mg of secukinumab, 27.2% with etanercept, and 2.8% with placebo (P<0.001 for each secukinumab dose vs. comparators). The rates of infection were higher with secukinumab than with placebo in both studies and were similar to those with etanercept. CONCLUSIONS Secukinumab was effective for psoriasis in two randomized trials, validating interleukin-17A as a therapeutic target.	[Langley, Richard G.] Dalhousie Univ, Halifax, NS B3H 1V7, Canada; [Papp, Kim] Clin Res, Waterloo, ON, Canada; [Papp, Kim; Spelman, Lynda] Prob Med Res, Waterloo, ON, Canada; [Wasel, Norman] Strat Med & Prob Med Res, Edmonton, AB, Canada; [Elewski, Boni E.] Univ Alabama Birmingham, Birmingham, AL USA; [Lebwohl, Mark] Mt Sinai Hosp, New York, NY 10029 USA; [Reich, Kristian] Dermatologikum Hamburg, Hamburg, Germany; [Reich, Kristian] Univ Gottingen, D-37073 Gottingen, Germany; [Griffiths, Christopher E. M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp, Dermatol Ctr, Manchester, Lancs, England; [Puig, Lluis] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Nakagawa, Hidemi] Jikei Univ, Sch Med, Tokyo, Japan; [Spelman, Lynda] Verac Clin Res, Woolloongabba, Qld, Australia; [Sigurgeirsson, Bardur] Univ Iceland, Dept Dermatol, Fac Med, Reykjavik, Iceland; [Rivas, Enrique] Dermos, Guatemala City, Guatemala; [Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Tsai, Tsen-Fang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Tyring, Stephen] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Tyring, Stephen] Ctr Clin Studies, Houston, TX USA; [Salko, Thomas; Hampele, Isabelle; Notter, Marianne; Karpov, Alexander; Helou, Silvia; Papavassilis, Charis] Novartis Pharmaceut, Basel, Switzerland	Dalhousie University; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai; Dermatologikum Hamburg; University of Gottingen; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Hospital of Santa Creu i Sant Pau; Jikei University; University of Iceland; National Taiwan University; National Taiwan University Hospital; National Taiwan University; University of Texas System; University of Texas Health Science Center Houston; Novartis	Langley, RG (corresponding author), Dalhousie Univ, 4195 Dickson Bldg,5820 Univ Ave, Halifax, NS B3H 1V7, Canada.	richardgblangley@gmail.com	Sinclair, Rodney/AAI-8355-2020; Sigurgeirsson, Bardur/AAP-7755-2020; Weidinger, Stephan/C-8461-2011; Griffiths, Christopher E.M./P-5448-2014; Kemeny, Lajos/ABF-1339-2021; Thaci, Prof. Dr Diamant/K-5455-2012; Sigurgeirsson, Bárður/B-6130-2011; Gooderham, Melinda/F-2551-2017	Sinclair, Rodney/0000-0001-6751-1428; Weidinger, Stephan/0000-0003-3944-252X; Griffiths, Christopher E.M./0000-0001-5371-4427; Kemeny, Lajos/0000-0002-2119-9501; Helfrich, Yolanda/0000-0003-4957-3910; Grob, Jean-Jacques/0000-0002-0667-153X; Papp, Kim A./0000-0001-9557-3642; Vender, Ronald/0000-0002-2624-2724; TSAI, TSEN-FANG/0000-0002-1498-1474; Paul, Carle/0000-0003-0165-5263; bachelez, herve/0000-0003-3567-9095; Gooderham, Melinda/0000-0001-8926-0113; Gonzalez Ardila, Cesar/0000-0002-5608-9054; Pavlovsky, Lev/0000-0001-8400-9587; Nikkels, Arjen/0000-0001-5240-4806; Szepietowski, Jacek/0000-0003-0766-6342; Sigurgeirsson, Bardur/0000-0002-9733-9742; Peris, Ketty/0000-0002-5237-0463; Kingo, Kulli/0000-0001-6301-9612	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	Funded by Novartis Pharmaceuticals; ERASURE and FIXTURE ClinicalTrials.gov numbers, NCT01365455 and NCT01358578, respectively.)	[Anonymous], 2009, J INVEST DERMATOL, V129, P2175; [Anonymous], 2013, ENBR; Bretz F, 2009, STAT MED, V28, P586, DOI 10.1002/sim.3495; Cai YH, 2013, INT IMMUNOPHARMACOL, V16, P388, DOI 10.1016/j.intimp.2013.02.018; Cai YH, 2011, IMMUNITY, V35, P649, DOI 10.1016/j.immuni.2011.10.006; de Korte J, 2004, J INVEST DERM SYMP P, V9, P140, DOI 10.1046/j.1087-0024.2003.09110.x; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Klein U, 2013, J INVEST DERMATOL, V133, pS172; Krstic A, 2012, IMMUNOL RES, V52, P34, DOI 10.1007/s12026-012-8276-8; Langley RG, 2013, BRIT J DERMATOL, V169, P1198, DOI 10.1111/bjd.12583; Langley RG, 2013, J DERMATOLOG TREAT; Lebwohl M, 2014, INT J DERMATOL, V53, P714, DOI 10.1111/j.1365-4632.2012.05798.x; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; Rich Sheldon J, 2004, J Manag Care Pharm, V10, P318; Weisman S, 2003, J Dermatolog Treat, V14, P158, DOI 10.1080/09546630310013360; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	25	1320	1366	8	149	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					326	338		10.1056/NEJMoa1314258	http://dx.doi.org/10.1056/NEJMoa1314258			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25007392	Green Published			2022-12-28	WOS:000339339800009
J	Blumenthal, D; Collins, SR				Blumenthal, David; Collins, Sara R.			Health Care Coverage under the Affordable Care Act - A Progress Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSURANCE		[Blumenthal, David; Collins, Sara R.] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							Blumenthal D., 2014, 3 RS HLTH INSURANCE; Collins S. R., 2014, AM EXPERIENCES HLTH; Collins SR, 2013, NEW US CENSUS DATA U; Doty M.M., 2013, COVERING YOUNG ADULT; Gabel J, 2006, HEALTH AFFAIR, V25, P832, DOI 10.1377/hlthaff.25.3.832; Graves J, 2014, OBAMACARE ENROLLMENT; Holohan J, 2013, COST NOT EXPANDING M; Levitt L., 2013, NUMBERS YOUNG INVINC; Lucia K., 2014, EXTENDED FIX CANCELE; McCue Michael J, 2013, Issue Brief (Commonw Fund), V35, P1; Radley DC, 2014, AIMING HIGHER RESULT; Schoen C., 2014, AM UNDERINSURED STAT, DOI 10.15868/socialsector.25071; Sommers B, 2014, HLTH AFF         APR; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552	14	138	138	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					275	281		10.1056/NEJMhpr1405667	http://dx.doi.org/10.1056/NEJMhpr1405667			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	24988300				2022-12-28	WOS:000338999800014
J	Gould, A; Udalski, A; Shin, IG; Porritt, I; Skowron, J; Han, C; Yee, JC; Kozlowski, S; Choi, JY; Poleski, R; Wyrzykowski, L; Ulaczyk, K; Pietrukowicz, P; Mroz, P; Szymanski, MK; Kubiak, M; Soszynski, I; Pietrzynski, G; Gaudi, BS; Christie, GW; Drummond, J; McCormick, J; Natusch, T; Ngan, H; Tan, TG; Albrow, M; DePoy, DL; Hwang, KH; Jung, YK; Lee, CU; Park, H; Pogge, RW; Abe, F; Bennett, DP; Bond, IA; Botzler, CS; Freeman, M; Fukui, A; Fukunaga, D; Itow, Y; Koshimoto, N; Larsen, P; Ling, CH; Masuda, K; Matsubara, Y; Muraki, Y; Namba, S; Ohnishi, K; Philpott, L; Rattenbury, NJ; Saito, T; Sullivan, DJ; Sumi, T; Suzuki, D; Tristram, PJ; Tsurumi, N; Wada, K; Yamai, N; Yock, PCM; Yonehara, A; Shvartzvald, Y; Maoz, D; Kaspi, S; Friedmann, M				Gould, A.; Udalski, A.; Shin, I. -G.; Porritt, I.; Skowron, J.; Han, C.; Yee, J. C.; Kozlowski, S.; Choi, J. -Y.; Poleski, R.; Wyrzykowski, L.; Ulaczyk, K.; Pietrukowicz, P.; Mroz, P.; Szymanski, M. K.; Kubiak, M.; Soszynski, I.; Pietrzynski, G.; Gaudi, B. S.; Christie, G. W.; Drummond, J.; McCormick, J.; Natusch, T.; Ngan, H.; Tan, T. -G.; Albrow, M.; DePoy, D. L.; Hwang, K. -H.; Jung, Y. K.; Lee, C. -U.; Park, H.; Pogge, R. W.; Abe, F.; Bennett, D. P.; Bond, I. A.; Botzler, C. S.; Freeman, M.; Fukui, A.; Fukunaga, D.; Itow, Y.; Koshimoto, N.; Larsen, P.; Ling, C. H.; Masuda, K.; Matsubara, Y.; Muraki, Y.; Namba, S.; Ohnishi, K.; Philpott, L.; Rattenbury, N. J.; Saito, To.; Sullivan, D. J.; Sumi, T.; Suzuki, D.; Tristram, P. J.; Tsurumi, N.; Wada, K.; Yamai, N.; Yock, P. C. M.; Yonehara, A.; Shvartzvald, Y.; Maoz, D.; Kaspi, S.; Friedmann, M.		OGLE Team; FUN Team Microlensing Follow; MOA Team Microlensing Observations; Wise Team Wise Observ	A terrestrial planet in a similar to 1-AU orbit around one member of a similar to 15-AU binary	SCIENCE			English	Article							MICROLENSING OBSERVATIONS; GALACTIC BULGE; SYSTEMS; STARS; COMPANION; PARALLAX; LENS	Using gravitational microlensing, we detected a cold terrestrial planet orbiting one member of a binary star system. The planet has low mass (twice Earth's) and lies projected at similar to 0.8 astronomical units (AU) from its host star, about the distance between Earth and the Sun. However, the planet's temperature is much lower, <60 Kelvin, because the host star is only 0.10 to 0.15 solar masses and therefore more than 400 times less luminous than the Sun. The host itself orbits a slightly more massive companion with projected separation of 10 to 15 AU. This detection is consistent with such systems being very common. Straightforward modification of current microlensing search strategies could increase sensitivity to planets in binary systems. With more detections, such binary-star planetary systems could constrain models of planet formation and evolution.	[Gould, A.; Yee, J. C.; Poleski, R.; Pietrzynski, G.; Gaudi, B. S.; Pogge, R. W.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Udalski, A.; Shin, I. -G.; Skowron, J.; Kozlowski, S.; Choi, J. -Y.; Poleski, R.; Wyrzykowski, L.; Ulaczyk, K.; Pietrukowicz, P.; Mroz, P.; Szymanski, M. K.; Kubiak, M.; Soszynski, I.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Han, C.; Hwang, K. -H.; Jung, Y. K.; Park, H.] Chungbuk Natl Univ, Dept Phys, Cheongju 371763, South Korea; [Porritt, I.] Turitea Observ, Palmerston North, New Zealand; [Yee, J. C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Wyrzykowski, L.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Pietrzynski, G.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Christie, G. W.] Auckland Observ, Auckland, New Zealand; [Drummond, J.; Natusch, T.; Ngan, H.] Possum Observ, Patutahi, New Zealand; [McCormick, J.] Farm Cove Observ, Ctr Backyard Astrophys, Auckland, New Zealand; [Natusch, T.] Auckland Univ Technol, Auckland, New Zealand; [Tan, T. -G.] Perth Exoplanet Survey Telescope, Perth, WA, Australia; [Albrow, M.] Univ Canterbury, Dept Phys & Astron, Christchurch 1, New Zealand; [DePoy, D. L.] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Lee, C. -U.] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [Abe, F.; Fukunaga, D.; Itow, Y.; Masuda, K.; Matsubara, Y.; Muraki, Y.; Tsurumi, N.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Bennett, D. P.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Bond, I. A.; Ling, C. H.] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand; [Botzler, C. S.; Freeman, M.; Larsen, P.; Rattenbury, N. J.; Yock, P. C. M.] Univ Auckland, Dept Phys, Auckland 1001, New Zealand; [Fukui, A.] Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; [Koshimoto, N.; Namba, S.; Sumi, T.; Suzuki, D.; Wada, K.] Osaka Univ, Dept Earth & Space Sci, Osaka 5600043, Japan; [Ohnishi, K.] Nagano Natl Coll Technol, Nagano 3818550, Japan; [Saito, To.] Tokyo Metropolitan Coll Aeronaut, Tokyo 1168523, Japan; [Sullivan, D. J.] Victoria Univ, Sch Chem & Phys Sci, Wellington, New Zealand; [Tristram, P. J.] Mt John Univ Observ, Lake Tekapo 8770, New Zealand; [Yamai, N.; Yonehara, A.] Kyoto Sangyo Univ, Fac Sci, Dept Phys, Kyoto 6038555, Japan; [Shvartzvald, Y.; Maoz, D.; Kaspi, S.; Friedmann, M.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Larsen, P.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Philpott, L.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada	University System of Ohio; Ohio State University; University of Warsaw; Warsaw University Observatory; Chungbuk National University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Cambridge; Universidad de Concepcion; Auckland University of Technology; University of Canterbury; Texas A&M University System; Texas A&M University College Station; Korea Astronomy & Space Science Institute (KASI); Nagoya University; University of Notre Dame; Massey University; University of Auckland; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Osaka University; Tokyo Metropolitan University; Victoria University Wellington; Kyoto Sangyo University; Tel Aviv University; University of Cambridge; University of British Columbia	Han, C (corresponding author), Chungbuk Natl Univ, Dept Phys, Cheongju 371763, South Korea.	cheongho@astroph.chungbuk.ac.kr	Szymański, Michał K/H-6951-2018; Fukui, Akihiko/W-2238-2017; Rattenbury, Nicholas James/ABB-2102-2021; Fukui, Akihiko/ABE-4506-2020; Kozlowski, Szymon/G-4799-2013; Szymański, Michał Krzysztof/X-5627-2019; Mroz, Przemek/ABH-9105-2020; Poleski, Radoslaw/AAM-7565-2021; Skowron, Jan/M-5186-2014; Choi, Joon-Young/AAW-1243-2020; Fukui, Akihiko/ABF-2092-2021	Szymański, Michał K/0000-0002-0548-8995; Fukui, Akihiko/0000-0002-4909-5763; Rattenbury, Nicholas James/0000-0001-5069-319X; Kozlowski, Szymon/0000-0003-4084-880X; Szymański, Michał Krzysztof/0000-0002-0548-8995; Poleski, Radoslaw/0000-0002-9245-6368; Skowron, Jan/0000-0002-2335-1730; Choi, Joon-Young/0000-0002-4359-8327; Mroz, Przemek/0000-0001-7016-1692; Philpott, Lydia/0000-0002-5286-8528; Lee, Chung-Uk/0000-0003-0043-3925; Porritt, Ian/0000-0001-6998-3402; Ulaczyk, Krzysztof/0000-0001-6364-408X; Albrow, Michael/0000-0003-3316-4012; Tan, Thiam-Guan/0000-0001-5603-6895; Yock, Philip/0000-0001-9716-7752	NSF [AST-1103471, AST-1211875]; NASA [NNGX12AB99G, NNX13AF64G]; Ohio State University fellowship; NASA Sagan fellowship; ERC AdG [246678]; IDEAS program; Polish MNiSW [IP2011026771]; Korea NRF CRIP [2009-0081561]; U.S.-Israel BSF; New Zealand Marsden Fund; Israel SF PBC-ICORE [1829/12];  [JSPS23340044];  [JSPS24253004]; Grants-in-Aid for Scientific Research [26247023] Funding Source: KAKEN; Direct For Mathematical & Physical Scien [1103471] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Ohio State University fellowship; NASA Sagan fellowship; ERC AdG; IDEAS program; Polish MNiSW(Ministry of Science and Higher Education, Poland); Korea NRF CRIP; U.S.-Israel BSF(US-Israel Binational Science Foundation); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Israel SF PBC-ICORE; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from NSF AST-1103471 (A. G., B. S. G., and J.C.Y.); NSF AST-1211875 (D. P. B.); NASA NNGX12AB99G (A. G., B. S. G., and R. W. P.); NASA NNX13AF64G (D. P. B.); Ohio State University fellowship and NASA Sagan fellowship (J.C.Y.); ERC AdG 246678 and IDEAS program (A. U.); Polish MNiSW IP2011026771 (S. K.); Korea NRF CRIP 2009-0081561 (C. H.); U.S.-Israel BSF (A. G. and D. M.); JSPS23340044 and JSPS24253004 (T. S.); New Zealand Marsden Fund (P.C.M.Y.); and Israel SF PBC-ICORE 1829/12 (D. M.). Data are available at astroph.chungbuk.ac.kr/similar to cheongho/OB130341/data.html.	Barbieri M, 2002, ASTRON ASTROPHYS, V396, P219, DOI 10.1051/0004-6361:20021357; Bond IA, 2001, MON NOT R ASTRON SOC, V327, P868, DOI 10.1046/j.1365-8711.2001.04776.x; Cassan A, 2012, NATURE, V481, P167, DOI 10.1038/nature10684; Dong SB, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/53; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Dumusque X, 2012, NATURE, V491, P207, DOI 10.1038/nature11572; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; Gaudi BS, 2012, ANNU REV ASTRON ASTR, V50, P411, DOI 10.1146/annurev-astro-081811-125518; Gould A, 1999, ASTROPHYS J, V516, P236, DOI 10.1086/307114; Gould A, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L28; Hatzes AP, 2003, ASTROPHYS J, V599, P1383, DOI 10.1086/379281; Kennedy GM, 2008, ASTROPHYS J, V673, P502, DOI 10.1086/524130; Lee DW, 2008, ASTROPHYS J, V672, P623, DOI 10.1086/523662; Mayor M, 2011, ASTRON ASTROPHYS; Petigura EA, 2013, P NATL ACAD SCI USA, V110, P19273, DOI 10.1073/pnas.1319909110; Quintana EV, 2007, ASTROPHYS J, V660, P807, DOI 10.1086/512542; Rafikov RR, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/1/L8; Shvartzvald Y, 2012, MON NOT R ASTRON SOC, V419, P3631, DOI 10.1111/j.1365-2966.2011.20014.x; Smith MC, 2003, MON NOT R ASTRON SOC, V339, P925, DOI 10.1046/j.1365-8711.2003.06183.x; Sumi T, 2003, ASTROPHYS J, V591, P204, DOI 10.1086/375212; Swift JJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/105; Welsh WF, 2012, NATURE, V481, P475, DOI 10.1038/nature10768; Yoo J, 2004, ASTROPHYS J, V603, P139, DOI 10.1086/381241; Zhu W., 2014, ASTROPHYS J; Zucker S, 2004, ASTRON ASTROPHYS, V426, P695, DOI 10.1051/0004-6361:20040384	26	73	73	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					46	49		10.1126/science.1251527	http://dx.doi.org/10.1126/science.1251527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994642	Green Submitted			2022-12-28	WOS:000338284400044
J	Lee, K; Fallahazad, B; Xue, JM; Dillen, DC; Kim, K; Taniguchi, T; Watanabe, K; Tutuc, E				Lee, Kayoung; Fallahazad, Babak; Xue, Jiamin; Dillen, David C.; Kim, Kyounghwan; Taniguchi, Takashi; Watanabe, Kenji; Tutuc, Emanuel			Chemical potential and quantum Hall ferromagnetism in bilayer graphene	SCIENCE			English	Article							BROKEN-SYMMETRY STATES; PHASE	Bilayer graphene has a distinctive electronic structure influenced by a complex interplay between various degrees of freedom. We probed its chemical potential using double bilayer graphene heterostructures, separated by a hexagonal boron nitride dielectric. The chemical potential has a nonlinear carrier density dependence and bears signatures of electron-electron interactions. The data allowed a direct measurement of the electric field-induced bandgap at zero magnetic field, the orbital Landau level (LL) energies, and the broken-symmetry quantum Hall state gaps at high magnetic fields. We observe spin-to-valley polarized transitions for all half-filled LLs, as well as emerging phases at filling factors v = 0 and v = +/- 2. Furthermore, the data reveal interaction-driven negative compressibility and electron-hole asymmetry in N = 0, 1 LLs.	[Lee, Kayoung; Fallahazad, Babak; Xue, Jiamin; Dillen, David C.; Kim, Kyounghwan; Tutuc, Emanuel] Univ Texas Austin, Microelect Res Ctr, Austin, TX 78758 USA; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	University of Texas System; University of Texas Austin; National Institute for Materials Science	Tutuc, E (corresponding author), Univ Texas Austin, Microelect Res Ctr, 10100 Burnet Rd, Austin, TX 78758 USA.	etutuc@mer.utexas.edu	WATANABE, Kenji/H-2825-2011; TANIGUCHI, Takashi/H-2718-2011	WATANABE, Kenji/0000-0003-3701-8119; 	Office of Naval Research, Nanoelectronics Research Initiative; Intel; Grants-in-Aid for Scientific Research [26248061] Funding Source: KAKEN	Office of Naval Research, Nanoelectronics Research Initiative; Intel(Intel Corporation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Office of Naval Research, Nanoelectronics Research Initiative, and Intel. We thank A. H. MacDonald, R. Cote, P. Kim, and F. Ghahari for discussions.	Borghi G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155403; Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Henriksen EA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.041412; Kharitonov M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.046803; Kim S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016803; Lambert J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115415; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; Min HK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155115; Nakamura M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266804; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Rutter GM, 2011, NAT PHYS, V7, P649, DOI [10.1038/NPHYS1988, 10.1038/nphys1988]; Yu GL, 2013, P NATL ACAD SCI USA, V110, P3282, DOI 10.1073/pnas.1300599110	25	101	101	5	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					58	61		10.1126/science.1251003	http://dx.doi.org/10.1126/science.1251003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994645	Green Submitted			2022-12-28	WOS:000338284400047
J	Huang, BL; Mackem, S				Huang, Bau-Lin; Mackem, Susan			EVOLUTIONARY DEVELOPMENTAL BIOLOGY Use it or lose it	NATURE			English	Editorial Material							VERTEBRATE LIMB; DIGIT LOSS; REDUCTION		[Huang, Bau-Lin; Mackem, Susan] NCI, Ctr Canc Res, Canc & Dev Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Huang, BL (corresponding author), NCI, Ctr Canc Res, Canc & Dev Biol Lab, Frederick, MD 21702 USA.	mackems@mail.nih.gov	Huang, Bau-Lin/S-4133-2019; Huang, Bau-Lin/K-8317-2019	Huang, Bau-Lin/0000-0003-3747-6697; 	NATIONAL CANCER INSTITUTE [ZIABC011119, ZIABC011118] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Butterfield NC, 2010, CURR TOP DEV BIOL, V90, P319, DOI 10.1016/S0070-2153(10)90009-4; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Cooper KL, 2014, NATURE, V511, P41, DOI 10.1038/nature13496; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; de Bakker MAG, 2013, NATURE, V500, P445, DOI 10.1038/nature12336; Lopez-Rios J, 2014, NATURE, V511, P46, DOI 10.1038/nature13289; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	12	4	4	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					34	35		10.1038/nature13509	http://dx.doi.org/10.1038/nature13509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990735				2022-12-28	WOS:000338199400024
J	Cook, D; Rocker, G				Cook, Deborah; Rocker, Graeme			Dying with Dignity in the Intensive Care Unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OF-LIFE CARE; SURROGATE DECISION-MAKERS; FAMILY-MEMBERS; MECHANICAL VENTILATION; PALLIATIVE CARE; RANDOMIZED-TRIAL; END; ICU; SUPPORT; RECOMMENDATIONS	THE TRADITIONAL GOALS OF INTENSIVE CARE ARE TO REDUCE THE -morbidity and mortality associated with critical illness, maintain organ function, and restore health. Despite technological advances, death in the intensive care unit (ICU) remains commonplace. Death rates vary widely within and among countries and are influenced by many factors.(1) Comparative international data are lacking, but an estimated one in five deaths in the United States occurs in a critical care bed.(2) In this review, we address the concept of dignity for patients dying in the ICU. When the organ dysfunction of critical illness defies treatment, when the goals of care can no longer be met, or when life support is likely to result in outcomes that are incongruent with patients' values, ICU clinicians must ensure that patients die with dignity. The definition of "dying with dignity" recognizes the intrinsic, unconditional quality of human worth but also external qualities of physical comfort, autonomy, meaningfulness, preparedness, and interpersonal connection.(3) Respect should be fostered by being mindful of the "ABCDs" of dignity-conserving care (attitudes, behaviors, compassion, and dialogue)(4) (Table 1). Preserving the dignity of patients, avoiding harm, and preventing or resolving conflict are conditions of the privilege and responsibility of caring for patients at the end of life. In our discussion of principles, evidence, and practices, we assume that there are no extant conflicts between the ICU team and the patient's family. Given the scope of this review, readers are referred elsewhere for guidance on conflict prevention and resolution in the ICU.(5,6) The concept of dying with dignity in the ICU implies that although clinicians may forgo some treatments, care can be enhanced as death approaches. Fundamental to maintaining dignity is the need to understand a patient's unique perspectives on what gives life meaning in a setting replete with depersonalizing devices. The goal is caring for patients in a manner that is consistent with their values at a time of incomparable vulnerability, when they rarely can speak for themselves. 7 For example, patients who value meaningful relationships may decline life-prolonging measures when such relationships are no longer possible. Conversely, patients for whom physical autonomy is not crucial may accept technological dependence if it confers a reasonable chance of an acceptable, albeit impaired, outcome. 8 At issue is what each patient would be willing to undergo for a given probability of survival and anticipated quality of life.	[Cook, Deborah] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Cook, Deborah] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8N 3Z5, Canada; [Cook, Deborah] McMaster Univ, Dept Biostat, Hamilton, ON L8N 3Z5, Canada; [Rocker, Graeme] Dalhousie Univ, Dept Med, Halifax, NS, Canada	McMaster University; McMaster University; McMaster University; Dalhousie University	Cook, D (corresponding author), McMaster Univ, Hlth Sci Ctr, Rm 2C11,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	debcook@mcmaster.ca						Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Back Anthony L, 2003, Ann Intern Med, V138, P439; Bowman K, 2010, END LIFE CARE INTENS; Brush DR, 2012, AM J RESP CRIT CARE, V186, P633, DOI 10.1164/rccm.201202-0354OC; Bulow HH, 2008, INTENS CARE MED, V34, P423, DOI 10.1007/s00134-007-0973-8; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; Chochinov H, 2007, BRIT MED J, V335, P184, DOI 10.1136/bmj.39244.650926.47; Choong K, 2010, CLIN INVEST MED, V33, pE240; Clarke EB, 2003, CRIT CARE MED, V31, P2255, DOI 10.1097/01.CCM.0000084849.96385.85; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Cook DJ, 1999, CAN MED ASSOC J, V161, P1109; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Curtis JR, 2007, CRIT CARE MED, V35, P932, DOI 10.1097/01.CCM.0000256725.73993.74; Curtis JR, 2011, AM J RESP CRIT CARE, V183, P348, DOI 10.1164/rccm.201006-1004OC; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Drazen JM, 2003, NEW ENGL J MED, V349, P1109, DOI 10.1056/NEJMp038146; Heyland DK, 2002, CRIT CARE MED, V30, P1413, DOI 10.1097/00003246-200207000-00002; Heyland DK, 2003, INTENS CARE MED, V29, P75, DOI 10.1007/s00134-002-1569-y; Heyland DK, 2006, CAN MED ASSOC J, V174, P627, DOI 10.1503/cmaj.050626; Hough CL, 2005, J CRIT CARE, V20, P20, DOI 10.1016/j.jcrc.2004.09.006; Kompanje EJO, 2008, INTENS CARE MED, V34, P1593, DOI 10.1007/s00134-008-1172-y; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lilly CM, 2007, NEW ENGL J MED, V356, P513, DOI 10.1056/NEJMe068253; Majesko A, 2012, CRIT CARE MED, V40, P2281, DOI 10.1097/CCM.0b013e3182533317; Maugans TA, 1996, ARCH FAM MED, V5, P11, DOI 10.1001/archfami.5.1.11; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Nelson JE, 2006, QUAL SAF HEALTH CARE, V15, P264, DOI 10.1136/qshc.2005.017707; Nelson JE, 2006, CRIT CARE MED, V34, P2547, DOI 10.1097/01.CCM.0000239233.63425.1D; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Prendergast TJ, 2010, END LIFE CARE ICU AD, P202; Proulx Kathryn, 2004, Am J Hosp Palliat Care, V21, P116, DOI 10.1177/104990910402100209; Scheunemann LP, 2012, AM J RESP CRIT CARE, V186, P480, DOI 10.1164/rccm.201204-0710CP; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Simpson C, 2004, BIOETHICS, V18, P428, DOI 10.1111/j.1467-8519.2004.00408.x; Sinuff T, 2009, CRIT CARE MED, V37, P154, DOI 10.1097/CCM.0b013e318192fb7c; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Sulmasy DP, 2009, CHEST, V135, P1634, DOI 10.1378/chest.08-2241; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; Wall RJ, 2007, CHEST, V132, P1425, DOI 10.1378/chest.07-0419; White DB, 2007, ARCH INTERN MED, V167, P461, DOI 10.1001/archinte.167.5.461; White DB, 2009, AM J RESP CRIT CARE, V180, P320, DOI 10.1164/rccm.200811-1776OC; World Health Organization, WHO DEF PALL CAR; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008; [No title captured]	50	154	168	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2506	2514		10.1056/NEJMra1208795	http://dx.doi.org/10.1056/NEJMra1208795			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963569				2022-12-28	WOS:000337804400008
J	Gladstone, DJ; Spring, M; Dorian, P; Panzov, V; Thorpe, KE; Hall, J; Vaid, H; O'Donnell, M; Laupacis, A; Cote, R; Sharma, M; Blakely, JA; Shuaib, A; Hachinski, V; Coutts, SB; Sahlas, DJ; Teal, P; Yip, S; Spence, JD; Buck, B; Verreault, S; Casaubon, LK; Penn, A; Selchen, D; Jin, A; Howse, D; Mehdiratta, M; Boyle, K; Aviv, R; Kapral, MK; Mamdani, M				Gladstone, David J.; Spring, Melanie; Dorian, Paul; Panzov, Val; Thorpe, Kevin E.; Hall, Judith; Vaid, Haris; O'Donnell, Martin; Laupacis, Andreas; Cote, Robert; Sharma, Mukul; Blakely, John A.; Shuaib, Ashfaq; Hachinski, Vladimir; Coutts, Shelagh B.; Sahlas, Demetrios J.; Teal, Phil; Yip, Samuel; Spence, J. David; Buck, Brian; Verreault, Steve; Casaubon, Leanne K.; Penn, Andrew; Selchen, Daniel; Jin, Albert; Howse, David; Mehdiratta, Manu; Boyle, Karl; Aviv, Richard; Kapral, Moira K.; Mamdani, Muhammad		EMBRACE Investigators Coordinators	Atrial Fibrillation in Patients with Cryptogenic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART RHYTHM ASSOCIATION; ISCHEMIC-STROKE; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; TASK-FORCE; ANTICOAGULATION; RISK; RECOMMENDATIONS; CLASSIFICATION; COLLABORATION	BACKGROUND Atrial fibrillation is a leading preventable cause of recurrent stroke for which early detection and treatment are critical. However, paroxysmal atrial fibrillation is often asymptomatic and likely to go undetected and untreated in the routine care of patients with ischemic stroke or transient ischemic attack (TIA). METHODS We randomly assigned 572 patients 55 years of age or older, without known atrial fibrillation, who had had a cryptogenic ischemic stroke or TIA within the previous 6 months (cause undetermined after standard tests, including 24-hour electrocardiography [ECG]), to undergo additional noninvasive ambulatory ECG monitoring with either a 30-day event-triggered recorder (intervention group) or a conventional 24-hour monitor (control group). The primary outcome was newly detected atrial fibrillation lasting 30 seconds or longer within 90 days after randomization. Secondary outcomes included episodes of atrial fibrillation lasting 2.5 minutes or longer and anticoagulation status at 90 days. RESULTS Atrial fibrillation lasting 30 seconds or longer was detected in 45 of 280 patients (16.1%) in the intervention group, as compared with 9 of 277 (3.2%) in the control group (absolute difference, 12.9 percentage points; 95% confidence interval [CI], 8.0 to 17.6; P<0.001; number needed to screen, 8). Atrial fibrillation lasting 2.5 minutes or longer was present in 28 of 284 patients (9.9%) in the intervention group, as compared with 7 of 277 (2.5%) in the control group (absolute difference, 7.4 percentage points; 95% CI, 3.4 to 11.3; P<0.001). By 90 days, oral anticoagulant therapy had been prescribed for more patients in the intervention group than in the control group (52 of 280 patients [18.6%] vs. 31 of 279 [11.1%]; absolute difference, 7.5 percentage points; 95% CI, 1.6 to 13.3; P = 0.01). CONCLUSIONS Among patients with a recent cryptogenic stroke or TIA who were 55 years of age or older, paroxysmal atrial fibrillation was common. Noninvasive ambulatory ECG monitoring for a target of 30 days significantly improved the detection of atrial fibrillation by a factor of more than five and nearly doubled the rate of anti-coagulant treatment, as compared with the standard practice of short-duration ECG monitoring.	[Gladstone, David J.] Univ Toronto, Div Neurol, Toronto, ON, Canada; [Gladstone, David J.; Dorian, Paul; Laupacis, Andreas; Sharma, Mukul; Blakely, John A.; Casaubon, Leanne K.; Selchen, Daniel; Mehdiratta, Manu; Boyle, Karl; Kapral, Moira K.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Thorpe, Kevin E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gladstone, David J.] Univ Toronto, Stroke Program, Toronto, ON, Canada; [Gladstone, David J.; Aviv, Richard] Sunnybrook Hlth Sci Ctr, Div Neurol, Dept Med, Toronto, ON M4N 3M5, Canada; [Gladstone, David J.; Aviv, Richard] Sunnybrook Hlth Sci Ctr, Brain Sci Program, Toronto, ON M4N 3M5, Canada; [Gladstone, David J.; Aviv, Richard] Sunnybrook Res Inst, Toronto, ON, Canada; [Gladstone, David J.] Heart & Stroke Fdn Canadian Partnership Stroke Re, Toronto, ON, Canada; [Panzov, Val; Thorpe, Kevin E.; Hall, Judith; Vaid, Haris; Laupacis, Andreas; Mamdani, Muhammad] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Gladstone, David J.; Sharma, Mukul] McMaster Univ, Hamilton, ON, Canada; [Cote, Robert] McGill Univ, Montreal, PQ, Canada; [Shuaib, Ashfaq; Buck, Brian] Univ Alberta, Edmonton, AB, Canada; [Hachinski, Vladimir; Spence, J. David] Univ Western Ontario, London, ON, Canada; [Coutts, Shelagh B.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci & Radiol, Calgary, AB, Canada; [Teal, Phil; Yip, Samuel] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Jin, Albert] Queens Univ, Kingston, ON, Canada; [Howse, David] Thunder Bay Reg Hlth Sci Ctr, Thunder Bay, ON, Canada; [Verreault, Steve] Univ Laval, Quebec City, PQ, Canada; [Penn, Andrew] Vancouver Isl Hlth Res Ctr, Victoria, BC, Canada; [O'Donnell, Martin] Natl Univ Ireland, Galway, Ireland	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McGill University; University of Alberta; Western University (University of Western Ontario); University of Calgary; University of British Columbia; Queens University - Canada; Northern Ontario School of Medicine; Laval University; Vancouver Island Health Authority; Ollscoil na Gaillimhe-University of Galway	Gladstone, DJ (corresponding author), Sunnybrook Hlth Sci Ctr, Reg Stroke Ctr, A442-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.gladstone@sunnybrook.ca	O'Donnell, Martin/ABE-7459-2020; Hill, Michael D/C-9073-2012; Barber, Philip A/C-7108-2016; Buck, Brian H/B-8482-2009; Spence, J. David/K-6396-2013	O'Donnell, Martin/0000-0002-7347-7761; Hill, Michael D/0000-0002-6269-1543; Buck, Brian H/0000-0002-7984-6062; Spence, J. David/0000-0001-7478-1098; Gladstone, David/0000-0003-0612-5544; Thorpe, Kevin/0000-0002-7586-3893; Sharma, Mukul/0000-0002-6119-342X; wein, theodore/0000-0002-8994-8628	Canadian Stroke Network; Alberta Innovates [201300690] Funding Source: researchfish	Canadian Stroke Network; Alberta Innovates	Funded by the Canadian Stroke Network and others; EMBRACE ClinicalTrials.gov number, NCT00846924.	Advanced Bioelectric Corporation, 2005, EUR CARDIOL REV, V1, P1; Al-Khatib SM, 2013, EUR HEART J, V34, P2464, DOI 10.1093/eurheartj/eht135; Bal S, 2012, STROKE, V43, P3387, DOI 10.1161/STROKEAHA.112.671172; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Binici Z, 2010, CIRCULATION, V121, P1904, DOI 10.1161/CIRCULATIONAHA.109.874982; Bogiatzi C, 2013, STROKE S, V44, pA193; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Camm AJ, 2012, AM J CARDIOL, V110, P270, DOI 10.1016/j.amjcard.2012.03.021; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Culebras A, 2014, NEUROLOGY, V82, P716, DOI 10.1212/WNL.0000000000000145; Diener HC, 2013, STROKE, V44, P298, DOI 10.1161/STROKEAHA.112.658252; Esperer HD, 2008, ANN NONINVAS ELECTRO, V13, P44, DOI 10.1111/j.1542-474X.2007.00200.x; Flaker G, 2012, J AM COLL CARDIOL, V59, P854, DOI 10.1016/j.jacc.2011.10.896; Fuster V, 2007, CIRCULATION, V116, pe138; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; Glotzer TV, 2013, CAN J CARDIOL, V29, pS14, DOI 10.1016/j.cjca.2013.03.023; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Goldstein LB, 2001, STROKE, V32, P1091, DOI 10.1161/01.STR.32.5.1091; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Higgins P, 2013, STROKE, V44, P2525, DOI 10.1161/STROKEAHA.113.001927; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Kamel H, 2012, J STROKE CEREBROVASC, V21, P726, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.008; Kamel H, 2010, STROKE, V41, P1514, DOI 10.1161/STROKEAHA.110.582437; Katsnelson M, 2013, STROKE, V44, P300, DOI 10.1161/STROKEAHA.112.658260; Kirchhof P, 2007, EUROPACE, V9, P1006, DOI 10.1093/europace/eum191; Kishore A, 2014, STROKE; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Liao J, 2007, STROKE, V38, P2935, DOI 10.1161/STROKEAHA.106.478685; Molina CA, 2013, STROKE, V44, P302, DOI 10.1161/STROKEAHA.112.658278; Rabinstein AA, 2013, J STROKE CEREBROVASC, V22, P1405, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.013; Saposnik G, 2013, STROKE, V44, P99, DOI 10.1161/STROKEAHA.112.676551; Seet RCS, 2011, CIRCULATION, V124, P477, DOI 10.1161/CIRCULATIONAHA.111.029801; Spring M, 2008, STROKE, V39, P571; Wachter R, 2011, STROKE, V42, pE36, DOI 10.1161/STROKEAHA.110.604173	41	783	809	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2467	2477		10.1056/NEJMoa1311376	http://dx.doi.org/10.1056/NEJMoa1311376			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963566				2022-12-28	WOS:000337804400004
J	Hopkinson, MN; Richter, C; Schedler, M; Glorius, F				Hopkinson, Matthew N.; Richter, Christian; Schedler, Michael; Glorius, Frank			An overview of N-heterocyclic carbenes	NATURE			English	Review							CROSS-COUPLING REACTIONS; SELECTIVE OLEFIN METATHESIS; METAL-COMPLEXES; NHC LIGANDS; ASYMMETRIC HYDROGENATION; ORGANOMETALLIC CATALYSIS; HOMOGENEOUS CATALYSIS; RUTHENIUM CATALYSTS; STABLE CARBENES; ACTIVATION	The successful isolation and characterization of an N-heterocyclic carbene in 1991 opened up a new class of organic compounds for investigation. From these beginnings as academic curiosities, N-heterocyclic carbenes today rank among the most powerful tools in organic chemistry, with numerous applications in commercially important processes. Here we provide a concise overview of N-heterocyclic carbenes in modern chemistry, summarizing their general properties and uses and highlighting how these features are being exploited in a selection of pioneering recent studies.	[Hopkinson, Matthew N.; Richter, Christian; Schedler, Michael; Glorius, Frank] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany	University of Munster	Glorius, F (corresponding author), Univ Munster, Inst Organ Chem, Corrensstr 40, D-48149 Munster, Germany.	glorius@uni-muenster.de	Hopkinson, Matthew/AAC-4782-2019; Glorius, Frank/K-6385-2015	Hopkinson, Matthew/0000-0002-0183-0466; Glorius, Frank/0000-0002-0648-956X	European Research Council under the European Community [25936]; Deutsche Forschungsgemeinschaft [SFB 858]; Alexander von Humboldt Foundation; Fonds der Chemischen Industrie	European Research Council under the European Community(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank the European Research Council under the European Community's Seventh Framework Program (FP7 2007-2013)/ERC grant agreement number 25936, the Deutsche Forschungsgemeinschaft (Leibniz Award and SFB 858), the Alexander von Humboldt Foundation (to M.N.H.) and the Fonds der Chemischen Industrie (to M.S.) for financial support.	Aldeco-Perez E, 2009, SCIENCE, V326, P556, DOI 10.1126/science.1178206; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Arduengo AJ, 1998, CHEM UNSERER ZEIT, V32, P6, DOI 10.1002/ciuz.19980320103; ARDUENGO AJ, 1995, J AM CHEM SOC, V117, P11027, DOI 10.1021/ja00149a034; ARDUENGO AJ, 1992, J AM CHEM SOC, V114, P5530, DOI 10.1021/ja00040a007; Arnold PL, 2009, CHEM REV, V109, P3599, DOI 10.1021/cr8005203; Benhamou L, 2011, CHEM REV, V111, P2705, DOI 10.1021/cr100328e; Berkessel A, 2012, ANGEW CHEM INT EDIT, V51, P12370, DOI 10.1002/anie.201205878; Bezier D, 2013, ADV SYNTH CATAL, V355, P19, DOI 10.1002/adsc.201200666; Biju AT, 2011, ACCOUNTS CHEM RES, V44, P1182, DOI 10.1021/ar2000716; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; Boydston AJ, 2005, J AM CHEM SOC, V127, P12496, DOI 10.1021/ja054029k; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Bugaut X, 2012, CHEM SOC REV, V41, P3511, DOI 10.1039/c2cs15333e; CARDIN DJ, 1972, CHEM REV, V72, P545, DOI 10.1021/cr60279a006; Chen XY, 2013, ORG BIOMOL CHEM, V11, P7991, DOI 10.1039/c3ob41469h; Chiang PC, 2011, RSC CATAL SER, P399; Crabtree RH, 2005, J ORGANOMET CHEM, V690, P5451, DOI 10.1016/j.jorganchem.2005.07.099; Crudden CM, 2004, COORDIN CHEM REV, V248, P2247, DOI 10.1016/j.ccr.2004.05.013; Curran DP, 2011, ANGEW CHEM INT EDIT, V50, P10294, DOI 10.1002/anie.201102717; de Fremont P, 2009, COORDIN CHEM REV, V253, P862, DOI 10.1016/j.ccr.2008.05.018; Delaude L, 2009, EUR J INORG CHEM, P1681, DOI 10.1002/ejic.200801227; Diez-Gonzalez S, 2007, COORDIN CHEM REV, V251, P874, DOI 10.1016/j.ccr.2006.10.004; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Droge T, 2010, ANGEW CHEM INT EDIT, V49, P6940, DOI 10.1002/anie.201001865; Dumas J.B., 1835, ANN CHIM PHYS, V58, P5; Dyker CA, 2008, ANGEW CHEM INT EDIT, V47, P3206, DOI 10.1002/anie.200705620; Enders D, 2007, CHEM REV, V107, P5606, DOI 10.1021/cr068372z; Endo K, 2011, J AM CHEM SOC, V133, P8525, DOI 10.1021/ja202818v; Fevre M, 2013, CHEM SOC REV, V42, P2142, DOI 10.1039/c2cs35383k; Fortman GC, 2011, CHEM SOC REV, V40, P5151, DOI 10.1039/c1cs15088j; Fu ZQ, 2013, NAT CHEM, V5, P835, DOI [10.1038/NCHEM.1710, 10.1038/nchem.1710]; Fuchter MJ, 2010, CHEM-EUR J, V16, P12286, DOI 10.1002/chem.201001120; Glorius F, 2007, TOP ORGANOMETAL CHEM, V21, P1, DOI 10.1007/3418_2006_059; Gu SJ, 2010, CHINESE J CATAL, V31, P875, DOI 10.1016/S1872-2067(09)60089-9; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; Hartung J, 2013, J AM CHEM SOC, V135, P10183, DOI 10.1021/ja4046422; Heinemann C, 1996, J AM CHEM SOC, V118, P2023, DOI 10.1021/ja9523294; Herrmann WA, 2002, ANGEW CHEM INT EDIT, V41, P1290, DOI 10.1002/1521-3773(20020415)41:8<1290::AID-ANIE1290>3.0.CO;2-Y; HERRMANN WA, 1995, ANGEW CHEM INT EDIT, V34, P2371, DOI 10.1002/anie.199523711; Herrmann WA, 1997, ANGEW CHEM INT EDIT, V36, P2162, DOI 10.1002/anie.199721621; Hickey JL, 2008, J AM CHEM SOC, V130, P12570, DOI 10.1021/ja804027j; Hillier AC, 2003, ORGANOMETALLICS, V22, P4322, DOI 10.1021/om034016k; Hindi KM, 2009, CHEM REV, V109, P3859, DOI 10.1021/cr800500u; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jacobsen H, 2009, COORDIN CHEM REV, V253, P687, DOI 10.1016/j.ccr.2008.06.006; Kantchev EAB, 2007, ANGEW CHEM INT EDIT, V46, P2768, DOI 10.1002/anie.200601663; Keitz BK, 2012, J AM CHEM SOC, V134, P693, DOI 10.1021/ja210225e; Kinjo R, 2011, SCIENCE, V333, P610, DOI 10.1126/science.1207573; Kolychev EL, 2013, TOP CURR CHEM, V334, P121, DOI 10.1007/128_2012_379; Kuhn N, 2005, COORDIN CHEM REV, V249, P829, DOI 10.1016/j.ccr.2004.10.003; Lara P, 2011, ANGEW CHEM INT EDIT, V50, P12080, DOI 10.1002/anie.201106348; Lavallo V, 2005, ANGEW CHEM INT EDIT, V44, P5705, DOI 10.1002/anie.200501841; Lee KM, 1997, ANGEW CHEM INT EDIT, V36, P1850, DOI 10.1002/anie.199718501; Li HP, 2011, J AM CHEM SOC, V133, P12410, DOI 10.1021/ja204974m; Mahoney JK, 2013, J AM CHEM SOC, V135, P18766, DOI 10.1021/ja4104765; Marciniec B, 2009, ADV SILICON SCI, V1, P1, DOI 10.1007/978-1-4020-8172-9; Marion N, 2008, ACCOUNTS CHEM RES, V41, P1440, DOI 10.1021/ar800020y; Marion N, 2008, CHEM SOC REV, V37, P1776, DOI 10.1039/b711132k; Martin CD, 2013, CHEM SCI, V4, P3020, DOI 10.1039/c3sc51174j; Martin D, 2011, CHEM SCI, V2, P389, DOI 10.1039/c0sc00388c; Melaimi M, 2010, ANGEW CHEM INT EDIT, V49, P8810, DOI 10.1002/anie.201000165; Mercs L, 2010, CHEM SOC REV, V39, P1903, DOI 10.1039/b902238b; Moerdyk JP, 2012, J AM CHEM SOC, V134, P6116, DOI 10.1021/ja3014105; Moerdyk JP, 2012, NAT CHEM, V4, P275, DOI 10.1038/nchem.1267; Nair V, 2011, CHEM SOC REV, V40, P5336, DOI 10.1039/c1cs15139h; Nelson DJ, 2013, CHEM SOC REV, V42, P6723, DOI 10.1039/c3cs60146c; Nemcsok D, 2004, ORGANOMETALLICS, V23, P3640, DOI 10.1021/om049802j; Nolan, 2006, N HETEROCYCLIC CARBE; Normand AT, 2008, EUR J INORG CHEM, P2781, DOI 10.1002/ejic.200800323; O'Brien CJ, 2006, CHEM-EUR J, V12, P4743, DOI 10.1002/chem.200600251; OFELE K, 1968, J ORGANOMET CHEM, V12, pP42, DOI 10.1016/S0022-328X(00)88691-X; Oisaki K, 2010, J AM CHEM SOC, V132, P9262, DOI 10.1021/ja103016y; Ortega N, 2012, ANGEW CHEM INT EDIT, V51, P1710, DOI 10.1002/anie.201107811; Powell MT, 2001, J AM CHEM SOC, V123, P8878, DOI 10.1021/ja016011p; Poyatos M, 2009, CHEM REV, V109, P3677, DOI 10.1021/cr800501s; Ranganath KVS, 2013, CATAL SCI TECHNOL, V3, P2161, DOI 10.1039/c3cy00118k; Ranganath KVS, 2010, ANGEW CHEM INT EDIT, V49, P7786, DOI 10.1002/anie.201002782; Ruiz DA, 2013, ANGEW CHEM INT EDIT, V52, P7590, DOI 10.1002/anie.201303457; Runyon JW, 2011, AUST J CHEM, V64, P1165, DOI 10.1071/CH11246; Ryan SJ, 2013, CHEM SOC REV, V42, P4906, DOI 10.1039/c3cs35522e; Samojlowicz C, 2009, CHEM REV, V109, P3708, DOI 10.1021/cr800524f; Sanford MS, 2001, J AM CHEM SOC, V123, P6543, DOI 10.1021/ja010624k; Schaper LA, 2013, ANGEW CHEM INT EDIT, V52, P270, DOI 10.1002/anie.201205119; Schedler M, 2013, ANGEW CHEM INT EDIT, V52, P2585, DOI 10.1002/anie.201209291; Schumacher A, 2013, ANGEW CHEM INT EDIT, V52, P7422, DOI 10.1002/anie.201301251; Schuster O, 2009, CHEM REV, V109, P3445, DOI 10.1021/cr8005087; TOLMAN CA, 1977, CHEM REV, V77, P313, DOI 10.1021/cr60307a002; Ueng SH, 2008, J AM CHEM SOC, V130, P10082, DOI 10.1021/ja804150k; Ukai T., 1943, J PHARM SOC JPN, V63, P296; Valente C, 2012, ANGEW CHEM INT EDIT, V51, P3314, DOI 10.1002/anie.201106131; Visbal R, 2014, CHEM SOC REV, V43, P3551, DOI 10.1039/c3cs60466g; Vora HU, 2012, ADV SYNTH CATAL, V354, P1617, DOI 10.1002/adsc.201200031; Vougioukalakis GC, 2010, CHEM REV, V110, P1746, DOI 10.1021/cr9002424; Wang FJ, 2012, COORDIN CHEM REV, V256, P804, DOI 10.1016/j.ccr.2011.11.013; Wang YZ, 2008, J AM CHEM SOC, V130, P14970, DOI 10.1021/ja807828t; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768; WANZLICK HW, 1968, ANGEW CHEM INT EDIT, V7, P141, DOI 10.1002/anie.196801412; Wurtz S, 2008, ACCOUNTS CHEM RES, V41, P1523, DOI 10.1021/ar8000876; Zhukhovitskiy AV, 2013, J AM CHEM SOC, V135, P7418, DOI 10.1021/ja401965d	100	2692	2703	68	1362	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					485	496		10.1038/nature13384	http://dx.doi.org/10.1038/nature13384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965649				2022-12-28	WOS:000337806300037
J	Boseley, S				Boseley, Sarah			Simon Stevens: visionary Chief Executive of NHS England	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2117	2117		10.1016/S0140-6736(14)61019-9	http://dx.doi.org/10.1016/S0140-6736(14)61019-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24953466				2022-12-28	WOS:000337906600014
J	Heyes, CM; Frith, CD				Heyes, Cecilia M.; Frith, Chris D.			The cultural evolution of mind reading	SCIENCE			English	Review							DUAL-TASK; INFANTS; LANGUAGE; BRAIN; CHILDREN; DISBELIEF; IMPLICIT; ORIGINS; TALK	It is not just a manner of speaking: "Mind reading," or working out what others are thinking and feeling, is markedly similar to print reading. Both of these distinctly human skills recover meaning from signs, depend on dedicated cortical areas, are subject to genetically heritable disorders, show cultural variation around a universal core, and regulate how people behave. But when it comes to development, the evidence is conflicting. Some studies show that, like learning to read print, learning to read minds is a long, hard process that depends on tuition. Others indicate that even very young, nonliterate infants are already capable of mind reading. Here, we propose a resolution to this conflict. We suggest that infants are equipped with neurocognitive mechanisms that yield accurate expectations about behavior ("automatic" or "implicit" mind reading), whereas "explicit" mind reading, like literacy, is a culturally inherited skill; it is passed from one generation to the next by verbal instruction.	[Heyes, Cecilia M.] Univ Oxford All Souls Coll, Oxford OX1 4AL, England; [Heyes, Cecilia M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 4AL, England; [Frith, Chris D.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	University of Oxford; University of Oxford; University of London; University College London	Heyes, CM (corresponding author), Univ Oxford All Souls Coll, Oxford OX1 4AL, England.	cecilia.heyes@all-souls.ox.ac.uk	Frith, Chris/A-2171-2009	Frith, Chris/0000-0002-8665-0690	Wellcome Trust [091593] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apperly I. A., 2011, MINDREADERS COGNITIV; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Baldwin DA, 1996, CHILD DEV, V67, P3135, DOI 10.1111/j.1467-8624.1996.tb01906.x; Baumeister RF, 2009, PERS SOC PSYCHOL B, V35, P260, DOI 10.1177/0146167208327217; Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Brem S, 2006, NEUROIMAGE, V29, P822, DOI 10.1016/j.neuroimage.2005.09.023; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Burrow Colin, 1993, EPIC ROMANCE HOMER M; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Carpenter M., 2013, AGENCY JOINT ATTENTI, P49, DOI DOI 10.1093/ACPROF:OSO/9780199988341.003.0003; Changizi MA, 2006, AM NAT, V167, pE117, DOI 10.1086/502806; Csibra G, 2003, PHILOS T R SOC B, V358, P447, DOI 10.1098/rstb.2002.1235; de Villiers PA, 2012, BRIT J DEV PSYCHOL, V30, P188, DOI 10.1111/j.2044-835X.2011.02072.x; Dehaene S., 2009, READING BRAIN NEW SC; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Frank MC, 2009, COGNITION, V110, P160, DOI 10.1016/j.cognition.2008.11.010; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Frith U, 2012, Q J EXP PSYCHOL, V65, P2073, DOI 10.1080/17470218.2012.697178; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Goldman AI, 2006, SIMULATING MINDS; Gopnik A, 2012, PSYCHOL BULL, V138, P1085, DOI 10.1037/a0028044; Harris WV, 2013, COLUMBIA STUD CLASS, V38, P1, DOI 10.1163/9789004249875; Heyes C, 2014, DEVELOPMENTAL SCI, V17, P647, DOI 10.1111/desc.12148; Heyes C, 2014, PERSPECT PSYCHOL SCI, V9, P131, DOI 10.1177/1745691613518076; Heyes C, 2012, PHILOS T R SOC B, V367, P2181, DOI 10.1098/rstb.2012.0120; Hughes C, 2005, CHILD DEV, V76, P356, DOI 10.1111/j.1467-8624.2005.00850_a.x; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Lillard A, 1998, PSYCHOL BULL, V123, P3, DOI 10.1037/0033-2909.123.1.3; Lohmann H, 2003, CHILD DEV, V74, P1130, DOI 10.1111/1467-8624.00597; Mayer A, 2013, INT J BEHAV DEV, V37, P21, DOI 10.1177/0165025412454030; McGeer V, 2008, FOLK PSYCHOLOGY RE-ASSESSED, P137; Meins E., 2012, ACCESS LANGUAGE COGN, P23, DOI DOI 10.1093/ACPROF:OSO/9780199592722.003.0002; Meristo M., 2012, ACCESS LANGUAGE COGN, P44; O'Brien K, 2011, J CHILD PSYCHOL PSYC, V52, P713, DOI 10.1111/j.1469-7610.2011.02389.x; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Perner J, 2010, COGNITION AND NEUROPSYCHOLOGY: INTERNATIONAL PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, VOL 1, P241; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Pyers JE, 2009, PSYCHOL SCI, V20, P805, DOI 10.1111/j.1467-9280.2009.02377.x; Qureshi AW, 2010, COGNITION, V117, P230, DOI 10.1016/j.cognition.2010.08.003; Rigoni D, 2011, PSYCHOL SCI, V22, P613, DOI 10.1177/0956797611405680; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Santiesteban I, 2014, J EXP PSYCHOL HUMAN, V40, P929, DOI 10.1037/a0035175; Schlesinger M, 1999, DEVELOPMENTAL SCI, V2, P195, DOI 10.1111/1467-7687.00068; Seeger Anthony, 1981, NATURE SOC CENTRAL B; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Shahaeian A, 2011, DEV PSYCHOL, V47, P1239, DOI 10.1037/a0023899; Skerry AE, 2013, P NATL ACAD SCI USA, V110, P18728, DOI 10.1073/pnas.1312322110; Slaughter V., 2012, ACCESS LANG COGN DEV, P3; Sterelny K., 2013, EVOLVED APPRENTICE; Taumoepeau M, 2006, CHILD DEV, V77, P465, DOI 10.1111/j.1467-8624.2006.00882.x; Taumoepeau M, 2008, CHILD DEV, V79, P284, DOI 10.1111/j.1467-8624.2007.01126.x; Thurman SM, 2013, PSYCHOL SCI, V24, P1133, DOI 10.1177/0956797612467212; Tipples J, 2008, PERCEPT PSYCHOPHYS, V70, P77, DOI 10.3758/PP.70.1.77; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vetter NC, 2012, CHILD NEUROPSYCHOL, P1	64	196	202	2	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1356	+	1243091	10.1126/science.1243091	http://dx.doi.org/10.1126/science.1243091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ2YQ	24948740				2022-12-28	WOS:000337531700029
J	Macaraig, M; Burzynski, J; Varma, JK				Macaraig, Michelle; Burzynski, Joseph; Varma, Jay K.			Tuberculosis Control in New York City - A Changing Landscape	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Macaraig, Michelle; Burzynski, Joseph; Varma, Jay K.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA	New York City Department of Health & Mental Hygiene	Macaraig, M (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.							[Anonymous], 2013, CONTR ANN TUB SUMM; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Krueger K, 2010, INT J TUBERC LUNG D, V14, P779; REICHMAN LB, 1991, AM REV RESPIR DIS, V144, P741, DOI 10.1164/ajrccm/144.4.741; Warkentin J, 2013, MMWR-MORBID MORTAL W, V62, P398	5	11	11	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2362	2365		10.1056/NEJMp1402147	http://dx.doi.org/10.1056/NEJMp1402147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24941176				2022-12-28	WOS:000337353000004
J	Voorhees, RM; Fernandez, IS; Scheres, SHW; Hegde, RS				Voorhees, Rebecca M.; Fernandez, Israel S.; Scheres, Sjors H. W.; Hegde, Ramanujan S.			Structure of the Mammalian Ribosome-Sec61 Complex to 3.4 angstrom Resolution	CELL			English	Article							EM STRUCTURE DETERMINATION; ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; PROTEIN-CONDUCTING CHANNEL; NASCENT SECRETORY PROTEINS; TRANSFER-RNA; CRYO-EM; ELECTRON CRYOMICROSCOPY; TRANSLOCATION CHANNEL; ELONGATION CYCLE	Cotranslational protein translocation is a universally conserved process for secretory and membrane protein biosynthesis. Nascent polypeptides emerging from a translating ribosome are either transported across or inserted into the membrane via the ribosome-bound Sec61 channel. Here, we report structures of a mammalian ribosome-Sec61 complex in both idle and translating states, determined to 3.4 and 3.9 angstrom resolution. The data sets permit building of a near-complete atomic model of the mammalian ribosome, visualization of A/P and P/E hybrid-state tRNAs, and analysis of a nascent polypeptide in the exit tunnel. Unprecedented chemical detail is observed for both the ribosome-Sec61 interaction and the conformational state of Sec61 upon ribosome binding. Comparison of the maps from idle and translating complexes suggests how conformational changes to the Sec61 channel could facilitate translocation of a secreted polypeptide. The high-resolution structure of the mammalian ribosome-Sec61 complex provides a valuable reference for future functional and structural studies.	[Voorhees, Rebecca M.; Fernandez, Israel S.; Scheres, Sjors H. W.; Hegde, Ramanujan S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Voorhees, RM (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	voorhees@mrc-lmb.cam.ac.uk; rhegde@mrc-lmb.cam.ac.uk	Scheres, Sjors H.W./AAY-2265-2021	Scheres, Sjors H.W./0000-0002-0462-6540; VOORHEES, REBECCA/0000-0003-1640-2293; Hegde, Ramanujan/0000-0001-8338-852X; Fernandez, Israel/0000-0001-7218-1603	UK Medical Research Council [MC_UP_A022_1007, MC_UP_A025_1013, MC_U105184332]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; MRC [MC_UP_A022_1007, MC_U105184332, MC_UP_A025_1013] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013, MC_UP_A022_1007, MC_U105184332] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Kasim Sader and Vinothkumar Ragunath for help with data collection; Alice Clark for reagents; Tim Stevens for bioinformatic analysis; Christos Savva for help with sample preparation and data collection; Shaoxia Chen, Greg McMullan, Jake Grimmett, and Toby Darling for technical support; and Alan Brown, Garib Murshudov, and Paul Emsley for help with model building and refinement. We are especially grateful to V. Ramakrishnan for advice, support, and critical reading of the manuscript. This work was supported by the UK Medical Research Council (MC_UP_A022_1007 to R.S.H., MC_UP_A025_1013 to S.H.W.S.) and a Wellcome Trust postdoctoral fellowship (R.M.V.). I.S.F. is supported by grants to V. Ramakrishnan including the UK Medical Research Council (MC_U105184332), a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation.	ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CONNOLLY T, 1989, J CELL BIOL, V108, P299, DOI 10.1083/jcb.108.2.299; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; HIRSH D, 1971, J MOL BIOL, V58, P459, DOI 10.1016/0022-2836(71)90363-9; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; PALADE GE, 1955, J BIOPHYS BIOCHEM CY, V1, P59, DOI 10.1083/jcb.1.1.59; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Pool MR, 2009, J CELL BIOL, V185, P889, DOI 10.1083/jcb.200807066; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	65	228	237	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1632	1643		10.1016/j.cell.2014.05.024	http://dx.doi.org/10.1016/j.cell.2014.05.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24930395	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000340941900017
J	Khan, SS; Butler, J; Gheorghiade, M				Khan, Sadiya S.; Butler, Javed; Gheorghiade, Mihai			Management of Comorbid Diabetes Mellitus and Worsening Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTDISCHARGE OUTCOMES; ASSOCIATION		[Khan, Sadiya S.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA	Northwestern University; Feinberg School of Medicine; Emory University	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 201 E Huron St,Galter 3-150, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu		Khan, Sadiya/0000-0003-0643-1859				Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Das SR, 2004, AM HEART J, V148, P883, DOI 10.1016/j.ahj.2004.04.019; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Greenberg BH, 2007, AM HEART J, V154, P646, DOI 10.1016/j.ahj.2007.05.001; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Maggioni AP, 2013, EUR HEART J, V34, P3117, DOI 10.1093/eurheartj/eht342; Sarma S, 2013, EUR J HEART FAIL, V15, P194, DOI 10.1093/eurjhf/hfs153; Shah SJ, 2013, CIRC-HEART FAIL, V6, P184, DOI 10.1161/CIRCHEARTFAILURE.112.972794; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049	10	39	41	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2379	2380		10.1001/jama.2014.4115	http://dx.doi.org/10.1001/jama.2014.4115			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938559				2022-12-28	WOS:000337301500015
J	Lehman, R				Lehman, Richard			HISTORY LESSONS The medical reformation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Dept Primary Healthcare, Oxford OX1 2JD, England	University of Oxford	Lehman, R (corresponding author), Univ Oxford, Dept Primary Healthcare, Oxford OX1 2JD, England.	edgar.lehman@btopenworld.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g3963	10.1136/bmj.g3963	http://dx.doi.org/10.1136/bmj.g3963			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24935285				2022-12-28	WOS:000337804300008
J	Fabic, MS; Choi, Y; Bongaarts, J; Darroch, JE; Ross, JA; Stover, J; Tsui, AO; Upadhyay, J; Starbird, E				Fabic, Madeleine S.; Choi, Yoonjoung; Bongaarts, John; Darroch, Jacqueline E.; Ross, John A.; Stover, John; Tsui, Amy O.; Upadhyay, Jagdish; Starbird, Ellen			Meeting demand for family planning within a generation: the post-2015 agenda	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; TRENDS; NEED		[Fabic, Madeleine S.; Choi, Yoonjoung; Starbird, Ellen] US Agcy Int Dev, Off Populat & Reprod Hlth, Bur Global Hlth, Washington, DC 20523 USA; [Bongaarts, John] Populat Council, New York, NY 10021 USA; [Darroch, Jacqueline E.] Guttmacher Inst, New York, NY USA; [Ross, John A.] Futures Grp Int, Wallkill, NY USA; [Stover, John] Futures Inst, Glastonbury, CT USA; [Tsui, Amy O.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Upadhyay, Jagdish] UN Populat Fund, New York, NY USA	United States Agency for International Development (USAID); Population Council; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United Nations Population Fund	Starbird, E (corresponding author), US Agcy Int Dev, Off Populat & Reprod Hlth, Bur Global Hlth, Washington, DC 20523 USA.	estarbird@usaid.gov		Choi, Yoonjoung/0000-0002-1116-0937	NICHD NIH HHS [R24 HD042854] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; FP2020, 2013, FP2020 PROGR REP 201; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Open Working Group on Sustainable Development Goals, 2014, FOC AR SUST DEV GOAL; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Sanhueza H., 2007, GLOBAL FAMILY PLANNI, P105120; Singh S, 2012, ADDING IT COSTS BENE; UN Development Policy and Analysis Division, CRIT ID LEAST DEV CO; UN Economic and Social Council, 2014, REP SECR GEN FRAM AC; UNAIDS, 2013, UNAIDSPCB331317 JOIN; UNFPA, 2008, FAM PLANN ENV STAB P; United Nations, 2013, NEW GLOB PARTN ER PO; UNPD, 2013, EST PROJ FAM PLANN I; World Health Organization, 2014, ENS HUM RIGHTS PROV	18	39	39	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1928	1931		10.1016/S0140-6736(14)61055-2	http://dx.doi.org/10.1016/S0140-6736(14)61055-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	24993915	Green Accepted			2022-12-28	WOS:000354541700009
J	Stones, W; Arulkumaran, S				Stones, William; Arulkumaran, Sabaratnam			Health-care professionals in midwifery care	LANCET			English	Editorial Material							CLINICAL OFFICERS; CESAREAN-SECTION		[Stones, William] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Stones, William] Univ Malawi, Coll Med, Zomba, Malawi; [Arulkumaran, Sabaratnam] Int Federat Gynecol & Obstet, London, England	University of St Andrews; University of Malawi	Stones, W (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland.	rws6@st-andrews.ac.uk	Stones, William/R-8618-2016	Stones, William/0000-0003-0699-2381				[Anonymous], 2012, IJGO, V119, P111, DOI DOI 10.1016/J.IJGO.2012.08.002; Dickens B, 2013, INT J GYNECOL OBSTET, V120, P206, DOI 10.1016/j.ijgo.2012.10.002; Figo Safe Motherhood And Newborn H, 2009, INT J GYNECOL OBSTET, V105, P74, DOI 10.1016/j.ijgo.2008.11.007; Homer CSE, 2014, LANCET; Hounton SH, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-34; Renfrew MJ, 2014, LANCET; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; Wilson A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2600	8	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1169	+		10.1016/S0140-6736(14)60857-6	http://dx.doi.org/10.1016/S0140-6736(14)60857-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	24965822				2022-12-28	WOS:000343002600008
J	Freedman, LP; Kruk, ME				Freedman, Lynn P.; Kruk, Margaret E.			Disrespect and abuse of women in childbirth: challenging the global quality and accountability agendas	LANCET			English	Editorial Material							TANZANIA; CARE		[Freedman, Lynn P.] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth & Averting Maternal De, New York, NY 10032 USA; [Kruk, Margaret E.] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management & Better Hlth Syst, New York, NY 10032 USA	Columbia University; Columbia University	Freedman, LP (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth & Averting Maternal De, New York, NY 10032 USA.	LFP1@columbia.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432				Bowser D, 2010, EXPLORING EVIDENCE D; Center for Reproductive Rights Federation of Women Lawyers-Kenya (FIDA), 2007, FAIL DEL VIOL WOM HU; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Leonard KL, 2014, HEALTH POLICY PLANN, V29, P85, DOI 10.1093/heapol/czs137; Mselle LT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-174; Renfrew MJ, 2014, LANCET; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; Van Lerberghe W, 2014, LANCET	8	175	176	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					E42	E44		10.1016/S0140-6736(14)60859-X	http://dx.doi.org/10.1016/S0140-6736(14)60859-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965825				2022-12-28	WOS:000342630600003
J	Kapoor, A				Kapoor, Akhil			PERSONAL VIEW A train offers hope to Punjab's patients with cancer but it isn't enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Sardar Patel Med Coll & Hosp, Acharya Tulsi Reg Canc Treatment & Res Ctr, Dept Radiat Oncol, Bikaner 334003, Rajasthan, India	Sardar Patel Medical College, Bikaner	Kapoor, A (corresponding author), Sardar Patel Med Coll & Hosp, Acharya Tulsi Reg Canc Treatment & Res Ctr, Dept Radiat Oncol, Bikaner 334003, Rajasthan, India.	kapoorakhil1987@gmail.com	Kapoor, Akhil/H-4224-2019	Kapoor, Akhil/0000-0001-6006-2631				Government of Punjab, 2013, STAT WID DOOR DOOR C; Indian Railways, CONC RUL; Kaur J., 2012, GOVERNANCE NOW  0420; Kaur Raminderjeet, 2011, Indian J Hum Genet, V17, P179, DOI 10.4103/0971-6866.92100; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Nayak R., 2013, HLTH SITE       0130; Sandhu K., 2009, TRIBUNE INDIA   1001; US Environmental Protection Agency, BANN SEV RESTR PEST; US Library of Congress, COUNTR STUD	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4484	10.1136/bmj.g4484	http://dx.doi.org/10.1136/bmj.g4484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005259				2022-12-28	WOS:000338993300010
J	Kou, A; Feldman, BE; Levin, AJ; Halperin, BI; Watanabe, K; Taniguchi, T; Yacoby, A				Kou, A.; Feldman, B. E.; Levin, A. J.; Halperin, B. I.; Watanabe, K.; Taniguchi, T.; Yacoby, A.			Electron-hole asymmetric integer and fractional quantum Hall effect in bilayer graphene	SCIENCE			English	Article							BROKEN-SYMMETRY STATES; TRANSITION; PHASE	The nature of fractional quantum Hall (FQH) states is determined by the interplay between the Coulomb interaction and the symmetries of the system. The distinct combination of spin, valley, and orbital degeneracies in bilayer graphene is predicted to produce an unusual and tunable sequence of FQH states. Here, we present local electronic compressibility measurements of the FQH effect in the lowest Landau level of bilayer graphene. We observe incompressible FQH states at filling factors n = 2p + 2/3, with hints of additional states appearing at v = 2p + 3/5, where p = -2, -1, 0, and 1. This sequence breaks particle-hole symmetry and obeys a v -> v + 2 symmetry, which highlights the importance of the orbital degeneracy for many-body states in bilayer graphene.	[Kou, A.; Feldman, B. E.; Levin, A. J.; Halperin, B. I.; Yacoby, A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kou, A.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan	Harvard University; Yale University; National Institute for Materials Science	Yacoby, A (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	yacoby@physics.harvard.edu	TANIGUCHI, Takashi/H-2718-2011; WATANABE, Kenji/H-2825-2011	WATANABE, Kenji/0000-0003-3701-8119; Feldman, Benjamin/0000-0002-4962-0548	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0001819]; Science and Technology Center for Integrated Quantum Materials under NSF [DMR-1231319]; NSF [ECS-0335765]; DOE Office of Science Graduate Fellowship Program; U.S. Department of Defense (National Defense Science and Engineering Graduate Fellowship program)	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Science and Technology Center for Integrated Quantum Materials under NSF; NSF(National Science Foundation (NSF)); DOE Office of Science Graduate Fellowship Program(United States Department of Energy (DOE)); U.S. Department of Defense (National Defense Science and Engineering Graduate Fellowship program)	We thank D. A. Abanin, R. Hegde, A. H. MacDonald, B. Skinner, and I. Sodemann for useful discussions and J. D. Sanchez-Yamagishi for help with fabrication. This work is partially supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award no. DE-SC0001819. Device optimization and initial measurements were supported by the 2009 U.S. Office of Naval Research Multidisciplinary University Research Initiative on Graphene Advanced Terahertz Engineering (Gate) at the Massachusetts Institute of Technology, Harvard University, Boston University, and the Nanoelectronics Research Initiative-South West Academy of Nanoelectronics program. This material is based, in part, on work supported by the Science and Technology Center for Integrated Quantum Materials, under NSF grant DMR-1231319. Devices were fabricated at the Center for Nanoscale Systems at Harvard University, supported by NSF under grant ECS-0335765. A. K. acknowledges support from the DOE Office of Science Graduate Fellowship Program. A. J. L. is supported through a fellowship from the U.S. Department of Defense (National Defense Science and Engineering Graduate Fellowship program).	Amet F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216601; Apalkov VM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186803; Apalkov VM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.036801; Bao WZ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246601; Cote R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035445; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Feldman BE, 2012, SCIENCE, V337, P1196, DOI 10.1126/science.1224784; Ghahari F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046801; Gorbar EV, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235460; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Ilani S, 2004, NATURE, V427, P328, DOI 10.1038/nature02230; Kharitonov M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.046803; Ki DK, 2014, NANO LETT, V14, P2135, DOI 10.1021/nl5003922; Kim S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016803; Lambert J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115415; Lee DS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056602; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; McCann E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161403; Nandkishore R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156803; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Papic Z, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.046602; Papic Z, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.241306; Papic Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.176602; Peterson MR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245129; Ponomarenko LA, 2011, NAT PHYS, V7, P958, DOI [10.1038/nphys2114, 10.1038/NPHYS2114]; Shizuya K, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045431; Skinner B, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.155417; Snizhko K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.201415; Toke C, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.241411; Toke C, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115455; Velasco J, 2012, NAT NANOTECHNOL, V7, P156, DOI [10.1038/nnano.2011.251, 10.1038/NNANO.2011.251]; Yacoby A, 1999, SOLID STATE COMMUN, V111, P1, DOI 10.1016/S0038-1098(99)00139-8; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; Yu GL, 2013, P NATL ACAD SCI USA, V110, P3282, DOI 10.1073/pnas.1300599110	43	80	83	0	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					55	57		10.1126/science.1250270	http://dx.doi.org/10.1126/science.1250270			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994644	Green Submitted			2022-12-28	WOS:000338284400046
J	Friedly, JL; Comstock, BA; Turner, JA; Heagerty, PJ; Deyo, RA; Sullivan, SD; Bauer, Z; Bresnahan, BW; Avins, AL; Nedeljkovic, SS; Nerenz, DR; Standaert, C; Kessler, L; Akuthota, V; Annaswamy, T; Chen, A; Diehn, F; Firtch, W; Gerges, FJ; Gilligan, C; Goldberg, H; Kennedy, DJ; Mandel, S; Tyburski, M; Sanders, W; Sibell, D; Smuck, M; Wasan, A; Won, L; Jarvik, JG				Friedly, Janna L.; Comstock, Bryan A.; Turner, Judith A.; Heagerty, Patrick J.; Deyo, Richard A.; Sullivan, Sean D.; Bauer, Zoya; Bresnahan, Brian W.; Avins, Andrew L.; Nedeljkovic, Srdjan S.; Nerenz, David R.; Standaert, Christopher; Kessler, Larry; Akuthota, Venu; Annaswamy, Thiru; Chen, Allen; Diehn, Felix; Firtch, William; Gerges, Frederic J.; Gilligan, Christopher; Goldberg, Harley; Kennedy, David J.; Mandel, Shlomo; Tyburski, Mark; Sanders, William; Sibell, David; Smuck, Matthew; Wasan, Ajay; Won, Lawrence; Jarvik, Jeffrey G.			A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BACK-PAIN; STEROID INJECTIONS; MEDICARE POPULATION; DISABILITY; EFFICACY; GROWTH	Background Epidural glucocorticoid injections are widely used to treat symptoms of lumbar spinal stenosis, a common cause of pain and disability in older adults. However, rigorous data are lacking regarding the effectiveness and safety of these injections. Methods In a double-blind, multisite trial, we randomly assigned 400 patients who had lumbar central spinal stenosis and moderate-to-severe leg pain and disability to receive epidural injections of glucocorticoids plus lidocaine or lidocaine alone. The patients received one or two injections before the primary outcome evaluation, performed 6 weeks after randomization and the first injection. The primary outcomes were the score on the Roland-Morris Disability Questionnaire (RMDQ, in which scores range from 0 to 24, with higher scores indicating greater physical disability) and the rating of the intensity of leg pain (on a scale from 0 to 10, with 0 indicating no pain and 10 indicating "pain as bad as you can imagine"). Results At 6 weeks, there were no significant between-group differences in the RMDQ score (adjusted difference in the average treatment effect between the glucocorticoid-lidocaine group and the lidocaine-alone group, -1.0 points; 95% confidence interval [CI], -2.1 to 0.1; P = 0.07) or the intensity of leg pain (adjusted difference in the average treatment effect, -0.2 points; 95% CI, -0.8 to 0.4; P = 0.48). A pre-specified secondary subgroup analysis with stratification according to type of injection (interlaminar vs. transforaminal) likewise showed no significant differences at 6 weeks. Conclusions In the treatment of lumbar spinal stenosis, epidural injection of glucocorticoids plus lidocaine offered minimal or no short-term benefit as compared with epidural injection of lidocaine alone. (Funded by the Agency for Healthcare Research and Quality; ClinicalTrials.gov number, NCT01238536.)	[Friedly, Janna L.; Comstock, Bryan A.; Turner, Judith A.; Heagerty, Patrick J.; Sullivan, Sean D.; Bauer, Zoya; Bresnahan, Brian W.; Kessler, Larry; Jarvik, Jeffrey G.] Univ Washington, Comparat Effectiveness Cost & Outcomes Res Ctr, Seattle, WA 98104 USA; [Friedly, Janna L.; Turner, Judith A.; Standaert, Christopher] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Comstock, Bryan A.; Heagerty, Patrick J.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Bauer, Zoya; Bresnahan, Brian W.; Jarvik, Jeffrey G.] Univ Washington, Dept Radiol, Seattle, WA 98104 USA; [Bresnahan, Brian W.; Kessler, Larry] Univ Washington, Dept Hlth Serv, Seattle, WA 98104 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Internal Med, Portland, OR 97201 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Publ Hlth, Portland, OR 97201 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Prevent Med, Portland, OR 97201 USA; [Sibell, David] Oregon Hlth & Sci Univ, Dept Anesthesiol, Portland, OR 97201 USA; [Sibell, David] Oregon Hlth & Sci Univ, Dept Perioperat Med, Portland, OR 97201 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Deyo, Richard A.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Avins, Andrew L.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Chen, Allen] Kaiser Permanente Martinez Med Ctr, Dept Phys Med & Rehabil, Martinez, CA USA; [Firtch, William] Stanford Univ, Med Ctr, Dept Phys Med & Rehabil, Kaiser Permanente Redwood City Med Ctr, Redwood City, CA USA; [Kennedy, David J.; Smuck, Matthew] Stanford Univ, Med Ctr, Dept Phys Med & Rehabil, Redwood City, CA USA; [Goldberg, Harley] Kaiser Permanente San Jose Med Ctr, Spine Care Serv, San Jose, CA USA; [Won, Lawrence] Kaiser Permanente San Jose Med Ctr, Dept Phys Med & Rehabil, San Jose, CA USA; [Tyburski, Mark] Kaiser Permanente Roseville Med Ctr, Dept Phys Med & Rehabil, Roseville, CA USA; [Nedeljkovic, Srdjan S.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Nedeljkovic, Srdjan S.] Harvard Vanguard Med Associates, Spine Unit, Boston, MA USA; [Gerges, Frederic J.] Massachusetts Gen Hosp, Dept Anesthesiol & Pain Med, St Elizabeths Med Ctr, Boston, MA 02114 USA; [Gilligan, Christopher] Massachusetts Gen Hosp, Ctr Pain Med, Boston, MA 02114 USA; [Nerenz, David R.] Henry Ford Hosp, Neurosci Inst, Detroit, MI 48202 USA; [Mandel, Shlomo] Henry Ford Hlth Syst, Dept Orthoped Surg, Detroit, MI USA; [Sanders, William] Henry Ford Hlth Syst, Dept Radiol, Detroit, MI USA; [Akuthota, Venu] Univ Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Annaswamy, Thiru] Dallas Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA; [Diehn, Felix] Mayo Clin, Dept Radiol, Rochester, MN USA; [Wasan, Ajay] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Wasan, Ajay] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Stanford University; Stanford University; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Harvard University; Brigham & Women's Hospital; Harvard Vanguard Medical Associates; Harvard University; Massachusetts General Hospital; St. Elizabeth's Medical Center; Harvard University; Massachusetts General Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedly, JL (corresponding author), Univ Washington, Dept Rehabil Med, 325 Ninth Ave, Seattle, WA 98104 USA.	friedlyj@uw.edu	Wasan, Ajay D./M-8084-2019; Annaswamy, Thiru/AAE-1965-2019; Jarvik, Jeffrey/AAL-4292-2021; Gilligan, Christopher/AAL-3831-2021	Wasan, Ajay D./0000-0002-6394-6077; Annaswamy, Thiru/0000-0002-3969-9221; Gilligan, Christopher/0000-0003-4769-9907; Kennedy, David/0000-0001-8061-0287; Smuck, Matthew/0000-0002-2990-069X	Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS019222] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by the Agency for Healthcare Research and Quality; ClinicalTrials.gov number, NCT01238536.	Al-Shoha A, 2012, SPINE, V37, pE1567, DOI 10.1097/BRS.0b013e318270280e; Ammendolia C, 2012, SPINE, V37, pE609, DOI 10.1097/BRS.0b013e318240d57d; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Barre Lisha, 2004, Pain Physician, V7, P187; Bicket MC, 2013, ANESTHESIOLOGY, V119, P907, DOI 10.1097/ALN.0b013e31829c2ddd; Botwin Kenneth, 2007, Pain Physician, V10, P547; Botwin KP, 2002, AM J PHYS MED REHAB, V81, P898, DOI 10.1097/00002060-200212000-00003; BRAZIER J, 1993, QUAL LIFE RES, V2, P169, DOI 10.1007/BF00435221; Bresnahan BW, 2013, PM&R, V5, P705, DOI 10.1016/j.pmrj.2013.05.012; Briggs, 2011, PAIN PHYSICIAN, V14, P217; Briggs VG, 2010, PAIN PHYSICIAN, V13, pE347; Cohen SP, 2009, ANESTHESIOLOGY, V111, P416, DOI 10.1097/ALN.0b013e3181ac1c47; Cooper Grant, 2004, Pain Physician, V7, P311; Cosgrove JL, 2011, AM J PHYS MED REHAB, V90, P1050, DOI 10.1097/PHM.0b013e31822dea76; Daffner Scott D, 2009, Instr Course Lect, V58, P657; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Englund Jon, 2007, Curr Sports Med Rep, V6, P50, DOI 10.1007/s11932-007-0012-0; Friedly J, 2008, ARCH PHYS MED REHAB, V89, P1011, DOI 10.1016/j.apmr.2007.10.037; Friedly J, 2007, SPINE, V32, P1754, DOI 10.1097/BRS.0b013e3180b9f96e; Friedly JL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-48; Harrast MA, 2008, CURR REV MUSCULOSKE, V1, P32, DOI 10.1007/s12178-007-9003-2; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P45, DOI 10.1016/j.jclinepi.2005.03.018; KAY J, 1994, ANESTH ANALG, V79, P501; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lansang MC, 2009, ENDOCR PRACT, V15, P225, DOI 10.4158/EP.15.3.225; Lee JH, 2009, CLIN J PAIN, V25, P206, DOI 10.1097/AJP.0b013e3181878f9e; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE349; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P199; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P833; Mandel S, 2013, J BONE JOINT SURG AM, V95A, P961, DOI 10.2106/JBJS.L.00844; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland MO, 2001, SPINE, V26, P847; Schaufele Michael K, 2006, Pain Physician, V9, P361; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stucki G, 1996, SPINE, V21, P796, DOI 10.1097/00007632-199604010-00004; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; Thomas E, 2003, CLIN RHEUMATOL, V22, P299, DOI 10.1007/s10067-003-0736-z; van Eijs F, 2012, ANESTHESIOLOGY, V116, P113, DOI 10.1097/ALN.0b013e31823da45f	40	213	216	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					11	21		10.1056/NEJMoa1313265	http://dx.doi.org/10.1056/NEJMoa1313265			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988555				2022-12-28	WOS:000338265700005
J	Hawkins, E; Anderson, B; Diffenbaugh, N; Mahlstein, I; Betts, R; Hegerl, G; Joshi, M; Knutti, R; McNeall, D; Solomon, S; Sutton, R; Syktus, J; Vecchi, G				Hawkins, Ed; Anderson, Bruce; Diffenbaugh, Noah; Mahlstein, Irina; Betts, Richard; Hegerl, Gabi; Joshi, Manoj; Knutti, Reto; McNeall, Doug; Solomon, Susan; Sutton, Rowan; Syktus, Jozef; Vecchi, Gabriel			Uncertainties in the timing of unprecedented climates	NATURE			English	Letter							VARIABILITY		[Hawkins, Ed; Sutton, Rowan] Univ Reading, Dept Meteorol, Natl Ctr Atmospher Sci, Reading RG6 6BB, Berks, England; [Anderson, Bruce] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Diffenbaugh, Noah] Stanford Univ, Sch Earth Sci, Stanford, CA 94305 USA; [Diffenbaugh, Noah] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Mahlstein, Irina] MeteoSwiss, Fed Off Meteorol & Climatol, CH-8058 Zurich, Switzerland; [Betts, Richard; McNeall, Doug] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England; [Betts, Richard] Univ Exeter, Dept Geog, Exeter EX4 4RJ, Devon, England; [Hegerl, Gabi] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Joshi, Manoj] Univ E Anglia, Sch Environm Sci, Ctr Ocean & Atmospher Sci, Norwich NR4 7TJ, Norfolk, England; [Knutti, Reto] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Solomon, Susan] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Syktus, Jozef] Dept Sci Informat Technol Innovat & Arts, Brisbane, Qld 4001, Australia; [Syktus, Jozef] Univ Queensland, Brisbane, Qld 4001, Australia; [Vecchi, Gabriel] Geophys Fluids Dynam Lab, Princeton, NJ 08540 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Reading; Boston University; Stanford University; Stanford University; Federal Office of Meteorology & Climatology (MeteoSwiss); Met Office - UK; Hadley Centre; University of Exeter; University of Edinburgh; University of East Anglia; Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT); University of Queensland	Hawkins, E (corresponding author), Univ Reading, Dept Meteorol, Natl Ctr Atmospher Sci, Reading RG6 6BB, Berks, England.	e.hawkins@reading.ac.uk	Vecchi, Gabriel/A-2413-2008; Knutti, Reto/B-8763-2008; Syktus, Jozef/E-7173-2011; Betts, Richard A/P-8976-2015; Hawkins, Ed/B-7921-2011; Joshi, Manoj/C-1795-2008; Diffenbaugh, Noah S/I-5920-2014	Vecchi, Gabriel/0000-0002-5085-224X; Knutti, Reto/0000-0001-8303-6700; Syktus, Jozef/0000-0003-1782-3073; Betts, Richard A/0000-0002-4929-0307; Hawkins, Ed/0000-0001-9477-3677; Joshi, Manoj/0000-0002-2948-2811; Diffenbaugh, Noah S/0000-0002-8856-4964; Sutton, Rowan/0000-0001-8345-8583; Hegerl, Gabriele/0000-0002-4159-1295	NERC [NE/I020792/1] Funding Source: UKRI; Natural Environment Research Council [ncas10009, NE/I020792/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson BT, 2011, CLIMATIC CHANGE, V108, P581, DOI 10.1007/s10584-011-0196-4; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Diffenbaugh NS, 2011, CLIMATIC CHANGE, V107, P615, DOI 10.1007/s10584-011-0112-y; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hegerl GC, 1996, J CLIMATE, V9, P2281, DOI 10.1175/1520-0442(1996)009<2281:DGGICC>2.0.CO;2; Ho CK, 2013, CLIM DYNAM, V41, P917, DOI 10.1007/s00382-012-1531-9; IPCC, 2013, CLIMATE CHANGE 2022; Jeffrey S, 2013, AUST METEOROL OCEAN, V63, P1; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Lempert R, 2004, CLIMATIC CHANGE, V65, P1, DOI 10.1023/B:CLIM.0000037561.75281.b3; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Mahlstein I, 2013, NAT CLIM CHANGE, V3, P739, DOI [10.1038/NCLIMATE1876, 10.1038/nclimate1876]; Mahlstein I, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053952; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Nagele P, 2003, BRIT J ANAESTH, V90, P514, DOI 10.1093/bja/aeg087; Raible C. C., 2013, BIOGEOSCI DISCUSS, V10, P18065; Solomon S., 2012, NATURE CLIM CHANGE, V2, P888; Syktus J, 1997, CLIM DYNAM, V13, P293, DOI 10.1007/s003820050167	21	59	59	5	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					E3	E5		10.1038/nature13523	http://dx.doi.org/10.1038/nature13523			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990757	Green Accepted			2022-12-28	WOS:000338199400003
J	Liu, E; Lee, HS; Aronsson, CA; Hagopian, WA; Koletzko, S; Rewers, MJ; Eisenbarth, GS; Bingley, PJ; Bonifacio, E; Simell, V; Agardh, D				Liu, Edwin; Lee, Hye-Seung; Aronsson, Carin A.; Hagopian, William A.; Koletzko, Sibylle; Rewers, Marian J.; Eisenbarth, George S.; Bingley, Polly J.; Bonifacio, Ezio; Simell, Ville; Agardh, Daniel		TEDDY Study Grp	Risk of Pediatric Celiac Disease According to HLA Haplotype and Country	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE DOSAGE; AUTOIMMUNITY; ANTIBODIES; CHILDHOOD; CHILDREN; GLUTEN	Background The presence of HLA haplotype DR3-DQ2 or DR4-DQ8 is associated with an increased risk of celiac disease. In addition, nearly all children with celiac disease have serum antibodies against tissue transglutaminase (tTG). Methods We studied 6403 children with HLA haplotype DR3-DQ2 or DR4-DQ8 prospectively from birth in the United States, Finland, Germany, and Sweden. The primary end point was the development of celiac disease autoimmunity, which was defined as the presence of tTG antibodies on two consecutive tests at least 3 months apart. The secondary end point was the development of celiac disease, which was defined for the purpose of this study as either a diagnosis on biopsy or persistently high levels of tTG antibodies. Results The median follow-up was 60 months (interquartile range, 46 to 77). Celiac disease autoimmunity developed in 786 children (12%). Of the 350 children who underwent biopsy, 291 had confirmed celiac disease; an additional 21 children who did not undergo biopsy had persistently high levels of tTG antibodies. The risks of celiac disease autoimmunity and celiac disease by the age of 5 years were 11% and 3%, respectively, among children with a single DR3-DQ2 haplotype, and 26% and 11%, respectively, among those with two copies (DR3-DQ2 homozygosity). In the adjusted model, the hazard ratios for celiac disease autoimmunity were 2.09 (95% confidence interval [CI], 1.70 to 2.56) among heterozygotes and 5.70 (95% CI, 4.66 to 6.97) among homozygotes, as compared with children who had the lowest-risk genotypes (DR4-DQ8 heterozygotes or homozygotes). Residence in Sweden was also independently associated with an increased risk of celiac disease autoimmunity (hazard ratio, 1.90; 95% CI, 1.61 to 2.25). Conclusions Children with the HLA haplotype DR3-DQ2, especially homozygotes, were found to be at high risk for celiac disease autoimmunity and celiac disease early in childhood. The higher risk in Sweden than in other countries highlights the importance of studying environmental factors associated with celiac disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.)	[Liu, Edwin] Univ Colorado Denver, Digest Hlth Inst, Childrens Hosp Colorado, Aurora, CO USA; [Liu, Edwin; Rewers, Marian J.; Eisenbarth, George S.] Univ Colorado Denver, Barbara Davis Ctr, Aurora, CO USA; [Lee, Hye-Seung] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA; [Aronsson, Carin A.; Agardh, Daniel] Lund Univ, Diabet & Celiac Dis Unit, Dept Clin Sci, Malmo, Sweden; [Hagopian, William A.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Koletzko, Sibylle] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Bonifacio, Ezio] Helmholz Zentrum Munchen, Forschergrp Diabet, Neuherberg, Germany; [Bingley, Polly J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Simell, Ville] Univ Turku, Dept Pediat, Turku Univ Hosp, Turku, Finland	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of South Florida; Lund University; Pacific Northwest Diabetes Research Institute (PNDRI); University of Munich; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bristol; University of Turku	Agardh, D (corresponding author), Skane Univ Hosp SUS, Dept Pediat, Diabet & Celiac Dis Unit, Entrance 72 60 10, SE-20502 Malmo, Sweden.	daniel.agardh@med.lu.se	Bonifacio, Ezio/E-7700-2010; Ziegler, Anette-Gabriele/M-4614-2014	Bonifacio, Ezio/0000-0002-8704-4713; Ziegler, Anette-Gabriele/0000-0002-6290-5548; Carreno, Gabriela/0000-0003-4725-6225; Kurppa, Kalle/0000-0003-4757-2164; Knip, Mikael/0000-0003-0474-0033; Hyoty, Heikki/0000-0003-0370-4145; Ridewood, Sophie/0000-0002-1845-361X; Ilonen, Jorma/0000-0002-9973-2062; Elding Larsson, Helena/0000-0003-3306-1742; Virtanen, Suvi/0000-0001-8928-0878	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK063861, U01DK063861, U01DK063829, UC4DK095300, U01DK063790, UC4DK063836, UC4DK063829, UC4DK063821, U01DK063863, U01DK063865, U01DK063821, UC4DK063863, UC4DK063865, U01DK063836] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.	Andren Aronsson C, 2013, MATERN CHILD NUTR; Bazzigaluppi E, 1999, J AUTOIMMUN, V12, P51, DOI 10.1006/jaut.1998.0253; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Hummel M, 2000, DIABETOLOGIA, V43, P1005, DOI 10.1007/s001250051483; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Lernmark B, 2011, CONTEMP CLIN TRIALS, V32, P517, DOI 10.1016/j.cct.2011.03.009; Li M, 2009, AM J GASTROENTEROL, V104, P154, DOI 10.1038/ajg.2008.8; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Murray JA, 2007, CLIN GASTROENTEROL H, V5, P1406, DOI 10.1016/j.cgh.2007.08.013; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Simell S, 2005, SCAND J GASTROENTERO, V40, P1182, DOI 10.1080/00365520510024034; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Vehik K, 2013, DIABETES-METAB RES, V29, P557, DOI 10.1002/dmrr.2427; Zubillaga P, 2002, J PEDIATR GASTR NUTR, V34, P548, DOI 10.1097/00005176-200205000-00014	21	197	203	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					42	49		10.1056/NEJMoa1313977	http://dx.doi.org/10.1056/NEJMoa1313977			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988556	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000338265700008
J	Lopez-Rios, J; Duchesne, A; Speziale, D; Andrey, G; Peterson, KA; Germann, P; Unal, E; Liu, J; Floriot, S; Barbey, S; Gallard, Y; Muller-Gerbl, M; Courtney, AD; Klopp, C; Rodriguez, S; Ivanek, R; Beisel, C; Wicking, C; Iber, D; Robert, B; McMahon, AP; Duboule, D; Zeller, R				Lopez-Rios, Javier; Duchesne, Amandine; Speziale, Dario; Andrey, Guillaume; Peterson, Kevin A.; Germann, Philipp; Uenal, Erkan; Liu, Jing; Floriot, Sandrine; Barbey, Sarah; Gallard, Yves; Mueller-Gerbl, Magdalena; Courtney, Andrew D.; Klopp, Christophe; Rodriguez, Sabrina; Ivanek, Robert; Beisel, Christian; Wicking, Carol; Iber, Dagmar; Robert, Benoit; McMahon, Andrew P.; Duboule, Denis; Zeller, Rolf			Attenuated sensing of SHH by Ptch1 underlies evolution of bovine limbs	NATURE			English	Article							GENE REGULATORY NETWORKS; SONIC-HEDGEHOG; BAC LIBRARY; DEVELOPMENTAL BASIS; DIGIT NUMBER; EXPRESSION; CONSTRUCTION; RANGE; MORPHOGEN; REDUCTION	The large spectrum of limb morphologies reflects the wide evolutionary diversification of the basic pentadactyl pattern in tetrapods. In even-toed ungulates (artiodactyls, including cattle), limbs are adapted for running as a consequence of progressive reduction of their distal skeleton to symmetrical and elongated middle digits with hoofed phalanges. Here we analyse bovine embryos to establish that polarized gene expression is progressively lost during limb development in comparison to the mouse. Notably, the transcriptional upregulation of the Ptch1 gene, which encodes a Sonic hedgehog (SHH) receptor, is disrupted specifically in the bovine limb bud mesenchyme. This is due to evolutionary alteration of a Ptch1 cis-regulatory module, which no longer responds to graded SHH signalling during bovine handplate development. Our study provides a molecular explanation for the loss of digit asymmetry in bovine limb buds and suggests that modifications affecting the Ptch1 cis-regulatory landscape have contributed to evolutionary diversification of artiodactyl limbs.	[Lopez-Rios, Javier; Duchesne, Amandine; Speziale, Dario; Uenal, Erkan; Ivanek, Robert; Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Duchesne, Amandine; Floriot, Sandrine; Rodriguez, Sabrina] INRA, Genet Anim & Biol Integrat, F-78350 Jouy En Josas, France; [Andrey, Guillaume; Duboule, Denis] Fed Inst Technol Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Peterson, Kevin A.; Liu, Jing; McMahon, Andrew P.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90089 USA; [Germann, Philipp; Uenal, Erkan; Beisel, Christian; Iber, Dagmar] Fed Inst Technol Zurich, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Germann, Philipp; Uenal, Erkan; Ivanek, Robert; Beisel, Christian; Iber, Dagmar] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Barbey, Sarah; Gallard, Yves] INRA, Domaine Expt Pin Haras, F-61310 Exmes, France; [Mueller-Gerbl, Magdalena] Univ Basel, Dept Biomed, Inst Anat, CH-4056 Basel, Switzerland; [Courtney, Andrew D.; Wicking, Carol] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Klopp, Christophe] INRA, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Robert, Benoit] Inst Pasteur, F-75015 Paris, France; [Robert, Benoit] CNRS, URA 2578, F-75015 Paris, France; [Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	University of Basel; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southern California; Swiss Institute of Bioinformatics; INRAE; University of Basel; University of Queensland; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Zeller, R (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.	amandine.duchesne@jouy.inra.fr; rolf.zeller@unibas.ch	Zeller, Rolf/C-2610-2013; Lopez-Rios, Javier/D-8094-2014; Iber, Dagmar/V-2846-2019; Andrey, Guillaume/AAL-4397-2020; Klopp, Christophe/J-3164-2019; Germann, Philipp/M-6769-2015; McMahon, Andrew P/ABE-7520-2020; Wicking, Carol/J-1814-2014	Zeller, Rolf/0000-0002-3186-7403; Lopez-Rios, Javier/0000-0001-6731-3798; Iber, Dagmar/0000-0001-8051-1035; Klopp, Christophe/0000-0001-7126-5477; Germann, Philipp/0000-0002-2057-4883; Duchesne, Amandine/0000-0002-9713-2274; duboule, denis/0000-0001-9961-2960; Beisel, Christian/0000-0001-5360-2193; Wicking, Carol/0000-0002-7225-3803; Andrey, Guillaume/0000-0002-0911-4907; Ivanek, Robert/0000-0002-8403-056X	SNF [31003A_130803/146248]; University of Basel; EU [PERG-GA-2009-246576]; SystemsX.ch iPhD Grant [20101078]; INRA; ANR grant [06-MRAR-027-01]; EPFL; ERC grant SystemsHox.ch; NIH grant [NS 033642]; Australian National Health; Medical Research Council [569713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER	SNF; University of Basel; EU(European Commission); SystemsX.ch iPhD Grant; INRA; ANR grant(French National Research Agency (ANR)); EPFL; ERC grant SystemsHox.ch; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Cooper and C. Tabin for sharing their results before publication and providing camel genomic DNA. Dolphin samples were received from C. Frere and D. Duffield. Pigmy hippopotamus mouth swabs for DNA extraction were provided by S. Furrer and B. Zimmerman from the Zoo of Zurich, whereas all other artiodactyl blood samples were donated from available frozen stocks by S. and M. Hoby from the Zoo of Basel. B. Wainwright provided the Ptch1 conditional mouse line. We are grateful to E. Terszowska and A. Offinger for mouse care; V. Metis and M. Rondon for assistance in colony maintenance and collection of Prx1-Cre Ptch1<SUP>Delta c/Delta c</SUP> mouse embryos; and N. Dumesnil for assistance in collecting bovine embryos. All lentivector-mediated transgenic mouse embryos were produced by the EPFL transgenic platform, whereas conventional mouse transgenic embryos were produced commercially by Cyagen Biosciences Inc. We thank S. Beck-Cormier, A. Gritli-Linde, D. Haag-Wackernagel, Y. Lallemand, P. Zimmermann, G. Nusspaumer and A. Zuniga for technical advice and input and M. Bertaud, I. Ginez, D. Jardet and M. Moroldo for technical assistance. We are grateful to V. Taylor and members of our research groups for critical discussions and input on the manuscript. This research was supported by SNF grants 31003A_130803/146248 and the University of Basel (to R.Z.), EU reintegration grant PERG-GA-2009-246576 (to J.L.-R.), SystemsX.ch iPhD Grant 20101078 (to D.I. and R.Z.), INRA (to A.D.), ANR grant No. 06-MRAR-027-01 (to B.R.), the EPFL and ERC grant SystemsHox.ch (to D.D.), NIH grant no. NS 033642 (to A.P.M.) and Australian National Health and Medical Research Council grant no. 569713 (to C.W.).	Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bouldin CM, 2010, P NATL ACAD SCI USA, V107, P5489, DOI 10.1073/pnas.0912818107; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Budras K-D, 2011, BOVINE ANATOMY, Vsecond; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Cooper K. L., NATURE IN PRESS; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Bakker MAG, 2013, NATURE, V500, P445, DOI 10.1038/nature12336; Eggen A, 2001, GENET SEL EVOL, V33, P543, DOI 10.1051/gse:2001132; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Koyama E, 2001, DEV DYNAM, V222, P178, DOI 10.1002/dvdy.1186; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Polly P. David, 2007, P245; Prothero D.R., 2007, EVOLUTION ARTIODACTY; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P664, DOI 10.1101/pdb.prot5639; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ross DGF, 2009, SEX DEV, V3, P273, DOI 10.1159/000252791; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schibler L, 1998, MAMM GENOME, V9, P119, DOI 10.1007/s003359900701; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stern DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0028; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Vaiman D, 1999, MAMM GENOME, V10, P585, DOI 10.1007/s003359901049; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	62	76	77	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					46	+		10.1038/nature13289	http://dx.doi.org/10.1038/nature13289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990743				2022-12-28	WOS:000338199400032
J	Gallant, JR; Traeger, LL; Volkening, JD; Moffett, H; Chen, PH; Novina, CD; Phillips, GN; Anand, R; Wells, GB; Pinch, M; Guth, R; Unguez, GA; Albert, JS; Zakon, HH; Samanta, MP; Sussman, MR				Gallant, Jason R.; Traeger, Lindsay L.; Volkening, Jeremy D.; Moffett, Howell; Chen, Po-Hao; Novina, Carl D.; Phillips, George N., Jr.; Anand, Rene; Wells, Gregg B.; Pinch, Matthew; Gueth, Robert; Unguez, Graciela A.; Albert, James S.; Zakon, Harold H.; Samanta, Manoj P.; Sussman, Michael R.			NONHUMAN GENETICS Genomic basis for the convergent evolution of electric organs	SCIENCE			English	Article							GROWTH; PROTEINS; SUBUNIT; MUSCLE; SIZE; EXPRESSION; MEMBRANES; DOGS	Little is known about the genetic basis of convergent traits that originate repeatedly over broad taxonomic scales. The myogenic electric organ has evolved six times in fishes to produce electric fields used in communication, navigation, predation, or defense. We have examined the genomic basis of the convergent anatomical and physiological origins of these organs by assembling the genome of the electric eel (Electrophorus electricus) and sequencing electric organ and skeletal muscle transcriptomes from three lineages that have independently evolved electric organs. Our results indicate that, despite millions of years of evolution and large differences in the morphology of electric organ cells, independent lineages have leveraged similar transcription factors and developmental and cellular pathways in the evolution of electric organs.	[Gallant, Jason R.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Gallant, Jason R.; Zakon, Harold H.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Traeger, Lindsay L.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Traeger, Lindsay L.; Volkening, Jeremy D.; Sussman, Michael R.] Univ Wisconsin, Biotechnol Ctr, Madison, WI 53706 USA; [Volkening, Jeremy D.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Moffett, Howell; Chen, Po-Hao; Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Moffett, Howell; Chen, Po-Hao; Novina, Carl D.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Chen, Po-Hao; Novina, Carl D.] Broad Inst Harvard & MIT, Cambridge, MA 02141 USA; [Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Anand, Rene] Ohio State Univ, Coll Med, Dept Pharmacol, Wexner Med Ctr, Columbus, OH 43210 USA; [Anand, Rene] Ohio State Univ, Coll Med, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Wells, Gregg B.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77483 USA; [Pinch, Matthew; Gueth, Robert; Unguez, Graciela A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Albert, James S.] Univ Louisiana, Dept Biol, Lafayette, LA 70503 USA; [Zakon, Harold H.] Univ Texas Austin, Austin, TX 78712 USA; [Zakon, Harold H.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Samanta, Manoj P.] Systemix Inst, Redmond, WA 98053 USA	Michigan State University; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rice University; Rice University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas A&M University System; Texas A&M University College Station; New Mexico State University; University of Louisiana Lafayette; University of Texas System; University of Texas Austin; Marine Biological Laboratory - Woods Hole	Zakon, HH (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.	h.zakon@austin.utexas.edu; manoj.samanta@systemix.org; msussman@wisc.edu	Volkening, Jeremy/AAC-2454-2020; Wells, Gregg/AAU-7798-2021; Gallant, Jason/A-9629-2015	Volkening, Jeremy/0000-0002-8892-7155; Gallant, Jason/0000-0002-6528-090X	NSF grant MCB [1144012]; NSF grant CNS [1248109]; NSF grant DEB [0741450]; W.M. Keck Foundation; NIH [R01 GM084879, R01 GM088670, 1SC1GM092297-01A1]; Texas A&M University Health Science Center College of Medicine; Cornell University Center for Vertebrate Genomics; University of Wisconsin Genetics NIH Graduate Training Grant; Morgridge Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133, SC1GM092297, R01GM088670, R01GM084879] Funding Source: NIH RePORTER	NSF grant MCB; NSF grant CNS; NSF grant DEB; W.M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center College of Medicine; Cornell University Center for Vertebrate Genomics; University of Wisconsin Genetics NIH Graduate Training Grant; Morgridge Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part by NSF grants MCB no. 1144012 (M.R.S.), CNS no. 1248109 (G.A.U.), and DEB no. 0741450 (J.S.A.); the W.M. Keck Foundation Distinguished Young Scholars in Medical Research (C.D.N.); NIH grants R01 GM084879 (H.H.Z.), R01 GM088670 (R.A.), and 1SC1GM092297-01A1 (G.A.U.); the Texas A&M University Health Science Center College of Medicine (G.B.W.); the Cornell University Center for Vertebrate Genomics (J.R.G.); the University of Wisconsin Genetics NIH Graduate Training Grant (L.L.T.); and the Morgridge Graduate Fellowship (J.D.V.). E. V. Armbrust provided computing assistance, and S. B. McKay assisted with data analysis. M. P. S. acknowledges useful discussions with R. Chikhi, R. Luo, and J. Simpson. We thank J. Bayliss for dissection of E. electricus and R. Amasino for help in preparing this manuscript. M. R. S. and L. L. T. acknowledge the guidance of J. Hyman, M. Adams, and J. Speers from the University of Wisconsin Biotechnology Center for their excellent assistance in E. electricus sequencing. The raw sequencing reads have been deposited in the National Center for Biotechnology Information short-read archive for the E. electricus genome (BioProject ID: PRJNA249073) and transcriptome sequences of E. electricus, S. macrurus, E. virescens, M. electricus, and B. brachyistius (BioProject ID: PRJNA248545). The whole-genome assemblies and annotation, together with the transcriptome assemblies, are available at http://efishgenomics.zoology.msu.edu, along with BLAST and genome-browsing services.	Albert J. S., 2005, PHYSL FISHES, P431; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; BLOCK BA, 1991, AM ZOOL, V31, P726; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Darwin C., 1859, ORIGIN SPECIES MEANS, V1, pix, DOI [10.5962/bhl.title.82303, DOI 10.5962/BHL.TITLE.82303]; Datta K, 2009, J BIOL CHEM, V284, P29666, DOI 10.1074/jbc.M109.034041; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Ghanbari H, 2001, MECH DEVELOP, V101, P271, DOI 10.1016/S0925-4773(00)00572-4; Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; Kluver N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029063; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Lowe J, 2004, BBA-BIOMEMBRANES, V1661, P40, DOI 10.1016/j.bbamem.2003.11.020; Mate SE, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-20; Mothe I, 1997, MOL ENDOCRINOL, V11, P1911, DOI 10.1210/me.11.13.1911; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Unguez GA, 1998, J NEUROSCI, V18, P9924; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064	24	126	128	14	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1522	1525		10.1126/science.1254432	http://dx.doi.org/10.1126/science.1254432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970089	Green Accepted			2022-12-28	WOS:000337889900052
J	Penny, AM; Wood, R; Curtis, A; Bowyer, F; Tostevin, R; Hoffman, KH				Penny, A. M.; Wood, R.; Curtis, A.; Bowyer, F.; Tostevin, R.; Hoffman, K-H			Ediacaran metazoan reefs from the Nama Group, Namibia	SCIENCE			English	Article							LIFE-STYLES; CLOUDINA; SECTION; BORINGS; FOSSILS; GROWTH	Reef-building in metazoans represents an important ecological innovation whereby individuals collectively enhance feeding efficiency and gain protection from competitors and predation. The appearance of metazoan reefs in the fossil record therefore indicates an adaptive response to complex ecological pressures. In the Nama Group, Namibia, we found evidence of reef-building by the earliest known skeletal metazoan, the globally distributed Cloudina, similar to 548 million years ago. These Cloudina reefs formed open frameworks without a microbial component but with mutual attachment and cementation between individuals. Orientated growth implies a passive suspension-feeding habit into nutrient-rich currents. The characteristics of Cloudina support the view that metazoan reef-building was promoted by the rise of substrate competitors and predators.	[Penny, A. M.; Wood, R.; Curtis, A.; Bowyer, F.] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JW, Midlothian, Scotland; [Tostevin, R.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Hoffman, K-H] Geol Survey Namibia, Windhoek, Namibia	University of Edinburgh; University of London; University College London	Penny, AM (corresponding author), Univ Edinburgh, Sch GeoSci, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	a.m.penny@ed.ac.uk		Tostevin, Rosalie/0000-0003-2843-7741	University of Edinburgh, School of Geosciences Scholarship; International Centre for Carbonate Reservoirs; Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity" [NE/I005978/1]; NERC [NE/I005978/1, NE/I005935/1] Funding Source: UKRI; Natural Environment Research Council [1511982, 1220713, NE/I005978/1, NE/I005935/1] Funding Source: researchfish	University of Edinburgh, School of Geosciences Scholarship; International Centre for Carbonate Reservoirs; Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity"(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.M.P. acknowledges funding from a University of Edinburgh, School of Geosciences Scholarship and the International Centre for Carbonate Reservoirs. R. W., R. T., and A. M. P. acknowledge support from Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity" (NE/I005978/1). F. B. thanks the Laidlaw Trust for fieldwork support. We thank the Geological Survey of Namibia; C. Husselmann for access to Driedoornvlagte; M. Hall for technical support; and A. Yu. Zhuravlev, B. MacGabhann, and S. Brusatte for comments and discussion. All data are available online in the supplementary materials on Science Online.	BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bengtson S., 2004, PALEONTOLOGICAL SOC, V10, P67, DOI DOI 10.1017/S1089332600002345; Bengtson S., 1992, TOP GEOBIOL, V20, P447; Brasier M.D., 1989, Oxford Monographs on Geology and Geophysics, V12, P117; Cai YP, 2014, GONDWANA RES, V25, P1008, DOI 10.1016/j.gr.2012.12.027; Cortijo I, 2010, PRECAMBRIAN RES, V176, P1, DOI 10.1016/j.precamres.2009.10.010; Droser ML, 2008, SCIENCE, V319, P1660, DOI 10.1126/science.1152595; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; GERMS GJB, 1972, AM J SCI, V272, P752, DOI 10.2475/ajs.272.8.752; GRANT SWF, 1990, AM J SCI, V290A, P261; Grotzinger J. P., 2002, COMMUN GEOL SURV NAM, V11, P77; Grotzinger JP, 2000, PALEOBIOLOGY, V26, P334, DOI 10.1666/0094-8373(2000)026<0334:CMITSR>2.0.CO;2; Hua H, 2005, GEOLOGY, V33, P277, DOI 10.1130/G21198.1; Hua H, 2003, PALAIOS, V18, P454, DOI 10.1669/0883-1351(2003)018<0454:BICSCP>2.0.CO;2; Jackson J. B. C., 1983, BIOTIC INTERACTIONS, V39; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kontorovich AE, 2008, RUSS GEOL GEOPHYS+, V49, P932, DOI 10.1016/j.rgg.2008.06.012; KRUSE PD, 1995, PALAIOS, V10, P291, DOI 10.2307/3515157; Narbonne GM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P413, DOI 10.1016/B978-0-444-59425-9.00018-4; Narbonne GM, 1997, J PALEONTOL, V71, P953, DOI 10.1017/S0022336000035940; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363; Vermeij G.J., 1993, NATURAL HIST SHELLS; Warren LV, 2011, TERRA NOVA, V23, P382, DOI 10.1111/j.1365-3121.2011.01023.x; Wood R., 1999, REEF EVOLUTION; Wood RA, 2002, SCIENCE, V296, P2383, DOI 10.1126/science.1071599; Wood RA, 2011, EARTH-SCI REV, V106, P184, DOI 10.1016/j.earscirev.2011.01.011	27	97	99	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1504	1506		10.1126/science.1253393	http://dx.doi.org/10.1126/science.1253393			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970084	Green Accepted			2022-12-28	WOS:000337889900047
J	Schreppler, S; Spethmann, N; Brahms, N; Botter, T; Barrios, M; Stamper-Kurn, DM				Schreppler, Sydney; Spethmann, Nicolas; Brahms, Nathan; Botter, Thierry; Barrios, Maryrose; Stamper-Kurn, Dan M.			Optically measuring force near the standard quantum limit	SCIENCE			English	Article							CAVITY OPTOMECHANICS; NOISE	The Heisenberg uncertainty principle sets a lower bound on the noise in a force measurement based on continuously detecting a mechanical oscillator's position. This bound, the standard quantum limit, can be reached when the oscillator subjected to the force is unperturbed by its environment and when measurement imprecision from photon shot noise is balanced against disturbance from measurement back-action. We applied an external force to the center-of-mass motion of an ultracold atom cloud in a high-finesse optical cavity and measured the resulting motion optically. When the driving force is resonant with the cloud's oscillation frequency, we achieve a sensitivity that is a factor of 4 above the standard quantum limit and consistent with theoretical predictions given the atoms' residual thermal disturbance and the photodetection quantum efficiency.	[Schreppler, Sydney; Spethmann, Nicolas; Brahms, Nathan; Botter, Thierry; Barrios, Maryrose; Stamper-Kurn, Dan M.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Stamper-Kurn, Dan M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schreppler, S (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	sschreppler@berkeley.edu	Stamper-Kurn, Dan/B-5442-2015	Stamper-Kurn, Dan/0000-0002-4845-5835; Spethmann, Nicolas/0000-0002-8983-0873	Air Force Office of Scientific Research; NSF; U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship program	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship program	This work was supported by the Air Force Office of Scientific Research and NSF. S. S. was supported by the U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship program.	Abbott B, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073032; Anetsberger G, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.061804; Anetsberger G, 2009, NAT PHYS, V5, P909, DOI 10.1038/NPHYS1425; Aspelmeyer M, 2014, QUANT SCI TECH, P1, DOI 10.1007/978-3-642-55312-7; Biercuk MJ, 2010, NAT NANOTECHNOL, V5, P646, DOI [10.1038/NNANO.2010.165, 10.1038/nnano.2010.165]; Botter T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.153001; Braginskii V. B., 1975, Soviet Physics - Uspekhi, V17, P644, DOI 10.1070/PU1975v017n05ABEH004362; Braginsky V. B., 1995, QUANTUM MEASUREMENT; Brennecke F, 2008, SCIENCE, V322, P235, DOI 10.1126/science.1163218; Caniard T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.110801; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; CAVES CM, 1980, PHYS REV LETT, V45, P75, DOI 10.1103/PhysRevLett.45.75; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; Geraci AA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.101101; Gupta S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213601; Hertzberg JB, 2010, NAT PHYS, V6, P213, DOI 10.1038/NPHYS1479; Marquardt F., 2009, PHYSICS, V2, P40, DOI DOI 10.1103/PHYSICS.2.40; Moser J, 2013, NAT NANOTECHNOL, V8, P493, DOI [10.1038/nnano.2013.97, 10.1038/NNANO.2013.97]; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Nichol JM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3025305; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Purdy TP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.133602; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; THORNE KS, 1980, REV MOD PHYS, V52, P285, DOI 10.1103/RevModPhys.52.285; Tittonen I, 1999, PHYS REV A, V59, P1038, DOI 10.1103/PhysRevA.59.1038; Tsang M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.123601; Westphal T, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.063806; Woolley MJ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063846; Xu X., 2013, BEATING STANDARD QUA	32	93	93	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1486	1489		10.1126/science.1249850	http://dx.doi.org/10.1126/science.1249850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970079	Green Submitted			2022-12-28	WOS:000337889900042
J	Dutta, S; Whicher, JR; Hansen, DA; Hale, WA; Chemler, JA; Congdon, GR; Narayan, ARH; Hakansson, K; Sherman, DH; Smith, JL; Skiniotis, G				Dutta, Somnath; Whicher, Jonathan R.; Hansen, Douglas A.; Hale, Wendi A.; Chemler, Joseph A.; Congdon, Grady R.; Narayan, Alison R. H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios			Structure of a modular polyketide synthase	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; ACYL CARRIER PROTEIN; 6-DEOXYERYTHRONOLIDE B SYNTHASE; ITERATIVE CHAIN ELONGATION; NEAR-ATOMIC-RESOLUTION; FATTY-ACID SYNTHASE; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; DOCKING DOMAINS; SUBSTRATE-SPECIFICITY	Polyketide natural products constitute a broad class of compounds with diverse structural features and biological activities. Their biosynthetic machinery, represented by type I polyketide synthases (PKSs), has an architecture in which successive modules catalyse two-carbon linear extensions and keto-group processing reactions on intermediates covalently tethered to carrier domains. Here we used electron cryo-microscopy to determine sub-nanometre-resolution three-dimensional reconstructions of a full-length PKS module from the bacterium Streptomyces venezuelae that revealed an unexpectedly different architecture compared to the homologous dimeric mammalian fatty acid synthase. A single reaction chamber provides access to all catalytic sites for the intramodule carrier domain. In contrast, the carrier from the preceding module uses a separate entrance outside the reaction chamber to deliver the upstream polyketide intermediate for subsequent extension and modification. This study reveals for the first time, to our knowledge, the structural basis for both intramodule and intermodule substrate transfer in polyketide synthases, and establishes a new model for molecular dissection of these multifunctional enzyme systems.	[Dutta, Somnath; Whicher, Jonathan R.; Hansen, Douglas A.; Chemler, Joseph A.; Congdon, Grady R.; Narayan, Alison R. H.; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hansen, Douglas A.; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Hale, Wendi A.; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Skiniotis, G (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.	skinioti@umich.edu	Hakansson, Kristina/G-9428-2016; Dutta, Somnath/AAI-2977-2020	Hakansson, Kristina/0000-0003-1926-0542; Hansen, Douglas/0000-0003-4681-650X; Skiniotis, Georgios/0000-0003-0238-7846	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program; Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship; Life Sciences Research Foundation; National Institutes of Health [1R21CA138331-01A1, GM076477, DK042303, DK090165]; Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE [R21CA138331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165, R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477, T32GM008597] Funding Source: NIH RePORTER	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Henderson for sharing the phase-randomization program and for valuable advice on the implementation of the tilt-pair validation, and Y. Cheng and X. Li for sharing the image sub-frame alignment program. This work was supported by the Pew Scholar Program in Biomedical Sciences (G.S.), the University of Michigan Biological Sciences Scholars Program (G.S.), Rackham Merit and American Foundation for Pharmaceutical Education predoctoral fellowships (D.A.H.), a National Research Service Award postdoctoral fellowship (J.A.C.), the Life Sciences Research Foundation (A.R.H.N.), National Institutes of Health grants 1R21CA138331-01A1 (K.H.),GM076477 (D.H.S. and J.L.S.), DK042303 (J.L.S.) and DK090165 (G.S.), and the Hans W. Vahlteich Professorship (to D.H.S.).	Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; Aldrich CC, 2005, J AM CHEM SOC, V127, P8910, DOI 10.1021/ja0504340; Aldrich CC, 2005, J AM CHEM SOC, V127, P8441, DOI 10.1021/ja042592h; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Beck BJ, 2003, J AM CHEM SOC, V125, P4682, DOI 10.1021/ja029974c; Beck BJ, 2002, CHEM BIOL, V9, P575, DOI 10.1016/S1074-5521(02)00146-1; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Buchholz TJ, 2009, ACS CHEM BIOL, V4, P41, DOI 10.1021/cb8002607; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Chemler JA, 2012, J AM CHEM SOC, V134, P7359, DOI 10.1021/ja2112228; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gehret JJ, 2011, J BIOL CHEM, V286, P14445, DOI 10.1074/jbc.M110.214635; Gokhale RS, 1998, BIOCHEMISTRY-US, V37, P2524, DOI 10.1021/bi971887n; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Kao CM, 1996, BIOCHEMISTRY-US, V35, P12363, DOI 10.1021/bi9616312; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Kapur S, 2010, P NATL ACAD SCI USA, V107, P22066, DOI 10.1073/pnas.1014081107; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kittendorf JD, 2007, CHEM BIOL, V14, P944, DOI 10.1016/j.chembiol.2007.07.013; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Murray SC, 2013, STRUCTURE, V21, P900, DOI 10.1016/j.str.2013.04.016; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rowe CJ, 2001, CHEM BIOL, V8, P475, DOI 10.1016/S1074-5521(01)00024-2; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Scaglione JB, 2010, ANGEW CHEM INT EDIT, V49, P5726, DOI 10.1002/anie.201000032; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; Whicher JR, 2013, CHEM BIOL, V20, P1340, DOI 10.1016/j.chembiol.2013.09.015; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yin YF, 2003, J AM CHEM SOC, V125, P5671, DOI 10.1021/ja034574q; Yuzawa S, 2012, BIOCHEMISTRY-US, V51, P3708, DOI 10.1021/bi300399u; Zheng JT, 2013, ACS CHEM BIOL, V8, P1263, DOI 10.1021/cb400047s; Zheng JT, 2012, NAT CHEM BIOL, V8, P615, DOI [10.1038/nchembio.964, 10.1038/NCHEMBIO.964]; Zheng JT, 2011, J MOL BIOL, V410, P105, DOI 10.1016/j.jmb.2011.04.065; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	64	185	191	3	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					512	+		10.1038/nature13423	http://dx.doi.org/10.1038/nature13423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965652	Green Accepted			2022-12-28	WOS:000337806300041
J	Whicher, JR; Dutta, S; Hansen, DA; Hale, WA; Chemler, JA; Dosey, AM; Narayan, ARH; Hakansson, K; Sherman, DH; Smith, JL; Skiniotis, G				Whicher, Jonathan R.; Dutta, Somnath; Hansen, Douglas A.; Hale, Wendi A.; Chemler, Joseph A.; Dosey, Annie M.; Narayan, Alison R. H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios			Structural rearrangements of a polyketide synthase module during its catalytic cycle	NATURE			English	Article							CHAIN ELONGATION; BIOSYNTHESIS; PIKROMYCIN; RESOLUTION; RECOGNITION; REVEALS; DESIGN; DOMAIN	The polyketide synthase (PKS) mega-enzyme assembly line uses a modular architecture to synthesize diverse and bioactive natural products that often constitute the core structures or complete chemical entities for many clinically approved therapeutic agents(1). The architecture of a full-length PKS module from the pikromycin pathway of Streptomyces venezuelae creates a reaction chamber for the intra-module acyl carrier protein (ACP) domain that carries building blocks and intermediates between acyltransferase, ketosynthase and ketoreductase active sites (see accompanying paper(2)). Here we determine electron cryo-microscopy structures of a full-length pikromycin PKS module in three key biochemical states of its catalytic cycle. Each biochemical state was confirmed by bottom-up liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry. The ACP domain is differentially and precisely positioned after polyketide chain substrate loading on the active site of the ketosynthase, after extension to the beta-keto intermediate, and after beta-hydroxy product generation. The structures reveal the ACP dynamics for sequential interactions with catalytic domains within the reaction chamber, and for transferring the elongated and processed polyketide substrate to the next module in the PKS pathway. During the enzymatic cycle the ketoreductase domain undergoes dramatic conformational rearrangements that enable optimal positioning for reductive processing of the ACP-bound polyketide chain elongation intermediate. These findings have crucial implications for the design of functional PKS modules, and for the engineering of pathways to generate pharmacologically relevant molecules.	[Whicher, Jonathan R.; Dutta, Somnath; Hansen, Douglas A.; Chemler, Joseph A.; Dosey, Annie M.; Narayan, Alison R. H.; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hansen, Douglas A.; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Hale, Wendi A.; Hakansson, Kristina; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Skiniotis, G (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kicki@umich.edu; davidhs@umich.edu; JanetSmith@umich.edu; skinioti@umich.edu	Hakansson, Kristina/G-9428-2016; Dutta, Somnath/AAI-2977-2020	Hakansson, Kristina/0000-0003-1926-0542; Hansen, Douglas/0000-0003-4681-650X; Skiniotis, Georgios/0000-0003-0238-7846	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program; Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship; Life Sciences Research Foundation; National Institutes of Health [1 R21CA138331-01A1, GM076477, DK042303, DK090165]; Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE [R21CA138331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303, R37DK042303, R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597, R01GM076477] Funding Source: NIH RePORTER	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pew Scholar Program in Biomedical Sciences (G.S.), the University of Michigan Biological Sciences Scholars Program (G.S.), Rackham Merit and American Foundation for Pharmaceutical Education predoctoral fellowships (D.A.H.), a National Research Service Award postdoctoral fellowship (J.A.C.), the Life Sciences Research Foundation (A.R.H.N.), National Institutes of Health grant 1 R21CA138331-01A1 (K.H.), GM076477 (D.H.S. and J.L.S.), DK042303 (J.L.S.), and DK090165 (G.S.), and the Hans W. Vahlteich Professorship (to D.H.S.).	Aldrich CC, 2005, J AM CHEM SOC, V127, P8910, DOI 10.1021/ja0504340; Aldrich CC, 2005, J AM CHEM SOC, V127, P8441, DOI 10.1021/ja042592h; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Beck BJ, 2003, J AM CHEM SOC, V125, P4682, DOI 10.1021/ja029974c; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kittendorf JD, 2006, CURR OPIN BIOTECH, V17, P597, DOI 10.1016/j.copbio.2006.09.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; Menzella HG, 2007, CHEM BIOL, V14, P143, DOI 10.1016/j.chembiol.2006.12.002; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sherman DH, 2005, NAT BIOTECHNOL, V23, P1083, DOI 10.1038/nbt0905-1083; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yin YF, 2003, J AM CHEM SOC, V125, P5671, DOI 10.1021/ja034574q; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	37	125	127	0	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					560	+		10.1038/nature13409	http://dx.doi.org/10.1038/nature13409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965656	Green Accepted			2022-12-28	WOS:000337806300052
J	Eswarappa, SM; Potdar, AA; Koch, WJ; Fan, Y; Vasu, K; Lindner, D; Wiiiard, B; Graham, LM; DiCorieto, PE; Fox, PL				Eswarappa, Sandeepa M.; Potdar, Alka A.; Koch, William J.; Fan, Yi; Vasu, Kommireddy; Lindner, Daniel; Wiiiard, Belinda; Graham, Linda M.; DiCorieto, Paul E.; Fox, Paul L.			Programmed Translational Readthrough Generates Antiangiogenic VEGF-Ax	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; STOP CODON READTHROUGH; INHIBITORY SPLICE VARIANT; SUPPRESSOR TRANSFER-RNAS; MESSENGER-RNA; IN-VIVO; TERMINATION CODONS; ESCHERICHIA-COLI; FACTOR ISOFORM; TUMOR-GROWTH	Translational readthrough, observed primarily in less complex organisms from viruses to Drosophila, expands the proteome by translating select transcripts beyond the canonical stop codon. Here, we show that vascular endothelial growth factor A (VEGFA) mRNA in mammalian endothelial cells undergoes programmed translational readthrough (PTR) generating VEGF-Ax, an isoform containing a unique 22-amino-acid C terminus extension. A cis-acting element in the VEGFA 30 UTR serves a dual function, not only encoding the appended peptide but also directing the PTR by decoding the UGA stop codon as serine. Heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 binds this element and promotes readthrough. Remarkably, VEGF-Ax exhibits antiangiogenic activity in contrast to the proangiogenic activity of VEGF-A. Pathophysiological significance of VEGF-Ax is indicated by robust expression in multiple human tissues but depletion in colon adenocarcinoma. Furthermore, genome-wide analysis revealed AGO1 and MTCH2 as authentic readthrough targets. Overall, our studies reveal a novel protein-regulated PTR event in a vertebrate system.	[Eswarappa, Sandeepa M.; Potdar, Alka A.; Koch, William J.; Fan, Yi; Vasu, Kommireddy; DiCorieto, Paul E.; Fox, Paul L.] Lerner Res Inst, Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Potdar, Alka A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lindner, Daniel] Taussig Canc Ctr, Cleveland Clin, Cleveland, OH 44195 USA; [Wiiiard, Belinda] Lerner Res Inst, Cleveland Clin, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Graham, Linda M.] Lerner Res Inst, Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fox, PL (corresponding author), Lerner Res Inst, Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	foxp@ccf.org	Kommireddy, Vasu/C-3928-2018; Eswarappa, Sandeep/AFG-1997-2022; Lindner, Daniel/ABB-5440-2020	Kommireddy, Vasu/0000-0002-7608-7566; Koch, William/0000-0002-4820-3451	NIH [P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359, R21 HL094841, S10 RR031537]; American Heart Association, Great Rivers Affiliate; Athymic Animal and Xenograft Core, NCI of the Case Comprehensive Cancer Center [P30 CA043703-23]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094841, P01HL029582, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Great Rivers Affiliate(American Heart Association); Athymic Animal and Xenograft Core, NCI of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359, and R21 HL094841 (to P.L. F.). S.M.E. was supported by a fellowship from the American Heart Association, Great Rivers Affiliate. A shared instrument grant (S10 RR031537) from the NIH (to B.W.) was used to purchase the Orbitrap mass spectrometer. Mouse studies were supported by the Athymic Animal and Xenograft Core, NCI P30 CA043703-23, of the Case Comprehensive Cancer Center (to D. L.). We are grateful to Donna Driscoll and Jodi Bubenik for helpful discussions. S.M.E. and P.L.F. are inventors on a patent that has been filed related to this work.	AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Bates DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068399; Bates DO, 2002, CANCER RES, V62, P4123; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cebe-Suarez S, 2008, FASEB J, V22, P3078, DOI 10.1096/fj.08-107219; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Cromer W, 2010, MICROCIRCULATION, V17, P536, DOI 10.1111/j.1549-8719.2010.00047.x; DIAMOND A, 1981, CELL, V25, P497, DOI 10.1016/0092-8674(81)90068-4; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Harris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035231; HATFIELD DL, 1990, CRIT REV BIOCHEM MOL, V25, P71, DOI 10.3109/10409239009090606; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Howard MT, 2004, ANN NEUROL, V55, P422, DOI 10.1002/ana.20052; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JALAJAKUMARI MB, 1989, MOL MICROBIOL, V3, P1685, DOI 10.1111/j.1365-2958.1989.tb00154.x; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kondo Jiro, 2005, Nucleic Acids Symp Ser (Oxf), P253; Konopatskaya O, 2006, MOL VIS, V12, P626; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LI GP, 1989, J VIROL, V63, P1326, DOI 10.1128/JVI.63.3.1326-1337.1989; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Manetti M, 2011, CIRC RES, V109, pE14, DOI 10.1161/CIRCRESAHA.111.242057; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; PELHAM HRB, 1978, NATURE, V272, P469, DOI 10.1038/272469a0; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Qiu Y, 2008, FASEB J, V22, P1104, DOI 10.1096/fj.07-9718com; Rajon E, 2011, P NATL ACAD SCI USA, V108, P1082, DOI 10.1073/pnas.1012918108; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rennel ES, 2009, BRIT J CANCER, V101, P1183, DOI 10.1038/sj.bjc.6605249; Rennel ES, 2008, EUR J CANCER, V44, P1883, DOI 10.1016/j.ejca.2008.05.027; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; SCHWARTZ SM, 1978, LAB INVEST, V38, P568; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shan JG, 2003, J NEUROSCI, V23, P8859; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; Tate WP, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1342; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Yamaguchi Y, 2012, J BIOL CHEM, V287, P17765, DOI 10.1074/jbc.M111.314468; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	66	128	129	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1605	1618		10.1016/j.cell.2014.04.033	http://dx.doi.org/10.1016/j.cell.2014.04.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949972	Green Accepted, Bronze			2022-12-28	WOS:000340941900015
J	Huybrechts, KF; Palmsten, K; Avorn, J; Cohen, LS; Holmes, LB; Franklin, JM; Mogun, H; Levin, R; Kowal, M; Setoguchi, S; Hernandez-Diaz, S				Huybrechts, Krista F.; Palmsten, Kristin; Avorn, Jerry; Cohen, Lee S.; Holmes, Lewis B.; Franklin, Jessica M.; Mogun, Helen; Levin, Raisa; Kowal, Mary; Setoguchi, Soko; Hernandez-Diaz, Sonia			Antidepressant Use in Pregnancy and the Risk of Cardiac Defects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; CONGENITAL-MALFORMATIONS; PAROXETINE; EXPOSURE; 1ST-TRIMESTER; PREVALENCE; METAANALYSIS; DEPRESSION; DISEASE; COHORT	BACKGROUND Whether the use of selective serotonin-reuptake inhibitors (SSRIs) and other antidepressants during pregnancy is associated with an increased risk of congenital cardiac defects is uncertain. In particular, there are concerns about a possible association between paroxetine use and right ventricular outflow tract obstruction and between sertraline use and ventricular septal defects. METHODS We performed a cohort study nested in the nationwide Medicaid Analytic eXtract for the period 2000 through 2007. The study included 949,504 pregnant women who were enrolled in Medicaid during the period from 3 months before the last menstrual period through 1 month after delivery and their liveborn infants. We compared the risk of major cardiac defects among infants born to women who took antidepressants during the first trimester with the risk among infants born to women who did not use antidepressants, with an unadjusted analysis and analyses that restricted the cohort to women with depression and that used propensity-score adjustment to control for depression severity and other potential confounders. RESULTS A total of 64,389 women (6.8%) used antidepressants during the first trimester. Overall, 6403 infants who were not exposed to antidepressants were born with a cardiac defect (72.3 infants with a cardiac defect per 10,000 infants), as compared with 580 infants with exposure (90.1 per 10,000 infants). Associations between antidepressant use and cardiac defects were attenuated with increasing levels of adjustment for confounding. The relative risks of any cardiac defect with the use of SSRIs were 1.25 (95% confidence interval [CI], 1.13 to 1.38) in the unadjusted analysis, 1.12 (95% CI, 1.00 to 1.26) in the analysis restricted to women with depression, and 1.06 (95% CI, 0.93 to 1.22) in the fully adjusted analysis restricted to women with depression. We found no significant association between the use of paroxetine and right ventricular outflow tract obstruction (relative risk, 1.07; 95% CI, 0.59 to 1.93) or between the use of sertraline and ventricular septal defects (relative risk, 1.04; 95% CI, 0.76 to 1.41). CONCLUSIONS The results of this large, population-based cohort study suggested no substantial increase in the risk of cardiac malformations attributable to antidepressant use during the first trimester.	[Huybrechts, Krista F.; Avorn, Jerry; Franklin, Jessica M.; Mogun, Helen; Levin, Raisa; Kowal, Mary; Setoguchi, Soko] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Huybrechts, Krista F.; Avorn, Jerry; Franklin, Jessica M.; Mogun, Helen; Levin, Raisa; Kowal, Mary; Setoguchi, Soko] Harvard Univ, Sch Med, Boston, MA USA; [Palmsten, Kristin; Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cohen, Lee S.] Massachusetts Gen Hosp, Ctr Womens Mental Hlth, Boston, MA 02114 USA; [Holmes, Lewis B.] MassGen Hosp Children, Med Genet Unit, Boston, MA USA; [Setoguchi, Soko] Duke Univ, Sch Med, Durham, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Duke University	Huybrechts, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	khuybrechts@partners.org			Agency for Healthcare Research and Quality; National Institutes of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by the Agency for Healthcare Research and Quality and the National Institutes of Health.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; [Anonymous], 2005, ANAL REPORTING GUIDE; Bar-Oz B, 2007, CLIN THER, V29, P918, DOI 10.1016/j.clinthera.2007.05.003; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Centers for Medicare & Medicaid Services, MED AN EXTR MAX GEN; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cole JA, 2007, PHARMACOEPIDEM DR S, V16, P1075, DOI 10.1002/pds.1463; Diav-Citrin O, 2008, CNS DRUGS, V22, P325, DOI 10.2165/00023210-200822040-00004; Einarson A, 2008, AM J PSYCHIAT, V165, P1208; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; Garcia G., 2008, MATERNAL CHILD HLTH; Greene MF, 2007, NEW ENGL J MED, V356, P2732, DOI 10.1056/NEJMe078079; Holmes LB, 2012, COMMON MALFORMATIONS, P116; Holmes LB, 2012, BIRTH DEFECTS RES A, V94, P208, DOI 10.1002/bdra.23001; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kallen B, 2006, REPROD TOXICOL, V21, P221, DOI 10.1016/j.reprotox.2005.11.006; Kallen BAJ, 2007, BIRTH DEFECTS RES A, V79, P301, DOI 10.1002/bdra.20327; Koren G, 2011, J POPUL THER CLIN PH, V18, pE174; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Malm H, 2005, OBSTET GYNECOL, V106, P1289, DOI 10.1097/01.AOG.0000187302.61812.53; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; O'Donnell J.M., 2012, GOODMAN GILMANS PHAR, P397; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Palmsten K, 2014, PHARMACOEPIDEMIOL DR; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Wichman CL, 2009, MAYO CLIN PROC, V84, P23, DOI 10.4065/84.1.23; Wogelius P, 2006, EPIDEMIOLOGY, V17, P701, DOI 10.1097/01.ede.0000239581.76793.ae; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627	38	211	217	3	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2397	2407		10.1056/NEJMoa1312828	http://dx.doi.org/10.1056/NEJMoa1312828			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24941178	Green Accepted, Bronze			2022-12-28	WOS:000337353000008
J	Procko, E; Berguig, GY; Shen, BW; Song, YF; Frayo, S; Convertine, AJ; Margineantu, D; Booth, G; Correia, BE; Cheng, YH; Schief, WR; Hockenbery, DM; Press, OW; Stoddard, BL; Stayton, PS; Baker, D				Procko, Erik; Berguig, Geoffrey Y.; Shen, Betty W.; Song, Yifan; Frayo, Shani; Convertine, Anthony J.; Margineantu, Daciana; Booth, Garrett; Correia, Bruno E.; Cheng, Yuanhua; Schief, William R.; Hockenbery, David M.; Press, Oliver W.; Stoddard, Barry L.; Stayton, Patrick S.; Baker, David			A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells	CELL			English	Article							INTRACELLULAR DELIVERY; EPITOPE-SCAFFOLDS; B-CELLS; VIRUS; HOMOLOG; BHRF1; ANTIBODIES; DYNAMICS; LIGANDS; PEPTIDE	Because apoptosis of infected cells can limit virus production and spread, some viruses have co-opted prosurvival genes from the host. This includes the Epstein-Barr virus (EBV) gene BHRF1, a homolog of human Bcl-2 proteins that block apoptosis and are associated with cancer. Computational design and experimental optimization were used to generate a novel protein called BINDI that binds BHRF1 with picomolar affinity. BINDI recognizes the hydrophobic cleft of BHRF1 in a manner similar to other Bcl-2 protein interactions but makes many additional contacts to achieve exceptional affinity and specificity. BINDI induces apoptosis in EBV-infected cancer lines, and when delivered with an antibody-targeted intracellular delivery carrier, BINDI suppressed tumor growth and extended survival in a xenograft disease model of EBV-positive human lymphoma. High-specificity-designed proteins that selectively kill target cells may provide an advantage over the toxic compounds used in current generation antibody-drug conjugates.	[Procko, Erik; Song, Yifan; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Berguig, Geoffrey Y.; Convertine, Anthony J.; Cheng, Yuanhua; Stayton, Patrick S.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Shen, Betty W.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Frayo, Shani; Margineantu, Daciana; Booth, Garrett; Hockenbery, David M.; Press, Oliver W.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Correia, Bruno E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Stayton, Patrick/C-1975-2018; Baker, David/K-8941-2012; Schief, William/ABF-3645-2020	Stayton, Patrick/0000-0001-6939-6371; Baker, David/0000-0001-7896-6217; Schief, William/0000-0002-1120-0150; Procko, Erik/0000-0002-0028-490X; Press, Oliver/0000-0002-3147-8037	National Institute of General Medical Studies of the National Institutes of Health (NIH) [P41GM103533, R01GM49857]; NIH [R21EB014572, R01CA076287, R01CA154897]; Washington State Life Sciences Discovery Fund [2496490]; Defence Threat Reduction Agency; David and Patricia Giuliani Family Foundation; National Science Foundation [SCI-0221529, SCI-0438443, SCI-0506411, PHY/0555655, OCI-0721124]; NATIONAL CANCER INSTITUTE [R01CA154897, R01CA076287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB014572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857, P41GM103533] Funding Source: NIH RePORTER	National Institute of General Medical Studies of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State Life Sciences Discovery Fund; Defence Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); David and Patricia Giuliani Family Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Studies of the National Institutes of Health (NIH) under award numbers P41GM103533 and R01GM49857; NIH grants R21EB014572, R01CA076287, and R01CA154897; the Washington State Life Sciences Discovery Fund grant 2496490 to the Center for Intracellular Delivery of Biologics; the Defence Threat Reduction Agency; and a grant by the David and Patricia Giuliani Family Foundation. Computational resources were provided by BOINC and supported by the National Science Foundation through awards SCI-0221529, SCI-0438443, SCI-0506411, PHY/0555655, and OCI-0721124. P.S.S. and O.W.P. are cofounders of PhaseRx Pharmaceuticals, which has licensed drug delivery technology from University of Washington that encompasses aspects of the polymeric carriers used in this study.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berguig GY, 2012, MOL PHARMACEUT, V9, P3506, DOI 10.1021/mp300338s; Caria S, 2012, ACTA CRYSTALLOGR F, V68, P1521, DOI 10.1107/S1744309112043333; Chin JW, 2001, ANGEW CHEM INT EDIT, V40, P3806, DOI 10.1002/1521-3773(20011015)40:20<3806::AID-ANIE3806>3.0.CO;2-B; Convertine AJ, 2010, BIOMACROMOLECULES, V11, P2904, DOI 10.1021/bm100652w; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Desbien AL, 2009, P NATL ACAD SCI USA, V106, P5663, DOI 10.1073/pnas.0901036106; Dutta S, 2013, ACS CHEM BIOL, V8, P778, DOI 10.1021/cb300679a; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Duvall CL, 2010, MOL PHARMACEUT, V7, P468, DOI 10.1021/mp9002267; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gemperli AC, 2005, J AM CHEM SOC, V127, P1596, DOI 10.1021/ja0441211; Goulet A, 2009, P NATL ACAD SCI USA, V106, P21155, DOI 10.1073/pnas.0909893106; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3191, DOI 10.1073/pnas.0436100100; ISHII HH, 1995, IMMUNOL CELL BIOL, V73, P463, DOI 10.1038/icb.1995.72; Kelly GL, 2013, J VIROL, V87, P2882, DOI 10.1128/JVI.03003-12; Kelly GL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000341; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee EF, 2009, J BIOL CHEM, V284, P30508, DOI 10.1074/jbc.M109.040725; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Manganiello MJ, 2012, BIOMATERIALS, V33, P2301, DOI 10.1016/j.biomaterials.2011.11.019; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; O'Connor OA, 2006, CLIN CANCER RES, V12, P2902, DOI 10.1158/1078-0432.CCR-05-0308; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Watanabe A, 2010, J VIROL, V84, P2893, DOI 10.1128/JVI.01616-09	38	93	107	1	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1644	1656		10.1016/j.cell.2014.04.034	http://dx.doi.org/10.1016/j.cell.2014.04.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949974	Bronze, Green Accepted			2022-12-28	WOS:000340941900018
J	Westman, EC				Westman, Eric C.			In overweight or obese patients with diabetes, a lifestyle intervention increased weight loss at 8 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; RISK		Duke Univ Hlth Syst, Durham, NC 27710 USA	Duke University	Westman, EC (corresponding author), Duke Univ Hlth Syst, Durham, NC 27710 USA.							Accurso A, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-9; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Seger JC, OBESITY ALGORITHM; Shai I, 2010, CIRCULATION, V121, P1200, DOI 10.1161/CIRCULATIONAHA.109.879254; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	8	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC4	10.7326/0003-4819-160-12-201406170-02004	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935510				2022-12-28	WOS:000337374900004
J	Harris, MF; Knechtli, C				Harris, Michael Frank; Knechtli, Christopher			A PATIENT'S JOURNEY Lymphoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harris, Michael Frank] Gore Cottage, Old Gore Lane, Emborough BA3 4SJ, Radstock, England; [Knechtli, Christopher] Royal United Hosp Bath NHS Trust, Bath BA1 3NG, Avon, England		Harris, MF (corresponding author), Gore Cottage, Old Gore Lane, Emborough BA3 4SJ, Radstock, England.	michaelharris681@btinternet.com						Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g3736	10.1136/bmj.g3736	http://dx.doi.org/10.1136/bmj.g3736			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24934281	Green Published, Bronze			2022-12-28	WOS:000337804300010
J	Adams, K				Adams, Kate			INTERNATIONAL HEALTH Afghanistan: a healthy future?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kateadams@doctors.org.uk						Afghan Public Health Institute Ministry of Public Health C. S. O, 2010, AFGH MORT SURV 2010; WHO, AFGH MAIN PUBL HLTH; World Bank, 2011, MENT HLTH AFGH	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2014	348								g3950	10.1136/bmj.g3950	http://dx.doi.org/10.1136/bmj.g3950			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1IW	24927765	Green Published			2022-12-28	WOS:000337410400004
J	Choudhary, P				Choudhary, Pratik			Continuous subcutaneous insulin infusion for type 2 diabetes	LANCET			English	Editorial Material							MULTIPLE DAILY INJECTIONS; THERAPY; HYPOGLYCEMIA; METAANALYSIS; ASSOCIATION		Kings Coll London, Weston Educ Ctr, Diabet Res Grp, London SE5 9RS, England	University of London; King's College London	Choudhary, P (corresponding author), Kings Coll London, Weston Educ Ctr, Diabet Res Grp, London SE5 9RS, England.	pratik.choudhary@kcl.ac.uk	Choudhary, Pratik/D-7701-2015	Choudhary, Pratik/0000-0001-7635-4735				Berkowitz SA, 2013, DIABETOLOGIA, V56, P2593, DOI 10.1007/s00125-013-3036-4; Gagnon-Auger M, 2010, DIABETES CARE, V33, P2502, DOI 10.2337/dc10-1126; Grunberger G, 2010, ENDOCR PRACT, V16, P746, DOI 10.4158/EP.16.5.746; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Herman WH, 2005, DIABETES CARE, V28, P1568, DOI 10.2337/diacare.28.7.1568; Nice, 2008, DIAB INS PUMP THER; Pickup JC, 2008, DIABETIC MED, V25, P765, DOI 10.1111/j.1464-5491.2008.02486.x; Raskin P, 2003, DIABETES CARE, V26, P2598, DOI 10.2337/diacare.26.9.2598; Reutrakul Sirimon, 2012, J Diabetes Sci Technol, V6, P412; Reznik Y, 2014, LANCET; Ritz P, 2014, SURG OBES RELAT DIS, V9, DOI [10.1016/j.soard.2013.12.012, DOI 10.1016/J.SOARD.2013.12.012]; Rodbard HW, 2014, ENDOCR PRACT, V20, P285, DOI 10.4158/EP13287.OR; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Thong KY, 2011, DIABETES OBES METAB, V13, P703, DOI 10.1111/j.1463-1326.2011.01393.x; Wainstein J, 2005, DIABETIC MED, V22, P1037, DOI 10.1111/j.1464-5491.2005.01597.x	15	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1240	1242		10.1016/S0140-6736(14)61098-9	http://dx.doi.org/10.1016/S0140-6736(14)61098-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24998010				2022-12-28	WOS:000343003400007
J	Gray, R; Ives, N; Rick, C; Patel, S; Gray, A; Jenkinson, C; McIntosh, E; Wheatley, K; Williams, A; Clarke, CE; Sandercock, P; Baigent, C; Crome, P; Williams, A; Abbott, R; Baker, M; Castleton, B; Clarke, CE; Counsell, C; Deb, AK; Fairweather, S; Fitzpatrick, R; Gray, A; Ives, N; Jenkinson, C; MacPhee, G; Malone, T; Mant, D; McIntosh, E; Ming, A; Morrish, P; Ohri, P; Pearce, V; Wood, B; Worth, P; Au, P; Boodell, T; Cheed, V; Clarke, CE; Daniels, J; Dowling, F; Edmondson, A; Gray, R; Hawker, R; Herd, C; Hilken, N; Ives, N; Kaur, S; Ottridge, R; Patel, S; Peto, L; Rick, C; Sidile, C; Tomlinson, C; Tyler, E; Wheatley, K; Winkles, N; Gray, A; McIntosh, E; Kent, S; Fitzpatrick, R; Jenkinson, C; Caie, L; Caslake, R; Coleman, R; Counsell, C; Crowley, P; Gerrie, L; Gordon, J; Harris, C; Leslie, V; Macleod, MA; Taylor, K; Barker, R; Forsyth, D; Halls, M; Lennox, G; Young, J; Azie, WE; Barrett, J; Monaghan, A; Turnbull, C; Vanek, H; Blake, D; Manford, M; Thangarajah, N; Johnson, M; Wallis, P; Carr, P; Cochrane, L; Prescott, R; Rose, A; Drover, MM; Karunaratne, P; McLaren, A; Jones, E; Nasar, M; Bayliss, M; Jones, P; Lewis, B; Dunn, A; Eckley, M; Price, J; Woodman, G; Forsyth, D; Halls, M; Young, J; Aldridge, G; Bhuvanendran, N; Lewis, S; Mann, C; Patel, K; Ghaus, N; Grueger, A; Mallinson, B; Wihl, G; Ballantyne, S; Clarke, CE; Coyle, S; Hornabrook, R; Hutchinson, S; Irfan, H; Lewthwaite, A; Nicholl, D; Poxon, S; Ritch, A; Davison, J; Dodds, S; Gray, C; Nath, U; Robinson, G; Deb, A; Aftab, N; Read, D; Villanueva, L; Alderton, L; Carr, P; Cochrane, L; Prescott, R; Rose, A; Burrows, E; Fletcher, P; Folkes, E; Gilbert, A; Hayes, H; Morrow, P; Silva, M; Baxter, G; Bell, J; Gorman, J; Lawrence, J; Rhind, G; Hindle, J; Jones, J; Ohri, P; Parry, M; Roberts, E; Subashchandran, R; Pycock, C; Aspden, L; Partington-Jones, L; Raw, J; Vanek, H; Wadhwa, U; Barber, R; Haywood, B; Heywood, P; Lewis, H; O'Sullivan, K; Prout, K; Whelan, L; Whone, A; Fletcher, P; Folkes, E; Fuller, G; Medcalf, P; Morrish, P; Silva, M; Aruldoss, P; Farmery, J; Liveley, K; Shelbourn, K; Sood, V; Bouifraden, K; Dalziel, J; Evans, C; Matheson, P; Overstall, P; Wales, E; Ward, G; Ponsford, J; Graham, A; Grimmer, SFM; Lockington, TJ; Sheehan, LJ; Williams, H; Fuller, J; Harrison, P; Roche, M; Shields, S; Glasspool, R; Hubbard, I; Walters, R; Barraclough, C; McClung, A; Moseley, L; Pathirana, CK; Abbott, R; Critchley, P; Wray, LG; Kendall, B; Lawden, M; Lo, N; Martey, J; Rajabally, Y; Simpson, B; Abbott, LR; Critchley, P; Kendall, B; Lawden, M; Martey, J; Rajabally, Y; Hindle, J; Ohri, P; Gale, A; Phiri, D; Sekaran, L; Sharma, A; Wijayasiri, S; Fleary, H; Monaghan, A; Silverdale, M; Vanek, H; Walker, D; Mcgee, M; Senthil, V; Reynolds, S; Arnould, D; Chong, S; Diem, D; Kundu, B; Quinn, N; Benamer, H; Billings, J; Corston, R; D'Costa, D; Green, M; Shuri, J; Cassidy, T; Dodds, S; Gani, A; Lawson, R; Noble, J; Chan, Y; Clipsham, K; Cochius, J; Dick, D; Hipperson, M; Lee, M; Payne, B; Reading, F; Roche, M; Sabanathan, K; Shields, S; Worth, P; Harper, G; Honan, W; Oxborough, L; Saunders, J; Stanley, J; McCann, P; Edmonds, P; Hand, A; O'Hanlon, S; Robinson, L; Walker, R; Bolam, D; Liddle, B; Ballantyne, SL; Byravan, R; Jones, P; Guptha, S; Noble, C; Roychowdhury, S; Ellis, C; Harries-Jones, R; Hillier, C; Milligan, N; Potter, J; Ebenezer, L; Raha, S; Thompson, S; Benamer, H; Crouch, R; Healy, K; Hornabrook, R; Johnson, M; Nicholl, D; Pall, H; Praamstra, P; Williams, A; Beaumont, D; Ell, S; McGourty, J; Jenkinson, M; McHenry, M; Scoble, N; Vahid, R; Findley, L; Misbahuddin, A; Adcock, J; Chatterjee, A; Collins, H; Fairweather, S; Flossman, E; Greenhall, R; Hart, H; Shaw, J; Singh, S; Talbot, K; Thompson, S; Weir, A; Gray, D; Sood, V; Sutherland, S; Wilson, M; Hughes, T; Jones, A; Morgan, L; Sastry, B; Abdel-Hafiz, A; Al-Modaris, F; Dutta, S; Mallik, T; Mondal, B; Roberts, J; Sinha, S; Amar, K; Atkins, S; Devadason, G; Martin, A; Thompson, C; Fenwick, G; Gormley, K; Gutowski, N; Harris, S; Harrower, T; Hemsley, A; Honan, W; James, M; Jeffreys, O; Malone, T; Pearce, V; Sheridan, R; Soper, C; Sword, J; Zeman, A; Gordon, C; McElwaine, T; Pressly, V; Chan, D; Saha, R; Howcroft, D; Mugweni, K; Robertson, D; Stephens, A; Whelan, E; Wright, A; Blane, N; Burns, S; Mutch, W; Roberts, R; Chikna, E; Chamberlain, J; Lee, J; Marigold, J; Adams, J; Dulay, J; Evans, S; Frankel, J; Garrard, P; Gibb, W; Gove, R; Holmes, C; Lawton, N; Malik, N; McElwaine, T; Morgan, S; Phipps, H; Pressly, V; Queen, V; Roberts, H; Tan, R; Turner, G; Weller, R; Zaman, S; O'Brien, A; Grosset, D; MacPhee, G; McGonigal, A; Vennard, C; Rektorova, I; Carey, G; Castleton, B; Dhakam, Z; Kalcantera, E; Long, C; Mandal, B; Martin, V; Nari, R; Nicholas, V; Sunderland, C; Franks, S; Hammans, S; Moffitt, V; Rice-Oxley, M; Elizabeth, J; Logan, A; Summers, B; Cooper, S; Darch, W; Homan, J; Hussain, M; Sharratt, D; Solanki, T; Bennett, J; Vassallo, J; Ford, A; Kendall, G; Stocker, K; Chaudhry, A; Grubneac, A; Kenton, A; Lindahl, A; Lismore, J; McConville, M; Peskett, R; Ponsford, J; Shehu, A; Strens, L; Hughes, T; Sastry, B; Barrett, J; Turnbull, C; Vanek, H; Moore, A; O'Brien, I; Watling, D; Wyatt, L; Jones, C; Mahan, T; Ullyart, K; Wood, B; Desai, H; Ferry, P; Grubneac, A; Ponsford, J; Ray, P; Rose, P; Shehu, A; Thanvi, B; Waters, S; Rizvi, S; Sa'Adu, A; Walker, E; Berry, G; Russell, N; Lennox, G; Ward, T; Abrams, J; Ashley, S; Steiger, M; Beal, A; Hawkins, J; Heller, A; Jenkinson, M; McHenry, M; Samuel, M; Scoble, N; Vahid, R; Caie, L; Leslie, V; Primrose, W; Hipperson, M; Pycock, C; Baker, K; Buckley, C; Bulley, S; Gibbons, D; Goodland, R; Heywood, P; Jones, L; Martin, L; Qadiri, MR; Rashed, K; Rowland-Axe, R; Stone, A; Whittuck, M				Gray, Richard; Ives, Natalie; Rick, Caroline; Patel, Smitaa; Gray, Alastair; Jenkinson, Crispin; McIntosh, Emma; Wheatley, Keith; Williams, Adrian; Clarke, Carl E.; Sandercock, P.; Baigent, C.; Crome, P.; Williams, A.; Abbott, R.; Baker, M.; Castleton, B.; Clarke, C. E.; Counsell, C.; Deb, A. K.; Fairweather, S.; Fitzpatrick, R.; Gray, A.; Ives, N.; Jenkinson, C.; MacPhee, G.; Malone, T.; Mant, D.; McIntosh, E.; Ming, A.; Morrish, P.; Ohri, P.; Pearce, V.; Wood, B.; Worth, P.; Au, P.; Boodell, T.; Cheed, V.; Clarke, C. E.; Daniels, J.; Dowling, F.; Edmondson, A.; Gray, R.; Hawker, R.; Herd, C.; Hilken, N.; Ives, N.; Kaur, S.; Ottridge, R.; Patel, S.; Peto, L.; Rick, C.; Sidile, C.; Tomlinson, C.; Tyler, E.; Wheatley, K.; Winkles, N.; Gray, A.; McIntosh, E.; Kent, S.; Fitzpatrick, R.; Jenkinson, C.; Caie, L.; Caslake, R.; Coleman, R.; Counsell, C.; Crowley, P.; Gerrie, L.; Gordon, J.; Harris, C.; Leslie, V.; Macleod, M. A.; Taylor, K.; Barker, R.; Forsyth, D.; Halls, M.; Lennox, G.; Young, J.; Azie, Wirral E.; Barrett, J.; Monaghan, A.; Turnbull, C.; Vanek, H.; Blake, D.; Manford, M.; Thangarajah, N.; Johnson, M.; Wallis, P.; Carr, P.; Cochrane, L.; Prescott, R.; Rose, A.; Drover, M.; Karunaratne, P.; McLaren, A.; Jones, E.; Nasar, M.; Bayliss, M.; Jones, P.; Lewis, B.; Dunn, A.; Eckley, M.; Price, J.; Woodman, G.; Forsyth, D.; Halls, M.; Young, J.; Aldridge, G.; Bhuvanendran, N.; Lewis, S.; Mann, C.; Patel, K.; Ghaus, N.; Grueger, A.; Mallinson, B.; Wihl, G.; Ballantyne, S.; Clarke, C. E.; Coyle, S.; Hornabrook, R.; Hutchinson, S.; Irfan, H.; Lewthwaite, A.; Nicholl, D.; Poxon, S.; Ritch, A.; Davison, J.; Dodds, S.; Gray, C.; Nath, U.; Robinson, G.; Deb, A.; Aftab, N.; Read, D.; Villanueva, L.; Alderton, L.; Carr, P.; Cochrane, L.; Prescott, R.; Rose, A.; Burrows, E.; Fletcher, P.; Folkes, E.; Gilbert, A.; Hayes, H.; Morrow, P.; Silva, M.; Baxter, G.; Bell, J.; Gorman, J.; Lawrence, J.; Rhind, G.; Hindle, J.; Jones, J.; Ohri, P.; Parry, M.; Roberts, E.; Subashchandran, R.; Pycock, C.; Aspden, L.; Partington-Jones, L.; Raw, J.; Vanek, H.; Wadhwa, U.; Barber, R.; Haywood, B.; Heywood, P.; Lewis, H.; O'Sullivan, K.; Prout, K.; Whelan, L.; Whone, A.; Fletcher, P.; Folkes, E.; Fuller, G.; Medcalf, P.; Morrish, P.; Silva, M.; Aruldoss, P.; Farmery, J.; Liveley, K.; Shelbourn, K.; Sood, V.; Bouifraden, K.; Dalziel, J.; Evans, C.; Matheson, P.; Overstall, P.; Wales, E.; Ward, G.; Ponsford, J.; Graham, A.; Grimmer, S. F. M.; Lockington, T. J.; Sheehan, L. J.; Williams, H.; Fuller, J.; Harrison, P.; Roche, M.; Shields, S.; Glasspool, R.; Hubbard, I.; Walters, R.; Barraclough, C.; McClung, A.; Moseley, L.; Pathirana, C. K.; Abbott, R.; Critchley, P.; Wray, L. Goodwin; Kendall, B.; Lawden, M.; Lo, N.; Martey, J.; Rajabally, Y.; Simpson, B.; Abbott, Leicester R.; Critchley, P.; Kendall, B.; Lawden, M.; Martey, J.; Rajabally, Y.; Hindle, J.; Ohri, P.; Gale, A.; Phiri, D.; Sekaran, L.; Sharma, A.; Wijayasiri, S.; Fleary, H.; Monaghan, A.; Silverdale, M.; Vanek, H.; Walker, D.; McGee, M.; Senthil, V.; Reynolds, S.; Arnould, D.; Chong, S.; Diem, D.; Kundu, B.; Quinn, N.; Benamer, H.; Billings, J.; Corston, R.; D'Costa, D.; Green, M.; Shuri, J.; Cassidy, T.; Dodds, S.; Gani, A.; Lawson, R.; Noble, J.; Chan, Y.; Clipsham, K.; Cochius, J.; Dick, D.; Hipperson, M.; Lee, M.; Payne, B.; Reading, F.; Roche, M.; Sabanathan, K.; Shields, S.; Worth, P.; Harper, G.; Honan, W.; Oxborough, L.; Saunders, J.; Stanley, J.; McCann, P.; Edmonds, P.; Hand, A.; O'Hanlon, S.; Robinson, L.; Walker, R.; Bolam, D.; Liddle, B.; Ballantyne, S. L.; Byravan, R.; Jones, P.; Guptha, S.; Noble, C.; Roychowdhury, S.; Ellis, C.; Harries-Jones, R.; Hillier, C.; Milligan, N.; Potter, J.; Ebenezer, L.; Raha, S.; Thompson, S.; Benamer, H.; Crouch, R.; Healy, K.; Hornabrook, R.; Johnson, M.; Nicholl, D.; Pall, H.; Praamstra, P.; Williams, A.; Beaumont, D.; Ell, S.; McGourty, J.; Jenkinson, M.; McHenry, M.; Scoble, N.; Vahid, R.; Findley, L.; Misbahuddin, A.; Adcock, J.; Chatterjee, A.; Collins, H.; Fairweather, S.; Flossman, E.; Greenhall, R.; Hart, H.; Shaw, J.; Singh, S.; Talbot, K.; Thompson, S.; Weir, A.; Gray, D.; Sood, V.; Sutherland, S.; Wilson, M.; Hughes, T.; Jones, A.; Morgan, L.; Sastry, B.; Abdel-Hafiz, A.; Al-Modaris, F.; Dutta, S.; Mallik, T.; Mondal, B.; Roberts, J.; Sinha, S.; Amar, K.; Atkins, S.; Devadason, G.; Martin, A.; Thompson, C.; Fenwick, G.; Gormley, K.; Gutowski, N.; Harris, S.; Harrower, T.; Hemsley, A.; Honan, W.; James, M.; Jeffreys, O.; Malone, T.; Pearce, V.; Sheridan, R.; Soper, C.; Sword, J.; Zeman, A.; Gordon, C.; McElwaine, T.; Pressly, V.; Chan, D.; Saha, R.; Howcroft, D.; Mugweni, K.; Robertson, D.; Stephens, A.; Whelan, E.; Wright, A.; Blane, N.; Burns, S.; Mutch, W.; Roberts, R.; Chikna, E.; Chamberlain, J.; Lee, J.; Marigold, J.; Adams, J.; Dulay, J.; Evans, S.; Frankel, J.; Garrard, P.; Gibb, W.; Gove, R.; Holmes, C.; Lawton, N.; Malik, N.; McElwaine, T.; Morgan, S.; Phipps, H.; Pressly, V.; Queen, V.; Roberts, H.; Tan, R.; Turner, G.; Weller, R.; Zaman, S.; O'Brien, A.; Grosset, D.; MacPhee, G.; McGonigal, A.; Vennard, C.; Rektorova, I.; Carey, G.; Castleton, B.; Dhakam, Z.; Kalcantera, E.; Long, C.; Mandal, B.; Martin, V.; Nari, R.; Nicholas, V.; Sunderland, C.; Franks, S.; Hammans, S.; Moffitt, V.; Rice-Oxley, M.; Elizabeth, J.; Logan, A.; Summers, B.; Cooper, S.; Darch, W.; Homan, J.; Hussain, M.; Sharratt, D.; Solanki, T.; Bennett, J.; Vassallo, J.; Ford, A.; Kendall, G.; Stocker, K.; Chaudhry, A.; Grubneac, A.; Kenton, A.; Lindahl, A.; Lismore, J.; McConville, M.; Peskett, R.; Ponsford, J.; Shehu, A.; Strens, L.; Hughes, T.; Sastry, B.; Barrett, J.; Turnbull, C.; Vanek, H.; Moore, A.; O'Brien, I.; Watling, D.; Wyatt, L.; Jones, C.; Mahan, T.; Ullyart, K.; Wood, B.; Desai, H.; Ferry, P.; Grubneac, A.; Ponsford, J.; Ray, P.; Rose, P.; Shehu, A.; Thanvi, B.; Waters, S.; Rizvi, S.; Sa'Adu, A.; Walker, E.; Berry, G.; Russell, N.; Lennox, G.; Ward, T.; Abrams, J.; Ashley, S.; Steiger, M.; Beal, A.; Hawkins, J.; Heller, A.; Jenkinson, M.; McHenry, M.; Samuel, M.; Scoble, N.; Vahid, R.; Caie, L.; Leslie, V.; Primrose, W.; Hipperson, M.; Pycock, C.; Baker, K.; Buckley, C.; Bulley, S.; Gibbons, D.; Goodland, R.; Heywood, P.; Jones, L.; Martin, L.; Qadiri, M. R.; Rashed, K.; Rowland-Axe, R.; Stone, A.; Whittuck, M.		PD MED Collaborative Grp	Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised	LANCET			English	Article							QUALITY-OF-LIFE; QUESTIONNAIRE PDQ-39	Background Whether initial treatment for Parkinson's disease should consist of levodopa, dopamine agonists, or monoamine oxidase type B inhibitors (MAOBI) is uncertain. We aimed to establish which of these three classes of drug, as initial treatment, provides the most effective long-term control of symptoms and best quality of life for people with early Parkinson's disease. Methods In this pragmatic, open-label randomised trial, patients newly diagnosed with Parkinson's disease were randomly assigned (by telephone call to a central office; 1:1:1) between levodopa-sparing therapy (dopamine agonists or MAOBI) and levodopa alone. Patients and investigators were not masked to group assignment. Primary outcomes were the mobility dimension on the 39-item patient-rated Parkinson's disease questionnaire (PDQ-39) quality-of-life scale (range 0-100 with six points defined as the minimally important difference) and cost-effectiveness. Analysis was intention to treat. This trial is registered, number ISRCTN69812316. Findings Between Nov 9,2000, and Dec 22,2009,1620 patients were assigned to study groups (528 to levodopa, 632 to dopamine agonist, 460 to MAOBI). With 3-year median follow-up, PDQ-39 mobility scores averaged 1.8 points (95% CI 0.5-3.0, p=0.005) better in patients randomly assigned to levodopa than those assigned to levodopa-sparing therapy, with no increase or attrition of benefit during 7 years' observation. PDQ-39 mobility scores were 1.4 points (95% CI 0.0-2.9, p=0.05) better in patients allocated MAOBI than in those allocated dopamine agonists. EQ-5D utility scores averaged 0.03 (95% CI 0.01-0.05; p=0.0002) better with levodopa than with levodopa-sparing therapy; rates of dementia (hazard ratio [HR] 0.81,95% CI 0.61-1.08, p=0.14), admissions to institutions (0.86,0.63-1.18; 13=0.4), and death (0.85, 0.69-1.06, p=0.17) were not significantly different, but the upper CIs precluded any substantial increase with levodopa compared with levodopa-sparing therapy. 179 (28%) of 632 patients allocated dopamine agonists and 104 (23%) of 460 patients allocated MAOBI discontinued allocated treatment because of sideeffects compared with 11 (2%) of 528 patients allocated levodopa (p<0.0001). Interpretation Very small but persistent benefits are shown for patient-rated mobility scores when treatment is initiated with levodopa compared with levodopa-sparing therapy. MAOBI as initial levodopa-sparing therapy was at least as effective as dopamine agonists.	[Gray, Richard; Gray, Alastair; Jenkinson, Crispin] Univ Oxford, Oxford, England; [Ives, Natalie; Rick, Caroline; Patel, Smitaa; Wheatley, Keith; Clarke, Carl E.] Univ Birmingham, Birmingham, W Midlands, England; [McIntosh, Emma] Univ Glasgow, Glasgow, Lanark, Scotland; [Williams, Adrian] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Clarke, Carl E.] Sandwell & West Birmingham Hosp, NHS Trust, Birmingham, W Midlands, England; [Clarke, C. E.; Ives, N.; Au, P.; Boodell, T.; Cheed, V.; Daniels, J.; Dowling, F.; Edmondson, A.; Gray, R.; Hawker, R.; Herd, C.; Hilken, N.; Kaur, S.; Ottridge, R.; Patel, S.; Peto, L.; Rick, C.; Sidile, C.; Tomlinson, C.; Tyler, E.; Wheatley, K.; Winkles, N.] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Fitzpatrick, R.; Gray, A.; Jenkinson, C.] Univ Oxford, Oxford OX1 2JD, England; [McIntosh, E.; Kent, S.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Counsell, C.; Caie, L.; Caslake, R.; Coleman, R.; Crowley, P.; Gerrie, L.; Gordon, J.; Harris, C.; Leslie, V.; Macleod, M. A.; Taylor, K.] Aberdeen Royal Infirm, Aberdeen, Scotland; [Barker, R.; Forsyth, D.; Halls, M.; Lennox, G.; Young, J.] Addenbrookes Hosp, Cambridge, England; [Azie, Wirral E.; Barrett, J.; Monaghan, A.; Turnbull, C.; Vanek, H.] Arrowe Pk Hosp, Wirral, Merseyside, England; [Blake, D.; Manford, M.; Thangarajah, N.] Bedford Hosp, Bedford, England; [Johnson, M.; Wallis, P.] Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [Carr, P.; Cochrane, L.; Prescott, R.; Rose, A.] Bishop Auckland Gen Hosp, Bishop Auckland, England; [Drover, M.; Karunaratne, P.; McLaren, A.] Borders Gen Hosp, Melrose, Scotland; [Jones, E.; Nasar, M.] Bridlington & Dist Hosp, Bridlington, England; [Bayliss, M.] Brighton Gen Hosp, Brighton, E Sussex, England; [Jones, P.; Lewis, B.] Bronglais Gen Hosp, Aberystwyth, Dyfed, Wales; [Dunn, A.; Eckley, M.; Price, J.; Woodman, G.] Bronllys Hosp, Brecon, Wales; [Forsyth, D.; Halls, M.; Young, J.] Brookfields Hosp, Cambridge, England; [Aldridge, G.; Bhuvanendran, N.; Lewis, S.; Mann, C.; Patel, K.] Bucknall Hosp, Stoke On Trent, Staffs, England; [Ghaus, N.; Grueger, A.; Mallinson, B.; Wihl, G.] Calderdale Royal Hosp, Halifax, NS, Canada; [Clarke, C. E.; Ballantyne, S.; Coyle, S.; Hornabrook, R.; Hutchinson, S.; Irfan, H.; Lewthwaite, A.; Poxon, S.; Ritch, A.] City Hosp, Birmingham, W Midlands, England; [Davison, J.; Dodds, S.; Gray, C.; Nath, U.; Robinson, G.] City Hosp, Sunderland, Tyne & Wear, England; [Deb, A.; Aftab, N.; Read, D.; Villanueva, L.] Colchester Gen Hosp, Colchester, Essex, England; [Carr, P.; Cochrane, L.; Prescott, R.; Rose, A.; Alderton, L.] Darlington Mem Hosp, Darlington, Durham, England; [Burrows, E.; Fletcher, P.; Folkes, E.; Gilbert, A.; Hayes, H.; Morrow, P.; Silva, M.] Delancey Hosp, Cheltenham, England; [Baxter, G.; Bell, J.; Gorman, J.; Lawrence, J.; Rhind, G.] Dumfries & Galloway Royal Infirm, Dumfries, Scotland; [Ohri, P.; Hindle, J.; Jones, J.; Parry, M.; Subashchandran, R.] Eryri Hosp, Caernarfon, Wales; [Pycock, C.] Evesham Community Hosp, Evesham, England; [Aspden, L.; Partington-Jones, L.; Raw, J.; Wadhwa, U.] Fairfield Hosp, Bury, England; [Barber, R.; Haywood, B.; Heywood, P.; Lewis, H.; O'Sullivan, K.; Prout, K.; Whone, A.; Whelan, E.] Frenchay Hosp, Bristol, Avon, England; [Morrish, P.; Fletcher, P.; Folkes, E.; Silva, M.; Fuller, G.; Medcalf, P.] Gloucestershire Royal Hosp, Gloucester, England; [Aruldoss, P.; Farmery, J.; Liveley, K.; Shelbourn, K.; Sood, V.] Grantham & Dist Hosp, Grantham, England; [Bouifraden, K.; Dalziel, J.; Evans, C.; Matheson, P.; Overstall, P.; Wales, E.; Ward, G.] Hereford Cty Hosp, Hereford, England; [Ponsford, J.] Hosp St Cross, Rugby, England; [Graham, A.; Grimmer, S. F. M.; Lockington, T. J.; Sheehan, L. J.; Williams, H.] Ipswich Hosp, Ipswich, Suffolk, England; [Fuller, J.; Harrison, P.; Roche, M.; Shields, S.] James Paget Hosp, Great Yarmouth, England; [Glasspool, R.; Hubbard, I.; Walters, R.] Gen Hosp Kettering, Kettering, England; [Barraclough, C.; McClung, A.; Moseley, L.; Pathirana, C. K.] Kidderminster Gen Hosp, Kidderminster, England; [Abbott, R.; Critchley, P.; Wray, L. Goodwin; Kendall, B.; Lawden, M.; Lo, N.; Rajabally, Y.; Simpson, B.] Leicester Gen Hosp, Leicester LE5 4PW, Leics, England; [Critchley, P.; Kendall, B.; Lawden, M.; Martey, J.; Rajabally, Y.; Abbott, Leicester R.] Leicester Royal Infirm, Leicester, Leics, England; [Ohri, P.; Hindle, J.] Llandudno Gen Hosp, Llandudno, Wales; [Gale, A.; Phiri, D.; Sekaran, L.; Sharma, A.; Wijayasiri, S.] Luton & Dunstable Hosp, Luton, Beds, England; [Monaghan, A.; Fleary, H.; Silverdale, M.; Walker, D.] Macclesfield Hosp, Macclesfield, Cheshire, England; [McGee, M.; Senthil, V.; Reynolds, S.] Manor Hosp, Walsall, W Midlands, England; [Arnould, D.; Chong, S.; Diem, D.; Kundu, B.] Medway Maritime Hosp, Gillingham, England; [Quinn, N.] Natl Hosp Neurol & Neurosci, London, England; [Benamer, H.; Billings, J.; Corston, R.; D'Costa, D.; Green, M.; Shuri, J.] New Cross Hosp, Wolverhampton, W Midlands, England; [Dodds, S.; Cassidy, T.; Gani, A.; Lawson, R.; Noble, J.] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Worth, P.; Roche, M.; Shields, S.; Chan, Y.; Clipsham, K.; Cochius, J.; Dick, D.; Hipperson, M.; Lee, M.; Payne, B.; Reading, F.; Sabanathan, K.; Stanley, J.] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [McCann, P.] North Manchester Gen Hosp, Manchester, Lancs, England; [Edmonds, P.; Hand, A.; O'Hanlon, S.; Robinson, L.; Walker, R.] North Tyneside Gen Hosp, North Shields, England; [Bolam, D.; Liddle, B.] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; [Jones, P.; Ballantyne, S. L.; Byravan, R.] Perry Tree Ctr, Birmingham, W Midlands, England; [Guptha, S.; Noble, C.; Roychowdhury, S.] Peterborough & Stamford NHS Trust, Peterborough, England; [Ellis, C.; Harries-Jones, R.; Hillier, C.; Milligan, N.] Poole Gen Hosp, Poole, Dorset, England; [Ebenezer, L.; Raha, S.; Thompson, S.] Princess Wales Hosp, Bridgend, Wales; [Williams, A.; Johnson, M.; Hornabrook, R.; Benamer, H.; Crouch, R.; Healy, K.; Pall, H.; Praamstra, P.] Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Beaumont, D.] Queen Elizabeth Hosp, Gateshead, England; [Ell, S.; McGourty, J.] Queen Elizabeth Hosp, Kings Lynn, England; [Jenkinson, M.; McHenry, M.; Scoble, N.; Vahid, R.] Queen Elizabeth Queen Mother Hosp, Margate, England; [Findley, L.; Misbahuddin, A.] Queens Hosp, Romsford, England; [Findley, L.; Misbahuddin, A.] Harold Wood Hosp, Romsford, England; [Fairweather, S.; Thompson, S.; Adcock, J.; Chatterjee, A.; Collins, H.; Flossman, E.; Greenhall, R.; Hart, H.; Shaw, J.; Singh, S.; Talbot, K.; Weir, A.] Radcliffe Infirm, Oxford, England; [Sood, V.; Gray, D.; Sutherland, S.; Wilson, M.] Raigmore Hosp, Inverness, Scotland; [Hughes, T.; Jones, A.; Morgan, L.; Sastry, B.] Rookwood Hosp, Cardiff, S Glam, Wales; [Abdel-Hafiz, A.; Al-Modaris, F.; Dutta, S.; Mallik, T.; Mondal, B.; Roberts, J.; Sinha, S.] Rotherham Dist Gen Hosp, Rotherham, S Yorkshire, England; [Amar, K.; Atkins, S.; Devadason, G.; Martin, A.; Thompson, C.] Royal Bournemouth Gen Hosp, Bournemouth, Dorset, England; [Malone, T.; Pearce, V.; Honan, W.; Fenwick, G.; Gormley, K.; Gutowski, N.; Harris, S.; Harrower, T.; Hemsley, A.; James, M.; Jeffreys, O.; Sheridan, R.; Soper, C.; Sword, J.; Zeman, A.] Royal Devon & Exeter Hosp, Wonford, England; [Gordon, C.; McElwaine, T.; Pressly, V.] Royal Hampshire Cty Hosp, Winchester, Hants, England; [Chan, D.; Saha, R.] Royal Sussex Cty Hosp, Brighton, E Sussex, England; [Howcroft, D.; Mugweni, K.; Robertson, D.; Stephens, A.; Whelan, E.; Wright, A.] Royal United Hosp, Bath BA1 3NG, Avon, England; [Blane, N.; Burns, S.; Mutch, W.; Roberts, R.] Royal Victoria Hosp, Dundee, Scotland; [Chikna, E.] Russian State Med Univ, Moscow 117437, Russia; [Chamberlain, J.; Lee, J.; Marigold, J.] Salisbury Dist Hosp, Salisbury, Wilts, England; [McElwaine, T.; Pressly, V.; Adams, J.; Dulay, J.; Evans, S.; Frankel, J.; Garrard, P.; Gibb, W.; Gove, R.; Holmes, C.; Lawton, N.; Malik, N.; Morgan, S.; Phipps, H.; Queen, V.; Roberts, H.; Tan, R.; Turner, G.; Weller, R.; Zaman, S.] Southampton Gen Hosp, Southampton, Hants, England; [O'Brien, A.] Southend Hosp, Southend On Sea, England; [MacPhee, G.; Grosset, D.; McGonigal, A.; Vennard, C.] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland; [Rektorova, I.] St Annes Teaching Hosp, Brno, Czech Republic; [Castleton, B.; Martin, A.; Carey, G.; Dhakam, Z.; Kalcantera, E.; Long, C.; Mandal, B.; Nari, R.; Nicholas, V.; Sunderland, C.] St Peters Hosp, Chertsey, England; [Franks, S.; Hammans, S.; Moffitt, V.; Rice-Oxley, M.] St Richards Hosp, Chichester, England; [Elizabeth, J.; Logan, A.; Summers, B.] Stafford Hosp, Stafford, England; [Cooper, S.; Darch, W.; Homan, J.; Hussain, M.; Sharratt, D.; Solanki, T.] Taunton & Somerset Hosp, Taunton, MA USA; [Bennett, J.; Vassallo, J.] Royal Oldham Hosp, Oldham, England; [Ford, A.; Kendall, G.; Stocker, K.] Torbay Dist Gen Hosp, Torquay, England; [Ponsford, J.; Chaudhry, A.; Grubneac, A.; Kenton, A.; Lindahl, A.; Lismore, J.; McConville, M.; Peskett, R.; Shehu, A.; Strens, L.] Univ Hosp, Coventry, W Midlands, England; [Hughes, T.; Sastry, B.] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales; [Barrett, J.; Turnbull, C.] Victoria Cent Hosp, Wirral, Merseyside, England; [Moore, A.; O'Brien, I.; Watling, D.; Wyatt, L.] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Wood, B.; Jones, C.; Mahan, T.; Ullyart, K.] Wansbeck Hosp, Ashington, England; [Grubneac, A.; Desai, H.; Ferry, P.; Ray, P.; Rose, P.; Thanvi, B.; Waters, S.] Warwick Hosp, Warwick, England; [Rizvi, S.; Sa'Adu, A.; Walker, E.] Watford Dist Gen Hosp, Watford, England; [Berry, G.; Russell, N.] West Cumberland Hosp, Whitehaven, England; [Lennox, G.; Ward, T.] W Suffolk Hosp, Bury St Edmunds, Suffolk, England; [Abrams, J.; Ashley, S.; Steiger, M.] Whiston Hosp, Prescot, England; [Jenkinson, C.; McHenry, M.; Scoble, N.; Vahid, R.; Beal, A.; Hawkins, J.; Heller, A.; Samuel, M.] William Harvey Hosp, Ashford, Kent, England; [Caie, L.; Leslie, V.; Primrose, W.] Woodend Gen Hosp, Aberdeen, Scotland; [Pycock, C.; Hipperson, M.] Worcester Royal Hosp, Worcester, MA USA; [Jones, J.; Heywood, P.; Baker, K.; Buckley, C.; Bulley, S.; Gibbons, D.; Goodland, R.; Martin, L.; Qadiri, M. R.; Rashed, K.; Rowland-Axe, R.; Stone, A.; Whittuck, M.] Yeovil Dist Hosp, Yeovil, England	University of Oxford; University of Birmingham; University of Glasgow; University of Birmingham; University of Birmingham; University of Oxford; University of Glasgow; University of Aberdeen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Heart of England NHS Foundation Trust; University of Birmingham; Brighton and Sussex University Hospitals NHS Trust; Brighton General Hospital; University of Birmingham; Gloucestershire Royal Hospital; Ipswich Hospital NHS Trust; Ipswich Hospital; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; Medway Maritime Hospital; New Cross Hospital; Newcastle General Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Northern General Hospital; Poole Hospital; University of Birmingham; Radcliffe Infirmary; University of Brighton; Pirogov Russian National Research Medical University; Salisbury District Hospital; University of Southampton; University of Glasgow; St Anne's University Hospital Brno (FNUSA-ICRC); University of Warwick; Cardiff University; Walton Centre; Watford General Hospital; Whiston Hospital	Gray, R (corresponding author), Univ Oxford, Oxford, England.		McGonigal, Aileen/V-3292-2018; Collins, Hannah/GSD-5229-2022; Hand, Annette/AAR-4442-2020; Gray, Richard/C-9945-2017; Roberts, Helen C/A-5551-2016; Whone, Alan/AAZ-4125-2020	McGonigal, Aileen/0000-0001-6775-5318; Gray, Richard/0000-0001-9694-4206; Roberts, Helen C/0000-0002-5291-1880; Grosset, Donald/0000-0002-2757-8203; Gray, Richard/0000-0003-4440-574X; Ives, Natalie/0000-0002-1664-7541; Lewis, Steff/0000-0003-1210-2314; Patel, Smitaa/0000-0002-4997-3829; Ottridge, Ryan/0000-0002-8685-2145; Whone, Alan/0000-0002-8931-4422; Clarke, Carl/0000-0003-2478-3436; Gray, Alastair/0000-0003-0239-7278; Herd, Clare/0000-0002-1351-1112; Silverdale, Monty/0000-0002-3295-6897; fitzpatrick, Ray/0000-0003-0607-0563; Roychowdhury, Sagorika/0000-0001-9376-3928; James, Martin/0000-0001-6065-6018; Rektorova, Irena/0000-0002-5455-4573; McIntosh, Emma/0000-0001-6340-3083	UK National Institute for Health Research Health Technology Assessment Programme [98/03/02]; UK Department of Health; UK Medical Research Council; Parkinson's UK; National Institute for Health Research [98/03/02] Funding Source: researchfish; Parkinson&quot;s UK [F-1001] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); UK Department of Health; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	PD MED was supported by funding from the UK National Institute for Health Research Health Technology Assessment Programme (project number 98/03/02). The University of Birmingham Clinical Trials Unit also received support from the UK Department of Health. Richard Gray is funded by the UK Medical Research Council, Emma McIntosh by Parkinson's UK. Alastair Gray is an NIHR Senior Investigator. The views and opinions expressed in this article are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. We thank all the investigators who contributed to the trial, the patients who agreed to enter the study, and the Dementia and Neurodegenerative Disease (DeNDRoN) Clinical Research Network for their help with recruitment. The PDQ-39 questionnaire was developed by Crispin Jenkinson, Ray Fitzpatrick, and Viv Peto in 1993, who have asserted their moral rights in it, and the copyright, which is owned by Isis Innovation Limited.	Caslake R, 2009, COCHRANE DB SYST REV, V4; Caslake R, 2013, PARKINSONISM RELAT D, V19, P515, DOI 10.1016/j.parkreldis.2013.01.014; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Food and Drug Administration, 1989, PER CENTR NERV SYST, P227; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Howard R, 2011, INT J GERIATR PSYCH, V26, P812, DOI 10.1002/gps.2607; Ives NJ, 2004, BMJ-BRIT MED J, V329, P593, DOI 10.1136/bmj.38184.606169.AE; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Jenkinson C, 2006, AGE AGEING, V35, P497, DOI 10.1093/ageing/afl055; Lees AJ, 1995, BRIT MED J, V311, P1602, DOI 10.1136/bmj.311.7020.1602; Macleod A, 2005, COCHRANE DB SYST REV, V3; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; National Institute for Health and Clinical Excellence, REV CLIN GUID CG 35; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Oertel WH, 1997, BAILLIERE CLIN NEUR, V6, P89; Olanow CW, 2010, MOVEMENT DISORD, V25, P1774, DOI 10.1002/mds.23288; Peto V, 2001, AGE AGEING, V30, P299, DOI 10.1093/ageing/30.4.299; Schafer J., 1999, ANAL INCOMPLETE MULT; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P67, DOI 10.1136/jnnp.69.1.67; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Stowe RL, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006564.pub2; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Utsumi H, 2012, ACTA MED OKAYAMA, V66, P163; van Hilten JJ, 2007, COCHRANE DB SYST REV, V4; van Hilten JJ, 2007, COCHRANE DB SYST REV, V4; Wheatley K, 2002, BMJ-BRIT MED J, V324, P1508, DOI 10.1136/bmj.324.7352.1508; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4	30	195	200	1	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1196	1205		10.1016/S0140-6736(14)60683-8	http://dx.doi.org/10.1016/S0140-6736(14)60683-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7MT	24928805				2022-12-28	WOS:000343002600026
J	Agarwal, S; Labrique, A				Agarwal, Smisha; Labrique, Alain			Newborn Health on the Line The Potential mHealth Applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MOBILE PHONES; TRIAL; CARE		[Agarwal, Smisha; Labrique, Alain] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Labrique, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,E5543, Baltimore, MD 21205 USA.	alabriqu@jhsph.edu		Agarwal, Smisha/0000-0002-7407-0066; Labrique, Alain/0000-0003-2502-7819				Berg M, 2009, EVERY CHILD COUNTS T; Gisore P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-15; Githinji S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054066; Lund S, 2012, BJOG-INT J OBSTET GY, V119, P1256, DOI 10.1111/j.1471-0528.2012.03413.x; Mitchell M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-95; Ngabo F, 2012, PAN AFR MED J, V13; Schiffman J, 2010, SEMIN PERINATOL, V34, P462, DOI 10.1053/j.semperi.2010.09.008; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; World Health Organization; UNICEF, 2012, UNICEF COUNTDOWN TO	9	41	42	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					229	230		10.1001/jama.2014.6371	http://dx.doi.org/10.1001/jama.2014.6371			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	24953141				2022-12-28	WOS:000338940300015
J	Chandel, NS; Tuveson, DA				Chandel, Navdeep S.; Tuveson, David A.			The Promise and Perils of Antioxidants for Cancer Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Tuveson, David A.] Cold Spring Harbor Lab, Lustgarten Fdn Lab, Cold Spring Harbor, NY 11724 USA	Northwestern University; Feinberg School of Medicine; Cold Spring Harbor Laboratory	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	5	135	141	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					177	178		10.1056/NEJMcibr1405701	http://dx.doi.org/10.1056/NEJMcibr1405701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006725				2022-12-28	WOS:000338645500015
J	Dvir, D; Webb, JG; Bleiziffer, S; Pasic, M; Waksman, R; Kodali, S; Barbanti, M; Latib, A; Schaefer, U; Rodes-Cabau, J; Treede, H; Piazza, N; Hildick-Smith, D; Himbert, D; Walther, T; Hengstenberg, C; Nissen, H; Bekeredjian, R; Presbitero, P; Ferrari, E; Segev, A; de Weger, A; Windecker, S; Moat, NE; Napodano, M; Wilbring, M; Cerillo, AG; Brecker, S; Tchetche, D; Lefevre, T; De Marco, F; Fiorina, C; Petronio, AS; Teles, RC; Testa, L; Laborde, JC; Leon, MB; Kornowski, R				Dvir, Danny; Webb, John G.; Bleiziffer, Sabine; Pasic, Miralem; Waksman, Ron; Kodali, Susheel; Barbanti, Marco; Latib, Azeem; Schaefer, Ulrich; Rodes-Cabau, Josep; Treede, Hendrik; Piazza, Nicolo; Hildick-Smith, David; Himbert, Dominique; Walther, Thomas; Hengstenberg, Christian; Nissen, Henrik; Bekeredjian, Raffi; Presbitero, Patrizia; Ferrari, Enrico; Segev, Amit; de Weger, Arend; Windecker, Stephan; Moat, Neil E.; Napodano, Massimo; Wilbring, Manuel; Cerillo, Alfredo G.; Brecker, Stephen; Tchetche, Didier; Lefevre, Thierry; De Marco, Federico; Fiorina, Claudia; Petronio, Anna Sonia; Teles, Rui C.; Testa, Luca; Laborde, Jean-Claude; Leon, Martin B.; Kornowski, Ran		Valve In Valve Int Data Registry	Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSTHESIS-PATIENT MISMATCH; HIGH-RISK PATIENTS; HEART-VALVES; NATIONAL DATABASE; ELDERLY-PATIENTS; REPLACEMENT; STENOSIS; IMPACT; ENLARGEMENT; SURVIVAL	IMPORTANCE Owing to a considerable shift toward bioprosthesis implantation rather than mechanical valves, it is expected that patients will increasingly present with degenerated bioprostheses in the next few years. Transcatheter aortic valve-in-valve implantation is a less invasive approach for patients with structural valve deterioration; however, a comprehensive evaluation of survival after the procedure has not yet been performed. OBJECTIVE To determine the survival of patients after transcatheter valve-in-valve implantation inside failed surgical bioprosthetic valves. DESIGN, SETTING, AND PARTICIPANTS Correlates for survivalwere evaluated using a multinational valve-in-valve registry that included 459 patients with degenerated bioprosthetic valves undergoing valve-in-valve implantation between 2007 and May 2013 in 55 centers (mean age, 77.6 [SD, 9.8] years; 56% men; median Society of Thoracic Surgeons mortality prediction score, 9.8%[interquartile range, 7.7%-16%]). Surgical valves were classified as small (<= 21 mm; 29.7%), intermediate (> 21 and < 25 mm; 39.3%), and large (<= 25 mm; 31%). Implanted devices included both balloon-and self-expandable valves. MAIN OUTCOMES AND MEASURES Survival, stroke, and New York Heart Association functional class. RESULTS Modes of bioprosthesis failure were stenosis (n = 181 [39.4%]), regurgitation (n = 139 [30.3%]), and combined (n = 139 [30.3%]). The stenosis group had a higher percentage of small valves (37% vs 20.9% and 26.6% in the regurgitation and combined groups, respectively; P =.005). Within 1 month following valve-in-valve implantation, 35 (7.6%) patients died, 8 (1.7%) had major stroke, and 313 (92.6%) of surviving patients had good functional status (New York Heart Association class I/II). The overall 1-year Kaplan-Meier survival rate was 83.2%(95% CI, 80.8%-84.7%; 62 death events; 228 survivors). Patients in the stenosis group had worse 1-year survival (76.6%; 95% CI, 68.9%-83.1%; 34 deaths; 86 survivors) in comparison with the regurgitation group (91.2%; 95% CI, 85.7%-96.7%; 10 deaths; 76 survivors) and the combined group (83.9%; 95% CI, 76.8%-91%; 18 deaths; 66 survivors) (P =.01). Similarly, patients with small valves had worse 1-year survival (74.8%[95% CI, 66.2%-83.4%]; 27 deaths; 57 survivors) vs with intermediate-sized valves (81.8%; 95% CI, 75.3%-88.3%; 26 deaths; 92 survivors) and with large valves (93.3%; 95% CI, 85.7%-96.7%; 7 deaths; 73 survivors) (P =.001). Factors associated with mortality within 1 year included having small surgical bioprosthesis (<= 21 mm; hazard ratio, 2.04; 95% CI, 1.14-3.67; P =.02) and baseline stenosis (vs regurgitation; hazard ratio, 3.07; 95% CI, 1.33-7.08; P =.008). CONCLUSIONS AND RELEVANCE In this registry of patients who underwent transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic valves, overall 1-year survival was 83.2%. Survival was lower among patients with small bioprostheses and those with predominant surgical valve stenosis.	[Dvir, Danny; Webb, John G.; Barbanti, Marco] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Bleiziffer, Sabine] German Heart Ctr, Munich, Germany; [Pasic, Miralem] Deutsch Herzzentrum Berlin, Berlin, Germany; [Waksman, Ron] Washington Hosp Ctr, Washington, DC 20010 USA; [Kodali, Susheel; Leon, Martin B.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Kodali, Susheel; Leon, Martin B.] Cardiovasc Res Fdn, New York, NY USA; [Latib, Azeem] Ist Sci San Raffaele, I-20132 Milan, Italy; [Schaefer, Ulrich] Asklepios Clin St Georg, Hamburg, Germany; [Rodes-Cabau, Josep] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Treede, Hendrik] Univ Heart Ctr Hamburg, Hamburg, Germany; [Piazza, Nicolo] McGill Univ, Ctr Hlth, Dept Intervent Cardiol, Montreal, PQ, Canada; [Hildick-Smith, David] Sussex Cardiac Ctr, Brighton, E Sussex, England; [Himbert, Dominique] Hosp Bichat, Paris, France; [Walther, Thomas] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Hengstenberg, Christian] Univ Klinikum Regensburg, Regensburg, Germany; [Nissen, Henrik] Odense Univ Hosp, DK-5000 Odense, Denmark; [Bekeredjian, Raffi] Heidelberg Univ, Heidelberg, Germany; [Presbitero, Patrizia] IRCCS Ist Clin Humanitas, Hemodynam & Invas Cardiol Unit, Milan, Italy; [Ferrari, Enrico] Univ Lausanne Hosp, Lausanne, Switzerland; [Segev, Amit] Sheba Med Ctr, Ramat Gan, Israel; [de Weger, Arend] Leids Univ Med Ctr, Leiden, Netherlands; [Windecker, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Moat, Neil E.] Royal Brompton Hosp, London SW3 6LY, England; [Napodano, Massimo] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Wilbring, Manuel] Univ Heart Ctr Dresden, Dresden, Germany; [Cerillo, Alfredo G.] G Pasquinucci Hosp, Massa, Italy; [Brecker, Stephen; Laborde, Jean-Claude] Univ London St Georges Hosp, London, England; [Tchetche, Didier] Clin Pasteur, Toulouse, France; [Lefevre, Thierry] Hop Jacques Cartier, Massy, France; [De Marco, Federico] Osped Niguarda Ca Granda, Milan, Italy; [Fiorina, Claudia] Azienda Osped Spedali Civili Brescia, Brescia, Italy; [Petronio, Anna Sonia] Azienda Osped Univ Pisana, Pisa, Italy; [Teles, Rui C.] Hosp Santa Cruz, Lisbon, Portugal; [Testa, Luca] Clin Inst S Ambrogio, Milan, Italy; [Kornowski, Ran] Rabin Med Ctr, Tel Aviv, Israel; [Kornowski, Ran] Tel Aviv Univ, IL-69978 Tel Aviv, Israel	St. Paul's Hospital; University of Saskatchewan; German Heart Centre Munich; German Heart Center Berlin; MedStar Washington Hospital Center; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Asklepios Klinik St. Georg; Quebec Heart & Lung Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Kerckhoff Clinic; University of Regensburg; University of Southern Denmark; Odense University Hospital; Ruprecht Karls University Heidelberg; Humanitas University; IRCCS Humanitas Research Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Chaim Sheba Medical Center; University of Bern; University Hospital of Bern; Royal Brompton Hospital; University of Padua; Technische Universitat Dresden; St Georges University London; Jacques Cartier Private Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Hospital Spedali Civili Brescia; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universidade de Lisboa; Rabin Medical Center; Tel Aviv University	Dvir, D (corresponding author), St Pauls Hosp, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	ddvir@providencehealth.bc.ca	Ferrari, Enrico/AAD-2897-2020; De Marco, Federico/AAB-4605-2021; Testa, Luca/J-8226-2018; Hengstenberg, Christian/U-5485-2019; Doğan, Ali/AAN-5331-2020; Barbanti, Marco/AAP-4373-2020; Bleiziffer, Sabine/AAU-2081-2020; Treede, Hendrik/I-3630-2017; Latib, Azeem/B-4165-2008	Ferrari, Enrico/0000-0002-2837-3242; De Marco, Federico/0000-0003-3554-6938; Barbanti, Marco/0000-0002-4903-5437; Latib, Azeem/0000-0001-9035-343X; SEgev, Amit/0000-0002-2290-0400; testa, luca/0000-0003-4687-3686; Cerillo, Alfredo Giuseppe/0000-0003-3430-2333	Edwards Lifesciences; Medtronic; Boston Scientific; St Jude; Biotronik; Abbott; Cordis	Edwards Lifesciences; Medtronic(Medtronic); Boston Scientific(Boston Scientific); St Jude(St. Jude Medical); Biotronik; Abbott(Abbott Laboratories); Cordis	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Webb reports grants and personal fees from Edwards Lifesciences. Dr Bleiziffer reports serving as proctor for Medtronic and JenaValve. Dr Kodali reports consultancy for Edwards Lifesciences, Claret Medical, and Merril Lifesciences and serving on the scientific advisory board for Thubrikar. Dr Latib reports serving on the scientific advisory board for Medtronic and as a consultant and proctor for Direct Flow Medical Inc. Dr Rodes-Cabau reports consultancy for Edwards Lifesciences and St Jude Medical. Dr Piazza reports receipt of grants and serving as a proctor for Medtronic. Dr Hildick-Smith reports personal fees from Medtronic, Edwards Lifesciences, and Boston Scientific. Dr Himbert reports serving as a consultant and proctor for Edwards Lifesciences and Medtronic. Dr Hengstenberg reports lecture/speakers bureau fees and travel reimbursement from Edwards Lifesciences. Dr Segev reports personal fees from Medtronic and Edwards Lifesciences. Dr Windecker reports receipt of grants from St Jude and Biotronik. Dr Moat reports personal fees from Medtronic. Dr Brecker reports serving as a proctor for Medtronic. Dr Lefevre reports serving as a proctor and receipt of fees for Edwards Lifesciences and travel reimbursement from Directflow and Symetis. Dr Petronio reports serving as a proctor for Medtronic. Dr Teles reports personal fees from Medtronic, Abbott, and Cordis. No other disclosures were reported.	Bedogni F, 2011, JACC-CARDIOVASC INTE, V4, P1228, DOI 10.1016/j.jcin.2011.10.002; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Brennan JM, 2013, CIRCULATION, V127, P1647, DOI 10.1161/CIRCULATIONAHA.113.002003; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Castro LJ, 2002, ANN THORAC SURG, V74, P31, DOI 10.1016/S0003-4975(02)03680-9; Connolly HM, 2000, CIRCULATION, V101, P1940, DOI 10.1161/01.CIR.101.16.1940; David TE, 2001, J THORAC CARDIOV SUR, V121, P268, DOI 10.1067/mtc.2001.112208; Dvir D, 2012, CIRCULATION, V126, P2335, DOI 10.1161/CIRCULATIONAHA.112.104505; Eggebrecht H, 2011, JACC-CARDIOVASC INTE, V4, P1218, DOI 10.1016/j.jcin.2011.07.015; Flameng W, 2010, CIRCULATION, V121, P2123, DOI 10.1161/CIRCULATIONAHA.109.901272; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Glower DD, 1998, ANN THORAC SURG, V66, pS44, DOI 10.1016/S0003-4975(98)01114-X; Gurvitch R, 2011, J AM COLL CARDIOL, V58, P2196, DOI 10.1016/j.jacc.2011.09.009; HE GW, 1995, ANN THORAC SURG, V59, P1056, DOI 10.1016/0003-4975(95)00075-V; Head SJ, 2012, EUR HEART J, V33, P1518, DOI 10.1093/eurheartj/ehs003; Khawaja MZ, 2010, J AM COLL CARDIOL, V55, P97, DOI 10.1016/j.jacc.2009.06.060; Kirsch M, 2004, J HEART VALVE DIS, V13, P991; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Maganti M, 2009, ANN THORAC SURG, V87, P521, DOI 10.1016/j.athoracsur.2008.09.030; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Nishida T, 2013, GEN THORAC CARDIOVAS, V61, P182, DOI 10.1007/s11748-013-0202-z; Peterson MD, 2007, ANN THORAC SURG, V83, P2044, DOI 10.1016/j.athoracsur.2007.01.059; Piazza N, 2011, JACC-CARDIOVASC INTE, V4, P733, DOI 10.1016/j.jcin.2011.05.007; Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Rosenhek R, 2003, J AM SOC ECHOCARDIOG, V16, P1116, DOI 10.1067/S0894-7317(03)00638-2; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sommers KE, 1997, ANN THORAC SURG, V63, P1608, DOI 10.1016/S0003-4975(97)00127-6; Tasca G, 2006, CIRCULATION, V113, P570, DOI 10.1161/CIRCULATIONAHA.105.587022; Urso S, 2009, J HEART VALVE DIS, V18, P248; Webb JG, 2013, CIRCULATION, V127, P2542, DOI 10.1161/CIRCULATIONAHA.113.000631; Webb JG, 2010, CIRCULATION, V121, P1848, DOI 10.1161/CIRCULATIONAHA.109.924613; WHEATLEY DJ, 1987, J THORAC CARDIOV SUR, V94, P367	35	614	632	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					162	170		10.1001/jama.2014.7246	http://dx.doi.org/10.1001/jama.2014.7246			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005653	Green Published, Bronze			2022-12-28	WOS:000338511200022
J	Aanen, DK; Bisseling, T				Aanen, Duur K.; Bisseling, Ton			The birth of cooperation	SCIENCE			English	Editorial Material							SYMBIOSIS; MUTUALISM; EVOLUTION		[Aanen, Duur K.] Wageningen Univ, Genet Lab, Dept Plant Sci, NL-6708 PB Wageningen, Netherlands; [Bisseling, Ton] Wageningen Univ, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands; [Bisseling, Ton] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Wageningen University & Research; Wageningen University & Research; King Saud University	Aanen, DK (corresponding author), Wageningen Univ, Genet Lab, Dept Plant Sci, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.		Bisseling, Ton/A-2421-2013					Aanen DK, 2007, TRENDS ECOL EVOL, V22, P506, DOI 10.1016/j.tree.2007.08.007; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; Frank SA, 1997, AM NAT, V150, pS80, DOI 10.1086/286051; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; LAW R, 1983, BIOL J LINN SOC, V20, P249, DOI 10.1111/j.1095-8312.1983.tb01876.x; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Lutzoni F, 2009, CURR BIOL, V19, pR502, DOI 10.1016/j.cub.2009.04.034; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Szathmary E, 1995, MAJOR TRANSITIONS EV	12	15	15	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					29	30		10.1126/science.1256542	http://dx.doi.org/10.1126/science.1256542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994634				2022-12-28	WOS:000338284400033
J	Mo, FY; Dong, GB				Mo, Fanyang; Dong, Guangbin			Regioselective ketone alpha-alkylation with simple olefins via dual activation	SCIENCE			English	Article							C BOND FORMATION; UNACTIVATED OLEFINS; CARBONYL-COMPOUNDS; INTRAMOLECULAR HYDROALKYLATION; DERIVATIVES; ALKENES; ORGANOCATALYSIS; CATALYSIS	Alkylation of carbonyl compounds is a commonly used carbon-carbon bond-forming reaction. However, the conventional enolate alkylation approach remains problematic due to lack of regioselectivity, risk of overalkylation, and the need for strongly basic conditions and expensive alkyl halide reagents. Here, we describe development of a ketone-alkylation strategy using simple olefins as the alkylating agents. This strategy employs a bifunctional catalyst comprising a secondary amine and a low-valent rhodium complex capable of activating ketones and olefins simultaneously. Both cyclic and acyclic ketones can be mono-alpha-alkylated with simple terminal olefins, such as ethylene, propylene, 1-hexene, and styrene, selectively at the less hindered site; a large number of functional groups are tolerated. The pH/redox neutral and byproduct-free nature of this dual-activation approach shows promise for large-scale syntheses.	[Mo, Fanyang; Dong, Guangbin] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Dong, GB (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.	gbdong@cm.utexas.edu	Mo, Fanyang/I-5347-2012	Mo, Fanyang/0000-0002-4140-3020	University of Texas at Austin; Cancer Prevention and Research Institute of Texas [R1118]; Welch Foundation [F-1781]; NSF [CAREER: CHE-1254935]	University of Texas at Austin; Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF))	We thank the University of Texas at Austin and Cancer Prevention and Research Institute of Texas (R1118) for a start-up fund and the Welch Foundation (F-1781) and NSF (CAREER: CHE-1254935) for research grants. A provisional patent based on this work has been filed by the University of Texas at Austin. G. D. is a Searle Scholar. We thank V. Lynch for x-ray crystallography. Metrical parameters for the crystal structures of compounds S3a to S3g, S3j, S3r, S3s, 4 to 6, and 8 are available free from the Cambridge Crystallographic Data Centre under reference numbers CCDC-1003268 to -1003281, respectively. We thank J. L. Sessler, M. J. Krische, and D. R. Siegel for loaning chemicals; B. A. Shoulders, S. Sorey, and A. Spangenberg for NMR advice; Y. Xu for thoughtful suggestions; A. Dermenci and H. Lim for proofreading the manuscript; and Z. Dong for checking and repeating the experimental procedure.	Anastas P.T., 1998, GREEN CHEM THEORY PR GREEN CHEM THEORY PR; Beeson TD, 2007, SCIENCE, V316, P582, DOI 10.1126/science. 1142696; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Comito RJ, 2013, J AM CHEM SOC, V135, P9358, DOI 10.1021/ja4047312; CONIA JM, 1975, SYNTHESIS-STUTTGART, P1; Denes F, 2010, CHEM REV, V110, P2366, DOI 10.1021/cr800420x; HEGEDUS LS, 1980, J AM CHEM SOC, V102, P4973, DOI 10.1021/ja00535a026; Iwahama T, 2000, CHEM COMMUN, P2317, DOI 10.1039/b007182j; Jun CH, 2002, TETRAHEDRON LETT, V43, P4233, DOI 10.1016/S0040-4039(02)00769-4; Kennedy-Smith JJ, 2004, J AM CHEM SOC, V126, P4526, DOI 10.1021/ja049487s; Kwak J, 2012, J AM CHEM SOC, V134, P17778, DOI 10.1021/ja308205d; Larock R.C., 2018, COMPREHENSIVE ORGANI; LEWIS LN, 1986, J AM CHEM SOC, V108, P2728, DOI 10.1021/ja00270a036; List B, 2007, CHEM REV, V107, P5413, DOI 10.1021/cr078412e; Majima S, 2012, TETRAHEDRON LETT, V53, P4381, DOI 10.1016/j.tetlet.2012.06.019; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Nakamura M, 2004, J AM CHEM SOC, V126, P11820, DOI 10.1021/ja0465193; Ono Y, 1996, PURE APPL CHEM, V68, P367, DOI 10.1351/pac199668020367; Park YJ, 2008, ACCOUNTS CHEM RES, V41, P222, DOI 10.1021/ar700133y; Pei T, 2001, J AM CHEM SOC, V123, P11290, DOI 10.1021/ja011764x; Rodriguez AL, 2000, ORG LETT, V2, P3285, DOI 10.1021/ol000174l; Sanchez D, 2012, ORG LETT, V14, P536, DOI 10.1021/ol203157s; Smith M.B., 2007, ADV ORGANIC CHEM REA, V6th ed, DOI 10.1002/9780470084960.ch15; STORK G, 1956, J AM CHEM SOC, V78, P5128, DOI 10.1021/ja01600a087; STORK G, 1954, J AM CHEM SOC, V76, P2029, DOI 10.1021/ja01636a103; vonOettingen W. F., 1964, HALOGENATED HYDROCAR; Wang X, 2003, ORG LETT, V5, P2699, DOI 10.1021/ol034879+; Wang ZQ, 2012, J AM CHEM SOC, V134, P13954, DOI 10.1021/ja306123m; Xiao YP, 2011, ANGEW CHEM INT EDIT, V50, P4937, DOI 10.1002/anie.201100044; Yao XQ, 2004, J AM CHEM SOC, V126, P6884, DOI 10.1021/ja0482637	30	207	207	2	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					68	72		10.1126/science.1254465	http://dx.doi.org/10.1126/science.1254465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994648				2022-12-28	WOS:000338284400050
J	Crosby, J; Peloso, GM; Auer, PL; Crosslin, DR; Stitziel, NO; Lange, LA; Lu, YC; Tang, ZZ; Zhang, H; Hindy, G; Masca, N; Stirrups, K; Kanoni, S; Do, R; Jun, G; Hu, YN; Kang, HM; Xue, CY; Goel, A; Farrall, M; Duga, S; Merlini, PA; Asselta, R; Girelli, D; Olivieri, O; Martinelli, N; Yin, W; Reilly, D; Speliotes, E; Fox, CS; Hveem, K; Holmen, OL; Nikpay, M; Farlow, DN; Assimes, TL; Franceschini, N; Robinson, J; North, KE; Martin, LW; DePristo, M; Gupta, N; Escher, SA; Jansson, JH; Van Zuydam, N; Palmer, CNA; Wareham, N; Koch, W; Meitinger, T; Peters, A; Lieb, W; Erbel, R; Konig, IR; Kruppa, J; Degenhardt, F; Gottesman, O; Bottinger, EP; O'Donnell, CJ; Psaty, BM; Ballantyne, CM; Abecasis, G; Ordovas, JM; Melander, O; Watkins, H; Orho-Melander, M; Ardissino, D; Loos, RJF; McPherson, R; Willer, CJ; Erdmann, J; Hall, AS; Samani, NJ; Deloukas, P; Schunkert, H; Wilson, JG; Kooperberg, C; Rich, SS; Tracy, RP; Lin, DY; Altshuler, D; Gabriel, S; Nickerson, DA; Jarvik, GP; Cupples, LA; Reiner, AP; Boerwinkle, E; Kathiresan, S				Crosby, Jacy; Peloso, Gina M.; Auer, Paul L.; Crosslin, David R.; Stitziel, Nathan O.; Lange, Leslie A.; Lu, Yingchang; Tang, Zheng-zheng; Zhang, He; Hindy, George; Masca, Nicholas; Stirrups, Kathleen; Kanoni, Stavroula; Do, Ron; Jun, Goo; Hu, Youna; Kang, Hyun Min; Xue, Chenyi; Goel, Anuj; Farrall, Martin; Duga, Stefano; Merlini, Pier Angelica; Asselta, Rosanna; Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola; Yin, Wu; Reilly, Dermot; Speliotes, Elizabeth; Fox, Caroline S.; Hveem, Kristian; Holmen, Oddgeir L.; Nikpay, Majid; Farlow, Deborah N.; Assimes, Themistocles L.; Franceschini, Nora; Robinson, Jennifer; North, Kari E.; Martin, Lisa W.; DePristo, Mark; Gupta, Namrata; Escher, Stefan A.; Jansson, Jan-Hakan; Van Zuydam, Natalie; Palmer, Colin N. A.; Wareham, Nicholas; Koch, Werner; Meitinger, Thomas; Peters, Annette; Lieb, Wolfgang; Erbel, Raimund; Konig, Inke R.; Kruppa, Jochen; Degenhardt, Franziska; Gottesman, Omri; Bottinger, Erwin P.; O'Donnell, Christopher J.; Psaty, Bruce M.; Ballantyne, Christie M.; Abecasis, Goncalo; Ordovas, Jose M.; Melander, Olle; Watkins, Hugh; Orho-Melander, Marju; Ardissino, Diego; Loos, Ruth J. F.; McPherson, Ruth; Willer, Cristen J.; Erdmann, Jeanette; Hall, Alistair S.; Samani, Nilesh J.; Deloukas, Panos; Schunkert, Heribert; Wilson, James G.; Kooperberg, Charles; Rich, Stephen S.; Tracy, Russell P.; Lin, Dan-Yu; Altshuler, David; Gabriel, Stacey; Nickerson, Deborah A.; Jarvik, Gail P.; Cupples, L. Adrienne; Reiner, Alex P.; Boerwinkle, Eric; Kathiresan, Sekar		Exome Sequencing Project; Natl Heart Lung Blood Inst	Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN C-III; CARDIOVASCULAR-DISEASE; PLASMA TRIGLYCERIDES; RICH LIPOPROTEINS; RARE VARIANTS; PCSK9; ASSOCIATIONS; INHIBITION; CAPTURE; DESIGN	Background Plasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype. Methods We sequenced the protein-coding regions of 18,666 genes in each of 3734 participants of European or African ancestry in the Exome Sequencing Project. We conducted tests to determine whether rare mutations in coding sequence, individually or in aggregate within a gene, were associated with plasma triglyceride levels. For mutations associated with triglyceride levels, we subsequently evaluated their association with the risk of coronary heart disease in 110,970 persons. Results An aggregate of rare mutations in the gene encoding apolipoprotein C3 (APOC3) was associated with lower plasma triglyceride levels. Among the four mutations that drove this result, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (IVS2+1G -> A and IVS3+1G -> T). The fourth was a missense mutation (A43T). Approximately 1 in 150 persons in the study was a heterozygous carrier of at least one of these four mutations. Triglyceride levels in the carriers were 39% lower than levels in noncarriers (P<1x10(-20)), and circulating levels of APOC3 in carriers were 46% lower than levels in noncarriers (P = 8x10(-10)). The risk of coronary heart disease among 498 carriers of any rare APOC3 mutation was 40% lower than the risk among 110,472 noncarriers (odds ratio, 0.60; 95% confidence interval, 0.47 to 0.75; P = 4x10(-6)). Conclusions Rare mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease. (Funded by the National Heart, Lung, and Blood Institute and others.)	[Crosby, Jacy] Univ Texas Houston, Dept Biostat Bioinformat & Syst Biol, Grad Sch Biomed Sci, Houston, TX USA; [Crosby, Jacy; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Ballantyne, Christie M.; Boerwinkle, Eric] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yin, Wu; Reilly, Dermot] Merck Sharp & Dohme Ltd, Boston, MA USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Peloso, Gina M.; Do, Ron; Farlow, Deborah N.; DePristo, Mark; Gupta, Namrata; Altshuler, David; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Auer, Paul L.] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Crosslin, David R.; Nickerson, Deborah A.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Kooperberg, Charles; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63130 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO 63130 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Tang, Zheng-zheng; Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Lu, Yingchang; Gottesman, Omri; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Zhang, He; Speliotes, Elizabeth; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhang, He; Xue, Chenyi; Speliotes, Elizabeth; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Zhang, He; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Jun, Goo; Hu, Youna; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Speliotes, Elizabeth] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Hindy, George; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Clin Res Ctr, Malmo, Sweden; [Escher, Stefan A.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Melander, Olle] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; Malmo Univ Hosp, Malmo, Sweden; [Jansson, Jan-Hakan] Skelleftea Hosp, Dept Med, Skelleftea, Sweden; [Jansson, Jan-Hakan] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Masca, Nicholas; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Masca, Nicholas; Samani, Nilesh J.] Natl Inst Hlth Res Leicester, Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Stirrups, Kathleen; Kanoni, Stavroula; Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Van Zuydam, Natalie; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Wareham, Nicholas; Cupples, L. Adrienne] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Hall, Alistair S.] Univ Leeds, Sch Med, Div Epidemiol, Leeds LS2 9JT, W Yorkshire, England; [Duga, Stefano; Asselta, Rosanna] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Merlini, Pier Angelica] Osped Niguarda Ca Granda, Div Cardiol, Milan, Italy; [Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola] Univ Verona, Dept Med, Sch Med, I-37100 Verona, Italy; [Ardissino, Diego] Azienda Osped Univ Parma, Div Cardiol, Parma, Italy; [Fox, Caroline S.; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Hveem, Kristian; Holmen, Oddgeir L.] Norwegian Univ Sci & Technol, Nord Trondelag Hlth Study HUNT Res Ctr, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Hveem, Kristian] Levanger Hosp, Levanger, Norway; [Holmen, Oddgeir L.] Univ Trondheim Hosp, St Olav Hosp, Trondheim, Norway; [Nikpay, Majid; McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Robinson, Jennifer] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Ames, IA USA; [Robinson, Jennifer] Univ Iowa, Dept Med, Coll Publ Hlth, Ames, IA USA; [Martin, Lisa W.] Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC USA; [Koch, Werner; Schunkert, Heribert] Deutsch Herzzentrum Munich, Munich, Germany; [Koch, Werner] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-80290 Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Koch, Werner; Peters, Annette] German Ctr Cardiovasc Res, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol & Biobank popgen, Kiel, Germany; [Erbel, Raimund] West German Heart Ctr, Dept Cardiol, Essen, Germany; [Konig, Inke R.; Kruppa, Jochen] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Lubeck, Germany; [Erdmann, Jeanette] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Integrat & Expt Genom, Lubeck, Germany; [Konig, Inke R.; Kruppa, Jochen] Univ Lubeck, Univ Klinikum Schleswig Holstein, Lubeck, Germany; [Erdmann, Jeanette] DZHK German Res Ctr Cardiovasc Res, Lubeck, Germany; [Degenhardt, Franziska] Univ Bonn, Inst Human Genet, Bonn, Germany; [Ordovas, Jose M.] Natl Ctr Cardiovasc Invest, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac, Madrid, Spain; [Deloukas, Panos] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Tracy, Russell P.] Univ Vermont, Dept Pathol, Coll Med, Burlington, VT 05405 USA; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck & Company; Tufts University; United States Department of Agriculture (USDA); Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wisconsin System; University of Wisconsin Milwaukee; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Fred Hutchinson Cancer Center; Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Umea University; University of Leicester; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Dundee; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Wellcome Trust Sanger Institute; University of Leeds; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Verona; University of Parma; University Hospital of Parma; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Ottawa; University of Ottawa Heart Institute; Stanford University; University of Iowa; University of Iowa; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; German Centre for Cardiovascular Research; University of Bonn; Centro Nacional de Investigaciones Cardiovasculares (CNIC); King Abdulaziz University; University of Mississippi; University of Mississippi Medical Center; University of Virginia; University of Vermont; University of Vermont	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Assimes, Themistocles Leonard/D-9696-2015; Altshuler, David M/A-4476-2009; Jarvik, Gail P/N-6476-2014; Girelli, Domenico/B-1183-2008; Erdmann, Jeanette/P-7513-2014; Duga, Stefano/F-8173-2014; Ardissino, Diego/AAC-4041-2022; Hall, Alistair/K-1953-2019; Meitinger, Thomas/O-1318-2015; Palmer, Colin NA/C-7053-2008; Loos, Ruth/GON-5877-2022; König, Inke R/A-4544-2009; Stitziel, Nathan/AAL-8413-2021; Olivieri, Oliviero/A-9126-2008; Auer, Paul/AAC-5060-2019; Ballantyne, Christie/A-6599-2008; Martinelli, Nicola/J-5622-2016; Study, GoDARTS/K-9448-2016; Degenhardt, Franziska/H-4169-2017; Erdmann, Jeanette/A-4417-2009; Kanoni, Stavroula/AAN-7161-2021; Loos, Ruth J F/Q-2862-2016; Peters, Annette/A-6117-2011; Asselta, Rosanna/AAC-2367-2019; , Jennifer/AAD-8336-2019; Deloukas, Panos/B-2922-2013; Jun, Goo/F-1941-2017; Lieb, Wolfgang/AAC-7650-2022; Hveem, Kristian/AFV-4683-2022; Ordovas, Jose/B-8727-2013	Assimes, Themistocles Leonard/0000-0003-2349-0009; Altshuler, David M/0000-0002-7250-4107; Jarvik, Gail P/0000-0002-6710-8708; Girelli, Domenico/0000-0001-9684-1899; Erdmann, Jeanette/0000-0002-4486-6231; Duga, Stefano/0000-0003-3457-1410; Palmer, Colin NA/0000-0002-6415-6560; König, Inke R/0000-0003-0504-6465; Stitziel, Nathan/0000-0002-4963-8211; Olivieri, Oliviero/0000-0001-8209-9056; Martinelli, Nicola/0000-0001-6465-5119; Kanoni, Stavroula/0000-0002-1691-9615; Loos, Ruth J F/0000-0002-8532-5087; Peters, Annette/0000-0001-6645-0985; Asselta, Rosanna/0000-0001-5351-0619; Deloukas, Panos/0000-0001-9251-070X; Jun, Goo/0000-0003-0891-0204; Cupples, L. Adrienne/0000-0003-0273-7965; Ordovas, Jose/0000-0002-7581-5680; Hall, Alistair/0000-0003-0306-7887; Meitinger, Thomas/0000-0002-8838-8403; Rich, Stephen/0000-0003-3872-7793; Melander, Olle/0000-0002-2581-484X; Hindy, George/0000-0002-7257-9299; Zhang, He/0000-0001-9198-6503; Kruppa, Jochen/0000-0001-8376-8864; Goel, Anuj/0000-0003-2307-4021; Watkins, Hugh/0000-0002-5287-9016; solinas, emilia/0000-0003-3532-1317; Ballantyne, Christie/0000-0002-6432-1730; Martin, Lisa Warsinger/0000-0003-4352-0914	National Heart, Lung, and Blood Institute; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011049, NNF14OC0009819, NNF13OC0005339] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208, RC2HL102923, ZIAHL006173, ZIAHL006094, RC2HL103010, RC2HL102926, RC2HL102925, ZIAHL006002, RC2HL102924, R01HL107816, ZIAHL006175, K08HL114642, R01HL109946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Heart, Lung, and Blood Institute and others.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; ACCORD Stud Group, 2010, NEW ENGL J MED, V1362, P1748; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bochem AE, 2014, CLIN GENET, V85, P433, DOI 10.1111/cge.12201; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Huff MW, 2013, CIRC RES, V112, P1405, DOI 10.1161/CIRCRESAHA.113.301464; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu HQ, 2000, J LIPID RES, V41, P1760; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WINDLER E, 1985, J LIPID RES, V26, P556; Zheng CY, 2010, CIRCULATION, V121, P1722, DOI 10.1161/CIRCULATIONAHA.109.875807	40	687	729	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					22	31		10.1056/NEJMoa1307095	http://dx.doi.org/10.1056/NEJMoa1307095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24941081	Green Published, Green Accepted			2022-12-28	WOS:000338265700006
J	Scott, KW; Jha, AK				Scott, Kirstin W.; Jha, Ashish K.			Putting Quality on the Global Health Agenda	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Scott, Kirstin W.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Initiat Global Hlth Qual, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University	Scott, KW (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Initiat Global Hlth Qual, Boston, MA 02115 USA.			Scott, Kirstin/0000-0002-5415-6479	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000055] Funding Source: NIH RePORTER; AHRQ HHS [T32 HS000055] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Jamison DT, 2014, LANCET, V383, P218; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452	5	69	71	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					3	5		10.1056/NEJMp1402157	http://dx.doi.org/10.1056/NEJMp1402157			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK2RA	24988552				2022-12-28	WOS:000338265700002
J	Ali, M				Ali, Mohsin			Treating tuberculosis as a social disease	LANCET			English	Editorial Material									Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England	University of Cambridge	Ali, M (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	ma611@cam.ac.uk						Barnes DS, 2000, MICROBES INFECT, V2, P431, DOI 10.1016/S1286-4579(00)00323-3; Craig GM, 2007, J ADV NURS, V58, P418, DOI 10.1111/j.1365-2648.2007.04257.x; Craig GA, 2008, J ADV NURS, V61, P413, DOI 10.1111/j.1365-2648.2007.04498.x; De Vries G, 2014, EURO SURVEILL, V19; Dubos R, 1952, WHITE PLAGUE TUBERCU; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, TUB SURV MON EUR 201; Public Health England, 2014, TB STRAT CONS; van Hest NA, 2014, EURO SURVEILL, V19	8	14	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2195	2195		10.1016/S0140-6736(14)61063-1	http://dx.doi.org/10.1016/S0140-6736(14)61063-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24976317				2022-12-28	WOS:000338657600008
J	Watts, G				Watts, Geoff			Victor Dzau: change and controversy at the Institute of Medicine Profile	LANCET			English	Biographical-Item																		DZAU V, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2203	2203		10.1016/S0140-6736(14)61073-4	http://dx.doi.org/10.1016/S0140-6736(14)61073-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK8DO	24976319				2022-12-28	WOS:000338657600012
J	Lorenz, UJ; Zewail, AH				Lorenz, Ulrich J.; Zewail, Ahmed H.			Observing liquid flow in nanotubes by 4D electron microscopy	SCIENCE			English	Article							CARBON NANOTUBES; FLUID-FLOW; WATER; NANOPIPES	Nanofluidics involves the study of fluid transport in nanometer-scale structures. We report the direct observation of fluid dynamics in a single zinc oxide nanotube with the high spatial and temporal resolution of four-dimensional (4D) electron microscopy. The nanotube is filled with metallic lead, which we melt in situ with a temperature jump induced by a heating laser pulse. We then use a short electron pulse to create an image of the ensuing dynamics of the hot liquid. Single-shot images elucidate the mechanism of irreversible processes, whereas stroboscopic diffraction patterns provide the heating and cooling rates of single nanotubes. The temporal changes of the images enable studies of the viscous friction involved in the flow of liquid within the nanotube, as well as studies of mechanical processes such as those that result in the formation of extrusions.	[Lorenz, Ulrich J.; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Lorenz, Ulrich/A-9524-2017	Lorenz, Ulrich/0000-0002-8869-5999; gaber, sarah/0000-0002-5995-7291	NSF [DMR-0964886]; Air Force Office of Scientific Research in the Physical Biology Center for Ultrafast Science and Technology at Caltech [FA9550-11-1-0055]; Gordon and Betty Moore Foundation; Swiss National Science Foundation	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Physical Biology Center for Ultrafast Science and Technology at Caltech; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Supported by NSF grant DMR-0964886 and Air Force Office of Scientific Research grant FA9550-11-1-0055 in the Physical Biology Center for Ultrafast Science and Technology at Caltech, which is supported by the Gordon and Betty Moore Foundation. U.J.L. was partly supported by a postdoctoral fellowship from the Swiss National Science Foundation.	[Anonymous], 2007, HDB LEAD BISM EUT AL; Bocquet L, 2007, SOFT MATTER, V3, P685, DOI 10.1039/b616490k; Bocquet L, 2010, CHEM SOC REV, V39, P1073, DOI 10.1039/b909366b; Chatain D, 2008, ANNU REV MATER RES, V38, P45, DOI 10.1146/annurev.matsci.38.060407.130210; Chen JY, 2005, SCIENCE, V310, P1480, DOI 10.1126/science.1120385; Chen Q, 2013, NANO LETT, V13, P4556, DOI 10.1021/nl402694n; Cottin-Bizonne C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056102; De Gennes P-G., 2004, CAPILLARITY WETTING, V336; Desgranges C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.184202; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Gogotsi Y, 2001, APPL PHYS LETT, V79, P1021, DOI 10.1063/1.1391228; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Link S, 1999, CHEM PHYS LETT, V315, P12, DOI 10.1016/S0009-2614(99)01214-2; Linstrom P. J., 2014, NIST STANDARD REFERE; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Naguib N, 2004, NANO LETT, V4, P2237, DOI 10.1021/nl0484907; Rossi MP, 2004, NANO LETT, V4, P989, DOI 10.1021/nl049688u; Ruan CY, 2007, NANO LETT, V7, P1290, DOI 10.1021/nl070269h; Sakai H, 1996, SURF SCI, V351, P285, DOI 10.1016/0039-6028(95)01263-X; Siria A, 2013, NATURE, V494, P455, DOI 10.1038/nature11876; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Thompson PA, 1997, NATURE, V389, P360, DOI 10.1038/38686; Wang CY, 2008, ADV MATER, V20, P4789, DOI 10.1002/adma.200703233; Whitby M, 2007, NAT NANOTECHNOL, V2, P87, DOI 10.1038/nnano.2006.175; Whitby M., 2011, HDB NANOPHYSICS NANO; Whitby M, 2008, NANO LETT, V8, P2632, DOI 10.1021/nl080705f; Xu Q, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4724313; Yi G, 1999, APPL PHYS LETT, V74, P1746, DOI 10.1063/1.123675; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zewail A. H., 2010, 4D ELECT MICROSCOPY; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	31	35	37	4	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1496	1500		10.1126/science.1253618	http://dx.doi.org/10.1126/science.1253618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970082	Green Submitted			2022-12-28	WOS:000337889900045
J	Riffell, JA; Shlizerman, E; Sanders, E; Abrell, L; Medina, B; Hinterwirth, AJ; Kutz, JN				Riffell, Jeffrey A.; Shlizerman, Eli; Sanders, Elischa; Abrell, Leif; Medina, Billie; Hinterwirth, Armin J.; Kutz, J. Nathan			Flower discrimination by pollinators in a dynamic chemical environment	SCIENCE			English	Article							PROJECTION NEURONS; MANDUCA-SEXTA; ODOR; RESPONSES; INSECTS	Pollinators use their sense of smell to locate flowers from long distances, but little is known about how they are able to discriminate their target odor from a m lange of other natural and anthropogenic odors. Here, we measured the plume from Datura wrightii flowers, a nectar resource for Manduca sexta moths, and show that the scent was dynamic and rapidly embedded among background odors. The moth's ability to track the odor was dependent on the background and odor frequency. By influencing the balance of excitation and inhibition in the antennal lobe, background odors altered the neuronal representation of the target odor and the ability of the moth to track the plume. These results show that the mix of odors present in the environment influences the pollinator's olfactory ability.	[Riffell, Jeffrey A.; Sanders, Elischa; Medina, Billie; Hinterwirth, Armin J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Shlizerman, Eli; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Abrell, Leif] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Arizona; University of Arizona	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu	Lei, Hong/ABH-1356-2020	Shlizerman, Eli/0000-0002-3136-4531; Abrell, Leif/0000-0003-2490-1180	University of Washington	University of Washington(University of Washington)	The authors thank B. Nguyen, W. Chan, K. Jardine, and J. Thornton for their assistance. This work was supported by funds from the University of Washington (J. A. R.). The electrophysiology data reported in this paper are tabulated in the supplementary materials (database S1).	Christensen TA, 1998, J NEUROSCI, V18, P5999; Dorsey Alfred, 2000, TOXICOLOGICAL PROFIL; FIELD RA, 1992, ATMOS ENVIRON A-GEN, V26, P2983, DOI 10.1016/0960-1686(92)90290-2; Girling RD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02779; Heinbockel T, 1999, J COMP NEUROL, V409, P1; HELMIG D, 1992, SCI TOTAL ENVIRON, V112, P233, DOI 10.1016/0048-9697(92)90190-4; Herrmann A., 2010, CHEM BIOL VOLATILES, DOI 10.1002/9780470669532; Jardine K, 2010, ATMOS CHEM PHYS, V10, P12191, DOI 10.5194/acp-10-12191-2010; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Shlizerman E., FRONT COMPU IN PRESS; STOCKHOUSE RE, 1976, AM MIDL NAT, V96, P241; THIERY D, 1986, ENTOMOL EXP APPL, V41, P165, DOI 10.1007/BF00195573; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Zimmer RK, 2008, J CHEM ECOL, V34, P822, DOI 10.1007/s10886-008-9486-3	22	129	135	6	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1515	1518		10.1126/science.1251041	http://dx.doi.org/10.1126/science.1251041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970087				2022-12-28	WOS:000337889900050
J	Connors, JM				Connors, Jean M.			Prophylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CLINICAL-PRACTICE GUIDELINES; RECEIVING CHEMOTHERAPY; PULMONARY-EMBOLISM; RISK-FACTORS; THROMBOSIS; THROMBOPROPHYLAXIS; ONCOLOGY		[Connors, Jean M.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Connors, Jean M.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Connors, JM (corresponding author), Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA.	jconnors@partners.org						Agnelli G, 2012, NEW ENGL J MED, V366, P601, DOI 10.1056/NEJMoa1108898; Agnelli G, 2009, LANCET ONCOL, V10, P943, DOI 10.1016/S1470-2045(09)70232-3; Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; den Exter PL, 2011, J CLIN ONCOL, V29, P2405, DOI 10.1200/JCO.2010.34.0984; Falanga A, 2009, J CLIN ONCOL, V27, P4848, DOI 10.1200/JCO.2009.22.8197; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Khorana AA, 2006, J CLIN ONCOL, V24, P484, DOI 10.1200/JCO.2005.03.8877; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2007, CANCER-AM CANCER SOC, V110, P2339, DOI 10.1002/cncr.23062; Lyman GH, 2013, ONCOLOGIST, V18, P1321, DOI 10.1634/theoncologist.2013-0226; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Maraveyas A, 2012, EUR J CANCER, V48, P1283, DOI 10.1016/j.ejca.2011.10.017; O'Connell CL, 2006, J CLIN ONCOL, V24, P4928, DOI 10.1200/JCO.2006.06.5870; Riess H, 2009, J CLIN ONCOL S, V27, p18S; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Stein PD, 2006, AM J MED, V119, P60, DOI 10.1016/j.amjmed.2005.06.058; Streiff MB, 2013, J NATL COMPR CANC NE, V11, P1402, DOI 10.6004/jnccn.2013.0163; Varki A, 2007, BLOOD, V110, P1723, DOI 10.1182/blood-2006-10-053736; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	22	34	43	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2515	2519		10.1056/NEJMra1401468	http://dx.doi.org/10.1056/NEJMra1401468			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963570				2022-12-28	WOS:000337804400009
J	Hoag, H				Hoag, Hannah			DRUG DELIVERY Brain food	NATURE			English	Editorial Material							NEUROGENESIS; GENERATION											Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Nakaguchi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/915160; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Wang Y, 2013, CURR TOP NUTRACEUT R, V11, P1	8	3	3	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S6	S7		10.1038/510S6a	http://dx.doi.org/10.1038/510S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964026	Bronze			2022-12-28	WOS:000337806300005
J	Shah, M				Shah, Maitri			Elephantiasis Nostras Verrucosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Conemaugh Hlth Syst, Johnstown, PA 15905 USA		Shah, M (corresponding author), Conemaugh Hlth Syst, Johnstown, PA 15905 USA.	maitri86@gmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2520	2520		10.1056/NEJMicm1310890	http://dx.doi.org/10.1056/NEJMicm1310890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963571				2022-12-28	WOS:000337804400010
J	Rees, J; Bultitude, M; Challacombe, B				Rees, Jonathan; Bultitude, Matthew; Challacombe, Ben			The management of lower urinary tract symptoms in men	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BENIGN PROSTATIC HYPERPLASIA; SEXUAL DYSFUNCTION; METAANALYSIS; COMBINATION; FINASTERIDE; NOCTURIA; DISEASE; PATHOPHYSIOLOGY; EPIDEMIOLOGY; MONOTHERAPY		[Rees, Jonathan] Backwell & Nailsea Med Grp, North Somerset BS48 1BZ, England; [Bultitude, Matthew; Challacombe, Ben] Guys & St Thomas NHS Fdn Trust, Urol Ctr, London, England	Guy's & St Thomas' NHS Foundation Trust	Rees, J (corresponding author), Backwell & Nailsea Med Grp, North Somerset BS48 1BZ, England.	drjonrees@gmail.com	Challacombe, Ben/AAM-9505-2020	Challacombe, Ben/0000-0001-8631-0314	GSK; Lilly; Pfizer; Astellas	GSK(GlaxoSmithKline); Lilly(Eli Lilly); Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals)	We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: JR has received fees for advisory boards and speaker fees from GSK, Lilly, Pfizer, and Astellas. MB has no interests to declare. BC has received speaker fees from GSK and Astellas.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005; [Anonymous], 2013, NICE TECHN APPR 290; Athanasopoulos A, 2011, EUR UROL, V60, P94, DOI 10.1016/j.eururo.2011.03.054; Blake-James BT, 2007, BJU INT, V99, P85, DOI 10.1111/j.1464-410X.2006.06574.x; Bosch JLHR, 2010, J UROLOGY, V184, P440, DOI 10.1016/j.juro.2010.04.011; Boyle P, 1996, UROLOGY, V48, P398, DOI 10.1016/S0090-4295(96)00353-6; Cornu JN, 2012, EUR UROL, V62, P877, DOI 10.1016/j.eururo.2012.07.004; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Gulur DM, 2011, BJU INT, V107, P702, DOI 10.1111/j.1464-410X.2010.09763.x; Hall SA, 2012, BJU INT, V109, P1676, DOI 10.1111/j.1464-410X.2011.10593.x; Hammarsten J, 2011, NAT REV UROL, V8, P483, DOI 10.1038/nrurol.2011.112; Hutchison A, 2006, EUR UROL, V50, P555, DOI 10.1016/j.eururo.2006.05.001; Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Kaplan SA, 2011, INT J CLIN PRACT, V65, P487, DOI 10.1111/j.1742-1241.2010.02611.x; Kashyap M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-57; Lourenco Tania, 2008, BMJ, V337, pa449, DOI 10.1136/bmj.39575.517674.BE; MacDonald R, 2012, BJU INT, V109, P1756, DOI 10.1111/j.1464-410X.2012.11172.x; Matsumoto S, 2013, BJU INT, V111, P647, DOI 10.1111/j.1464-410X.2012.11591.x; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; National Institute for Health and Clinical Excellence, MAN LOW UR TRACT SYM; Nickel JC, 2011, BJU INT, V108, P388, DOI 10.1111/j.1464-410X.2011.10195.x; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Oelke M, 2012, EUR UROL, V61, P917, DOI 10.1016/j.eururo.2012.01.013; Omar MI, 2014, BJU INT, V113, P24, DOI 10.1111/bju.12281; Parsons JK, 2009, BJU INT, V104, P63, DOI 10.1111/j.1464-410X.2008.08317.x; Paterson J, 1997, BRIT J UROL, V79, P892, DOI 10.1046/j.1464-410X.1997.00180.x; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Speakman MJ, 2004, BJU INT, V93, P985, DOI 10.1111/j.1464-410X.2004.04765.x; T Brown C, 2007, BRIT MED J, V334, P25, DOI 10.1136/bmj.39010.551319.AE; Tacklind J, 2010, COCHRANE DB SYST REV, V10; Treagust J, 2001, J PUBLIC HEALTH MED, V23, P141, DOI 10.1093/pubmed/23.2.141; Weiss JP, 2011, BJU INT, V108, P6, DOI 10.1111/j.1464-410X.2011.10175.x; Wilt TJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f325	39	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2014	348								g3861	10.1136/bmj.g3861	http://dx.doi.org/10.1136/bmj.g3861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UG	24963071				2022-12-28	WOS:000338201800004
J	Marion, E; Song, OR; Christophe, T; Babonneau, J; Fenistein, D; Eyer, J; Letournel, F; Henrion, D; Clere, N; Paille, V; Guerineau, NC; Saint Andre, JP; Gersbach, P; Altmann, KH; Stinear, TP; Comoglio, Y; Sandoz, G; Preisser, L; Delneste, Y; Yeramian, E; Marsollier, L; Brodin, P				Marion, Estelle; Song, Ok-Ryul; Christophe, Thierry; Babonneau, Jeremie; Fenistein, Denis; Eyer, Joel; Letournel, Frank; Henrion, Daniel; Clere, Nicolas; Paille, Vincent; Guerineau, Nathalie C.; Saint Andre, Jean-Paul; Gersbach, Philipp; Altmann, Karl-Heinz; Stinear, Timothy Paul; Comoglio, Yannick; Sandoz, Guillaume; Preisser, Laurence; Delneste, Yves; Yeramian, Edouard; Marsollier, Laurent; Brodin, Priscille			Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways	CELL			English	Article							MYCOLACTONE; MODULATION; INFECTION; PAINLESSNESS; INHIBITION; ANTAGONIST; ACTIVATION; DIAGNOSIS; EFFICACY; CANCER	Mycobacterium ulcerans, the etiological agent of Buruli ulcer, causes extensive skin lesions, which despite their severity are not accompanied by pain. It was previously thought that this remarkable analgesia is ensured by direct nerve cell destruction. We demonstrate here that M. ulcerans-induced hypoesthesia is instead achieved through a specific neurological pathway triggered by the secreted mycobacterial polyketide mycolactone. We decipher this pathway at the molecular level, showing that mycolactone elicits signaling through type 2 angiotensin II receptors (AT(2)Rs), leading to potassium-dependent hyperpolarization of neurons. We further validate the physiological relevance of this mechanism with in vivo studies of pain sensitivity in mice infected with M. ulcerans, following the disruption of the identified pathway. Our findings shed new light on molecular mechanisms evolved by natural systems for the induction of very effective analgesia, opening up the prospect of new families of analgesics derived from such systems.	[Marion, Estelle; Song, Ok-Ryul; Marsollier, Laurent] Inserm Avenir, F-49933 Angers, France; [Marion, Estelle; Song, Ok-Ryul; Christophe, Thierry; Babonneau, Jeremie; Fenistein, Denis; Marsollier, Laurent; Brodin, Priscille] Inserm Avenir, Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea; [Song, Ok-Ryul; Brodin, Priscille] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun, Inserm U1019,CNRS UMR8204, F-59000 Lille, France; [Eyer, Joel; Letournel, Frank] UPRES, EA 3143, Lab Neurobiol & Transgenese, F-49933 Angers, France; [Fenistein, Denis; Paille, Vincent; Guerineau, Nathalie C.] Inserm 1083, CNRS, UMR 6214, Lab Biol Neurovasc & Mitochondriale Integree, F-49933 Angers, France; [Clere, Nicolas] Inserm U1063, F-49933 Angers, France; [Saint Andre, Jean-Paul] Lab Anatomie Pathol, F-49933 Angers, France; [Gersbach, Philipp; Altmann, Karl-Heinz] ETH, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Stinear, Timothy Paul] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Comoglio, Yannick; Sandoz, Guillaume] Univ Nice Sophia Antipolis, Inst Biol Valrose,Inserm Avenir, Labs Excellence Lon Channel Sci & Therapeut Nice, Inserm U1091,CNRS UMR 7277, F-06108 Nice, France; [Preisser, Laurence; Delneste, Yves; Marsollier, Laurent] Univ & CHU, CRCNA, CNRS U6299, Equipe 7,Inserm U892, F-49933 Angers, France; [Yeramian, Edouard] CNRS, Inst Pasteur, UMR 3528, Unite Bioinformat Struct, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Pasteur Korea; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Marsollier, L (corresponding author), Inserm Avenir, 4 Rue Larrey, F-49933 Angers, France.	laurent.marsollier@inserm.fr; priscille.brodin@inserm.fr	Delneste, Yves/O-3956-2016; Letournel, Franck/K-4263-2015; Henrion, Daniel/AAK-1995-2021; DELNESTE, Yves/K-7367-2015; Marsollier, Laurent/P-6178-2015; Henrion, Daniel/J-8141-2015; Brodin, Priscille/N-6979-2019; Eyer, Joel/V-8679-2019; Brodin, Priscille/E-5802-2014; Clere, Nicolas/K-4414-2015; Henrion, Daniel/N-7023-2015; Eyer, Joel/K-4265-2015; sandoz, guillaume/AAI-9236-2020; Marion, Estelle/G-3437-2016; preisser, laurence/K-7583-2015	Henrion, Daniel/0000-0003-1094-0285; DELNESTE, Yves/0000-0002-2142-596X; Henrion, Daniel/0000-0003-1094-0285; Brodin, Priscille/0000-0003-0991-7344; Eyer, Joel/0000-0001-6301-7465; Brodin, Priscille/0000-0003-0991-7344; Henrion, Daniel/0000-0003-1094-0285; Eyer, Joel/0000-0001-6301-7465; sandoz, guillaume/0000-0003-1251-0852; Marion, Estelle/0000-0003-4917-9665; Stinear, Timothy/0000-0003-0150-123X; Clere, Nicolas/0000-0002-6008-597X; Guerineau, Nathalie/0000-0003-2517-4210; Paille, Vincent/0000-0003-0424-0821; letournel, franck/0000-0003-2925-4453; Laurent, Marsollier/0000-0001-5497-5995; deboosere, Nathalie/0000-0002-2873-5485	Korea Research Foundation [K20802001409-09B1300-03700]; INSERM-Avenir; ANRS; Projet Tranversal de Recherche de l'Institut Pasteur [PTR212]; STAR Project; Raoul Follereau Foundation; European Community (ERC-STG) [260901]; European Community (MM4TB) [260872]; Agence Nationale de Recherche; Feder (Equipex Imaginex BioMed) [12001407 (D-AL)]; Region Nord Pas de Calais [1200080]; Region Pays de la Loire (ARMINA project)	Korea Research Foundation(National Research Foundation of Korea); INSERM-Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANRS(ANRSFrench National Research Agency (ANR)); Projet Tranversal de Recherche de l'Institut Pasteur; STAR Project; Raoul Follereau Foundation; European Community (ERC-STG); European Community (MM4TB); Agence Nationale de Recherche(French National Research Agency (ANR)); Feder (Equipex Imaginex BioMed); Region Nord Pas de Calais(Region Hauts-de-France); Region Pays de la Loire (ARMINA project)(Region Pays de la Loire)	We gratefully acknowledge Natacha Denisenko, Viviane Cassisa, Camille Dantec, Rimi Oh, Jean-Philippe Carralot, Antoine Caillon, and Pierre Legras for their technical assistance; Gerd Pluschke and Nicole Scherr for generous gift of the synthetic mycolactone; Gaspard Deloison, Elizabeth Werkmeister, Antonino Bongiovanni, and Frank Lafont from the Biolmaging Center of Lille for technical assistance; Guillaume Mabilleau from the SCIAM platform for electron microscopy; Francois Trottein for advices on prostaglandins; and Olivier Neyrolles for his critical reading of the manuscript. Lutz Hein generated and generously offered the AT<INF>2</INF>R KO mice for the experiments. Financial support for this work was provided by the Korea Research Foundation (Grant K20802001409-09B1300-03700), INSERM-Avenir, ANRS, Projet Tranversal de Recherche de l'Institut Pasteur (PTR212), the STAR Project, the Raoul Follereau Foundation, the European Community (ERC-STG Grant n degrees 260901, MM4TB Grant n degrees 260872), the Agence Nationale de Recherche, the Feder (12001407 (D-AL) Equipex Imaginex BioMed), the Region Nord Pas de Calais (1200080), and the Region Pays de la Loire (ARMINA project).	Anand U, 2013, EUR J PAIN, V17, P1012, DOI 10.1002/j.1532-2149.2012.00269.x; Asiedu K, 2000, BURULI ULCER MYCOBAC; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bedecs K, 1997, BIOCHEM J, V325, P449, DOI 10.1042/bj3250449; Besson JM, 1999, LANCET, V353, P1610, DOI 10.1016/S0140-6736(99)01313-6; Carralot JP, 2009, J BIOMOL SCREEN, V14, P151, DOI 10.1177/1087057108328762; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; DallAsta V, 1997, EXP CELL RES, V231, P260, DOI 10.1006/excr.1996.3469; En J, 2008, INFECT IMMUN, V76, P2002, DOI 10.1128/IAI.01588-07; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Gersbach P, 2011, CHEM-EUR J, V17, P13017, DOI 10.1002/chem.201101799; Goto M, 2006, AM J PATHOL, V168, P805, DOI 10.2353/ajpath.2006.050375; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Guenin-Mace L, 2013, J CLIN INVEST, V123, P1501, DOI 10.1172/JCI66576; Guenin-Mace L, 2011, P NATL ACAD SCI USA, V108, P12833, DOI 10.1073/pnas.1016496108; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; KANG J, 1994, AM J PHYSIOL-CELL PH, V267, pC1389, DOI 10.1152/ajpcell.1994.267.5.C1389; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Muralidharan A, 2014, PAIN MED, V15, P93, DOI 10.1111/pme.12258; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Nouet S, 2000, TRENDS ENDOCRIN MET, V11, P1, DOI 10.1016/S1043-2760(99)00205-2; Pelegrini-Da-Silva A, 2005, NEUROSCIENCE, V132, P453, DOI 10.1016/j.neuroscience.2004.12.046; Rice ASC, 2014, LANCET, V383, P1637, DOI 10.1016/S0140-6736(13)62337-5; Sandoz G, 2012, NEURON, V74, P1005, DOI 10.1016/j.neuron.2012.04.026; Sarfo FS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002101; Scherr N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002143; Simmonds RE, 2009, J IMMUNOL, V182, P2194, DOI 10.4049/jimmunol.0802294; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Smith MT, 2013, PAIN MED, V14, P692, DOI 10.1111/pme.12063; Sumners C, 1998, CELL SIGNAL, V10, P303, DOI 10.1016/S0898-6568(97)00133-2; Szelenyi I, 2013, INFLAMM RES, V62, P251, DOI 10.1007/s00011-013-0592-5; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Torrado E, 2010, J IMMUNOL, V184, P947, DOI 10.4049/jimmunol.0902717; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; Williams FMK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003095	42	118	121	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1565	1576		10.1016/j.cell.2014.04.040	http://dx.doi.org/10.1016/j.cell.2014.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949969	Bronze			2022-12-28	WOS:000340941900012
J	Marquardt, S; Escalante-Chong, R; Pho, N; Wang, J; Churchman, LS; Springer, M; Buratowski, S				Marquardt, Sebastian; Escalante-Chong, Renan; Pho, Nam; Wang, Jue; Churchman, L. Stirling; Springer, Michael; Buratowski, Stephen			A Chromatin-Based Mechanism for Limiting Divergent Noncoding Transcription	CELL			English	Article							HISTONE H3; BIDIRECTIONAL PROMOTERS; SET2 METHYLATION; RNA; ACETYLATION; LYSINE-56; TERMINATION; CHAPERONE; UPSTREAM; EXCHANGE	In addition to their annotated transcript, many eukaryotic mRNA promoters produce divergent noncoding transcripts. To define determinants of divergent promoter directionality, we used genomic replacement experiments. Sequences within noncoding transcripts specified their degradation pathways, and functional protein-coding transcripts could be produced in the divergent direction. To screen for mutants affecting the ratio of transcription in each direction, a bidirectional fluorescent protein reporter construct was introduced into the yeast nonessential gene deletion collection. We identified chromatin assembly as an important regulator of divergent transcription. Mutations in the CAF-I complex caused genome-wide derepression of nascent divergent noncoding transcription. In opposition to the CAF-I chromatin assembly pathway, H3K56 hyperacetylation, together with the nucleosome remodeler SWI/SNF, facilitated divergent transcription by promoting rapid nucleosome turnover. We propose that these chromatin-mediated effects control divergent transcription initiation, complementing downstream pathways linked to early termination and degradation of the noncoding RNAs.	[Marquardt, Sebastian; Buratowski, Stephen] Harvard Med Sch, Dept Biol Chem & Mol Physiol, Boston, MA 02115 USA; [Escalante-Chong, Renan; Wang, Jue; Springer, Michael] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Pho, Nam] Harvard Med Sch, Res Comp Grp, Boston, MA 02115 USA; [Churchman, L. Stirling] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Physiol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu	Marquardt, Sebastian/AAU-8009-2021; Marquardt, Sebastian/C-2902-2015	Marquardt, Sebastian/0000-0003-1709-2717; Marquardt, Sebastian/0000-0003-1709-2717; /0000-0001-6913-4910	Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; NIH [HG007173NIH, GM46498, GM56663]; Harvard Medical School [NCRR 1S10RR028832-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663, R01GM046498, R29GM046498] Funding Source: NIH RePORTER	Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ollie Rando for strains, Magdelana Murawska for help with NET-seq, Jody Moore for help with flow cytometry, Hannah Mischo for reagents, and members of S.B. and M.S. labs for discussion. This work was supported by a Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation to S.M., grants from the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and NIH HG007173NIH to S.C., and NIH grants GM46498 and GM56663 to S.B. Support for the high-performance computer cluster at Harvard Medical School provided through grant NCRR 1S10RR028832-01.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Churchman L Stirling, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0414s98; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Preker P, 2009, CELL CYCLE, V8, P1106; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	48	76	78	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1712	1723		10.1016/j.cell.2014.04.036	http://dx.doi.org/10.1016/j.cell.2014.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949978	Bronze, Green Accepted			2022-12-28	WOS:000340941900023
J	Iijima, K; Sako, M; Nozu, K; Mori, R; Tuchida, N; Kamei, K; Miura, K; Aya, K; Nakanishi, K; Ohtomo, Y; Takahashi, S; Tanaka, R; Kaito, H; Nakamura, H; Ito, KIS; Ito, S; Ohashi, Y				Iijima, Kazumoto; Sako, Mayumi; Nozu, Kandai; Mori, Rintaro; Tuchida, Nao; Kamei, Koichi; Miura, Kenichiro; Aya, Kunihiko; Nakanishi, Koichi; Ohtomo, Yoshiyuki; Takahashi, Shori; Tanaka, Ryojiro; Kaito, Hiroshi; Nakamura, Hidefumi; Ishikura, Kenji; Ito, Shuichi; Ohashi, Yasuo		RCRNS Study Grp	Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial	LANCET			English	Article							B-CELLS; FOLLOW-UP; CYCLOSPORINE; CHILDREN; THERAPY; SAFE	Background Rituximab could be an effective treatment for childhood-onset, complicated, frequently relapsing nephrotic syndrome (FRNS) and steroid-dependent nephrotic syndrome (SDNS). We investigated the efficacy and safety of rituximab in patients with high disease activity. Methods We did a multicentre, double-blind, randomised, placebo-controlled trial at nine centres in Japan. We screened patients aged 2 years or older experiencing a relapse of FRNS or SDNS, which had originally been diagnosed as nephrotic syndrome when aged 1-18 years. Patients with complicated FRNS or SDNS who met all other criteria were eligible for inclusion after remission of the relapse at screening. We used a computer-generated sequence to randomly assign patients (1:1) to receive rituximab (375 mg/m(2)) or placebo once weekly for 4 weeks, with age, institution, treatment history, and the intervals between the previous three relapses as adjustment factors. Patients, guardians, caregivers, physicians, and individuals assessing outcomes were masked to assignments. All patients received standard steroid treatment for the relapse at screening and stopped taking immunosuppressive agents by 169 days after randomisation. Patients were followed up for 1 year. The primary endpoint was the relapse-free period. Safety endpoints were frequency and severity of adverse events. Patients who received their assigned intervention were included in analyses. This trial is registered with the University Hospital Medical Information Network clinical trials registry, number UMIN000001405. Findings Patients were centrally registered between Nov 13, 2008, and May 19, 2010. Of 52 patients who underwent randomisation, 48 received the assigned intervention (24 were given rituximab and 24 placebo). The median relapse-free period was significantly longer in the rituximab group (267 days, 95% CI 223-374) than in the placebo group (101 days, 70-155; hazard ratio: 0.27, 0.14-0.53; p < 0.0001). Ten patients (42%) in the rituximab group and six (25%) in the placebo group had at least one serious adverse event (p = 0.36). Interpretation Rituximab is an effective and safe treatment for childhood-onset, complicated FRNS and SDNS.	[Iijima, Kazumoto; Nozu, Kandai] Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sako, Mayumi; Nakamura, Hidefumi] Natl Ctr Child Hlth & Dev, Ctr Social & Clin Res, Natl Res Inst Child Hlth & Dev, Dept Dev Strategy,Div Clin Trials,Setagaya Ku, Tokyo, Japan; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Ctr Social & Clin Res, Natl Res Inst Child Hlth & Dev, Dept Hlth Policy,Setagaya Ku, Tokyo, Japan; [Tuchida, Nao] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Setagaya Ku, Tokyo, Japan; [Kamei, Koichi] Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Setagaya Ku, Tokyo, Japan; [Miura, Kenichiro] Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, Tokyo, Japan; [Ohashi, Yasuo] Chuo Univ, Bunkyo Ku, Tokyo 112, Japan; [Aya, Kunihiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat, Okayama, Japan; [Nakanishi, Koichi] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Ohtomo, Yoshiyuki] Juntendo Univ, Nerima Hosp, Dept Pediat, Nerima ku, Tokyo, Japan; [Takahashi, Shori] Surugadai Nihon Univ Hosp, Dept Pediat, Chiyoda Ku, Tokyo, Japan; [Tanaka, Ryojiro] Hyogo Prefectural Kobe Childrens Hosp, Dept Nephrol, Suma Ku, Kobe, Hyogo, Japan; [Ishikura, Kenji] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Fuchu, Tokyo, Japan	Kobe University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; University of Tokyo; Chuo University; Okayama University; Wakayama Medical University; Juntendo University; Nihon University; Tokyo Metropolitan Children's Medical Center	Iijima, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	iijima@med.kobe-u.ac.jp	Takahashi, Shori/AAS-7147-2021; Nozu, Kandai/Q-9383-2019; Takahashi, Shori/AAE-6723-2020; Nakanishi, Koichi/AAF-6381-2020; Ito, Shuichi/AAD-1962-2022	Takahashi, Shori/0000-0001-6327-535X; Nakanishi, Koichi/0000-0001-8681-9129; Mori, Rintaro/0000-0001-7656-6156	Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Japanese Ministry of Health, Labour and Welfare.	Araya C, 2009, PEDIATR NEPHROL, V24, P1691, DOI 10.1007/s00467-009-1214-x; Benz K, 2004, PEDIATR NEPHROL, V19, P794, DOI 10.1007/s00467-004-1434-z; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Bugatti S, 2007, AUTOIMMUN REV, V7, P137, DOI 10.1016/j.autrev.2007.02.017; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chaumais MC, 2009, PEDIATR NEPHROL, V24, P1753, DOI 10.1007/s00467-009-1195-9; Cravedi P, 2007, CLIN J AM SOC NEPHRO, V2, P932, DOI 10.2215/CJN.01180307; Durkan A, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002290, 10.1002/14651858.CD002290]; Eddy AA, 2003, LANCET, V362, P629, DOI 10.1016/S0140-6736(03)14184-0; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Gilbert RD, 2006, PEDIATR NEPHROL, V21, P1698, DOI 10.1007/s00467-006-0228-x; Guigonis V, 2008, PEDIATR NEPHROL, V23, P1269, DOI 10.1007/s00467-008-0814-1; Hamasaki Y, 2009, PEDIATR NEPHROL, V24, P2177, DOI 10.1007/s00467-009-1264-0; Hashimura Y, 2009, PEDIATR NEPHROL, V24, P1181, DOI 10.1007/s00467-009-1119-8; Hodson EM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003594.pub4; Iijima K, 2002, KIDNEY INT, V61, P1801, DOI 10.1046/j.1523-1755.2002.00303.x; Inoue Y, 1999, PEDIATR NEPHROL, V13, P33, DOI 10.1007/s004670050558; Ishikura K, 2008, KIDNEY INT, V73, P1167, DOI 10.1038/ki.2008.24; Ishikura K, 2012, CLIN J AM SOC NEPHRO, V7, P1576, DOI 10.2215/CJN.00110112; Ishikura K, 2010, NEPHROL DIAL TRANSPL, V25, P3956, DOI 10.1093/ndt/gfq318; Kelesidis T, 2011, INT J INFECT DIS, V15, pE2, DOI 10.1016/j.ijid.2010.03.025; Kemper MJ, 2012, NEPHROL DIAL TRANSPL, V27, P1910, DOI 10.1093/ndt/gfr548; *KIDN DIS IMPR GLO, 2012, KDIGO CLIN PRACT GUI; Le Berre L, 2009, J AM SOC NEPHROL, V20, P57, DOI 10.1681/ASN.2007111244; Liu K, 2009, AUTOIMMUN REV, V8, P214, DOI 10.1016/j.autrev.2008.07.048; Maloney DG, 2001, ANTI-CANCER DRUG, V12, pS1; Ravani P, 2013, KIDNEY INT, V84, P1025, DOI 10.1038/ki.2013.211; Ravani P, 2011, CLIN J AM SOC NEPHRO, V6, P1308, DOI 10.2215/CJN.09421010; Ruggenenti P, 2014, J AM SOC NEPHROL, V25, P850, DOI 10.1681/ASN.2013030251; SCHULMAN SL, 1988, J PEDIATR-US, V113, P996, DOI 10.1016/S0022-3476(88)80570-5; Sellier-Leclerc AL, 2013, PEDIATR NEPHROL, V28, P1875, DOI 10.1007/s00467-013-2485-9; Sfikakis PP, 2005, ARTHRITIS RHEUM-US, V52, P501, DOI 10.1002/art.20858; SHALHOUB RJ, 1974, LANCET, V2, P556; Stasi R, 2008, BLOOD, V112, P1147, DOI 10.1182/blood-2007-12-129262; The Scientific Committee of the Japanese Society for Pediatric Nephrology, 2005 JAP SOC PED NEP	35	219	244	5	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1273	1281		10.1016/S0140-6736(14)60541-9	http://dx.doi.org/10.1016/S0140-6736(14)60541-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24965823				2022-12-28	WOS:000343003400030
J	Newby, LK; Marber, MS; Melloni, C; Sarov-Blat, L; Aberle, LH; Aylward, PE; Cai, GQ; de Winter, RJ; Hamm, CW; Heitner, JF; Kim, R; Lerman, A; Patel, MR; Tanguay, JF; Lepore, JJ; Al-Khalidi, HR; Sprecher, DL; Granger, CB				Newby, L. Kristin; Marber, Michael S.; Melloni, Chiara; Sarov-Blat, Lea; Aberle, Laura H.; Aylward, Philip E.; Cai, Gengqian; de Winter, Robbert J.; Hamm, Christian W.; Heitner, John F.; Kim, Raymond; Lerman, Amir; Patel, Manesh R.; Tanguay, Jean-Francois; Lepore, John J.; Al-Khalidi, Hussein R.; Sprecher, Dennis L.; Granger, Christopher B.		SOLSTICE Investigators	Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial	LANCET			English	Article							IMPROVES CARDIAC-FUNCTION; INFLAMMATION; APOPTOSIS; ISCHEMIA; HEART; MAPK	Background p38 MAPK inhibition has potential myocardial protective effects. We assessed losmapimod, a potent oral p38 MAPK inhibitor, in patients with non-ST-segment elevation myocardial infarction (NSTEMI) in a double-blind, randomised, placebo-controlled trial. Methods From October, 2009, to November, 2011, NSTEMI patients were assigned oral losmapimod (7 . 5 mg or 15 . 0 mg loading dose followed by 7 . 5 mg twice daily) or matching placebo in a 3: 3: 2 ratio. Safety outcomes were serious adverse events and alanine aminotransferase (ALT) concentrations over 12 weeks, and cardiac events (death, myocardial infarction, recurrent ischaemia, stroke, and heart failure) at 90 days. Efficacy outcomes were high-sensitivity C-reactive protein (hsCRP) and B-type natriuretic peptide (BNP) concentrations at 72 h and 12 weeks, and troponin I area under the curve (AUC) over 72 h. The losmapimod groups were pooled for analysis. This trial is registered with ClinicalTrials.gov, number NCT00910962. Findings Of 535 patients enrolled, 526 (98%) received at least one dose of study treatment (losmapimod n=388 and placebo n=138). Safety outcomes did not differ between groups. HsCRP concentrations at 72 h were lower in the losmapimod group than in the placebo group (geometric mean 64 . 1 nmol/L, 95% CI 53 . 0-77 . 6 vs 110 . 8 nmol/L, 83 . 1-147 . 7; p=0 . 0009) but were similar at 12 weeks. Early geometric mean BNP concentrations were similar at 72 h but significantly lower in the losmapimod group at 12 weeks (37 . 2 ng/L, 95% CI 32 . 3-42 . 9 vs 49 . 4 ng/L, 38 . 7-63 . 0; p=0 . 04). Mean troponin I AUC values did not differ. Interpretation p38 MAPK inhibition with oral losmapimod was well tolerated in NSTEMI patients and might improve outcomes after acute coronary syndromes.	[Newby, L. Kristin; Melloni, Chiara; Aberle, Laura H.; Patel, Manesh R.; Al-Khalidi, Hussein R.; Granger, Christopher B.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Kim, Raymond] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Marber, Michael S.] Kings Coll London, St Thomas Hosp, Rayne Inst, BHF Ctr,Div Cardiovasc, London, England; [Sarov-Blat, Lea; Cai, Gengqian; Lepore, John J.; Sprecher, Dennis L.] GlaxoSmithKline, Heart Failure Discovery Performance Unit, Philadelphia, PA USA; [Aylward, Philip E.] Flinders Univ & Med Ctr, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [de Winter, Robbert J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Hamm, Christian W.] Kerckhoff Heart & Thoraxctr, Bad Nauheim, Germany; [Heitner, John F.] New York Methodist Hosp, Div Cardiol, Brooklyn, NY USA; [Lerman, Amir] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Tanguay, Jean-Francois] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada	Duke University; Duke University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; GlaxoSmithKline; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Amsterdam; Academic Medical Center Amsterdam; Kerckhoff Clinic; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; Mayo Clinic; Universite de Montreal	Newby, LK (corresponding author), POB 17969, Durham, NC 27715 USA.	kristin.newby@duke.edu	Patel, Manesh/AAC-5385-2019; Hamm, Christian W./I-3155-2017; Kim, Raymond J/B-1426-2008; marber, michael/AAW-7916-2021	Hamm, Christian W./0000-0001-6763-4161; Rolfe, Timothy/0000-0001-8798-840X; Marber, Michael/0000-0002-3463-7128; Aylward, Philip/0000-0002-5358-8552; Baumbach, Andreas/0000-0001-7707-2254	GlaxoSmithKline; MRC [G0802033, G1001138] Funding Source: UKRI; Medical Research Council [G1001138, G0802033] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GlaxoSmithKline.	Barbour AM, 2013, BRIT J CLIN PHARMACO, V76, P99, DOI 10.1111/bcp.12063; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Elkhawad M, 2012, JACC-CARDIOVASC IMAG, V5, P911, DOI 10.1016/j.jcmg.2012.02.016; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Kompa AR, 2008, J PHARMACOL EXP THER, V325, P741, DOI 10.1124/jpet.107.133546; Li ZH, 2006, AM J PHYSIOL-HEART C, V291, pH1972, DOI 10.1152/ajpheart.00043.2006; Liu YH, 2005, J CARD FAIL, V11, P74, DOI 10.1016/j.cardfail.2004.04.004; Ma XL, 1999, CIRCULATION, V99, P1685, DOI 10.1161/01.CIR.99.13.1685; Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021; Marber Michael S, 2010, Drug Discov Today Dis Mech, V7, pe123, DOI 10.1016/j.ddmec.2010.07.006; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Melloni C, 2012, AM HEART J, V164, P646, DOI 10.1016/j.ahj.2012.07.030; Sarov-Blat L, 2010, ARTERIOSCL THROM VAS, V30, P2256, DOI 10.1161/ATVBAHA.110.209205; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; Seeger FH, 2010, BASIC RES CARDIOL, V105, P389, DOI 10.1007/s00395-009-0072-9; Surinkaew S, 2013, J CARDIOVASC PHARM, V61, P133, DOI 10.1097/FJC.0b013e318279b7b1; Yang SY, 2013, EUR J CLIN PHARMACOL, V69, P1261, DOI 10.1007/s00228-012-1469-1	18	106	111	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1187	1195		10.1016/S0140-6736(14)60417-7	http://dx.doi.org/10.1016/S0140-6736(14)60417-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7MT	24930728				2022-12-28	WOS:000343002600025
J	Gostin, LO; Glasner, AY				Gostin, Lawrence O.; Glasner, Aliza Y.			E-Cigarettes, Vaping, and Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Glasner, Aliza Y.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; Centers for Disease Control and Prevention (CDC), 2014, NEW CDC STUDY FINDS; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Cressey D, 2014, NATURE, V508, P159, DOI 10.1038/508159a; Crotty Alexander LE, 2014, PRESENTED AT 2014 AM; European Commission, 2014, HEALTH EU NEWSLETTER; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Park SJ, 2014, CLIN CANCER RES, V20; US Food and Drug Administration (FDA), CTP FOIA ELECTRONIC; US House of Representatives Democrats Committee on Energy and Commerce, 2014, GATEWAY TO ADDICTION	10	47	48	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					595	596		10.1001/jama.2014.7883	http://dx.doi.org/10.1001/jama.2014.7883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	24979277	Green Published			2022-12-28	WOS:000340136400014
J	Obeso, JA; Rodriguez-Oroz, MC; Stamelou, M; Bhatia, KP; Burn, DJ				Obeso, Jose A.; Rodriguez-Oroz, Maria C.; Stamelou, Maria; Bhatia, Kailash P.; Burn, David J.			The expanding universe of disorders of the basal ganglia	LANCET			English	Article							IMPULSE CONTROL DISORDERS; DE-NOVO MUTATIONS; PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; HUNTINGTONS-DISEASE; REPEAT EXPANSIONS; ALTERNATING HEMIPLEGIA; FUNCTIONAL-ANATOMY; BRAIN-STIMULATION; PRIMATE MODELS	The basal ganglia were originally thought to be associated purely with motor control. However, dysfunction and pathology of different regions and circuits are now known to give rise to many clinical manifestations beyond the association of basal ganglia dysfunction with movement disorders. Moreover, disorders that were thought to be caused by dysfunction of the basal ganglia only, such as Parkinson's disease and Huntington's disease, have diverse abnormalities distributed not only in the brain but also in the peripheral and autonomic nervous systems; this knowledge poses new questions and challenges. We discuss advances and the unanswered questions, and ways in which progress might be made.	[Obeso, Jose A.] Univ Navarra, Clin Univ, Dept Neurol & Neurosci Area, Movement Disorders Lab, E-31080 Pamplona, Spain; [Obeso, Jose A.] Univ Navarra, Sch Med, E-31080 Pamplona, Spain; [Obeso, Jose A.] Univ Navarra, CIMA, E-31080 Pamplona, Spain; [Obeso, Jose A.; Rodriguez-Oroz, Maria C.] Ctr Invest Redes Enfermedades Neurodegenerat CIBE, Madrid, Spain; [Rodriguez-Oroz, Maria C.] Univ Hosp Donostia, Dept Neurol, Bilbao, Spain; [Rodriguez-Oroz, Maria C.] Ikerbasque, Basque Fdn Sci, BioDonostia Res Inst, Neuroscience Unit, Bilbao, Spain; [Stamelou, Maria] Univ Athens, Attiko Hosp, Dept Neurol 2, Movement Disorders Clin, GR-10679 Athens, Greece; [Stamelou, Maria; Bhatia, Kailash P.] UCL, Inst Neurol, Dept Motor Neurosci & Movement, London, England; [Burn, David J.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Navarra; University of Navarra; University of Navarra; University Hospital Donostia; Basque Foundation for Science; National & Kapodistrian University of Athens; University Hospital Attikon; University of London; University College London; Newcastle University - UK	Obeso, JA (corresponding author), Univ Navarra, Ave Pio XII 55, Pamplona 31180, Spain.	jobeso@unav.es	Burn, David/ABD-6052-2021; Rodriguez-Oroz, Maria Cruz/D-1490-2018	Rodriguez-Oroz, Maria Cruz/0000-0001-5962-772X; Burn, David/0000-0001-7658-1209	CIBERNED (Institute Carlos III, Spain); Spanish Ministry of Science and Education; UTE-University of Navarra (FIMA); NIHR Newcastle Biomedical Research Unit, Parkinson's UK; Michael J Fox Foundation; CIBERNED, Government of Basque Country; Spanish Health Institute; Eran-net; Wellcome; MRC strategic initiative; Parkinson's UK; Dystonia Coalition	CIBERNED (Institute Carlos III, Spain); Spanish Ministry of Science and Education(Spanish Government); UTE-University of Navarra (FIMA); NIHR Newcastle Biomedical Research Unit, Parkinson's UK; Michael J Fox Foundation; CIBERNED, Government of Basque Country; Spanish Health Institute; Eran-net; Wellcome; MRC strategic initiative; Parkinson's UK(Parkinson's UK); Dystonia Coalition	JAO's research is funded by the CIBERNED (Institute Carlos III, Spain) and Spanish Ministry of Science and Education and the UTE-University of Navarra (FIMA) agreement. DJB's research is supported by NIHR Newcastle Biomedical Research Unit, Parkinson's UK, and the Michael J Fox Foundation. MCR-O receives grants from CIBERNED, Government of Basque Country and Spanish Health Institute, and Eran-net. KPB has research funding from the Wellcome and MRC strategic initiative; Parkinson's UK, and the Dystonia Coalition. We dedicate this paper to the memory of Prof C David Marsden, whose effort and dedication to decipher the mysteries and manifestations of basal ganglia dysfunction continue to motivate us.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alegre M, 2013, EXP NEUROL, V239, P1, DOI 10.1016/j.expneurol.2012.08.027; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Apartis E, 2012, NEUROLOGY, V79, P1898, DOI 10.1212/WNL.0b013e318271f7ff; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Bastiaens J, 2013, MOVEMENT DISORD, V28, P327, DOI 10.1002/mds.25291; Baunez C, 1999, PSYCHOPHARMACOLOGY, V141, P57, DOI 10.1007/s002130050806; Bohnen NI, 2007, J NEUROL NEUROSUR PS, V78, P641, DOI 10.1136/jnnp.2006.100073; Burn DJ, 2012, MOVEMENT DISORD, V27, P379, DOI 10.1002/mds.24041; Cavanna AE, 2009, J NEUROPSYCH CLIN N, V21, P13, DOI 10.1176/appi.neuropsych.21.1.13; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Chen-Plotkin AS, 2011, ARCH NEUROL-CHICAGO, V68, P488, DOI 10.1001/archneurol.2011.53; Cilia R, 2010, NEUROBIOL DIS, V39, P98, DOI 10.1016/j.nbd.2010.03.013; Cooper-Knock J, 2012, BRAIN, V135, P751, DOI 10.1093/brain/awr365; CROSSMAN AR, 1987, NEUROSCIENCE, V21, P1, DOI 10.1016/0306-4522(87)90322-8; Dale RC, 2012, DEV MED CHILD NEUROL, V54, P958, DOI 10.1111/j.1469-8749.2012.04394.x; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Djarmati A, 2009, LANCET NEUROL, V8, P447, DOI 10.1016/S1474-4422(09)70083-3; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Duncan GW, 2013, MOVEMENT DISORD, V28, P425, DOI 10.1002/mds.25352; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; Frisina PG, 2009, PARKINSONISM RELAT D, V15, P144, DOI 10.1016/j.parkreldis.2008.04.038; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Ganos C, 2013, NEUROSCI BIOBEHAV R, V37, P1050, DOI 10.1016/j.neubiorev.2012.11.004; Gardiner AR, 2012, NEUROLOGY, V79, P2115, DOI 10.1212/WNL.0b013e3182752c5a; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; Hariz M, 2013, MOVEMENT DISORD, V28, P1784, DOI 10.1002/mds.25665; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Houlden H, 2010, NEUROLOGY, V74, P846, DOI 10.1212/WNL.0b013e3181d5276d; Hutchinson M, 2013, MOVEMENT DISORD, V28, P1766, DOI 10.1002/mds.25676; Kaat LD, 2007, NEUROLOGY, V69, P723, DOI 10.1212/01.wnl.0000267643.24870.26; Kagi G, 2010, MOVEMENT DISORD, V25, P1279, DOI 10.1002/mds.22897; Khan NL, 2003, BRAIN, V126, P1279, DOI 10.1093/brain/awg142; Lambert C, 2012, NEUROIMAGE, V60, P83, DOI 10.1016/j.neuroimage.2011.11.082; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lesage S, 2013, BRAIN, V136, P385, DOI 10.1093/brain/aws357; Lhommee E, 2012, BRAIN, V135, P1463, DOI 10.1093/brain/aws078; Lohmann K, 2013, MOVEMENT DISORD, V28, P899, DOI 10.1002/mds.25536; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; MARSDEN CD, 1982, NEUROLOGY, V32, P514, DOI 10.1212/WNL.32.5.514; MARSDEN CD, 1994, BRAIN, V117, P877, DOI 10.1093/brain/117.4.877; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martin JP, 1927, BRAIN, V50, P637, DOI 10.1093/brain/50.3-4.637; MITCHELL IJ, 1989, NEUROSCIENCE, V32, P213, DOI 10.1016/0306-4522(89)90120-6; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Novak MJU, 2012, BRAIN, V135, P1165, DOI 10.1093/brain/aws024; O'Dowd S, 2012, MOVEMENT DISORD, V27, P1072, DOI 10.1002/mds.25022; Obeso I, BRAIN IN PRESS; Obeso JA, 2000, ANN NEUROL, V47, pS22; Ohshima S, 2010, PARKINSONISM RELAT D, V16, P612, DOI 10.1016/j.parkreldis.2010.07.001; Okun MS, 2013, MOVEMENT DISORD, V28, P1915, DOI 10.1002/mds.25735; Papp KV, 2011, BRAIN COGNITION, V77, P280, DOI 10.1016/j.bandc.2011.07.009; Parent M, 2010, CAN J NEUROL SCI, V37, P313, DOI 10.1017/S0317167100010209; Park HK, 2011, NEUROLOGY, V77, P82, DOI 10.1212/WNL.0b013e318221ad25; Peall KJ, 2011, MOVEMENT DISORD, V26, P1939, DOI 10.1002/mds.23791; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Rodriguez-Oroz MC, 2011, BRAIN, V134, P36, DOI 10.1093/brain/awq301; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Schneider SA, 2012, NEUROGENETICS, V13, P133, DOI 10.1007/s10048-012-0318-9; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Stamelou M, 2013, MOVEMENT DISORD, V28, P1184, DOI 10.1002/mds.25509; Stamelou M, 2012, NEUROLOGY, V79, P435, DOI 10.1212/WNL.0b013e318261714a; Stamelou M, 2012, BRAIN, V135, P1668, DOI 10.1093/brain/awr224; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; Svetel M, 2009, PARKINSONISM RELAT D, V15, P772, DOI 10.1016/j.parkreldis.2009.01.010; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; van Eimeren T, 2010, NEUROLOGY, V75, P1711, DOI 10.1212/WNL.0b013e3181fc27fa; van Tricht MJ, 2012, J NEUROL NEUROSUR PS, V83, P814, DOI 10.1136/jnnp-2011-301386; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2013, NEUROLOGY, V80, P176, DOI 10.1212/WNL.0b013e31827b915c; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Wilkinson L, 2007, BRAIN RES, V1137, P117, DOI 10.1016/j.brainres.2006.12.051; Wilson SAK, 1912, LANCET, V1, P1115; Wilson SAK, 1925, LANCET, V2, P1	83	109	113	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					523	531		10.1016/S0140-6736(13)62418-6	http://dx.doi.org/10.1016/S0140-6736(13)62418-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	24954674				2022-12-28	WOS:000340198300031
J	Edenhofer, O; Minx, J				Edenhofer, Ottmar; Minx, Jan			Mapmakers and navigators, facts and values	SCIENCE			English	Editorial Material													Edenhofer, Ottmar/E-1886-2013; Minx, Jan C/AAC-5948-2019	Edenhofer, Ottmar/0000-0001-6029-5208; Minx, Jan C/0000-0002-2862-0178				Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1	1	44	44	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					37	38		10.1126/science.1255998	http://dx.doi.org/10.1126/science.1255998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994640				2022-12-28	WOS:000338284400039
J	Foth, C; Tischlinger, H; Rauhut, OWM				Foth, Christian; Tischlinger, Helmut; Rauhut, Oliver W. M.			New specimen of Archaeopteryx provides insights into the evolution of pennaceous feathers	NATURE			English	Article							LONG FEATHERS; CHINA; DINOSAUR; FLIGHT; THEROPOD; PLUMAGE; ORIGIN; BIRDS	Discoveries of bird-like theropod dinosaurs and basal avialans in recent decades have helped to put the iconic 'Urvogel' Archaeopteryx(1) into context(2-6) and have yielded important new data on the origin and early evolution of feathers(7). However, the biological context under which pennaceous feathers evolved is still debated. Here we describe a new specimen of Archaeopteryx with extensive feather preservation, not only on the wings and tail, but also on the body and legs. The new specimen shows that the entire body was covered in pennaceous feathers, and that the hindlimbs had long, symmetrical feathers along the tibiotarsus but short feathers on the tarsometatarsus. Furthermore, the wing plumage demonstrates that several recent interpretations(8,9) are problematic. An analysis of the phylogenetic distribution of pennaceous feathers on the tail, hindlimb and arms of advanced maniraptorans and basal avialans strongly indicates that these structures evolved in a functional context other than flight, most probably in relation to display, as suggested by some previous studies(10-12). Pennaceous feathers thus represented an exaptation and were later, in several lineages and following different patterns, recruited for aerodynamic functions. This indicates that the origin of flight in avialans was more complex than previously thought and might have involved several convergent achievements of aerial abilities.	[Foth, Christian; Rauhut, Oliver W. M.] Bayer Staatssammlung Palaontol & Geol, Staatliche Nat Wissenschaftliche Sammlungen Bayer, D-80333 Munich, Germany; [Foth, Christian; Rauhut, Oliver W. M.] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Foth, Christian; Rauhut, Oliver W. M.] Univ Munich, GeoBioCtr, D-80333 Munich, Germany	University of Munich; University of Munich	Rauhut, OWM (corresponding author), Bayer Staatssammlung Palaontol & Geol, Staatliche Nat Wissenschaftliche Sammlungen Bayer, Richard Wagner Str 10, D-80333 Munich, Germany.	o.rauhut@lrz.uni-muenchen.de	Rauhut, Oliver/AAG-1029-2020	Rauhut, Oliver/0000-0003-3958-603X	Volkswagen Foundation [I/84 640]	Volkswagen Foundation(Volkswagen)	We thank B. Pohl for making the specimen available for study, C. Keilmann and R. Albersdorfer for assistance, Xu X. for access to material, and R. Carney, G. Mayr and A. Lopez-Arbarello for discussions. This study was supported by the Volkswagen Foundation under grant I/84 640 (to O.W.M.R.).	Chiappe LM, 2002, ANNU REV ECOL SYST, V33, P91, DOI 10.1146/annurev.ecolsys.33.010802.150517; Chiappe LM, 2014, PEERJ, V2, DOI 10.7717/peerj.234; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Foth C, 2012, PALAEONTOL Z, V86, P91, DOI 10.1007/s12542-011-0111-3; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; Godefroit Pascal, 2013, Nature Communications, V4, P1; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Qiang, 2005, Dizhi Tongbao, V24, P197; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Lucas A. M., 1972, AVIAN ANATOMY INTEGU, P197; Meseguer Jose, 2012, Spanish Journal of Palaeontology, V27, P125; NACHTIGALL W, 1971, Z VERGL PHYSIOL, V71, P326, DOI 10.1007/BF00298144; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; O'Connor J, 2013, P NATL ACAD SCI USA, V110, P17404, DOI 10.1073/pnas.1316979110; O'Connor JK, 2012, GEOSCIENCES, V2, P157, DOI 10.3390/geosciences2030157; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Turner AH, 2012, B AM MUS NAT HIST, P5; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	30	138	143	0	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					79	U421		10.1038/nature13467	http://dx.doi.org/10.1038/nature13467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990749				2022-12-28	WOS:000338199400039
J	Kong, XX; Banks, A; Liu, T; Kazak, L; Rao, RR; Cohen, P; Wang, X; Yu, S; Lo, JC; Tseng, YH; Cypess, AM; Xue, R; Kleiner, S; Kang, S; Spiegelman, BM; Rosen, ED				Kong, Xingxing; Banks, Alexander; Liu, Tiemin; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Wang, Xun; Yu, Songtao; Lo, James C.; Tseng, Yu-Hua; Cypess, Aaron M.; Xue, Ruidan; Kleiner, Sandra; Kang, Sona; Spiegelman, Bruce M.; Rosen, Evan D.			IRF4 Is a Key Thermogenic Transcriptional Partner of PGC-1 alpha	CELL			English	Article							BROWN ADIPOSE-TISSUE; REGULATORY FACTOR 4; UNCOUPLING PROTEIN GENE; RECEPTOR-ALPHA; COLD-EXPOSURE; FAT; EXPRESSION; CELL; COACTIVATOR; EXPANSION	Brown fat can reduce obesity through the dissipation of calories as heat. Control of thermogenic gene expression occurs via the induction of various coactivators, most notably PGC-1 alpha. In contrast, the transcription factor partner(s) of these cofactors are poorly described. Here, we identify interferon regulatory factor 4 (IRF4) as a dominant transcriptional effector of thermogenesis. IRF4 is induced by cold and cAMP in adipocytes and is sufficient to promote increased thermogenic gene expression, energy expenditure, and cold tolerance. Conversely, knockout of IRF4 in UCP1(+) cells causes reduced thermogenic gene expression and energy expenditure, obesity, and cold intolerance. IRF4 also induces the expression of PGC-1 alpha and PRDM16 and interacts with PGC-1 alpha, driving Ucp1 expression. Finally, cold, beta-agonists, or forced expression of PGC-1 alpha are unable to cause thermogenic gene expression in the absence of IRF4. These studies establish IRF4 as a transcriptional driver of a program of thermogenic gene expression and energy expenditure.	[Kong, Xingxing; Liu, Tiemin; Wang, Xun; Kang, Sona; Rosen, Evan D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; [Kong, Xingxing; Liu, Tiemin; Wang, Xun; Kang, Sona; Rosen, Evan D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Banks, Alexander; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Lo, James C.; Kleiner, Sandra; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Banks, Alexander; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Lo, James C.; Kleiner, Sandra; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Yu, Songtao] Northwestern Univ, Childrens Mem Res Ctr, Sch Med, Dept Pediat, Chicago, IL 60614 USA; [Tseng, Yu-Hua; Cypess, Aaron M.; Xue, Ruidan] Harvard Univ, Joslin Diabet Ctr, Sch Med, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Rosen, Evan D.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Northwestern University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rosen, ED (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA.	erosen@bidmc.harvard.edu	Lo, James/GYR-1149-2022; ç, æ /AAU-6965-2020; Tseng, Yu-Hua/AAE-6471-2021; Banks, Alexander/B-4832-2012	Lo, James/0000-0003-0244-1670; Tseng, Yu-Hua/0000-0003-2053-9559; Banks, Alexander/0000-0003-1787-6925	American Heart Association (AHA) postdoctoral fellowship; NIH [R01 DK31405, R01 DK085171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102170, R01DK085171, K08DK097303, ZIADK075112, T32DK007516, R01DK031405, P30DK043351, R01DK054477, R01DK077097] Funding Source: NIH RePORTER	American Heart Association (AHA) postdoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge Ulf Klein (Columbia University) for the Irf4<SUP>flox</SUP> mice. PGC-1 alpha constructs were the gift of Pere Puigserver; other plasmids were from Lisa Madisen and Hongkui Zeng. The Electron Microscopy core of the Beth Israel Deaconess Medical Center (BIDMC) performed the EM analysis. We thank members of the E. D. R. and B. M. S. laboratories, and Saverio Cinti, for helpful discussions and technical advice. This work was funded by an American Heart Association (AHA) postdoctoral fellowship to X. K., NIH R01 DK31405 to B. M. S., and NIH R01 DK085171 to E. D. R. B. M. S. is a founder of and shareholder in Ember Therapeutics, and S. K. is an employee of the Genomics Institute of the Novartis Research Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BOYER BB, 1991, MOL CELL BIOL, V11, P4147, DOI 10.1128/MCB.11.8.4147; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ferrer MD, 2009, J SPORT SCI, V27, P49, DOI 10.1080/02640410802409683; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jiang DS, 2013, HYPERTENSION, V61, P1193, DOI 10.1161/HYPERTENSIONAHA.111.00614; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Larose M, 1996, J BIOL CHEM, V271, P31533, DOI 10.1074/jbc.271.49.31533; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Manfredi LH, 2013, J APPL PHYSIOL, V115, P1496, DOI 10.1152/japplphysiol.00474.2013; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; TOKUYAMA K, 1986, AM J PHYSIOL, V251, pE407, DOI 10.1152/ajpendo.1986.251.4.E407; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2007, EXPERT OPIN THER TAR, V11, P1329, DOI 10.1517/14728222.11.10.1329; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	57	174	178	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					69	83		10.1016/j.cell.2014.04.049	http://dx.doi.org/10.1016/j.cell.2014.04.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995979	Green Accepted, Bronze			2022-12-28	WOS:000340943100008
J	Lo, JC; Ljubicic, S; Leibiger, B; Kern, M; Leibiger, IB; Moede, T; Kelly, ME; Bhowmick, DC; Murano, I; Cohen, P; Banks, AS; Khandekar, MJ; Dietrich, A; Flier, JS; Cinti, S; Blueher, M; Danial, NN; Berggren, PO; Spiegelman, BM				Lo, James C.; Ljubicic, Sanda; Leibiger, Barbara; Kern, Matthias; Leibiger, Ingo B.; Moede, Tilo; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Murano, Incoronata; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Dietrich, Arne; Flier, Jeffrey S.; Cinti, Saverio; Blueher, Matthias; Danial, Nika N.; Berggren, Per-Olof; Spiegelman, Bruce M.			Adipsin Is an Adipokine that Improves beta Cell Function in Diabetes	CELL			English	Article							COMPLEMENT FACTOR-D; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; OBESITY; SECRETION; INFLAMMATION; PATHWAY; ADIPONECTIN; ADIPOCYTE	A hallmark of type 2 diabetes mellitus (T2DM) is the development of pancreatic beta cell failure, which results in insulinopenia and hyperglycemia. We show that the adipokine adipsin has a beneficial role in maintaining beta cell function. Animals genetically lacking adipsin have glucose intolerance due to insulinopenia; isolated islets from these mice have reduced glucose-stimulated insulin secretion. Replenishment of adipsin to diabetic mice treated hyperglycemia by boosting insulin secretion. We identify C3a, a peptide generated by adipsin, as a potent insulin secretagogue and show that the C3a receptor is required for these beneficial effects of adipsin. C3a acts on islets by augmenting ATP levels, respiration, and cytosolic free Ca2+. Finally, we demonstrate that T2DM patients with b cell failure are deficient in adipsin. These findings indicate that the adipsin/C3a pathway connects adipocyte function to b cell physiology, and manipulation of this molecular switch may serve as a therapy in T2DM.	[Lo, James C.; Ljubicic, Sanda; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Danial, Nika N.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lo, James C.; Ljubicic, Sanda; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Danial, Nika N.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Lo, James C.; Cohen, Paul] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Leibiger, Barbara; Leibiger, Ingo B.; Moede, Tilo; Berggren, Per-Olof] Rolf Luft Res Ctr Diabet & Endocrinol, Karolinska Inst, S-17176 Stockholm, Sweden; [Kern, Matthias; Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Murano, Incoronata; Cinti, Saverio] Univ Ancona, Dept Expt & Clin Med, I-60020 Ancona, Italy; [Dietrich, Arne] Univ Leipzig, Dept Surg, D-04103 Leipzig, Germany; [Flier, Jeffrey S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Karolinska Institutet; Leipzig University; Marche Polytechnic University; Leipzig University; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Banks, Alexander/B-4832-2012; Lo, James/GYR-1149-2022; Flier, jeffrey/AAG-6223-2019	Banks, Alexander/0000-0003-1787-6925; Lo, James/0000-0003-0244-1670; Moede, Tilo/0000-0002-2045-9244; CINTI, Saverio/0000-0003-0362-5017; Berggren, Per-Olof/0000-0001-8991-413X	Swiss National Science Foundation postdoctoral fellowship; Swedish Research Council; Family Erling-Persson Foundation; Novo Nordisk Foundation; Stichting af Jochnick Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Knut and Alice Wallenberg Foundation; DIABAT [HEALTH-F2-2011-278373]; Deutsche Forschungsgemeinschaft "Obesity mechanisms'' [SFB 1052/1, B01]; NIH [DK097303, DK078081, DK031405];  [ERC-2013-AdG 338936-BetaImage]; Novo Nordisk Fonden [NNF12OC1016557] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, K08DK097303, R01DK078081, P30DK043351, R01DK031405] Funding Source: NIH RePORTER	Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Stichting af Jochnick Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); DIABAT; Deutsche Forschungsgemeinschaft "Obesity mechanisms''(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Gregory L. Stahl (Brigham and Women's Hospital) for generously providing Adipsin<SUP>-/-</SUP> mice. We are grateful to Drs. Rana Gupta, Shingo Kajimura, Jennifer Estall, Christiane Wrann, Linus Tsai, Susan Bonner-Weir, Pere Puigserver, and Evan Rosen for helpful discussions. We thank Jennifer Hollister-Lock and the Islet Isolation Core at Joslin Diabetes Center for help with islet perfusions. Fluorescence images were acquired in the Confocal and Light Microscopy Core Facility at the Dana-Farber Cancer Institute. S. L. was supported by a Swiss National Science Foundation postdoctoral fellowship. This work was supported by the Swedish Research Council, the Family Erling-Persson Foundation, the Novo Nordisk Foundation, the Stichting af Jochnick Foundation, the Strategic Research Program in Diabetes at Karolinska Institutet, the ERC-2013-AdG 338936-BetaImage, the Knut and Alice Wallenberg Foundation, DIABAT HEALTH-F2-2011-278373 (S. C.), Deutsche Forschungsgemeinschaft the SFB 1052/1: "Obesity mechanisms'' (project B01 to M. B.), and NIH grants DK097303 (J.C.L.), DK078081 (N.N.D.), and DK031405 (B. M. S.).	Ahren B, 2003, INT J OBESITY, V27, P1037, DOI 10.1038/sj.ijo.0802369; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; CHOY LN, 1992, J BIOL CHEM, V267, P12736; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Dahlke K, 2011, J IMMUNOL, V186, P3066, DOI 10.4049/jimmunol.1002741; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dunmore SJ, 2013, J ENDOCRINOL, V216, pT37, DOI 10.1530/JOE-12-0278; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Enerback L., 1986, MAST CELL DIFFERENTI, P167; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NAPOLITANO A, 1994, INT J OBESITY, V18, P213; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PLATT KA, 1994, J BIOL CHEM, V269, P28558; Pomeroy C, 1997, CLIN EXP IMMUNOL, V108, P507, DOI 10.1046/j.1365-2249.1997.3921287.x; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; TURNER RC, 1995, DIABETES, V44, P1249; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wetsel RA, 1999, J BIOL CHEM, V274, P19429, DOI 10.1074/jbc.274.27.19429; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Zhang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE1433, DOI 10.1152/ajpendo.00664.2006	61	215	227	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					41	53		10.1016/j.cell.2014.06.005	http://dx.doi.org/10.1016/j.cell.2014.06.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995977	Green Accepted, Bronze			2022-12-28	WOS:000340943100006
J	Mora, C; Frazier, AG; Longman, RJ; Dacks, RS; Walton, MM; Tong, EJ; Sanchez, JJ; Kaiser, LR; Stender, YO; Anderson, JM; Ambrosino, CM; Fernandez-Silva, I; Giuseffi, LM; Giambelluca, TW				Mora, Camilo; Frazier, Abby G.; Longman, Ryan J.; Dacks, Rachel S.; Walton, Maya M.; Tong, Eric J.; Sanchez, Joseph J.; Kaiser, Lauren R.; Stender, Yuko O.; Anderson, James M.; Ambrosino, Christine M.; Fernandez-Silva, Iria; Giuseffi, Louise M.; Giambelluca, Thomas W.			Uncertainties in the timing of unprecedented climates Reply	NATURE			English	Letter									[Mora, Camilo; Frazier, Abby G.; Longman, Ryan J.; Sanchez, Joseph J.; Kaiser, Lauren R.; Stender, Yuko O.; Giuseffi, Louise M.; Giambelluca, Thomas W.] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Dacks, Rachel S.; Walton, Maya M.; Anderson, James M.; Ambrosino, Christine M.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Walton, Maya M.; Tong, Eric J.; Stender, Yuko O.; Anderson, James M.; Ambrosino, Christine M.; Fernandez-Silva, Iria] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Tong, Eric J.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Fernandez-Silva, Iria] Univ Ryukyus, Transdisciplinary Org Subtrop Isl Studies TRO SIS, Nishihara, Okinawa 9030213, Japan	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of the Ryukyus	Mora, C (corresponding author), Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA.	cmora@hawaii.edu	Fernandez-Silva, Iria/AAA-8996-2020; Frazier, Abby/P-5511-2017	Frazier, Abby/0000-0003-4076-4577; Giambelluca, Thomas/0000-0002-6798-3780; Anderson, James/0000-0002-4900-5916				Altman DG, 2005, BRIT MED J, V331, P903, DOI 10.1136/bmj.331.7521.903; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Hawkins E, 2014, NATURE, V511, pE3, DOI 10.1038/nature13523; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076	5	6	6	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					E5	E6		10.1038/nature13524	http://dx.doi.org/10.1038/nature13524			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990758				2022-12-28	WOS:000338199400004
J	Salter, MW; Beggs, S				Salter, Michael W.; Beggs, Simon			Sublime Microglia: Expanding Roles for the Guardians of the CNS	CELL			English	Review							TISSUE-RESIDENT MACROPHAGES; ONSET ALZHEIMERS-DISEASE; NEUROPATHIC PAIN; NEUROTROPHIC FACTOR; HIPPOCAMPAL NEUROGENESIS; IN-VIVO; TRANSCRIPTION FACTOR; ANION GRADIENT; NEURONAL DEATH; KNOCKOUT MICE	Recent findings challenge the concept that microglia solely function in disease states in the central nervous system (CNS). Rather than simply reacting to CNS injury, infection, or pathology, emerging lines of evidence indicate that microglia sculpt the structure of the CNS, refine neuronal circuitry and network connectivity, and contribute to plasticity. These physiological functions of microglia in the normal CNS begin during development and persist into maturity. Here, we develop a conceptual framework for functions of microglia beyond neuroinflammation and discuss the rich repertoire of signaling and communication motifs in microglia that are critical both in pathology and for the normal physiology of the CNS.	[Salter, Michael W.; Beggs, Simon] Univ Toronto, Ctr Study Pain, Neurosci & Mental Hlth Program, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Salter, Michael W.] Univ Toronto, Ctr Study Pain, Dept Physiol, Fac Med, Toronto, ON M5G 1X8, Canada; [Salter, Michael W.; Beggs, Simon] Univ Toronto, Ctr Study Pain, Dept Physiol, Fac Dent, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Salter, MW (corresponding author), Univ Toronto, Ctr Study Pain, Neurosci & Mental Hlth Program, Hosp Sick Children, 100 Coll St, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca	Beggs, Simon/AAI-4438-2021	Beggs, Simon/0000-0002-1582-8391	Canadian Institutes of Health Research (CIHR) [MT-11219]; Krembil Foundation; Ontario Research Fund Research Excellence Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Ontario Research Fund Research Excellence Program	The work of the authors is supported by grants from the Canadian Institutes of Health Research (CIHR; grant number MT-11219), the Krembil Foundation, and the Ontario Research Fund Research Excellence Program. M.W.S. holds a Canada Research Chair (Tier I) in Neuroplasticity and Pain and is the Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children.	Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Buckley PF, 2011, CURR OPIN PSYCHIATR, V24, P122, DOI 10.1097/YCO.0b013e3283436eb7; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen GQ, 1999, J NEUROSCI, V19, P7983; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Danese S, 2011, AM J PHYSIOL-GASTR L, V300, pG716, DOI 10.1152/ajpgi.00472.2010; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Greter M, 2013, GLIA, V61, P121, DOI 10.1002/glia.22408; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Koeglsperger T, 2013, GLIA, V61, P985, DOI 10.1002/glia.22490; Koizumi S, 2013, GLIA, V61, P47, DOI 10.1002/glia.22358; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nakajima K, 2002, J NEUROCHEM, V80, P697, DOI 10.1046/j.0022-3042.2001.00752.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nistico R, 2012, MOL NEUROBIOL, V46, P572, DOI 10.1007/s12035-012-8324-3; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheffel J, 2012, GLIA, V60, P1930, DOI 10.1002/glia.22409; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stoop R, 1996, J NEUROSCI, V16, P3256; Toyomitsu E, 2012, PURINERG SIGNAL, V8, P301, DOI 10.1007/s11302-011-9288-x; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2013, GLIA, V61, P55, DOI 10.1002/glia.22379; Tsuda M, 2009, J CELL MOL MED, V13, P3251, DOI 10.1111/j.1582-4934.2009.00719.x; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Vinnakota K, 2013, NEURO-ONCOLOGY, V15, P1457, DOI 10.1093/neuonc/not115; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang JF, 2014, NEURON, V82, P195, DOI 10.1016/j.neuron.2014.01.043	88	355	374	4	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					15	24		10.1016/j.cell.2014.06.008	http://dx.doi.org/10.1016/j.cell.2014.06.008			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995975	Bronze			2022-12-28	WOS:000340943100004
J	Celum, C; Morrow, RA; Donnell, D; Hong, T; Hendrix, CW; Thomas, KK; Fife, KH; Nakku-Joloba, E; Mujugira, A; Baeten, JM				Celum, Connie; Morrow, Rhoda A.; Donnell, Deborah; Hong, Ting; Hendrix, Craig W.; Thomas, Katherine K.; Fife, Kenneth H.; Nakku-Joloba, Edith; Mujugira, Andrew; Baeten, Jared M.		Partners PrEP Study Team	Daily Oral Tenofovir and Emtricitabine-Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1-Uninfected Men and Women A Subgroup Analysis of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; DISOPROXIL FUMARATE; MALE CIRCUMCISION; HIV PREVENTION; DOUBLE-BLIND; HEPATITIS-B; TRANSMISSION; HSV-2; INFECTION; SUPPRESSION	Background: Daily oral preexposure prophylaxis (PrEP) using the antiretroviral tenofovir disoproxil fumarate (TDF) alone or in combination with emtricitabine (FTC-TDF) reduces the risk for HIV-1 acquisition. Tenofovir has in vitro activity against herpes simplex virus type 2 (HSV-2). Objective: To assess the efficacy of daily oral PrEP with tenofovir and FTC-TDF in the prevention of HSV-2 acquisition. Design: Subgroup analysis of data from a randomized, placebo-controlled trial with concealed allocation. (ClinicalTrials.gov: NCT00557245) Setting: Multiple sites in Kenya and Uganda. Participants: Heterosexual men and women who were seronegative for HIV-1 and HSV-2 and at high risk for HIV-1 acquisition due to having an HIV-1-infected partner. Measurements: HSV-2 seroconversion. Results: A total of 131 participants seroconverted to HSV-2 (79 of 1041 assigned to tenofovir or FTC-TDF PrEP [HSV-2 incidence, 5.6 per 100 person-years] and 52 of 481 assigned to placebo [HSV-2 incidence, 7.7 per 100 person-years]). The hazard ratio (HR) for HSV-2 acquisition with daily oral PrEP was 0.70 (95% CI, 0.49 to 0.99; P = 0.047) compared with placebo, and the absolute risk reduction was 2.1 per 100 person-years. Among the 1044 participants with HSV-2-infected partners, the HR for PrEP was 0.67 (CI, 0.46 to 0.98; P = 0.038) compared with placebo, and the absolute risk reduction was 3.1 per 100 person-years. Limitation: Randomization was not stratified by HSV-2 status, and diagnostic tests to exclude participants with acute HSV-2 at baseline are not available. Conclusion: Daily oral tenofovir-based PrEP significantly reduced the risk for HSV-2 acquisition among heterosexual men and women. Modest protection against HSV-2 is an added benefit of HIV-1 prevention with oral tenofovir-based PrEP.	[Celum, Connie; Donnell, Deborah; Hong, Ting; Thomas, Katherine K.; Mujugira, Andrew; Baeten, Jared M.] Univ Washington, Seattle, WA 98104 USA; [Morrow, Rhoda A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Hendrix, Craig W.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA; [Fife, Kenneth H.] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; [Nakku-Joloba, Edith] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis; Makerere University	Celum, C (corresponding author), Univ Washington, 325 Ninth Ave,UW Box 359927, Seattle, WA 98104 USA.		Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Thomas, Katherine K/0000-0002-7024-468X; Were, Edwin/0000-0002-4783-0795; Donnell, Deborah/0000-0002-0587-7480; Mujugira, Andrew/0000-0001-6646-6733	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Primary Funding Source: Bill & Melinda Gates Foundation.	Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BALZARINI J, 1993, ANTIMICROB AGENTS CH, V37, P332, DOI 10.1128/AAC.37.2.332; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Breslow NE, 2009, STAT BIOSCI, V1, P32, DOI 10.1007/s12561-009-9001-6; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Centre for the AIDS Programme of Research in South Africa, 2010, EFF SAF VAG MICR 1 T; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Dropulic LK, 2010, CLIN PHARMACOL THER, V88, P610, DOI 10.1038/clpt.2010.178; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gatanaga H, 2013, CLIN INFECT DIS, V56, P1812, DOI 10.1093/cid/cit145; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; Lama J, 2011, 18 C RETR OPP INF BO; Lingappa J, 2010, INT J STD AIDS, V21, P611, DOI 10.1258/ijsa.2009.008477; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Mahiane SG, 2009, AIDS, V23, P377, DOI 10.1097/QAD.0b013e32831c5497; Martin ET, 2009, ARCH INTERN MED, V169, P1233, DOI 10.1001/archinternmed.2009.177; Mehta SD, 2012, AIDS, V26, P1141, DOI 10.1097/QAD.0b013e328352d116; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; Muiru AN, 2013, J INFECT DIS, V208, P1093, DOI 10.1093/infdis/jit303; Mujugira A, 2013, J INFECT DIS, V208, P1366, DOI 10.1093/infdis/jit333; Mujugira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025828; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Price H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068152; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Soriano V, 2013, CLIN LIVER DIS, V17, P489, DOI 10.1016/j.cld.2013.05.008; Tan DHS, 2012, INT J WOMENS HEALTH, V4, P341, DOI 10.2147/IJWH.S27601; Tan DHS, 2011, AIDS, V25, P207, DOI 10.1097/QAD.0b013e328341ddf7; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260	41	42	42	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					11	+		10.7326/M13-2471	http://dx.doi.org/10.7326/M13-2471			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24979446				2022-12-28	WOS:000338419700002
J	Gelber, AC				Gelber, Allan C.			Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EVIDENCE-BASED RECOMMENDATIONS; EULAR-STANDING-COMMITTEE; KNEE OSTEOARTHRITIS; OLDER-ADULTS; TASK-FORCE; OARSI RECOMMENDATIONS; HIP OSTEOARTHRITIS; PHYSICAL-THERAPY; SUBSEQUENT KNEE; MENISCAL TEAR											ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; Altman R, 1986, ARTHRITIS RHEUM, V29; BAKER DG, 1993, NEW ENGL J MED, V329, P1013, DOI 10.1056/NEJM199309303291407; Belamy N, 2006, COCHRANE DB SYST REV; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Deyle GD, 2000, ANN INTERN MED, V132, P173, DOI 10.7326/0003-4819-132-3-200002010-00002; Englund M, 2003, ARTHRITIS RHEUM-US, V48, P2178, DOI 10.1002/art.11088; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Felson DT, 2007, ARTHRIT RHEUM-ARTHR, V57, P6, DOI 10.1002/art.22464; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2003, ANN INTERN MED, V139, P330, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00008; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 2000, ANN INTERN MED, V133, P72637; Gelber AC, 1999, AM J MED, V107, P542, DOI 10.1016/S0002-9343(99)00292-2; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Gossec L, 2011, OSTEOARTHR CARTILAGE, V19, P147, DOI 10.1016/j.joca.2010.10.025; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Lane NE, 2007, NEW ENGL J MED, V357, P1413, DOI 10.1056/NEJMcp071112; Lin FY, 2004, BMJ-BRIT MED J, V329, P324, DOI 10.1136/bmj.38159.639028.7C; Manheimer E, 2007, ANN INTERN MED, V146, P868, DOI 10.7326/0003-4819-146-12-200706190-00008; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Parkes MJ, 2013, JAMA-J AM MED ASSOC, V310, P72320; Pincus T, 2001, ARTHRITIS RHEUM-US, V44, P1587, DOI 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X; Punzi L, 2004, BEST PRACT RES CL RH, V18, P739, DOI 10.1016/j.berh.2004.05.010; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Roddy E, 2005, RHEUMATOLOGY, V44, P67, DOI 10.1093/rheumatology/keh399; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Siverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; SPIEGEL BMR, 2006, AM J MED, V119, pNIL56, DOI [DOI 10.1016/j.amjmed.2005.11.020, DOI 10.1016/J.AMJMED.2005.11.020]; Superic Cabuslay E, 1996, ARTHRIT CARE RES, V9, P292; Uthman OA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5555; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yazigi F, 2013, BMC MUSCULOSKEL DIS, V14, P320; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886; Zhang YQ, 2001, ARTHRITIS RHEUM, V44, P2065, DOI 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z	55	18	18	3	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					1	16	ITC1	10.7326/0003-4819-161-1-201407010-01001	http://dx.doi.org/10.7326/0003-4819-161-1-201407010-01001			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QX	24979462				2022-12-28	WOS:000364907900001
J	Boulware, DR; Meya, DB; Muzoora, C; Rolfes, MA; Hullsiek, KH; Musubire, A; Taseera, K; Nabeta, HW; Schutz, C; Williams, DA; Rajasingham, R; Rhein, J; Thienemann, F; Lo, MW; Nielsen, K; Bergemann, TL; Kambugu, A; Manabe, YC; Janoff, EN; Bohjanen, PR; Meintjes, G				Boulware, David R.; Meya, David B.; Muzoora, Conrad; Rolfes, Melissa A.; Hullsiek, Katherine Huppler; Musubire, Abdu; Taseera, Kabanda; Nabeta, Henry W.; Schutz, Charlotte; Williams, Darlisha A.; Rajasingham, Radha; Rhein, Joshua; Thienemann, Friedrich; Lo, Melanie W.; Nielsen, Kirsten; Bergemann, Tracy L.; Kambugu, Andrew; Manabe, Yukari C.; Janoff, Edward N.; Bohjanen, Paul R.; Meintjes, Graeme		COAT Trial Team	Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HIGH-DOSE FLUCONAZOLE; EARLY MORTALITY; TUBERCULOUS MENINGITIS; AMPHOTERICIN-B; HIV; INFECTION; ADULTS; DISEASE; COHORT	BACKGROUND Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency syndrome-related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; however, the question of when ART should be initiated after diagnosis of cryptococcal meningitis remains unanswered. METHODS We assessed survival at 26 weeks among 177 human immunodeficiency virus-infected adults in Uganda and South Africa who had cryptococcal meningitis and had not previously received ART. We randomly assigned study participants to undergo either earlier ART initiation (1 to 2 weeks after diagnosis) or deferred ART initiation (5 weeks after diagnosis). Participants received amphotericin B (0.7 to 1.0 mg per kilogram of body weight per day) and fluconazole (800 mg per day) for 14 days, followed by consolidation therapy with fluconazole. RESULTS The 26-week mortality with earlier ART initiation was significantly higher than with deferred ART initiation (45% [40 of 88 patients] vs. 30% [27 of 89 patients]; hazard ratio for death, 1.73; 95% confidence interval [CI], 1.06 to 2.82; P = 0.03). The excess deaths associated with earlier ART initiation occurred 2 to 5 weeks after diagnosis (P = 0.007 for the comparison between groups); mortality was similar in the two groups thereafter. Among patients with few white cells in their cerebrospinal fluid (<5 per cubic millimeter) at randomization, mortality was particularly elevated with earlier ART as compared with deferred ART (hazard ratio, 3.87; 95% CI, 1.41 to 10.58; P = 0.008). The incidence of recognized cryptococcal immune reconstitution inflammatory syndrome did not differ significantly between the earlier-ART group and the deferred-ART group (20% and 13%, respectively; P = 0.32). All other clinical, immunologic, virologic, and microbiologic outcomes, as well as adverse events, were similar between the groups. CONCLUSIONS Deferring ART for 5 weeks after the diagnosis of cryptococcal meningitis was associated with significantly improved survival, as compared with initiating ART at 1 to 2 weeks, especially among patients with a paucity of white cells in cerebrospinal fluid.	[Boulware, David R.; Meya, David B.; Rolfes, Melissa A.; Hullsiek, Katherine Huppler; Williams, Darlisha A.; Rajasingham, Radha; Rhein, Joshua; Lo, Melanie W.; Nielsen, Kirsten; Bergemann, Tracy L.; Bohjanen, Paul R.] Univ Minnesota, Minneapolis, MN USA; [Meya, David B.; Musubire, Abdu; Nabeta, Henry W.; Williams, Darlisha A.; Rajasingham, Radha; Rhein, Joshua; Lo, Melanie W.; Kambugu, Andrew; Manabe, Yukari C.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Meya, David B.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Muzoora, Conrad; Taseera, Kabanda] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Schutz, Charlotte; Thienemann, Friedrich; Meintjes, Graeme] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Manabe, Yukari C.] Johns Hopkins Sch Med, Baltimore, MD USA; [Janoff, Edward N.] Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO USA; [Janoff, Edward N.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	University of Minnesota System; University of Minnesota Twin Cities; Makerere University; Makerere University; Mbarara University of Science & Technology; University of Cape Town; Johns Hopkins University; Johns Hopkins Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Imperial College London	Boulware, DR (corresponding author), MTRF 3-222,2001 6th St SE, Minneapolis, MN 55455 USA.	boulw001@umn.edu	Muzoora, Conrad/AAV-7023-2021; Boulware, David R/AAF-7124-2021; Schutz, Charlotte/G-6864-2016; Rhein, Josh/H-5354-2019; Boulware, David R/GRS-0999-2022; Bohjanen, Paul/B-2329-2015; hlupeni, admire/M-1539-2018; Meya, David/AAO-2796-2020; Thienemann, Friedrich/AAX-1197-2020	Muzoora, Conrad/0000-0002-7866-5198; Schutz, Charlotte/0000-0001-8329-6158; Rhein, Josh/0000-0002-0480-9646; Boulware, David R/0000-0002-4715-0060; Bohjanen, Paul/0000-0002-2772-3597; Thienemann, Friedrich/0000-0002-4801-2030; Bahr, Nathan/0000-0002-9431-8938; Nielsen, Kirsten/0000-0002-2318-168X; Meintjes, Graeme/0000-0003-1196-4414; Scriven, James/0000-0001-8463-7137; McDonald, Tami/0000-0002-7053-8987; Bergemann, Tracy/0000-0003-3902-2605; Rolfes, Melissa/0000-0002-0483-9941; , David/0000-0002-8854-0321	National Institute of Allergy and Infectious Diseases; FOGARTY INTERNATIONAL CENTER [D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055433, K23AI073192, U01AI089244, R34AI081554, K24AI096925] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases and others; COAT ClinicalTrials.gov number, NCT01075152.	Bahr N, 2013, CURR INFECT DIS REP, V15, P583, DOI 10.1007/s11908-013-0378-5; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bicanic T, 2009, JAIDS-J ACQ IMM DEF, V51, P130, DOI 10.1097/QAI.0b013e3181a56f2e; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bisson GP, 2013, CLIN INFECT DIS, V56, P1165, DOI 10.1093/cid/cit019; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Boulware DR, 2010, J INFECT DIS, V202, P962, DOI 10.1086/655785; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Chang CC, 2013, AIDS, V27, P2089, DOI 10.1097/QAD.0b013e3283614a8d; Cohen DB, 2010, TROP MED INT HEALTH, V15, P910, DOI 10.1111/j.1365-3156.2010.02565.x; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Grant PM, 2012, CURR HIV-AIDS REP, V9, P251, DOI 10.1007/s11904-012-0126-8; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Group for Enteric Respiratory and Meningeal Disease Surveillance in South Africa, GERMS SA ANN REP 201; Haddow LJ, 2010, LANCET INFECT DIS, V10, P791, DOI 10.1016/S1473-3099(10)70170-5; Hakim JG, 2000, AIDS, V14, P1401, DOI 10.1097/00002030-200007070-00013; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Muzoora CK, 2012, J INFECTION, V64, P76, DOI 10.1016/j.jinf.2011.10.014; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	40	270	295	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2487	2498		10.1056/NEJMoa1312884	http://dx.doi.org/10.1056/NEJMoa1312884			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963568	Green Accepted			2022-12-28	WOS:000337804400006
J	Sedgwick, P				Sedgwick, Philip			What is a non-randomised controlled trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS; ALLOCATION; RANDOMIZATION; BIAS		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Formoso G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5391; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2820; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1742; Sedgwick P, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3345; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7951; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1324; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7453; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4176	8	9	9	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2014	348								g4115	10.1136/bmj.g4115	http://dx.doi.org/10.1136/bmj.g4115			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LI	24951505				2022-12-28	WOS:000337806000007
J	Weisz, E; Choi, HK; Sivan, I; Heiblum, M; Gefen, Y; Mahalu, D; Umansky, V				Weisz, E.; Choi, H. K.; Sivan, I.; Heiblum, M.; Gefen, Y.; Mahalu, D.; Umansky, V.			An electronic quantum eraser	SCIENCE			English	Article							DELAYED-CHOICE EXPERIMENT; COMPLEMENTARITY; INTERFEROMETER; INTERFERENCE; UNCERTAINTY; DETECTOR	The quantum eraser is a device that illustrates the quantum principle of complementarity and shows how a dephased system can regain its lost quantum behavior by erasing the "which-path" information already obtained about it. Thus far, quantum erasers were constructed predominantly in optical systems. Here, we present a realization of a quantum eraser in a mesoscopic electronic device. The use of interacting electrons, instead of noninteracting photons, allows control over the extracted information and a smooth variation of the degree of quantum erasure. The demonstrated system can serve as a first step toward a variety of more complex setups.	[Weisz, E.; Choi, H. K.; Sivan, I.; Heiblum, M.; Gefen, Y.; Mahalu, D.; Umansky, V.] Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Heiblum, M (corresponding author), Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	moty.heiblum@weizmann.ac.il	Umansky, Vladimir/P-1334-2019; heiblum, moty/Q-1193-2019	Umansky, Vladimir/0000-0001-5727-2064; 	Israeli Science Foundation; Minerva foundation; U.S.-Israel Binational Science Foundation (BSF); European Research Council under the European Community's Seventh Framework Program (FP7)/ERC [227716]; German Israeli Project Cooperation (DIP)	Israeli Science Foundation(Israel Science Foundation); Minerva foundation; U.S.-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); European Research Council under the European Community's Seventh Framework Program (FP7)/ERC(European Research Council (ERC)); German Israeli Project Cooperation (DIP)	We thank K. Kang, Y. Chung, I. Neder, and H. Inoue for useful discussions. M. H. and Y. G. acknowledge the partial support of the Israeli Science Foundation, the Minerva foundation, and the U.S.-Israel Binational Science Foundation (BSF). M. H. acknowledges also the support of the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 227716, and the German Israeli Project Cooperation (DIP).	AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Bertet P, 2001, NATURE, V411, P166, DOI 10.1038/35075517; Bohr N, 1928, NATURE, V121, P580, DOI 10.1038/121580a0; Buks E, 1998, NATURE, V391, P871, DOI 10.1038/36057; Buscemi F, 2012, EUR PHYS J D, V66, DOI 10.1140/epjd/e2012-30469-5; Chang DI, 2008, NAT PHYS, V4, P205, DOI 10.1038/nphys854; Chen W, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155308; Dressel J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045320; Durr S, 1998, NATURE, V395, P33, DOI 10.1038/25653; Englert BG, 1996, PHYS REV LETT, V77, P2154, DOI 10.1103/PhysRevLett.77.2154; ENGLERT BG, 1995, NATURE, V375, P367, DOI 10.1038/375367b0; Feynman R., 1965, FEYNMANN LECT PHYS, V3; HERZOG TJ, 1995, PHYS REV LETT, V75, P3034, DOI 10.1103/PhysRevLett.75.3034; JAEGER G, 1995, PHYS REV A, V51, P54, DOI 10.1103/PhysRevA.51.54; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Kaiser F, 2012, SCIENCE, V338, P637, DOI 10.1126/science.1226755; Kang K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125326; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; KWIAT PG, 1994, PHYS REV A, V49, P61, DOI 10.1103/PhysRevA.49.61; KWIAT PG, 1992, PHYS REV A, V45, P7729, DOI 10.1103/PhysRevA.45.7729; Ma XS, 2013, P NATL ACAD SCI USA, V110, P1221, DOI 10.1073/pnas.1213201110; Neder I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.036803; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; Peruzzo A, 2012, SCIENCE, V338, P634, DOI 10.1126/science.1226719; Rosenow B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256805; SCULLY MO, 1982, PHYS REV A, V25, P2208, DOI 10.1103/PhysRevA.25.2208; SCULLY MO, 1991, NATURE, V351, P111, DOI 10.1038/351111a0; Shpitalnik V, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226802; Sprinzak D, 2000, PHYS REV LETT, V84, P5820, DOI 10.1103/PhysRevLett.84.5820; STERN A, 1990, PHYS REV A, V41, P3436, DOI 10.1103/PhysRevA.41.3436; STOREY EP, 1995, NATURE, V375, P368, DOI 10.1038/375368a0; Vyshnevyy AA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165302; Vyshnevyy AA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165417; Wheeler J. A., 1983, QUANTUM THEORY MEASU; WOOTTERS WK, 1979, PHYS REV D, V19, P473, DOI 10.1103/PhysRevD.19.473	35	30	30	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1363	1366		10.1126/science.1248459	http://dx.doi.org/10.1126/science.1248459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948731	Green Submitted			2022-12-28	WOS:000337531700031
J	Greenstone, M; Hack, M				Greenstone, Michael; Hack, Melissa			Obstructive sleep apnoea	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; RISK; HYPERTENSION; ASSOCIATION; COMMUNITY; MEN; PREVALENCE; MANAGEMENT; DIAGNOSIS		[Greenstone, Michael] Castle Hill Hosp, Cottingham HU16 5JQ, East Yorkshire, England; [Hack, Melissa] Royal Gwent Hosp, Newport NPT 2VB, Gwent, Wales	University of Hull; Royal Gwent Hospital	Greenstone, M (corresponding author), Castle Hill Hosp, Cottingham HU16 5JQ, East Yorkshire, England.	mike.greenstone@hey.nhs.uk						Anandam A, 2013, SLEEP BREATH, V17, P227, DOI 10.1007/s11325-012-0677-3; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Bonsignore MR, 2013, EUR RESPIR REV, V22, P353, DOI 10.1183/09059180.00003413; Browaldh N, 2013, THORAX, V68, P846, DOI 10.1136/thoraxjnl-2012-202610; Chung F, 2013, OBES SURG, V23, P2050, DOI 10.1007/s11695-013-1006-z; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Corral-Penafiel J, 2013, EUR RESPIR REV, V22, P312, DOI 10.1183/09059180.00004213; DEEGAN PC, 1995, EUR RESPIR J, V8, P1161, DOI 10.1183/09031936.95.08071161; DOUGLAS NJ, 1992, LANCET, V339, P347, DOI 10.1016/0140-6736(92)91660-Z; Driving and Vehicle Licensing Agency, 2013, OBSTR SLEEP APN SYND; Ferguson KA, 2006, SLEEP, V29, P244, DOI 10.1093/sleep/29.2.244; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Greenburg DL, 2009, AM J MED, V122, P535, DOI 10.1016/j.amjmed.2008.10.037; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Haniffa M, 2004, COCHRANE DB SYST REV, V4; Ip MSM, 2004, CHEST, V125, P127, DOI 10.1378/chest.125.1.127; Ip MSM, 2001, CHEST, V119, P62, DOI 10.1378/chest.119.1.62; Iranzo A, 2010, EUR RESPIR MONOGR, P17, DOI 10.1183/1025448x.00006710; Johansson K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3017; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; Lam JCM, 2010, EUR RESPIR MONOGR, P189, DOI 10.1183/1025448x.00024809; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Mason M, 2013, COCHRANE DB SYST REV, V5; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Medical Advisory Secretariat, 2009, Ont Health Technol Assess Ser, V9, P1; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Parati G, 2013, EUR RESPIR J, V41, P523, DOI 10.1183/09031936.00226711; Pedrosa RP, 2011, HYPERTENSION, V58, P811, DOI 10.1161/HYPERTENSIONAHA.111.179788; Peppard PE, 2000, NEW ENGL J MED, V58, P811; Scottish Intercollegiate Guidelines Network, 2003, MAN OBSTR SLEEP APN; Shneerson J, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002875; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Tuomilehto HPI, 2009, AM J RESP CRIT CARE, V179, P320, DOI 10.1164/rccm.200805-669OC; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	40	54	55	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g3745	10.1136/bmj.g3745	http://dx.doi.org/10.1136/bmj.g3745			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24939874				2022-12-28	WOS:000337804900010
J	Venn, O; Turner, I; Mathieson, I; de Groot, N; Bontrop, R; McVean, G				Venn, Oliver; Turner, Isaac; Mathieson, Iain; de Groot, Natasja; Bontrop, Ronald; McVean, Gil			NONHUMAN GENETICS Strong male bias drives germline mutation in chimpanzees	SCIENCE			English	Article							HUMAN-EVOLUTION; GENOME; HUMANS; NUCLEOTIDE; RATES; APES; MAP; DNA	Germline mutation determines rates of molecular evolution, genetic diversity, and fitness load. In humans, the average point mutation rate is 1.2 x 10(-8) per base pair per generation, with every additional year of father's age contributing two mutations across the genome and males contributing three to four times as many mutations as females. To assess whether such patterns are shared with our closest living relatives, we sequenced the genomes of a nine-member pedigree of Western chimpanzees, Pan troglodytes verus. Our results indicate a mutation rate of 1.2 x 10(-8) per base pair per generation, but a male contribution seven to eight times that of females and a paternal age effect of three mutations per year of father's age. Thus, mutation rates and patterns differ between closely related species.	[Venn, Oliver; Turner, Isaac; Mathieson, Iain; McVean, Gil] Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [de Groot, Natasja; Bontrop, Ronald] Biomed Primate Res Ctr, NL-2288 GJ Rijswijk, Netherlands	University of Oxford; Wellcome Centre for Human Genetics	McVean, G (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	mcvean@well.ox.ac.uk	Turner, Isaac/T-1092-2019; Bontrop, Ronald E/J-3628-2012	Bontrop, Ronald E/0000-0003-0874-6467; McVean, Gil/0000-0002-5012-4162; Turner, Isaac/0000-0002-2378-4886	Wellcome Trust [086786/Z/08/Z, 090532/Z/09/Z]; MRC hub grant [G0900747 91070]; MRC [G0900747] Funding Source: UKRI; Medical Research Council [G0900747] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by Wellcome Trust grants 086786/Z/08/Z to O.V. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics and by MRC hub grant G0900747 91070. We thank M. Przeworski and D. Reich for discussion and comments on the manuscript and A. Kong for providing data on request from reference (6). Samples were provided through the Transnational Access Activity in the European Primate Network (EUPRIM-NET) under the Convention on International Trade of Endangered Species (CITES) authorization and a Material Transfer Agreement between the University of Oxford and the Foundation Biomedical Primate Research Centre. Read-level data are accessible under SRA Study accession no. PRJEB5937 from www.ebi.ac.uk/ena/data/view/PRJEB5937. All other project data are available from ftp://birch.well.ox.ac.uk.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Hvilsom C, 2012, P NATL ACAD SCI USA, V109, P2054, DOI 10.1073/pnas.1106877109; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; MARSON J, 1991, BIOL REPROD, V44, P448, DOI 10.1095/biolreprod44.3.448; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Nachman MW, 2000, GENETICS, V156, P297; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2010, MOL ECOL, V19, P5332, DOI 10.1111/j.1365-294X.2010.04888.x; Presgraves DC, 2009, TRENDS ECOL EVOL, V24, P533, DOI 10.1016/j.tree.2009.04.007; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Short R.V., 1979, Advances in the Study of Behavior, V9, P131, DOI 10.1016/S0065-3454(08)60035-2; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060	24	86	86	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1272	1275		10.1126/science.344.6189.1272	http://dx.doi.org/10.1126/science.344.6189.1272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926018	Green Accepted			2022-12-28	WOS:000337077500038
J	Walker, C				Walker, Cathy			The fun of science	SCIENCE			English	Editorial Material																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1314	1314		10.1126/science.344.6189.1314	http://dx.doi.org/10.1126/science.344.6189.1314			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI7ND	24926023				2022-12-28	WOS:000337077500047
J	Rintoul, RC; Ritchie, AJ; Edwards, JG; Waller, DA; Coonar, AS; Bennett, M; Lovato, E; Hughes, V; Fox-Rushby, JA; Sharples, LD; Collaborators, M				Rintoul, Robert C.; Ritchie, Andrew J.; Edwards, John G.; Waller, David A.; Coonar, Aman S.; Bennett, Maxine; Lovato, Eleonora; Hughes, Victoria; Fox-Rushby, Julia A.; Sharples, Linda D.; Collaborators, MesoVATS			Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; EXTRAPLEURAL PNEUMONECTOMY; EUROPEAN-ORGANIZATION; PHASE-III; PLEURECTOMY/DECORTICATION; MANAGEMENT; MORTALITY; CISPLATIN; SURGERY	Background Malignant pleural mesothelioma incidence continues to rise, with few available evidence-based therapeutic options. Results of previous non-randomised studies suggested that video-assisted thoracoscopic partial pleurectomy (VAT-PP) might improve symptom control and survival. We aimed to compare efficacy in terms of overall survival, and cost, of VAT-PP and talc pleurodesis in patients with malignant pleural mesothelioma. Methods We undertook an open-label, parallel-group, randomised, controlled trial in patients aged 18 years or older with any subtype of confirmed or suspected mesothelioma with pleural effusion, recruited from 12 hospitals in the UK. Eligible patients were randomly assigned (1:1) to either VAT-PP or talc pleurodesis by computer-generated random numbers, stratified by European Organisation for Research and Treatment of Cancer risk category (high vs low). The primary outcome was overall survival at 1 year, analysed by intention to treat (all patients randomly assigned to a treatment group with a final diagnosis of mesothelioma). This trial is registered with ClinicalTrials.gov, number NCT00821860. Findings Between Oct 24, 2003, and Jan 24, 2012, we randomly assigned 196 patients, of whom 175 (88 assigned to talc pleurodesis, 87 assigned to VAT-PP) had confirmed mesothelioma. Overall survival at 1 year was 52% (95% CI 41-62) in the VAT-PP group and 57% (46-66) in the talc pleurodesis group (hazard ratio 1.04 [95% CI 0.76-1.42]; p=0.81). Surgical complications were significantly more common after VAT-PP than after talc pleurodesis, occurring in 24 (31%) of 78 patients who completed VAT-PP versus ten (14%) of 73 patients who completed talc pleurodesis (p=0.019), as were respiratory complications (19 [24%] vs 11 [15%]; p=0.22) and air-leak beyond 10 days (five [6%] vs one [1%]; p=0.21), although not significantly so. Median hospital stay was longer at 7 days (IQR 5-11) in patients who received VAT-PP compared with 3 days (2-5) for those who received talc pleurodesis (p<0.0001). Interpretation VAT-PP is not recommended to improve overall survival in patients with pleural effusion due to malignant pleural mesothelioma, and talc pleurodesis might be preferable considering the fewer complications and shorter hospital stay associated with this treatment.	[Rintoul, Robert C.; Hughes, Victoria; Sharples, Linda D.] Papworth Hosp, Dept Thorac Oncol, Cambridge CB3 8RE, England; [Ritchie, Andrew J.] Essex Cardiothorac Ctr, Basildon, England; [Edwards, John G.] No Gen Hosp, Dept Cardiothorac Surg, Sheffield S5 7AU, S Yorkshire, England; [Waller, David A.] Glenfield Gen Hosp, Dept Thorac Surg, Leicester LE3 9QP, Leics, England; [Coonar, Aman S.] Papworth Hosp, Dept Thorac Surg, Cambridge CB3 8RE, England; [Bennett, Maxine; Sharples, Linda D.] MRC Biostat Unit, Cambridge, England; [Lovato, Eleonora] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Sharples, Linda D.] Univ Leeds, Clin Trials Res Unit, Leeds LS2 9JT, W Yorkshire, England	Papworth Hospital; Northern General Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Papworth Hospital; MRC Biostatistics Unit; Brunel University; University of Leeds	Sharples, LD (corresponding author), Univ Leeds, Clin Trials Res Unit, Leeds LS2 9JT, W Yorkshire, England.	l.sharples@leeds.ac.uk	Rintoul, Robert Campbell/Q-1727-2015; Edwards, Jeff/P-9759-2016	Rintoul, Robert Campbell/0000-0003-3875-3780; Edwards, Jeff/0000-0001-7298-1889; Sharples, Linda/0000-0003-0894-966X; Lim, Eric/0000-0002-9078-3226; Fox-Rushby, Julia/0000-0003-0748-0871; Edwards, John/0000-0002-7935-5327	BUPA Foundation; MRC [MC_UP_1302/2, MC_U105232027] Funding Source: UKRI; Medical Research Council [MC_UP_1302/2, MC_U105232027] Funding Source: researchfish	BUPA Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	BUPA Foundation.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Antony VB, 2000, AM J RESP CRIT CARE, V162, P1987, DOI 10.1164/ajrccm.162.5.ats8-00; Antunes G, 2003, THORAX, V58, pII29, DOI 10.1136/thorax.58.suppl_2.ii29; Asbestos Diseases Research Institute, 2013, GUID DIAGN TREATM MA; Bielsa S, 2011, LUNG, V189, P151, DOI 10.1007/s00408-011-9283-6; Bottomley A, 2006, J CLIN ONCOL, V24, P1435, DOI 10.1200/JCO.2005.03.3027; Canto A, 1997, THORAC CARDIOV SURG, V45, P16, DOI 10.1055/s-2007-1013677; Cao C, 2013, LUNG CANCER, V81, P319, DOI 10.1016/j.lungcan.2013.04.024; Curran D, 1998, J CLIN ONCOL, V16, P145, DOI 10.1200/JCO.1998.16.1.145; Curtis L, 2015, UNIT COSTS HLTH SOCI; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Flores RM, 2008, J THORAC CARDIOV SUR, V135, P620, DOI 10.1016/j.jtcvs.2007.10.054; Fysh ETH, 2013, THORAX, V68, P594, DOI 10.1136/thoraxjnl-2012-203043; Halstead JC, 2005, EJSO, V31, P314, DOI 10.1016/j.ejso.2004.08.014; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; Kind P., 1996, QUAL LIFE PHARMACOEC, V25, P3110, DOI [10.1097/00007632-200012150-00005, DOI 10.1097/00007632-200012150-00005]; Lang-Lazdunski L, 2012, J THORAC ONCOL, V7, P737, DOI 10.1097/JTO.0b013e31824ab6c5; LYDICK E, 1995, QUAL LIFE RES, V4, P41, DOI 10.1007/BF00434382; Nakas A, 2008, EUR J CARDIO-THORAC, V33, P83, DOI 10.1016/j.ejcts.2007.09.039; PETO J, 1995, LANCET, V345, P535, DOI 10.1016/S0140-6736(95)90462-X; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Rahman NM, 2010, THORAX, V65, P54, DOI 10.1136/thx.2010.137018; Rice D, 2011, J THORAC ONCOL, V6, P1304, DOI 10.1097/JTO.0b013e3182208e3f; Rodriguez-Panadero F, 2012, RESPIRATION, V83, P91, DOI 10.1159/000335419; Rusch V W, 1995, Chest, V108, P1122; Teh E, 2011, J ROY SOC MED, V104, P69, DOI 10.1258/jrsm.2010.100345; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wiggins J, 2007, THORAX, V62, P1, DOI 10.1136/thx.2007.087619	30	136	137	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1118	1127		10.1016/S0140-6736(14)60418-9	http://dx.doi.org/10.1016/S0140-6736(14)60418-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	24942631	Green Submitted			2022-12-28	WOS:000342630600032
J	Robertson, P; Mahadevan, S; Endl, M; Roy, A				Robertson, Paul; Mahadevan, Suvrath; Endl, Michael; Roy, Arpita			Stellar activity masquerading as planets in the habitable zone of the M dwarf Gliese 581	SCIENCE			English	Article							RADIAL-VELOCITY VARIABILITY; LOW-MASS STARS; M-CIRCLE-PLUS; HARPS SEARCH; EXOPLANET	The M dwarf star Gliese 581 is believed to host four planets, including one (GJ 581d) near the habitable zone that could possibly support liquid water on its surface if it is a rocky planet. The detection of another habitable-zone planet-GJ 581g-is disputed, as its significance depends on the eccentricity assumed for d. Analyzing stellar activity using the Ha line, we measure a stellar rotation period of 130 +/- 2 days and a correlation for H alpha modulation with radial velocity. Correcting for activity greatly diminishes the signal of GJ 581d (to 1.5 standard deviations) while significantly boosting the signals of the other known super-Earth planets. GJ 581d does not exist, but is an artifact of stellar activity which, when incompletely corrected, causes the false detection of planet g.	[Robertson, Paul; Mahadevan, Suvrath; Roy, Arpita] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Robertson, Paul; Mahadevan, Suvrath; Roy, Arpita] Penn State Univ, Ctr Exoplanets & Habitable Worlds, University Pk, PA 16802 USA; [Mahadevan, Suvrath; Roy, Arpita] Penn State Univ, Penn State Astrobiol Res Ctr, University Pk, PA 16802 USA; [Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin	Robertson, P (corresponding author), Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA.	pmr19@psu.edu	Robertson, Paul/AEV-0522-2022	Robertson, Paul/0000-0003-0149-9678; Mahadevan, Suvrath/0000-0001-9596-7983; Roy, Arpita/0000-0001-8127-5775	NSF [AST-1006676, AST-1126413, AST-1310885, AST-1313075]; Penn State Astrobiology Research Center; NASA Astrobiology Institute [NNA09DA76A]; Center for Exoplanets and Habitable Worlds; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; NASA through the Origins of Solar Systems Program [NNX09AB30G]; Direct For Mathematical & Physical Scien [1006676, 1126413] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Penn State Astrobiology Research Center; NASA Astrobiology Institute; Center for Exoplanets and Habitable Worlds; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; NASA through the Origins of Solar Systems Program; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from NSF grants AST-1006676, AST-1126413, AST-1310885, The Penn State Astrobiology Research Center, and the NASA Astrobiology Institute (NNA09DA76A) in our pursuit of precise RVs in the near infrared. This work was supported by funding from the Center for Exoplanets and Habitable Worlds. The Center for Exoplanets and Habitable Worlds is supported by the Pennsylvania State University, the Eberly College of Science, and the Pennsylvania Space Grant Consortium. M. E. is supported by NASA through the Origins of Solar Systems Program grant NNX09AB30G and grant AST-1313075 from the NSF. This research has made use of the Keck Observatory Archive (KOA), which is operated by the W. M. Keck Observatory and the NASA Exoplanet Science Institute (NExScI), under contract with the National Aeronautics and Space Administration. We thank C. Bender for assistance in studying telluric absorption in the vicinity of Ha. The data produced for this study are included in table S3 of the supplementary materials.	Baluev RV, 2013, MON NOT R ASTRON SOC, V429, P2052, DOI 10.1093/mnras/sts476; Boisse I, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219115; Bonfils X, 2005, ASTRON ASTROPHYS, V443, pL15, DOI 10.1051/0004-6361:200500193; Bonfils X, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201014704; Diaz RF, 2007, MON NOT R ASTRON SOC, V378, P1007, DOI 10.1111/j.1365-2966.2007.11833.x; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Forveille T., 2011, ARXIV11092505; Gregory PC, 2011, MON NOT R ASTRON SOC, V415, P2523, DOI 10.1111/j.1365-2966.2011.18877.x; Hatzes AP, 2013, ASTRON NACHR, V334, P616, DOI 10.1002/asna.201311913; JEFFERYS WH, 1987, CELESTIAL MECH, V41, P39, DOI 10.1007/BF01238750; Joiner DA, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/160; Kopparapu RK, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L8; Kurster M, 2003, ASTRON ASTROPHYS, V403, P1077, DOI 10.1051/0004-6361:20030396; Lestrade JF, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220325; Mayor M, 2009, ASTRON ASTROPHYS, V507, P487, DOI 10.1051/0004-6361/200912172; Meschiari S, 2009, PUBL ASTRON SOC PAC, V121, P1016, DOI 10.1086/605730; Robertson P, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/3; Selsis F, 2007, ASTRON ASTROPHYS, V476, P1373, DOI 10.1051/0004-6361:20078091; Stassun KG, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/47; dos Santos MT, 2012, CELEST MECH DYN ASTR, V113, P49, DOI 10.1007/s10569-012-9407-1; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; Vogt SS, 2012, ASTRON NACHR, V333, P561, DOI 10.1002/asna.201211707; Vogt SS, 2010, ASTROPHYS J, V723, P954, DOI 10.1088/0004-637X/723/1/954; Wordsworth RD, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L48; Zechmeister M, 2009, ASTRON ASTROPHYS, V496, P577, DOI 10.1051/0004-6361:200811296	26	152	153	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					440	444		10.1126/science.1253253	http://dx.doi.org/10.1126/science.1253253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	24993348	Green Submitted			2022-12-28	WOS:000339655100040
J	Maldarelli, F; Wu, X; Su, L; Simonetti, FR; Shao, W; Hill, S; Spindler, J; Ferris, AL; Mellors, JW; Kearney, MF; Coffin, JM; Hughes, SH				Maldarelli, F.; Wu, X.; Su, L.; Simonetti, F. R.; Shao, W.; Hill, S.; Spindler, J.; Ferris, A. L.; Mellors, J. W.; Kearney, M. F.; Coffin, J. M.; Hughes, S. H.			Specific HIV integration sites are linked to clonal expansion and persistence of infected cells	SCIENCE			English	Article							CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; RESERVOIR; GENES; CURE; IDENTIFICATION; LYMPHOMAS; DYNAMICS; DNA	The persistence of HIV-infected cells in individuals on suppressive combination antiretroviral therapy (cART) presents a major barrier for curing HIV infections. HIV integrates its DNA into many sites in the host genome; we identified 2410 integration sites in peripheral blood lymphocytes of five infected individuals on cART. About 40% of the integrations were in clonally expanded cells. Approximately 50% of the infected cells in one patient were from a single clone, and some clones persisted for many years. There were multiple independent integrations in several genes, including MKL2 and BACH2; many of these integrations were in clonally expanded cells. Our findings show that HIV integration sites can play a critical role in expansion and persistence of HIV-infected cells.	[Maldarelli, F.; Simonetti, F. R.; Hill, S.; Spindler, J.; Ferris, A. L.; Kearney, M. F.; Hughes, S. H.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Wu, X.; Su, L.; Shao, W.] Leidos Biomed Res, Frederick, MD 21702 USA; [Simonetti, F. R.] Univ Milan, Dept Biomed & Clin Sci L Sacco, I-20122 Milan, Italy; [Mellors, J. W.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Coffin, J. M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; Luigi Sacco Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University	Hughes, SH (corresponding author), NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA.	hughesst@mail.nih.gov	Kearney, Mary/AAU-8132-2020; Maldarelli, Frank/O-2428-2016	Kearney, Mary/0000-0003-3839-6576	Federal funds from the National Cancer Institute, an NIH; National Cancer Institute [HSSN261200800001E, 25XS119]; American Cancer Society; F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE [ZIABC011426, R37CA089441, R01CA089441] Funding Source: NIH RePORTER	Federal funds from the National Cancer Institute, an NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are indebted to the study participants and to the clinical staff of the National Institute of Allergy and Infectious Diseases/Critical Care Medicine Department clinic who cared for them. We thank C. Lane, H. Malech, H. Imamichi, S. Matsushita, and L. Frenkel for stimulating discussions. We are grateful to J. Meyer and A. Kane for help with the figures and T. Burdette for help in preparing the manuscript. The data presented in this work is tabulated in the main paper and in the supplementary materials. The integration sites are compiled in table S3; the data can also be accessed using the National Center for Biotechnology Information accession no. PRJNA241020. Funding for this research was provided with Federal funds from the National Cancer Institute, an NIH Bench to Bedside award (F. M.), and by funds from the National Cancer Institute under contract HSSN261200800001E (X. W. and L. S.). J. M. C. was supported by a Research Professorship from the American Cancer Society with additional support from the F. M. Kirby Foundation and by funding from the National Cancer Institute (Leidos contract 25XS119). J. W. M. was supported by funding from the National Cancer Institute (Leidos contract 25XS119). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; De Ravin S. S., 2014, J VIROL; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Flucke U, 2013, HISTOPATHOLOGY, V62, P925, DOI 10.1111/his.12100; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; HERNDIER BG, 1992, BLOOD, V79, P1768; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Imamichi H., 2014, AIDS; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Katano H, 2007, MICROBES INFECT, V9, P1581, DOI 10.1016/j.micinf.2007.09.008; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kobayashi S, 2011, GENE CHROMOSOME CANC, V50, P207, DOI 10.1002/gcc.20845; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Mack KD, 2003, JAIDS-J ACQ IMM DEF, V33, P308, DOI 10.1097/00126334-200307010-00004; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Palmer S, 2011, J INTERN MED, V270, P550, DOI 10.1111/j.1365-2796.2011.02457.x; Rosenberg N., 1997, P475; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SHIRAMIZU B, 1994, CANCER RES, V54, P2069; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	29	532	540	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					179	183		10.1126/science.1254194	http://dx.doi.org/10.1126/science.1254194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	24968937	Green Accepted			2022-12-28	WOS:000339409900044
J	Burns, CG; Burns, CE				Burns, C. Geoffrey; Burns, Caroline E.			A crowning achievement for deciphering coronary origins	SCIENCE			English	Editorial Material							ENDOTHELIAL-CELLS; ARTERIES; FORM		[Burns, C. Geoffrey; Burns, Caroline E.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Burns, C. Geoffrey; Burns, Caroline E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Burns, C. Geoffrey; Burns, Caroline E.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University	Burns, CG (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.	cburns6@mgh.harvard.edu						Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Fuster V., 2013, HURSTS HEART, V13th; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Kumar V, 2009, ROBBINS COTRAN PATHO; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Satpathy MMBR., 2008, CLIN DIAGNOSIS CONGE; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Tomanek RJ, 1996, CARDIOVASC RES, V31, pE46; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023	13	3	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					28	29		10.1126/science.1256866	http://dx.doi.org/10.1126/science.1256866			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994633				2022-12-28	WOS:000338284400032
J	Iversen, L; Tu, HL; Lin, WC; Christensen, SM; Abel, SM; Iwig, J; Wu, HJ; Gureasko, J; Rhodes, C; Petit, RS; Hansen, SD; Thill, P; Yu, CH; Stamou, D; Chakraborty, AK; Kuriyan, J; Groves, JT				Iversen, Lars; Tu, Hsiung-Lin; Lin, Wan-Chen; Christensen, Sune M.; Abel, Steven M.; Iwig, Jeff; Wu, Hung-Jen; Gureasko, Jodi; Rhodes, Christopher; Petit, Rebecca S.; Hansen, Scott D.; Thill, Peter; Yu, Cheng-Han; Stamou, Dimitrios; Chakraborty, Arup K.; Kuriyan, John; Groves, Jay T.			Ras activation by SOS: Allosteric regulation by altered fluctuation dynamics	SCIENCE			English	Article							SINGLE-MOLECULE; SIGNAL-TRANSDUCTION; ENZYME CATALYSIS; PLASMA-MEMBRANE; HISTONE DOMAIN; SEVENLESS; CELL; PROTEINS; TIME; AUTOINHIBITION	Activation of the small guanosine triphosphatase H-Ras by the exchange factor Son of Sevenless (SOS) is an important hub for signal transduction. Multiple layers of regulation, through protein and membrane interactions, govern activity of SOS. We characterized the specific activity of individual SOS molecules catalyzing nucleotide exchange in H-Ras. Single-molecule kinetic traces revealed that SOS samples a broad distribution of turnover rates through stochastic fluctuations between distinct, long-lived (more than 100 seconds), functional states. The expected allosteric activation of SOS by Ras-guanosine triphosphate (GTP) was conspicuously absent in the mean rate. However, fluctuations into highly active states were modulated by Ras-GTP. This reveals a mechanism in which functional output may be determined by the dynamical spectrum of rates sampled by a small number of enzymes, rather than the ensemble average.	[Iversen, Lars; Tu, Hsiung-Lin; Lin, Wan-Chen; Christensen, Sune M.; Wu, Hung-Jen; Petit, Rebecca S.; Hansen, Scott D.; Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Abel, Steven M.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Iwig, Jeff; Gureasko, Jodi; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rhodes, Christopher] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Thill, Peter; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Yu, Cheng-Han; Groves, Jay T.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Stamou, Dimitrios] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Groves, Jay T.] Berkeley Educ Alliance Res Singapore, Singapore 138602, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); National University of Singapore; University of Copenhagen; University of Copenhagen; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Groves, JT (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Tu, Hsiung-Lin/B-6814-2018; Stamou, Dimitrios/D-5042-2016; Yu, Cheng-han/K-8732-2013; Iversen, Lars/C-5298-2011; Wu, Hung-Jen/H-3769-2016	Tu, Hsiung-Lin/0000-0003-1125-1879; Stamou, Dimitrios/0000-0001-8456-8995; Yu, Cheng-han/0000-0002-8821-8877; Iversen, Lars/0000-0002-1314-130X; Wu, Hung-Jen/0000-0003-3082-7431; Abel, Steven/0000-0003-0491-8647; Christensen, Sune/0000-0001-9650-6660	NIH [P01 AI091580]; Danish Council for Independent Research, Natural Sciences; Mechanobiology Institute, National University of Singapore; Berkeley Education Alliance for Research in Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Mechanobiology Institute, National University of Singapore(National University of Singapore); Berkeley Education Alliance for Research in Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Major support was provided by NIH P01 AI091580. Additional support was provided by the Danish Council for Independent Research, Natural Sciences (L. I., S. M. C., and D. S.), by the Mechanobiology Institute, National University of Singapore (C.-H.Y. and J.T.G.), and by the Berkeley Education Alliance for Research in Singapore (J.T.G.). L. I., H.-L. T., W.-C. L., and J.T.G. planned and designed the research; H.-L. T. and L. I. performed experiments and analyzed data; S. M. C. and W.-C. L. assisted with experiments; H.-L. T., S. M. C., and H.-J.W. developed algorithms for data analysis; H.-L. T., S. M. A., and P. T. performed stochastic simulations; J.I., J.G., and S. D. H. prepared proteins; C.-H.Y., C. R., and R. S. P. prepared patterned substrates; L. I., H.-L. T., and J.T.G. wrote the manuscript; J.T.G. supervised the project. All authors commented on the manuscript.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Ensign DL, 2010, J PHYS CHEM B, V114, P280, DOI 10.1021/jp906786b; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Prakash MK, 2007, P NATL ACAD SCI USA, V104, P15982, DOI 10.1073/pnas.0707859104; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	43	85	87	1	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					50	54		10.1126/science.1250373	http://dx.doi.org/10.1126/science.1250373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994643	Green Accepted			2022-12-28	WOS:000338284400045
J	Pekkurnaz, G; Trinidad, JC; Wang, XN; Kong, D; Schwarz, TL				Pekkurnaz, Gulcin; Trinidad, Jonathan C.; Wang, Xinnan; Kong, Dong; Schwarz, Thomas L.			Glucose Regulates Mitochondrial Motility via Milton Modification by O-GlcNAc Transferase	CELL			English	Article							AXONAL-TRANSPORT; PHOSPHORYLATION; PROTEIN; BRAIN; GLYCOSYLATION; DYNAMICS; NEURONS; IDENTIFICATION; GLCNACYLATION; LOCALIZATION	Cells allocate substantial resources toward monitoring levels of nutrients that can be used for ATP generation by mitochondria. Among the many specialized cell types, neurons are particularly dependent on mitochondria due to their complex morphology and regional energy needs. Here, we report a molecular mechanism by which nutrient availability in the form of extracellular glucose and the enzyme O-GlcNAc Transferase (OGT), whose activity depends on glucose availability, regulates mitochondrial motility in neurons. Activation of OGT diminishes mitochondrial motility. We establish the mitochondrial motor-adaptor protein Milton as a required substrate for OGT to arrest mitochondrial motility by mapping and mutating the key O-GlcNAcylated serine residues. We find that the GlcNAcylation state of Milton is altered by extracellular glucose and that OGT alters mitochondrial motility in vivo. Our findings suggest that, by dynamically regulating Milton GlcNAcylation, OGT tailors mitochondrial dynamics in neurons based on nutrient availability.	[Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Univ, Boston Childrens Hosp, F M Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA; [Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Trinidad, Jonathan C.] Indiana Univ, Dept Chem, Biol Mass Spectrometry Facil, Bloomington, IN 47405 USA; [Wang, Xinnan] Stanford Univ, Dept Neurosurg, Stanford, CA 94304 USA; [Kong, Dong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Schwarz, TL (corresponding author), Harvard Univ, Boston Childrens Hosp, F M Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu	Trinidad, Jonathan/GWR-2077-2022	Pekkurnaz, Gulcin/0000-0002-7388-6178	IDDRC Molecular Genetics and Imaging Cores [P30HD18655]; Ellison Medical Foundation;  [K01DK094943];  [P30DK46200];  [5R01GM069808-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, K01DK094943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	IDDRC Molecular Genetics and Imaging Cores; Ellison Medical Foundation(Lawrence Ellison Foundation); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the gift of plasmid constructs from Drs. P. Aspenstrom for myc-hMiro1/2; G. Hajnoczky for Mito-DsRed; G. W. Hart for OGT and Xpress-hMilton1; X. Yang for eGFP-OGT; H. T. Cline for Syp-CFP; M. Sahin for scrambled shRNA; M. J. Reginato for OGT shRNA; K. J. Verhey for KHC-mCit; and M. Greenberg for pEGFP-N1. We thank S. Vasquez, K. Pereira, K. Apaydin, and Dr. M. Sahin's laboratory for assistance with primary hippocampal neuron cultures; X. Ho, E. Ling, and Y. Guo for technical assistance; L. Ding from Harvard NeuroDiscovery Center, Enhanced Neuroimaging Core for assistance with development of Kymolyzer; the IDDRC Molecular Genetics and Imaging Cores (grant number P30HD18655). We also thank Drs. M. Banghart, R. Cartoni, M. A. Cronin, B. Lowell, G. Yellen, and M. Tantama and A. Nasser and M. Hamilton for support and valuable input. D. K. was supported by K01DK094943 and P30DK46200. This work was supported by 5R01GM069808-08 and the Ellison Medical Foundation.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Dash MB, 2013, J NEUROCHEM, V124, P79, DOI 10.1111/jnc.12063; Fort AG, 2011, J BIOL CHEM, V286, P22875, DOI 10.1074/jbc.M111.219709; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Huang CW, 2007, J NEUROSCI RES, V85, P1468, DOI 10.1002/jnr.21284; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Ji S, 2011, AMINO ACIDS, V40, P809, DOI 10.1007/s00726-010-0698-9; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li Y, 2009, J CELL BIOL, V185, P1065, DOI 10.1083/jcb.200811033; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Lopez-Domenech G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1829; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Matthews JA, 2007, MOL CELL BIOCHEM, V298, P109, DOI 10.1007/s11010-006-9358-5; Nie DY, 2012, METHODS MOL BIOL, V821, P393, DOI 10.1007/978-1-61779-430-8_25; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Peppiatt C, 2004, NATURE, V431, P137, DOI 10.1038/431137a; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; SILVER IA, 1994, J NEUROSCI, V14, P5068; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	50	171	174	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					54	68		10.1016/j.cell.2014.06.007	http://dx.doi.org/10.1016/j.cell.2014.06.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995978	Bronze, Green Accepted			2022-12-28	WOS:000340943100007
J	Phillippe, M				Phillippe, Mark			Cell-free Fetal DNA - A Trigger for Parturition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MATERNAL PLASMA; PRENATAL-DIAGNOSIS		Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Phillippe, M (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.							[Anonymous], 1998, AM J HUM GENET, V62, P768; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Khosrotehrani K, 2004, HUM REPROD, V19, P2460, DOI 10.1093/humrep/deh445; Leung TN, 1999, LANCET, V354, P780; Majer S, 2007, PRENATAL DIAG, V27, P1219, DOI 10.1002/pd.1875; Mitsunaga F, 2010, EXP ANIM TOKYO, V59, P255, DOI 10.1538/expanim.59.255; Scharfe-Nugent A, 2012, J IMMUNOL, V188, P5706, DOI 10.4049/jimmunol.1103454	7	50	54	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2534	2536		10.1056/NEJMcibr1404324	http://dx.doi.org/10.1056/NEJMcibr1404324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963574				2022-12-28	WOS:000337804400014
J	Yong, E				Yong, Ed			FIRST RESPONSE Race against time	NATURE			English	Editorial Material																		Fassbender K, 2003, STROKE, V34, pE44, DOI 10.1161/01.STR.0000075573.22885.3B; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Silke W., 2012, LANCET NEUROL, V11, P397	4	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S5	S5		10.1038/510S5a	http://dx.doi.org/10.1038/510S5a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964025				2022-12-28	WOS:000337806300004
J	Ahrends, R; Ota, A; Kovary, KM; Kudo, T; Park, BO; Teruel, MN				Ahrends, Robert; Ota, Asuka; Kovary, Kyle M.; Kudo, Takamasa; Park, Byung Ouk; Teruel, Mary N.			Controlling low rates of cell differentiation through noise and ultrahigh feedback	SCIENCE			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; STEM-CELLS; DEDIFFERENTIATION; ADIPOGENESIS; EXPRESSION; DYNAMICS; BIOLOGY; BINDING	Mammalian tissue size is maintained by slow replacement of de-differentiating and dying cells. For adipocytes, key regulators of glucose and lipid metabolism, the renewal rate is only 10% per year. We used computational modeling, quantitative mass spectrometry, and single-cell microscopy to show that cell-to-cell variability, or noise, in protein abundance acts within a network of more than six positive feedbacks to permit pre-adipocytes to differentiate at very low rates. This reconciles two fundamental opposing requirements: High cell-to-cell signal variability is needed to generate very low differentiation rates, whereas low signal variability is needed to prevent differentiated cells from de-differentiating. Higher eukaryotes can thus control low rates of near irreversible cell fate decisions through a balancing act between noise and ultrahigh feedback connectivity.	[Ahrends, Robert; Ota, Asuka; Kovary, Kyle M.; Kudo, Takamasa; Park, Byung Ouk; Teruel, Mary N.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Teruel, MN (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mteruel@stanford.edu		Teruel, Mary/0000-0002-2854-3598; Ahrends, Robert/0000-0003-0232-3375; Kovary, Kyle/0000-0002-7616-2968	Stanford University New Faculty Startup Funds; NIH [P50GM107615]; Deutsche Forschungsgemeinschaft Fellowship [AH 220/1-1]; American Heart Association Fellowship [13POST17090092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	Stanford University New Faculty Startup Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Fellowship(German Research Foundation (DFG)); American Heart Association Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Meyer, S. Collins, G. Anderson, S. Spencer, together with members of the Teruel lab, for thoughtful comments and discussions. This work is supported by Stanford University New Faculty Startup Funds and NIH P50GM107615 (M.N.T.), Deutsche Forschungsgemeinschaft Fellowship AH 220/1-1 (R. A.), and American Heart Association Fellowship 13POST17090092 (A.O.).	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Berry DC, 2013, DEVELOPMENT, V140, P3939, DOI 10.1242/dev.080549; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Kim HE, 2013, BIOCHEM J, V453, P49, DOI 10.1042/BJ20121598; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Palani S, 2012, CELL REP, V1, P215, DOI 10.1016/j.celrep.2012.01.007; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tchoukalova YD, 2004, AM J PHYSIOL-REG I, V287, pR1132, DOI 10.1152/ajpregu.00337.2004; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	29	57	57	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1384	1389		10.1126/science.1252079	http://dx.doi.org/10.1126/science.1252079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948735	Green Accepted			2022-12-28	WOS:000337531700037
J	Cho, A				Cho, Adrian			COMPUTER SCIENCE Quantum or not, controversial computer yields no speedup	SCIENCE			English	News Item																			0	9	9	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1330	1331		10.1126/science.344.6190.1330	http://dx.doi.org/10.1126/science.344.6190.1330			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948715				2022-12-28	WOS:000337531700012
J	Audet, P; Burgmann, R				Audet, Pascal; Buergmann, Roland			Possible control of subduction zone slow-earthquake periodicity by silica enrichment	NATURE			English	Article							NON-VOLCANIC TREMOR; NEW-ZEALAND; NORTHERN CASCADIA; EPISODIC TREMOR; SOUTHERN MEXICO; KM DEPTH; SLIP; QUARTZ; VELOCITY; CRUSTAL	Seismic and geodetic observations in subduction zone forearcs indicate that slow earthquakes, including episodic tremor and slip, recur at intervals of less than six months to more than two years(1,2). In Cascadia, slow slip is segmented along strike(3) and tremor data show a gradation from large, infrequent slip episodes to small, frequent slip events with increasing depth of the plate interface(4). Observations(5-7) and models(8,9) of slow slip and tremor require the presence of near-lithostatic pore-fluid pressures in slow-earthquake source regions; however, direct evidence of factors controlling the variability in recurrence times is elusive. Here we compile seismic data from subduction zone forearcs exhibiting recurring slow earthquakes and show that the average ratio of compressional (P)-wave velocity to shear (S)-wave velocity (v(P)/v(S)) of the overlying forearc crust ranges between 1.6 and 2.0 and is linearly related to the average recurrence time of slow earthquakes. In northern Cascadia, forearc v(P)/v(S) values decrease with increasing depth of the plate interface and with decreasing tremor-episode recurrence intervals. Low v(P)/v(S) values require a large addition of quartz in a mostly mafic forearc environment(10,11). We propose that silica enrichment varying from 5 per cent to 15 per cent by volume from slab-derived fluids and upward mineralization in quartz veins(12) can explain the range of observed v(P)/v(S) values as well as the downdip decrease in v(P)/v(S). The solubility of silica depends on temperature(13), and deposition prevails near the base of the forearc crust(11). We further propose that the strong temperature dependence of healing and permeability reduction in silica-rich fault gouge via dissolution-precipitation creep(14) can explain the reduction in tremor recurrence time with progressive silica enrichment. Lower gouge permeability at higher temperatures leads to faster fluid overpressure development and low effective fault-normal stress, and therefore shorter recurrence times. Our results also agree with numerical models of slip stabilization under fault zone dilatancy strengthening(15) caused by decreasing fluid pressure as pore space increases. This implies that temperature-dependent silica deposition, permeability reduction and fluid overpressure development control dilatancy and slow-earthquake behaviour.	[Audet, Pascal] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Buergmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Buergmann, Roland] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA	University of Ottawa; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Audet, P (corresponding author), Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada.	pascal.audet@uottawa.ca	Burgmann, Roland/AAE-5138-2022	Burgmann, Roland/0000-0002-3560-044X; Audet, Pascal/0000-0003-2364-9454	Natural Science and Engineering Research Council (Canada); Miller Institute for Basic Research in Science (University of California, Berkeley)	Natural Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Miller Institute for Basic Research in Science (University of California, Berkeley)(University of California System)	Data used in this study come from the Japan Meteorological Agency, New Zealand National Seismograph Network, and the Tectonic Observatory (Caltech). Funding for this work comes from the Natural Science and Engineering Research Council (Canada) and the Miller Institute for Basic Research in Science (University of California, Berkeley). We thank N. Beeler, A. Rubin and P. Ampuero for discussions and comments.	Ansell JH, 1996, PHYS EARTH PLANET IN, V93, P3, DOI 10.1016/0031-9201(95)03085-9; Audet P, 2013, NAT GEOSCI, V6, P852, DOI 10.1038/ngeo1927; Audet P, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006053; Audet P, 2009, NATURE, V457, P76, DOI 10.1038/nature07650; Beroza GC, 2011, ANNU REV EARTH PL SC, V39, P271, DOI 10.1146/annurev-earth-040809-152531; Breeding CM, 2002, GEOLOGY, V30, P499, DOI 10.1130/0091-7613(2002)030<0499:SDFAQV>2.0.CO;2; Brudzinski MR, 2007, GEOLOGY, V35, P907, DOI 10.1130/G23740A.1; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; Dempsey DE, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009218; DeShon HR, 2006, GEOPHYS J INT, V164, P109, DOI [10.1111/j.1365-246X.2005.02809.x, 10.1111/j.1365-246X.2005.02809.X]; Fisher DM, 2014, J STRUCT GEOL, V69, P395, DOI 10.1016/j.jsg.2014.03.010; Frederiksen AW, 2000, GEOPHYS J INT, V141, P401, DOI 10.1046/j.1365-246x.2000.00090.x; Frederiksen AW, 2003, GEOPHYS J INT, V155, P200, DOI 10.1046/j.1365-246X.2003.02043.x; Giger SB, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004828; Hansen RTJ, 2012, EARTH PLANET SC LETT, V337, P25, DOI 10.1016/j.epsl.2012.05.031; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Heki K, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005739; Huesca-Perez E, 2012, GEOFIS INT, V51, P281; Jiang Y, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004058; KERN H, 1982, PHYS EARTH PLANET IN, V29, P12, DOI 10.1016/0031-9201(82)90133-9; Liu YJ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004930; Liu YJ, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50298; Lowry AR, 2006, NATURE, V442, P802, DOI 10.1038/nature05055; Lowry AR, 2011, NATURE, V471, P353, DOI 10.1038/nature09912; MANNING CE, 1994, GEOCHIM COSMOCHIM AC, V58, P4831, DOI 10.1016/0016-7037(94)90214-3; Matsubara M, 2009, TECTONOPHYSICS, V472, P6, DOI 10.1016/j.tecto.2008.06.013; Obara K, 2011, J GEODYN, V52, P229, DOI 10.1016/j.jog.2011.04.002; Peacock SM, 2011, GEOLOGY, V39, P471, DOI 10.1130/G31649.1; Pollitz FF, 2013, J GEOPHYS RES-SOL EA, V118, P2445, DOI 10.1002/jgrb.50181; Ramachandran K, 2012, SOLID EARTH, V3, P121, DOI 10.5194/se-3-121-2012; Reyners M, 2006, GEOPHYS J INT, V165, P565, DOI 10.1111/j.1365-246X.2006.02897.x; Schwartz SY, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000208; Segall P, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007449; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Shen ZK, 2005, B SEISMOL SOC AM, V95, P2009, DOI 10.1785/0120050020; Sillitoe RH, 2008, ECON GEOL, V103, P663, DOI 10.2113/gsecongeo.103.4.663; Song TRA, 2009, SCIENCE, V324, P502, DOI 10.1126/science.1167595; Vergnolle M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006852; Wada I, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005190; Wallace LM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007717; Wech AG, 2011, NAT GEOSCI, V4, P624, DOI 10.1038/ngeo1215	41	131	131	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					389	+		10.1038/nature13391	http://dx.doi.org/10.1038/nature13391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24943955				2022-12-28	WOS:000337350200033
J	Schottker, B; Jorde, R; Peasey, A; Thorand, B; Jansen, EHJM; de Groot, L; Streppel, M; Gardiner, J; Ordonez-Mena, JM; Perna, L; Wilsgaard, T; Rathmann, W; Feskens, E; Kampman, E; Siganos, G; Njolstad, I; Mathiesen, EB; Kubinova, R; Pajak, A; Topor-Madry, R; Tamosiunas, A; Hughes, M; Kee, F; Bobak, M; Trichopoulou, A; Boffetta, P; Brenner, H				Schoettker, Ben; Jorde, Rolf; Peasey, Anne; Thorand, Barbara; Jansen, Eugene H. J. M.; de Groot, Lisette; Streppel, Martinette; Gardiner, Julian; Ordonez-Mena, Jose Manuel; Perna, Laura; Wilsgaard, Tom; Rathmann, Wolfgang; Feskens, Edith; Kampman, Ellen; Siganos, Galatios; Njolstad, Inger; Mathiesen, Ellisiv Bogeberg; Kubinova, Ruzena; Pajak, Andrzej; Topor-Madry, Roman; Tamosiunas, Abdonas; Hughes, Maria; Kee, Frank; Bobak, Martin; Trichopoulou, Antonia; Boffetta, Paolo; Brenner, Hermann		Consortium Hlth Ageing Network	Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERUM 25-HYDROXYVITAMIN D; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; MONICA/KORA AUGSBURG; RISK; POPULATION; CANCER; HORMONE; EASTERN; EVENTS	Objective To investigate the association between serum 25-hydroxyvitamin D concentrations (25(OH) D) and mortality in a large consortium of cohort studies paying particular attention to potential age, sex, season, and country differences. Design Meta-analysis of individual participant data of eight prospective cohort studies from Europe and the US. Setting General population. Participants 26 018 men and women aged 50-79 years Main outcome measures All-cause, cardiovascular, and cancer mortality. Results 25(OH) D concentrations varied strongly by season (higher in summer), country (higher in US and northern Europe) and sex (higher in men), but no consistent trend with age was observed. During follow-up, 6695 study participants died, among whom 2624 died of cardiovascular diseases and 2227 died of cancer. For each cohort and analysis, 25(OH) D quintiles were defined with cohort and subgroup specific cut-off values. Comparing bottom versus top quintiles resulted in a pooled risk ratio of 1.57 (95% CI 1.36 to 1.81) for all-cause mortality. Risk ratios for cardiovascular mortality were similar in magnitude to that for all-cause mortality in subjects both with and without a history of cardiovascular disease at baseline. With respect to cancer mortality, an association was only observed among subjects with a history of cancer (risk ratio, 1.70 (1.00 to 2.88)). Analyses using all quintiles suggest curvilinear, inverse, dose-response curves for the aforementioned relationships. No strong age, sex, season, or country specific differences were detected. Heterogeneity was low in most meta-analyses. Conclusions Despite levels of 25(OH) D strongly varying with country, sex, and season, the association between 25(OH) D level and all-cause and cause-specific mortality was remarkably consistent. Results from a long term randomised controlled trial addressing longevity are being awaited before vitamin D supplementation can be recommended in most individuals with low 25(OH) D levels.	[Schoettker, Ben; Ordonez-Mena, Jose Manuel; Perna, Laura; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Jorde, Rolf] Univ Tromso UiT, Dept Clin Med, Tromso Endocrine Res Grp, N-9037 Tromso, Norway; [Jorde, Rolf] Univ Hosp North Norway, Div Internal Med, N-9038 Tromso, Norway; [Peasey, Anne; Gardiner, Julian; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Thorand, Barbara] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Jansen, Eugene H. J. M.] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [de Groot, Lisette; Streppel, Martinette; Feskens, Edith; Kampman, Ellen] Wageningen Univ, Div Human Nutr, NL-6700 EV Wageningen, Netherlands; [Ordonez-Mena, Jose Manuel] Heidelberg Univ, NAR, Heidelberg, Germany; [Wilsgaard, Tom; Siganos, Galatios; Njolstad, Inger] UiT, Dept Community Med, Epidemiol Chron Dis Res Grp, N-9037 Tromso, Norway; [Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, Inst Biometr & Epidemiol, German Diabet Ctr, D-40225 Dusseldorf, Germany; [Mathiesen, Ellisiv Bogeberg] UiT, Dept Clin Med, Brain & Circulat Res Grp, N-9037 Tromso, Norway; [Kubinova, Ruzena] Natl Inst Publ Hlth, Prague, Czech Republic; [Pajak, Andrzej; Topor-Madry, Roman] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Krakow, Poland; [Tamosiunas, Abdonas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Hughes, Maria; Kee, Frank] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; [Trichopoulou, Antonia; Boffetta, Paolo] Hellen Hlth Fdn, Athens 11527, Greece; [Trichopoulou, Antonia] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Helmholtz Association; German Cancer Research Center (DKFZ); UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of London; University College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Ruprecht Karls University Heidelberg; UiT The Arctic University of Tromso; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; UiT The Arctic University of Tromso; National Institute of Public Health (SZU) - Czech Republic; Jagiellonian University; Collegium Medicum Jagiellonian University; Lithuanian University of Health Sciences; Queens University Belfast; Athens Medical School; National & Kapodistrian University of Athens; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Schottker, B (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	b.schoettker@dkfz.de	TRICHOPOULOU, ANTONIA/ABF-8727-2021; Brenner, Hermann/ABE-6383-2020; Tamosiunas, Abdonas/AAD-4274-2021; Gardiner, Julian/AAO-2583-2020; Ordónez-Mena, José M./I-6787-2017; Boffetta, Paolo/AAI-7767-2021; Feskens, Edith/ABI-1446-2020; Topor-Madry, Roman/ABF-5449-2020; Brenner, Hermann/B-4627-2017; Thorand, Barbara/B-5349-2014; Schöttker, Ben/F-8183-2014; Kampman, E./H-8057-2014; Njolstad, Inger/X-3784-2019	TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Brenner, Hermann/0000-0002-6129-1572; Ordónez-Mena, José M./0000-0002-8965-104X; Boffetta, Paolo/0000-0002-3811-2791; Feskens, Edith/0000-0001-5819-2488; Brenner, Hermann/0000-0002-6129-1572; Thorand, Barbara/0000-0002-8416-6440; Schöttker, Ben/0000-0002-1217-4521; de Groot, Lisette/0000-0003-2778-2789; Peasey, Anne/0000-0001-7434-2079; Bobak, Martin/0000-0002-2633-6851; Hughes, Maria/0000-0002-2364-7152	CHANCES project funded in the FP7 framework programme of DG-RESEARCH in the European Commission [242244]; Baden-Wurttemberg state Ministry of Science, Research and Arts (Stuttgart, Germany); Federal Ministry of Education and Research (Berlin, Germany); Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany); German Cancer Aid [108250, 108426]; Norwegian Research Council; Helmholtz Zentrum Munchen; German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Federal Ministry of Education and Research; German Research Foundation [TH-784/2-1, TH-784/2-2]; Federal Ministry of Health; University of Ulm; German Diabetes Center; Ministry of Innovation, Science, Research, and Technology of the state North Rhine Westphalia; CHANCES; EU; Welcome Trust [064947, 081081]; US National Institute on Ageing [R01 AG23522-01]; Mac Arthur Foundation; MRC [MR/K023241/1, G0601463] Funding Source: UKRI; Medical Research Council [G0601463, MC_CF023241, MR/K023241/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER	CHANCES project funded in the FP7 framework programme of DG-RESEARCH in the European Commission; Baden-Wurttemberg state Ministry of Science, Research and Arts (Stuttgart, Germany); Federal Ministry of Education and Research (Berlin, Germany)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany); German Cancer Aid(Deutsche Krebshilfe); Norwegian Research Council(Research Council of NorwayEuropean Commission); Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health - German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Health; University of Ulm; German Diabetes Center; Ministry of Innovation, Science, Research, and Technology of the state North Rhine Westphalia; CHANCES; EU(European Commission); Welcome Trust(Wellcome Trust); US National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mac Arthur Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This analysis was part of the CHANCES project funded in the FP7 framework programme of DG-RESEARCH in the European Commission (Grant No 242244). The CHANCES project is coordinated by the Hellenic Health Foundation, Greece. Further funding sources of participating cohorts: The ESTHER study was funded by the Baden-Wurttemberg state Ministry of Science, Research and Arts (Stuttgart, Germany), the Federal Ministry of Education and Research (Berlin, Germany) and the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany). Measurements of 25(OH) D in men were conducted in the context of the German Cancer Aid project number 108250 and 108426. The Tromso Study was performed by the University of Tromso in cooperation with the National Health Screening Service. The study was funded by the Norwegian Research Council. The MONICA/KORA Augsburg cohort study was financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria and supported by grants from the German Federal Ministry of Education and Research. Additional funds for the present study were provided by the German Research Foundation (TH-784/2-1 and TH-784/2-2), the Federal Ministry of Health, the University of Ulm, the German Diabetes Center and the Ministry of Innovation, Science, Research, and Technology of the state North Rhine Westphalia. For this analysis, data of the MONICA/KORA Augsburg study were provided by the MORGAM Data Centre, at THL in Helsinki, Finland. CHANCES funding was used for data coding and transfer. The SENECA study was funded as a Concerted Action within the EURONUT programme of the EU. The HAPIEE study was funded by the Welcome Trust (064947 and 081081), the US National Institute on Ageing (R01 AG23522-01), and a grant from Mac Arthur Foundation. The study's funders played no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were independent from the funders.	Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; BJELAKOVIC G, 2014, COCHRANE DB SYST REV, P7469, DOI [10.1002/14651858.cd007470.pub3, DOI 10.1002/14651858.CD007470.PUB3]; Boylan S, 2011, PUBLIC HEALTH NUTR, V14, P678, DOI 10.1017/S1368980010002570; Brouwer-Brolsma EM, 2013, OSTEOPOROSIS INT, V24, P1567, DOI 10.1007/s00198-012-2231-3; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Chang EM, 2014, J CLIN ENDOCR METAB; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, 2011, DIET REF INT CALC VI; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Geskus RB, 2011, BIOMETRICS, V67, P39, DOI 10.1111/j.1541-0420.2010.01420.x; Holick MF, 2010, PUBLIC HEALTH REV, V32, P267, DOI 10.1007/BF03391602; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karakas M, 2013, J CLIN ENDOCR METAB, V98, P272, DOI 10.1210/jc.2012-2368; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Kohl M, 2012, PSHREG SAS MACRO PRO; Kupferschmidt K, 2012, SCIENCE, V337, P1476, DOI 10.1126/science.337.6101.1476; Maalmi H, 2014, EUR J CANCER, V50, P1510, DOI 10.1016/j.ejca.2014.02.006; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Mosekilde L, 2005, CLIN ENDOCRINOL, V62, P265, DOI 10.1111/j.1365-2265.2005.02226.x; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Schottker B, 2013, AM J CLIN NUTR, V97, P782, DOI 10.3945/ajcn.112.047712; Schottker B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048774; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Thorand B, 2011, DIABETES CARE, V34, P2320, DOI 10.2337/dc11-0775; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Yin L, 2013, PREV MED, V57, P753, DOI 10.1016/j.ypmed.2013.08.026; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	36	252	259	0	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g3656	10.1136/bmj.g3656	http://dx.doi.org/10.1136/bmj.g3656			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24938302	Green Published, hybrid			2022-12-28	WOS:000337804900002
J	Simon, G				Simon, Gregory			In treatment-resistant depression, adding cognitive-behavioral therapy to usual care was cost-effective at 1 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Grp Hlth Res Inst, Seattle, WA 98101 USA		Simon, G (corresponding author), Grp Hlth Res Inst, Seattle, WA 98101 USA.							Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Simon GE, 2013, JAMA INTERN MED, V173, P1004, DOI 10.1001/jamainternmed.2013.925; Simon GE, 2009, ARCH GEN PSYCHIAT, V66, P1081, DOI 10.1001/archgenpsychiatry.2009.123	4	1	1	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC13	10.7326/0003-4819-160-12-201406170-02013	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935507				2022-12-28	WOS:000337374900013
J	Weedon-Fekjaer, H; Romundstad, PR; Vatten, LJ				Weedon-Fekjaer, Harald; Romundstad, Pal R.; Vatten, Lars J.			Modern mammography screening and breast cancer mortality: population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NORWAY; REGISTRY; QUALITY; TRENDS; IMPACT	Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening. Conclusion Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.	[Weedon-Fekjaer, Harald; Romundstad, Pal R.; Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7491 Trondheim, Norway; [Weedon-Fekjaer, Harald] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Weedon-Fekjaer, Harald] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Vatten, Lars J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Weedon-Fekjaer, H (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7491 Trondheim, Norway.	harald.weedon-fekjar@medisin.uio.no	Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; Weedon-Fekjær, Harald/B-6900-2008	Weedon-Fekjær, Harald/0000-0002-9109-0034; Romundstad, Pal Richard/0000-0003-2061-4336	Norwegian Research Council [189503]; NATIONAL CANCER INSTITUTE [U01CA152958] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Norwegian Research Council (reference No 189503).	Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.012077; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], IARC HDB CANC PREV H; Ascunce EN, 2007, J MED SCREEN, V14, P14, DOI 10.1258/096914107780154558; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; CISNET. Cancer Intervention and Surveillance Modeling Network, 2012, CANC INT SURV MOD NE; Clarke M, 1998, LANCET, V351, P1451; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Falk RS, 2013, INT J CANCER, V133, P705, DOI 10.1002/ijc.28052; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Hakama M, 1997, BRIT MED J, V314, P864; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Hofvind S, 2013, CANCER-AM CANCER SOC, V119, P3106, DOI 10.1002/cncr.28174; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lynge E, 2011, ACTA ONCOL, V50, P1062, DOI 10.3109/0284186X.2011.599339; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Moss SM, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.012079; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Olsen AH, 2007, EPIDEMIOLOGY, V18, P487, DOI 10.1097/EDE.0b013e318060cbbd; Olsen AH, 2013, INT J CANCER, V132, P208, DOI 10.1002/ijc.27609; Paci E, 2002, EUR J CANCER, V38, P568, DOI 10.1016/S0959-8049(01)00382-3; Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Weedon-Fekjaer H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e299; Welch HG, 2010, NEW ENGL J MED, V363, P1276, DOI 10.1056/NEJMe1008369	31	92	99	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g3701	10.1136/bmj.g3701	http://dx.doi.org/10.1136/bmj.g3701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24951459	Green Published, hybrid			2022-12-28	WOS:000337804900001
J	Renfrew, MJ; McFadden, A; Bastos, MH; Campbell, J; Channon, AA; Cheung, NF; Silva, DRAD; Downe, S; Kennedy, HP; Malata, A; McCormick, F; Wick, L; Declercq, E				Renfrew, Mary J.; McFadden, Alison; Bastos, Maria Helena; Campbell, James; Channon, Andrew Amos; Cheung, Ngai Fen; Audebert Delage Silva, Deborah Rachel; Downe, Soo; Kennedy, Holly Powell; Malata, Address; McCormick, Felicia; Wick, Laura; Declercq, Eugene			Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care	LANCET			English	Article							CESAREAN-SECTION RATES; LOW-RISK WOMEN; CANADIAN MIDWIFERY; COST-EFFECTIVENESS; BIRTH ATTENDANTS; LOW-INCOME; HEALTH; DELIVERY; MORTALITY; COUNTRIES	In this first paper in a series of four papers on midwifery, we aimed to examine, comprehensively and systematically, the contribution midwifery can make to the quality of care of women and infants globally, and the role of midwives and others in providing midwifery care. Drawing on international definitions and current practice, we mapped the scope of midwifery. We then developed a framework for quality maternal and newborn care using a mixed-methods approach including synthesis of findings from systematic reviews of women's views and experiences, effective practices, and maternal and newborn care providers. The framework differentiates between what care is provided and how and by whom it is provided, and describes the care and services that childbearing women and newborn infants need in all settings. We identified more than 50 short-term, medium-term, and long-term outcomes that could be improved by care within the scope of midwifery; reduced maternal and neonatal mortality and morbidity, reduced stillbirth and preterm birth, decreased number of unnecessary interventions, and improved psychosocial and public health outcomes. Midwifery was associated with more efficient use of resources and improved outcomes when provided by midwives who were educated, trained, licensed, and regulated. Our findings support a system-level shift from maternal and newborn care focused on identification and treatment of pathology for the minority to skilled care for all. This change includes preventive and supportive care that works to strengthen women's capabilities in the context of respectful relationships, is tailored to their needs, focuses on promotion of normal reproductive processes, and in which first-line management of complications and accessible emergency treatment are provided when needed. Midwifery is pivotal to this approach, which requires effective interdisciplinary teamwork and integration across facility and community settings. Future planning for maternal and newborn care systems can benefit from using the quality framework in planning workforce development and resource allocation.	[Renfrew, Mary J.; McFadden, Alison] Univ Dundee, Coll Med Dent & Nursing, Sch Nursing & Midwifery, Mother & Infant Res Unit, Dundee DD1 4HJ, Scotland; [Bastos, Maria Helena] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Campbell, James] Inst Cooperac Social Integrare, Barcelona, Spain; [Channon, Andrew Amos] Univ Southampton, Fac Social & Human Sci, Div Social Stat & Demog, Southampton, Hants, England; [Cheung, Ngai Fen] Maternal & Child Hlth Assoc China, Midwifery Expert Comm, Beijing, Peoples R China; [Audebert Delage Silva, Deborah Rachel] Parto Principio Mulheres Rede Pela Maternidade At, Sao Caetano do Sul, Brazil; [Downe, Soo] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England; [Kennedy, Holly Powell] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Malata, Address] Univ Malawi, Kamuzu Coll Nursing, Lilongwe, Malawi; [McCormick, Felicia] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Wick, Laura] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel; [Declercq, Eugene] Boston Univ, Sch Publ Hlth, Community Hlth Sci, Boston, MD USA	University of Dundee; Pan American Health Organization; University of Southampton; University of Central Lancashire; Yale University; University of Malawi; University of York - UK; Birzeit University; Boston University	Renfrew, MJ (corresponding author), Univ Dundee, Coll Med Dent & Nursing, Sch Nursing & Midwifery, Mother & Infant Res Unit, Dundee DD1 4HJ, Scotland.	m.renfrew@dundee.ac.uk	Bastos, Maria Helena/AAS-3664-2020	Bastos, Maria Helena/0000-0002-1001-1083; Channon, Andrew/0000-0003-4855-0418; Cheung, Ngai Fen/0000-0002-2246-3925; Renfrew, Mary/0000-0003-2905-403X; McFadden, Alison/0000-0002-5164-2025	Bill and Melinda Gates Foundation [OPP1042500]; University of York; University of Dundee	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of York(European Commission); University of Dundee	The work on this paper was supported partly through a grant from the Bill and Melinda Gates Foundation to the University of York and the University of Dundee (grant number OPP1042500), and additional support from the University of York and the University of Dundee. The funding organisations had no role in the undertaking of the analysis and synthesis of the findings of this report. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers or the Bill and Melinda Gates Foundation. Thomson Prentice was the technical editor for the Lancet Series on Midwifery. Project support was provided by Natalie Muir, and administrative support by Jenny Brown and Tracy Sparey. Julie Glanville from the York Health Economics Consortium led the literature searches, and the Midwives Information and Resource Service (MIDIRS) supported the search work. Mari Tikkanen and her colleagues from M4ID produced figure 2. Marcos Dias contributed to the analysis and classification of the systematic reviews. Linda Orr and Jenna Breckenridge contributed to the review of meta-syntheses. We thank the close readers and colleagues who made helpful contributions: Olaya Astudillo, Agneta Bridges, Mariam Claeson, Bernadette Daelmans, Frances Day-Stirk, Declan Devane, France Donnay, Elizabeth Duff, Frances Ganges, Atf Gherissi, Wendy Graham, Metin Gulmezoglu, Kathy Herschderfer, Elizabeth Mason, Blerta Maliqi, Matthews Mathai, Zoe Mullan, Frances McConville, Jennifer McNeil, Mary Newburn, Hermen Ormel, Kerreen Reiger, Severin Ritter von Xylander, Arul Sabaratnam, Kerri Schuiling, Kate Somers, Kate Teela, Joyce Thompson, and Cathy Warwick. All co-authors of the Lancet Series on Midwifery contributed to the concepts and commented on drafts of this paper. Members of the Lancet Series on Midwifery Helicopter Group made important additional contributions: Vincent Fauveau, Nester Moyo, Susan Murray, and Veronica Walford. Other members of the Lancet Series on Midwifery Executive Group made important contributions throughout the writing of this paper: Luc de Bernis, Helga Fogstad, Caroline S E Homer, Zoe Matthews, and Petra ten Hoope-Bender.	Aasheim V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006672.pub2; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; Alderdice F, 2013, MIDWIFERY, V29, P389, DOI 10.1016/j.midw.2012.05.010; Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub2; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD003755.PUB2; [Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; [Anonymous], 2013, MILL DEV GOALS REP 2; [Anonymous], 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000225; [Anonymous], 2005, COCHRANE DATABASE SY; Australian Health Ministers Conference, 2011, AUSTR HLTH MIN C NAT; Basevi V, 2001, COCHRANE DB SYST REV, V4; Beck CT, 2004, NURS RES, V53, P216, DOI 10.1097/00006199-200407000-00004; BECKMANN MM, 2006, COCHRANE DB SYST REV, V1; Begley CM, 2011, COCHRANE DB SYST REV, V11; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bourgeault IL, 2000, SOCIOL HEALTH ILL, V22, P172, DOI 10.1111/1467-9566.00198; [Brasil Ministerio da Saude Ministerio da Saude], 2012, SAUD BRAS 2011 AN SI; Brocklehurst P., 2002, COCHRANE DB SYST REV; Brocklehurst P, 2000, COCHRANE DB SYST REV, V4; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Buppasiri P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007079.pub2; Carroli G, 2009, COCHRANE DB SYST REV, V01, DOI [10.1002/14651858.CD000081.pub2, DOI 10.1002/14651858.CD000081.PUB2]; Cheung NF, 2009, EVIDENCE BASED MIDWI, V7, P101; Cheung Ngai, 2011, PROMOTING NORMAL BIR, P190; Cheung NF, 2009, MIDWIFERY, V25, P744, DOI 10.1016/j.midw.2008.01.009; Chou D, 2013, COCHRANE DB SYST REV, V1; Cluett ER, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000111.pub3; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub2; Conrad P, 2010, SOC SCI MED, V70, P1943, DOI 10.1016/j.socscimed.2010.02.019; COTTER A, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001808, DOI 10.1002/14651858.CD001808]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Crowther C, 2000, COCHRANE DB SYST REV, V2; Crowther CA, 2013, COCHRANE DB SYST REV, V2; Crowther CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000110.pub2; Dare MR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005302.pub2; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Das J, 2012, SOC SCI MED, V75, P1660, DOI 10.1016/j.socscimed.2012.06.018; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; DeJong J, 2012, PUBLIC HEALTH IN THE ARABWORLD, P249; DEMICHELI V, 2005, COCHRANE DB SYST REV, V4, P2959, DOI DOI 10.1002/14651858.CD2959.PDBC; Dennett Sue, 2002, Health Serv J, V112, P24; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Deussen AR, 2011, COCHRANE DB SYST REV, V5; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Dodd J, 2004, COCHRANE DB SYST REV, V4; dos Santos ML, 2010, REV TEMPUS ACTAS SAU, V4, P17; Dowswell T, 2010, COCHRANE DB SYST REV, V8; Dowswell T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub2; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Duley L, 2010, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD000128.PUB2; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000127.pub2; Dyson L, 2005, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001688.PUB2; Engel C., 2003, NZ COLL MIDWIVES J, V21, P12; Entwistle V, 2012, J HEALTH SERV RES PO, V17, P70, DOI 10.1258/jhsrp.2011.011029; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; French L.M., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001067.PUB2; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Gibbons L, 2010, 30 WHO; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Green JM, 2012, BIRTH-ISS PERINAT C, V39, P291, DOI 10.1111/birt.12003; Gulmezoglu AM, 2011, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD000220.PUB2; Haider BA, 2012, COCHRANE DB SYST REV, V11; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hassan-Bitar S, 2011, MIDWIFERY, V27, P154, DOI 10.1016/j.midw.2009.05.007; Hedayati H, 2003, COCHRANE DB SYST REV, V3; Hodnett E, 2012, COCHRANE DB SYST REV, V10; Hodnett ED, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000012.pub4; Hodnett ED, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000198.pub2; Hofmeyr GJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub3; Hofmeyr GJ, 2002, COCHRANE DB SYST REV, V1; Hofmeyr GJ, 2012, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD.(000083.PUB2); Homer CSE, 2009, MIDWIFERY, V25, P673, DOI 10.1016/j.midw.2007.11.003; Homer CSE, 2014, LANCET; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000010.pub3; Hunter S, 2007, COCHRANE DB SYST REV, V4; Hutton EK, 2009, BIRTH-ISS PERINAT C, V36, P180, DOI 10.1111/j.1523-536X.2009.00322.x; International Confederation of Midwives, 2013, ESS COMP BAS MIDW PR; International Confederation of Midwives (ICM), 2017, DEF MIDW INT CONF; International ICF, 2012, MEAS DHS STATCOMPILE; International Institute for Population Sciences (IIPS) Macro International Inc, 2006, IND DEM HLTH SURV 20; International Labour Office, 2012, INT STAND CLASS OCC, VI; Jaafar SH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007202.pub3; Jewell D. J., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001142, DOI 10.1002/14651858.CD001142]; Jin M., 2009, JILIN MED J, V3, P198; Johanson R, 2002, BRIT MED J, V324, P892, DOI 10.1136/bmj.324.7342.892; Kavanagh J, 2005, COCHRANE DB SYST REV, V3; Kettle C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000947.pub3; Khan-Neelofur D, 1998, PAEDIATR PERINAT EP, V12, P7, DOI 10.1046/j.1365-3016.12.s2.6.x; Klomp T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009351.pub2; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Koblinsky M, 2012, J HEALTH POPUL NUTR, V30, P124, DOI 10.3329/jhpn.v30i2.11294; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Lauzon L, 2001, COCHRANE DB SYST REV, V3; Lawrence A, 2009, COCHRANE DB SYST REV, V2; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Liabsuetrakul T, 2007, COCHRANE DB SYST REV, V2; Lopez LM, 2012, COCHRANE DB SYST REV, V15; Loudon I., 1992, DEATH CHILDBIRTH INT; Lu X., 2012, CHINA CAESAREAN SECT; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Malott AM, 2009, J OBSTET GYNAECOL CA, V31, P974, DOI 10.1016/S1701-2163(16)34328-6; Mander R, 2010, J CLIN NURS, V19, P517, DOI 10.1111/j.1365-2702.2009.02849.x; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Mason Frances, 2013, SUPERFOOD BABIES OVE; Mavalankar D, 2011, MIDWIFERY, V27, P700, DOI 10.1016/j.midw.2010.05.010; Mills J., 2001, COCHRANE DB SYST REV, V1; Mori R., 2012, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD000230.PUB4:; Mori R., 2012, COCHRANE DB SYST REV, V3; Murray S, 1996, MIDWIVES SAFER MOTHE, P89; Nardin JM, 2011, COCHRANE DB SYST REV, V5; National Department of Health, 2009, MIN TASKF MAT HLTH P; Oliveira-Menegozzo JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005944.pub2; Ota E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub2; Pang R., 2012, CHINE J NURS ED, V7, P293; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009997; Pennick VE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001139.pub2; Perkins BB, 2003, MED DELIVERY BUSINES; Petticrew M, 2003, J EPIDEMIOL COMMUN H, V57, P527, DOI 10.1136/jech.57.7.527; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2013, WORLD POP PROSP 2012; Renfrew MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub4; Requejo J, 2012, COUNTDOWN 2015 MATER; Reveiz L, 2013, COCHRANE DB SYST REV, V7; Royal College of Obstetricians and Gynaecologists Royal College of Midwives Royal College of Anaesthetists Royal College of Paediatrics and Child Health, 2007, MIN STAND ORG DEL CA; Rumbold A, 2011, COCHRANE DB SYST REV, V1; Ryan P, 2013, MIDWIFERY, V29, P368, DOI 10.1016/j.midw.2012.02.005; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Sandall J, 2010, J MIDWIFERY WOM HEAL, V55, P255, DOI 10.1016/j.jmwh.2010.02.002; Save the Children, 2013, STAT WORLDS MOTH; Seneviratne HR, 2000, INT J GYNECOL OBSTET, V70, P113, DOI 10.1016/S0020-7292(00)00223-X; Shaban I, 2012, MIDWIFERY, V28, P106, DOI 10.1016/j.midw.2010.11.012; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; Sharma B, 2013, MIDWIFERY, V29, P628, DOI 10.1016/j.midw.2012.05.008; Shepperd S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000086; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Singh S, 2009, ADDING IT COSTS BENE; Siriwachirachai T, 2010, COCHRANE DB SYST REV, V12; Smaill F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub2; Smith CA, 2011, COCHRANE DB SYST REV, V7; Smith CA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009290.pub2; Smith CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009514; Smyth RM, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD14006167.PUB14651854.; Soltani H, 2011, COCHRANE DB SYST REV, V9; Soltani H, 2010, COCHRANE DB SYST REV, V8; Souza ASR, 2010, FEMINA, V38, P506; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Steer PJ, 2009, LANCET, V374, P675, DOI 10.1016/S0140-6736(09)61544-0; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Sturt AS, 2010, COCHRANE DB SYST REV, V3; Su LL, 2012, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005457.PUB3; Sufang G, 2007, B WORLD HEALTH ORGAN, V85, P755, DOI 10.2471/BLT.06.035808; Suwannachat B, 2012, COCHRANE DB SYST REV, V8; Swadpanich U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006178.pub2; The Cochrane Collaboration Pregnancy and Childbirth Group, 2014, REV PUBL COCHR LIB; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; Tuncalp O, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000494.pub4; UNFPA, 2011, STAT WORLDS MIDW 201; UNFPA, 2007, MAT MORT UPD 2006 EX; UNFPA International Confederation of Midwives WHO, 2010, GLOB CALL ACT STRENG; UNICEF, 2012, STAT WORLDS CHILDR 2; UNICEF, 2017, LEVELS TRENDS CHILD; UNICEF, 2010, 2009 COV EV SURV ALL; UNICEF WHO, 2013, EV NEWB ACT PLAN END; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; Van Lerberghe W, 2014, LANCET; van Teijlingen E, 2009, SOCIOL RES ONLINE, V14; Vazquez JC, 2011, COCHRANE DB SYST REV, V1; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2008, MON BUILD BLOCKS HLT; WHO, 2002, STRAT DIR STRENGTH N; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Wilson A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7102; World Health Organization, 2006, QUAL CAR PROC MAK ST; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; 杨雪峰, 2002, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V18, P45	193	574	586	8	125	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1129	1145		10.1016/S0140-6736(14)60789-3	http://dx.doi.org/10.1016/S0140-6736(14)60789-3			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965816				2022-12-28	WOS:000342630600034
J	Mok, TSK; Loong, HH				Mok, Tony S. K.; Loong, Herbert H.			A REVELation in non-small-cell lung cancer treatment?	LANCET			English	Editorial Material							ENDOTHELIAL GROWTH-FACTOR; PHASE-III; BEVACIZUMAB; CHEMOTHERAPY; TRIAL; COMBINATION; CARBOPLATIN; MUTATIONS; DOCETAXEL		[Mok, Tony S. K.; Loong, Herbert H.] Chinese Univ Hong Kong, Dept Clin Oncol, Fac Med, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; State Key Lab Oncology South China	Mok, TSK (corresponding author), Chinese Univ Hong Kong, Dept Clin Oncol, Fac Med, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China.	tony@clo.cuhk.edu.hk	Mok, Tony Shu Kam/B-2310-2019; Loong, Herbert/J-5413-2017	Mok, Tony Shu Kam/0000-0002-8251-0551; Loong, Herbert/0000-0002-6607-1106				Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; Garon EB, 2014, LANCET; Jubb AM, 2006, J CLIN ONCOL, V24, P217, DOI 10.1200/JCO.2005.01.5388; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miles DW, 2013, BRIT J CANCER, V108, P1052, DOI 10.1038/bjc.2013.69; Mok T, 2014, J THORAC ONCOL, V9, P848, DOI 10.1097/JTO.0000000000000160; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824	12	4	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					640	642		10.1016/S0140-6736(14)60895-3	http://dx.doi.org/10.1016/S0140-6736(14)60895-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	24933331				2022-12-28	WOS:000341359100007
J	Dal-Re, R; Ndebele, P; Higgs, E; Sewankambo, N; Wendler, D				Dal-Re, Rafael; Ndebele, Paul; Higgs, Elizabeth; Sewankambo, Nelson; Wendler, David			Protections for clinical trials in low and middle income countries need strengthening not weakening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OBLIGATIONS; PROVISION; BENEFITS; WORLD		[Dal-Re, Rafael] Univ Autonoma Madrid, BUC Biosci UAM CSIC Program, E-28049 Madrid, Spain; [Ndebele, Paul] Med Res Council Zimbabwe, Harare, Zimbabwe; [Higgs, Elizabeth] NIAID, Div Clin Res, Off Director, NIH, Bethesda, MD 20892 USA; [Sewankambo, Nelson] Makerere Univ, Coll Hlth Sci, Makerere, Uganda; [Wendler, David] NIH, Unit Vulnerable Populat, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	Autonomous University of Madrid; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Dal-Re, R (corresponding author), Univ Autonoma Madrid, BUC Biosci UAM CSIC Program, Int Campus Excellence, E-28049 Madrid, Spain.	Rafael.dalre@fuam.uam.es		Sewankambo, Nelson/0000-0001-9362-053X; Ndebele, Paul/0000-0001-9669-1544				[Anonymous], 2002, SCIENCE, V298, P2133; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Arrowsmith J, 2012, NAT REV DRUG DISCOV, V11, P17, DOI 10.1038/nrd3630; Ballantyne AJ, 2010, AM J BIOETHICS, V10, P26, DOI 10.1080/15265161.2010.482629; Casarett D, 2001, IRB, V23, P1, DOI 10.2307/3563676; Cohen ERM, 2009, DEV WORLD BIOETH, V9, P74, DOI 10.1111/j.1471-8847.2008.00233.x; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Department of Health Education and Welfare, 1979, FED REGISTER, V44, P192; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Duijnhoven RG, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001407; Emanuel EJ, 2005, LANCET, V366, P336, DOI 10.1016/S0140-6736(05)66992-9; Emmanuel Ezekiel J., 2008, OXFORD TXB CLIN RES, P719; Gbadegesin S, 2006, BIOETHICS, V20, P248, DOI 10.1111/j.1467-8519.2006.00501.x; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Lavery JV, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-384; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; London Alex John, 2010, Hastings Cent Rep, V40, P34; Medical Ethics Committee, 2013, WORLD MED J, V59, P169; Medical Research Council, 2004, MRC ETH GUID RES INV; Megan B, 2012, J EVAL CLIN PRACT, V18, P209, DOI 10.1111/j.1365-2753.2010.01553.x; Millum J, 2013, JAMA-J AM MED ASSOC, V310, P2143, DOI 10.1001/jama.2013.281632; National Bioethics Advisory Commission, 2001, ETH POL ISS INT RES; Osrin D, 2009, B WORLD HEALTH ORGAN, V87, P772, DOI 10.2471/BLT.08.051060; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Ramjee G, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-10; Taylor HA, 2012, DEV WORLD BIOETH, V12, P157, DOI 10.1111/j.1471-8847.2012.00333.x; Wertheimer A, 2008, J MED ETHICS, V34, P389, DOI 10.1136/jme.2007.021857; *WORLD MED ASS, 2000, DECL HELS ETH PRINC; *WORLD MED ASS, 2004, CLAR DECL HELS; World Medical Association, 2008, DECL HELS ETH PRINC; World Medical Association, 2013, DECL HELS ETH PRINC; World Medical Association Declaration of Helsinki Working Group, 2013, REV TEXT PU IN PRESS; Zong ZY, 2008, J MED ETHICS, V34, P188, DOI 10.1136/jme.2006.018754	33	13	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2014	349								g4254	10.1136/bmj.g4254	http://dx.doi.org/10.1136/bmj.g4254			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK7ZK	24996885	Green Published			2022-12-28	WOS:000338646700001
J	Curran, KA				Curran, Kelly A.			Too Much Information - The Ethics of Self-Disclosure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Adolescent Med, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Curran, KA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Adolescent Med, Oklahoma City, OK 73190 USA.								0	4	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					8	9		10.1056/NEJMp1404119	http://dx.doi.org/10.1056/NEJMp1404119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK2RA	24988554				2022-12-28	WOS:000338265700004
J	Fara, P				Fara, Patricia			A temporary liberation	NATURE			English	Editorial Material									Univ Cambridge, Clare Coll, Cambridge CB2 1TN, England	University of Cambridge	Fara, P (corresponding author), Univ Cambridge, Clare Coll, Cambridge CB2 1TN, England.	pf10006@cam.ac.uk							0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					25	27		10.1038/511025a	http://dx.doi.org/10.1038/511025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24999506	Bronze			2022-12-28	WOS:000338199400016
J	Jones, C; Pollit, V; Fitzmaurice, D; Cowan, C				Jones, Clare; Pollit, Vicki; Fitzmaurice, David; Cowan, Campbell		Guideline Dev Grp	The management of atrial fibrillation: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTICOAGULANTS; STROKE; RISK		[Jones, Clare; Pollit, Vicki] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Fitzmaurice, David] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Cowan, Campbell] Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England	Royal College of Physicians; University of Birmingham; Leeds General Infirmary; University of Leeds	Jones, C (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	clare.jones@rcplondon.ac.uk						Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cowan C, 2013, HEART, V99, P1166, DOI 10.1136/heartjnl-2012-303472; GRADE Working Group, GRAD REC ASS DEV EV; Holt TA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656856; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lord J, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17580; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; National Institute for Health and Care Excellence, 2012, RIV PREV STROK SYST, V256; National Institute for Health and Care Excellence, 2012, DAB ET PREV STROK SY; National Institute for Health and Care Excellence, 2013, DEV NICE CLIN GUID; National Institute for Health and Care Excellence, 2013, SUPP COMM ANT THER; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS MAN V, VCG144; National Institute for Health and Care Excellence, 2014, NICE CLIN GUID; National Institute for Health and Care Excellence, 2013, AP PREV STROK SYST E; National Institute for Health and Care Excellence, 2012, PAT EXP AD NHS SERV; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236	18	56	62	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2014	348								g3655	10.1136/bmj.g3655	http://dx.doi.org/10.1136/bmj.g3655			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LH	24948694	Green Published			2022-12-28	WOS:000337805800007
J	Lancaster, T				Lancaster, Tim			In pregnant smokers, the nicotine patch did not increase abstinence or birthweight more than placebo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Lancaster, T (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.			Lancaster, Timothy Ross/0000-0002-0580-1099					0	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC11	10.7326/0003-4819-160-12-201406170-02011	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935505				2022-12-28	WOS:000337374900011
J	Chai, WX; Ho, MGR				Chai, Wanxing; Ho, Michael Gong-Ruey			Disseminated varicella zoster virus encephalitis	LANCET			English	Editorial Material									[Chai, Wanxing] Tufts Univ, Sch Med, Lahey Hosp & Med Ctr, Burlington, MA 01805 USA; [Ho, Michael Gong-Ruey] Tufts Univ, Sch Med, Carney Hosp, Boston, MA 02111 USA	Lahey Hospital & Medical Center; Tufts University; Tufts University	Chai, WX (corresponding author), Tufts Univ, Sch Med, Lahey Hosp & Med Ctr, 41 Mall Rd, Burlington, MA 01805 USA.	wanxing.chai_ho@tufts.edu							0	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1698	1698		10.1016/S0140-6736(14)60755-8	http://dx.doi.org/10.1016/S0140-6736(14)60755-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	24999086				2022-12-28	WOS:000345116200032
J	Bakaeen, FG; Blaustein, A; Kibbe, MR				Bakaeen, Faisal G.; Blaustein, Alvin; Kibbe, Melina R.			Health Care at the VA Recommendations for Change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bakaeen, Faisal G.] Texas Heart Inst, Div Cardiovasc Surg, Michael E DeBakey Vet Affairs Med Ctr, Dept Cardiovasc Surg, Houston, TX 77025 USA; [Bakaeen, Faisal G.] Baylor Coll Med, Div Cardiothorac Surg, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Blaustein, Alvin] Michael E DeBakey VA Med Ctr, Div Cardiol, Houston, TX 77030 USA; [Blaustein, Alvin] Baylor Coll Med, Dept Med, Div Cardiol, Houston, TX 77030 USA; [Kibbe, Melina R.] Jesse Brown Vet Affairs Med Ctr, Surg Serv, Chicago, IL USA; [Kibbe, Melina R.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA	Texas Heart Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine	Bakaeen, FG (corresponding author), Michael E DeBakey VA Med Ctr, OCL 112,2002 Holcombe Blvd, Houston, TX 77030 USA.	fbakaeen@bcm.edu						Centers for Disease Control and Prevention, NAT HLTH EXP AV ANN; Chumbler NR, 2011, MED CARE, V49, pS36, DOI 10.1097/MLR.0b013e3181d558f9; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; National Center for Veterans Analysis and Statistics, 2013, TRENDS UT VA PROGR S; Oppel Jr Richard A., 2014, NY TIMES; Veterans Health Administration, INT REP REV PAT WAIT	6	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					481	482		10.1001/jama.2014.8054	http://dx.doi.org/10.1001/jama.2014.8054			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	24945974				2022-12-28	WOS:000339808600012
J	Bernier, R; Golzio, C; Xiong, B; Stessman, HA; Coe, BP; Penn, O; Witherspoon, K; Gerdts, J; Baker, C; Vulto-van Silfhout, AT; Schuurs-Hoeijmakers, JH; Fichera, M; Bosco, P; Buono, S; Alberti, A; Failla, P; Peeters, H; Steyaert, J; Vissers, LELM; Francescatto, L; Mefford, HC; Rosenfeld, JA; Bakken, T; O'Roak, BJ; Pawlus, M; Moon, R; Shendure, J; Amaral, DG; Lein, E; Rankin, J; Romano, C; de Vries, BBA; Katsanis, N; Eichler, EE				Bernier, Raphael; Golzio, Christelle; Xiong, Bo; Stessman, Holly A.; Coe, Bradley P.; Penn, Osnat; Witherspoon, Kali; Gerdts, Jennifer; Baker, Carl; Vulto-van Silfhout, Anneke T.; Schuurs-Hoeijmakers, Janneke H.; Fichera, Marco; Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Failla, Pinella; Peeters, Hilde; Steyaert, Jean; Vissers, Lisenka E. L. M.; Francescatto, Ludmila; Mefford, Heather C.; Rosenfeld, Jill A.; Bakken, Trygve; O'Roak, Brian J.; Pawlus, Matthew; Moon, Randall; Shendure, Jay; Amaral, David G.; Lein, Ed; Rankin, Julia; Romano, Corrado; de Vries, Bert B. A.; Katsanis, Nicholas; Eichler, Evan E.			Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development	CELL			English	Article							DE-NOVO MUTATIONS; HEART-DISEASE; GENE; ABNORMALITIES; EXPRESSION; CHILDREN; 16P11.2; PROTEIN; RISK	Autism spectrum disorder (ASD) is a heterogeneous disease in which efforts to define subtypes behaviorally have met with limited success. Hypothesizing that genetically based subtype identification may prove more productive, we resequenced the ASD-associated gene CHD8 in 3,730 children with developmental delay or ASD. We identified a total of 15 independent mutations; no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings. In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints. chd8 disruption in zebrafish recapitulates features of the human phenotype, including increased head size as a result of expansion of the forebrain/midbrain and impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons. Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.	[Bernier, Raphael; Gerdts, Jennifer] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Golzio, Christelle; Francescatto, Ludmila; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Xiong, Bo; Coe, Bradley P.; Penn, Osnat; Witherspoon, Kali; Baker, Carl; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Vulto-van Silfhout, Anneke T.; Schuurs-Hoeijmakers, Janneke H.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Fichera, Marco; Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Failla, Pinella; Romano, Corrado] IRCCS Associaz Oasi Maria Santissima, I-94018 Troina, Italy; [Fichera, Marco] Univ Catania, I-95123 Catania, Italy; [Peeters, Hilde] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Peeters, Hilde; Steyaert, Jean] Leuven Autism Res LAuRes, B-3000 Leuven, Belgium; [Steyaert, Jean] Katholieke Univ Leuven, Dept Child & Adolescent Psychiat, B-3000 Leuven, Belgium; [Steyaert, Jean] Maastricht Univ, Acad Hosp Maastricht, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Steyaert, Jean] Maastricht Univ, Res Inst Growth & Dev GROW, NL-6200 MD Maastricht, Netherlands; [Mefford, Heather C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Bakken, Trygve] Allen Inst Brain Sci, Seattle, WA 98103 USA; [O'Roak, Brian J.] OHSU, Portland, OR 97208 USA; [Pawlus, Matthew; Moon, Randall] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [Amaral, David G.] Univ Calif Davis, MIND Inst, Autism Phenome Project, Sacramento, CA 95817 USA; [Rankin, Julia] Peninsula Clin Genet Serv, Exeter EX1 2ED, Devon, England; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; University of Washington; University of Washington Seattle; Radboud University Nijmegen; University of Catania; KU Leuven; University Hospital Leuven; KU Leuven; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; University of Washington; University of Washington Seattle; Allen Institute for Brain Science; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Xiong, Bo/M-3605-2014; Bakken, Trygve E./R-4622-2017; Buono, Serafino/D-8568-2017; Failla, Pinella/AAE-9963-2019; Peeters, Hilde/AAA-7338-2020; Shendure, Jay/AAU-3684-2021; Alberti, Antonino/D-5653-2017; Vissers, Lisenka ELM/A-2598-2015; Coe, Bradley/A-2878-2009; Romano, Corrado/B-9695-2008; Fichera, Marco/K-9220-2016; AT, Vulto-van Silfhout/H-4199-2015; Moon, Randall/M-5605-2019; Steyaert, Jean/B-5326-2015	Bakken, Trygve E./0000-0003-3373-7386; Buono, Serafino/0000-0002-3786-3323; Failla, Pinella/0000-0003-3969-7266; Alberti, Antonino/0000-0001-6742-7429; Vissers, Lisenka ELM/0000-0001-6470-5497; Romano, Corrado/0000-0003-1049-0683; Fichera, Marco/0000-0002-8225-6880; Moon, Randall/0000-0002-9352-1408; Shendure, Jay/0000-0002-1516-1865; Steyaert, Jean/0000-0003-2512-4694; Coe, Bradley/0000-0001-8471-4016; Xiong, Bo/0000-0002-2695-9100; Golzio, Christelle/0000-0002-4420-3921; Pawlus, Matthew/0000-0001-6007-7198; O'Roak, Brian/0000-0002-4141-0095; Stessman, Holly/0000-0002-0764-3493; Peeters, Hilde/0000-0002-7295-3375; Katsanis, Nicholas/0000-0002-2480-0171	Simons Foundation Autism Research Initiative (SFARI) [303241]; NIH/NIMH [R01MH101221]; SFARI [239983]; NIH [P50MH094268]; NARSAD Young Investigator Grant from BBRF; European Commission; GENCODYS [241995]; Dutch Organisation for Health Research and Development (ZON-MW) [917-86-319, 912-12-109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221, P50MH094268] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); SFARI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Grant from BBRF(NARSAD); European Commission(European CommissionEuropean Commission Joint Research Centre); GENCODYS; Dutch Organisation for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Simons Foundation Autism Research Initiative (SFARI) 303241 and NIH/NIMH R01MH101221 to E.E.E.; by SFARI 239983 and NIH P50MH094268 to N.K.; by a NARSAD Young Investigator Grant from BBRF to C.G.; and by the European Commission: GENCODYS grant 241995 under FP7 and the Dutch Organisation for Health Research and Development (ZON-MW grants 917-86-319 and 912-12-109) to B.B.A.d.V. E.E.E. is an Investigator of the Howard Hughes Medical Institute and is on the scientific advisory board for DNAnexus, Inc. N.K. is a Distinguished Brumley Professor. We thank all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We are grateful to D. Raible and H. S. Zimmermann for providing zebrafish resources and for helpful discussions, to T. Brown for help with manuscript preparation, and to J. Huddleston and M. Malig for sequencing support.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chaste P, 2013, BIOL PSYCHIAT, V74, P576, DOI 10.1016/j.biopsych.2013.04.018; CIMENT G, 1983, NATURE, V305, P424, DOI 10.1038/305424a0; Cocchiaro JL, 2013, JOVE-J VIS EXP, DOI 10.3791/4434; D'Autreaux F, 2007, DEVELOPMENT, V134, P2237, DOI 10.1242/dev.003814; Field HA, 2009, NEUROGASTROENT MOTIL, V21, P304, DOI 10.1111/j.1365-2982.2008.01234.x; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; HITTNER HM, 1979, J PEDIAT OPHTH STRAB, V16, P122; Houdayer C, 2011, METHODS MOL BIOL, V760, P269, DOI 10.1007/978-1-61779-176-5_17; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Schulze TG, 2004, HUM HERED, V58, P131, DOI 10.1159/000083539; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Westerfield M., 1995, ZEBR BOOK GUID LAB U; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	43	450	466	4	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					263	276		10.1016/j.cell.2014.06.017	http://dx.doi.org/10.1016/j.cell.2014.06.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998929	Green Accepted, Bronze			2022-12-28	WOS:000340943600008
J	Koegelenberg, CFN; Noor, F; Bateman, ED; van Zyl-Smit, RN; Bruning, A; O'Brien, JA; Smith, C; Abdool-Gaffar, MS; Emanuel, S; Esterhuizen, TM; Irusen, EM				Koegelenberg, Coenraad F. N.; Noor, Firdows; Bateman, Eric D.; van Zyl-Smit, Richard N.; Bruning, Axel; O'Brien, John A.; Smith, Clifford; Abdool-Gaffar, Mohamed S.; Emanuel, Shaunagh; Esterhuizen, Tonya M.; Irusen, Elvis M.			Efficacy of Varenicline Combined With Nicotine Replacement Therapy vs Varenicline Alone for Smoking Cessation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; COMBINATION; SMOKERS; DEPENDENCE; PLACEBO	IMPORTANCE Behavioral approaches and pharmacotherapy are of proven benefit in assisting smokers to quit, but it is unclear whether combining nicotine replacement therapy (NRT) with varenicline to improve abstinence is effective and safe. OBJECTIVE To evaluate the efficacy and Safety of combining varenicline and a nicotine patch vs varenicline alone in smoking cessation. DESIGN, SETTING, AND PARTICIPANTS Randomized, blinded, placebo-controlled clinical trial with a 12-week treatment period and a further 12-week follow-up conducted in 7 centers in South Africa from April 2011 to October 2012. Four hundred forty-six generally healthy smokers were randomized (1:1); 435 were included in the efficacy and safety analyses. INTERVENTIONS Nicotine or placebo patch treatment began 2 weeks before a target quit date (TQD) and continued for a further 12 weeks. Varenicline was begun 1 week prior to TQD, continued for a further 12 weeks, and tapered off during week 13. MAIN OUTCOMES AND MEASURES Tobacco abstinencewas established and confirmed by exhaled carbon monoxide measurements at TQD and at intervals thereafter up to 24 weeks. The primary end point was the 4-week exhaled carbon monoxide-confirmed continuous abstinence rate for weeks 9 through 12 of treatment, ie, the proportion of participants able to maintain complete abstinence from smoking for the last 4 weeks of treatment, as assessed using multiple imputation analysis. Secondary end points included point prevalence abstinence at 6 months, continuous abstinence rate from weeks 9 through 24, and adverse events. Multiple imputation also was used to address loss to follow-up. RESULTS The combination treatment was associated with a higher continuous abstinence rate at 12 weeks (55.4% vs 40.9%; odds ratio [OR], 1.85; 95% CI, 1.19-2.89; P =.007) and 24 weeks (49.0% vs 32.6%; OR, 1.98; 95% CI, 1.25-3.14; P =.004) and point prevalence abstinence rate at 6 months (65.1% vs 46.7%; OR, 2.13; 95% CI, 1.32-3.43; P =.002). In the combination treatment group, there was a numerically greater incidence of nausea, sleep disturbance, skin reactions, constipation, and depression, with only skin reactions reaching statistical significance (14.4% vs 7.8%; P =.03); the varenicline-alone group experienced more abnormal dreams and headaches. CONCLUSIONS AND RELEVANCE Varenicline in combination with NRT was more effective than varenicline alone at achieving tobacco abstinence at 12 weeks (end of treatment) and at 6 months. Further studies are needed to assess long-term efficacy and safety.	[Koegelenberg, Coenraad F. N.; Noor, Firdows; Esterhuizen, Tonya M.; Irusen, Elvis M.] Univ Stellenbosch, ZA-7505 Cape Town, South Africa; [Bateman, Eric D.; van Zyl-Smit, Richard N.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Bruning, Axel] Gatesville Melomed Hosp, Cape Town, South Africa; [O'Brien, John A.] Christiaan Barnard Mem Hosp, Cape Town, South Africa; [Smith, Clifford] Rochester Pl Med Ctr, Johannesburg, South Africa; [Abdool-Gaffar, Mohamed S.] Kingsway Med Ctr, Durban, South Africa; [Emanuel, Shaunagh] Synopsis Res Unit, Cape Town, South Africa	Stellenbosch University; University of Cape Town	Koegelenberg, CFN (corresponding author), Univ Stellenbosch, Dept Med, Div Pulmonol, POB 19063, ZA-7505 Cape Town, South Africa.	coeniefn@sun.ac.za	Irusen, Elvis/AAU-4571-2020	van Zyl-Smit, Richard/0000-0002-4115-5362	Pfizer, New York, New York; McNeil, Helsingborg, Sweden	Pfizer, New York, New York(Pfizer); McNeil, Helsingborg, Sweden	This study was supported by unrestricted grants from Pfizer, New York, New York, and McNeil, Helsingborg, Sweden. Varenicline was supplied by Pfizer, and both active and placebo NRT patches were supplied by McNeil.	Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Besada NA, 2010, EUR RESP J S54, V36; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Ebbert JO, 2014, JAMA-J AM MED ASSOC, V311, P155, DOI 10.1001/jama.2013.283185; Ebbert JO, 2009, NICOTINE TOB RES, V11, P572, DOI 10.1093/ntr/ntp042; Fiore MC, 2008, TREATING TOBACCO USE; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hajek P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-140; Harrison-Woolrych M, 2013, PHARMACOEPIDEM DR S, V22, P1086, DOI 10.1002/pds.3489; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kaplan YC, CASE REP OBSTET GYNE, DOI [10.1155/2014/263981, DOI 10.1155/2014/263981]; Lindson-Hawley N, 2013, JAMA-J AM MED ASSOC, V310, P91, DOI 10.1001/jama.2013.6473; Lindson-Hawley N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub3; Ossip DJ, 2009, NICOTINE TOB RES, V11, P408, DOI 10.1093/ntr/ntp005; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Rigotti NA, 2012, JAMA-J AM MED ASSOC, V308, P1573, DOI 10.1001/jama.2012.13043; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Welsch SK, 1999, EXP CLIN PSYCHOPHARM, V7, P354, DOI 10.1037/1064-1297.7.4.354	21	110	115	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					155	161		10.1001/jama.2014.7195	http://dx.doi.org/10.1001/jama.2014.7195			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005652				2022-12-28	WOS:000338511200021
J	Cooper, KL; Sears, KE; Uygur, A; Maier, J; Baczkowski, KS; Brosnahan, M; Antczak, D; Skidmore, JA; Tabin, CJ				Cooper, Kimberly L.; Sears, Karen E.; Uygur, Aysu; Maier, Jennifer; Baczkowski, Karl-Stephan; Brosnahan, Margaret; Antczak, Doug; Skidmore, Julian A.; Tabin, Clifford J.			Patterning and post-patterning modes of evolutionary digit loss in mammals	NATURE			English	Article							APICAL ECTODERMAL RIDGE; PROGRAMMED CELL-DEATH; LIMB DEVELOPMENT; VERTEBRATE LIMB; DEVELOPMENTAL BASIS; REDUCTION; HEDGEHOG; BUD; HEMIERGIS; NUMBER	A reduction in the number of digits has evolved many times in tetrapods, particularly in cursorial mammals that travel over deserts and plains, yet the underlying developmental mechanisms have remained elusive. Here we show that digit loss can occur both during early limbpatterning and at later post-patterning stages of chondrogenesis. In the 'odd-toed' jerboa (Dipus sagitta) and horse and the 'even-toed' camel, extensive cell death sculpts the tissue around the remaining toes. In contrast, digit loss inthepig is orchestrated by earlier limb patterning mechanisms including downregulation of Ptch1 expression but no increase in cell death. Together these data demonstrate remarkable plasticity in the mechanisms of vertebrate limb evolution and shed light on the complexity of morphological convergence, particularly within the artiodactyl lineage.	[Cooper, Kimberly L.; Uygur, Aysu; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sears, Karen E.; Maier, Jennifer] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Baczkowski, Karl-Stephan] Ecole Normale Super Lyon, F-69007 Lyon, France; [Brosnahan, Margaret; Antczak, Doug] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Skidmore, Julian A.] Camel Reprod Ctr, Dubai, U Arab Emirates	Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Urbana-Champaign; Ecole Normale Superieure de Lyon (ENS de LYON); Cornell University	Cooper, KL (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	kcooper@ucsd.edu; ksears@life.illinois.edu		Sears, Karen/0000-0001-9744-9602; Antczak, Douglas/0000-0003-3336-5818	NIH [R37HD032443]; NSF IOS grant [1257873]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IOS grant(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Lopez-Rios and R. Zeller (University of Basel, Switzerland) for generously providing data and discussion before publication. We also thank J. Carlos Izpisua Belmonte and A. Aguirre for sharing space and materials to complete experiments subsequent to review. Jerboa embryos were harvested with the assistance of S. Wu and colleagues in Xinjiang, China. Pig embryos were harvested with the assistance of D. Urban. Additional horse embryos were provided by R. Turner and H. Galatino-Homer (University of Pennsylvania) and by R. Fritsche and S. Lyle (Louisiana State University). Mouse Gli1 probe plasmid, used in the pig in situ, was provided by A. Joyner. This work was supported by NIH grant R37HD032443 to C.J.T., and NSF IOS grant 1257873 to K.E.S.	ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Cooper K. L, 2011, COLD SPRING HARB PRO; Cooper LN, 2007, ANAT REC, V290, P654, DOI 10.1002/ar.20532; Fernandez-Teran MA, 2006, DEV DYNAM, V235, P2521, DOI 10.1002/dvdy.20916; Ferrari D, 1998, DEV BIOL, V197, P12, DOI 10.1006/dbio.1998.8880; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Pizette S, 2001, DEVELOPMENT, V128, P4463; Prothero D.R., 2007, EVOLUTION ARTIODACTY; Rasweiler J. J., 2009, COLD SPRING HARB PRO; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Romer A, 1936, VERTEBRATE PALEONTOL; ROSE KD, 1982, SCIENCE, V216, P621, DOI 10.1126/science.216.4546.621; Rose KD, 1996, P NATL ACAD SCI USA, V93, P1705, DOI 10.1073/pnas.93.4.1705; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Shapiro MD, 2002, J MORPHOL, V254, P211, DOI 10.1002/jmor.10027; Shenbrot GI., 2008, JERBOAS MAMMALS RUSS; Skinner A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-310; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Theodor J., 2007, EVOLUTION ARTIODACTY; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Walker E. P., 1964, MAMMALS WORLD; Whole-mount R. R., 2009, COLD SPRING HARB PRO; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	36	90	93	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					41	U537		10.1038/nature13496	http://dx.doi.org/10.1038/nature13496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990742	Green Accepted			2022-12-28	WOS:000338199400031
J	Wiseman, H				Wiseman, Howard			Bell's theorem still reverberates	NATURE			English	Editorial Material							INEQUALITIES		Griffith Univ, Ctr Quantum Dynam, Brisbane, Qld 4111, Australia	Griffith University	Wiseman, H (corresponding author), Griffith Univ, Ctr Quantum Dynam, Brisbane, Qld 4111, Australia.	h.wiseman@griffith.edu.au	Wiseman, Howard M/A-7266-2008	Wiseman, Howard M/0000-0001-6815-854X				Aravind PK, 2002, FOUND PHYS LETT, V15, P397, DOI 10.1023/A:1021272729475; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Bell J.S., 1976, EPISTEMOL LETT, V9, P11; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Christensen BG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130406; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Kent A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.012107; Maudlin T., 2011, QUANTUM NONLOCALITY	9	15	16	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					467	469		10.1038/510467a	http://dx.doi.org/10.1038/510467a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24971439	Bronze			2022-12-28	WOS:000337806300022
J	Thornton, S				Thornton, Sarah			Beyond rhetoric: we need a strategy for patient involvement in the health service	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thornton, Sarah] NHS User, York, N Yorkshire, England		Thornton, S (corresponding author), NHS User, York, N Yorkshire, England.	hinyork@yahoo.co.uk						*DEP HLTH, 2000, CM48181; Department of Health, 2010, CM7881; Health Overview and Scrutiny Committee Westminster Primary Care Trust, 2008, PAT PUBL INV FOR LOC; Humphries R., 2012, HLTH WELLBEING BOARD; Mason JK, 2013, MASON MCCALL SMITHS, V9th; NHS England, 2014, BUSINESS; The NHS Institute for Innovation and Improvement, 2008, PROC MAPP OV; Trebble T, 2010, BMJ-BRIT MED J, V341, pc394	8	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2014	348								g4072	10.1136/bmj.g4072	http://dx.doi.org/10.1136/bmj.g4072			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UE	24957899				2022-12-28	WOS:000338201400008
J	Binder, PM; Pipes, RM				Binder, P. -M.; Pipes, R. M.			APPLIED MATHEMATICS How chaos forgets and remembers	NATURE			English	Editorial Material									[Binder, P. -M.; Pipes, R. M.] Univ Hawaii, Dept Phys & Astron, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo	Binder, PM (corresponding author), Univ Hawaii, Dept Phys & Astron, Hilo, HI 96720 USA.	pbinder@hawaii.edu	Binder, P. -M./L-9889-2015					[Anonymous], 1999, TIME REVERSIBILITY C; Binder PM, 2010, CHAOS, V20, DOI 10.1063/1.3298244; James R. G., 2014, PHYS LETT A; Lorenz Edward N., 1995, ESSENCE CHAOS; Morse M, 1938, AM J MATH, V60, P815, DOI 10.2307/2371264; Motter A, 2013, PHYS TODAY, V66, P27, DOI 10.1063/PT.3.1977; [No title captured]	7	4	4	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					343	344		10.1038/510343a	http://dx.doi.org/10.1038/510343a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24943950				2022-12-28	WOS:000337350200021
J	Schmidt-Kaler, F				Schmidt-Kaler, Ferdinand			QUANTUM PHYSICS Feel the force	NATURE			English	Editorial Material									Johannes Gutenberg Univ Mainz, Inst Phys, QUANTUM, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Schmidt-Kaler, F (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, QUANTUM, D-55128 Mainz, Germany.	fsk@uni-mainz.de	Schmidt-Kaler, Ferdinand/E-2151-2017	Schmidt-Kaler, Ferdinand/0000-0002-5697-2568				Harter A, 2014, CONTEMP PHYS, V55, P33, DOI 10.1080/00107514.2013.854618; Kotler S, 2014, NATURE, V510, P376, DOI 10.1038/nature13403; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Schmidt-Kaler F, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/53001; Zhao N, 2012, NAT NANOTECHNOL, V7, P657, DOI [10.1038/nnano.2012.152, 10.1038/NNANO.2012.152]	6	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					349	349		10.1038/510349a	http://dx.doi.org/10.1038/510349a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24943951				2022-12-28	WOS:000337350200025
J	Holmes, D				Holmes, David			Petra ten Hoope-Bender: a "midwife's midwife"	LANCET			English	Biographical-Item																		HOOPEBENDER PT, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1178	1178		10.1016/S0140-6736(14)61045-X	http://dx.doi.org/10.1016/S0140-6736(14)61045-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7MT	24965815				2022-12-28	WOS:000343002600013
J	Bessede, A; Gargaro, M; Pallotta, MT; Matino, D; Servillo, G; Brunacci, C; Bicciato, S; Mazza, EMC; Macchiarulo, A; Vacca, C; Iannitti, R; Tissi, L; Volpi, C; Belladonna, ML; Orabona, C; Bianchi, R; Lanz, TV; Platten, M; Della Fazia, MA; Piobbico, D; Zelante, T; Funakoshi, H; Nakamura, T; Gilot, D; Denison, MS; Guillemin, GJ; DuHadaway, JB; Prendergast, GC; Metz, R; Geffard, M; Boon, L; Pirro, M; Iorio, A; Veyret, B; Romani, L; Grohmann, U; Fallarino, F; Puccetti, P				Bessede, Alban; Gargaro, Marco; Pallotta, Maria T.; Matino, Davide; Servillo, Giuseppe; Brunacci, Cinzia; Bicciato, Silvio; Mazza, Emilia M. C.; Macchiarulo, Antonio; Vacca, Carmine; Iannitti, Rossana; Tissi, Luciana; Volpi, Claudia; Belladonna, Maria L.; Orabona, Ciriana; Bianchi, Roberta; Lanz, Tobias V.; Platten, Michael; Della Fazia, Maria A.; Piobbico, Danilo; Zelante, Teresa; Funakoshi, Hiroshi; Nakamura, Toshikazu; Gilot, David; Denison, Michael S.; Guillemin, Gilles J.; DuHadaway, James B.; Prendergast, George C.; Metz, Richard; Geffard, Michel; Boon, Louis; Pirro, Matteo; Iorio, Alfonso; Veyret, Bernard; Romani, Luigina; Grohmann, Ursula; Fallarino, Francesca; Puccetti, Paolo			Aryl hydrocarbon receptor control of a disease tolerance defence pathway	NATURE			English	Article							REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; ENDOTOXIN TOLERANCE; LIGAND-BINDING; AH RECEPTOR; KYNURENINE; IDO; INFECTION	Disease tolerance is the ability of the host to reduce the effect of infection on host fitness. Analysis of disease tolerance pathways could provide new approaches for treating infections and other inflammatory diseases. Typically, an initial exposure to bacterial lipopolysaccharide (LPS) induces a state of refractoriness to further LPS challenge (endotoxin tolerance). We found that a first exposure of mice to LPS activated the ligand-operated transcription factor aryl hydrocarbon receptor (AhR) and the hepatic enzyme tryptophan 2,3-dioxygenase, which provided an activating ligand to the former, to down-regulate early inflammatory gene expression. However, on LPS rechallenge, AhR engaged in long-term regulation of systemic inflammation only in the presence of indoleamine 2,3-dioxygenase 1 (IDO1). AhR-complex-associated Src kinase activity promoted IDO1 phosphorylation and signalling ability. There sulting endotoxin-tolerant state was found to protect mice against immunopathology in Gram-negative and Gram-positive infections, pointing to a role for AhRin contributing to host fitness.	[Bessede, Alban; Gargaro, Marco; Pallotta, Maria T.; Matino, Davide; Servillo, Giuseppe; Brunacci, Cinzia; Vacca, Carmine; Iannitti, Rossana; Tissi, Luciana; Volpi, Claudia; Belladonna, Maria L.; Orabona, Ciriana; Bianchi, Roberta; Della Fazia, Maria A.; Piobbico, Danilo; Zelante, Teresa; Romani, Luigina; Grohmann, Ursula; Fallarino, Francesca; Puccetti, Paolo] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy; [Bessede, Alban; Geffard, Michel; Veyret, Bernard] Univ Bordeaux, IMS Lab, F-33607 Pessac, France; [Bicciato, Silvio; Mazza, Emilia M. C.] Univ Modena & Reggio Emilia, Ctr Genome Res, I-41125 Modena, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Chem & Technol Drugs, I-06123 Perugia, Italy; [Lanz, Tobias V.; Platten, Michael] German Canc Res Ctr, Expt Neuroimmunol Unit, D-69120 Heidelberg, Germany; [Lanz, Tobias V.; Platten, Michael] Univ Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany; [Funakoshi, Hiroshi] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido 0788510, Japan; [Nakamura, Toshikazu] Osaka Univ, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan; [Gilot, David] Univ Rennes 1, CNRS UMR6290, Inst Genet & Dev Rennes, F-35043 Rennes, France; [Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Guillemin, Gilles J.] Macquarie Univ, ASAM, N Ryde, NSW 2109, Australia; [DuHadaway, James B.; Prendergast, George C.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Metz, Richard] New Link Genetics Corp, Ames, IA 50010 USA; [Boon, Louis] Bioceros, NL-3584 Utrecht, Netherlands; [Pirro, Matteo] Univ Perugia, Dept Med, I-06132 Perugia, Italy; [Iorio, Alfonso] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada	University of Perugia; UDICE-French Research Universities; Universite de Bordeaux; Universita di Modena e Reggio Emilia; University of Perugia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Asahikawa Medical College; Osaka University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of California System; University of California Davis; Macquarie University; Lankenau Medical Center; Lankenau Institute for Medical Research; University of Perugia; McMaster University	Puccetti, P (corresponding author), Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy.	fllfnc@tin.it; plopcc@tin.it	Gargaro, Marco/K-7077-2016; Matino, Davide/M-1426-2015; Macchiarulo, Antonio/L-2846-2017; Platten, Michael/F-2902-2013; Orabona, Ciriana/L-8725-2015; Vacca, Carmine/AAE-7046-2019; Pirro, Matteo/AAC-2318-2022; zelante, teresa/F-7933-2017; Pallotta, Maria Teresa/K-7021-2016; Matino, Davide/J-9576-2019; BICCIATO, Silvio/J-4466-2019; Grohmann, Ursula/T-6545-2019; Iorio, Alfonso/B-9478-2013; Guillemin, Gilles J/C-3878-2015; Romani, Luigina/O-9987-2018; Boon, Laurence/HCI-3629-2022; Mazza, Emilia Maria Cristina/HHZ-8915-2022; Bicciato, Silvio/C-9825-2009; Fallarino, Francesca/O-3358-2013	Gargaro, Marco/0000-0003-0645-9800; Matino, Davide/0000-0002-9902-4074; Macchiarulo, Antonio/0000-0001-9535-4183; Platten, Michael/0000-0002-4746-887X; Orabona, Ciriana/0000-0003-3113-0572; Vacca, Carmine/0000-0002-3799-8164; zelante, teresa/0000-0002-7071-0302; Pallotta, Maria Teresa/0000-0002-0417-1638; BICCIATO, Silvio/0000-0002-1944-7078; Iorio, Alfonso/0000-0002-3331-8766; Guillemin, Gilles J/0000-0001-8105-4470; Mazza, Emilia Maria Cristina/0000-0003-2424-3640; Bicciato, Silvio/0000-0002-1944-7078; Piobbico, Danilo/0000-0003-4240-1526; Boon, Louis/0000-0002-0937-9171; Bianchi, Roberta/0000-0001-5914-4701; VOLPI, CLAUDIA/0000-0002-3967-7954; Grohmann, Ursula/0000-0001-7952-1850; Pirro, Matteo/0000-0002-5527-4821; Della Fazia, Maria Agnese/0000-0002-5373-8477; Belladonna, Maria Laura/0000-0001-6522-0870; Fallarino, Francesca/0000-0002-8501-2136; Puccetti, Paolo/0000-0001-6674-2128; Servillo, Giuseppe/0000-0001-7960-7689; Romani, Luigina/0000-0002-1356-525X	Italian Association for Cancer Research (AIRC); Fondazione Italiana Sclerosi Multipla [2010/R/17]; Associazione Umbra Contro il Cancro; Bayer Grants4Target Focus [2012-03-0630]; Bayer Early Career Investigator Award from the US National Institutes of Environmental Health Sciences [R01ES007685]; Specific Targeted Research Project FUNMETA; Regione dell'Umbria [GR-2008-1138004]; Italian Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA109542, P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685] Funding Source: NIH RePORTER	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Umbra Contro il Cancro; Bayer Grants4Target Focus; Bayer Early Career Investigator Award from the US National Institutes of Environmental Health Sciences; Specific Targeted Research Project FUNMETA; Regione dell'Umbria(Regione Umbria); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funding from the Italian Association for Cancer Research (AIRC, to P. P.), Fondazione Italiana Sclerosi Multipla Project No. 2010/R/17 (to F. F.), Associazione Umbra Contro il Cancro (to G. S. & M. A. D. F.), Bayer Grants4Target Focus Grant no. 2012-03-0630 (to A. I., F. F. and D. M.), Bayer Early Career Investigator Award (to D. M.), Grant no. R01ES007685 from the US National Institutes of Environmental Health Sciences (to M. S. D.), the Specific Targeted Research Project FUNMETA (to L. R.), and the Italian Ministry of Health in association with Regione dell'Umbria (GR-2008-1138004 to C.O.) We thank D. Fuchs for serum kynurenine determinations. We also thank G. Andrielli for digital art and image editing and G. Ricci for histopathology.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Chambers MC, 2012, P NATL ACAD SCI USA, V109, P13886, DOI 10.1073/pnas.1211724109; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Doreswamy V, 2011, CLIN EXP ALLERGY, V41, P9, DOI 10.1111/j.1365-2222.2010.03628.x; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Howard G. J., 2009, ENV HLTH PERSPECT, V118, P666; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Murray MF, 2007, CURR DRUG METAB, V8, P197, DOI 10.2174/138920007780362509; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Puliti M, 2009, INFECT IMMUN, V77, P1524, DOI 10.1128/IAI.00965-08; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; Randi AS, 2008, TOXICOL LETT, V177, P116, DOI 10.1016/j.toxlet.2008.01.003; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	50	419	446	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					184	+		10.1038/nature13323	http://dx.doi.org/10.1038/nature13323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24930766	Green Accepted, Green Submitted			2022-12-28	WOS:000338649800036
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Why the delays in counting the dead?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						MRC Biostatistics Unit, 2014, CHAR TELL PRIM MIN O	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2014	349								g4305	10.1136/bmj.g4305	http://dx.doi.org/10.1136/bmj.g4305			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZD	25007914				2022-12-28	WOS:000338993500007
J	Jabbar-Lopez, ZK; Wu, KCP; Reynolds, NJ				Jabbar-Lopez, Z. K.; Wu, K. C. P.; Reynolds, N. J.			THERAPEUTICS Newer agents for psoriasis in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC PLAQUE PSORIASIS; TOPICAL CALCIPOTRIOL; FUMARIC-ACID; DOUBLE-BLIND; VS. METHOTREXATE; EFFICACY; PLACEBO; SAFETY; MANAGEMENT; ARTHRITIS		[Jabbar-Lopez, Z. K.; Wu, K. C. P.; Reynolds, N. J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Reynolds, NJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	nick.reynolds@ncl.ac.uk		Jabbar-Lopez, Zarif/0000-0003-4127-8263; Reynolds, Nick/0000-0002-6484-825X	Wellcome Trust Funding Source: Medline; National Institute for Health Research [ACF-2013-01-001] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		ALTMEYER PJ, 1994, J AM ACAD DERMATOL, V30, P977, DOI 10.1016/S0190-9622(94)70121-0; Arani SF, 2011, BRIT J DERMATOL, V164, P855, DOI 10.1111/j.1365-2133.2010.10195.x; Ashcroft DM, 2000, BMJ-BRIT MED J, V320, P963, DOI 10.1136/bmj.320.7240.963; BOURKE JF, 1994, CLIN ENDOCRINOL, V41, P295, DOI 10.1111/j.1365-2265.1994.tb02548.x; Chen X, 2013, COCHRANE DB SYST REV, V10; Committee, 2014, BRIT NATL FORMULARY; Ermis U, 2013, NEW ENGL J MED, V368, P1657, DOI 10.1056/NEJMc1211805; Famenini S, 2013, CUTIS, V92, P140; Ibbotson SH, 2004, BRIT J DERMATOL, V151, P283, DOI 10.1111/j.1365-2133.2004.06128.x; Kienbaum S, 1996, BRIT J DERMATOL, V135, P647, DOI 10.1046/j.1365-2133.1996.d01-1060.x; Kirke SM, 2007, J INVEST DERMATOL, V127, P1641, DOI 10.1038/sj.jid.5700767; Mason AR, 2013, COCHRANE DB SYST REV, V3; Menter A, 2008, J AM ACAD DERMATOL, V58, P826, DOI 10.1016/j.jaad.2008.02.039; Menter A, 2010, J AM ACAD DERMATOL, V62, P114, DOI 10.1016/j.jaad.2009.08.026; MORTENSEN L, 1993, ACTA DERM-VENEREOL, V73, P300; Nast A, 2012, J DTSCH DERMATOL GES, V10, DOI 10.1111/j.1610-0387.2012.07919.x; National Institute for Health and Care Excellence, 2006, TA103 NAT I HLTH CAR; National Institute for Health and Care Excellence, 2012, CG153 NAT I HLTH CAR; Ortonne JP, 2003, BRIT J DERMATOL, V148, P326, DOI 10.1046/j.1365-2133.2003.05228.x; Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x; PEETERS AJ, 1992, BRIT J RHEUMATOL, V31, P502; Samarasekera E, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6712; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Sawyer L, 2013, BRIT J DERMATOL, V168, P1095, DOI 10.1111/bjd.12261; Schmitt J, 2014, BRIT J DERMATOL, V170, P274, DOI 10.1111/bjd.12663; Scottish Intercollegiate Guidelines Network, 2010, DIAGN MAN PSOR PSOR; Tremezaygues L, 2011, DERM-ENDOCRINOL, V3, P180, DOI [10.4161/derm.3.3.17534, 10.4161/derm.17534]; Weatherhead SC, 2013, PHOTOCH PHOTOBIO SCI, V12, P47, DOI 10.1039/c2pp25116g; Woolacott N, 2006, HEALTH TECHNOL ASSES, V10, P1	29	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2014	349								g4026	10.1136/bmj.g4026	http://dx.doi.org/10.1136/bmj.g4026			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZD	25008099				2022-12-28	WOS:000338993500001
J	Power, SB				Power, Scott B.			Expulsion from history	NATURE			English	Editorial Material							UNCERTAINTIES		Bur Meteorol, Melbourne, Vic 3001, Australia	Bureau of Meteorology - Australia	Power, SB (corresponding author), Bur Meteorol, GPO Box 1289, Melbourne, Vic 3001, Australia.	s.power@bom.gov.au	Power, Scott Brendan/AAF-3370-2019	Power, Scott Brendan/0000-0002-9596-4368				Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; Hawkins E, 2014, NATURE, V511, pE3, DOI 10.1038/nature13523; IPCC, 2018, SUMMARY POLICYMAKERS; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Mora C, 2014, NATURE, V511, pE5, DOI 10.1038/nature13524; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Power SB, 2012, J CLIMATE, V25, P3792, DOI 10.1175/JCLI-D-11-00354.1; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271	11	8	8	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					38	39		10.1038/511038a	http://dx.doi.org/10.1038/511038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1TN	24990739				2022-12-28	WOS:000338199400027
J	Rice, CM; Yadav, S; Boyanton, B; Subedi, P; Band, J				Rice, Casey M.; Yadav, Siddhartha; Boyanton, Bobby; Subedi, Prajan; Band, Jeffrey			A Creeping Suspicion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; POLYMERASE-CHAIN-REACTION; CEREBROSPINAL-FLUID; DIAGNOSIS; PCR; SYSTEM		[Rice, Casey M.; Band, Jeffrey] William Beaumont Hosp, Dept Infect Dis, Royal Oak, MI 48072 USA; [Yadav, Siddhartha; Subedi, Prajan] William Beaumont Hosp, Dept Internal Med, Royal Oak, MI 48073 USA; [Boyanton, Bobby] William Beaumont Hosp, Dept Clin Pathol, Royal Oak, MI 48072 USA; [Boyanton, Bobby; Band, Jeffrey] Oakland Univ, William Beaumont Sch Med, Rochester, MI USA	Beaumont Health; Beaumont Health; Beaumont Health; Oakland University	Rice, CM (corresponding author), William Beaumont Hosp, Dept Infect Dis, Royal Oak, MI 48072 USA.	caseyrice.md@gmail.com	Boyanton, Bobby/AEV-9164-2022; Yadav, Siddhartha/J-5828-2014	Boyanton, Bobby/0000-0002-5665-7357; Yadav, Siddhartha/0000-0003-4630-9903				Adler AC, 2011, CASE REP NEUROL, V3, P172, DOI 10.1159/000330298; Akhan SC, 2001, INFECTION, V29, P359, DOI 10.1007/s15010-001-1095-9; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; BARNETT EM, 1994, J INFECT DIS, V169, P782, DOI 10.1093/infdis/169.4.782; De Tiege X, 2003, CLIN INFECT DIS, V36, P1335, DOI 10.1086/374839; DeBiasi RL, 2002, J CLIN VIROL, V25, pS5, DOI 10.1016/S1386-6532(02)00028-8; Denes E, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13107; Domingues RB, 1998, J CLIN MICROBIOL, V36, P2229, DOI 10.1128/JCM.36.8.2229-2234.1998; Hjalmarsson A, 2007, CLIN INFECT DIS, V45, P875, DOI 10.1086/521262; LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; STROOP WG, 1986, J INFECT DIS, V153, P721, DOI 10.1093/infdis/153.4.721; Weil AA, 2002, CLIN INFECT DIS, V34, P1154, DOI 10.1086/339550; WHITLEY RJ, 1989, JAMA-J AM MED ASSOC, V262, P234, DOI 10.1001/jama.262.2.234; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303	15	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					68	73		10.1056/NEJMcps1212310	http://dx.doi.org/10.1056/NEJMcps1212310			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988560				2022-12-28	WOS:000338265700013
J	Mollan, KR; Smurzynski, M; Eron, JJ; Daar, ES; Campbell, TB; Sax, PE; Gulick, RM; Na, L; O'Keefe, L; Robertson, KR; Tierney, C				Mollan, Katie R.; Smurzynski, Marlene; Eron, Joseph J.; Daar, Eric S.; Campbell, Thomas B.; Sax, Paul E.; Gulick, Roy M.; Na, Lumine; O'Keefe, Lauren; Robertson, Kevin R.; Tierney, Camlin			Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide An Analysis of Trial Data	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; FOLLOW-UP; NEUROPSYCHOLOGICAL PERFORMANCE; INDIVIDUALS; DEPRESSION; REGIMENS; IMPACT; STIGMA; PART; PREDICTORS	Background: The relationship between efavirenz use and suicidality is not well-defined. Objective: To compare time to suicidality with efavirenz-containing versus efavirenz-free antiretroviral regimens for initial treatment of HIV. Design: Participant-level data were analyzed from 4 AIDS Clinical Trials Group, antiretroviral-naive studies conducted from 2001 to 2010. Within each study, participants were randomly assigned to an efavirenz-containing (n = 3241) or efavirenz-free (n = 2091) regimen. (ClinicalTrials.gov: NCT00013520 [A5095], NCT00050895 [A5142], NCT00084136 [A5175], and NCT 00118898 [A5202]) Setting: AIDS Clinical Trials Group sites; 74% of participants enrolled in the United States. Patients: Antiretroviral-naive participants. Intervention: Efavirenz versus efavirenz-free regimens. Measurements: Suicidality was defined as suicidal ideation or attempted or completed suicide. Groups were compared with a hazard ratio and 95% CI estimated from a Cox model, stratified by study. Results: Seventy-three percent of participants were men, the median age was 37 years, and 32% had documented psychiatric history or received psychoactive medication within 30 days before entering the study. Median follow-up was 96 weeks. Suicidality incidence per 1000 person-years was 8.08 (47 events) in the efavirenz group and 3.66 (15 events) in the efavirenz-free group (hazard ratio, 2.28 [95% CI, 1.27 to 4.10]; P = 0.006). Incidence of attempted or completed suicide was 2.90 (17 events) and 1.22 (5 events) in the efavirenz and efavirenz-free groups, respectively (hazard ratio, 2.58 [CI, 0.94 to 7.06]; P = 0.065). Eight suicides in the efavirenz group and 1 in the efavirenz-free group were reported. Limitation: There was not a standardized questionnaire about suicidal ideation or attempt. Efavirenz was open-label in 3 of 4 studies. Conclusion: Initial treatment with an efavirenz-containing antiretroviral regimen was associated with a 2-fold increased hazard of suicidality compared with a regimen without efavirenz.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Ctr Biostat AIDS Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA; George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; Univ Colorado Denver, Aurora, CO USA; Weill Cornell Med Coll, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; George Washington University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cornell University	Tierney, C (corresponding author), Harvard Univ, Sch Publ Hlth, 651 Huntington Ave, Boston, MA 02115 USA.				National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068636, U01AI068636, U01AI069423, U01AI038858, UM1AI069399, UM1AI069419, UM1AI069423, U01AI068634, UM1AI106701, UM1AI068634, P30AI050410, UM1AI069412, UM1AI069432, K24AI051966, U01AI069419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Primary Funding Source: National Institutes of Health.	Albrecht MA, 2001, NEW ENGL J MED, V345, P398, DOI 10.1056/NEJM200108093450602; [Anonymous], GUID VERS 7 0; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2013, EF PACK INS; Blanch J, 2001, CLIN INFECT DIS, V33, P270, DOI 10.1086/321828; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Clifford DB, 2009, HIV CLIN TRIALS, V10, P343, DOI 10.1310/hct1006-343; Clifford DB, 2005, ANN INTERN MED, V143, P714, DOI 10.7326/0003-4819-143-10-200511150-00008; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colibazzi Tiziano, 2006, Prim Care Companion J Clin Psychiatry, V8, P201; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Dawson S, 2005, INT J STD AIDS, V16, P769, DOI 10.1258/095646205774763261; Decloedt EH, 2013, EXPERT OPIN DRUG SAF, V12, P841, DOI 10.1517/14740338.2013.823396; *DIV AIDS, 2004, DIV AIDS TABL GRAD S; Gallien S, 2011, J ANTIMICROB CHEMOTH, V66, P184, DOI 10.1093/jac/dkq395; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Groenwold RHH, 2009, ARCH INTERN MED, V169, P1532, DOI 10.1001/archinternmed.2009.250; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasse B, 2005, CLIN INFECT DIS, V40, pE22, DOI 10.1086/427031; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Journot V, 2006, CLIN INFECT DIS, V42, P1790, DOI 10.1086/504323; Kenedi CA, 2011, AIDS BEHAV, V15, P1803, DOI 10.1007/s10461-011-9939-5; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Lochet P, 2003, HIV Med, V4, P62, DOI 10.1046/j.1468-1293.2003.00136.x; Lowenhaupt EA, 2007, CLIN INFECT DIS, V45, pE128, DOI 10.1086/522764; National Institute of Mental Health, MENT HLTH MED; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Oquendo MA, 2001, AM J PSYCHIAT, V158, P1652, DOI 10.1176/appi.ajp.158.10.1652; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Persson A, 2006, SOC SCI MED, V63, P1586, DOI 10.1016/j.socscimed.2006.04.001; Peyriere H, 2001, AIDS, V15, P1323, DOI 10.1097/00002030-200107060-00025; Pompili M, 2003, BRIT J PSYCHIAT, V183, P173, DOI 10.1192/S0007125000162774; Poulsen HD, 2003, AIDS, V17, P451, DOI 10.1097/00002030-200302140-00026; Protopopescu C, 2012, ANTIVIR THER, V17, P1079, DOI 10.3851/IMP2102; Puzantian T, 2002, PHARMACOTHERAPY, V22, P930, DOI 10.1592/phco.22.11.930.33624; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robertson K, 2006, DEATH STUD, V30, P455, DOI 10.1080/07481180600614435; Robertson K, 2012, J NEUROVIROL, V18, P388, DOI 10.1007/s13365-012-0120-3; Romao PRT, 2011, NEUROTOX RES, V19, P73, DOI 10.1007/s12640-009-9141-y; Scourfield A, 2012, AIDS, V26, P1399, DOI 10.1097/QAD.0b013e328353b047; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P163; Stack S, 2011, SOC SCI MED, V72, P1211, DOI 10.1016/j.socscimed.2011.01.028; Stanistreet D, 2001, MED SCI LAW, V41, P111, DOI 10.1177/002580240104100205; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tovar-y-Romo LB, 2012, J PHARMACOL EXP THER, V343, P696, DOI 10.1124/jpet.112.195701; U. S. Food and Drug Administration, 2000, CTR DRUG EV RES APPR; Varnik P, 2012, INJURY PREV, V18, P321, DOI 10.1136/injuryprev-2011-040070; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1	53	129	132	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					1	+		10.7326/M14-0293	http://dx.doi.org/10.7326/M14-0293			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24979445	Green Accepted			2022-12-28	WOS:000338419700001
J	Szyszka, P				Szyszka, Paul			Follow the odor	SCIENCE			English	Editorial Material							ANTENNAL LOBE; MIXTURES		Univ Konstanz, Dept Neurobiol, D-78457 Constance, Germany	University of Konstanz	Szyszka, P (corresponding author), Univ Konstanz, Dept Neurobiol, D-78457 Constance, Germany.	paul.szyszka@uni-konstanz.de	Szyszka, Paul/ABC-7508-2020	Szyszka, Paul/0000-0003-2043-6656				Baker TC, 1998, NATURE, V393, P530, DOI 10.1038/31131; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Jinks A, 2001, PHYSIOL BEHAV, V72, P51, DOI 10.1016/S0031-9384(00)00407-8; Riffell JA, 2014, SCIENCE, V344, P1515, DOI 10.1126/science.1251041; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Smith BH, 1998, PHYSIOL BEHAV, V65, P397, DOI 10.1016/S0031-9384(98)00142-5; Szyszka P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036096; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524	9	3	3	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1454	1454		10.1126/science.1255748	http://dx.doi.org/10.1126/science.1255748			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970067				2022-12-28	WOS:000337889900023
J	King, AM; Reid-Yu, SA; Wang, WL; King, DT; De Pascale, G; Strynadka, NC; Walsh, TR; Coombes, BK; Wright, GD				King, Andrew M.; Reid-Yu, Sarah A.; Wang, Wenliang; King, Dustin T.; De Pascale, Gianfranco; Strynadka, Natalie C.; Walsh, Timothy R.; Coombes, Brian K.; Wright, Gerard D.			Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; KLEBSIELLA-PNEUMONIAE; MICROBIAL INHIBITORS	The emergence and spread of carbapenem-resistant Gram-negative pathogens is a global public health problem. The acquisition of metallo-beta-lactamases (MBLs) such as NDM-1 is a principle contributor to the emergence of carbapenem-resistant Gram-negative pathogens that threatens the use of penicillin, cephalosporin and carbapenem antibiotics to treat infections. To date, a clinical inhibitor of MBLs that could reverse resistance and re-sensitize resistant Gram-negative pathogens to carbapenems has not been found. Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2. AMA also fully restored the activity of meropenem against Enterobacteriaceae, Acinetobacter spp. and Pseudomonas spp. possessing either VIM or NDM-type alleles. In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropenem activity, demonstrating that a combination of AMA and a carbapenem antibiotic has therapeutic potential to address the clinical challenge of MBL-positive carbapenem-resistant Gram-negative pathogens.	[King, Andrew M.; Wang, Wenliang; De Pascale, Gianfranco; Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [King, Andrew M.; Wright, Gerard D.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4K1, Canada; [Reid-Yu, Sarah A.; Coombes, Brian K.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [King, Dustin T.; Strynadka, Natalie C.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Walsh, Timothy R.] Cardiff Univ, Cardiff Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	McMaster University; McMaster University; McMaster University; University of British Columbia; Cardiff University	Wright, GD (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131; King, Dustin/0000-0003-1775-2885; Coombes, Brian/0000-0001-9883-1010; Walsh, Timothy/0000-0003-4315-4096	UK Medical Research Council [G1100135]; Canadian Institutes of Health Research [MT-13536]; Natural Sciences and Engineering Research Council [237480]; Canada Research Chair in Infectious Disease Pathogenesis; Antibiotic Biochemistry; Medical Research Council [G1100135] Funding Source: researchfish; MRC [G1100135] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Infectious Disease Pathogenesis; Antibiotic Biochemistry; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Mulvey (Public Health Agency of Canada) and R. Melano (Public Health Ontario) for clinical strains. We thank L. Rossi for her work in constructing the screening strain. AMA inhibition activity on clinical strains by T.R.W. was funded by the UK Medical Research Council (G1100135). This research was funded by a Canadian Institutes of Health Research Grant (MT-13536), Natural Sciences and Engineering Research Council Grant (237480), and by a Canada Research Chair in Infectious Disease Pathogenesis (to B.K.C.) and Antibiotic Biochemistry (to G.D.W.).	ARAI K, 1993, BIOSCI BIOTECH BIOCH, V57, P1944, DOI 10.1271/bbb.57.1944; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Buynak JD, 2013, EXPERT OPIN THER PAT, V23, P1469, DOI 10.1517/13543776.2013.831071; CDC, 2013, ANTIBIOTIC RESISTANC; Chang Y, 2013, LAB TRENDS DECEMBER; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; Endimiani A, 2011, ANTIMICROB AGENTS CH, V55, P82, DOI 10.1128/AAC.01198-10; EUCAST, 2014, BREAKP TABL INT MICS; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Frere J. M., 2011, BETA LACTAMASES; Frias M, 2014, MMWR-MORBID MORTAL W, V62, P1051; HAENNI AL, 1965, HELV CHIM ACTA, V48, P729, DOI 10.1002/hlca.19650480409; HOLMQUIST B, 1979, ANAL BIOCHEM, V95, P540, DOI 10.1016/0003-2697(79)90769-3; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Lee M, 2005, J ORG CHEM, V70, P367, DOI 10.1021/jo0487395; Marra A, 2012, ANTIMICROB AGENTS CH, V56, P4671, DOI 10.1128/AAC.00276-12; MATSUURA A, 1993, JPN J PHARMACOL, V63, P187, DOI 10.1254/jjp.63.187; MIKAMI Y, 1983, AGR BIOL CHEM TOKYO, V47, P2693, DOI 10.1080/00021369.1983.10866020; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Shlaes DM, 2013, ANN NY ACAD SCI, V1277, P105, DOI 10.1111/nyas.12010; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	358	376	4	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					503	+		10.1038/nature13445	http://dx.doi.org/10.1038/nature13445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965651	Green Accepted			2022-12-28	WOS:000337806300039
J	Zheng, XY; Lee, H; Weisgraber, TH; Shusteff, M; DeOtte, J; Duoss, EB; Kuntz, JD; Biener, MM; Ge, Q; Jackson, JA; Kucheyev, SO; Fang, NX; Spadaccini, CM				Zheng, Xiaoyu; Lee, Howon; Weisgraber, Todd H.; Shusteff, Maxim; DeOtte, Joshua; Duoss, Eric B.; Kuntz, Joshua D.; Biener, Monika M.; Ge, Qi; Jackson, Julie A.; Kucheyev, Sergei O.; Fang, Nicholas X.; Spadaccini, Christopher M.			Ultralight, Ultrastiff Mechanical Metamaterials	SCIENCE			English	Article							COMPRESSIVE BEHAVIOR; DEFORMATION; STRENGTH; KELVIN; FOAMS	The mechanical properties of ordinary materials degrade substantially with reduced density because their structural elements bend under applied load. We report a class of microarchitected materials that maintain a nearly constant stiffness per unit mass density, even at ultralow density. This performance derives from a network of nearly isotropic microscale unit cells with high structural connectivity and nanoscale features, whose structural members are designed to carry loads in tension or compression. Production of these microlattices, with polymers, metals, or ceramics as constituent materials, is made possible by projection microstereolithography (an additive micromanufacturing technique) combined with nanoscale coating and postprocessing. We found that these materials exhibit ultrastiff properties across more than three orders of magnitude in density, regardless of the constituent material.	[Zheng, Xiaoyu; Weisgraber, Todd H.; Shusteff, Maxim; DeOtte, Joshua; Duoss, Eric B.; Kuntz, Joshua D.; Biener, Monika M.; Jackson, Julie A.; Kucheyev, Sergei O.; Spadaccini, Christopher M.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Lee, Howon; Ge, Qi; Fang, Nicholas X.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Massachusetts Institute of Technology (MIT)	Zheng, XY (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	zheng3@llnl.gov; nicfang@mit.edu; spadaccini2@llnl.gov	Ge, Qi/B-2485-2015; Ge, Qi/N-1913-2019; Lee, Howon/A-1486-2012; Shusteff, Maxim/AAE-3505-2020; Duoss, Eric/AAW-3224-2021; Kuntz, Joshua D/I-3159-2014; Zheng, Xiaoyu/I-2193-2014; Fang, Nicholas/A-5856-2008	Ge, Qi/0000-0002-8666-8532; Ge, Qi/0000-0002-8666-8532; Lee, Howon/0000-0001-5778-2398; Fang, Nicholas/0000-0001-5713-629X; Zheng, Xiaoyu/0000-0001-8685-5728; /0000-0001-7000-1963; Duoss, Eric/0000-0002-5473-2528; Kuntz, Joshua/0000-0002-7630-6730; DeOtte, Joshua/0000-0002-4388-7129; Weisgraber, Todd/0000-0001-5183-9525	U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; LDRD Strategic Initiative [11-SI-005]; DARPA MCMA (Materials with Controlled Microstructural Architecture)	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); LDRD Strategic Initiative; DARPA MCMA (Materials with Controlled Microstructural Architecture)	This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Supported by LDRD Strategic Initiative 11-SI-005 and DARPA MCMA (Materials with Controlled Microstructural Architecture, Program Manager J. Goldwasser). The authors at Lawrence Livermore National Laboratory thank H. Rathbun for useful discussions on modeling the lattice structures, M. Worsley for taking SEM images, and C. Harvey for technical support. N.X.F. thanks S. Cai at University of California San Diego for insightful input regarding buckling modes in ceramic octet-truss lattices (LLNL-JRNL-640334).	Ando K, 1999, J WOOD SCI, V45, P120, DOI 10.1007/BF01192328; Arcaute K, 2011, TISSUE ENG PART C-ME, V17, P27, DOI [10.1089/ten.tec.2010.0011, 10.1089/ten.TEC.2010.0011]; Baudis S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055003; Bauer J, 2014, P NATL ACAD SCI USA, V111, P2453, DOI 10.1073/pnas.1315147111; Cheung KC, 2013, SCIENCE, V341, P1219, DOI 10.1126/science.1240889; Cochran JK, 2002, PROCESSSING AND PROPERTIES OF LIGHTWEIGHT CELLULAR METALS AND STRUCTURES, P127; DAM CQ, 1990, J MATER RES, V5, P163, DOI 10.1557/JMR.1990.0163; DAY P, 1984, MOD CAST, V74, P16; Deshpande VS, 2001, J MECH PHYS SOLIDS, V49, P1747, DOI 10.1016/S0022-5096(01)00010-2; Fan HL, 2009, MATER DESIGN, V30, P511, DOI 10.1016/j.matdes.2008.05.061; Fan HY, 2007, NAT MATER, V6, P418, DOI 10.1038/nmat1913; Gibson J., 2001, CELLULAR SOLIDS STRU; Gibson LJ, 2003, MRS BULL, V28, P270, DOI 10.1557/mrs2003.79; Hyun S, 2009, COMP MATER SCI, V46, P73, DOI 10.1016/j.commatsci.2009.02.007; Jacobsen AJ, 2007, ADV MATER, V19, P3892, DOI 10.1002/adma.200700797; Jang DC, 2013, NAT MATER, V12, P893, DOI [10.1038/NMAT3738, 10.1038/nmat3738]; Jang WY, 2010, INT J SOLIDS STRUCT, V47, P2872, DOI 10.1016/j.ijsolstr.2010.06.014; Kepler JA, 2011, COMPOS SCI TECHNOL, V71, P46, DOI 10.1016/j.compscitech.2010.10.002; Kucheyev SO, 2012, ADV MATER, V24, P776, DOI 10.1002/adma.201103561; Kwon OY, 2006, J IND ENG CHEM, V12, P306; Li MQ, 2007, RARE METAL MAT ENG, V36, P575; Lyu N, 2006, J MECH DESIGN, V128, P527, DOI 10.1115/1.2181599; Maloney KJ, 2013, APL MATER, V1, DOI 10.1063/1.4818168; Meza LR, 2014, J MATER SCI, V49, P2496, DOI 10.1007/s10853-013-7945-x; Moreau LM, 2012, NANO LETT, V12, P4530, DOI 10.1021/nl301642g; Olson RA, 2005, ADV ENG MATER, V7, P187, DOI 10.1002/adem.200500021; Qiu L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2251; Rayneau-Kirkhope D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.204301; Renton J. D., 2002, ELASTIC BEAMS FRAMES; Ryan TM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0172; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Schaedler TA, 2014, ADV ENG MATER, V16, P276, DOI 10.1002/adem.201300206; Shen JH, 2013, KEY ENG MATER, V535-536, P465, DOI [10.4028/www.scientific.net/KEM.535-536.465, 10.4028/www.scientific.net/KEM.537.46]; Sun C, 2005, SENSOR ACTUAT A-PHYS, V121, P113, DOI 10.1016/j.sna.2004.12.011; Takahashi Y, 2010, INT J MECH SCI, V52, P377, DOI 10.1016/j.ijmecsci.2009.10.009; Tantikom K, 2004, MATER TRANS, V45, P509, DOI 10.2320/matertrans.45.509; TILLOTSON TM, 1992, J NON-CRYST SOLIDS, V145, P44, DOI 10.1016/S0022-3093(05)80427-2; Torrents A, 2012, ACTA MATER, V60, P3511, DOI 10.1016/j.actamat.2012.03.007; Valdevit L, 2006, INT J HEAT MASS TRAN, V49, P3819, DOI 10.1016/j.ijheatmasstransfer.2006.03.042; Valdevit L, 2011, J AM CERAM SOC, V94, P1, DOI 10.1111/j.1551-2916.2011.04599.x; Van Liedekerke P, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026006; Worsley MA, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086293; ZHANG J, 1992, INT J MECH SCI, V34, P475, DOI 10.1016/0020-7403(92)90013-7; Zheng XY, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4769050	44	1188	1245	91	1303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1373	1377		10.1126/science.1252291	http://dx.doi.org/10.1126/science.1252291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948733	Green Submitted			2022-12-28	WOS:000337531700034
J	Wiesel, T				Wiesel, Torsten			Turning brain drain into brain circulation	NATURE			English	Editorial Material									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Wiesel, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	wiesel@rockefeller.edu							0	6	6	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					213	214		10.1038/510213a	http://dx.doi.org/10.1038/510213a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI7AT	24926501	Bronze			2022-12-28	WOS:000337032400028
J	Trepo, C; Chan, HLY; Lok, A				Trepo, Christian; Chan, Henry L. Y.; Lok, Anna			Hepatitis B virus infection	LANCET			English	Article							E-ANTIGEN SEROCONVERSION; TENOFOVIR DISOPROXIL FUMARATE; HBEAG-POSITIVE PATIENTS; SURFACE-ANTIGEN; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; FOLLOW-UP; ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA-2A; HBSAG SEROCLEARANCE	Hepatitis B virus infection is a major public health problem worldwide; roughly 30% of the world's population show serological evidence of current or past infection. Hepatitis B virus is a partly double-stranded DNA virus with several serological markers: HBsAg and anti-HBs, HBeAg and anti-HBe, and anti-HBc IgM and IgG. It is transmitted through contact with infected blood and semen. A safe and effective vaccine has been available since 1981, and, although variable, the implementation of universal vaccination in infants has resulted in a sharp decline in prevalence. Hepatitis B virus is not cytopathic; both liver damage and viral control-and therefore clinical outcome-depend on the complex interplay between virus replication and host immune response. Overall, as much as 40% of men and 15% of women with perinatally acquired hepatitis B virus infection will die of liver cirrhosis or hepatocellular carcinoma. In addition to decreasing hepatic inflammation, long-term antiviral treatment can reverse cirrhosis and reduce hepatocellular carcinoma. Development of new therapies that can improve HBsAg clearance and virological cure is warranted.	[Trepo, Christian] Hosp Civils Lyon, Croix Rousse Hosp, Dept Hepatol, Lyon, France; [Trepo, Christian] INSERM U1052, Lyon, France; [Chan, Henry L. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Henry L. Y.] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Lok, Anna] Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Ann Arbor, MI USA	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Chinese University of Hong Kong; Chinese University of Hong Kong; University of Michigan System; University of Michigan	Trepo, C (corresponding author), Croix Rousse Hosp, Dept Hepatol, 103 Grande Rue Croix Rousse, F-69004 Lyon, France.	christian.trepo@chu-lyon.fr	Chan, Henry Lik-Yuen/B-9636-2008	Chan, Henry Lik-Yuen/0000-0002-7790-1611	Alice Lohrman Andrews Professorship through the Tuktawa Foundation; National Institutes of Health [U01 DK082863]; French National Agency for Research on AIDS and Viral Hepatitis (ANRS); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082863] Funding Source: NIH RePORTER	Alice Lohrman Andrews Professorship through the Tuktawa Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AL is supported by the Alice Lohrman Andrews Professorship through the Tuktawa Foundation and a grant from the National Institutes of Health (U01 DK082863). CT is supported by grants from the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). We are grateful to Pierre Pradat for his skilful review of the published work and to Fabien Zoulim for his critical input.	Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; BEASLEY RP, 1981, LANCET, V2, P1129; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Bertoletti A, 2010, ANTIVIR THER, V15, P15, DOI 10.3851/IMP1620; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Boni C, 2012, GASTROENTEROLOGY, V143, P963, DOI 10.1053/j.gastro.2012.07.014; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Busch MP, 2004, TRANSFUS CLIN BIOL, V11, P26, DOI 10.1016/j.tracli.2003.12.003; Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; Chu CM, 2007, GASTROENTEROLOGY, V133, P1458, DOI 10.1053/j.gastro.2007.08.039; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Fattovich G, 2008, GUT, V57, P84, DOI 10.1136/gut.2007.128496; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; FitzSimons D, 2013, VACCINE, V31, P584, DOI 10.1016/j.vaccine.2012.10.101; Hahne SJM, 2012, EPIDEMIOL INFECT, V140, P1469, DOI 10.1017/S095026881100224X; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jeng WJ, 2013, HEPATOLOGY, V58, P1888, DOI 10.1002/hep.26549; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lampertico P, 2013, HEPATOLOGY, V57, P890, DOI 10.1002/hep.25749; Lampertico P, 2012, GUT, V61, P18, DOI 10.1136/gutjnl-2012-302085; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee MH, 2013, HEPATOLOGY, V58, P546, DOI 10.1002/hep.26385; LIAW YF, 1983, GASTROENTEROLOGY, V84, P216; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Liu J, 2013, J HEPATOL, V58, P853, DOI 10.1016/j.jhep.2012.12.006; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1990, J HEPATOL, V10, P29, DOI 10.1016/0168-8278(90)90069-4; LOK ASF, 1987, GASTROENTEROLOGY, V92, P1839, DOI 10.1016/0016-5085(87)90613-5; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Martinot-Peignoux M, 2013, J HEPATOL, V58, P1089, DOI 10.1016/j.jhep.2013.01.028; MARUYAMA T, 1993, GASTROENTEROLOGY, V105, P1141, DOI 10.1016/0016-5085(93)90960-K; McMahon BJ, 2009, J INFECT DIS, V200, P1390, DOI 10.1086/606119; Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029; Michel ML, 2011, J HEPATOL, V54, P1286, DOI 10.1016/j.jhep.2010.12.031; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Mitchell T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027717; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; OKAMOTO H, 1994, J VIROL, V68, P8102, DOI 10.1128/JVI.68.12.8102-8110.1994; Pan CQ, 2013, SEMIN LIVER DIS, V33, P138, DOI 10.1055/s-0033-1345718; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Scaglione SJ, 2012, GASTROENTEROLOGY, V142, P1360, DOI 10.1053/j.gastro.2012.01.044; Simonetti J, 2010, HEPATOLOGY, V51, P1531, DOI 10.1002/hep.23464; Sonneveld MJ, 2013, HEPATOLOGY, V58, P872, DOI 10.1002/hep.26436; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Trepo C, 2013, VIRAL HEPATITIS; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Van Damme P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4057; Wasley Annemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Wen WH, 2013, J HEPATOL, V59, P24, DOI 10.1016/j.jhep.2013.02.015; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301; World Health Organization, GLOB IMM DAT; Wu IC, 2010, HEPATOLOGY, V51, P1185, DOI 10.1002/hep.23424; Wu TW, 2013, HEPATOLOGY, V57, P38, DOI 10.1002/hep.25988; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yapali S, 2014, CLIN GASTROENTEROL H, V12, P16, DOI 10.1016/j.cgh.2013.04.036; Yeo W, 2013, J GASTROEN HEPATOL, V28, P31, DOI 10.1111/j.1440-1746.2012.07280.x; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008; Zoulim F, 2013, GASTROENTEROLOGY, V144, P1342, DOI 10.1053/j.gastro.2013.04.028	99	966	1054	16	241	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2053	2063		10.1016/S0140-6736(14)60220-8	http://dx.doi.org/10.1016/S0140-6736(14)60220-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	24954675				2022-12-28	WOS:000346353600027
J	Johnston, BD				Johnston, Brian D.			Why is UK performance in child and youth mortality so poor?	LANCET			English	Editorial Material							SOCIAL DETERMINANTS; HEALTH; INEQUALITIES; EUROPE; CARE		Univ Washington, Dept Pediat, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle	Johnston, BD (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98104 USA.	bdj@uw.edu	Johnston, Brian/AIB-8836-2022	Johnston, Brian/0000-0002-6980-8775				Armour-Marshall J, 2012, EUR J PUBLIC HEALTH, V22, P61, DOI 10.1093/eurpub/ckr004; Barak S, 2010, ACTA PAEDIATR, V99, P13, DOI 10.1111/j.1651-2227.2009.01546.x; Blackburn CM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-101; de Graaf JP, 2013, CURR OPIN OBSTET GYN, V25, P98, DOI 10.1097/GCO.0b013e32835ec9b0; Department of Health, 2013, 18733 DEP HLTH; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Kim D, 2013, INT J ENV RES PUB HE, V10, P2296, DOI 10.3390/ijerph10062296; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Sidebotham P, 2011, INJURY PREV, V17, P55, DOI 10.1136/ip.2010.027169; Viner RM, 2014, LANCET; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wolfe I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1277	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					837	838		10.1016/S0140-6736(14)60754-6	http://dx.doi.org/10.1016/S0140-6736(14)60754-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	24929451				2022-12-28	WOS:000341362200007
J	Garon, EB; Ciuleanu, TE; Arrieta, O; Prabhash, K; Syrigos, KN; Goksel, T; Park, K; Gorbunova, V; Kowalyszyn, RD; Pikiel, J; Czyzewicz, G; Orlov, SV; Lewanski, CR; Thomas, M; Bidoli, P; Dakhil, S; Gans, S; Kim, JH; Grigorescu, A; Karaseva, N; Reck, M; Cappuzzo, F; Alexandris, E; Sashegyi, A; Yurasov, S; Perol, M				Garon, Edward B.; Ciuleanu, Tudor-Eliade; Arrieta, Oscar; Prabhash, Kumar; Syrigos, Konstantinos N.; Goksel, Tuncay; Park, Keunchil; Gorbunova, Vera; Dario Kowalyszyn, Ruben; Pikiel, Joanna; Czyzewicz, Grzegorz; Orlov, Sergey V.; Lewanski, Conrad R.; Thomas, Michael; Bidoli, Paolo; Dakhil, Shaker; Gans, Steven; Kim, Joo-Hang; Grigorescu, Alexandru; Karaseva, Nina; Reck, Martin; Cappuzzo, Federico; Alexandris, Ekaterine; Sashegyi, Andreas; Yurasov, Sergey; Perol, Maurice			Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial	LANCET			English	Article							III TRIAL; BEVACIZUMAB; CARBOPLATIN; PACLITAXEL; CHEMOTHERAPY; SURVIVAL; ANGIOGENESIS; ERLOTINIB; LIFE	Background Ramucirumab is a human IgG1 monoclonal antibody that targets the extracellular domain of VEGFR-2. We aimed to assess efficacy and safety of treatment with docetaxel plus ramucirumab or placebo as second-line treatment for patients with stage IV non-small-cell-lung cancer (NSCLC) after platinum-based therapy. Methods In this multicentre, double-blind, randomised phase 3 trial (REVEL), we enrolled patients with squamous or non-squamous NSCLC who had progressed during or after a first-line platinum-based chemotherapy regimen. Patients were randomly allocated (1:1) with a centralised, interactive voice-response system (stratified by sex, region, performance status, and previous maintenance therapy [yes vs no]) to receive docetaxel 75 mg/m(2) and either ramucirumab (10 mg/kg) or placebo on day 1 of a 21 day cycle until disease progression, unacceptable toxicity, withdrawal, or death. The primary endpoint was overall survival in all patients allocated to treatment. We assessed adverse events according to treatment received. This study is registered with ClinicalTrials.gov, number NCT01168973. Findings Between Dec 3, 2010, and Jan 24, 2013, we screened 1825 patients, of whom 1253 patients were randomly allocated to treatment. Median overall survival was 10.5 months (IQR 5.1-21.2) for 628 patients allocated ramucirumab plus docetaxel and 9.1 months (4.2-18.0) for 625 patients who received placebo plus docetaxel (hazard ratio 0.86, 95% CI 0.75-0.98; p=0.023). Median progression-free survival was 4.5 months (IQR 2.3-8.3) for the ramucirumab group compared with 3.0 months (1.4-6.9) for the control group (0.76, 0.68-0.86; p<0.0001). We noted treatment-emergent adverse events in 613 (98%) of 627 patients in the ramucirumab safety population and 594 (95%) of 618 patients in the control safety population. The most common grade 3 or worse adverse events were neutropenia (306 patients [49%] in the ramucirumab group vs 246 [40%] in the control group), febrile neutropenia (100 [16%] vs 62 [10%]), fatigue (88 [14%] vs 65 [10%]), leucopenia (86 [14%] vs 77 [12%]), and hypertension (35 [6%] vs 13 [2%]). The numbers of deaths from adverse events (31 [5%] vs 35 [6%]) and grade 3 or worse pulmonary haemorrhage (eight [1%] vs eight [1%]) did not differ between groups. Toxicities were manageable with appropriate dose reductions and supportive care. Interpretation Ramucirumab plus docetaxel improves survival as second-line treatment of patients with stage IV NSCLC.	[Garon, Edward B.] Univ Calif Los Angeles, David Geffen Sch Med, Translat Res Oncol US Network, Los Angeles, CA 90095 USA; [Ciuleanu, Tudor-Eliade] Inst Oncol Ion Chiricuta, Cluj Napoca, Romania; [Ciuleanu, Tudor-Eliade] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania; [Arrieta, Oscar] Inst Nacl Cancerol INCAN, Mexico City, DF, Mexico; [Prabhash, Kumar] Tata Mem Hosp, Bombay, Maharashtra, India; [Syrigos, Konstantinos N.] Sotiria Gen Hosp, Athens Sch Med, Oncol Unit GPP, Athens, Greece; [Goksel, Tuncay] Ege Univ, Sch Med, Izmir, Turkey; [Park, Keunchil] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Gorbunova, Vera] NN Blokhin Canc Res Ctr, Dept Chemotherapy, Moscow, Russia; [Dario Kowalyszyn, Ruben] Clin Viedma, Ctr Invest Clin, Viedma, Argentina; [Pikiel, Joanna] Wojewodzkie Ctr Onkol, Gdansk, Poland; [Czyzewicz, Grzegorz] John Paul 2 Hosp, Dept Chemotherapy, Krakow, Poland; [Orlov, Sergey V.] Pavlov State Med Univ, St Petersburg, Russia; [Lewanski, Conrad R.] Charing Cross Hosp, London, England; [Thomas, Michael] Univ Klinikum Heidelberg, Thoraxklin, Translat Lung Res Ctr Heidelberg TLRC H, German Ctr Lung Res DZL, Heidelberg, Germany; [Bidoli, Paolo] San Gerardo Hosp, Monza, Italy; [Dakhil, Shaker] Canc Ctr Kansas, Wichita, KS USA; [Gans, Steven] St Jansdal Hosp, Herderwijk, Netherlands; [Kim, Joo-Hang] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South Korea; [Grigorescu, Alexandru] Inst Oncol, Dept Med Oncol, Bucharest, Romania; [Karaseva, Nina] City Clin Oncol Dispensary, St Petersburg, Russia; [Reck, Martin] German Ctr Lung Res DZL, LungenClin Grosshansdorf, Grosshansdorf, Germany; [Cappuzzo, Federico] Ist Toscano Tumori, Livorno, Italy; [Alexandris, Ekaterine; Yurasov, Sergey] Eli Lilly, ImClone Syst, Bridgewater, NJ USA; [Sashegyi, Andreas] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Perol, Maurice] Leon Berard Canc Ctr, Lyon, France	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy; Instituto Nacional de Cancerologia (INCAN); Tata Memorial Centre (TMC); Tata Memorial Hospital; Athens Medical School; National & Kapodistrian University of Athens; Ege University; Sungkyunkwan University (SKKU); Samsung Medical Center; N.N. Blokhin Russian Cancer Research Center; Pavlov First Saint Petersburg State Medical University; Imperial College London; Ruprecht Karls University Heidelberg; San Gerardo Hospital; Cancer Center of Kansas; Yonsei University; Yonsei University Health System; Institute of Oncology "Prof. Dr. Al Trestioreanu"; Grosshansdorf Hospital; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Eli Lilly; Eli Lilly; UNICANCER; Centre Leon Berard	Garon, EB (corresponding author), Translat Oncol Res Lab, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA.	egaron@mednet.ucla.edu	Cappuzzo, federico/R-2827-2016; Arrieta, Oscar/ABH-6022-2020; Orlov, Sergey/AAC-8379-2022; Ciuleanu, Tudor-Eliade/ABH-8452-2020; Reck, Martin/ABF-5721-2020; Park, Keunchil/ABD-7072-2021; GRIGORESCU, Alexandru Calin/M-7751-2018; Park, Keunchil/ABD-5852-2021; Syrigos, Kostas/AAE-8045-2019	Cappuzzo, federico/0000-0002-6295-6767; Reck, Martin/0000-0002-5348-4462; Park, Keunchil/0000-0002-4846-7449; Orlov, Sergey/0000-0001-6080-8042; Arrieta, Oscar/0000-0002-1164-3779; Ciuleanu, Tudor Eliade/0000-0003-0958-5597	Eli Lilly	Eli Lilly(Eli Lilly)	Funding Eli Lilly.	Booth CM, 2012, J CLIN ONCOL, V30, P1030, DOI 10.1200/JCO.2011.38.7571; Crino L, 2014, EUR RESPIR REV, V23, P79, DOI 10.1183/09059180.00008913; Di Maio M, 2010, EUR J CANCER, V46, P735, DOI 10.1016/j.ejca.2009.12.013; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Garon EB, 2012, CLIN LUNG CANCER, V13, P505, DOI 10.1016/j.cllc.2012.06.007; Gerber DE, 2013, J CLIN ONCOL, V31, P1009, DOI 10.1200/JCO.2012.43.7459; Hainsworth JD, 2011, J THORAC ONCOL, V6, P109, DOI 10.1097/JTO.0b013e3181f94ad4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; HOLLEN PJ, 1993, EUR J CANCER, V29A, pS51, DOI 10.1016/S0959-8049(05)80262-X; Hotta K, 2007, J THORAC ONCOL, V2, P402, DOI 10.1097/01.JTO.0000268673.95119.c7; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Leighl NB, 2012, CURR ONCOL, V19, pS52, DOI 10.3747/co.19.1114; Li TH, 2013, J CLIN ONCOL, V31, P1039, DOI 10.1200/JCO.2012.45.3753; Mackey J, 2013, SAN ANT BREAST CANC; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sandler AB, 2009, J CLIN ONCOL, V27, P1405, DOI 10.1200/JCO.2008.16.2412; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Spratlin JL, 2010, J CLIN ONCOL, V28, P780, DOI 10.1200/JCO.2009.23.7537; Stinchcombe Thomas E, 2009, Proc Am Thorac Soc, V6, P233, DOI 10.1513/pats.200809-110LC; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; *US DEP HHS, COMM TERM CRIT ADV E; Wilke H, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.3_suppl.lba7; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	34	804	841	4	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					665	673		10.1016/S0140-6736(14)60845-X	http://dx.doi.org/10.1016/S0140-6736(14)60845-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	24933332				2022-12-28	WOS:000341359100024
J	Chaddah, P				Chaddah, Praveen			Not all plagiarism requires a retraction	NATURE			English	Editorial Material									Univ Grants Commiss, Dept Atom Energy Consortium Sci Res, Indore, Madhya Pradesh, India		Chaddah, P (corresponding author), Univ Grants Commiss, Dept Atom Energy Consortium Sci Res, Indore, Madhya Pradesh, India.	chaddah.praveen@gmail.com							0	7	7	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					127	127		10.1038/511127a	http://dx.doi.org/10.1038/511127a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25008489	Bronze			2022-12-28	WOS:000338649800013
J	Mankaney, GN; Vipperla, K				Mankaney, Gautam Naresh; Vipperla, Kishore			Acquired Acrodermatitis Enteropathica	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mankaney, Gautam Naresh; Vipperla, Kishore] Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mankaney, GN (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	mankaneygn@upmc.edu							0	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					67	67		10.1056/NEJMicm1312911	http://dx.doi.org/10.1056/NEJMicm1312911			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988559				2022-12-28	WOS:000338265700011
J	Mayer-Barber, KD; Andrade, BB; Oland, SD; Amaral, EP; Barber, DL; Gonzales, J; Derrick, SC; Shi, RR; Kumar, NP; Wei, W; Yuan, X; Zhang, GL; Cai, Y; Babu, S; Catalfamo, M; Salazar, AM; Via, LE; Barry, CE; Sher, A				Mayer-Barber, Katrin D.; Andrade, Bruno B.; Oland, Sandra D.; Amaral, Eduardo P.; Barber, Daniel L.; Gonzales, Jacqueline; Derrick, Steven C.; Shi, Ruiru; Kumar, Nathella Pavan; Wei, Wang; Yuan, Xing; Zhang, Guolong; Cai, Ying; Babu, Subash; Catalfamo, Marta; Salazar, Andres M.; Via, Laura E.; Barry, Clifton E., III; Sher, Alan			Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; INDUCTION; SUSCEPTIBILITY; INFLAMMATION; INFECTION; IMMUNITY; INNATE	Tuberculosis remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent(1). Despite chemotherapy, the global tuberculosis epidemic has intensified because of HIV co-infection, the lack of an effective vaccine and the emergence of multi-drug-resistant bacteria(2-5). Alternative host-directed strategies could be exploited to improve treatment efficacy and outcome, contain drug-resistant strains and reduce disease severity and mortality(6). The innate inflammatory response elicited by Mycobacterium tuberculosis (Mtb) represents a logical host target(7). Here we demonstrate that interleukin-1 (IL-1) confers host resistance through the induction of eicosanoids that limit excessive type I interferon (IFN) production and foster bacterial containment. We further show that, in infected mice and patients, reduced IL-1 responses and/or excessive type I IFN induction are linked to an eicosanoid imbalance associated with disease exacerbation. Host-directed immunotherapy with clinically approved drugs that augment prostaglandin E2 levels in these settings prevented acute mortality of Mtb-infected mice. Thus, IL-1 and type I IFNs represent two major counter-regulatory classes of inflammatory cytokines that control the outcome of Mtb infection and are functionally linked via eicosanoids. Our findings establish proof of concept for host-directed treatment strategies that manipulate the host eicosanoid network and represent feasible alternatives to conventional chemotherapy.	[Mayer-Barber, Katrin D.; Andrade, Bruno B.; Oland, Sandra D.; Amaral, Eduardo P.; Sher, Alan] NIAID, Immunobiol Sect, LPD, NIH, Bethesda, MD 20892 USA; [Amaral, Eduardo P.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Barber, Daniel L.] NIAID, Lymphocyte Biol Unit T, LPD, NIH, Bethesda, MD 20892 USA; [Gonzales, Jacqueline; Via, Laura E.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Derrick, Steven C.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Shi, Ruiru; Wei, Wang; Yuan, Xing] Henan Chest Hosp, Zhengzhou 450003, Peoples R China; [Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, NIH, Madras 600031, Tamil Nadu, India; [Kumar, Nathella Pavan] NIRT, Madras 600031, Tamil Nadu, India; [Zhang, Guolong] SinoUS Int Res Ctr TB, Zhengzhou 450003, Peoples R China; [Zhang, Guolong] Henan Publ Hlth Ctr, Zhengzhou 450003, Peoples R China; [Babu, Subash] NIAID, Helminth Immunol Sect, LPD, NIH, Bethesda, MD 20892 USA; [Catalfamo, Marta] NIAID, Clin & Mol Retrovirol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC 20008 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mayer-Barber, KD (corresponding author), NIAID, Immunobiol Sect, LPD, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mayerk@niaid.nih.gov	Barry, III, Clifton/H-3839-2012; Zhang, Guolong/HCI-5587-2022; Barry, Clifton E/ABE-7992-2020; Babu, Subash/GXG-4746-2022; Andrade, Bruno/AAI-2248-2020; Kumar, Nathella Pavan/AAU-2328-2021; Amaral, Eduardo EP/M-2456-2014; Via, Laura/AAD-3917-2021; Andrade, Bruno/J-9111-2012	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Amaral, Eduardo EP/0000-0001-5465-8113; Via, Laura/0000-0001-6074-9521; Andrade, Bruno/0000-0001-6833-3811	NIAID Intramural Research program; Concept Acceleration Program-Award from DMID, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001081, ZIAAI000783, ZIAAI001044, ZIAAI000734, ZIAAI001065, ZIAAI001171] Funding Source: NIH RePORTER	NIAID Intramural Research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Concept Acceleration Program-Award from DMID, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID Intramural Research program and a Concept Acceleration Program-Award (K.D.M.-B., B.B.A. and A.S.) from DMID, NIAID. We are grateful to K. Elkins, S. Morris, M. Belcher as well as the NIAID ABSL3 support staff for facilitating our animal studies. We thank R. Chen, L. Goldfeder and Q. Gao for sharing their clinical trial expertise and research facilities, respectively. We also thank K. Kauffman, R. Thompson, S. Hieny, P. Dayal, D. Surman, L. Meng, Z. Li, L. Lifa, Q. Shen and Z. Huang for technical assistance, H. Boshoff for help with direct anti-mycobacterial activity assays and M. S. Jawahar, V. V. Banurekha and R. Sridhar for recruitment and clinical evaluation of patients in Chennai, India. We are grateful to F. Andrade Neto, H. Remold, K. Arora, J. Aliberti, M. Moayeri, P. Murphy, A. O'Garra, R. Germain and C. Serhan for discussion or critical reading of the manuscript. Finally, we thank the patients, volunteer participants, and clinical staff of the Tuberculosis department of Henan Chest Hospital in Zhengzhou, China and the Department of Clinical Research (NIRT) and Department of Thoracic Medicine (Government Stanley Medical Hospital) in Chennai, India for their participation in our clinical studies.	Andrade BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062618; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bishai W, 2013, NAT MED, V19, P410, DOI 10.1038/nm.3153; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Humason G. L., 1979, ANIMAL TISSUE TECHNI, P355; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; Kirtikara K, 1998, J EXP MED, V187, P517, DOI 10.1084/jem.187.4.517; Kuo HP, 2000, AM J RESP CRIT CARE, V161, P192, DOI 10.1164/ajrccm.161.1.9902113; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Rousu J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003018; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tsao T.C.Y., 1999, Tubercle and Lung Disease, V79, P279, DOI 10.1054/tuld.1999.0215; Wang C H, 2001, Respirology, V6, P79	32	481	496	1	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					99	U491		10.1038/nature13489	http://dx.doi.org/10.1038/nature13489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990750	Green Accepted, Green Published			2022-12-28	WOS:000338199400044
J	Boissan, M; Montagnac, G; Shen, QF; Griparic, L; Guitton, J; Romao, M; Sauvonnet, N; Lagache, T; Lascu, I; Raposo, G; Desbourdes, C; Schlattner, U; Lacombe, ML; Polo, S; van der Bliek, AM; Roux, A; Chavrier, P				Boissan, Mathieu; Montagnac, Guillaume; Shen, Qinfang; Griparic, Lorena; Guitton, Jerome; Romao, Maryse; Sauvonnet, Nathalie; Lagache, Thibault; Lascu, Ioan; Raposo, Graca; Desbourdes, Celine; Schlattner, Uwe; Lacombe, Marie-Lise; Polo, Simona; van der Bliek, Alexander M.; Roux, Aurelien; Chavrier, Philippe			Nucleoside diphosphate kinases fuel dynamin superfamily proteins with GTP for membrane remodeling	SCIENCE			English	Article							FISSION; CARDIOLIPIN; MECHANISM; HOMOLOG; RINGS; NM23; AWD	Dynamin superfamily molecular motors use guanosine triphosphate (GTP) as a source of energy for membrane-remodeling events. We found that knockdown of nucleoside diphosphate kinases (NDPKs) NM23-H1/H2, which produce GTP through adenosine triphosphate (ATP)-driven conversion of guanosine diphosphate (GDP), inhibited dynamin-mediated endocytosis. NM23-H1/H2 localized at clathrin-coated pits and interacted with the proline-rich domain of dynamin. In vitro, NM23-H1/H2 were recruited to dynamin-induced tubules, stimulated GTP-loading on dynamin, and triggered fission in the presence of ATP and GDP. NM23-H4, a mitochondria-specific NDPK, colocalized with mitochondrial dynamin-like OPA1 involved in mitochondria inner membrane fusion and increased GTP-loading on OPA1. Like OPA1 loss of function, silencing of NM23-H4 but not NM23-H1/H2 resulted in mitochondrial fragmentation, reflecting fusion defects. Thus, NDPKs interact with and provide GTP to dynamins, allowing these motor proteins to work with high thermodynamic efficiency.	[Boissan, Mathieu; Montagnac, Guillaume; Romao, Maryse; Raposo, Graca; Chavrier, Philippe] Inst Curie, Res Ctr, Paris, France; [Boissan, Mathieu; Montagnac, Guillaume; Chavrier, Philippe] CNRS, UMR 144, Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] Univ Paris 06, Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] INSERM, UMR S 938, St Antoine Res Ctr, Paris, France; [Shen, Qinfang; Griparic, Lorena; van der Bliek, Alexander M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Guitton, Jerome] Hosp Civils Lyon, Pierre Benite, France; [Guitton, Jerome] Univ Lyon, Lyon, France; [Romao, Maryse; Raposo, Graca] CNRS, UMR 144, Paris, France; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France; [Lagache, Thibault] Inst Pasteur, Quantitat Image Anal Unit, Paris, France; [Lascu, Ioan] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France; [Desbourdes, Celine; Schlattner, Uwe] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget, Grenoble, France; [Desbourdes, Celine; Schlattner, Uwe] INSERM, U1055, Grenoble, France; [Polo, Simona] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Polo, Simona] Univ Milan, Dipartimento Sci Salute, Milan, Italy; [Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Roux, Aurelien] Swiss Natl Ctr Competence Res Program Chem Biol, Geneva, Switzerland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Geneva	Boissan, M (corresponding author), Inst Curie, Res Ctr, Paris, France.	mathieu.boissan@inserm.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/B-4707-2010; Schlattner, Uwe/D-1267-2009; Roux, Aurelien/AAU-1262-2021; Polo, Simona/P-3509-2014; Roux, Aurelien R/G-9541-2013; Lagache, Thibaut/AAC-1067-2020; CHAVRIER, Philippe/AAG-2645-2020	CHAVRIER, Philippe/0000-0002-7351-733X; Schlattner, Uwe/0000-0003-1159-5911; Roux, Aurelien R/0000-0002-6088-0711; Lagache, Thibaut/0000-0002-7033-4677; CHAVRIER, Philippe/0000-0002-7351-733X; Raposo, graca/0000-0001-9590-1298; sauvonnet, nathalie/0000-0003-0306-3376; Guitton, Jerome/0000-0001-6180-5708; Polo, Simona/0000-0001-5536-9399	Institut Curie; CNRS; Fondation ARC pour la Recherche sur le Cancer; Groupement des Entreprises Francaises contre le Cancer; Fondation pour la Recherche Medicale; Human Frontier Science Program; Swiss National Fund for Research Grant; European Research Council	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Groupement des Entreprises Francaises contre le Cancer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program(Human Frontier Science Program); Swiss National Fund for Research Grant; European Research Council(European Research Council (ERC)European Commission)	We thank P. De Camilli, E. Smythe, and J. Bertoglio for reagents; S. L. Schmid and M. Mettlen for discussion; the Nikon Imaging Center@Institut Curie & Centre National de la Recherche Scientifique (CNRS) for image acquisition; and I. Hurbain for EM quantification. This work was supported by Institut Curie, CNRS, Fondation ARC pour la Recherche sur le Cancer, Groupement des Entreprises Francaises contre le Cancer, Fondation pour la Recherche Medicale, the Human Frontier Science Program, the Swiss National Fund for Research Grant, and the European Research Council.	Binns DD, 2000, BIOCHEMISTRY-US, V39, P7188, DOI 10.1021/bi000033r; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lascu I, 1997, J BIOL CHEM, V272, P15599, DOI 10.1074/jbc.272.25.15599; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Nallamothu G, 2008, MOL CELL BIOL, V28, P1964, DOI 10.1128/MCB.01743-07; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schlattner U, 2013, J BIOL CHEM, V288, P111, DOI 10.1074/jbc.M112.408633; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072	21	92	93	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1510	1515		10.1126/science.1253768	http://dx.doi.org/10.1126/science.1253768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970086	Green Accepted			2022-12-28	WOS:000337889900049
J	Patorno, E; Neuman, MD; Schneeweiss, S; Mogun, H; Bateman, BT				Patorno, Elisabetta; Neuman, Mark D.; Schneeweiss, Sebastian; Mogun, Helen; Bateman, Brian T.			Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAJOR NONCARDIAC SURGERY; GENERAL-ANESTHESIA; REGIONAL ANESTHESIA; RANDOMIZED-TRIALS; MORTALITY; OUTCOMES; METAANALYSIS; RISK; COMPLICATIONS; THERAPY	Objective To evaluate the effect of anesthesia type on the risk of in-hospital mortality among adults undergoing hip fracture surgery in the United States. Design Retrospective cohort study. Setting Premier research database, United States. Participants 73 284 adults undergoing hip fracture surgery on hospital day 2 or greater between 2007 and 2011. Of those, 61 554 (84.0%) received general anesthesia, 6939 (9.5%) regional anesthesia, and 4791 (6.5%) combined general and regional anesthesia. Main outcome measure In-hospital all cause mortality. Results In-hospital deaths occurred in 1362 (2.2%) patients receiving general anesthesia, 144 (2.1%) receiving regional anesthesia, and 115 (2.4%) receiving combined anesthesia. In the multivariable adjusted analysis, when compared with general anesthesia the mortality risk did not differ significantly between regional anesthesia (risk ratio 0.93, 95% confidence interval 0.78 to 1.11) or combined anesthesia (1.00, 0.82 to 1.22). A mixed effects analysis accounting for differences between hospitals produced similar results: compared with general anesthesia the risk from regional anesthesia was 0.91 (0.75 to 1.10) and from combined anesthesia was 0.98 (0.79 to 1.21). Findings were also consistent in subgroup analyses. Conclusions In this large nationwide sample of hospital admissions, mortality risk did not differ significantly by anesthesia type among patients undergoing hip fracture surgery. Our results suggest that if the previously posited beneficial effect of regional anesthesia on short term mortality exists, it is likely to be more modest than previously reported.	[Patorno, Elisabetta; Schneeweiss, Sebastian; Mogun, Helen; Bateman, Brian T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA; [Neuman, Mark D.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Bateman, Brian T.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital	Patorno, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA.	epatorno@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School; Foundation for Anesthesia Education and Research (Rochester, MN); National Institute on Aging [K08AG043548]; Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health [K08HD075831]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG043548] Funding Source: NIH RePORTER	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School; Foundation for Anesthesia Education and Research (Rochester, MN); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School and by grants to MDN from the Foundation for Anesthesia Education and Research (Rochester, MN) and the National Institute on Aging (K08AG043548) and to BTB from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award No K08HD075831. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 1988, INT CLASS DIS CLIN M; Bateman BT, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5416; Beaupre LA, 2005, J GEN INTERN MED, V20, P1019, DOI 10.1111/j.1525-1497.2005.00219.x; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kettner SC, 2011, BRIT J ANAESTH, V107, P90, DOI 10.1093/bja/aer340; Kulik A, 2008, CIRCULATION, V118, P1785, DOI 10.1161/CIRCULATIONAHA.108.799445; Lawrence VA, 2002, ARCH INTERN MED, V162, P2053, DOI 10.1001/archinte.162.18.2053; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Luger TJ, 2010, OSTEOPOROSIS INT, V21, pS555, DOI 10.1007/s00198-010-1399-7; Macfarlane AJR, 2009, CLIN ORTHOP RELAT R, V467, P2379, DOI 10.1007/s11999-008-0666-9; Memtsoudis SG, 2013, ANESTHESIOLOGY, V118, P1046, DOI 10.1097/ALN.0b013e318286061d; MODIG J, 1983, BRIT J ANAESTH, V55, P625, DOI 10.1093/bja/55.7.625; MODIG J, 1988, ACTA ANAESTH SCAND, V32, P44, DOI 10.1111/j.1399-6576.1988.tb02842.x; National Center for Health Statistics, 2014, NAT HOSP DISCH SURV; Neuman MD, 2012, ANESTHESIOLOGY, V117, P72, DOI 10.1097/ALN.0b013e3182545e7c; Neuman MD, 2009, J AM GERIATR SOC, V57, P2046, DOI 10.1111/j.1532-5415.2009.02492.x; Nishimori M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005059.pub2; O'Hara DA, 2000, ANESTHESIOLOGY, V92, P947, DOI 10.1097/00000542-200004000-00011; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Parker MJ, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; Radcliff TA, 2008, J BONE JOINT SURG AM, V90A, P34, DOI 10.2106/JBJS.G.00065; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Romano P. S., 1993, J CLIN EPIDEMIOL, V46, P81; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Svircevic V, 2011, ANESTHESIOLOGY, V114, P271, DOI 10.1097/ALN.0b013e318201d300; Urwin SC, 2000, BRIT J ANAESTH, V84, P450, DOI 10.1093/oxfordjournals.bja.a013468; Werawatganon T., 2005, COCHRANE DB SYST REV, V1; White SM, 2014, ANAESTHESIA, V69, P224, DOI 10.1111/anae.12542	33	64	68	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2014	348								g4022	10.1136/bmj.g4022	http://dx.doi.org/10.1136/bmj.g4022			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UP	24972901	Green Published, hybrid			2022-12-28	WOS:000338202700001
J	Stolper, DA; Lawson, M; Davis, CL; Ferreira, AA; Neto, EVS; Ellis, GS; Lewan, MD; Martini, AM; Tang, Y; Schoell, M; Sessions, AL; Eiler, JM				Stolper, D. A.; Lawson, M.; Davis, C. L.; Ferreira, A. A.; Santos Neto, E. V.; Ellis, G. S.; Lewan, M. D.; Martini, A. M.; Tang, Y.; Schoell, M.; Sessions, A. L.; Eiler, J. M.			Formation temperatures of thermogenic and biogenic methane	SCIENCE			English	Article							NATURAL-GAS GENERATION; ISOTOPE FRACTIONATION; PETROLEUM; CARBON; CONSTRAINTS; SHALE; OIL; OXIDATION; EXPULSION; KINETICS	Methane is an important greenhouse gas and energy resource generated dominantly by methanogens at low temperatures and through the breakdown of organic molecules at high temperatures. However, methane-formation temperatures in nature are often poorly constrained. We measured formation temperatures of thermogenic and biogenic methane using a "clumped isotope" technique. Thermogenic gases yield formation temperatures between 157 degrees and 221 degrees C, within the nominal gas window, and biogenic gases yield formation temperatures consistent with their comparatively lower-temperature formational environments (<50 degrees C). In systems where gases have migrated and other proxies for gas-generation temperature yield ambiguous results, methane clumped-isotope temperatures distinguish among and allow for independent tests of possible gas-formation models.	[Stolper, D. A.; Sessions, A. L.; Eiler, J. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lawson, M.; Davis, C. L.] ExxonMobil Upstream Res Co, Houston, TX USA; [Ferreira, A. A.; Santos Neto, E. V.] Petrobras Res & Dev Ctr CENPES, Div Geochem, Rio De Janeiro, RJ, Brazil; [Ellis, G. S.; Lewan, M. D.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [Martini, A. M.] Amherst Coll, Dept Geol, Amherst, MA 01002 USA; [Tang, Y.] Power Environm & Energy Res Inst, Covina, CA USA; [Schoell, M.] GasConsult Int Inc, Berkeley, CA USA	California Institute of Technology; Exxon Mobil Corporation; Petrobras; United States Department of the Interior; United States Geological Survey; Amherst College	Stolper, DA (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	dstolper@caltech.edu	Sessions, Alex/ABC-9207-2020; Ellis, Geoffrey S/G-8970-2011	Sessions, Alex/0000-0001-6120-2763; Lawson, Michael/0000-0003-2743-3773; Ellis, Geoffrey/0000-0003-4519-3320	NSF; Petrobras; ExxonMobil; Caltech	NSF(National Science Foundation (NSF)); Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); ExxonMobil(Exxon Mobil Corporation); Caltech	This work was supported by the NSF, Petrobras, ExxonMobil, and Caltech. We thank Petrobras and ExxonMobil for providing samples and permission to publish, C. Araujo and B. Peterson for helpful discussions, and R. Burruss and three anonymous reviewers for helpful comments on the manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. All data used to support the conclusions in this manuscript are provided in the supplementary materials.	[Anonymous], 21665 UCID LAWR LIV; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; Curtis JB, 2002, AAPG BULL, V86, P1921, DOI 10.1306/61eeddbe-173e-11d7-8645000102c1865d; Eiler JM, 2007, EARTH PLANET SC LETT, V262, P309, DOI 10.1016/j.epsl.2007.08.020; ENGLAND WA, 1987, J GEOL SOC LONDON, V144, P327, DOI 10.1144/gsjgs.144.2.0327; ESPITALIE J, 1988, ORG GEOCHEM, V13, P893, DOI 10.1016/0146-6380(88)90243-4; Hammes U, 2011, AAPG BULL, V95, P1643, DOI 10.1306/02141110128; Hoering T., 1984, ORG GEOCHEM, V5, P267, DOI DOI 10.1016/0146-6380(84)90014-7; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; Lash GG, 2011, AAPG BULL, V95, P61, DOI 10.1306/06301009150; Lewan MD, 2002, ORG GEOCHEM, V33, P1457, DOI 10.1016/S0146-6380(02)00182-1; Lewan MD, 1997, GEOCHIM COSMOCHIM AC, V61, P3691, DOI 10.1016/S0016-7037(97)00176-2; Lorant F, 1998, CHEM GEOL, V147, P249, DOI 10.1016/S0009-2541(98)00017-5; Mahlstedt N, 2012, MAR PETROL GEOL, V31, P27, DOI 10.1016/j.marpetgeo.2011.06.011; Mango FD, 1997, GEOCHIM COSMOCHIM AC, V61, P5347, DOI 10.1016/S0016-7037(97)00310-4; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; Martini AM, 1996, NATURE, V383, P155, DOI 10.1038/383155a0; Ni YY, 2011, GEOCHIM COSMOCHIM AC, V75, P2696, DOI 10.1016/j.gca.2011.02.016; PRICE LC, 1995, NATURE, V378, P368, DOI 10.1038/378368a0; Prinzhofer AA, 1995, CHEM GEOL, V126, P281, DOI 10.1016/0009-2541(95)00123-9; Prinzhofer A, 2010, MAR PETROL GEOL, V27, P1273, DOI 10.1016/j.marpetgeo.2010.03.004; QUIGLEY TM, 1988, NATURE, V333, P549, DOI 10.1038/333549a0; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; SCHOELL M, 1983, AAPG BULL, V67, P2225; Seewald JS, 2003, NATURE, V426, P327, DOI 10.1038/nature02132; Seewald JS, 1998, GEOCHIM COSMOCHIM AC, V62, P1599, DOI 10.1016/S0016-7037(98)00000-3; Stolper DA, 2014, GEOCHIM COSMOCHIM AC, V126, P169, DOI 10.1016/j.gca.2013.10.045; Stolper D. A., 2014, MINERAL MAG, V78, P2393; Tang Y, 2000, GEOCHIM COSMOCHIM AC, V64, P2673, DOI 10.1016/S0016-7037(00)00377-X; Tissot B.P., 1984, PETROLEUM FORMATION, Vsecond, DOI [10.1007/978-3-642-87813-8, DOI 10.1007/978-3-642-87813-8]; TRINDADE LAF, 1992, AAPG BULL, V76, P1903; UNGERER P, 1990, ORG GEOCHEM, V16, P1, DOI 10.1016/0146-6380(90)90022-R; Valentine DL, 2011, ANNU REV MAR SCI, V3, P147, DOI 10.1146/annurev-marine-120709-142734; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wilhelms A, 2001, NATURE, V411, P1034, DOI 10.1038/35082535; Xiao Y, 2001, REV MINERAL GEOCHEM, V42, P383, DOI 10.2138/rmg.2001.42.11	38	171	187	7	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1500	1503		10.1126/science.1254509	http://dx.doi.org/10.1126/science.1254509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970083	Green Accepted			2022-12-28	WOS:000337889900046
J	Meziane-Cherif, D; Courvalin, P				Meziane-Cherif, Djalal; Courvalin, Patrice			ANTIBIOTIC RESISTANCE To the rescue of old drugs	NATURE			English	Editorial Material							BETA-LACTAMASE INHIBITORS		[Meziane-Cherif, Djalal; Courvalin, Patrice] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meziane-Cherif, D (corresponding author), Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris, France.	djalal.meziane-cherif@pasteur.fr; patrice.courvalin@pasteur.fr						Courvalin P., 2010, ANTIBIOGRAM; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; MATSUURA A, 1993, JPN J PHARMACOL, V63, P187, DOI 10.1254/jjp.63.187; Siemann S, 2002, BBA-GEN SUBJECTS, V1571, P190, DOI 10.1016/S0304-4165(02)00258-1; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392	9	16	16	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					477	478		10.1038/510477a	http://dx.doi.org/10.1038/510477a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965645				2022-12-28	WOS:000337806300032
J	Scott, DC; Sviderskiy, VO; Monda, JK; Lydeard, JR; Cho, SE; Harper, JW; Schulman, BA				Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Lydeard, John R.; Cho, Shein Ei; Harper, J. Wade; Schulman, Brenda A.			Structure of a RING E3 Trapped in Action Reveals Ligation Mechanism for the Ubiquitin-like Protein NEDD8	CELL			English	Article							COMPLEX REVEALS; LIGASE COMPLEX; ACTIVATION; SCF; CONJUGATION; SUBSTRATE; ENZYME; INSIGHTS; BINDING; E2	Most E3 ligases use a RING domain to activate a thioester-linked E2 similar to ubiquitin-like protein (UBL) intermediate and promote UBL transfer to a remotely bound target protein. Nonetheless, RING E3 mechanisms matching a specific UBL and acceptor lysine remain elusive, including for RBX1, which mediates NEDD8 ligation to cullins and >10% of all ubiquitination. We report the structure of a trapped RING E3-E2 similar to UBL-target intermediate representing RBX1-UBC12 similar to NEDD8-CUL1-DCN1, which reveals the mechanism of NEDD8 ligation and how a particular UBL and acceptor lysine are matched by a multifunctional RING E3. Numerous mechanisms specify cullin neddylation while preventing noncognate ubiquitin ligation. Notably, E2-E3-target and RING-E2 similar to UBL modules are not optimized to function independently, but instead require integration by the UBL and target for maximal reactivity. The UBL and target regulate the catalytic machinery by positioning the RING-E2 similar to UBL catalytic center, licensing the acceptor lysine, and influencing E2 reactivity, thereby driving their specific coupling by a multifunctional RING E3.	[Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Cho, Shein Ei; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Cho, Shein Ei; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Lydeard, John R.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Harvard University; Harvard Medical School	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Harper, Jeffrey/0000-0002-6944-7236; Sviderskiy, Vladislav/0000-0002-9692-5328; Schulman, Brenda/0000-0002-3083-1126	Howard Hughes Medical Institute (HHMI); American Lebanese Syrian Associated Charities (ALSAC); NIH [5P30CA021765, R01GM069530, R01AG011085]; Damon Runyon [DRG 2061-10]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Bozeman, D. W. Miller, J. Bollinger, D. J. Miller, and I. Kurinov for support. Funding was provided by the Howard Hughes Medical Institute (HHMI), the American Lebanese Syrian Associated Charities (ALSAC), NIH (5P30CA021765, R01GM069530 to B.A.S. and R01AG011085 to J.W.H.), and Damon Runyon (DRG 2061-10 to J.R.L.). B.A.S. is an Investigator of Howard Hughes Medical Institute.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang H, 2014, NAT CHEM BIOL, V10, P156, DOI [10.1038/NCHEMBIO.1412, 10.1038/nchembio.1412]; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kobashigawa Y, 2011, P NATL ACAD SCI USA, V108, P20579, DOI 10.1073/pnas.1110712108; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Stanley DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003085; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	52	128	133	2	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1671	1684		10.1016/j.cell.2014.04.037	http://dx.doi.org/10.1016/j.cell.2014.04.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949976	Green Accepted, Bronze			2022-12-28	WOS:000340941900020
J	[Anonymous]				[Anonymous]			Screening an Asymptomatic Person for Genetic Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Dimmock, David/I-7913-2015	Dimmock, David/0000-0001-6690-2523					0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2442	2443						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24941182				2022-12-28	WOS:000337353000014
J	King, KM; Adams, BD				King, Kevin M.; Adams, Bruce D.			In septic shock, early goal-directed or standard protocol-based therapy did not reduce mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEVERE SEPSIS		[King, Kevin M.; Adams, Bruce D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Emergency Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	King, KM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Emergency Med, San Antonio, TX 78229 USA.							Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Swan HJ, 2005, ANESTHESIOLOGY, V103, P890, DOI 10.1097/00000542-200510000-00029	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC9	10.7326/0003-4819-160-12-201406170-02009	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935515				2022-12-28	WOS:000337374900009
J	Li, J; Li, X; Wang, Q; Hu, S; Wang, YF; Masoudi, FA; Spertus, JA; Krumholz, HM; Jiang, LX				Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Wang, Yongfei; Masoudi, Frederick A.; Spertus, John A.; Krumholz, Harlan M.; Jiang, Lixin		China PEACE Collaborative Grp	RETRACTED: ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data (Retracted article. See vol. 385, pg. 402, 2015)	LANCET			English	Article; Retracted Publication							ACUTE CORONARY SYNDROMES; STANDARDIZED MORTALITY-RATES; QUALITY-OF-CARE; REPERFUSION THERAPY; PRACTICE PATTERNS; IMPROVEMENT; TRANSITION; TRENDS; REFORM	Background Despite the importance of ST-segment elevation myocardial infarction (STEMI) in China, no nationally representative studies have characterised the clinical profiles, management, and outcomes of this cardiac event during the past decade. We aimed to assess trends in characteristics, treatment, and outcomes for patients with STEMI in China between 2001 and 2011. Methods In a retrospective analysis of hospital records, we used a two-stage random sampling design to create a nationally representative sample of patients in China admitted to hospital for STEMI in 3 years (2001, 2006, and 2011). In the first stage, we used a simple random-sampling procedure stratified by economic-geographical region to generate a list of participating hospitals. In the second stage we obtained case data for rates of STEMI, treatments, and baseline characteristics from patients attending each sampled hospital with a systematic sampling approach. We weighted our findings to estimate nationally representative rates and assess changes from 2001 to 2011. This study is registered with ClinicalTrials.gov, number NCT01624883. Findings We sampled 175 hospitals (162 participated in the study) and 18 631 acute myocardial infarction admissions, of which 13 815 were STEMI admissions. 12 264 patients were included in analysis of treatments, procedures, and tests, and 11 986 were included in analysis of in-hospital outcomes. Between 2001 and 2011, estimated national rates of hospital admission for STEMI per 100 000 people increased (from 3.5 in 2001, to 7.9 in 2006, to 15.4 in 2011; p(trend)<0.0001) and the prevalence of risk factors-including smoking, hypertension, diabetes, and dyslipidaemia-increased. We noted significant increases in use of aspirin within 24 h (79.7% [95% CI 77.9-81.5] in 2001 vs 91.2% [90.5-91.8] in 2011, p(trend)<0.0001) and clopidogrel (1.5% [95% CI 1.0-2.1] in 2001 vs 82.1% [81.1-83.0] in 2011, p(trend)<0.0001) in patients without documented contraindications. Despite an increase in the use of primary percutaneous coronary intervention (10.6% [95% CI 8.6-12.6] in 2001 vs 28.1% [26.6-29.7] in 2011, p(trend)<0.0001), the proportion of patients who did not receive reperfusion did not significantly change (45.3% [95% CI 42.1-48.5] in 2001 vs 44.8% [43.1-46.5] in 2011, p(trend)=0.69). The median length of hospital stay decreased from 12 days (IQR 7-18) in 2001 to 10 days (6-14) in 2011 (p(trend)<0.0001). Adjusted in-hospital mortality did not significantly change between 2001 and 2011 (odds ratio 0.82, 95% CI 0.62-1.10, p(trend)=0.07). Interpretation During the past decade in China, hospital admissions for STEMI have risen; in these patients, comorbidities and the intensity of testing and treatment have increased. Quality of care has improved for some treatments, but important gaps persist and in-hospital mortality has not decreased. National efforts are needed to improve the care and outcomes for patients with STEMI in China.	[Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Jiang, Lixin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China; [Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yongfei; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yongfei; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT USA; [Masoudi, Frederick A.] Univ Colorado, Div Cardiol, Aurora, CO USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Yale University; Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Jiang, LX (corresponding author), Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.	jiangl@fwoxford.org	Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021	Normand, Sharon-Lise/0000-0001-7027-4769; Li, Xi/0000-0003-2249-688X	National Health and Family Planning Commission of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Health and Family Planning Commission of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Health and Family Planning Commission of China.	[Anonymous], 2010, LANCET, V376, P657, DOI 10.1016/S0140-6736(10)61315-3; [Anonymous], 2007, CHIN STAT YB; [Anonymous], 2012, CHIN STAT YB; [Anonymous], 2000, 5 CENSUS DATA COUNTY; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; COLLINS R, 1995, LANCET, V345, P669; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; [Editorial Board of Chinese Journal of Circulation Editorial Board of Chinese Journal of Cardiology China Society of Cardiology of Chinese Medical Association], 2001, CHIN J CIRC, V16, P407; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Gao R, 2008, HEART, V94, P554, DOI 10.1136/hrt.2007.119750; Gershlick AH, 2013, LANCET, V382, P624, DOI 10.1016/S0140-6736(13)61454-3; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Li J, 2007, Cochrane Database Syst Rev, pCD002755; Liu Qun, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P213, DOI 10.3760/cma.j.issn.0253-3758.2009.03.004; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Masoudi FA, 2013, J AM COLL CARDIOL, V62, P1931, DOI 10.1016/j.jacc.2013.05.099; Mehta RH, 2004, J AM COLL CARDIOL, V43, P2166, DOI 10.1016/j.jacc.2003.08.067; Ministry of Health of the People's Republic of China, QUAL STAND TERT GEN; Ministry of Health of the People's Republic of China, 2012, CHIN PUBL HLTH STAT; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; *SAS I, MI PROC; Simms AD, 2013, HEART, V99, P35, DOI 10.1136/heartjnl-2012-302632; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; The World Bank, HLTH HARM LIF CHIN S; Thygesen K, 2007, EUR HEART J, V28, P2525; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Wu TX, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004465.pub2; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	41	272	366	4	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					441	451		10.1016/S0140-6736(14)60921-1	http://dx.doi.org/10.1016/S0140-6736(14)60921-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	24969506	Green Accepted			2022-12-28	WOS:000348509900031
J	Lang, AE; Marras, C				Lang, Anthony E.; Marras, Connie			Initiating dopaminergic treatment in Parkinson's disease	LANCET			English	Editorial Material							CONTROLLED-TRIAL; LEVODOPA; PRAMIPEXOLE; DYSKINESIA		[Lang, Anthony E.] Univ Hlth Network, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada; Univ Toronto, Dept Med, Div Neurol, Toronto, ON M5S 2J7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Lang, AE (corresponding author), Univ Hlth Network, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada.	lang@uhnres.utoronto.ca	Lang, Anthony/ABF-8114-2021	Lang, Anthony/0000-0003-1229-3667				Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Holloway R, 2000, JAMA-J AM MED ASSOC, V284, P1931, DOI 10.1001/jama.284.15.1931; Katzenschlager R, 2008, NEUROLOGY, V71, P474, DOI 10.1212/01.wnl.0000310812.43352.66; Kurlan R, 2005, NEUROLOGY, V64, P923, DOI 10.1212/01.WNL.0000152880.77812.5B; Oertel WH, 2006, MOVEMENT DISORD, V21, P343, DOI 10.1002/mds.20724; Olanow CW, 2013, MOVEMENT DISORD, V28, P1064, DOI 10.1002/mds.25364; Pd Med Collaborative Group, 2014, LANCET; Quinn N, 1987, Mov Disord, V2, P73, DOI 10.1002/mds.870020201; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Rinne UK, 1998, DRUGS, V55, P23, DOI 10.2165/00003495-199855001-00004; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; 2009, ARCH NEUROL, V66, P563	14	16	17	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1164	1166		10.1016/S0140-6736(14)60962-4	http://dx.doi.org/10.1016/S0140-6736(14)60962-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7MT	24928806				2022-12-28	WOS:000343002600006
J	Stingele, J; Schwarz, MS; Bloemeke, N; Wolf, PG; Jentsch, S				Stingele, Julian; Schwarz, Michael S.; Bloemeke, Nicolas; Wolf, Peter G.; Jentsch, Stefan			A DNA-Dependent Protease Involved in DNA-Protein Crosslink Repair	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; TOPOISOMERASE-I; HOMOLOGOUS RECOMBINATION; DVC1 C1ORF124; UBIQUITIN; SUMO; REPLICATION; CDC48; P97; REGULATOR	Toxic DNA-protein crosslinks (DPCs) arise by ionizing irradiation and UV light, are particularly caused by endogenously produced reactive compounds such as formaldehyde, and also occur during compromised topoisomerase action. Although nucleotide excision repair and homologous recombination contribute to cell survival uponDPCs, hardly anything is known about mechanisms that target the protein component of DPCs directly. Here, we identify the metalloprotease Wss1 as being crucial for cell survival upon exposure to formaldehyde and topoisomerase 1-dependent DNA damage. Yeast mutants lacking Wss1 accumulate DPCs and exhibit gross chromosomal rearrangements. Notably, in vitro assays indicate that substrates such as topoisomerase 1 are processed by the metalloprotease directly and in a DNA-dependent manner. Thus, our data suggest that Wss1 contributes to survival of DPC-harboring cells by acting on DPCs proteolytically. We propose that DPC proteolysis enables repair of these unique lesions via downstream canonical DNA repair pathways.	[Stingele, Julian; Schwarz, Michael S.; Bloemeke, Nicolas; Wolf, Peter G.; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Stingele, Julian/K-7490-2012	Stingele, Julian/0000-0001-6020-2075	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; ERC Advanced Grant; Louis-Jeantet Foundation	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; ERC Advanced Grant; Louis-Jeantet Foundation	We thank A. Strasser for technical assistance, J. Rech for help with robot-based techniques, the MPIB Microchemistry Core Facility for help with protein purification, and S. Bergink, M. Kern, C. Lademann, B. Pfander, I. Psakhye, and J. Renkawitz for discussions. S.J. is supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, RUBICON EU Network of Excellence, ERC Advanced Grant, and the Louis-Jeantet Foundation.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Biggins S, 2001, GENETICS, V159, P453; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Friedberg EC, 2014, DNA REPAIR MUTAGENES; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; Grogan D, 2012, MUTAT RES-FUND MOL M, V731, P92, DOI 10.1016/j.mrfmmm.2011.12.004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kanellis P, 2007, PLOS GENET, V3, P1438, DOI 10.1371/journal.pgen.0030134; Kim MS, 2013, NUCLEIC ACIDS RES, V41, P1661, DOI 10.1093/nar/gks1267; Kohn KW, 2000, CELL BIOCHEM BIOPHYS, V33, P175, DOI 10.1385/CBB:33:2:175; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Mullen JR, 2011, GENETICS, V187, P73, DOI 10.1534/genetics.110.124347; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2013, J BIOL CHEM, V288, P4649, DOI 10.1074/jbc.M112.419358; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Su D, 2010, MOL CELL BIOL, V30, P3734, DOI 10.1128/MCB.00673-10; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Vaz Bruno, 2013, Frontiers in Genetics, V4, P60, DOI 10.3389/fgene.2013.00060; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	55	169	176	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					327	338		10.1016/j.cell.2014.04.053	http://dx.doi.org/10.1016/j.cell.2014.04.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998930	Bronze			2022-12-28	WOS:000340943600013
J	Finn, KM; Ginns, LC; Robbins, GK; Wu, CC; Branda, JA				Finn, Kathleen M.; Ginns, Leo C.; Robbins, Gregory K.; Wu, Carol C.; Branda, John A.			Case 20-2014: A 65-Year-Old Man with Dyspnea and Progressively Worsening Lung Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE; GROUND-GLASS OPACITY; ANTIRETROVIRAL THERAPY; OPPORTUNISTIC INFECTIONS; INTERSTITIAL PNEUMONIA; HIV; IMMUNODEFICIENCY; DIAGNOSIS; ACCURACY		[Finn, Kathleen M.; Ginns, Leo C.; Robbins, Gregory K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wu, Carol C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Finn, Kathleen M.; Ginns, Leo C.; Robbins, Gregory K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wu, Carol C.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Finn, KM (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020	Robbins, Gregory/0000-0001-7545-5817				AIDSinfo, GUIDELINES USE ANTIR; [Anonymous], 2009, NEW ENGL J MED, V361, P1189; AREND SM, 1995, ARCH INTERN MED, V155, P2436, DOI 10.1001/archinte.155.22.2436; Black H, 2007, CHEST, V131, P524, DOI 10.1378/chest.06-1074; Bouros D, 2000, EUR RESPIR J, V15, P412, DOI 10.1034/j.1399-3003.2000.15b31.x; BOZZETTE SA, 1990, NEW ENGL J MED, V323, P1451, DOI 10.1056/NEJM199011223232104; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Collins J, 1997, AM J ROENTGENOL, V169, P355, DOI 10.2214/ajr.169.2.9242736; Cordier JF, 2006, EUR RESPIR J, V28, P422, DOI 10.1183/09031936.06.00013505; Desmet S, 2009, J CLIN MICROBIOL, V47, P3871, DOI 10.1128/JCM.01756-09; Eddleston M, 1997, CLIN INFECT DIS, V24, P52, DOI 10.1093/clinids/24.1.52; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Finkelstein DM, 1996, J ACQ IMMUN DEF SYND, V12, P38, DOI 10.1097/00042560-199605010-00006; Fujita J, 1999, RESP MED, V93, P113, DOI 10.1016/S0954-6111(99)90300-1; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; HARTMAN TE, 1994, AM J ROENTGENOL, V162, P547, DOI 10.2214/ajr.162.3.8109494; Held J, 2011, CLIN MICROBIOL INFEC, V17, P595, DOI 10.1111/j.1469-0691.2010.03318.x; HO DD, 1993, NEW ENGL J MED, V328, P380, DOI 10.1056/NEJM199302113280602; Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; MASUR H, 1990, NEW ENGL J MED, V323, P1500, DOI 10.1056/NEJM199011223232131; Miller WT, 2005, AM J ROENTGENOL, V184, P613, DOI 10.2214/ajr.184.2.01840613; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; Panel on opportunistic infections in HIV-infected adults and adolescents, GUID PREV TREATM OPP; PRATTER MR, 1989, ARCH INTERN MED, V149, P2277, DOI 10.1001/archinte.149.10.2277; Raynaud C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-117; Reyes CV, 2009, HEART LUNG, V38, P526, DOI 10.1016/j.hrtlng.2009.05.002; Ryu JH, 2005, CHEST, V127, P178, DOI 10.1378/chest.127.1.178; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; Sreenivasan S, 2011, J GLOB INFECT DIS, V3, P265, DOI 10.4103/0974-777X.83533; Straus SE, 2000, JAMA-J AM MED ASSOC, V283, P1853, DOI 10.1001/jama.283.14.1853; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Twigg HL, 2013, CLIN CHEST MED, V34, P155, DOI 10.1016/j.ccm.2013.01.004; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	38	5	5	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2521	2530		10.1056/NEJMcpc1400841	http://dx.doi.org/10.1056/NEJMcpc1400841			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963572				2022-12-28	WOS:000337804400012
J	Hwang, TJ; Bourgeois, FT; Seeger, JD				Hwang, Thomas J.; Bourgeois, Florence T.; Seeger, John D.			Drug Safety in the Digital Age	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WIKIPEDIA; INFORMATION		[Hwang, Thomas J.] Blackstone Grp, London, England; [Bourgeois, Florence T.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Bourgeois, Florence T.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Bourgeois, Florence T.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Seeger, John D.] Harvard Univ, Sch Med, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA; [Seeger, John D.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hwang, TJ (corresponding author), Blackstone Grp, London, England.		Bourgeois, Florence/H-6710-2016	Bourgeois, Florence/0000-0001-7798-4560; Hwang, Thomas/0000-0003-0717-1497				Bould MD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1585; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Heilman JM, 2011, J MED INTERNET RES, V13, P153, DOI 10.2196/jmir.1589; Hwang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071966; Kupferberg N, 2011, J MED LIBR ASSOC, V99, P310, DOI 10.3163/1536-5050.99.4.010	5	16	17	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2460	2462		10.1056/NEJMp1401767	http://dx.doi.org/10.1056/NEJMp1401767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963564				2022-12-28	WOS:000337804400002
J	Owens, B				Owens, Brian			STROKE	NATURE			English	Editorial Material																			0	15	15	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S1	S1		10.1038/510S1a	http://dx.doi.org/10.1038/510S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964020	Bronze			2022-12-28	WOS:000337806300001
J	Reyes, AV; Carlson, AE; Beard, BL; Hatfield, RG; Stoner, JS; Winsor, K; Welke, B; Ullman, DJ				Reyes, Alberto V.; Carlson, Anders E.; Beard, Brian L.; Hatfield, Robert G.; Stoner, Joseph S.; Winsor, Kelsey; Welke, Bethany; Ullman, David J.			South Greenland ice-sheet collapse during Marine Isotope Stage 11	NATURE			English	Article							KETILIDIAN MOBILE BELT; DEEP-SEA SEDIMENTS; NORTH-ATLANTIC; CLAY-SIZE; CONTINENTAL-CRUST; WESTERN BOUNDARY; LABRADOR SEA; EIRIK DRIFT; LEVEL RISE; ND	Varying levels of boreal summer insolation and associated Earth system feedbacks led to differing climate and ice-sheet states during late-Quaternary interglaciations. In particular, Marine Isotope Stage (MIS) 11 was an exceptionally long interglaciation and potentially had a global mean sea level 6 to 13 metres above the present level around 410,000 to 400,000 years ago(1,2), implying substantial mass loss fromtheGreenland ice sheet (GIS). There are, however, nomodel simulations and only limitedproxy data(3,4) to constrain themagnitude of the GIS response to climate change during this 'super interglacial'(5), thus confounding efforts to assess climate/ice-sheet threshold behaviour(6,7) and associated sea-level rise(1,2). Here we show that the south GIS was drastically smaller during MIS 11 than it is now, with only a small residual ice dome over southernmost Greenland. We use the strontium-neodymium-lead isotopic composition of proglacial sediment discharged from south Greenland to constrain the provenance of terrigenous silt deposited on the Eirik Drift, a sedimentary deposit off the south Greenland margin. We identify a major reduction in sediment input derived from south Greenland's Pre-cambrian bedrock terranes, probably reflecting the cessation of sub-glacial erosion and sediment transport(8) as a result of near-complete deglaciation of south Greenland. Comparison with ice-sheet configurations from numerical models(7,9-12) suggests that the GIS lost about 4.5 to 6 metres of sea-level-equivalent volume during MIS 11. This is evidence for late-Quaternary GIS collapse after it crossed a climate/ice-sheet stability threshold that may have been no more than several degrees above pre-industrial temperatures(6,7).	[Reyes, Alberto V.; Carlson, Anders E.; Beard, Brian L.; Winsor, Kelsey; Welke, Bethany; Ullman, David J.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Reyes, Alberto V.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland; [Carlson, Anders E.; Hatfield, Robert G.; Stoner, Joseph S.; Ullman, David J.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Wisconsin System; University of Wisconsin Madison; Queens University Belfast; Oregon State University	Reyes, AV (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	areyes@ualberta.ca; acarlson@coas.oregonstate.edu	Hatfield, Robert/G-6854-2019	Hatfield, Robert/0000-0002-6372-0027; Reyes, Alberto/0000-0002-7838-4214	US NSF [ANS-0902571, ANS-0902751]; Canadian NSERC fellowship	US NSF(National Science Foundation (NSF)); Canadian NSERC fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank A. de Vernal for access to pollen records and archived sediment; C. Hillaire-Marcel for discussions of MD99-2227 stratigraphy and geochemistry; J. Briner, B. Hudson, S. Kelley and N. Larsen for providing samples; and E. Colville, P. Holm and S. Strano for assistance in the field. This research was supported by US NSF awards ANS-0902571 (A.E.C., B.L.B.) and -0902751 (J.S.S.), and a Canadian NSERC fellowship (A.V.R.).	Aksu A.E., 1989, Proceedings of the Ocean Drilling Program Scientific Results, V105, P617, DOI 10.2973/odp.proc.sr.105.140.1989; Albarede F, 1995, INTRO GEOCHEMICAL MO, P1; Andreasen R, 2004, CONTRIB MINERAL PETR, V147, P438, DOI 10.1007/s00410-004-0566-2; Bamber JL, 2013, CRYOSPHERE, V7, P499, DOI 10.5194/tc-7-499-2013; Barker AK, 2006, GEOLOGY, V34, P481, DOI 10.1130/G22366.1; Bauch HA, 2013, QUATERNARY SCI REV, V63, P1, DOI 10.1016/j.quascirev.2012.11.023; Bernstein S, 1998, EARTH PLANET SC LETT, V160, P845, DOI 10.1016/S0012-821X(98)00132-0; Bierman PR, 2014, SCIENCE, V344, P402, DOI 10.1126/science.1249047; Birkelund T., 1974, OCEAN BASIN MARGIN, P125; Born A, 2012, CRYOSPHERE, V6, P1239, DOI 10.5194/tc-6-1239-2012; Carlson A, 2008, GEOLOGY, V36, P359, DOI 10.1130/G24519A.1; Channell JET, 2009, EARTH PLANET SC LETT, V283, P14, DOI 10.1016/j.epsl.2009.03.012; Channell J. E. T., 2004, IODP SCI PROSP; CHURCH M, 1972, GEOL SOC AM BULL, V83, P3059, DOI 10.1130/0016-7606(1972)83[3059:PSACOF]2.0.CO;2; Colville EJ, 2011, SCIENCE, V333, P620, DOI 10.1126/science.1204673; Cowton T, 2012, GEOLOGY, V40, P343, DOI 10.1130/G32687.1; Crocket KC, 2013, QUATERNARY SCI REV, V82, P133, DOI 10.1016/j.quascirev.2013.10.020; Cronin TM, 2013, QUATERNARY SCI REV, V79, P157, DOI 10.1016/j.quascirev.2012.12.010; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; Dawes PR, 2009, GEOL SURV DEN GREENL, P57; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Escher A., 1976, GEOLOGY GREENLAND, P12; Evans HF, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001720; Fagel N, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000993; Fagel N, 2006, MAR GEOL, V232, P87, DOI 10.1016/j.margeo.2006.08.006; Farmer GL, 2003, EARTH PLANET SC LETT, V209, P227, DOI 10.1016/S0012-821X(03)00068-2; Faure G., 1986, PRINCIPLES ISOTOPE G, P141; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Friend CRL, 2005, J GEOL SOC LONDON, V162, P147, DOI 10.1144/0016-764903-161; Froese DG, 2008, SCIENCE, V321, P1648, DOI 10.1126/science.1157525; Fyke JG, 2011, GEOSCI MODEL DEV, V4, P117, DOI 10.5194/gmd-4-117-2011; GOLDSTEIN SJ, 1988, EARTH PLANET SC LETT, V87, P249, DOI 10.1016/0012-821X(88)90013-1; Hansen H, 1999, CHEM GEOL, V157, P89, DOI 10.1016/S0009-2541(98)00196-X; Hasholt B., 1996, P INT S ER SED YIELD, P105; Hatfield RG, 2013, EARTH PLANET SC LETT, V368, P69, DOI 10.1016/j.epsl.2013.03.001; Helmke JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000794; Helsen MM, 2013, CLIM PAST, V9, P1773, DOI 10.5194/cp-9-1773-2013; Higgins AK, 2008, GEOL SOC AM MEM, V202, P1; Hillaire-Marcel C., 1999, IMAGES 5 BOARD MARIO; Hillaire-Marcel C, 2011, MAR GEOL, V279, P188, DOI 10.1016/j.margeo.2010.11.001; HILLAIREMARCEL C, 1994, CAN J EARTH SCI, V31, P63, DOI 10.1139/e94-007; Holm P.M., 1988, GEOL SOC SPEC PUBL, V39, P181, DOI DOI 10.1144/GSL.SP.1988.039.01.17; Hunter S, 2007, DEEP-SEA RES PT I, V54, P2036, DOI 10.1016/j.dsr.2007.09.007; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Innocent C, 1997, EARTH PLANET SC LETT, V146, P607, DOI 10.1016/S0012-821X(96)00251-8; Innocent C, 2000, MAR GEOL, V168, P79, DOI 10.1016/S0025-3227(00)00052-9; JACOBSEN SB, 1980, EARTH PLANET SC LETT, V50, P139, DOI 10.1016/0012-821X(80)90125-9; KALSBEEK F, 1985, EARTH PLANET SC LETT, V73, P65, DOI 10.1016/0012-821X(85)90035-4; Lhomme N, 2005, QUATERNARY SCI REV, V24, P173, DOI 10.1016/j.quascirev.2004.08.020; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Marker M., 1999, GEOLOGY GREENLAND SU, V181, P171; Mazaud A, 2012, EARTH PLANET SC LETT, V357, P137, DOI 10.1016/j.epsl.2012.09.037; Melles M, 2012, SCIENCE, V337, P315, DOI 10.1126/science.1222135; Michalopoulos P, 2004, GEOCHIM COSMOCHIM AC, V68, P1061, DOI 10.1016/j.gca.2003.07.018; OHMURA A, 1991, J GLACIOL, V37, P140; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; PATCHETT PJ, 1984, CONTRIB MINERAL PETR, V87, P311, DOI 10.1007/BF00381287; Prins MA, 2002, GEOLOGY, V30, P555, DOI 10.1130/0091-7613(2002)030<0555:OCAIDI>2.0.CO;2; Quiquet A, 2013, CLIM PAST, V9, P353, DOI 10.5194/cp-9-353-2013; R Core Team, 2013, R PROJ STAT COMP; Raymo ME, 2012, NATURE, V483, P453, DOI 10.1038/nature10891; Ridley J, 2010, CLIM DYNAM, V35, P1065, DOI 10.1007/s00382-009-0646-0; Robinson A, 2012, NAT CLIM CHANGE, V2, P429, DOI 10.1038/NCLIMATE1449; Rohling EJ, 2010, EARTH PLANET SC LETT, V291, P97, DOI 10.1016/j.epsl.2009.12.054; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; Saunders A. D., 1999, P OCEAN DRILLING PRO, V163, P77; Stanford JD, 2011, GLOBAL PLANET CHANGE, V79, P244, DOI 10.1016/j.gloplacha.2011.02.001; Stevenson R, 1997, LITHOS, V40, P189, DOI 10.1016/S0024-4937(97)00025-X; Stone EJ, 2013, CLIM PAST, V9, P621, DOI 10.5194/cp-9-621-2013; STONER JS, 1995, GEOLOGY, V23, P241, DOI 10.1130/0091-7613(1995)023<0241:MPODSS>2.3.CO;2; Tarasov L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001731; Vaks A, 2013, SCIENCE, V340, P183, DOI 10.1126/science.1228729; VANBREEMEN O, 1974, GEOL SOC AM BULL, V85, P403, DOI 10.1130/0016-7606(1974)85<403:IAGSOG>2.0.CO;2; Verplanck EP, 2009, EARTH PLANET SC LETT, V286, P52, DOI 10.1016/j.epsl.2009.06.012; Whitehouse MJ, 1998, PRECAMBRIAN RES, V91, P365, DOI 10.1016/S0301-9268(98)00058-8; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Winsor K, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004263	77	74	75	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					525	+		10.1038/nature13456	http://dx.doi.org/10.1038/nature13456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965655				2022-12-28	WOS:000337806300044
J	Greenwood, B				Greenwood, Brian			The use of a placebo in vaccine trials	LANCET			English	Editorial Material							CONJUGATE VACCINE; MENINGITIS; PNEUMONIA; DISEASE		London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Greenwood, B (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.	brian.greenwood@lshtm.ac.uk						Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Rid A, 2014, VACCINE, V32, P4708, DOI 10.1016/j.vaccine.2014.04.022; WHO, 2013, EXP CONS USE PLAC VA	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2101	2102		10.1016/S0140-6736(14)60926-0	http://dx.doi.org/10.1016/S0140-6736(14)60926-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24953464				2022-12-28	WOS:000337906600004
J	Watts, G				Watts, Geoff			Jacinto Convit Garcia Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2120	2120		10.1016/S0140-6736(14)61021-7	http://dx.doi.org/10.1016/S0140-6736(14)61021-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24959642				2022-12-28	WOS:000337906600016
J	Bianco, P; Sipp, D				Bianco, Paolo; Sipp, Douglas			Sell help not hope	NATURE			English	Editorial Material							TRIALS; EUROPE; CELL		[Bianco, Paolo] Univ Roma La Sapienza, Rome, Italy; [Sipp, Douglas] RIKEN Ctr Dev Biol, Off Res Commun, Kobe, Hyogo, Japan	Sapienza University Rome; RIKEN	Bianco, P (corresponding author), Univ Roma La Sapienza, Rome, Italy.	paolo.bianco@uniroma1.it	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938				Allison M, 2012, NAT BIOTECHNOL, V30, P41, DOI 10.1038/nbt.2083; Bianco P, 2013, EMBO J, V32, P1489, DOI 10.1038/emboj.2013.114; Caplan AI, 2014, STEM CELL TRANSL MED, V3, P560, DOI 10.5966/sctm.2013-0180; Gottlieb S, 2012, WALL STREET J; Hara A., 2014, THER INNOV REGUL SCI; London AJ, 2012, SCIENCE, V336, P544, DOI 10.1126/science.1216086; Mazzucato M., 2013, ENTREPRENEURIAL STAT; Melchiorri D, 2013, NAT REV DRUG DISCOV, V12, P719, DOI 10.1038/nrd3835-c1; Sipp D, 2012, REGEN MED, V7, P105, DOI [10.2217/RME.12.75, 10.2217/rme.12.75]; Von Eschenbach A., 2012, WALL STREET J	10	39	39	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					336	337		10.1038/510336a	http://dx.doi.org/10.1038/510336a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24955467	Bronze			2022-12-28	WOS:000337350200013
J	Gorman, MP; Rincon, SP; Pierce, VM				Gorman, Mark P.; Rincon, Sandra P.; Pierce, Virginia M.			Case 19-2014: A 19-Year-Old Woman with Headache, Fever, Stiff Neck, and Mental-Status Changes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOPLASMA-PNEUMONIAE; NEUROMYELITIS-OPTICA; INFECTIOUS-DISEASES; CEREBROSPINAL-FLUID; ENCEPHALITIS; MENINGOENCEPHALITIS; SPECTRUM		[Gorman, Mark P.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Rincon, Sandra P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gorman, Mark P.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Rincon, Sandra P.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Pierce, Virginia M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gorman, MP (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.			Pierce, Virginia/0000-0002-3723-1326				Bitnun Ari, 2010, Curr Infect Dis Rep, V12, P282, DOI 10.1007/s11908-010-0105-4; Christie LJ, 2007, J NEUROIMMUNOL, V189, P129, DOI 10.1016/j.jneuroim.2007.06.017; Christie LJ, 2007, PEDIATRICS, V120, P305, DOI 10.1542/peds.2007-0240; Csango PA, 2004, CLIN MICROBIOL INFEC, V10, P1094, DOI 10.1111/j.1469-0691.2004.00993.x; FINK CG, 1995, J CLIN PATHOL-CL MOL, V48, pM51; Fitch MT, 2008, NAT CLIN PRACT NEURO, V4, P97, DOI 10.1038/ncpneuro0713; Gable MS, 2009, EUR J CLIN MICROBIOL, V28, P1421, DOI 10.1007/s10096-009-0799-0; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; Gyure KA, 2009, J NEUROPATH EXP NEUR, V68, P1053, DOI 10.1097/NEN.0b013e3181b88114; Hutchinson C, 2010, LANCET NEUROL, V9, P1045, DOI 10.1016/S1474-4422(10)70243-X; Hutchinson C, 2010, LANCET NEUROL, V9, P1078, DOI 10.1016/S1474-4422(10)70243-X; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037; Lotze TE, 2008, PEDIATRICS, V122, pE1039, DOI 10.1542/peds.2007-2758; Martinez-Torres F, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-40; MEHLER MF, 1988, J NEUROL NEUROSUR PS, V51, P725, DOI 10.1136/jnnp.51.5.725; Narita M, 2001, CLIN INFECT DIS, V33, P916, DOI 10.1086/322709; Nir-Paz R, 2006, CLIN MICROBIOL INFEC, V12, P685, DOI 10.1111/j.1469-0691.2006.01469.x; O'Mahony J, 2013, J CHILD NEUROL, V28, P184, DOI 10.1177/0883073812443006; Petropoulou KA, 2005, AM J NEURORADIOL, V26, P1986; Pickering L., 2012, RED BOOK 2012 REPORT, P518; Salvarani C, 2007, ANN NEUROL, V62, P442, DOI 10.1002/ana.21226; Socan M, 2001, CLIN INFECT DIS, V32, pE31, DOI 10.1086/318446; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f; Waites KB, 2011, MANUAL CLIN MICROBIO, V1, P970	28	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2427	2438		10.1056/NEJMcpc1400838	http://dx.doi.org/10.1056/NEJMcpc1400838			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24941181				2022-12-28	WOS:000337353000012
J	Vvedenskaya, IO; Vahedian-Movahed, H; Bird, JG; Knoblauch, JG; Goldman, SR; Zhang, Y; Ebright, RH; Nickels, BE				Vvedenskaya, Irina O.; Vahedian-Movahed, Hanif; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Zhang, Yu; Ebright, Richard H.; Nickels, Bryce E.			TRANSCRIPTION Interactions between RNA polymerase and the "core recognition element" counteract pausing	SCIENCE			English	Article							STRUCTURAL BASIS; SINGLE-MOLECULE; REVEALS	Transcription elongation is interrupted by sequences that inhibit nucleotide addition and cause RNA polymerase (RNAP) to pause. Here, by use of native elongating transcript sequencing (NET-seq) and a variant of NET-seq that enables analysis of mutant RNAP derivatives in merodiploid cells (mNET-seq), we analyze transcriptional pausing genome-wide in vivo in Escherichia coli. We identify a consensus pause-inducing sequence element, G(-10)Y(-1)G(+1) (where -1 corresponds to the position of the RNA 3' end). We demonstrate that sequence-specific interactions between RNAP core enzyme and a core recognition element (CRE) that stabilize transcription initiation complexes also occur in transcription elongation complexes and facilitate pause read-through by stabilizing RNAP in a posttranslocated register. Our findings identify key sequence determinants of transcriptional pausing and establish that RNAP-CRE interactions modulate pausing.	[Vvedenskaya, Irina O.; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Vvedenskaya, Irina O.; Vahedian-Movahed, Hanif; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Zhang, Yu; Ebright, Richard H.; Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Vahedian-Movahed, Hanif; Bird, Jeremy G.; Zhang, Yu; Ebright, Richard H.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu; bnickels@waksman.rutgers.edu	Zhang, Yu/AAV-5722-2021; Ebright, Richard/O-3321-2019; Nickels, Bryce/AAF-2549-2020; Zhang, Yu/J-5225-2014	Zhang, Yu/0000-0002-1778-8389; Ebright, Richard/0000-0001-8915-7140; Nickels, Bryce/0000-0001-7449-8831; Bird, Jeremy/0000-0003-2690-8474	NIH grants [GM041376, GM088343, GM096454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096454, R37GM041376, R01GM088343, R01GM041376] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM041376 (R.H.E.), GM088343 (B.E.N.), and GM096454 (B.E.N.). Reads are deposited in the Sequence Read Archive (accession SRP039384).	AIVAZASHVILI V A, 1981, Molekulyarnaya Biologiya (Moscow), V15, P915; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Dangkulwanich M, 2014, CHEM REV, V114, P3203, DOI 10.1021/cr400730x; Dangkulwanich M, 2013, ELIFE, V2, DOI 10.7554/eLife.00971; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; LEE DN, 1990, J BIOL CHEM, V265, P15145; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou J, 2011, MOL CELL, V44, P635, DOI 10.1016/j.molcel.2011.09.018	20	116	117	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1285	1289		10.1126/science.1253458	http://dx.doi.org/10.1126/science.1253458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926020	Green Accepted			2022-12-28	WOS:000337077500041
J	Azzopardi, D; Strohm, B; Marlow, N; Brocklehurst, P; Deierl, A; Eddama, O; Goodwin, J; Halliday, HL; Juszczak, E; Kapellou, O; Levene, M; Linsell, L; Omar, O; Thoresen, M; Tusor, N; Whitelaw, A; Edwards, AD				Azzopardi, Denis; Strohm, Brenda; Marlow, Neil; Brocklehurst, Peter; Deierl, Aniko; Eddama, Oya; Goodwin, Julia; Halliday, Henry L.; Juszczak, Edmund; Kapellou, Olga; Levene, Malcolm; Linsell, Louise; Omar, Omar; Thoresen, Marianne; Tusor, Nora; Whitelaw, Andrew; Edwards, A. David		TOBY Study Grp	Effects of Hypothermia for Perinatal Asphyxia on Childhood Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEONATAL ENCEPHALOPATHY; CEREBRAL-PALSY; CLASSIFICATION-SYSTEM; SCALES	Background In the Total Body Hypothermia for Neonatal Encephalopathy Trial (TOBY), newborns with asphyxial encephalopathy who received hypothermic therapy had improved neurologic outcomes at 18 months of age, but it is uncertain whether such therapy results in longer-term neurocognitive benefits. Methods We randomly assigned 325 newborns with asphyxial encephalopathy who were born at a gestational age of 36 weeks or more to receive standard care alone (control) or standard care with hypothermia to a rectal temperature of 33 to 34 degrees C for 72 hours within 6 hours after birth. We evaluated the neurocognitive function of these children at 6 to 7 years of age. The primary outcome of this analysis was the frequency of survival with an IQ score of 85 or higher. Results A total of 75 of 145 children (52%) in the hypothermia group versus 52 of 132 (39%) in the control group survived with an IQ score of 85 or more (relative risk, 1.31; P = 0.04). The proportions of children who died were similar in the hypothermia group and the control group (29% and 30%, respectively). More children in the hypothermia group than in the control group survived without neurologic abnormalities (65 of 145 [45%] vs. 37 of 132 [28%]; relative risk, 1.60; 95% confidence interval, 1.15 to 2.22). Among survivors, children in the hypothermia group, as compared with those in the control group, had significant reductions in the risk of cerebral palsy (21% vs. 36%, P = 0.03) and the risk of moderate or severe disability (22% vs. 37%, P = 0.03); they also had significantly better motor-function scores. There was no significant between-group difference in parental assessments of children's health status and in results on 10 of 11 psychometric tests. Conclusions Moderate hypothermia after perinatal asphyxia resulted in improved neurocognitive outcomes in middle childhood.	[Azzopardi, Denis; Tusor, Nora; Edwards, A. David] Kings Coll London, Ctr Dev Brain, London WC2R 2LS, England; [Marlow, Neil; Brocklehurst, Peter] UCL, Inst Womens Hlth, London, England; [Azzopardi, Denis; Deierl, Aniko] Univ London Imperial Coll Sci Technol & Med, Inst Clin Sci, London, England; [Kapellou, Olga] Homerton Univ Hosp, London, England; [Strohm, Brenda; Eddama, Oya; Goodwin, Julia; Juszczak, Edmund; Linsell, Louise; Omar, Omar] Univ Oxford, Natl Perinatal Epidemiol Unit, Clin Trials Unit, Oxford, England; [Halliday, Henry L.] Royal Matern Hosp, Belfast, Antrim, North Ireland; [Levene, Malcolm] Univ Leeds, Leeds, W Yorkshire, England; [Thoresen, Marianne; Whitelaw, Andrew] Univ Bristol, Bristol, Avon, England	University of London; King's College London; University of London; University College London; Imperial College London; University of London; Queen Mary University London; University of Oxford; University of Leeds; University of Bristol	Azzopardi, D (corresponding author), St Thomas Hosp, Dept Perinatal Imaging, Kings Coll London, Ctr Dev Brain, Westminster Bridge Rd, London SE1 7EH, England.	denis.azzopardi@kcl.ac.uk	Edwards, Anthony/HCI-9626-2022; Marlow, Neil/D-2918-2009; Hemingway, Harry/C-1219-2009	Marlow, Neil/0000-0001-5890-2953; Blennow, Mats/0000-0001-9517-0261; Halliday, Henry/0000-0001-7978-4992; Hemingway, Harry/0000-0003-2279-0624; Edwards, Anthony David/0000-0003-4801-7066; Tusor, Nora/0000-0002-3664-7397	United Kingdom Medical Research Council; National Institute for Health Research Biomedical Research Centres at Imperial College London; University of Oxford; King's College London; MRC [G0801320, G0100126] Funding Source: UKRI; Medical Research Council [MC_PC_13041, MR/K006584/1, G0100126, G0801320] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10034] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centres at Imperial College London; University of Oxford; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the United Kingdom Medical Research Council and the National Institute for Health Research Biomedical Research Centres at Imperial College London, the University of Oxford, and King's College London.	Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Barnett AL, 2004, ARCH DIS CHILD, V89, P637, DOI 10.1136/adc.2002.019349; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; de Haan M, 2006, TRENDS NEUROSCI, V29, P374, DOI 10.1016/j.tins.2006.05.008; Drummond M, 2001, ANN MED, V33, P344, DOI 10.3109/07853890109002088; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Guillet R, 2012, PEDIATR RES, V71, P205, DOI 10.1038/pr.2011.30; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Korkman M., 2007, NEPSY 2 BATERIA NEUR; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Pickering S., 2001, WORKING MEMORY TEST; Reid R, 1998, J ABNORM CHILD PSYCH, V26, P187, DOI 10.1023/A:1022620217886; Rosenbaum PL, 2008, DEV MED CHILD NEUROL, V50, P249, DOI 10.1111/j.1469-8749.2008.02045.x; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Touwen B. C. L, 1979, EXAMINATION CHILD MI; WECHSLER D, 2004, WECHSLER PRESCHOOL P; Wolke D, 2002, PEDIATRICS, V109, P1054, DOI 10.1542/peds.109.6.1054	20	388	404	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					140	149		10.1056/NEJMoa1315788	http://dx.doi.org/10.1056/NEJMoa1315788			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006720	Green Published, Green Submitted			2022-12-28	WOS:000338645500010
J	Venna, N; Niles, JL; Lev, MH; Frosch, MP				Venna, Nagagopal; Niles, John L.; Lev, Michael H.; Frosch, Matthew P.			Case 21-2014: A 68-Year-Old Man with a Sudden Onset of Diplopia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEGENERS-GRANULOMATOSIS; NEUROLOGICAL INVOLVEMENT; DIAGNOSIS; DISEASE; MANIFESTATIONS; THERAPY; ANCA		[Venna, Nagagopal; Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Niles, John L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lev, Michael H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Venna, Nagagopal] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Niles, John L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lev, Michael H.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Venna, N (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861				Chow FC, 2011, SEMIN NEUROL, V31, P286, DOI 10.1055/s-0031-1287658; de Groot K, 2001, ARCH NEUROL-CHICAGO, V58, P1215, DOI 10.1001/archneur.58.8.1215; DRACHMAN DA, 1963, ARCH NEUROL-CHICAGO, V8, P145, DOI 10.1001/archneur.1963.00460020045003; Fuentes AG, 2012, RHEUMATOL INT, V32, P2529, DOI 10.1007/s00296-010-1367-8; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6; Greco P, 2007, RHEUMATOLOGY, V46, P1375, DOI 10.1093/rheumatology/kem094; Holle JU, 2011, CURR OPIN RHEUMATOL, V23, P7, DOI 10.1097/BOR.0b013e32834115f9; NISHINO H, 1993, ANN NEUROL, V33, P4, DOI 10.1002/ana.410330103; NISHINO H, 1993, NEUROLOGY, V43, P1334, DOI 10.1212/WNL.43.7.1334; Provenzale JM, 1996, AM J NEURORADIOL, V17, P785; Reinhold-Keller E, 2001, CLIN EXP RHEUMATOL, V19, P541; Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636; Seror R, 2006, MEDICINE, V85, P54, DOI 10.1097/01.md.0000200166.90373.41; Stone JH, 2005, NEW ENGL J MED, V352, P351; Tarhan NC, 2004, AM J ROENTGENOL, V182, P809, DOI 10.2214/ajr.182.3.1820809; Tavazzi E, 2011, CLIN MICROBIOL INFEC, V17, P1776, DOI 10.1111/j.1469-0691.2011.03653.x; Visvesvara GS, 2010, CURR OPIN INFECT DIS, V23, P590, DOI 10.1097/QCO.0b013e32833ed78b; Warnatz K, 2003, ANN RHEUM DIS, V62, P50, DOI 10.1136/ard.62.1.50; Yuh WTC, 1999, AM J NEURORADIOL, V20, P87	19	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					162	173		10.1056/NEJMcpc1403308	http://dx.doi.org/10.1056/NEJMcpc1403308			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006723				2022-12-28	WOS:000338645500013
J	Scheller, NM; Pasternak, B; Svanstrom, H; Hviid, A				Scheller, Nikolai Madrid; Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders			Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CASE SERIES; SAFETY; IMMUNIZATION; AUTOIMMUNE; ADOLESCENT		[Scheller, Nikolai Madrid; Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Scheller, NM (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nmscheller@gmail.com	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127				Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Siegrist CA, 2007, CAN MED ASSOC J, V177, P1352, DOI 10.1503/cmaj.071134; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	6	25	26	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					187	188		10.1001/jama.2014.2198	http://dx.doi.org/10.1001/jama.2014.2198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005658				2022-12-28	WOS:000338511200027
J	Young, MJ; Scheinberg, E; Bursztajn, H				Young, Michael J.; Scheinberg, Ethan; Bursztajn, Harold			Direct-to-Patient Laboratory Test Reporting Balancing Access With Effective Clinical Communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Young, Michael J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Young, Michael J.] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Scheinberg, Ethan] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Bursztajn, Harold] Harvard Univ, Sch Med, Program Psychiat & Law, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Bursztajn, Harold] Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA; [Bursztajn, Harold] UNESCO Bioeth Chair, Amer Unit, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Young, MJ (corresponding author), Harvard Univ, Sch Med, 260 Longwood Ave, Boston, MA 02115 USA.	michael_young@hms.harvard.edu						Bursztajn H, 1990, MED CHOICES MED CHAN; Centers for Medicare & Medicaid Services (CMS) HHS; Centers for Disease Control and Prevention (CDC) HHS; Office for Civil Rights (OCR) HHS, 2014, FED REG, V79, P7289; De Freitas J, 2013, J ROY SOC MED, V106, P184, DOI 10.1177/0141076813476679; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650	4	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					127	128		10.1001/jama.2014.5823	http://dx.doi.org/10.1001/jama.2014.5823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	24933597				2022-12-28	WOS:000338511200014
J	Bauer, UE; Briss, PA; Goodman, RA; Bowman, BA				Bauer, Ursula E.; Briss, Peter A.; Goodman, Richard A.; Bowman, Barbara A.			Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA	LANCET			English	Article							UNITED-STATES; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; RISK-FACTORS; 21 REGIONS; HEALTH; IMPROVEMENTS; PREVALENCE; PROGRAM; OBESITY	With non-communicable conditions accounting for nearly two-thirds of deaths worldwide, the emergence of chronic diseases as the predominant challenge to global health is undisputed. In the USA, chronic diseases are the main causes of poor health, disability, and death, and account for most of health-care expenditures. The chronic disease burden in the USA largely results from a short list of risk factors-including tobacco use, poor diet and physical inactivity (both strongly associated with obesity), excessive alcohol consumption, uncontrolled high blood pressure, and hyperlipidaemia-that can be effectively addressed for individuals and populations. Increases in the burden of chronic diseases are attributable to incidence and prevalence of leading chronic conditions and risk factors (which occur individually and in combination), and population demographics, including ageing and health disparities. To effectively and equitably address the chronic disease burden, public health and health-care systems need to deploy integrated approaches that bundle strategies and interventions, address many risk factors and conditions simultaneously, create population-wide changes, help the population subgroups most affected, and rely on implementation by many sectors, including public-private partnerships and involvement from all stakeholders. To help to meet the chronic disease burden, the US Centers for Disease Control and Prevention (CDC) uses four cross-cutting strategies: (1) epidemiology and surveillance to monitor trends and inform programmes; (2) environmental approaches that promote health and support healthy behaviours; (3) health system interventions to improve the effective use of clinical and other preventive services; and (4) community resources linked to clinical services that sustain improved management of chronic conditions. Establishment of community conditions to support healthy behaviours and promote effective management of chronic conditions will deliver healthier students to schools, healthier workers to employers and businesses, and a healthier population to the health-care system. Collectively, these four strategies will prevent the occurrence of chronic diseases, foster early detection and slow disease progression in people with chronic conditions, reduce complications, support an improved quality of life, and reduce demand on the health-care system. Of crucial importance, with strengthened collaboration between the public health and health-care sectors, the health-care system better uses prevention and early detection services, and population health is improved and sustained by solidifying collaborations between communities and health-care providers. This collaborative approach will improve health equity by building communities that promote health rather than disease, have more accessible and direct care, and focus the health-care system on improving population health.	[Bauer, Ursula E.; Briss, Peter A.; Goodman, Richard A.; Bowman, Barbara A.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Goodman, RA (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30341 USA.	rag4@cdc.gov						Adams Patricia F, 2012, Vital Health Stat 10, P1; Administration on Aging, AM REC REINV ACT COM; Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Anderson G, 2010, CHRONIC CARE MAKING; [Anonymous], 2010, MULT CHRON COND STRA; [Anonymous], CDCRFADP131305 GRANT; [Anonymous], EARLY RELEASE SELECT; Ashman JJ, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120308; Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062; Brownson RC, 2004, PUBLIC HEALTH REP, V119, P230, DOI 10.1016/j.phr.2004.04.001; Bunnell R, 2012, J COMMUN HEALTH, V37, P1081, DOI 10.1007/s10900-012-9542-3; Buntin MB, 2010, HEALTH AFFAIR, V29, P1214, DOI 10.1377/hlthaff.2010.0503; Centers for Disease Control and Prevention, NAT BREAST CERV CANC; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, MEAN US EL REC; Centers for Disease Control and Prevention, THIS EARL REL EARL R; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Centers for Disease Control and Prevention, 2000, RED TOB US REP SURG; Centers for Disease Control and Prevention (CDC), 2013, PROGR CHILDH OB; Centers for Medicare and Medicaid Services, STAT INN MOD GEN INF; Centers for Medicare and Medicaid Services, HLTH CAR INN AW PROJ; Centers for Medicare and Medicaid Services, NAT HLTH EXP DAT NAT; Centers for Medicare and Medicaid Services, 2012, CHRON COND MED BEN C; Committee on Population at the National Research Council, 2013, US HLTH INT PERSP SH; Community Preventive Services Task Force, GUID COMM PREV SERV; Curtis Kathryn M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; DeVol R, 2007, UNHEALTHY AM EC BURD; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Frieden TR, 2013, CDC HLTH DISPARITIES; Healthy People.gov, 2010, 2020 TOP OBJ; Hoyert D. L., 2012, NATL VITAL STAT REPO, V61; Institute of Medicine, 2012, ACC PROGR OB PREV SO; Koh HK, 2010, NEW ENGL J MED, V363, P1296, DOI 10.1056/NEJMp1008560; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Li Chaoyang, 2011, Morbidity and Mortality Weekly Report, V60, P1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Machlin SR, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120172; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Milstein B, 2011, HEALTH AFFAIR, V30, P823, DOI 10.1377/hlthaff.2010.1116; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Center for Health Statistics, 2013, 2012 SPEC FEAT EM CA; National Heart Lung and Blood Institute, MORB MORT 2012 CHART; National Prevention Council, 2012, NAT PREV COUNC ACT P; Organization WH, 2016, GLOBAL STATUS REPORT; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; Pearson TA, 2013, CIRCULATION, V127, P1730, DOI 10.1161/CIR.0b013e31828f8a94; Robert Wood Johnson Foundation, COUNT HLTH RANK ROAD; Rudegeair P., 2012, REUTERS         1211; Steiner CA, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.120292e, 10.5888/pcd10.120292]; United Health Foundation, 2012, AM HLTH RANK CALL AC; United Nations General Assembly, 2012, POL DECL HIGH LEV M; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; USDA Economic Research Service, FOOD ACC RES ATL; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; Wegner M.V., 2010, CHRONIC DIS EPIDEMIO; Woolf SH, 2013, US HLTH INT PERSPECT, P1; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P771, DOI 10.1001/jama.2013.91; World Health Organization, UN HIGH LEV M NONC D; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	68	720	733	16	274	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					45	52		10.1016/S0140-6736(14)60648-6	http://dx.doi.org/10.1016/S0140-6736(14)60648-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24996589				2022-12-28	WOS:000338919600025
J	Khabbaz, RF; Moseley, RR; Steiner, RJ; Levitt, AM; Bell, BP				Khabbaz, Rima F.; Moseley, Robin R.; Steiner, Riley J.; Levitt, Alexandra M.; Bell, Beth P.			Challenges of infectious diseases in the USA	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CARE-ASSOCIATED INFECTIONS; BLOOD-STREAM INFECTIONS; MOUNTAIN-SPOTTED-FEVER; NILE-VIRUS-INFECTION; CHRONIC HEPATITIS-C; UNITED-STATES; ACTIVE SURVEILLANCE; HIV PREVENTION; PERSONS BORN	In the USA, infectious diseases continue to exact a substantial toll on health and health-care resources. Endemic diseases such as chronic hepatitis, HIV, and other sexually transmitted infections affect millions of individuals and widen health disparities. Additional concerns include health-care-associated and foodborne infections-both of which have been targets of broad prevention efforts, with success in some areas, yet major challenges remain. Although substantial progress in reduction of the burden of vaccine-preventable diseases has been made, continued cases and outbreaks of these diseases persist, driven by various contributing factors. Worldwide, emerging and reemerging infections continue to challenge prevention and control strategies while the growing problem of antimicrobial resistance needs urgent action. An important priority for control of infectious disease is to ensure that scientific and technological advances in molecular diagnostics and bioinformatics are well integrated into public health. Broad and diverse partnerships across governments, health care, academia, and industry, and with the public, are essential to effectively reduce the burden of infectious diseases.	[Khabbaz, Rima F.; Moseley, Robin R.; Levitt, Alexandra M.] Ctr Dis Control & Prevent, Off Infect Dis, Atlanta, GA 30333 USA; [Steiner, Riley J.] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA; [Bell, Beth P.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Khabbaz, RF (corresponding author), Ctr Dis Control & Prevent, Off Infect Dis, Atlanta, GA 30333 USA.	rfk1@cdc.gov						Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Adams S, 2010, MED PRIN PRACT, V19, P421, DOI 10.1159/000320299; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1424; [Anonymous], PREV EM INF DIS STRA; [Anonymous], 2013, NATL STATE HEALTHCAR; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], DIS BURD VIR HEP A B; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], ACT PLAN PREV CAR TR; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], TEST MAK US STRONG; [Anonymous], HIV SURVEILL SUPPLEM; [Anonymous], ACT PLAN PREV HEALTH; [Anonymous], NIH NIAID DMID RES A; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], 62 EP INT SERV EIS C; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], EM INF MICR THREATS; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], W NIL VIR DIS CAS RE; [Anonymous], MULT OUTBR FUNG MEN; [Anonymous], 2011, HIGH IMP HIV PREV CD; [Anonymous], PREP RESP CHIK VIR I; [Anonymous], HIV SURV REP; [Anonymous], VIR HEP POP; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], IMPACT 13 VALENT PNE; [Anonymous], LANCET; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], 2005, MMWR MORB MORTAL WKL; [Anonymous], MMWR MORB MORTAL WKL; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Bornschlegel K, 2013, MMWR-MORBID MORTAL W, V62, P357; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Burton DC, 2011, INFECT CONT HOSP EP, V32, P748, DOI 10.1086/660872; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Centers for Disease Control and Prevention, 2013, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P539; Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V61, P671; Chen SY, 2011, J INFECT DIS, V203, P1517, DOI 10.1093/infdis/jir115; Chitnis AS, 2012, INFECT CONT HOSP EP, V33, P984, DOI 10.1086/667738; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Cronquist AB, 2012, CLIN INFECT DIS, V54, pS432, DOI 10.1093/cid/cis267; Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Demma LJ, 2006, VECTOR-BORNE ZOONOT, V6, P423, DOI 10.1089/vbz.2006.6.423; Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043; Desai R, 2012, CLIN INFECT DIS, V55, pE28, DOI 10.1093/cid/cis443; DiOrio Mary, 2012, Morbidity and Mortality Weekly Report, V61, P764; Dobbins Claire, 2012, Morbidity and Mortality Weekly Report, V61, P186; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; Frieden TR, 2014, LANCET, V383, P764, DOI 10.1016/S0140-6736(14)60189-6; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gastanaduy PA, 2014, MMWR-MORBID MORTAL W, V63, P496; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Gordin FM, 2012, JAMA-J AM MED ASSOC, V308, P283, DOI 10.1001/jama.2012.7505; Guh AY, 2012, MED CARE, V50, P785, DOI 10.1097/MLR.0b013e31825517d4; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Herbst JH, 2012, JAIDS-J ACQ IMM DEF, V59, P530, DOI 10.1097/QAI.0b013e3182479077; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Hook EW, 2013, MMWR-MORBID MORTAL W, V62, P103; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Khan G, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-66; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Lipkin WI, 2013, NAT REV MICROBIOL, V11, P133, DOI 10.1038/nrmicro2949; Luetkemeyer Anne F, 2010, Top HIV Med, V18, P143; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Miramontes R, 2013, MMWR-MORBID MORTAL W, V62, P201; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; Morens DM, 2012, MBIO, V3, DOI 10.1128/mBio.00494-12; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; Osadebe Lynda U., 2012, Morbidity and Mortality Weekly Report, V61, P952; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Relman DA, 2013, JAMA-J AM MED ASSOC, V309, P1531, DOI 10.1001/jama.2013.3678; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Reves RR, 2012, AM J RESP CRIT CARE, V186, pI, DOI 10.1164/rccm.201206-1039ED; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6019; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scott RD, 2009, DIRECT MED COSTS HEA; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Srinivasan A, 2010, INFECT CONT HOSP EP, V31, pS70, DOI 10.1086/655987; Tate JE, 2013, PEDIATR INFECT DIS J, V32, P741, DOI 10.1097/INF.0b013e31828d639c; Tohme RA, 2013, AM J PUBLIC HEALTH, V103, P112, DOI 10.2105/AJPH.2012.300858; Ward JW, 2013, CLIN LIVER DIS, V17, P1, DOI 10.1016/j.cld.2012.09.011; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Whitney CG, 2014, MMWR-MORBID MORTAL W, V63, P352; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Wong KK, 2012, EMERG INFECT DIS, V18, P1937, DOI 10.3201/eid1812.121097; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, MIDDL E RESP SYNDR C; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9	123	62	63	1	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					53	63		10.1016/S0140-6736(14)60890-4	http://dx.doi.org/10.1016/S0140-6736(14)60890-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1XL	24996590	Bronze, Green Published			2022-12-28	WOS:000338919600026
J	Owens, B				Owens, Brian			Mapping biomedical research in the USA	LANCET			English	Editorial Material																			0	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					11	14		10.1016/S0140-6736(14)61114-4	http://dx.doi.org/10.1016/S0140-6736(14)61114-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1XL	25003180				2022-12-28	WOS:000338919600009
J	Kittinger, JN				Kittinger, John N. (Jack)			A giant leap	SCIENCE			English	Editorial Material																			0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					110	110						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994656				2022-12-28	WOS:000338284400060
J	LeRoy, BJ; Yankowitz, M				LeRoy, Brian J.; Yankowitz, Matthew			Emergent complex states in bilayer graphene	SCIENCE			English	Editorial Material									[LeRoy, Brian J.; Yankowitz, Matthew] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	University of Arizona	LeRoy, BJ (corresponding author), Univ Arizona, Dept Phys, Tucson, AZ 85721 USA.	leroy@physics.arizona.edu	LeRoy, Brian J/J-9112-2012	LeRoy, Brian J/0000-0003-1610-5424				JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Ki DK, 2014, NANO LETT, V14, P2135, DOI 10.1021/nl5003922; Kou A, 2014, SCIENCE, V345, P55, DOI 10.1126/science.1250270; Maher P, 2014, SCIENCE, V345, P61, DOI 10.1126/science.1252875; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	9	8	8	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					31	32		10.1126/science.1256545	http://dx.doi.org/10.1126/science.1256545			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994635				2022-12-28	WOS:000338284400034
J	Hyman, SE				Hyman, Steven E.			How Far Can Mice Carry Autism Research?	CELL			English	Editorial Material							SYSTEMS; MOUSE	In the face of growing controversy about the utility of genetic mouse models of human disease, Rothwell et al. report on a shared mechanism by which two different neuroligin-3 mutations, associated with autism spectrum disorders in humans, produce an enhancement in motor learning. The open question is how much we can learn about human ills from such models.	Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hyman, SE (corresponding author), Broad Inst MIT & Harvard, 75 Ames St, Cambridge, MA 02142 USA.	seh@harvard.edu						Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Ioannidis J. P, 2012, SCI TRANSL MED, V4, p51ps15; McCarroll SA, 2013, NEURON, V80, P578, DOI 10.1016/j.neuron.2013.10.046; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110	8	11	11	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					13	14		10.1016/j.cell.2014.06.032	http://dx.doi.org/10.1016/j.cell.2014.06.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995974	Bronze			2022-12-28	WOS:000340943100003
J	Benger, J				Benger, Jonathan			Think about the care in healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England	University of Bristol	Benger, J (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England.	jbenger@nhs.net		Benger, Jonathan/0000-0001-6131-0916				Francis R., 2013, REPORT MID STAFFORDS; NHS England, 2013, HIGH QUAL CAR ALL NO; Pennycook, 2013, DOES IT PAY CARE UND; Smulian M., 2012, HLTH SERVICES J	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2014	348								g4210	10.1136/bmj.g4210	http://dx.doi.org/10.1136/bmj.g4210			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UE	24957750	Green Published			2022-12-28	WOS:000338201400013
J	Fell, GL; Robinson, KC; Mao, J; Woolf, CJ; Fisher, DE				Fell, Gillian L.; Robinson, Kathleen C.; Mao, Jianren; Woolf, Clifford J.; Fisher, David E.			Skin beta-Endorphin Mediates Addiction to UV Light	CELL			English	Article							FREQUENT INDOOR TANNERS; ULTRAVIOLET-RADIATION; ENDOGENOUS OPIOIDS; NUCLEUS-ACCUMBENS; PLASMA-LEVELS; SUN EXPOSURE; MICE; WITHDRAWAL; INDUCTION; EXERCISE	UV light is an established carcinogen, yet evidence suggests that UV-seeking behavior has addictive features. Following UV exposure, epidermal keratinocytes synthesize proopiomelanocortin (POMC) that is processed to melanocyte-stimulating hormone, inducing tanning. We show that, in rodents, another POMC-derived peptide, beta-endorphin, is coordinately synthesized in skin, elevating plasma levels after low-dose UV. Increases in pain-related thresholds are observed and reversed by pharmacologic opioid antagonism. Opioid blockade also elicits withdrawal signs after chronic UV exposure. This effect was sufficient to guide operant behavioral choices to avoidance of opioid withdrawal (conditioned place aversion). These UV-induced nociceptive and behavioral effects were absent in beta-endorphin knockout mice and in mice lacking p53-mediated POMC induction in epidermal keratinocytes. Although primordial UV addiction, mediated by the hedonic action of beta-endorphin and anhedonic effects of withdrawal, may theoretically have enhanced evolutionary vitamin D biosynthesis, it now may contribute to the relentless rise in skin cancer incidence in humans.	[Fell, Gillian L.; Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA; [Fell, Gillian L.; Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA 02114 USA; [Mao, Jianren] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MGH Ctr Translat Pain Res,Dept Anesthesia Critica, Boston, MA 02114 USA; [Woolf, Clifford J.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02114 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA.	dfisher3@partners.org	Woolf, Clifford/A-9784-2010; Fisher, David/AAH-2878-2019		NIH [R01 AR043369-16, P01CA163222, R01 CA150226-03]; Melanoma Research Alliance; US-Israel Binational Science Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [P01CA163222, R01CA150226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge Dr. Charles Berde, Dr. Jeff Mogil, Ms. Vivien Igras, Mr. John Dellorusso, Ms. Teri Herbert, Ms. Leeza Hargreaves, Dr. Roydon Price, and Dr. Grewo Lim for productive discussions during the early phases of this project and for technical assistance with the experiments and manuscript. The authors thank Dr. Mary Jeanne Kreek for useful discussions. The authors also acknowledge Douglas Hayden from the MGH Biostatistics Center for consultation regarding the statistical analysis. This work was supported by NIH under award numbers R01 AR043369-16, P01CA163222, and R01 CA150226-03 and by grants from the Melanoma Research Alliance, the US-Israel Binational Science Foundation, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.E.F.).	ARAVICH PF, 1993, BRAIN RES, V622, P1, DOI 10.1016/0006-8993(93)90794-N; Bender T, 2007, EUR J APPL PHYSIOL, V100, P371, DOI 10.1007/s00421-007-0469-9; BILBEY DLJ, 1960, BRIT J PHARM CHEMOTH, V15, P540, DOI 10.1111/j.1476-5381.1960.tb00277.x; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dassule HR, 2000, DEVELOPMENT, V127, P4775; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Fassoulaki A, 2007, ANESTH ANALG, V104, P312, DOI 10.1213/01.ane.0000250911.43942.4e; Feldman SR, 2004, J AM ACAD DERMATOL, V51, P45, DOI 10.1016/j.jaad.2004.01.053; Gambichler T, 2002, BRIT J DERMATOL, V147, P1207, DOI 10.1046/j.1365-2133.2002.04859.x; Gandini S, 2011, PROG BIOPHYS MOL BIO, V107, P362, DOI 10.1016/j.pbiomolbio.2011.09.011; Gianoulakis C, 1996, ALCOHOL, V13, P19, DOI 10.1016/0741-8329(95)02035-7; Gianoulakis C, 2009, CURR TOP MED CHEM, V9, P999, DOI 10.2174/156802609789630956; Glass MJ, 2008, EXP NEUROL, V213, P57, DOI 10.1016/j.expneurol.2008.04.045; Harrington CR, 2011, CLIN EXP DERMATOL, V36, P33, DOI 10.1111/j.1365-2230.2010.03882.x; Harrington CR, 2012, ADDICT BIOL, V17, P680, DOI 10.1111/j.1369-1600.2010.00312.x; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; KASTIN AJ, 1979, PHARMACOL BIOCHEM BE, V11, P713, DOI 10.1016/0091-3057(79)90268-5; Kaur M, 2006, J AM ACAD DERMATOL, V54, P919, DOI 10.1016/j.jaad.2006.01.062; Kaur M, 2006, J AM ACAD DERMATOL, V54, P709, DOI 10.1016/j.jaad.2005.11.1059; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Kourosh AS, 2010, AM J DRUG ALCOHOL AB, V36, P284, DOI 10.3109/00952990.2010.491883; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; LEVINS PC, 1983, LANCET, V2, P166; Mao J, 2000, NEUROSCI LETT, V280, P13, DOI 10.1016/S0304-3940(99)00998-2; Marino S, 2000, GENE DEV, V14, P994; MCMURRAY RG, 1990, CHRONOBIOL INT, V7, P135, DOI 10.3109/07420529009056965; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Nguyen AT, 2012, EUR J PHARMACOL, V686, P50, DOI 10.1016/j.ejphar.2012.04.040; Olive MF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0002.2001; Olson VG, 2006, SYNAPSE, V60, P553, DOI 10.1002/syn.20328; PETRAGLIA F, 1990, J ENDOCRINOL INVEST, V13, P19, DOI 10.1007/BF03348571; Racz I, 2008, BIOL PSYCHIAT, V64, P989, DOI 10.1016/j.biopsych.2008.05.008; Robinson JK, 1997, J AM ACAD DERMATOL, V37, P179, DOI 10.1016/S0190-9622(97)80122-3; Roma PG, 2005, PHARMACOL BIOCHEM BE, V82, P163, DOI 10.1016/j.pbb.2005.08.004; Roth-Deri I, 2003, J NEUROCHEM, V84, P930, DOI 10.1046/j.1471-4159.2003.01584.x; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SCHOFFELMEER ANM, 1991, J PHARMACOL EXP THER, V258, P237; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Technology Planning and Management Corporation, 2000, REP CARC BACKGR DOC; Trigo JM, 2009, NEUROPHARMACOLOGY, V56, P1147, DOI 10.1016/j.neuropharm.2009.03.013; TSENG LF, 1976, NATURE, V263, P239, DOI 10.1038/263239a0; US-EPA, 1994, FED EXP ULTR IND WHA; Warthan MM, 2005, ARCH DERMATOL, V141, P963, DOI 10.1001/archderm.141.8.963; Weitemier AZ, 2009, EUR J NEUROSCI, V29, P1015, DOI 10.1111/j.1460-9568.2009.06652.x; Welch CC, 1996, BRAIN RES, V721, P126, DOI 10.1016/0006-8993(96)00151-5; Wintzen M, 2001, PHOTODERMATOL PHOTO, V17, P256, DOI 10.1034/j.1600-0781.2001.170602.x; Zeller S, 2006, J AM ACAD DERMATOL, V54, P589, DOI 10.1016/j.jaad.2005.12.038	54	152	156	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1527	1534		10.1016/j.cell.2014.04.032	http://dx.doi.org/10.1016/j.cell.2014.04.032			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949966	Green Accepted, Bronze			2022-12-28	WOS:000340941900009
J	Chhetri, SK; Mills, RJ; Shaunak, S; Emsley, HCA				Chhetri, S. K.; Mills, R. J.; Shaunak, S.; Emsley, H. C. A.			EASILY MISSED? Copper deficiency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GASTRIC BYPASS-SURGERY; BILIOPANCREATIC DIVERSION; BARIATRIC SURGERY; MYELOPATHY		[Chhetri, S. K.; Mills, R. J.; Shaunak, S.; Emsley, H. C. A.] Royal Preston Hosp, Dept Neurol, Preston PR2 9HT, Lancs, England; [Chhetri, S. K.; Emsley, H. C. A.] Univ Manchester, Manchester M13 9PL, Lancs, England	Royal Preston Hospital; University of Manchester	Emsley, HCA (corresponding author), Royal Preston Hosp, Dept Neurol, Preston PR2 9HT, Lancs, England.	hedley.emsley@manchester.ac.uk	Chhetri, Suresh/T-8723-2019	chhetri, Suresh Kumar/0000-0002-3325-5582; Emsley, Hedley/0000-0003-0129-4488				Balsa JA, 2011, OBES SURG, V21, P744, DOI 10.1007/s11695-011-0389-y; de Luis DA, 2008, ANN NUTR METAB, V53, P234, DOI 10.1159/000185641; Gabreyes AA, 2013, EUR J HAEMATOL, V90, P1, DOI 10.1111/ejh.12020; Gletsu-Miller N, 2012, INT J OBESITY, V36, P328, DOI 10.1038/ijo.2011.159; Griffith DP, 2009, OBESITY, V17, P827, DOI 10.1038/oby.2008.614; Halfdanarson TR, 2008, EUR J HAEMATOL, V80, P523, DOI 10.1111/j.1600-0609.2008.01050.x; Jaiser SR, 2010, J NEUROL, V257, P869, DOI 10.1007/s00415-010-5511-x; Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010; Robinson Sara D, 2013, Proc (Bayl Univ Med Cent), V26, P382; Yarandi SS, 2014, J CLIN GASTROENTEROL	10	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g3691	10.1136/bmj.g3691	http://dx.doi.org/10.1136/bmj.g3691			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24938531				2022-12-28	WOS:000337804900011
J	Fossat, P; Bacque-Cazenave, J; De Deurwaerdere, P; Delbecque, JP; Cattaert, D				Fossat, Pascal; Bacque-Cazenave, Julien; De Deurwaerdere, Philippe; Delbecque, Jean-Paul; Cattaert, Daniel			COMPARATIVE BEHAVIOR Anxiety-like behavior in crayfish is controlled by serotonin	SCIENCE			English	Article							5-HYDROXYTRYPTAMINE; LOCALIZATION; RELEASE; AMINES	Anxiety, a behavioral consequence of stress, has been characterized in humans and some vertebrates, but not invertebrates. Here, we demonstrate that after exposure to stress, crayfish sustainably avoided the aversive illuminated arms of an aquatic plus-maze. This behavior was correlated with an increase in brain serotonin and was abolished by the injection of the benzodiazepine anxiolytic chlordiazepoxide. Serotonin injection into unstressed crayfish induced avoidance; again, this effect was reversed by injection with chlordiazepoxide. Our results demonstrate that crayfish exhibit a form of anxiety similar to that described in vertebrates, suggesting the conservation of several underlying mechanisms during evolution. Analyses of this ancestral behavior in a simple model reveal a new route to understanding anxiety and may alter our conceptions of the emotional status of invertebrates.	[Fossat, Pascal; Bacque-Cazenave, Julien; De Deurwaerdere, Philippe; Delbecque, Jean-Paul; Cattaert, Daniel] Univ Bordeaux, Dept Life Sci & Hlth, F-33076 Bordeaux, France; [Fossat, Pascal; Bacque-Cazenave, Julien; Delbecque, Jean-Paul; Cattaert, Daniel] CNRS, UMR 5287, Inst Neurosci Cognit & Integrat Aquitaine, F-33405 Talence, France; [De Deurwaerdere, Philippe] CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33076 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Cattaert, D (corresponding author), Univ Bordeaux, Dept Life Sci & Hlth, F-33076 Bordeaux, France.	daniel.cattaert@u-bordeaux.fr	Bacqué-Cazenave, Julien/ADC-8934-2022; De Deurwaerdère, Philippe/I-5834-2019	De Deurwaerdère, Philippe/0000-0002-1226-3516; Bacque-Cazenave, Julien/0000-0001-9917-8885; Fossat, Pascal/0000-0001-5117-0817	CNRS; "Conseil Regional d'Aquitaine" [2010301037]; European Cooperation in Science and Technology Action [CM1103]	CNRS(Centre National de la Recherche Scientifique (CNRS)); "Conseil Regional d'Aquitaine"(Region Nouvelle-Aquitaine); European Cooperation in Science and Technology Action	This work was supported by CNRS and "Conseil Regional d'Aquitaine" (2010301037). P.D.D. acknowledges support from European Cooperation in Science and Technology Action CM1103. We thank E. Coutureau, A. Marchand, P. Meyrand, M. Corio, and D. H. Edwards for advice and S. Builles and D. Cheyrou (Reserve Naturelle de Bruges) for providing animals. The data used in this study are presented in table S2. Values for PCA analysis are presented at the end of the supplementary materials.	Aquiloni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050047; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Belzung Catherine, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/59676; Blanchard D. C., 2008, HDB ANXIETY FEAR; De Deurwaerdere P, 1998, J NEUROSCI, V18, P6528; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; FLOREY E, 1991, CAN J PHYSIOL PHARM, V69, P1049, DOI 10.1139/y91-156; HANDLEY SL, 1993, PSYCHOPHARMACOLOGY, V112, P13, DOI 10.1007/BF02247358; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Kawai N, 2004, BEHAV BRAIN RES, V150, P229, DOI 10.1016/S0166-4328(03)00261-4; Langworthy K, 1997, CELL TISSUE RES, V288, P191, DOI 10.1007/s004410050806; Lee CY, 2001, PHYSIOL BIOCHEM ZOOL, V74, P376, DOI 10.1086/320430; Lopez-Munoz F, 2011, J ANXIETY DISORD, V25, P554, DOI 10.1016/j.janxdis.2011.01.002; Lorenzon S, 2005, J EXP BIOL, V208, P3341, DOI 10.1242/jeb.01761; MATTSON MP, 1986, GEN COMP ENDOCR, V62, P419, DOI 10.1016/0016-6480(86)90052-3; Momohara Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074489; Peeke HVS, 2000, J COMP PHYSIOL A, V186, P575, DOI 10.1007/s003590000113; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Rodriguez-Sosa L, 2006, COMP BIOCHEM PHYS C, V142, P220, DOI 10.1016/j.cbpc.2005.10.006; Rodriguez-Sosa L, 1997, J EXP BIOL, V200, P3067; Snyder MJ, 2000, MAR FRESHW BEHAV PHY, V34, P37, DOI 10.1080/10236240009379058; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; WALTERS ET, 1981, SCIENCE, V211, P504, DOI 10.1126/science.7192881; Yamane S, 2002, J COMP PHYSIOL A, V188, P13, DOI 10.1007/s00359-001-0274-6	27	113	118	9	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1293	1297		10.1126/science.1248811	http://dx.doi.org/10.1126/science.1248811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926022				2022-12-28	WOS:000337077500043
J	Jousimo, J; Tack, AJM; Ovaskainen, O; Mononen, T; Susi, H; Tollenaere, C; Laine, AL				Jousimo, Jussi; Tack, Ayco J. M.; Ovaskainen, Otso; Mononen, Tommi; Susi, Hanna; Tollenaere, Charlotte; Laine, Anna-Liisa			DISEASE ECOLOGY Ecological and evolutionary effects of fragmentation on infectious disease dynamics	SCIENCE			English	Article							PLANT-PATHOGEN METAPOPULATION; LOCAL ADAPTATION; HOST; POPULATION; COEVOLUTION; RESISTANCE; DISPERSAL; SCALE; SIZE	Ecological theory predicts that disease incidence increases with increasing density of host networks, yet evolutionary theory suggests that host resistance increases accordingly. To test the combined effects of ecological and evolutionary forces on host-pathogen systems, we analyzed the spatiotemporal dynamics of a plant (Plantago lanceolata)-fungal pathogen (Podosphaera plantaginis) relationship for 12 years in over 4000 host populations. Disease prevalence at the metapopulation level was low, with high annual pathogen extinction rates balanced by frequent (re-) colonizations. Highly connected host populations experienced less pathogen colonization and higher pathogen extinction rates than expected; a laboratory assay confirmed that this phenomenon was caused by higher levels of disease resistance in highly connected host populations.	[Jousimo, Jussi; Tack, Ayco J. M.; Ovaskainen, Otso; Mononen, Tommi; Susi, Hanna; Tollenaere, Charlotte; Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, FI-00014 Helsinki, Finland; [Mononen, Tommi] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, FI-00076 Aalto, Finland	University of Helsinki; Aalto University	Laine, AL (corresponding author), Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Post Off Box 65,Viikinkaari 1, FI-00014 Helsinki, Finland.	anna-liisa.laine@helsinki.fi	Tack, Ayco/B-7120-2017; Ovaskainen, Otso/AGN-4838-2022; Tollenaere, Charlotte/ABB-6175-2020; Ovaskainen, Otso/D-9119-2012; Laine, Anna-Liisa/B-1398-2016	Tack, Ayco/0000-0002-3550-1070; Ovaskainen, Otso/0000-0001-9750-4421; Tollenaere, Charlotte/0000-0003-2045-2824; Ovaskainen, Otso/0000-0001-9750-4421; Laine, Anna-Liisa/0000-0002-0703-5850; Mononen, Tommi/0000-0002-3603-0813	Academy of Finland [250444, 136393, 133499]; European Research Council (Independent Starting grant PATHEVOL) [281517]	Academy of Finland(Academy of Finland); European Research Council (Independent Starting grant PATHEVOL)	We acknowledge I. Hanski, S. Ojanen, and M. Nieminen for organizing the large-scale field surveys in land and E. Meyke for managing the database. The numerous biology students who have participated in years 2001 and 2012 are gratefully acknowledged for their hard work in the field. H. Hohti and the Finnish Meteorological Institute kindly provided the rainfall radar images. I. Hanski, J.Antonovics, and R. Penczykowski provided valuable comments on the manuscript. This work was supported by funding from the Academy of Finland (grant nos. 250444, 136393, and 133499) and the European Research Council (Independent Starting grant PATHEVOL; 281517) to A.L.L. The data presented in this paper are deposited in Dryad (10.5061/dryad.vf210).	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Antonovics J., 2004, ECOLOGY GENETICS EVO, P471, DOI DOI 10.1016/B978-012323448-3/50021-0; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Bradley DJ, 2008, ECOL LETT, V11, P461, DOI 10.1111/j.1461-0248.2008.01162.x; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; Cressey D, 2013, NATURE, V493, P587, DOI 10.1038/493587a; Decaestecker E, 2013, ECOL LETT, V16, P1455, DOI 10.1111/ele.12186; Duffy MA, 2012, SCIENCE, V335, P1636, DOI 10.1126/science.1215429; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gandon S, 2009, AM NAT, V173, P212, DOI 10.1086/593706; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Hanski I., 1999, METAPOPULATION ECOLO; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Laine AL, 2006, P ROY SOC B-BIOL SCI, V273, P267, DOI 10.1098/rspb.2005.3303; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P1665, DOI 10.1111/j.1420-9101.2007.01359.x; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Ovaskainen O, 2006, ECOLOGY, V87, P880, DOI 10.1890/0012-9658(2006)87[880:IESFED]2.0.CO;2; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Smith DL, 2011, J ECOL, V99, P634, DOI 10.1111/j.1365-2745.2010.01788.x; Tack AJM, 2014, NEW PHYTOL, V202, P297, DOI 10.1111/nph.12646; Thompson J.N., 2005, INTERSPEC INTERACT; Thrall PH, 2012, ECOL LETT, V15, P425, DOI 10.1111/j.1461-0248.2012.01749.x; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; THRALL PH, 1995, CAN J BOT, V73, pS1249, DOI 10.1139/b95-385; Tollenaere C, 2013, J EVOLUTION BIOL, V26, P1716, DOI 10.1111/jeb.12169; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237	31	123	124	1	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1289	1293		10.1126/science.1253621	http://dx.doi.org/10.1126/science.1253621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926021				2022-12-28	WOS:000337077500042
J	Kirtane, AJ; Stone, GW				Kirtane, Ajay J.; Stone, Gregg W.			STEMI care in China: a world opportunity	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; MORTALITY; SURVIVAL		[Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Herbert & Sandi Feinberg Intervent Cardiol & Hear, New York, NY 10022 USA; Cardiovasc Res Fdn, New York, NY 10022 USA	Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF)	Stone, GW (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, Herbert & Sandi Feinberg Intervent Cardiol & Hear, New York, NY 10022 USA.	gs2184@columbia.edu						Chen ZM, 2005, LANCET, V366, P1622; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Chew DP, 2010, HEART, V96, P1201, DOI 10.1136/hrt.2009.184853; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kristensen SD, 2014, EUR HEART J, V35, P1957, DOI 10.1093/eurheartj/eht529; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570	12	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					400	401		10.1016/S0140-6736(14)61033-3	http://dx.doi.org/10.1016/S0140-6736(14)61033-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ9CT	24969507				2022-12-28	WOS:000348509900007
J	Shahzad, A; Kemp, I; Mars, C; Wilson, K; Roome, C; Cooper, R; Andron, M; Appleby, C; Fisher, M; Khand, A; Kunadian, B; Mills, JD; Morris, JL; Morrison, WL; Munir, S; Palmer, ND; Perry, RA; Ramsdale, DR; Velavan, P; Stables, RH				Shahzad, Adeel; Kemp, Ian; Mars, Christine; Wilson, Keith; Roome, Claire; Cooper, Rob; Andron, Mohammed; Appleby, Clare; Fisher, Mike; Khand, Aleem; Kunadian, Babu; Mills, Joseph D.; Morris, John L.; Morrison, William L.; Munir, Shahzad; Palmer, Nick D.; Perry, Raphael A.; Ramsdale, David R.; Velavan, Periaswamy; Stables, Rod H.		HEAT-PPCI Trial Investigators	Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial	LANCET			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; THROMBUS ASPIRATION; PRIMARY PCI; ANGIOPLASTY; GUIDELINES; MANAGEMENT	Background Bivalirudin, with selective use of glycoprotein (GP) IIb/IIIa inhibitor agents, is an accepted standard of care in primary percutaneous coronary intervention (PPCI). We aimed to compare antithrombotic therapy with bivalirudin or unfractionated heparin during this procedure. Methods In our open-label, randomised controlled trial, we enrolled consecutive adults scheduled for angiography in the context of a PPCI presentation at Liverpool Heart and Chest Hospital (Liverpool, UK) with a strategy of delayed consent. Before angiography, we randomly allocated patients (1:1; stratified by age [<75 years vs >= 75 years] and presence of cardiogenic shock [yes vs no]) to heparin (70 U/kg) or bivalirudin (bolus 0.75 mg/kg; infusion 1.75 mg/kg per h). Patients were followed up for 28 days. The primary efficacy outcome was a composite of all-cause mortality, cerebrovascular accident, reinfarction, or unplanned target lesion revascularisation. The primary safety outcome was incidence of major bleeding (type 3-5 as per Bleeding Academic Research Consortium definitions). This study is registered with ClinicalTrials.gov, number NCT01519518. Findings Between Feb 7, 2012, and Nov 20, 2013, 1829 of 1917 patients undergoing emergency angiography at our centre (representing 97% of trial-naive presentations) were randomly allocated treatment, with 1812 included in the final analyses. 751 (83%) of 905 patients in the bivalirudin group and 740 (82%) of 907 patients in the heparin group had a percutaneous coronary intervention. The rate of GP IIb/IIIa inhibitor use was much the same between groups (122 patients [13%] in the bivalirudin group and 140 patients [15%] in the heparin group). The primary efficacy outcome occurred in 79 (8.7%) of 905 patients in the bivalirudin group and 52 (5.7%) of 907 patients in the heparin group (absolute risk difference 3.0%; relative risk [RR] 1.52, 95% CI 1.09-2.13, p=0.01). The primary safety outcome occurred in 32 (3.5%) of 905 patients in the bivalirudin group and 28 (3.1%) of 907 patients in the heparin group (0.4%; 1.15, 0.70-1.89, p=0.59). Interpretation Compared with bivalirudin, heparin reduces the incidence of major adverse ischaemic events in the setting of PPCI, with no increase in bleeding complications. Systematic use of heparin rather than bivalirudin would reduce drug costs substantially.	[Shahzad, Adeel; Kemp, Ian; Mars, Christine; Wilson, Keith; Roome, Claire; Cooper, Rob; Andron, Mohammed; Appleby, Clare; Fisher, Mike; Khand, Aleem; Kunadian, Babu; Mills, Joseph D.; Morris, John L.; Morrison, William L.; Munir, Shahzad; Palmer, Nick D.; Perry, Raphael A.; Ramsdale, David R.; Velavan, Periaswamy; Stables, Rod H.] Liverpool Heart & Chest Hosp NHS Fdn Trust, Inst Cardiovasc Med & Sci, Liverpool L14 3PE, Merseyside, England	Liverpool Heart & Chest Hospital	Stables, RH (corresponding author), Liverpool Heart & Chest Hosp NHS Fdn Trust, Inst Cardiovasc Med & Sci, Liverpool L14 3PE, Merseyside, England.	rod.stables@lhch.nhs.uk		Cooper, Robert/0000-0001-7482-828X; Velavan, Periaswamy/0000-0001-9076-6891	Liverpool Heart and Chest Hospital, UK National Institute of Health Research, The Medicines Company, AstraZeneca, The Bentley Drivers Club (UK)	Liverpool Heart and Chest Hospital, UK National Institute of Health Research, The Medicines Company, AstraZeneca, The Bentley Drivers Club (UK)	Liverpool Heart and Chest Hospital, UK National Institute of Health Research, The Medicines Company, AstraZeneca, The Bentley Drivers Club (UK)	BITTL JA, 1995, AM HEART J, V130, P658, DOI 10.1016/0002-8703(95)90303-8; Dangas GD, 2011, J AM COLL CARDIOL, V57, P2309, DOI 10.1016/j.jacc.2011.01.038; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kaptchuk TJ, 2001, J CLIN EPIDEMIOL, V54, P541, DOI 10.1016/S0895-4356(00)00347-4; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416	14	386	393	2	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1849	1858		10.1016/S0140-6736(14)60924-7	http://dx.doi.org/10.1016/S0140-6736(14)60924-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	25002178				2022-12-28	WOS:000345116800025
J	Attaran, A				Attaran, Amir			A modest but meaningful decision for Indian drug patents	LANCET			English	Editorial Material									Univ Ottawa, Fac Law & Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law & Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						[Anonymous], 2013, HINDU BUSINESS  0605; Eban K, LATEST CLAIM FRAUD G; Eban K, 2013, DIRTY MED; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; India-Parliamentary Standing Committee on Health and Family Welfare, 59 IND PARL STAND CO; Laxminarayan P, 2013, India Patent, Patent No. 255388; United States Department of Justice, GEN DRUG MAN RANB PL	7	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					477	479		10.1016/S0140-6736(13)60845-4	http://dx.doi.org/10.1016/S0140-6736(13)60845-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	24976117				2022-12-28	WOS:000340198300008
J	Keranen, KM; Weingarten, M; Abers, GA; Bekins, BA; Ge, S				Keranen, K. M.; Weingarten, M.; Abers, G. A.; Bekins, B. A.; Ge, S.			Sharp increase in central Oklahoma seismicity since 2008 induced by massive wastewater injection	SCIENCE			English	Article							EARTHQUAKE SEQUENCE; STRESS; FLUID; MAGNITUDE; FAULT	Unconventional oil and gas production provides a rapidly growing energy source; however, high-production states in the United States, such as Oklahoma, face sharply rising numbers of earthquakes. Subsurface pressure data required to unequivocally link earthquakes to wastewater injection are rarely accessible. Here we use seismicity and hydrogeological models to show that fluid migration from high-rate disposal wells in Oklahoma is potentially responsible for the largest swarm. Earthquake hypocenters occur within disposal formations and upper basement, between 2- and 5-kilometer depth. The modeled fluid pressure perturbation propagates throughout the same depth range and tracks earthquakes to distances of 35 kilometers, with a triggering threshold of similar to 0.07 megapascals. Although thousands of disposal wells operate aseismically, four of the highest-rate wells are capable of inducing 20% of 2008 to 2013 central U.S. seismicity.	[Keranen, K. M.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA; [Weingarten, M.; Ge, S.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Abers, G. A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Bekins, B. A.] US Geol Survey, Menlo Pk, CA 94025 USA	Cornell University; University of Colorado System; University of Colorado Boulder; Columbia University; United States Department of the Interior; United States Geological Survey	Keranen, KM (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA.	keranen@cornell.edu			USGS National Earthquake Hazards Reduction Program (NEHRP) [G13AP00025]; USGS Powell Center [G13AC00023]; NEHRP [G13AP00024]; National Science Foundation	USGS National Earthquake Hazards Reduction Program (NEHRP)(United States Geological Survey); USGS Powell Center; NEHRP(United States Geological Survey); National Science Foundation(National Science Foundation (NSF))	This research benefited from discussion with E. Cochran, W. Ellsworth, and participants in a U.S. Geological Survey (USGS) Powell Center Working Group on Understanding Fluid Injection Induced Seismicity (M. W., B. A. B., and S. G. are part of this group). C. Hogan identified many P and S phases. K. M. K was partially supported by USGS National Earthquake Hazards Reduction Program (NEHRP) grant G13AP00025, M. W. was partially supported by the USGS Powell Center grant G13AC00023, and G. A. A. was partially supported by NEHRP grant G13AP00024. This project used seismic data from EarthScope's Transportable Array, a facility funded by the National Science Foundation. Seismic waveforms are from the Incorporated Research Institutions for Seismology Data Management Center and the USGS CWB Query. Well data are from the Oklahoma Corporation Commission and the Oklahoma Geological Survey. Lists of wells and the local earthquake catalog are available as supplementary materials on Science Online.	[Anonymous], 2013, J GEOPHYS RES, V118, P3506; Chernicky D., 2000, WORLD OIL; Davis S. D., 1993, Seismological Research Letters, V64, P207; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Frohlich C, 2012, P NATL ACAD SCI USA, V109, P13934, DOI 10.1073/pnas.1207728109; Frohlich C, 2011, B SEISMOL SOC AM, V101, P327, DOI 10.1785/0120100131; Gatewood L. E., 1970, AAPG MEMOIR, V14; Gay S.P., 2003, SHALE SHAKER, V54, P39; Holland AA, 2013, SEISMOL RES LETT, V84, P876, DOI 10.1785/0220120153; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; Justinic AH, 2013, B SEISMOL SOC AM, V103, P3083, DOI 10.1785/0120120336; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; Luza K. V., 1981, OKLAHOMA GEOLOGICAL, V81-3, P1; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Murray KE, 2013, ENVIRON SCI TECHNOL, V47, P4918, DOI 10.1021/es4000593; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; Seeber L, 2000, NATURE, V407, P69, DOI 10.1038/35024055; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Sumy DF, 2014, J GEOPHYS RES-SOL EA, V119, P1904, DOI 10.1002/2013JB010612; van der Elst NJ, 2013, SCIENCE, V341, P164, DOI 10.1126/science.1238948; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Zoback MD, 2002, INT GEOL REV, V44, P383, DOI 10.2747/0020-6814.44.5.383; ZOBACK ML, 1992, J GEOPHYS RES-SOL EA, V97, P11703, DOI 10.1029/92JB00221	24	506	513	13	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					448	451		10.1126/science.1255802	http://dx.doi.org/10.1126/science.1255802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	24993347				2022-12-28	WOS:000339655100042
J	Kaufman, AM; Lester, BJ; Reynolds, CM; Wall, ML; Foss-Feig, M; Hazzard, KRA; Rey, AM; Regal, CA				Kaufman, A. M.; Lester, B. J.; Reynolds, C. M.; Wall, M. L.; Foss-Feig, M.; Hazzard, K. R. A.; Rey, A. M.; Regal, C. A.			Two-particle quantum interference in tunnel-coupled optical tweezers	SCIENCE			English	Article							SINGLE ATOMS; COHERENCE; PHOTONS; LATTICE; INDISTINGUISHABILITY	The quantum statistics of atoms is typically observed in the behavior of an ensemble via macroscopic observables. However, quantum statistics modifies the behavior of even two particles. Here, we demonstrate near-complete control over all the internal and external degrees of freedom of two laser-cooled Rb-87 atoms trapped in two optical tweezers. This controllability allows us to observe signatures of indistinguishability via two-particle interference. Our work establishes laser-cooled atoms in optical tweezers as a promising route to bottom-up engineering of scalable, low-entropy quantum systems.	[Kaufman, A. M.; Lester, B. J.; Reynolds, C. M.; Wall, M. L.; Hazzard, K. R. A.; Rey, A. M.; Regal, C. A.] Univ Colorado, NIST, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Kaufman, A. M.; Lester, B. J.; Reynolds, C. M.; Wall, M. L.; Hazzard, K. R. A.; Rey, A. M.; Regal, C. A.] Univ Colorado, Boulder, CO 80309 USA; [Kaufman, A. M.; Lester, B. J.; Reynolds, C. M.; Wall, M. L.; Hazzard, K. R. A.; Rey, A. M.; Regal, C. A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Foss-Feig, M.] Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Foss-Feig, M.] NIST, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Regal, CA (corresponding author), Univ Colorado, NIST, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	regal@colorado.edu		Lester, Brian/0000-0002-4297-2508; REGAL, CINDY/0000-0002-0000-2140	David and Lucile Packard Foundation; National Science Foundation (NSF) [1125844]; Clare Boothe Luce Foundation; National Defense Science and Engineering Graduate Fellowships; NSF Graduate Research Fellowship Program; NSF-Physics at the Information Frontier; Army Research Office; Air Force Office of Scientific Research; National Research Council postdoctoral fellowship	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); Clare Boothe Luce Foundation; National Defense Science and Engineering Graduate Fellowships; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF-Physics at the Information Frontier(National Science Foundation (NSF)); Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Research Council postdoctoral fellowship	We thank T. P. Purdy for useful discussions. This work was supported by the David and Lucile Packard Foundation and the National Science Foundation (NSF) under grant no. 1125844. C. A. R. acknowledges support from the Clare Boothe Luce Foundation, A. M. K. and C. M. R. from the National Defense Science and Engineering Graduate Fellowships, and B.J.L. from the NSF Graduate Research Fellowship Program. K. R. A. H., M. L. W., and A. M. R. acknowledge funding from NSF-Physics at the Information Frontier, Army Research Office and Air Force Office of Scientific Research. K. R. A. H. and M.F.-F. acknowledge support from a National Research Council postdoctoral fellowship.	Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Beugnon J, 2006, NATURE, V440, P779, DOI 10.1038/nature04628; Bocquillon E, 2013, SCIENCE, V339, P1054, DOI 10.1126/science.1232572; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; Egorov M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.053614; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; GLAUBER RJ, 1963, PHYS REV, V130, P2529, DOI 10.1103/PhysRev.130.2529; Hodgman SS, 2011, SCIENCE, V331, P1046, DOI 10.1126/science.1198481; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Jeltes T, 2007, NATURE, V445, P402, DOI 10.1038/nature05513; Kaufman AM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041014; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; Lang C, 2013, NAT PHYS, V9, P345, DOI [10.1038/nphys2612, 10.1038/NPHYS2612]; Ma RC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.095301; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Ottl A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090404; Schellekens M, 2005, SCIENCE, V310, P648, DOI 10.1126/science.1118024; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Sebby-Strabley J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200405; Serwane F, 2011, SCIENCE, V332, P336, DOI 10.1126/science.1201351; Steffen A, 2012, P NATL ACAD SCI USA, V109, P9770, DOI 10.1073/pnas.1204285109; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; Vetsch E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203603; Vuletic V, 1998, PHYS REV LETT, V81, P5768, DOI 10.1103/PhysRevLett.81.5768; Weiss DS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.040302; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Yasuda M, 1996, PHYS REV LETT, V77, P3090, DOI 10.1103/PhysRevLett.77.3090	31	139	139	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					306	309		10.1126/science.1250057	http://dx.doi.org/10.1126/science.1250057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24968938	Green Submitted			2022-12-28	WOS:000339400700046
J	Dahabreh, IJ; Kent, DM				Dahabreh, Issa J.; Kent, David M.			Can the Learning Health Care System Be Educated With Observational Data?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROPENSITY SCORE; RANDOMIZED-TRIALS		[Dahabreh, Issa J.] Brown Univ, Sch Publ Hlth, Ctr Evidence Based Med, Providence, RI 02912 USA; [Dahabreh, Issa J.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Kent, David M.] Tufts Med Ctr, PACE Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	Brown University; Brown University; Tufts Medical Center	Kent, DM (corresponding author), Tufts Med Ctr, PACE Ctr, Inst Clin Res & Hlth Policy Studies, 800 Washington St, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org						Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Lonjon G, 2014, ANN SURG, V259, P18, DOI 10.1097/SLA.0000000000000256; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shadish WR, 2008, J AM STAT ASSOC, V103, P1334, DOI 10.1198/016214508000000733; Tannen RL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b81	8	51	51	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					129	130		10.1001/jama.2014.4364	http://dx.doi.org/10.1001/jama.2014.4364			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005647				2022-12-28	WOS:000338511200015
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED The BMJ is wrong: doctor assisted dying would overmedicalise death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bingham J., 2014, DAILY TELEGRAPH, DOI [10674267/Family-breakdowncouldcost-taxpayers-46bn.htmlhttp://www.telegraph.co.uk/women/sex/divorce/10674267/Familybreakdown-could-cost-taxpayers-46bn.html, DOI 10674267/FAMILY-BREAKDOWNCOULDCOST-TAXPAYERS-46BN.HTMLHTTP://WWW.TELEGRAPH.CO.UK/WOMEN/SEX/DIVORCE/10674267/FAMILYBREAKDOWN-COULD-COST-TAXPAYERS-46BN.HTML]; Delamothe T, 2014, BMJ-BRIT MED J, V348, pg4094; Heath I, 2013, JAMA INTERN MED, V173, P956, DOI 10.1001/jamainternmed.2013.970; Marmot M, 2010, FAIR SOC HLTH LIVES; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; The Royal College of Midwives, CAMP NORM BIRTH	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4502	10.1136/bmj.g4502	http://dx.doi.org/10.1136/bmj.g4502			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005033	Bronze, Green Published			2022-12-28	WOS:000338993300013
J	Sedgwick, P				Sedgwick, Philip			Measuring the performance of screening tests	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Luck AJ, 2002, BRIT MED J, V325, P755, DOI 10.1136/bmj.325.7367.755; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2493; Sedgwick P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3986	3	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2014	349								g4438	10.1136/bmj.g4438	http://dx.doi.org/10.1136/bmj.g4438			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2YY	25001573				2022-12-28	WOS:000338993000002
J	Lu, M; Lawrence, DA; Marsters, S; Acosta-Alvear, D; Kimmig, P; Mendez, AS; Paton, AW; Paton, JC; Walter, P; Ashkenazi, A				Lu, Min; Lawrence, David A.; Marsters, Scot; Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Paton, Adrienne W.; Paton, James C.; Walter, Peter; Ashkenazi, Avi			Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT UP-REGULATION; ER STRESS; DOWN-REGULATION; CELL-DEATH; PATHWAY; ACTIVATION; EXPRESSION; CASPASE-2; TRAIL	Protein folding by the endoplasmic reticulum (ER) is physiologically critical; its disruption causes ER stress and augments disease. ER stress activates the unfolded protein response (UPR) to restore homeostasis. If stress persists, the UPR induces apoptotic cell death, but the mechanisms remain elusive. Here, we report that unmitigated ER stress promoted apoptosis through cell-autonomous, UPR-controlled activation of death receptor 5 (DR5). ER stressors induced DR5 transcription via the UPR mediator CHOP; however, the UPR sensor IRE1 alpha transiently catalyzed DR5 mRNA decay, which allowed time for adaptation. Persistent ER stress built up intracellular DR5 protein, driving ligand-independent DR5 activation and apoptosis engagement via caspase-8. Thus, DR5 integrates opposing UPR signals to couple ER stress and apoptotic cell fate.	[Lu, Min; Lawrence, David A.; Marsters, Scot; Ashkenazi, Avi] Genentech Inc, Canc Immunol, San Francisco, CA 94080 USA; [Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Roche Holding; Genentech; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Adelaide	Walter, P (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	peter@walterlab.ucsf.edu; aa@gene.com	Acosta-Alvear, Diego/V-8048-2019; Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589; Acosta-Alvear, Diego/0000-0002-1139-8486	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM032384, T32 GM064337] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337, R01GM032384] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Martin-Perez R, 2012, APOPTOSIS, V17, P349, DOI 10.1007/s10495-011-0673-2; Niederreiter L, 2013, J EXP MED, V210, P2041, DOI 10.1084/jem.20122341; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Salvesen GS, 2011, CELL, V147, DOI 10.1016/j.cell.2011.09.030; Sandow JJ, 2014, CELL DEATH DIFFER, V21, P475, DOI 10.1038/cdd.2013.168; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	25	379	400	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					98	101		10.1126/science.1254312	http://dx.doi.org/10.1126/science.1254312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994655	Green Accepted			2022-12-28	WOS:000338284400059
J	Bishop, RE				Bishop, Russell E.			Lipopolysaccharide rolls out the barrel	NATURE			English	Editorial Material							OUTER-MEMBRANE; STRUCTURAL BASIS; TRANSPORT		[Bishop, Russell E.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Bishop, Russell E.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Bishop, RE (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.	bishopr@mcmaster.ca			Canadian Institutes of Health Research [125979-1] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Cuesta-Seijo JA, 2010, STRUCTURE, V18, P1210, DOI 10.1016/j.str.2010.06.014; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Khan MA, 2009, BIOCHEMISTRY-US, V48, P9745, DOI 10.1021/bi9013566; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Werneburg M, 2012, CHEMBIOCHEM, V13, P1767, DOI 10.1002/cbic.201200276; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600	12	12	12	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					37	38		10.1038/nature13508	http://dx.doi.org/10.1038/nature13508			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990738	Green Accepted			2022-12-28	WOS:000338199400026
J	Sedgwick, P				Sedgwick, Philip			Pitfalls of statistical hypothesis testing: type I and type II errors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Puder JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6195; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4285	4	19	20	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g4287	10.1136/bmj.g4287	http://dx.doi.org/10.1136/bmj.g4287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24994622				2022-12-28	WOS:000338646100005
J	Shao, DD; Xue, W; Krall, EB; Bhutkar, A; Piccioni, F; Wang, XX; Schinzel, AC; Sood, S; Rosenbluh, J; Kim, JW; Zwang, Y; Roberts, TM; Root, DE; Jacks, T; Hahn, WC				Shao, Diane D.; Xue, Wen; Krall, Elsa B.; Bhutkar, Arjun; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Sood, Sabina; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Root, David E.; Jacks, Tyler; Hahn, William C.			KRAS and YAP1 Converge to Regulate EMT and Tumor Survival	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; ONCOGENIC RAS; C-FOS; CANDIDATE ONCOGENE; CONTACT INHIBITION; HIPPO PATHWAY; BETA-CATENIN; ORGAN SIZE; ACTIVATION	Cancer cells that express oncogenic alleles of RAS typically require sustained expression of the mutant allele for survival, but the molecular basis of this oncogene dependency remains incompletely understood. To identify genes that can functionally substitute for oncogenic RAS, we systematically expressed 15,294 open reading frames in a human KRAS-dependent colon cancer cell line engineered to express an inducible KRAS-specific shRNA. We found 147 genes that promoted survival upon KRAS suppression. In particular, the transcriptional coactivator YAP1 rescued cell viability in KRAS-dependent cells upon suppression of KRAS and was required for KRAS-induced cell transformation. Acquired resistance to Kras suppression in a Kras-driven murine lung cancer model also involved increased YAP1 signaling. KRAS and YAP1 converge on the transcription factor FOS and activate a transcriptional program involved in regulating the epithelial-mesenchymal transition (EMT). Together, these findings implicate transcriptional regulation of EMT by YAP1 as a significant component of oncogenic RAS signaling.	[Shao, Diane D.; Krall, Elsa B.; Wang, Xiaoxing; Schinzel, Anna C.; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shao, Diane D.; Krall, Elsa B.; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Root, David E.; Jacks, Tyler; Hahn, William C.] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [Xue, Wen; Bhutkar, Arjun; Sood, Sabina; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Jacks, T (corresponding author), Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA.	tjacks@mit.edu; william_hahn@dfci.harvard.edu	Shao, Diane/GRO-3470-2022	Rosenbluh, Joseph/0000-0001-9815-8049; Shao, Diane/0000-0003-2087-4082	U.S. National Institutes of Health [R01 CA140545, U01 CA176058, P01 CA050661, K99 CA169512, T32 GM007753]; National Cancer Institute [P30-CA14051]; Howard Hughes Medical Institute; Daniel K. Ludwig Fund for Cancer Research; American Association for Cancer Research; Leukemia Lymphoma Society; Svenson Family Foundation; Department of Defense [W81XWH-10-1-0062, W81XWH-12-1-0115]; Hope Funds for Cancer Research [HFCR-11-03-03]; NATIONAL CANCER INSTITUTE [P50CA127003, P30CA014051, U01CA176058, P01CA154303, K99CA169512, P01CA050661, R00CA169512, R01CA140545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Daniel K. Ludwig Fund for Cancer Research; American Association for Cancer Research; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Svenson Family Foundation; Department of Defense(United States Department of Defense); Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by R01 CA140545 (W.C.H.), U01 CA176058 (W.C.H.), P01 CA050661 (W.C.H. and T.M.R.), K99 CA169512 (W.X.), and T32 GM007753 (D.S.) from the U.S. National Institutes of Health; and Koch Institute Support Grant P30-CA14051 (T.J.) from the National Cancer Institute. Additional support was provided by Howard Hughes Medical Institute (T.J.), Daniel K. Ludwig Fund for Cancer Research (T.J.), American Association for Cancer Research (W.X.), the Leukemia Lymphoma Society (W.X.), the Svenson Family Foundation (J.R.), fellowships W81XWH-10-1-0062 (X.W.) and W81XWH-12-1-0115 (Y.Z.) from the Department of Defense, and fellowship HFCR-11-03-03 from Hope Funds for Cancer Research (E.B.K.). T.M.R. and W.C.H. are consultants for Novartis.	Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fuchs IB, 2002, ANTICANCER RES, V22, P3415; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kielbasa SM, 2010, NUCLEIC ACIDS RES, V38, pW275, DOI 10.1093/nar/gkq438; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; LEDWITH BJ, 1990, MOL CELL BIOL, V10, P1545, DOI 10.1128/MCB.10.4.1545; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2013, ONCOGENE, V32, P3922, DOI 10.1038/onc.2012.520; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wong CE, 2013, GENE DEV, V27, P670, DOI 10.1101/gad.210427.112; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031994; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	59	511	523	4	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					171	184		10.1016/j.cell.2014.06.004	http://dx.doi.org/10.1016/j.cell.2014.06.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24954536	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000340943100016
J	Lopez-Fraga, M; Dominguez-Gil, B; Capron, AM; Van Assche, K; Martin, D; Cozzi, E; Delmonico, FL				Lopez-Fraga, Marta; Dominguez-Gil, Beatriz; Capron, Alexander M.; Van Assche, Kristof; Martin, Dominique; Cozzi, Emanuele; Delmonico, Francis L.			A needed Convention against trafficking in human organs Comment	LANCET			English	Editorial Material									[Lopez-Fraga, Marta] European Comm Organ Transplantat, European Directorate Qual Med & HealthCare, Council Europe, F-67081 Strasbourg, France; [Dominguez-Gil, Beatriz] Org Nacl Trasplantes, Dept Med, Madrid, Spain; [Capron, Alexander M.] Univ So Calif, Pacific Ctr Hlth Policy & Eth, Los Angeles, CA USA; [Van Assche, Kristof] Vrije Univ Brussel, Res Grp Law Sci Technol & Soc, Brussels, Belgium; [Martin, Dominique] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth & Soc, Melbourne, VA, Australia; [Cozzi, Emanuele] Ist Super Sanita, Ctr Nazl Trapianti, I-00161 Rome, Italy; [Cozzi, Emanuele] Padua Univ Hosp, Transplant Immunol Unit, Padua, Italy; [Delmonico, Francis L.] Transplantat Soc, Montreal, PQ, Canada; [Delmonico, Francis L.] World Hlth Org, Geneva, Switzerland; [Delmonico, Francis L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Delmonico, Francis L.] New England Organ Bank Inc, Waltham, MA USA	University of Southern California; Vrije Universiteit Brussel; University of Melbourne; Istituto Superiore di Sanita (ISS); University of Padua; Azienda Ospedaliera - Universita di Padova; World Health Organization; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lopez-Fraga, M (corresponding author), European Comm Organ Transplantat, European Directorate Qual Med & HealthCare, Council Europe, F-67081 Strasbourg, France.	marta.fraga@edqm.eu		Van Assche, Kristof WJ/0000-0002-8368-1993; Dominguez-Gil, Beatriz/0000-0002-5695-8993; Cozzi, Emanuele/0000-0001-7855-5055; Martin, Dominique/0000-0001-9363-0770; Lopez-Fraga, Marta/0000-0002-4155-3053	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Budiani-Saberi DA, 2008, AM J TRANSPLANT, V8, P925, DOI 10.1111/j.1600-6143.2008.02200.x; Council of Europe, 1997, CONV PROT HUM RIGHTS; Danovitch GM, 2014, KIDNEY INT, V85, P248, DOI 10.1038/ki.2013.466; European Committee on Crime Problems, EXPL REP CO IN PRESS; Global Observatory on Organ Donation and Transplantation, 2012, GLOB DISTR COUNTR LE; Global Observatory on Organ Donation and Transplantation, 2012, GLOB OBS ORG DON TRA; Joint Council of Europe/United Nations Study, 2009, TRAFF ORG TISS CELLS; Shimazono Y, 2007, B WORLD HEALTH ORGAN, V85, P955, DOI 10.2471/BLT.06.039370; United Nations Office of Drugs and Crime, 2000, PROT PREV SUPPR PUN; WHO, 1987, DEV GUID PRINC HUM O	10	23	24	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2187	2189		10.1016/S0140-6736(14)60835-7	http://dx.doi.org/10.1016/S0140-6736(14)60835-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24976316				2022-12-28	WOS:000338657600004
J	van Loosdrecht, MCM; Brdjanovic, D				van Loosdrecht, Mark C. M.; Brdjanovic, Damir			Anticipating the next century of wastewater treatment	SCIENCE			English	Editorial Material							RECOVERY		[van Loosdrecht, Mark C. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Brdjanovic, Damir] UNESCO IHE Inst Water Educ, NL-2611 AX Delft, Netherlands	Delft University of Technology; IHE Delft Institute for Water Education	van Loosdrecht, MCM (corresponding author), Delft Univ Technol, Dept Biotechnol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	m.c.m.vanLoosdrecht@tudelft.nl	van Loosdrecht, Mark/AAA-9997-2019; van Loosdrecht, Mark C.M./B-2738-2009	van Loosdrecht, Mark C.M./0000-0003-0658-4775				[Anonymous], [No title captured]; Ardern E., 1914, J SOC CHEM IND LOND, V33, P523, DOI [DOI 10.1002/JCTB.5000331005, DOI 10.1002/JCTB.50003]; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; de Kreuk M, 2005, BIOTECHNOL BIOENG, V90, P761, DOI 10.1002/bit.20470; du Pisani PL, 2006, DESALINATION, V188, P79, DOI 10.1016/j.desal.2005.04.104; Giesen A., 2012, WATER-SUI, V4, P28; Grant SB, 2012, SCIENCE, V337, P681, DOI 10.1126/science.1216852; Guest JS, 2009, ENVIRON SCI TECHNOL, V43, P6126, DOI 10.1021/es9010515; Judd S, 2008, TRENDS BIOTECHNOL, V26, P109, DOI 10.1016/j.tibtech.2007.11.005; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Law I. B., 2003, WATER J AUST WATER A, V30, P31; Lin Y, 2010, WATER RES, V44, P3355, DOI 10.1016/j.watres.2010.03.019; Loosdrecht M. van, 2012, Water 21, P17; Ruiken CJ, 2013, WATER RES, V47, P43, DOI 10.1016/j.watres.2012.08.023; Siezen RJ, 2008, MICROB BIOTECHNOL, V1, P333, DOI 10.1111/j.1751-7915.2008.00059.x; Vairavamoorthy K., 2010, UNESCO REPORT ENG IS	16	405	415	49	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1452	1453		10.1126/science.1255183	http://dx.doi.org/10.1126/science.1255183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970066				2022-12-28	WOS:000337889900022
J	Arzt, E				Arzt, Eduardo			Strengthen networks	NATURE			English	Editorial Material									[Arzt, Eduardo] BioMed CONICET, Buenos Aires, DF, Argentina; [Arzt, Eduardo] Inst Max Planck Soc, Buenos Aires, DF, Argentina		Arzt, E (corresponding author), BioMed CONICET, Buenos Aires, DF, Argentina.		; Ribeiro, Sidarta/C-5794-2016	Orjeda, Gisella/0000-0003-3013-5523; Ribeiro, Sidarta/0000-0001-9325-9545					0	3	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					209	210		10.1038/510209a	http://dx.doi.org/10.1038/510209a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24926500	Bronze			2022-12-28	WOS:000337032400019
J	Jonas, DE; Feltner, C; Amick, HR; Sheridan, S; Zheng, ZJ; Watford, DJ; Carter, JL; Rowe, CJ; Harris, R				Jonas, Daniel E.; Feltner, Cynthia; Amick, Halle R.; Sheridan, Stacey; Zheng, Zhi-Jie; Watford, Daniel J.; Carter, Jamie L.; Rowe, Cassandra J.; Harris, Russell			Screening for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							CLINICALLY USEFUL MEASURES; UNITED-STATES; NATURAL-HISTORY; MEDICARE BENEFICIARIES; PERIOPERATIVE DEATH; DUPLEX ULTRASOUND; HEART-DISEASE; RISK-FACTORS; ENDARTERECTOMY; STROKE	Background: Approximately 10% of ischemic strokes are caused by carotid artery stenosis (CAS). Estimated prevalence of asymptomatic CAS is 1%. Purpose: To evaluate evidence on screening and treating asymptomatic adults for CAS. Data Sources: MEDLINE, the Cochrane Library, EMBASE, and trial registries through September 2013; MEDLINE through March 2014 for trials. Study Selection: Good-or fair-quality trials of screening, carotid endarterectomy (CEA), or stenting compared with medical therapy or of intensification of medical therapy; systematic reviews; multi-institution studies reporting harms; and externally validated risk-stratification tools. Data Extraction: Dual extraction and quality assessment. Data Synthesis: No trials compared screening with no screening or stenting with medical therapy or assessed intensification of medical therapy, and no externally validated, reliable risk-stratification tools were found. Given the specificity of ultrasonography (range, 88% to 94% for CAS >= 50% to >= 70%), its use in low-prevalence populations would yield many false-positive results. Absolute reduction of non-perioperative strokes was 5.5% (95% CI, 3.9% to 7.0%; 3 trials; 5223 participants) over approximately 5 years for CEA compared with medical therapy. The 30-day rates of stroke or death after CEA in trials and cohort studies were 2.4% (CI, 1.7% to 3.1%; 6 trials; 3435 participants) and 3.3% (CI, 2.7% to 3.9%; 7 studies; 17 474 participants), respectively. Other harms of interventions included myocardial infarction, nerve injury, and hematoma. Limitations: Trials may have overestimated benefits and used highly selected surgeons. Medical therapy used in trials was outdated, and stroke rates have declined in recent decades. Harms may have been underreported. Conclusion: Current evidence does not establish incremental overall benefit of CEA, stenting, or intensification of medical therapy. Potential for overall benefit is limited by low prevalence and harms.	Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; Res Triangle Inst Int, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute	Jonas, DE (corresponding author), Univ N Carolina, Dept Med, 5034 Old Clin Bldg,CB 7110, Chapel Hill, NC 27599 USA.	daniel_jonas@med.unc.edu			Agency for Healthcare Research and Quality; Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA290201200015iTO2]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.; Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract HHSA290201200015iTO2).	Abbott AL, 2009, STROKE, V40, pE573, DOI 10.1161/STROKEAHA.109.556068; [Anonymous], 1989, Stroke, V20, P844; Baker WH, 2000, STROKE, V31, P2330, DOI 10.1161/01.STR.31.10.2330; Bertges DJ, 2010, J VASC SURG, V52, P674, DOI 10.1016/j.jvs.2010.03.031; BLAKELEY DD, 1995, ANN INTERN MED, V122, P360, DOI 10.7326/0003-4819-122-5-199503010-00007; Bratzler D W, 1996, J Okla State Med Assoc, V89, P423; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Calvillo-King L, 2010, STROKE, V41, P2786, DOI 10.1161/STROKEAHA.110.599019; Cebul RD, 1998, JAMA-J AM MED ASSOC, V279, P1282, DOI 10.1001/jama.279.16.1282; Chambers BR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001923.pub2; Chaturvedi S, 2010, STROKE, V41, P757, DOI 10.1161/STROKEAHA.109.569426; den Hartog AG, 2013, STROKE, V44, P1652, DOI 10.1161/STROKEAHA.111.000348; DIENER HC, 1991, STROKE, V22, P1229; Fairman R, 2007, ANN SURG, V246, P551, DOI 10.1097/SLA.0b013e3181567a39; Folkersen L, 2012, MOL MED, V18, P669, DOI 10.2119/molmed.2011.00479; Giacovelli JK, 2010, J VASC SURG, V52, P906, DOI 10.1016/j.jvs.2010.05.010; Giles KA, 2010, J VASC SURG, V52, P1497, DOI 10.1016/j.jvs.2010.06.174; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Goodney PP, 2008, J VASC SURG, V48, P1139, DOI 10.1016/j.jvs.2008.05.013; Gray WA, 2009, CIRC-CARDIOVASC INTE, V2, P159, DOI 10.1161/CIRCINTERVENTIONS.108.823013; HALL H, 2008, SCI BASED MED; Halliday A, 2004, LANCET, V363, P1491; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; HALLIDAY AW, 1994, EUR J VASCULAR SURG, V8, P703; HALLIDAY AW, 1995, INT ANGIOL, V14, P18; Halm EA, 2007, NEUROLOGY, V68, P187, DOI 10.1212/01.wnl.0000251197.98197.e9; Halm EA, 2005, J VASC SURG, V42, P420, DOI 10.1016/j.jvs.2005.05.029; Halm EA, 2003, STROKE, V34, P1464, DOI 10.1161/01.STR.0000072514.79745.7D; Halm EA, 2009, STROKE, V40, P221, DOI 10.1161/STROKEAHA.108.524785; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; HOBSON RW, 1986, STROKE, V17, P534; Hopkins LN, 2010, J STROKE CEREBROVASC, V19, P153, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.001; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Jacobowitz GR, 2003, J VASC SURG, V38, P705, DOI 10.1016/S0741-5214(03)00730-4; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Jonas DE, 2014, AHRQ PUBLICATION, V14-EHC029-EF; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; Kistler JP, 2000, NEW ENGL J MED, V342, P1743, DOI 10.1056/NEJM200006083422310; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2010, STATA J, V10, P395, DOI 10.1177/1536867X1001000307; Kresowik TF, 2004, J VASC SURG, V39, P372, DOI 10.1016/j.jvs.2003.09.023; Kresowik TF, 2001, J VASC SURG, V33, P227, DOI 10.1067/mva.2001.111881; Kresowik TF, 2000, J VASC SURG, V31, P918, DOI 10.1067/mva.2000.106418; LAL BK, 2013, ENDOVASCULAR TODAY, P73; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lewis RF, 1997, ANN INTERN MED, V127, P13, DOI 10.7326/0003-4819-127-1-199707010-00003; Longstreth WT, 1998, STROKE, V29, P2371, DOI 10.1161/01.STR.29.11.2371; MANSOUR MA, 1995, J VASC SURG, V21, P346, DOI 10.1016/S0741-5214(95)70275-X; Matsumura JS, 2010, J VASC SURG, V52, P576, DOI 10.1016/j.jvs.2010.03.064; McPhee JT, 2007, J VASC SURG, V46, P1112, DOI 10.1016/j.jvs.2007.08.030; McPhee JT, 2008, J VASC SURG, V48, P1442, DOI 10.1016/j.jvs.2008.07.017; Momjian-Mayor I, 2012, STROKE, V43, P1260, DOI 10.1161/STROKEAHA.111.634766; Muluk SC, 1999, J VASC SURG, V29, P208, DOI 10.1016/S0741-5214(99)70374-5; Nederkoorn PJ, 2003, STROKE, V34, P1324, DOI 10.1161/01.STR.0000068367.08991.A2; Nehler MR, 1996, J VASC SURG, V24, P580, DOI 10.1016/S0741-5214(96)70073-3; Nicolaides AN, 2010, J VASC SURG, V52, P1486, DOI 10.1016/j.jvs.2010.07.021; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Patel MR, 2010, ARCH INTERN MED, V170, P1218, DOI 10.1001/archinternmed.2010.194; Prati P, 2011, CEREBROVASC DIS, V31, P300, DOI 10.1159/000320852; Press MJ, 2006, ARCH INTERN MED, V166, P914, DOI 10.1001/archinte.166.8.914; Qureshi AI, 2001, J NEUROIMAGING, V11, P105, DOI 10.1111/j.1552-6569.2001.tb00019.x; Raman G., 2012, MANAGEMENT ASYMPTOMA; Raman G, 2013, ANN INTERN MED, V158, P676, DOI 10.7326/0003-4819-158-9-201305070-00007; Rockman CB, 2005, J VASC SURG, V42, P870, DOI 10.1016/j.jvs.2005.07.043; Rockman CB, 1997, J VASC SURG, V25, P423, DOI 10.1016/S0741-5214(97)70250-7; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sabeti S, 2004, RADIOLOGY, V232, P431, DOI 10.1148/radiol.2321030791; Sackett D. L., 1997, EVIDENCE BASED MED P; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; SINCLAIR JC, 1994, J CLIN EPIDEMIOL, V47, P881, DOI 10.1016/0895-4356(94)90191-0; Suri MFK, 2008, J NEUROIMAGING, V18, P142, DOI 10.1111/j.1552-6569.2007.00192.x; Sutton AJAK, 2000, METHODS METAANALYSIS; Timaran CH, 2009, J VASC SURG, V49, P623, DOI 10.1016/j.jvs.2008.09.064; TOWNE JB, 1990, J VASC SURG, V11, P252, DOI 10.1067/mva.1990.16484; USPSTF, 2007, ANN INTERN MED, V147, P854, DOI 10.7326/0003-4819-147-12-200712180-00005; Vouyouka AG, 2012, J VASC SURG, V56, P334, DOI 10.1016/j.jvs.2012.01.066; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; West SL., 2010, AHRQ PUBLICATION; WIEBERS DO, 1992, MAYO CLIN PROC, V67, P513; WOLFF T, 2007, AHRQ PUBLICATION; Wolff T, 2007, ANN INTERN MED, V147, P860, DOI 10.7326/0003-4819-147-12-200712180-00006; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Young B, 1996, STROKE, V27, P2216, DOI 10.1161/01.STR.27.12.2216; Young KC, 2011, AM J NEURORADIOL, V32, P170, DOI 10.3174/ajnr.A2253; Yuo TH, 2013, J VASC SURG, V57, P627, DOI 10.1016/j.jvs.2012.09.036	91	65	71	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					336	U151		10.7326/M14-0530	http://dx.doi.org/10.7326/M14-0530			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO7VT	25004169				2022-12-28	WOS:000341561400004
J	Tobin, MJ				Tobin, Martin J.			PERSONAL VIEW Put down your smartphone and pick up a book	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tobin, Martin J.] Edward Hines Jr Vet Affairs Hosp, Div Pulm & Crit Care Med, Hines, IL 60141 USA; [Tobin, Martin J.] Loyola Univ Chicago, Stritch Sch Med, Hines, IL 60141 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	Tobin, MJ (corresponding author), Edward Hines Jr Vet Affairs Hosp, Div Pulm & Crit Care Med, Hines, IL 60141 USA.	mtobin2@lumc.edu						Carr N., ATLANTIC MONTHLY; Epstein J, 1985, PLAUSIBLE PREJUDICES, P384; Feinberg B, 1973, WILSON Q, P228; Feinberg B, 2013, WILSON Q, P228; Kahneman D, 2011, FARRAR STRAUS GIROUX, P234; Mangen A, 2013, INT J EDUC RES, V58, P61, DOI 10.1016/j.ijer.2012.12.002; Proust Marcel, 2011, READING, P3; Rosen C, 2009, WILSON Q, V33, P48; Russell B., 1924, WILSON Q; Thoreau HD, 1995, DENT, P79; Wolf M, 2007, PROUST SQUID STORY S, P22	11	7	7	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4521	10.1136/bmj.g4521	http://dx.doi.org/10.1136/bmj.g4521			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005872				2022-12-28	WOS:000338993300017
J	Jaffe, HW; Frieden, TR				Jaffe, Harold W.; Frieden, Thomas R.			Improving health in the USA: progress and challenges	LANCET			English	Editorial Material							LIFE EXPECTANCY; AIR-POLLUTION; UNITED-STATES; CHILDREN; TRENDS		[Jaffe, Harold W.; Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Jaffe, HW (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	hwj1@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Bauer UE, 2014, LANCET; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P689; Centers for Medicare and Medicaid Services, 2014, NAT HLTH EXP DAT; Frieden TR, 2013, NEW ENGL J MED, V368, P1857, DOI 10.1056/NEJMp1303819; Haegerich TM, 2014, LANCET; Khabbaz RF, 2014, LANCET; Khan AS, 2014, LANCET; Lorenzoni L, 2014, LANCET; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; National Center for Health Statistics, 2013, DHHS PUBL; National Highway Traffic Safety Administration, 2010, TRAFF SAF FACTS HIGH; National Research Council and Institute of Medicine, 2013, US HLTH INT PERSP SH; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Schuchat A, 2014, LANCET; Shaw FE, 2014, LANCET; United States Environmental Protection Agency, 2013, IN AR DES 2012 REV P; Zhao Z, 2013, VACCINE, V31, P2324, DOI 10.1016/j.vaccine.2013.03.018	20	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					3	5		10.1016/S0140-6736(14)61032-1	http://dx.doi.org/10.1016/S0140-6736(14)61032-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24998006				2022-12-28	WOS:000338919600004
J	Shaw, FE; Asomugha, CN; Conway, PH; Rein, AS				Shaw, Frederic E.; Asomugha, Chisara N.; Conway, Patrick H.; Rein, Andrew S.			The Patient Protection and Affordable Care Act: opportunities for prevention and public health	LANCET			English	Article							MEDICARE; AGENCIES	The Patient Protection and Affordable Care Act, which was enacted by the US Congress in 2010, marks the greatest change in US health policy since the 1960s. The law is intended to address fundamental problems within the US health system, including the high and rising cost of care, inadequate access to health insurance and health services for many Americans, and low health-care efficiency and quality. By 2019, the law will bring health coverage-and the health benefits of insurance-to an estimated 25 million more Americans. It has already restrained discriminatory insurance practices, made coverage more affordable, and realised new provisions to curb costs (including tests of new health-care delivery models). The new law establishes the first National Prevention Strategy, adds substantial new funding for prevention and public health programmes, and promotes the use of recommended clinical preventive services and other measures, and thus represents a major opportunity for prevention and public health. The law also provides impetus for greater collaboration between the US health-care and public health systems, which have traditionally operated separately with little interaction. Taken together, the various effects of the Patient Protection and Affordable Care Act can advance the health of the US population.	[Shaw, Frederic E.; Rein, Andrew S.] US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Asomugha, Chisara N.; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Medicare & Medicaid Services	Rein, AS (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	reinandys@yahoo.com						Abrams M, 2011, COMMONW FUND; Andrews M, DESPITE HLTH LAWS PR; [Anonymous], HOSP VAL BAS PURCH; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Beitsch LM, 2006, J PUBLIC HEALTH MAN, V12, P232; Bernstein A, HLTH ACCESS CARE EMP; Berwick DM, 2013, JAMA-J AM MED ASSOC, V310, P1921, DOI 10.1001/jama.2013.281965; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Brodie, 2014, KAISER HLTH TRACKING; Calman Neil, 2012, Am J Public Health, V102, pe13, DOI 10.2105/AJPH.2012.301000; Cassidy A, HLTH POLICY BRIEF PR; Center for Consumer Information & Insurance Oversight, CMS ESS HLTH BEN STA; Centers for Disease Control and Prevention, 2014, COMM TRANSF GRANTS; Centers for Medicare and Medicaid Services, COMM BAS CAR TRANS P; Centers for Medicare and Medicaid Services (CMS), NAT HLTH EXP 2012 HI; Centers for Medicare & Medicaid Services, HOSP ACQ COND PRES A; Centers for Medicare & Medicaid Services, AFF CAR ACT UPD IMPL; Centers for Medicare & Medicaid Services, 2014, QUEST ANSW OPT AV CO; Centers for Medicare & Medicaid Services (CMS), CMS FAST FACTS; Congressional Budget Office, CBOS APR 2014 EST EF; CTRS. FOR MEDICARE & MEDICAID SERVS, 2012, NAT HLTH EXP TABL; Cutler DM, 2013, HEALTH AFFAIR, V32, P841, DOI 10.1377/hlthaff.2012.0289; De Lew N, 2000, HEALTH CARE FINANC R, V22, P75; Farley Thomas, 2012, Morbidity and Mortality Weekly Report, V61, P1017; Frieden Thomas R, 2012, MMWR Suppl, V61, P1; George Mary G, 2012, MMWR Suppl, V61, P11; Hadley J, 2008, HEALTH AFFAIR, V27, pW399, DOI 10.1377/hlthaff.27.5.w399; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Institute of Medicine, CLIN PREV SERV WOM C; Institute of Medicine, 2012, PRIM CAR PUBL HLTH E; Jost TS, 2014, NEW ENGL J MED, V370, P894, DOI 10.1056/NEJMp1401212; Kenney GM, 2012, TIMELY ANAL IMMEDIAT; Koh HK, 2010, NEW ENGL J MED, V363, P1296, DOI 10.1056/NEJMp1008560; Kronick R, GROWTH MEDICARE SPEN; Lallemand NC, 2012, REDUCING WASTE HLTH, DOI 10.1377/hpb20121213.959735/full; Larch Martin., 2020, NUMERICAL COMPLIANCE; Levy H, 2008, ANNU REV PUBL HEALTH, V29, P399, DOI 10.1146/annurev.publhealth.28.021406.144042; Madamala K, 2011, AM J PUBLIC HEALTH, V101, P1179, DOI 10.2105/AJPH.2010.300011; Martin AB, 2014, HEALTH AFFAIR, V33, P67, DOI 10.1377/hlthaff.2013.1254; McAfee T, 2013, LANCET, V382, P2003, DOI 10.1016/S0140-6736(13)61686-4; Nardin R, UNINSURED IMPLEMENTA; National Prevention Strategy, 2011, NAT PREV STRAT AM PL; Office for the Assistant Secretary for Planning and Evaluation, LONG TERM GROWTH MED; Office of the Assistant Secretary for Planning and Evaluation, REP SHOWS AFF CAR AC; Ryu AJ, 2013, HEALTH AFFAIR, V32, P835, DOI 10.1377/hlthaff.2012.1297; Scutchfield F Douglas, 2012, Am J Prev Med, V42, pS97, DOI 10.1016/j.amepre.2012.04.001; Skopec L, 71 MILLION ADDITIONA; Smith D, CALIFORNIAS INNOVATI; Stolberg SG, OBAMA SIGNS HLTH CAR; The Henry J Kaiser Family Foundation, UN PRIM KEY FACTS HL; The Henry J Kaiser Family Foundation, HLTH INS MARK REF RA; The White House, DEF RED HLTH CAR REF; Topol EJ., TOPOL ASKS SEBELIUS; U. S. Department of Health and Human Services, 2012 ANN PROGR REP C; US Department of Health and Human Services, 2011 REP C NAT STRAT; US Department of Health and Human Services, DO I QUAL EX FEE NOT; US Department of Health and Human Services, HLTH INS MARK MARCH; WOCI and WDHS (Wisconsin Office of the Commissioner of Insurance and Wis-consin Department of Health Services), 2014, WISC UN APPR OP AFF	58	80	80	1	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					75	82		10.1016/S0140-6736(14)60259-2	http://dx.doi.org/10.1016/S0140-6736(14)60259-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24993913				2022-12-28	WOS:000338919600028
J	Greten, FR				Greten, Florian R.			YAP1 Takes Over when Oncogenic K-Ras Slumbers	CELL			English	Editorial Material							THERAPY; KRAS	It is of great therapeutic importance to understand why tumors relapse after the failure of therapies targeting oncogenes to which cancer cells are addicted. In this issue, Kapoor et al. and Shao et al. identify the transcriptional coactivator YAP1 as a central driver of compensation for the loss of K-Ras signaling in K-Ras-dependent cancers.	Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany		Greten, FR (corresponding author), Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	greten@gsh.uni-frankfurt.de	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080				Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	9	18	20	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					11	12		10.1016/j.cell.2014.06.021	http://dx.doi.org/10.1016/j.cell.2014.06.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995973	Bronze			2022-12-28	WOS:000340943100002
J	Snyder, A				Snyder, Alison			Gerald Edelman Obituary	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2206	2206		10.1016/S0140-6736(14)61075-8	http://dx.doi.org/10.1016/S0140-6736(14)61075-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK8DO	24983091	Bronze			2022-12-28	WOS:000338657600014
J	Gregg, JM; Kumar, A				Gregg, J. Marty; Kumar, Amit			APPLIED PHYSICS Trawling for complements	NATURE			English	Editorial Material							WALLS		[Gregg, J. Marty; Kumar, Amit] Queens Univ Belfast, Ctr Nanostruct Media, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Gregg, JM (corresponding author), Queens Univ Belfast, Ctr Nanostruct Media, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland.	m.gregg@qub.ac.uk; a.kumar@qub.ac.uk	Kumar, Amit/C-9662-2012	Kumar, Amit/0000-0002-1194-5531; Gregg, Marty/0000-0002-6451-7768				Aird A, 1998, J PHYS-CONDENS MAT, V10, pL377, DOI 10.1088/0953-8984/10/22/003; Bark CW, 2012, NANO LETT, V12, P1765, DOI 10.1021/nl3001088; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Hong S, 2014, P NATL ACAD SCI USA, V111, P6566, DOI 10.1073/pnas.1324178111; Kim Y, 2012, ACS NANO, V6, P7026, DOI 10.1021/nn3020757; Sluka T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2839; Whyte JR, 2014, ADV MATER, V26, P293, DOI 10.1002/adma.201303567	7	5	5	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					481	482		10.1038/510481a	http://dx.doi.org/10.1038/510481a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965647	Green Accepted			2022-12-28	WOS:000337806300035
J	Rothman, DJ				Rothman, David J.			Where We Die	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ Coll Phys & Surg, Ctr Study Soc & Med, New York, NY 10032 USA	Columbia University	Rothman, DJ (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Study Soc & Med, 630 W 168th St, New York, NY 10032 USA.							Faust Drew Gilpin, 2009, THIS REPUBLIC SUFFER; National Center for Health Statistics, HLTH US 2010 SPEC FE; Rothman S., 1994, INT J HIST SPORT; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624	4	15	17	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2457	2460		10.1056/NEJMp1404427	http://dx.doi.org/10.1056/NEJMp1404427			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ6KY	24963563				2022-12-28	WOS:000337804400001
J	Arie, S				Arie, Sophie			Would today's international agreements prevent another outbreak like SARS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						[Anonymous], 2014, LANCET RESP MED, V2, P436; [Anonymous], 2014, NEWSWEEK; Heymann DL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1499; MacKenzie D., 2014, NEW SCI; McCarthy M, 2014, BMJ-BRIT MED J, V348, pg1589; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Sridhar D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3841; World Bank, PEOPL PATH OUR PLAN, V2; World Health Organization, MIDDL E RESP SYNDR C; World Health Organization (WHO), AL RESP CAP BUILD IN	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2014	348								g4123	10.1136/bmj.g4123	http://dx.doi.org/10.1136/bmj.g4123			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UE	24957245				2022-12-28	WOS:000338201400010
J	Spruston, N				Spruston, Nelson			Assembling Cell Ensembles	CELL			English	Editorial Material							NEURONS; MIGRATION	The way the hippocampus processes information and encodes memories in the form of "cell assemblies'' is likely determined in part by how its circuits are wired up during development. In this issue, Xu et al. now provide new insight into how neurons arising from a single common precursor migrate to their final destination and form functionally synchronous ensembles.	Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Spruston, N (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus 19700 Helix Dr, Ashburn, VA 20147 USA.	sprustonn@janelia.hhmi.org		Spruston, Nelson/0000-0003-3118-1636	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Frotscher M, 2007, HIPPOCAMPUS BOOK, P115; Hebb Donald O., 1949, ORG BEHAV; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Xu HT, 2014, CELL, V157, P1552, DOI 10.1016/j.cell.2014.03.067; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	10	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1502	1504		10.1016/j.cell.2014.05.032	http://dx.doi.org/10.1016/j.cell.2014.05.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949961	Bronze			2022-12-28	WOS:000340941900004
J	Appleby, J				Appleby, John			Prescription charges: are they worth it? John Appleby assesses whether the policy of charging for prescriptions in England is helping or harming the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ABOLITION; WALES		Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Cohen D., 2013, WALES ONLINE    0610; Cohen D, 2010, VALUE HEALTH, V13, P675, DOI 10.1111/j.1524-4733.2010.00717.x; Groves Sam, 2010, Int J Pharm Pract, V18, P332, DOI 10.1111/j.2042-7174.2010.00063.x; Health and Social Care Information Centre, 2013, PRESCR DISP COMM STA; Social Market Foundation Health Commission, 2004, US CHARG HEALTHC	5	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g3944	10.1136/bmj.g3944	http://dx.doi.org/10.1136/bmj.g3944			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24943227				2022-12-28	WOS:000337804900019
J	Yousafzai, AK; Rasheed, MA; Rizvi, A; Armstrong, R; Bhutta, ZA				Yousafzai, Aisha K.; Rasheed, Muneera A.; Rizvi, Arjumand; Armstrong, Robert; Bhutta, Zulfiqar A.			Effect of integrated responsive stimulation and nutrition interventions in the Lady Health Worker programme in Pakistan on child development, growth, and health outcomes: a cluster-randomised factorial effectiveness trial	LANCET			English	Article							UNDERNOURISHED JAMAICAN CHILDREN; PSYCHOSOCIAL STIMULATION; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; STUNTED CHILDREN; LOW-INCOME; SUPPLEMENTATION; BANGLADESH; CHALLENGES; STRATEGIES	Background Stimulation and nutrition delivered through health programmes at a large scale could potentially benefit more than 200 million young children worldwide who are not meeting their developmental potential. We investigated the feasibility and effectiveness of the integration of interventions to enhance child development and growth outcomes in the Lady Health Worker (LHW) programme in Sindh, Pakistan. Methods We implemented a community-based cluster-randomised effectiveness trial through the LHW programme in rural Sindh, Pakistan, with a 2 x 2 factorial design. We randomly allocated 80 clusters (LHW catchments) of children to receive routine health and nutrition services (controls; n=368), nutrition education and multiple micronutrient powders (enhanced nutrition; n=364), responsive stimulation (responsive stimulation; n=383), or a combination of both enriched interventions (n=374). The allocation ratio was 1:20 (ie, 20 clusters per intervention group). The data collection team were masked to the allocated intervention. All children born in the study area between April, 2009, and March, 2010, were eligible for enrolment if they were up to 2.5 months old without signs of severe impairments. Interventions were delivered by LHWs to families with children up to 24 months of age in routine monthly group sessions and home visits. The primary endpoints were child development at 12 and 24 months of age (assessed with the Bayley Scales of Infant and Toddler Development, Third Edition) and growth at 24 months of age. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT007159636. Findings 1489 mother-infant dyads were enrolled into the study, of whom 1411 (93%) were followed up until the children were 24 months old. Children who received responsive stimulation had significantly higher development scores on the cognitive, language, and motor scales at 12 and 24 months of age, and on the social-emotional scale at 12 months of age, than did those who did not receive the intervention. Children who received enhanced nutrition had significantly higher development scores on the cognitive, language, and social-emotional scales at 12 months of age than those who did not receive this intervention, but at 24 months of age only the language scores remained significantly higher. We did not record any additive benefits when responsive stimulation was combined with nutrition interventions. Responsive stimulation effect sizes (Cohen's d) were 0.6 for cognition, 0.7 for language, and 0.5 for motor development at 24 months of age; these effect sizes were slightly smaller for the combined intervention group and were low to moderate for the enhanced nutrition intervention alone. Children exposed to enhanced nutrition had significantly better height-for-age Z scores at 6 months (p<0.0001) and 18 months (p=0.02) than did children not exposed to enhanced nutrition. Longitudinal analysis showed a small benefit to linear growth from enrolment to 24 months (p=0.026) in the children who received the enhanced nutrition intervention. Interpretation The responsive stimulation intervention can be delivered effectively by LHWs and positively affects development outcomes. The absence of a major effect of the enhanced nutrition intervention on growth shows the need for further analysis of mediating variables (eg, household food security status) that will help to optimise future nutrition implementation design.	[Yousafzai, Aisha K.; Rasheed, Muneera A.; Rizvi, Arjumand; Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Dept Paediat & Child Hlth, Karachi 74800, Pakistan; [Armstrong, Robert] Aga Khan Univ East Africa, Nairobi, Kenya; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada	Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Yousafzai, AK (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Dept Paediat & Child Hlth, Stadium Rd,POB 3500, Karachi 74800, Pakistan.	aisha.yousafzai@aku.edu		Armstrong, Robert/0000-0001-9319-3961	UNICEF	UNICEF	UNICEF.	Aboud FE, 2011, PEDIATRICS, V127, pE1191, DOI 10.1542/peds.2010-2160; Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Alderman H, 2010, J DEV ORIG HLTH DIS, V1, P19, DOI 10.1017/S2040174409990158; Bayley N., 2019, BAYLEY SCALES INFANT; Bhutta ZA, 2007, SINDH LOW BIRTH WEIG; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blair C, 2011, DEV PSYCHOPATHOL, V23, P845, DOI 10.1017/S0954579411000344; Cambell MK, 2012, BMJ-BRIT MED J, V345, pe5661; Coates J, 2003, HOUSEHOLD FOOD INSEC; Cogill B, 2003, ANTHROPOMETRIC INDIC; DiGirolamo AM, 2014, ANN NY ACAD SCI, V1308, P46, DOI 10.1111/nyas.12323; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Eshel N, 2006, B WORLD HEALTH ORGAN, V84, P991, DOI 10.2471/BLT.06.030163; Fernald LC, 2009, EXAMINING EARLY CHIL; Fernald LCH, 2011, DEVELOPMENTAL SCI, V14, P832, DOI 10.1111/j.1467-7687.2010.01032.x; Gardner JMM, 2005, AM J CLIN NUTR, V82, P399, DOI 10.1093/ajcn/82.2.399; Gillespie S, 2013, LANCET, V382, P552, DOI 10.1016/S0140-6736(13)60842-9; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Hafeez A, 2011, J PAK MED ASSOC, V61, P210; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Krebs NF, 2012, AM J CLIN NUTR, V96, P840, DOI 10.3945/ajcn.112.041962; Morris J, 2012, AM J ORTHOPSYCHIAT, V82, P349, DOI 10.1111/j.1939-0025.2012.01168.x; Nahar B, 2012, EUR J CLIN NUTR, V66, P701, DOI 10.1038/ejcn.2012.13; Oxford Policy Management, 2009, HLTH START PROGRAM E; Powell C, 2004, BMJ-BRIT MED J, V329, P89, DOI 10.1136/bmj.38132.503472.7C; Shonkoff JP, 2012, PEDIATRICS, V129, pE460, DOI 10.1542/peds.2011-0366; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; United Nations Children's Fund World Health Organization, 2009, CAR CHILD DEV; Vazir S, 2013, MATERN CHILD NUTR, V9, P99, DOI 10.1111/j.1740-8709.2012.00413.x; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WALKER SP, 1991, AM J CLIN NUTR, V54, P642, DOI 10.1093/ajcn/54.4.642; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; WHO, 2000, ACLUSTER DES AN CLUS; Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129	39	215	222	1	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1282	1293		10.1016/S0140-6736(14)60455-4	http://dx.doi.org/10.1016/S0140-6736(14)60455-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24947106				2022-12-28	WOS:000343003400031
J	Kompa, AR; Krum, H				Kompa, Andrew R.; Krum, Henry			Protein kinases as cardiovascular therapeutic targets	LANCET			English	Editorial Material							IMPROVES CARDIAC-FUNCTION; P38; INFARCTION; INHIBITORS; DESIGN		[Kompa, Andrew R.; Krum, Henry] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia	Monash University	Kompa, AR (corresponding author), Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.	andrew.kompa@monash.edu		Kompa, Andrew/0000-0003-1002-2302				Karcher SC, 2009, CURR TOP MED CHEM, V9, P655, DOI 10.2174/156802609789007363; Kompa AR, 2008, J PHARMACOL EXP THER, V325, P741, DOI 10.1124/jpet.107.133546; Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Melloni C, 2012, AM HEART J, V164, P646, DOI 10.1016/j.ahj.2012.07.030; Newby LK, 2014, LANCET; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; SEE F, 2004, DRUG DISCOV TODAY TH, V1, P149, DOI DOI 10.1016/J.DDSTR.2004.08.024; Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281	11	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1162	1164		10.1016/S0140-6736(14)60606-1	http://dx.doi.org/10.1016/S0140-6736(14)60606-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7MT	24930729				2022-12-28	WOS:000343002600005
J	Dubash, NK; Fleurbaey, M; Kartha, S				Dubash, Navroz K.; Fleurbaey, Marc; Kartha, Sivan			Political implications of data presentation	SCIENCE			English	Editorial Material													Fleurbaey, Marc/HHS-9231-2022	Kartha, Sivan/0000-0002-6014-2161					0	16	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					36	37		10.1126/science.1255734	http://dx.doi.org/10.1126/science.1255734			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994639				2022-12-28	WOS:000338284400038
J	Wible, B				Wible, Brad			IPCC lessons from Berlin	SCIENCE			English	Editorial Material																			0	7	7	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					34	34		10.1126/science.345.6192.34-a	http://dx.doi.org/10.1126/science.345.6192.34-a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994637				2022-12-28	WOS:000338284400036
J	Morell, V				Morell, Virginia			When the bat sings	SCIENCE			English	Editorial Material																			0	6	6	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1334	1337		10.1126/science.344.6190.1334	http://dx.doi.org/10.1126/science.344.6190.1334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948718				2022-12-28	WOS:000337531700015
J	Rotimi, C				Rotimi, Charles		H3Africa Consortium	Enabling the genomic revolution in Africa	SCIENCE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; APOL1 RISK VARIANTS; HIV-ASSOCIATED NEPHROPATHY; POPULATION		[Rotimi, Charles] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Rotimi, C (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.	rotimic@mail.nih.gov	Owen, Andrew/M-7509-2017; Hide, Winston Hide/C-7217-2009; Tiffin, Nicki/ABA-9391-2020; Ameni, Gobena/AAR-4201-2020; Makani, Julie/E-8525-2017; Pare, Guillaume/T-9631-2018; Hide, Winston/R-3815-2019; Ramesar, Raj S/I-6941-2015; McCurdy, Sheryl A/F-9107-2016; Nicol, Mark/W-4149-2019; Stein, Dan/A-1752-2008; Mayige, Mary/GLU-6412-2022; Hide, Winston A/V-2727-2017; Adebamowo, Clement/C-8778-2011; Engel, Mark/AAP-6570-2020; Martin, Darren/ABE-3614-2021; De Vries, Jantina/I-2752-2014; Bishop, Ozlem Tastan/J-3084-2016; Anabwani, Gabriel/I-2371-2016; Norris, Shane/C-4664-2014; McCarthy, Mark/M-3763-2015; Smeeth, Liam/X-5862-2018; christoffels, alan/C-3269-2014; Mbanya, Jean Claude N/T-5147-2018; Mpoloka, Sununguko/GQP-6235-2022; Hazelhurst, Scott/A-5591-2009; Kamal Kassim, Samar/G-4701-2015	Owen, Andrew/0000-0002-9819-7651; Hide, Winston Hide/0000-0002-8621-3271; Tiffin, Nicki/0000-0001-5083-2735; Ameni, Gobena/0000-0003-3987-0671; Makani, Julie/0000-0002-4801-6250; Pare, Guillaume/0000-0002-6795-4760; Hide, Winston/0000-0002-8621-3271; Ramesar, Raj S/0000-0001-5688-1634; McCurdy, Sheryl A/0000-0003-0526-1608; Nicol, Mark/0000-0002-1366-4805; Stein, Dan/0000-0001-7218-7810; Mayige, Mary/0000-0003-4861-7870; Hide, Winston A/0000-0002-8621-3271; Adebamowo, Clement/0000-0002-6571-2880; Engel, Mark/0000-0002-1334-8829; De Vries, Jantina/0000-0001-7192-2633; Bishop, Ozlem Tastan/0000-0001-6861-7849; Everett, Dean/0000-0002-8458-6779; Lesosky, Maia/0000-0002-2026-958X; Adebamowo, Sally/0000-0003-4713-2433; Mulder, Nicola J/0000-0003-4905-0941; Mahomva, Chengetai/0000-0001-7933-5441; Anabwani, Gabriel/0000-0002-8555-4373; Norris, Shane/0000-0001-7124-3788; Swanepoel, Carmen/0000-0002-3344-5546; Lombard, Zane/0000-0002-7997-2616; McCarthy, Mark/0000-0002-4393-0510; Tollman, Stephen/0000-0003-0744-7588; Joloba, Moses/0000-0002-0334-9983; Rasooly, Rebekah/0000-0002-6357-5528; Kyobutungi, Catherine/0000-0002-5344-5631; Masiga, Daniel/0000-0001-7513-0887; Parekh, Rulan/0000-0001-6313-5752; Msefula, Chisomo/0000-0003-2304-886X; Nguyen, Anh/0000-0001-6280-0490; Smeeth, Liam/0000-0002-9168-6022; Zar, Heather/0000-0002-9046-759X; Garry, Robert/0000-0002-5683-3250; Gomez-Olive, Francesc Xavier/0000-0002-4876-0848; christoffels, alan/0000-0002-0420-2916; Matovu, Enock/0000-0003-0714-7032; Motala, Ayesha/0000-0003-0517-1784; Kumuthini, Judit/0000-0002-8008-1917; Keavney, Bernard/0000-0001-9573-0812; Ofori-Acquah, Solomon/0000-0001-5000-3048; Crowther, Nigel/0000-0002-5766-1745; Mbanya, Jean Claude N/0000-0001-9651-8653; Tinto, Halidou/0000-0002-0472-3586; Tangwa, Godfrey B./0000-0003-0062-8108; Carstens, Nadia/0000-0003-4754-7030; ODURO, ABRAHAM/0000-0002-4191-7419; Mpoloka, Sununguko/0000-0003-0147-1819; TOBIN, EKAETE/0000-0001-5059-807X; Benkahla, Alia/0000-0001-9988-3250; Akinyemi, Rufus/0000-0001-5286-428X; Cordell, Heather/0000-0002-1879-5572; Dareng, Eileen/0000-0003-0802-419X; Levitt, Naomi/0000-0001-6480-8066; Fakunle, Eyitayo/0000-0001-7123-008X; Nyarko, Alexander/0000-0002-9923-360X; King, Mary-Claire/0000-0001-9426-1743; Kapiga, Saidi/0000-0003-1753-4060; Happi, Christian/0000-0002-3056-6705; Bethke, Lara/0000-0002-1316-4704; Tukei, Vincent Joseph/0000-0002-9525-2600; ElSayed, Ahmed/0000-0001-7422-7169; Akpalu, Albert/0000-0002-4802-9852; Nkomazana, Oathokwa/0000-0002-2040-4059; Amodu, Olukemi/0000-0003-1477-4229; Hazelhurst, Scott/0000-0002-0581-149X; Merle, Corinne/0000-0003-4229-365X; Wachinou, Ablo Prudence/0000-0002-1024-9665; Moxey-Mims, Marva/0000-0001-8542-9313; Kasvosve, Ishmael/0000-0002-2046-545X; Owolabi, Mayowa/0000-0003-1146-3070; Mocumbi, Ana/0000-0002-9564-2860; Ramsay, Michele/0000-0002-4156-4801; Kahn, Kathleen/0000-0003-3339-3931; Arulogun, Oyedunni/0000-0002-2173-4682; Patterton, Hugh-George/0000-0003-2550-0493; Adeyemo, Adebowale/0000-0002-3105-3231; Kamal Kassim, Samar/0000-0002-4359-6620; Jongeneel, Cornelis Victor/0000-0002-3922-1906; lawlor, Rita/0000-0003-3160-0634; Boima, Vincent/0000-0002-0562-6307; Wade, Alisha/0000-0002-1158-2523; McIlleron, Helen/0000-0002-0982-6226	FOGARTY INTERNATIONAL CENTER [D43TW009140] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006947, U54HG006939, U01HG007459, UH2HG007051, U54HG006938, U01HG007044, UH3HG007008, U54HG007479, ZIAHG200362, U41HG006941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104621, U19AI089696, U54AI110398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; MRC [G0800247, MC_U123292700] Funding Source: UKRI; British Heart Foundation [RG/08/012/25941] Funding Source: Medline; FIC NIH HHS [D43 TW009140, U2R TW010679] Funding Source: Medline; Medical Research Council [G0800247, MC_U123292700] Funding Source: Medline; NHGRI NIH HHS [U54 HG006947, U41 HG006941, U54 HG007479, U01 HG007459, U54 HG006938, U24 HG007008, U01 HG009716, UH2 HG007051, UH3 HG007008, U01 HG007044, U54 HG006939] Funding Source: Medline; NHLBI NIH HHS [U24 HL135600] Funding Source: Medline; NIAID NIH HHS [R01 AI104621, U54 AI110398, U19 AI089696] Funding Source: Medline; NIMHD NIH HHS [P20 MD006899] Funding Source: Medline; NINDS NIH HHS [R01 NS107900] Funding Source: Medline; Wellcome Trust [085349, 095009, 095201, 104111, 098610, 093727, 098504, 099313] Funding Source: Medline; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; Wellcome Trust [099310/Z/12/Z] Funding Source: researchfish	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2010, NATURE, V465, P990; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; Behar DM, 2011, AM J NEPHROL, V34, P452, DOI 10.1159/000332378; Bentley AR, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/748984; De Vre R., 2010, MCKINSEY Q REPORT; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Rotimi CN, 2010, GENOME MED, V2, DOI 10.1186/gm141; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Ulasi II, 2013, NEPHRON CLIN PRACT, V123, P123, DOI 10.1159/000353223	11	245	245	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1346	1348		10.1126/science.1251546	http://dx.doi.org/10.1126/science.1251546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948725	Green Accepted			2022-12-28	WOS:000337531700022
J	Garwood, R				Garwood, Russell			Uprooting researchers can drive them out of science	NATURE			English	Editorial Material									Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester	Garwood, R (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	russell.garwood@manchester.ac.uk		Garwood, Russell/0000-0002-2803-9471					0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					313	313		10.1038/510313a	http://dx.doi.org/10.1038/510313a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24943925				2022-12-28	WOS:000337350200004
J	Kansagara, D; Papak, J; Pasha, AS; O'Neil, M; Freeman, M; Relevo, R; Quinones, A; Motu'apuaka, M; Jou, JH				Kansagara, Devan; Papak, Joel; Pasha, Amirala S.; O'Neil, Maya; Freeman, Michele; Relevo, Rose; Quinones, Ana; Motu'apuaka, Makalapua; Jou, Janice H.			Screening for Hepatocellular Carcinoma in Chronic Liver Disease A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CIRRHOTIC-PATIENTS; NATURAL-HISTORY; SURVEILLANCE PROGRAM; COST-EFFECTIVENESS; EARLY-DIAGNOSIS; HEPATITIS-C; GROWTH-RATE; CANCER; SURVIVAL; IMPROVES	Background: Guidelines recommend routine screening for hepatocellular carcinoma (HCC) in high-risk patients, but the strength of evidence supporting these recommendations is unclear. Purpose: To review the benefits and harms of HCC screening in patients with chronic liver disease. Data Sources: MEDLINE, PsycINFO, and ClinicalTrials.gov from inception to April 2014; Cochrane databases to June 2013; reference lists; and technical advisors. Study Selection: English-language trials and observational studies comparing screening versus no screening, studies of harms, and trials comparing different screening intervals. Data Extraction: Mortality and adverse events were the outcomes of interest. Individual-study quality and the overall strength of evidence were dual-reviewed using published criteria. Data Synthesis: Of 13 801 citations, 22 studies met inclusion criteria. The overall strength of evidence on the effects of screening was very low. One large trial of patients with hepatitis B found decreased HCC mortality with periodic ultrasonographic screening (rate ratio, 0.63 [95% CI, 0.41 to 0.98]), but the study was limited by methodological flaws. Another trial in patients with hepatitis B found no survival benefit with periodic alpha-fetoprotein screening. In 18 observational studies, screened patients had earlier-stage HCC than clinically diagnosed patients, but lead- and length-time biases confounded the effects on mortality. Two trials found no survival differences between shorter (3- to 4-month) and longer (6- to 12-month) screening intervals. Harms of screening were not well-studied. Limitations: Only English-language studies were included. The evidence base is limited by methodological issues and a paucity of trials. Conclusion: There is very-low-strength evidence about the effects of HCC screening on mortality in patients with chronic liver disease. Screening tests can identify early-stage HCC, but whether systematic screening leads to a survival advantage over clinical diagnosis is uncertain.	[Kansagara, Devan; O'Neil, Maya; Freeman, Michele; Relevo, Rose] Portland VA Med Ctr, Portland, OR 97239 USA; [Papak, Joel; Jou, Janice H.] Portland VA Med Ctr, Dept Med, Portland, OR 97239 USA; [Pasha, Amirala S.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Quinones, Ana] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Motu'apuaka, Makalapua] Oregon Evidence Based Practice Ctr, Portland, OR 97233 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University	Kansagara, D (corresponding author), Portland VA Med Ctr, RD71,3710 SW US Veterans Hosp Rd, Portland, OR 97239 USA.	kansagar@ohsu.edu		Pasha, Amirala/0000-0002-4474-9502; Quinones, Ana/0000-0001-6554-7734	U.S. Department of Veterans Affairs Quality Enhancement Research Initiative	U.S. Department of Veterans Affairs Quality Enhancement Research Initiative	U.S. Department of Veterans Affairs Quality Enhancement Research Initiative.	Aghoram R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002799.pub2; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Asiyanbola B, 2008, J GASTROINTEST SURG, V12, P842, DOI 10.1007/s11605-008-0494-y; BARBARA L, 1992, HEPATOLOGY, V16, P132, DOI 10.1002/hep.1840160122; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Chou R, AHRQ PUBLIC IN PRESS; COTTONE M, 1989, GASTROENTEROLOGY, V96, P1566, DOI 10.1016/0016-5085(89)90528-3; Cucchetti A, 2014, J HEPATOL; Cucchetti A, 2013, BEST PRACT RES CL GA, V27, P961, DOI 10.1016/j.bpg.2013.08.021; Davila JA, 2007, J CLIN GASTROENTEROL, V41, P777, DOI 10.1097/MCG.0b013e3180381560; Deeks J J, 2003, Health Technol Assess, V7, piii; EBARA M, 1986, GASTROENTEROLOGY, V90, P289, DOI 10.1016/0016-5085(86)90923-6; El-Serag HB, 2011, GUT, V60, P992, DOI 10.1136/gut.2010.230508; Etzioni R, 2002, J NATL CANCER I, V94, P981; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fletcher RH, 1988, CLIN EPIDEMIOLOGY ES, V2nd; Gaba RC, 2013, ANN HEPATOL, V12, P766, DOI 10.1016/S1665-2681(19)31318-3; Giannini E, 2000, HEPATO-GASTROENTEROL, V47, P1395; Guyatt GH, 2012, CHEST, V141, p53S, DOI 10.1378/chest.11-2288; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Health Services Research & Development, 2014, ESP REP PROGR; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Izzo F, 2013, HPB, V15, P985, DOI 10.1111/hpb.12080; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kansagara D, 2013, SCREENING HEPATOCELL; Kemp W, 2005, J GASTROEN HEPATOL, V20, P873, DOI 10.1111/j.1440-1746.2005.03844.x; Kuo YH, 2010, EUR J CANCER, V46, P744, DOI 10.1016/j.ejca.2009.12.018; Lederle FA, 2012, ANN INTERN MED, V156, P387, DOI 10.7326/0003-4819-156-5-201203060-00012; Leykum LK, 2007, CLIN GASTROENTEROL H, V5, P508, DOI 10.1016/j.cgh.2007.01.014; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Moher D, 2003, Health Technol Assess, V7, P1; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pascual S, 2008, LIVER INT, V28, P682, DOI 10.1111/j.1478-3231.2008.01710.x; Rahman A, 2012, J GASTROINTEST SURG, V16, P1897, DOI 10.1007/s11605-012-1973-8; Schlansky B, 2013, HEPATOLOGY, V58, p208A; Sherman M, 2012, HEPATOLOGY, V56, P793, DOI 10.1002/hep.25869; SHEU JC, 1985, GASTROENTEROLOGY, V89, P259, DOI 10.1016/0016-5085(85)90324-5; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624; Tanaka H, 2006, LIVER INT, V26, P543, DOI 10.1111/j.1478-3231.2006.01270.x; Taura N, 2005, ONCOL REP, V14, P999; Tong MJ, 2010, DIGEST DIS SCI, V55, P826, DOI 10.1007/s10620-009-1059-y; Trevisani F, 2004, AM J GASTROENTEROL, V99, P1470, DOI 10.1111/j.1572-0241.2004.30137.x; Trevisani F, 2002, AM J GASTROENTEROL, V97, P734; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Viswanathan M, 2012, ASSESSING RISK BIAS; Wang JH, 2013, AM J GASTROENTEROL, V108, P416, DOI 10.1038/ajg.2012.445; Wong GLH, 2008, LIVER INT, V28, P79, DOI 10.1111/j.1478-3231.2007.01576.x; Yu EWR, 2004, CANCER J, V10, P317, DOI 10.1097/00130404-200409000-00009; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	56	145	148	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					261	+		10.7326/M14-0558	http://dx.doi.org/10.7326/M14-0558			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	24934699				2022-12-28	WOS:000342347300016
J	Stroebel, D; Paoletti, P				Stroebel, David; Paoletti, Pierre			NEUROSCIENCE A structure to remember	NATURE			English	Editorial Material							VOLTAGE-DEPENDENT BLOCK; SUBUNIT ARRANGEMENT; GLUTAMATE-RECEPTOR; NMDA RECEPTORS; DYNAMICS; BINDING; NEURONS; CHANNEL		[Stroebel, David; Paoletti, Pierre] Ecole Normale Super, Inst Biol, CNRS, INSERM,U1024,UMR8197, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Stroebel, D (corresponding author), Ecole Normale Super, Inst Biol, CNRS, INSERM,U1024,UMR8197, F-75005 Paris, France.	david.stroebel@ens.fr; pierre.paoletti@ens.fr	Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				Burger PB, 2012, MOL PHARMACOL, V82, P344, DOI 10.1124/mol.112.078568; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	14	1	2	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					162	163		10.1038/511162a	http://dx.doi.org/10.1038/511162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008517				2022-12-28	WOS:000338649800031
J	Yablokov, A				Yablokov, Alexey			Academy 'reform' is stifling Russian science	NATURE			English	Editorial Material									[Yablokov, Alexey] Russian Acad Sci, Moscow 117901, Russia	Russian Academy of Sciences	Yablokov, A (corresponding author), Russian Acad Sci, Moscow 117901, Russia.	alexey.ablokov@gmail.com							0	5	5	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					7	7		10.1038/511007a	http://dx.doi.org/10.1038/511007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1TN	24990710	Bronze			2022-12-28	WOS:000338199400008
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Doctors treating their families	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA		Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				American Medical Association, 1991, OP 8 19 SELF TREATM; College of Physicians and Surgeons of Ontario C, 2007, TREAT SELF FAM MEMB; DUSDIEKER LB, 1993, AM J DIS CHILD, V147, P146, DOI 10.1001/archpedi.1993.02160260036018; Fromme EK, 2008, ANN INTERN MED, V149, P825, DOI 10.7326/0003-4819-149-11-200812020-00011; LAPUMA J, 1991, NEW ENGL J MED, V325, P1290, DOI 10.1056/NEJM199110313251806; UK General Medical Counsel, 2013, TREAT FAM MEMB; Youn A., CNN HLTH	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2014	348								g4281	10.1136/bmj.g4281	http://dx.doi.org/10.1136/bmj.g4281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UM	24969412				2022-12-28	WOS:000338202400004
J	Reurink, G; Goudswaard, GJ; Moen, MH; Weir, A; Verhaar, JAN; Bierma-Zeinstra, SMA; Maas, M; Tol, JL				Reurink, Gustaaf; Goudswaard, Gert Jan; Moen, Maarten H.; Weir, Adam; Verhaar, Jan A. N.; Bierma-Zeinstra, Sita M. A.; Maas, Mario; Tol, Johannes L.		Dutch Hamstring Injection Therapy	Platelet-Rich Plasma Injections in Acute Muscle Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							REHABILITATION		[Reurink, Gustaaf; Verhaar, Jan A. N.; Bierma-Zeinstra, Sita M. A.] Erasmus MC, Rotterdam, Netherlands; [Goudswaard, Gert Jan; Tol, Johannes L.] Aspetar Qatar Orthoped & Sports Med Hosp, Doha, Qatar; [Moen, Maarten H.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Weir, Adam] Med Ctr Hague, Antoniushove Leidschenda, Netherlands; [Maas, Mario] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Aspetar Orthopaedic & Sports Medicine Hospital; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Reurink, G (corresponding author), Erasmus MC, Rotterdam, Netherlands.	g.reurink@erasmusmc.nl	Bierma-Zeinstra, Sita/AAF-2122-2019; Verhaar, Jan/AAH-1372-2020	Verhaar, Jan/0000-0003-3016-9600; Reurink, Gustaaf/0000-0002-4299-7780				Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Heiderscheit BC, 2010, J ORTHOP SPORT PHYS, V40, P67, DOI 10.2519/jospt.2010.3047; Mason D, 2007, COCHRANE DB SYST REV, V1; Moraes VY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010071.pub2; Sherry MA, 2004, J ORTHOP SPORT PHYS, V34, P116, DOI 10.2519/jospt.2004.34.3.116	5	102	103	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2546	2547		10.1056/NEJMc1402340	http://dx.doi.org/10.1056/NEJMc1402340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963588	Bronze			2022-12-28	WOS:000337804400028
J	Chatenoud, L				Chatenoud, Lucienne			Teaching the immune system "self" respect and tolerance	SCIENCE			English	Editorial Material							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; AUTOIMMUNE; BETA; RITUXIMAB; DEPLETION; DISEASES		[Chatenoud, Lucienne] Univ Paris 05, Sorbonne Paris Cite, F-75475 Paris, France; [Chatenoud, Lucienne] Hop Necker Enfants Malad, INSERM, U1151, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chatenoud, L (corresponding author), Univ Paris 05, Sorbonne Paris Cite, F-75475 Paris, France.	lucienne.chatenoud@inserm.fr						Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Kasagi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008895; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Marek-Trzonkowska N, 2013, PEDIATR DIABETES, V14, P322, DOI 10.1111/pedi.12029; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schwartz RH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006908; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552	15	4	4	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1343	1344		10.1126/science.1256864	http://dx.doi.org/10.1126/science.1256864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948722				2022-12-28	WOS:000337531700019
J	Sellberg, JA; Huang, C; McQueen, TA; Loh, ND; Laksmono, H; Schlesinger, D; Sierra, RG; Nordlund, D; Hampton, CY; Starodub, D; DePonte, DP; Beye, M; Chen, C; Martin, AV; Barty, A; Wikfeldt, KT; Weiss, TM; Caronna, C; Feldkamp, J; Skinner, LB; Seibert, MM; Messerschmidt, M; Williams, GJ; Boutet, S; Pettersson, LGM; Bogan, MJ; Nilsson, A				Sellberg, J. A.; Huang, C.; McQueen, T. A.; Loh, N. D.; Laksmono, H.; Schlesinger, D.; Sierra, R. G.; Nordlund, D.; Hampton, C. Y.; Starodub, D.; DePonte, D. P.; Beye, M.; Chen, C.; Martin, A. V.; Barty, A.; Wikfeldt, K. T.; Weiss, T. M.; Caronna, C.; Feldkamp, J.; Skinner, L. B.; Seibert, M. M.; Messerschmidt, M.; Williams, G. J.; Boutet, S.; Pettersson, L. G. M.; Bogan, M. J.; Nilsson, A.			Ultrafast X-ray probing of water structure below the homogeneous ice nucleation temperature	NATURE			English	Article							LIQUID WATER; SUPERCOOLED WATER; SCATTERING; SINGULARITY	Water has a number of anomalous physical properties, and some of these become drastically enhanced on supercooling below the freezing point. Particular interest has focused on thermodynamic response functions that can be described using a normal component and an anomalous component that seems to diverge at about 228 kelvin (refs 1-3). This has prompted debate about conflicting theories(4-12) that aim to explain many of the anomalous thermodynamic properties of water. One popular theory attributes the divergence to a phase transition between two forms of liquid water occurring in the 'no man's land' that lies below the homogeneous ice nucleation temperature (T-H) at approximately 232 kelvin(13) and above about 160 kelvin(14), and where rapid ice crystallization has prevented any measurements of the bulk liquid phase. In fact, the reliable determination of the structure of liquid water typically requires temperatures above about 250 kelvin(2,15). Water crystallization has been inhibited by using nanoconfinement(16), nanodroplets(17) and association with biomolecules(16) to give liquid samples at temperatures below T-H, but such measurements rely on nanoscopic volumes of water where the interaction with the confining surfaces makes the relevance to bulk water unclear(18). Here we demonstrate that femtosecond X-ray laser pulses can be used to probe the structure of liquid water in micrometre-sized droplets that have been evaporatively cooled(19-21) below TH. We find experimental evidence for the existence of metastable bulk liquid water down to temperatures of 227(-1)(+2) kelvin in the previously largely unexplored no man's land. We observe a continuous and accelerating increase in structural ordering on supercooling to approximately 229 kelvin, where the number of droplets containing ice crystals increases rapidly. But a few droplets remain liquid for about a millisecond even at this temperature. The hope now is that these observations and our detailed structural data will help identify those theories that best describe and explain the behaviour of water.	[Sellberg, J. A.; McQueen, T. A.; Beye, M.; Chen, C.; Nilsson, A.] SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, Menlo Pk, CA 94025 USA; [Sellberg, J. A.; Schlesinger, D.; Wikfeldt, K. T.; Pettersson, L. G. M.; Nilsson, A.] Stockholm Univ, AlbaNova Univ Ctr, Dept Phys, S-10691 Stockholm, Sweden; [Huang, C.; Nordlund, D.; Weiss, T. M.; Nilsson, A.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Stanford, CA 94309 USA; [McQueen, T. A.; Chen, C.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Loh, N. D.; Laksmono, H.; Sierra, R. G.; Hampton, C. Y.; Starodub, D.; Bogan, M. J.] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [DePonte, D. P.; Martin, A. V.; Barty, A.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [DePonte, D. P.; Caronna, C.; Feldkamp, J.; Seibert, M. M.; Messerschmidt, M.; Williams, G. J.; Boutet, S.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Stanford, CA 94309 USA; [Beye, M.] Helmholtz Zentrum Berlin Mat & Energie GmbH, Inst Methods & Instrumentat Synchrotron Radiat Re, D-12489 Berlin, Germany; [Skinner, L. B.] SUNY Stony Brook, Mineral Phys Inst, Stony Brook, NY 11794 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stockholm University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sellberg, JA (corresponding author), SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	sellberg@slac.stanford.edu; nilsson@slac.stanford.edu	Messerschmidt, Marc/F-3796-2010; Young, Michelle A/N-7228-2017; Schlesinger, Daniel/AAT-5986-2020; Loh, Duane/I-7371-2013; Skinner, Lawrie/I-2603-2012; Sellberg, Jonas A/C-6506-2009; Schlesinger, Daniel/F-6313-2013; Nilsson, Anders/E-1943-2011; Schlesinger, Daniel/I-8883-2017; Nordlund, Dennis/A-8902-2008; Pettersson, Lars GM/J-4925-2013; Beye, Martin/F-1165-2011; Barty, Anton/K-5137-2014; Messerschmidt, Marc/Y-8929-2019	Messerschmidt, Marc/0000-0002-8641-3302; Schlesinger, Daniel/0000-0001-7889-1964; Loh, Duane/0000-0002-8886-510X; Skinner, Lawrie/0000-0001-7317-1642; Sellberg, Jonas A/0000-0003-2793-5052; Nilsson, Anders/0000-0003-1968-8696; Schlesinger, Daniel/0000-0001-7889-1964; Nordlund, Dennis/0000-0001-9524-6908; Pettersson, Lars GM/0000-0003-1133-9934; Beye, Martin/0000-0002-3924-2993; Barty, Anton/0000-0003-4751-2727; Messerschmidt, Marc/0000-0002-8641-3302; MARTIN, ANDREW/0000-0003-3704-1829; Seibert, Mark Marvin/0000-0003-0251-0744	US Department of Energy (DOE) through the SLAC Laboratory Directed Research and Development Program, Office of Basic Energy Sciences through SSRL; US Department of Energy (DOE) through the SLAC Laboratory Directed Research and Development Program, Office of Basic Energy Sciences through LCLS; AMOS programme within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences; Swedish Research Council; National Institutes of Health, National Center for Research Resources, Biomedical Technology Grant; US Department of Energy, Office of Biological and Environmental Research	US Department of Energy (DOE) through the SLAC Laboratory Directed Research and Development Program, Office of Basic Energy Sciences through SSRL(United States Department of Energy (DOE)); US Department of Energy (DOE) through the SLAC Laboratory Directed Research and Development Program, Office of Basic Energy Sciences through LCLS(United States Department of Energy (DOE)); AMOS programme within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences(United States Department of Energy (DOE)); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health, National Center for Research Resources, Biomedical Technology Grant; US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We acknowledge the US Department of Energy (DOE) through the SLAC Laboratory Directed Research and Development Program, Office of Basic Energy Sciences through SSRL and LCLS; the AMOS programme within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences; and the Swedish Research Council for financial support. The molecular dynamics simulations were performed on resources provided by the Swedish National Infrastructure for Computing at the NSC and HPC2N centres. Parts of this research were carried out at LCLS at the SLAC National Accelerator Laboratory. LCLS is an Office of Science User Facility operated for the DOE Office of Science by Stanford University. We also acknowledge the support of the SSRL Structural Molecular Biology group funded by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Grant and the US Department of Energy, Office of Biological and Environmental Research. We wish to thank D. Schafer and M. Hayes for mechanical support; W. Ghonsalves and F. Hoeflich for software support; the SLAC detector group for assistance with the Cornell-SLAC pixel array detector; H. Nakatsutsumi, K. Beyerlein and C. Gati for nozzle support; D. Bowron for providing the data files from ref. 22; J. Spence and C. Stan for discussions; and H. E. Stanley, V. Molinero, C. A. Angell and D. Chandler for critical reading of the manuscript.	Angell CA, 2008, SCIENCE, V319, P582, DOI 10.1126/science.1131939; ANGELL CA, 1982, J PHYS CHEM-US, V86, P998, DOI 10.1021/j100395a032; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Bowron DT, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2378921; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Errington JR, 2001, NATURE, V409, P318, DOI 10.1038/35053024; FAUBEL M, 1988, Z PHYS D ATOM MOL CL, V10, P269, DOI 10.1007/BF01384861; Holten V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00713; Huang CC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3495974; Levinger NE, 2002, SCIENCE, V298, P1722, DOI 10.1126/science.1079322; Limmer DT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643333; Lord Rayleigh F.R.S., 1879, P LOND MATH SOC, V10, P4; Mallamace F, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/6/064103; Manka A, 2012, PHYS CHEM CHEM PHYS, V14, P4505, DOI 10.1039/c2cp23116f; MASON BJ, 1958, ADV PHYS, V7, P221, DOI 10.1080/00018735800101237; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; NARTEN AH, 1967, DISCUSS FARADAY SOC, P97; Neuefeind J, 2011, MOL PHYS, V109, P279, DOI 10.1080/00268976.2010.520040; OKHULKOV AV, 1994, J CHEM PHYS, V100, P1578, DOI 10.1063/1.466584; Overduin SD, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803868; Palmer JC, 2013, FARADAY DISCUSS, V167, P77, DOI 10.1039/c3fd00074e; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Skinner LB, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790861; Smith RS, 1999, NATURE, V398, P788, DOI 10.1038/19725; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P982, DOI 10.1021/j100395a030; Tulk CA, 2002, SCIENCE, V297, P1320, DOI 10.1126/science.1074178; Wikfeldt KT, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3594545	30	316	324	8	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					381	+		10.1038/nature13266	http://dx.doi.org/10.1038/nature13266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24943953				2022-12-28	WOS:000337350200031
J	Hodson, EM; Craig, JC				Hodson, Elisabeth M.; Craig, Jonathan C.			Rituximab for childhood-onset nephrotic syndrome	LANCET			English	Editorial Material							CHILDREN; THERAPY		[Hodson, Elisabeth M.; Craig, Jonathan C.] Childrens Hosp, Ctr Kidney Res, Westmead, NSW 2145, Australia; [Hodson, Elisabeth M.; Craig, Jonathan C.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Hodson, EM (corresponding author), Childrens Hosp, Ctr Kidney Res, Westmead, NSW 2145, Australia.	elisabeth.hodson@health.nsw.gov.au	Craig, Jonathan/E-2813-2013; Hodson, Elisabeth/S-4590-2019	Craig, Jonathan/0000-0002-2548-4035; 				Ardelean DS, 2010, PEDIATRICS, V126, pE243, DOI 10.1542/peds.2009-3395; Boyer O, 2013, NAT REV NEPHROL, V9, P562, DOI 10.1038/nrneph.2013.153; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Chaumais MC, 2009, PEDIATR NEPHROL, V24, P1753, DOI 10.1007/s00467-009-1195-9; Czarniak P, 2013, PEDIATR NEPHROL, V28, P987, DOI 10.1007/s00467-013-2457-0; Hamasaki Y, 2009, PEDIATR NEPHROL, V24, P2177, DOI 10.1007/s00467-009-1264-0; Iijima K, 2014, LANCET, V384, P1273, DOI 10.1016/S0140-6736(14)60541-9; Kemper MJ, 2012, NEPHROL DIAL TRANSPL, V27, P1910, DOI 10.1093/ndt/gfr548; Lombel RM, 2013, PEDIATR NEPHROL, V28, P415, DOI 10.1007/s00467-012-2310-x; Pravitsitthikul N, 2013, COCHRANE DB SYST REV, V10; Ravani P, 2013, KIDNEY INT, V84, P1025, DOI 10.1038/ki.2013.211; Ravani P, 2011, CLIN J AM SOC NEPHRO, V6, P1308, DOI 10.2215/CJN.09421010; Sellier-Leclerc AL, 2013, PEDIATR NEPHROL, V28, P1875, DOI 10.1007/s00467-013-2485-9; Tellier S, 2013, PEDIATR NEPHROL, V28, P911, DOI 10.1007/s00467-012-2406-3	14	6	7	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1242	1243		10.1016/S0140-6736(14)60654-1	http://dx.doi.org/10.1016/S0140-6736(14)60654-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24965824				2022-12-28	WOS:000343003400008
J	Squires, D				Squires, David			The Global Slowdown in Health Care Spending Growth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Squires, D (corresponding author), Commonwealth Fund, 1 E 75th St, New York, NY 10021 USA.	ds@cmwf.org						[Anonymous], 2013, ASSESSING THE EFFECT; Blumenthal D, 2013, NEW ENGL J MED, V369, P2551, DOI 10.1056/NEJMhpr1310415; Chandra A, 2013, WORKING PAPER 19700; Kanavos P, 2013, HEALTH AFFAIR, V32, P753, DOI 10.1377/hlthaff.2012.0920; Martin AB, 2014, HEALTH AFFAIR, V33, P67, DOI 10.1377/hlthaff.2013.1254; OECD, 2013, OECD HEALTH DATA 201; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P10, DOI 10.1377/hlthaff.23.3.10; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276	8	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					485	486		10.1001/jama.2014.7221	http://dx.doi.org/10.1001/jama.2014.7221			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM4FL	24967728				2022-12-28	WOS:000339808600014
J	Troelsen, T; Hilberg, O				Troelsen, Thomas; Hilberg, Ole			Tuberculous Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Troelsen, Thomas; Hilberg, Ole] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark	Aarhus University	Troelsen, T (corresponding author), Aarhus Univ Hosp, DK-8000 Aarhus, Denmark.	troelsentt@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					161	161		10.1056/NEJMicm1311878	http://dx.doi.org/10.1056/NEJMicm1311878			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006722				2022-12-28	WOS:000338645500012
J	Stokes, L				Stokes, Lynne			Sample Size Calculation for a Hypothesis Test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMBINATION; VARENICLINE		So Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA	Southern Methodist University	Stokes, L (corresponding author), So Methodist Univ, Dept Stat Sci, POB 750100, Dallas, TX 75275 USA.	slstokes@smu.edu						Besada NA, 2010, EUR RESP J S54, V36; Ebbert JO, 2009, NICOTINE TOB RES, V11, P572, DOI 10.1093/ntr/ntp042; Hajek P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-140; Koegelenberg CFN, 2014, JAMA-J AM MED ASSOC, V312, P155, DOI 10.1001/jama.2014.7195	4	11	11	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					180	181		10.1001/jama.2014.8295	http://dx.doi.org/10.1001/jama.2014.8295			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005655				2022-12-28	WOS:000338511200024
J	Haycock, PC; Heydon, EE; Kaptoge, S; Butterworth, AS; Thompson, A; Willeit, P				Haycock, Philip C.; Heydon, Emma E.; Kaptoge, Stephen; Butterworth, Adam S.; Thompson, Alex; Willeit, Peter			Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; HUMAN ATHEROSCLEROSIS; CELL SENESCENCE; ISCHEMIC-STROKE; ASSOCIATION; HEALTH; BLOOD; AGE; EPIDEMIOLOGY	Objective To assess the association between leucocyte telomere length and risk of cardiovascular disease. Design Systematic review and meta-analysis. Data sources Studies published up to March 2014 identified through searches of Medline, Web of Science, and Embase. Eligibility criteria Prospective and retrospective studies that reported on associations between leucocyte telomere length and coronary heart disease (defined as non-fatal myocardial infarction, coronary heart disease death, or coronary revascularisation) or cerebrovascular disease (defined as non-fatal stroke or death from cerebrovascular disease) and were broadly representative of general populations-that is, they did not select cohort or control participants on the basis of pre-existing cardiovascular disease or diabetes. Results Twenty four studies involving 43 725 participants and 8400 patients with cardiovascular disease (5566 with coronary heart disease and 2834 with cerebrovascular disease) were found to be eligible. In a comparison of the shortest versus longest third of leucocyte telomere length, the pooled relative risk for coronary heart disease was 1.54 (95% confidence interval 1.30 to 1.83) in all studies, 1.40 (1.15 to 1.70) in prospective studies, and 1.80 (1.32 to 2.44) in retrospective studies. Heterogeneity between studies was moderate (I-2=64%, 41% to 77%, P-het<0.001) and was not significantly explained by mean age of participants (P=0.23), the proportion of male participants (P=0.45), or distinction between retrospective versus prospective studies (P=0.32). Findings for coronary heart disease were similar in meta-analyses restricted to studies that adjusted for conventional vascular risk factors (relative risk 1.42, 95% confidence interval 1.17 to 1.73); studies with >= 200 cases (1.44, 1.20 to 1.74); studies with a high quality score (1.53, 1.22 to 1.92); and in analyses that corrected for publication bias (1.34, 1.12 to 1.60). The pooled relative risk for cerebrovascular disease was 1.42 (1.11 to 1.81), with no significant heterogeneity between studies (I2= 41%, 0% to 72%, P-het=0.08). Shorter telomeres were not significantly associated with cerebrovascular disease risk in prospective studies (1.14, 0.85 to 1.54) or in studies with a high quality score (1.21, 0.83 to 1.76). Conclusion Available observational data show an inverse association between leucocyte telomere length and risk of coronary heart disease independent of conventional vascular risk factors. The association with cerebrovascular disease is less certain.	[Haycock, Philip C.; Heydon, Emma E.; Kaptoge, Stephen; Butterworth, Adam S.; Thompson, Alex; Willeit, Peter] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Haycock, Philip C.] Univ Bristol, MRC, Integrat Epidemiol Unit, Sch Social & Community Med, Bristol, Avon, England; [Thompson, Alex] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England; [Willeit, Peter] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria	University of Cambridge; University of Bristol; Roche Holding; Medical University of Innsbruck	Haycock, PC (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England.	haycock@bristol.ac.uk	Haycock, Philip/I-6188-2019; Willeit, Peter/HCI-7091-2022	Haycock, Philip/0000-0001-5001-3350; Willeit, Peter/0000-0002-1866-7159; Butterworth, Adam/0000-0002-6915-9015	British Heart Foundation [RG/13/13/30194]; UK Medical Research Council [MR/L003120/1]; MRC [MR/L003120/1, G0800270] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1, G0800270] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Cardiovascular Epidemiology Unit is supported by a core grant from the British Heart Foundation (RG/13/13/30194) and the UK Medical Research Council (MR/L003120/1).	Balasubramanyam M, 2007, INDIAN J MED RES, V125, P441; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chene G, 1996, AM J EPIDEMIOL, V144, P610; Codd V, 2009, HEART, V95, P135; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cui GL, 2014, ATHEROSCLEROSIS, V233, P375, DOI 10.1016/j.atherosclerosis.2014.01.008; Ding H, 2012, STROKE, V43, P658, DOI 10.1161/STROKEAHA.111.637207; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epel ES, 2009, AGING-US, V1, P81; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jiang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068254; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Maubaret CG, 2010, J MOL MED, V88, P785, DOI 10.1007/s00109-010-0624-3; McCartney M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e681; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Mukherjee M, 2009, HEART, V95, P669, DOI 10.1136/hrt.2008.150250; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; Panayiotou AG, 2010, ATHEROSCLEROSIS, V211, P176, DOI 10.1016/j.atherosclerosis.2010.01.037; Russo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049206; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Schurks M, 2013, EUR J NEUROL, V20, P1068, DOI 10.1111/ene.12135; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Spyridopoulos I, 2009, CIRCULATION, V120, P1364, DOI 10.1161/CIRCULATIONAHA.109.854299; Starr JM, 2007, EXP GERONTOL, V42, P571, DOI 10.1016/j.exger.2006.12.002; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Weischer M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004191; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Wells G., NEWCASTLE OTTAWA SCA; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Ye SQ, 2013, AM J CARDIOL, V111, P962, DOI 10.1016/j.amjcard.2012.12.017; Zee RYL, 2010, REJUV RES, V13, P411, DOI 10.1089/rej.2009.0975; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004; Zhang WL, 2013, CLIN SCI, V125, P27, DOI 10.1042/CS20120691; Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993	50	484	487	3	51	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4227	10.1136/bmj.g4227	http://dx.doi.org/10.1136/bmj.g4227			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25006006	Green Published, hybrid			2022-12-28	WOS:000338993300002
J	Sugrue, A; Egan, A; O'Regan, A				Sugrue, Alan; Egan, Aoife; O'Regan, Anthony			CASE REPORT A woman with macrocytic anaemia and confusion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATIENTS RECEIVING METFORMIN; VITAMIN-B12 DEFICIENCY; MEGALOBLASTIC-ANEMIA; COBALAMIN DEFICIENCY; CLINICAL-MANIFESTATIONS; PERNICIOUS-ANEMIA; ELDERLY-PATIENTS; THERAPY; MALABSORPTION; PANCYTOPENIA		[Sugrue, Alan; Egan, Aoife; O'Regan, Anthony] Galway Univ Hosp, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Sugrue, A (corresponding author), Galway Univ Hosp, Galway, Ireland.	alansugrue@gmail.com	Sugrue, Alan/AAN-8589-2021	Egan, Aoife/0000-0003-0379-9279				ABDALLA SH, 1986, T ROY SOC TROP MED H, V80, P557, DOI 10.1016/0035-9203(86)90138-0; Acharya U, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-26; Albers U, 2012, INT J VITAM NUTR RES, V82, P104, DOI 10.1024/0300-9831/a000099; Andres E, 2006, CLIN LAB HAEMATOL, V28, P50, DOI 10.1111/j.1365-2257.2006.00755.x; Andres E, 2005, AM J MED, V118, P1154, DOI 10.1016/j.amjmed.2005.02.026; Andres E, 2007, EUR J INTERN MED, V18, P456, DOI 10.1016/j.ejim.2007.02.013; Andres E, 2007, ARCH INTERN MED, V167, P729, DOI 10.1001/archinte.167.7.729-a; Andres E, 2010, EXPERT OPIN PHARMACO, V11, P249, DOI 10.1517/14656560903456053; Arendt JFB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045979; Au WY, 1998, CLIN LAB HAEMATOL, V20, P217, DOI 10.1046/j.1365-2257.1998.00143.x; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Carey J, 2012, BMJ CASE REP, V2012; Carmel R, 2008, BLOOD, V112, P2214, DOI 10.1182/blood-2008-03-040253; CHANARIN I, 1985, LANCET, V2, P1168; EICHACKER P, 1985, AM J HEMATOL, V18, P41, DOI 10.1002/ajh.2830180107; Halfdanarson TR, 2008, EUR J HAEMATOL, V80, P448, DOI 10.1111/j.1600-0609.2008.01043.x; Hammel I, 2012, BIOL BIOMED REP, V2; Heil SG, 2012, ANN CLIN BIOCHEM, V49, P184, DOI 10.1258/acb.2011.011039; Hoffbrand V, 1997, BRIT MED J, V314, P430, DOI 10.1136/bmj.314.7078.430; Kaferle J, 2009, AM FAM PHYSICIAN, V79, P203; Kickler T.S., 2005, TRANSFUSION, V45, P1233; Kim HI, 2011, ANN SURG ONCOL, V18, P3711, DOI 10.1245/s10434-011-1764-6; Kos E, 2012, ENDOCR PRACT, V18, P179, DOI 10.4158/EP11009.OR; KUHNE T, 1991, EUR J PEDIATR, V150, P205; Liu K, 2011, ASIAN J GERONTOL GER, V6, P82; Loukili NH, 2004, REV MED INTERNE, V25, P556, DOI 10.1016/j.revmed.2004.03.008; Marks PW, 2004, NEW ENGL J MED, V351, P1333, DOI 10.1056/NEJMcpc040921; MATCHAR DB, 1994, AM J MED SCI, V308, P276, DOI 10.1097/00000441-199411000-00004; MCPHEE AJ, 1988, ARCH DIS CHILD, V63, P921, DOI 10.1136/adc.63.8.921; Oberley MJ, 2013, AM J HEMATOL, V88, P522, DOI 10.1002/ajh.23421; Quentin C, 2012, EUR J PEDIATR, V171, P193, DOI 10.1007/s00431-011-1577-4; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Rozgony Nancy R., 2010, Journal of Nutrition for the Elderly, V29, P87, DOI 10.1080/01639360903574734; SAVAGE D, 1994, BRIT J HAEMATOL, V86, P844, DOI 10.1111/j.1365-2141.1994.tb04840.x; Savage DG, 2000, AM J MED SCI, V319, P343, DOI 10.1097/00000441-200006000-00001; Schrier S, 2004, UPTODATE, P26; Simsek OP, 2004, J PEDIAT HEMATOL ONC, V26, P834; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Steele RH, 2002, INT J STD AIDS, V13, P748, DOI 10.1258/095646202320753691; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; TUNGTRONGCHITR R, 1993, INT J VITAM NUTR RES, V63, P201; ZIMRAN A, 1983, AM J CLIN NUTR, V37, P855, DOI 10.1093/ajcn/37.5.855	42	3	3	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4388	10.1136/bmj.g4388	http://dx.doi.org/10.1136/bmj.g4388			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25004916				2022-12-28	WOS:000338993300007
J	Khan, AS; Lurie, N				Khan, Ali S.; Lurie, Nicole			Health security in 2014: building on preparedness knowledge for emerging health threats	LANCET			English	Editorial Material							H7N9		[Khan, Ali S.] Ctr Dis Control & Prevent, US Dept HHS, Atlanta, GA 30333 USA; [Lurie, Nicole] US Dept HHS, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA	Centers for Disease Control & Prevention - USA	Khan, AS (corresponding author), Ctr Dis Control & Prevent, US Dept HHS, 1600 Clifton Rd,MS D-44, Atlanta, GA 30333 USA.	askhan@cdc.gov						Centers for Public Health Preparedness, 2007, 2006 2007 ASPH CDC V; Engelman A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-84; Frieden T., 2013, ARMS RACE GETTING AH; Khan AS, 2011, LANCET, V378, P953, DOI 10.1016/S0140-6736(11)61263-4; Kohn S, 2010, PUBLIC HEALTH REP, V125, P43, DOI 10.1177/00333549101250S507; Krisberg K., 2013, NATIONS HLTH, V43, P1; Salathe M, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds16; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; US Centers for Disease Control and Prevention, 2012, CRIT ROL STAT HLTH D; US Centers for Disease Control and Prevention, 2013, MULT FUNG MEN OUTBR; US Department of Health and Human Services, 2013, NAT HLTH SEC STRAT; Wang Y, 2013, NEW ENGL J MED, V368, P2348, DOI 10.1056/NEJMp1305311; Wells KB, 2013, AM J PUBLIC HEALTH, V103, P1172, DOI 10.2105/AJPH.2013.301407	14	10	12	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					93	97		10.1016/S0140-6736(14)60260-9	http://dx.doi.org/10.1016/S0140-6736(14)60260-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24998007	Bronze, Green Published			2022-12-28	WOS:000338919600030
J	Anderson, WH; Mackay, IR				Anderson, Warwick H.; Mackay, Ian R.			Gut Reactions - From Celiac Affection to Autoimmune Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Anderson, Warwick H.] Univ Sydney, Sydney, NSW 2006, Australia; [Mackay, Ian R.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	University of Sydney; Monash University	Anderson, WH (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.			Anderson, Warwick/0000-0002-2572-035X				ANDERSON CM, 1952, LANCET, V259, P836, DOI 10.1016/S0140-6736(52)90795-2; Anderson W, 2014, JOHNS HOPK BIOGR DIS, P1; Gee S., 1888, ST BARTHOLOMEWS HOSP, V24, P17; Herter Christian, 1908, INFANTILISM CHRONIC; TAYLOR KB, 1961, BMJ-BRIT MED J, V2, P1727, DOI 10.1136/bmj.2.5269.1727	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					6	7		10.1056/NEJMp1405192	http://dx.doi.org/10.1056/NEJMp1405192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988553				2022-12-28	WOS:000338265700003
J	Ensrud, KE; Taylor, BC; Peters, KW; Gourlay, ML; Donaldson, MG; Leslie, WD; Blackwell, TL; Fink, HA; Orwoll, ES; Schousboe, J				Ensrud, Kristine E.; Taylor, Brent C.; Peters, Katherine W.; Gourlay, Margaret L.; Donaldson, Meghan G.; Leslie, William D.; Blackwell, Terri L.; Fink, Howard A.; Orwoll, Eric S.; Schousboe, John		Osteoporotic Fractures Men MrOS St	Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-MINERAL DENSITY; OSTEOPOROTIC FRACTURES; POSTMENOPAUSAL WOMEN; CLINICAL-PRACTICE; DOUBLE-BLIND; US ADULTS; VERTEBRAL FRACTURES; ZOLEDRONIC ACID; ELDERLY-WOMEN; HIP FRACTURE	Objectives To quantify incremental effects of applying different criteria to identify men who are candidates for drug treatment to prevent fracture and to examine the extent to which fracture probabilities vary across distinct categories of men defined by these criteria. Design Cross sectional and longitudinal analysis of a prospective cohort study. Setting Multicenter Osteoporotic Fractures in Men (MrOS) study in the United States. Participants 5880 untreated community dwelling men aged 65 years or over classified into four distinct groups: osteoporosis by World Health Organization criteria alone; osteoporosis by National Osteoporosis Foundation (NOF) but not WHO criteria; no osteoporosis but at high fracture risk (at or above NOF derived FRAX intervention thresholds recommended for US); and no osteoporosis and at low fracture risk (below NOF derived FRAX intervention thresholds recommended for US). Main outcome measures Proportion of men identified for drug treatment; predicted 10 year probabilities of hip and major osteoporotic fracture calculated using FRAX algorithm with femoral neck bone mineral density; observed 10 year probabilities for confirmed incident hip and major osteoporotic (hip, clinical vertebral, wrist, or humerus) fracture events calculated using cumulative incidence estimation, accounting for competing risk of mortality. Results 130 (2.2%) men were identified as having osteoporosis by using the WHO definition, and an additional 422 were identified by applying the NOF definition (total osteoporosis prevalence 9.4%). Application of NOF derived FRAX intervention thresholds led to 936 (15.9%) additional men without osteoporosis being identified as at high fracture risk, raising the total prevalence of men potentially eligible for drug treatment to 25.3%. Observed 10 year hip fracture probabilities were 20.6% for men with osteoporosis by WHO criteria alone, 6.8% for men with osteoporosis by NOF (but not WHO) criteria, 6.4% for men without osteoporosis but classified as at high fracture risk, and 1.5% for men without osteoporosis and classified as at low fracture risk. A similar pattern was noted in observed fracture probabilities for major osteoporotic fracture. Among men with osteoporosis by WHO criteria, observed fracture probabilities were greater than FRAX predicted probabilities (20.6% v 9.5% for hip fracture and 30.0% v 17.4% for major osteoporotic fracture). Conclusions and relevance Choice of definition of osteoporosis and use of NOF derived FRAX intervention thresholds have major effects on the proportion of older men identified as warranting drug treatment to prevent fracture. Among men identified with osteoporosis by WHO criteria, who comprised 2% of the study population, actual observed fracture probabilities during 10 years of follow-up were highest and exceeded FRAX predicted fracture probabilities. On the basis of findings from randomized trials in women, these men are most likely to benefit from treatment. Expanding indications for treatment beyond this small group has uncertain value owing to lower observed fracture probabilities and uncertain benefits of treatment among men not selected on the basis of WHO criteria.	[Ensrud, Kristine E.; Taylor, Brent C.; Fink, Howard A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.; Taylor, Brent C.; Fink, Howard A.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Ensrud, Kristine E.; Taylor, Brent C.; Fink, Howard A.] VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Peters, Katherine W.; Blackwell, Terri L.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Gourlay, Margaret L.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA; [Donaldson, Meghan G.] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC V5Z 1M9, Canada; [Leslie, William D.] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Orwoll, Eric S.] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97201 USA; [Schousboe, John] Pk Nicollet Clin, St Louis Pk, MN USA; [Schousboe, John] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia; University of Manitoba; Oregon Health & Science University; University of Minnesota System; University of Minnesota Twin Cities	Ensrud, KE (corresponding author), One Vet Dr 111-0, Minneapolis, MN 55417 USA.	ensru001@umn.edu	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Leslie, William/0000-0002-1056-1691; Ensrud, Kristine/0000-0002-9069-3036	National Institutes of Health (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging; National Center for Research Resources; NIH Roadmap for Medical Research [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01 AG027810, UL1 TR000128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045583, U01AR045632, U01AR045654, U01AR066160, U01AR045647, U01AR045614, U01AR045580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018197, U01AG027810, U01AG042145, U01AG042168, U01AG042124, U01AG042139] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health (NIH) funding. The following institutes provide support: the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute on Aging, the National Center for Research Resources, and NIH Roadmap for Medical Research under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01 AG027810, and UL1 TR000128. The funding agencies had no direct role in the conduct of the study; the collection, management, analyses, and interpretation of the data; or the preparation or approval of the manuscript.	ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; [Anonymous], 2010, CLIN GUID PREV TREAT; [Anonymous], 2011, FRAX WHO FRACTURE RI; Berry SD, 2010, OSTEOPOROSIS INT, V21, P53, DOI 10.1007/s00198-009-1127-3; Binkley Neil C, 2002, J Clin Densitom, V5 Suppl, pS19, DOI 10.1385/JCD:5:3S:S19; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Boonen S, 2012, NEW ENGL J MED, V367, P1714, DOI 10.1056/NEJMoa1204061; Boonen S, 2009, J BONE MINER RES, V24, P719, DOI 10.1359/JBMR.081214; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cawthon PM, 2009, J BONE MINER RES, V24, P1728, DOI [10.1359/JBMR.090419, 10.1359/jbmr.090419]; Compston J, 2013, MATURITAS, V75, P392, DOI 10.1016/j.maturitas.2013.05.013; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Donaldson MG, 2012, J BONE MINER RES, V27, P1804, DOI 10.1002/jbmr.1625; Donaldson MG, 2010, J BONE MINER RES, V25, P1506, DOI 10.1002/jbmr.55; Douglas F, 2012, OSTEOPOROSIS INT, V23, P2135, DOI 10.1007/s00198-011-1823-7; Ebeling PR, 2008, NEW ENGL J MED, V358, P1474, DOI 10.1056/NEJMcp0707217; Endocrine Society, 2009, END SOC STAT IND REL; Ensrud KE, 2011, NEW ENGL J MED, V364, P1634, DOI 10.1056/NEJMcp1009697; Ettinger B, 2013, OSTEOPOROSIS INT, V24, P1185, DOI 10.1007/s00198-012-2215-3; Faulkner KG, 2002, J CLIN DENSITOM, V5, P87, DOI 10.1385/JCD:5:1:087; Hans DB, 2011, J CLIN DENSITOM, V14, P171, DOI 10.1016/j.jocd.2011.05.007; International Osteoporosis Foundation, 2013, ANN REP 2012 INT OST; International Society for Clinical Densitometry, 2007, 2007 ISCD OFF POS AD; International Society for Clinical Densitometry, 2013, 2013 ISCD OFF POS AD; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Jorgensen EB, 2008, KAIS, V2021, P1, DOI [DOI 10.1002/14651858.CD001155.PUB2, 10.1002/mp.15257]; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2789, DOI 10.1007/s00198-011-1632-z; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kanis JA, 2010, BONE, V47, P729, DOI 10.1016/j.bone.2010.06.009; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Kelly TL., 1990, J BONE MIN RES, V5, pS249; Looker AC, 2012, OSTEOPOROSIS INT, V23, P1351, DOI 10.1007/s00198-011-1693-z; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; McCloskey EV, 2009, OSTEOPOROSIS INT, V20, P811, DOI 10.1007/s00198-008-0786-9; McCloskey EV, 2012, J BONE MINER RES, V27, P1480, DOI 10.1002/jbmr.1606; McCloskey EV, 2007, J BONE MINER RES, V22, P135, DOI 10.1359/JBMR.061008; McClung MR, 2012, J BONE MINER RES, V27, P211, DOI 10.1002/jbmr.536; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; National Osteoporosis Foundation, 2013, 2012 ANN REP NAT OST; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Orwoll E, 2012, J CLIN ENDOCR METAB, V97, P3161, DOI 10.1210/jc.2012-1569; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Richy F, 2004, J CLIN DENSITOM, V7, P127, DOI 10.1385/JCD:7:2:127; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Tosteson ANA, 2008, OSTEOPOROSIS INT, V19, P437, DOI 10.1007/s00198-007-0550-6; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045	60	22	22	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g4120	10.1136/bmj.g4120	http://dx.doi.org/10.1136/bmj.g4120			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24994809	Green Published, hybrid			2022-12-28	WOS:000338646100003
J	Taylor, G				Taylor, Greg			ASTROPHYSICS A tight duo in a trio of black holes	NATURE			English	Editorial Material							ACTIVE GALACTIC NUCLEI		Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	University of New Mexico	Taylor, G (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.	gbtaylor@unm.edu						BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Condon J., 2011, NARIT C SER; Deane RP, 2014, NATURE, V511, P57, DOI 10.1038/nature13454; Gaskell CM, 2010, NATURE, V463, pE1, DOI 10.1038/nature08665; Helmboldt JF, 2007, ASTROPHYS J, V658, P203, DOI 10.1086/511005; Hughes SA, 2003, ANN PHYS-NEW YORK, V303, P142, DOI 10.1016/S0003-4916(02)00025-8; Milosavljevic M, 2001, ASTROPHYS J, V563, P34, DOI 10.1086/323830; Rodriguez C, 2006, ASTROPHYS J, V646, P49, DOI 10.1086/504825; Smith KL, 2010, ASTROPHYS J, V716, P866, DOI 10.1088/0004-637X/716/1/866	9	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					35	37		10.1038/nature13511	http://dx.doi.org/10.1038/nature13511			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990736				2022-12-28	WOS:000338199400025
J	Rivera, LB; Bergers, G				Rivera, Lee B.; Bergers, Gabriele			Targeting vascular sprouts	SCIENCE			English	Editorial Material							ENDOTHELIAL-CELLS; GLYCOLYSIS; ANGIOGENESIS; PGC-1-ALPHA; CANCER		[Rivera, Lee B.; Bergers, Gabriele] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rivera, LB (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94158 USA.	gabriele.bergers@ucsf.edu	Bergers, Gabriele/AAJ-5535-2020	Bergers, Gabriele/0000-0003-3545-5171				Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; DOBRINA A, 1983, BIOCHIM BIOPHYS ACTA, V762, P295, DOI 10.1016/0167-4889(83)90084-8; Granchi C, 2012, CHEMMEDCHEM, V7, P1318, DOI 10.1002/cmdc.201200176; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008	12	21	22	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1449	1450		10.1126/science.1257071	http://dx.doi.org/10.1126/science.1257071			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970064				2022-12-28	WOS:000337889900020
J	Fante, RJ; Trobe, JD				Fante, Ryan James; Trobe, Jonathan D.			Bilateral Corneal Abrasions from Airbag Deployment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fante, Ryan James; Trobe, Jonathan D.] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fante, RJ (corresponding author), Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA.	jdtrobe@med.umich.edu		Trobe, Jonathan/0000-0003-0728-6729					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					E40	E40		10.1056/NEJMicm1313137	http://dx.doi.org/10.1056/NEJMicm1313137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963592				2022-12-28	WOS:000337804400011
J	Withington, P				Withington, Phil			The art of intoxication	LANCET			English	Editorial Material									Univ Sheffield, Dept Hist, Sheffield S3 7RA, S Yorkshire, England	University of Sheffield	Withington, P (corresponding author), Univ Sheffield, Dept Hist, Sheffield S3 7RA, S Yorkshire, England.	p.withington@sheffield.ac.uk			Economic and Social Research Council [ES/K00493X/1] Funding Source: researchfish; ESRC [ES/K00493X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Herring J., 2013, INTOXICATION SOC PRO, DOI [10.1057/9781137008336, DOI 10.1057/9781137008336]; Withington P, 2014, PRESENT SUPPLEMENTS	2	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2118	2119		10.1016/S0140-6736(14)61020-5	http://dx.doi.org/10.1016/S0140-6736(14)61020-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AJ7VG	24959641				2022-12-28	WOS:000337906600015
J	Hatziioannou, T; Del Prete, GQ; Keele, BF; Estes, JD; McNatt, MW; Bitzegeio, J; Raymond, A; Rodriguez, A; Schmidt, F; Mac Trubey, C; Smedley, J; Piatak, M; KewalRamani, VN; Lifson, JD; Bieniasz, PD				Hatziioannou, Theodora; Del Prete, Gregory Q.; Keele, Brandon F.; Estes, Jacob D.; McNatt, Matthew W.; Bitzegeio, Julia; Raymond, Alice; Rodriguez, Anthony; Schmidt, Fabian; Mac Trubey, C.; Smedley, Jeremy; Piatak, Michael, Jr.; KewalRamani, Vineet N.; Lifson, Jeffrey D.; Bieniasz, Paul D.			HIV-1-induced AIDS in monkeys	SCIENCE			English	Article							IMMUNODEFICIENCY; INFECTION; HIV/AIDS; MODELS	Primate lentiviruses exhibit narrow host tropism, reducing the occurrence of zoonoses but also impairing the development of optimal animal models of AIDS. To delineate the factors limiting cross-species HIV-1 transmission, we passaged a modified HIV-1 in pigtailed macaques that were transiently depleted of CD8(+) cells during acute infection. During adaptation over four passages in macaques, HIV-1 acquired the ability to antagonize the macaque restriction factor tetherin, replicated at progressively higher levels, and ultimately caused marked CD4(+) T cell depletion and AIDS-defining conditions. Transient treatment with an antibody to CD8 during acute HIV-1 infection caused rapid progression to AIDS, whereas untreated animals exhibited an elite controller phenotype. Thus, an adapted HIV-1 can cause AIDS in macaques, and stark differences in outcome can be determined by immunological perturbations during early infection.	[Hatziioannou, Theodora; McNatt, Matthew W.; Bitzegeio, Julia; Raymond, Alice; Rodriguez, Anthony; Schmidt, Fabian; Bieniasz, Paul D.] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Del Prete, Gregory Q.; Keele, Brandon F.; Estes, Jacob D.; Mac Trubey, C.; Piatak, Michael, Jr.; Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res, Frederick, MD 21702 USA; [McNatt, Matthew W.; Bitzegeio, Julia; Schmidt, Fabian; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10016 USA; [Smedley, Jeremy] Frederick Natl Lab, Lab Anim Sci Program, Leidos Biomed Res, Frederick, MD 21702 USA; [KewalRamani, Vineet N.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Bieniasz, Paul D.] Howard Hughes Med Inst, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Hatziioannou, T (corresponding author), Aaron Diamond AIDS Res Ctr, 455 First Ave, New York, NY 10016 USA.	thatziio@adarc.org; vineet.kewalramani@nih.gov; lifsonj@mail.nih.gov; pbienias@adarc.org	KewalRamani, Vineet/V-5084-2019	Smedley, Jeremy/0000-0003-3369-4662	NIH [R37AI64003, R01AI50111, R01AI078788]; Deutsche Forschungsgemeinschaft [BI1540/1-1]; Howard Hughes Medical Institute; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050111, R37AI064003, R01AI078788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data presented in this paper are tabulated in the main paper and in the supplementary materials. HIV-1 Env sequences used in Fig. 3 have been deposited in GenBank (accession numbers KJ201545 through KJ201764). Sequences encompassing the full-length viral genome for P5 and P6 have also been deposited in GenBank (accession numbers KJ767573 through KJ767592). This work was supported by NIH grants R37AI64003 and R01AI50111 (to P. D. B.) and R01AI078788 (to T. H.); Deutsche Forschungsgemeinschaft fellowship BI1540/1-1 (to J.B.); the Howard Hughes Medical Institute; and in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. We thank V. Coalter, A. Wiles, R. Wiles, and D. Johnson for assistance with study coordination and sample processing. Histology support was provided by the Pathology/Histotechnology Laboratory core service located at the Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Ambrose Z, 2007, TRENDS BIOTECHNOL, V25, P333, DOI 10.1016/j.tibtech.2007.05.004; Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Hirsch VM, 2004, J VIROL, V78, P275, DOI 10.1128/JVI.78.1.275-284.2004; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; RAO TKS, 1991, ANNU REV MED, V42, P391, DOI 10.1146/annurev.med.42.1.391; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Sina ST, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S7; Stephens EB, 1998, J VIROL, V72, P8820, DOI 10.1128/JVI.72.11.8820-8832.1998; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Veazey RS, 2008, J VIROL, V82, P5618, DOI 10.1128/JVI.02748-07; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Virgen CA, 2007, J VIROL, V81, P13932, DOI 10.1128/JVI.01760-07	24	66	66	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1401	1405		10.1126/science.1250761	http://dx.doi.org/10.1126/science.1250761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948736	Green Accepted			2022-12-28	WOS:000337531700041
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Unit of observation versus unit of analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS; RANDOMIZATION		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Pickett KE, 2007, BMJ-BRIT MED J, V335, P1080, DOI 10.1136/bmj.39377.580162.55; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3297; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2979; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2820; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1215; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1816; Sedgwick P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4654; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4670	9	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2014	348								g3840	10.1136/bmj.g3840	http://dx.doi.org/10.1136/bmj.g3840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1IW	24927764				2022-12-28	WOS:000337410400002
J	Kalcheim, C; Rohrer, H				Kalcheim, Chaya; Rohrer, Hermann			Following the same nerve track toward different cell fates	SCIENCE			English	Editorial Material							NEURAL CREST; MELANOCYTES; GANGLIA		[Kalcheim, Chaya] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Med Neurobiol, IL-91010 Jerusalem, Israel; [Kalcheim, Chaya] Hebrew Univ Jerusalem, Hadassah Med Sch, Safra Ctr Brain Res ELSC, IL-91010 Jerusalem, Israel; [Rohrer, Hermann] Max Planck Inst Brain Res, Res Grp Dev Neurobiol, Frankfurt, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Max Planck Society	Kalcheim, C (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Med Neurobiol, IL-91010 Jerusalem, Israel.	kalcheim@cc.huji.ac.il; hermann.rohrer@brain.mpg.de						Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Cannon W.B., 1963, WISDOM BODY; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; FURBER S, 1987, J NEUROSCI, V7, P1816; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Krispin S, 2010, DEVELOPMENT, V137, P585, DOI 10.1242/dev.041509; Le Douarin NM, 1999, NEURAL CREST, V2; Nitzan E, 2013, P NATL ACAD SCI USA, V110, P12709, DOI 10.1073/pnas.1306287110; Rohrer H, 2011, EUR J NEUROSCI, V34, P1563, DOI 10.1111/j.1460-9568.2011.07860.x	12	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					32	33		10.1126/science.1257175	http://dx.doi.org/10.1126/science.1257175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994636				2022-12-28	WOS:000338284400035
J	Ninan, S; Walton, C; Barlow, G				Ninan, Sean; Walton, Carly; Barlow, Gavin			RATIONAL TESTING Investigation of suspected urinary tract infection in older people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ASYMPTOMATIC BACTERIURIA; DIAGNOSIS; SYMPTOMS; CULTURE; FEVER; MEN		[Ninan, Sean] Calderdale Royal Hosp, Salterhebble HX3 0PW, Halifax, England; [Walton, Carly] Pinderfields Gen Hosp, Wakefield WF4 1DG, W Yorkshire, England; [Barlow, Gavin] Castle Hill Hosp, Dept Infect & Trop Med, Kingston Upon Hull HU16 5JQ, N Humberside, England	Pinderfields Hospital; University of Hull	Ninan, S (corresponding author), Calderdale Royal Hosp, Salterhebble HX3 0PW, Halifax, England.	sean.ninan@nhs.net						ABRUTYN E, 1994, ANN INTERN MED, V120, P827, DOI 10.7326/0003-4819-120-10-199405150-00003; [Anonymous], 2012, MAN SUSP BACT UR TRA; BOSCIA JA, 1986, AM J MED, V81, P979, DOI 10.1016/0002-9343(86)90391-8; BOSCIA JA, 1989, ANN INTERN MED, V110, P404, DOI 10.7326/0003-4819-110-5-404; Cai T, 2012, CLIN INFECT DIS, V55, P771, DOI 10.1093/cid/cis534; Cormican M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4780; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876; Graham JC, 2001, J CLIN PATHOL, V54, P911, DOI 10.1136/jcp.54.12.911; Juthani-Mehta M, 2005, J AM GERIATR SOC, V53, P1986, DOI 10.1111/j.1532-5415.2005.00470.x; Juthani-Mehta M, 2007, INFECT CONT HOSP EP, V28, P889, DOI 10.1086/518752; Juthani-Mehta M, 2009, J AM GERIATR SOC, V57, P963, DOI 10.1111/j.1532-5415.2009.02227.x; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; LIPSKY BA, 1987, J INFECT DIS, V155, P847, DOI 10.1093/infdis/155.5.847; Liu A, 2010, AGE AGEING, V39, P559, DOI 10.1093/ageing/afq067; National Institute for Health and Clinical Excellence National Clinical Guideline Centre, 2010, DEL DIAGN PREV MAN; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; NICOLLE LE, 1987, AM J MED, V83, P27, DOI 10.1016/0002-9343(87)90493-1; Norman DC, 2000, CLIN INFECT DIS, V31, P148, DOI 10.1086/313896; OUSLANDER JG, 1987, ARCH INTERN MED, V147, P286, DOI 10.1001/archinte.147.2.286; OUSLANDER JG, 1995, ANN INTERN MED, V122, P749, DOI 10.7326/0003-4819-122-10-199505150-00003; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802; WASSERMAN M, 1989, J AM GERIATR SOC, V37, P537, DOI 10.1111/j.1532-5415.1989.tb05686.x; Wester AL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-346; Woodford HJ, 2009, J AM GERIATR SOC, V57, P107, DOI 10.1111/j.1532-5415.2008.02073.x; [No title captured]; [No title captured]	27	21	22	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g4070	10.1136/bmj.g4070	http://dx.doi.org/10.1136/bmj.g4070			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24994808				2022-12-28	WOS:000338646100002
J	Bloomfield, HE; Olson, A; Greer, N; Cantor, A; MacDonald, R; Rutks, I; Wilt, TJ				Bloomfield, Hanna E.; Olson, Andrew; Greer, Nancy; Cantor, Amy; MacDonald, Roderick; Rutks, Indulis; Wilt, Timothy J.			Screening Pelvic Examinations in Asymptomatic, Average-Risk Adult Women: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; OVARIAN-CANCER; INFLAMMATORY-DISEASE; GYNECOLOGIC EXAMINATION; PAP-SMEAR; ATTITUDES; TRAUMA; PAIN; CARE	Background: Pelvic examination is often included in well-woman visits even when cervical cancer screening is not required. Purpose: To evaluate the diagnostic accuracy, benefits, and harms of pelvic examination in asymptomatic, nonpregnant, average-risk adult women. Cervical cancer screening was not included. Data Sources: MEDLINE and Cochrane databases through January 2014 and reference lists from identified studies. Study Selection: 52 English-language studies, 32 of which included primary data. Data Extraction: Data were extracted on study and sample characteristics, interventions, and outcomes. Quality of the diagnostic accuracy studies was evaluated using a published instrument, and quality of the survey studies was evaluated with metrics assessing population representativeness, instrument development, and response rates. Data Synthesis: The positive predictive value of pelvic examination for detecting ovarian cancer was less than 4% in the 2 studies that reported this metric. No studies that investigated the morbidity or mortality benefits of screening pelvic examination for any condition were identified. The percentage of women reporting pelvic examination-related pain or discomfort ranged from 11% to 60% (median, 35%; 8 studies [n = 4576]). Corresponding figures for fear, embarrassment, or anxiety ranged from 10% to 80% (median, 34%; 7 studies [n = 10 702]). Limitation: Only English-language publications were included; the evidence on diagnostic accuracy, morbidity, and mortality was scant; and the studies reporting harms were generally low quality. Conclusion: No data supporting the use of pelvic examination in asymptomatic, average-risk women were found. Low-quality data suggest that pelvic examinations may cause pain, discomfort, fear, anxiety, or embarrassment in about 30% of women.	Minneapolis Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Cantor, Amy] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Oregon Health & Science University	Bloomfield, HE (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr,Mail Code 151, Minneapolis, MN 55417 USA.	Hanna.Bloomfield@va.gov		Cantor, Amy/0000-0002-4467-8484; Olson, Andrew/0000-0002-7226-5783; bloomfield, hanna/0000-0002-0756-7064	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	Primary Funding Source: Department of Veterans Affairs.	ADAMS CH, 1993, WOMEN HEALTH, V20, P45, DOI 10.1300/J013v20n02_04; Adonakis GL, 1996, EUR J OBSTET GYN R B, V65, P221, DOI 10.1016/0301-2115(95)02369-0; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; [Anonymous], 2011, Obstet Gynecol, V117, P742, DOI 10.1097/AOG.0b013e31821477db; Armstrong L, 2012, EUR J CONTRACEP REPR, V17, P307, DOI 10.3109/13625187.2012.672665; Berkowitz Z, 2013, JAMA INTERN MED, V173, P922, DOI 10.1001/jamainternmed.2013.368; Blake D R, 2003, J Pediatr Adolesc Gynecol, V16, P25, DOI 10.1016/S1083-3188(02)00207-3; Bourne PA, 2010, N AM J MED SCI, V2, P478, DOI 10.4297/najms.2010.2478; BROADMORE J, 1986, NEW ZEAL MED J, V99, P8; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; CDC, 2010, GUIDELINES TREATMENT; Committee on Gynecologic Practice, 2012, Obstet Gynecol, V120, P421, DOI 10.1097/AOG.0b013e3182680517; Deeks JJ., 2009, COCHRANE DATABASE SY; Farley MS, 2002, J FAM PRACTICE, V51, P827; Fiddes P, 2003, CONTRACEPTION, V67, P313, DOI 10.1016/S0010-7824(02)00540-1; Fisher LD, 2004, CLIN PEDIATR, V43, P153, DOI 10.1177/000992280404300204; Goldshore M, 2013, AM J OBSTET GYNECOL, V208, pS166, DOI 10.1016/j.ajog.2012.10.543; Golomb D, 1983, R I Med J, V66, P281; Gray-Swain MR, 2006, CURR OPIN OBSTET GYN, V18, P503, DOI 10.1097/01.gco.0000242952.87125.69; GROVER SR, 1995, MED J AUSTRALIA, V162, P408, DOI 10.5694/j.1326-5377.1995.tb139967.x; HAAR E, 1977, MED CARE, V15, P787, DOI 10.1097/00005650-197709000-00006; Harper C, 2001, FAM PLANN PERSPECT, V33, P13, DOI 10.2307/2673737; HESSELIUS I, 1975, SCAND J SOC MED, V3, P129, DOI 10.1177/140349487500300304; Hilden M, 2003, ACTA OBSTET GYN SCAN, V82, P1030; Hoyo C, 2005, PREV MED, V41, P439, DOI 10.1016/j.ypmed.2004.11.021; JACOBS I, 1988, LANCET, V1, P268; Johnson Robert E, 2002, MMWR Recomm Rep, V51, P1; Kahn JA, 2003, OBSTET GYNECOL, V101, P490, DOI 10.1016/S0029-7844(02)02592-9; Lang AJ, 2003, BEHAV MED, V28, P150, DOI 10.1080/08964280309596053; Lee TT, 2007, J WOMENS HEALTH, V16, P1291, DOI 10.1089/jwh.2006.0208; Leeners B, 2007, PSYCHOSOMATICS, V48, P385, DOI 10.1176/appi.psy.48.5.385; LeFevre ML, 2013, JAMA INTERN MED, V173, P856, DOI 10.1001/jamainternmed.2013.535; Mehrotra A, 2007, ARCH INTERN MED, V167, P1876, DOI 10.1001/archinte.167.17.1876; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Morgan RJ, 2012, J NATL COMPR CANC NE, V10, P1339, DOI 10.6004/jnccn.2012.0140; Morioka-Douglas N, 2013, JAMA INTERN MED, V173, P855, DOI 10.1001/jamainternmed.2013.316; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Munday PE, 2000, J INFECTION, V40, P31, DOI 10.1053/jinf.1999.0609; OSOFSKY HJ, 1967, OBSTET GYNECOL, V30, P146; Perkins RB, 2013, AM J PREV MED, V45, P175, DOI 10.1016/j.amepre.2013.03.019; PETRAVAGE JB, 1979, J FAM PRACTICE, V9, P1039; Robohm JS, 1996, WOMEN HEALTH, V24, P59; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Satterwhite C. L., 2011, Morbidity and Mortality Weekly Report, V60, P370; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Smith RA, 2011, CA-CANCER J CLIN, V61, P8, DOI 10.3322/caac.20096; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; STACEY CM, 1994, INT J STD AIDS, V5, P338, DOI 10.1177/095646249400500510; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; Stewart RA, 2008, AUST FAM PHYSICIAN, V37, P493; Stormo AR, 2011, ARCH INTERN MED, V171, P2053, DOI 10.1001/archinternmed.2011.575; Stormo AR, 2012, PREV MED, V54, P415, DOI 10.1016/j.ypmed.2012.03.012; Taylor VM, 2004, CANCER EPIDEM BIOMAR, V13, P613; Watson-Johnson LC, 2012, J WOMENS HEALTH, V21, P17, DOI 10.1089/jwh.2011.2751; Weitlauf JC, 2010, J WOMENS HEALTH, V19, P1271, DOI 10.1089/jwh.2009.1673; Weitlauf JC, 2008, OBSTET GYNECOL, V112, P1343, DOI 10.1097/AOG.0b013e31818e4678; Westhoff CL, 2011, J WOMENS HEALTH, V20, P5, DOI 10.1089/jwh.2010.2349; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wijma B, 1998, ACTA OBSTET GYN SCAN, V77, P422, DOI 10.1034/j.1600-0412.1998.770411.x; Yu CKH, 1998, BRIT J FAM PLAN, V23, P127	62	40	43	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					46	+		10.7326/M13-2881	http://dx.doi.org/10.7326/M13-2881			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24979449				2022-12-28	WOS:000338419700005
J	Berridge, V				Berridge, Virginia			Electronic cigarettes and history	LANCET			English	Editorial Material							TOBACCO; SMOKING		London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Hist Publ Hlth, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Berridge, V (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Hist Publ Hlth, London WC1H 9SH, England.	Virginia.Berridge@lshtm.ac.uk		berridge, virginia/0000-0001-8011-8348				Anderson S, 2007, ADDICTION, V102, P704, DOI 10.1111/j.1360-0443.2007.01790.x; Berridge V., 2007, MARKETING HLTH SMOKI; Berridge V., 2013, DEMONS OUR CHANGING; Houses of Parliament Parliamentary Office of Science and Technology, 2014, POSTNOTE, V455, P1; Parascandola M, 2005, NICOTINE TOB RES, V7, P779, DOI 10.1080/14622200500262584; Williams -Alvarez J., 2014, WHAT YOU NEED KNOW L	6	14	14	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2204	2205		10.1016/S0140-6736(14)61074-6	http://dx.doi.org/10.1016/S0140-6736(14)61074-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24983089				2022-12-28	WOS:000338657600013
J	Costandi, M				Costandi, Moheb			REHABILITATION Machine recovery	NATURE			English	Editorial Material							ROBOT-ASSISTED THERAPY; UPPER-LIMB IMPAIRMENT; STROKE											Burgar CG, 2011, J REHABIL RES DEV, V48, P445, DOI 10.1682/JRRD.2010.04.0062; Jarrasse N., 2013, IEEE INT C REH ROB; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Lambercy O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-63; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Taheri H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-10; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442	9	8	8	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S8	S9		10.1038/510S8a	http://dx.doi.org/10.1038/510S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964027				2022-12-28	WOS:000337806300006
J	Fukushima, FB; Bezerra, DM; Boas, PJFV; Valle, AP; Vidal, EIO				Fukushima, Fernanda B.; Bezerra, Dailson M.; Villas Boas, Paulo J. F.; Valle, Adriana P.; Vidal, Edison I. O.			Complex regional pain syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fukushima, Fernanda B.; Bezerra, Dailson M.] Univ Estadual Paulista UNESP, Dept Anesthesiol, BR-18618970 Botucatu, SP, Brazil; [Villas Boas, Paulo J. F.; Valle, Adriana P.; Vidal, Edison I. O.] Univ Estadual Paulista UNESP, Dept Internal Med, BR-18618970 Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Fukushima, FB (corresponding author), Univ Estadual Paulista UNESP, Dept Anesthesiol, BR-18618970 Botucatu, SP, Brazil.	ffukushima@fmb.unesp.br	Valle, Adriana P/F-9897-2014; Fukushima, Fernanda Bono/E-3196-2012; Valle, Adriana/ABI-5894-2020; Boas, Paulo J F Villas/I-4656-2014; Fukushima, Fernanda Bono/AAR-2740-2021; Vidal, Edison Iglesias de Oliveira/G-1882-2012	Valle, Adriana P/0000-0002-0090-8524; Fukushima, Fernanda Bono/0000-0001-8055-5425; Boas, Paulo J F Villas/0000-0001-9876-3222; Vidal, Edison Iglesias de Oliveira/0000-0002-1573-4678				Albazaz R, 2008, ANN VASC SURG, V22, P297, DOI 10.1016/j.avsg.2007.10.006; Allen G, 1999, PAIN, V80, P539, DOI 10.1016/S0304-3959(98)00246-2; Beerthuizen A, 2012, PAIN, V153, P1187, DOI 10.1016/j.pain.2012.01.026; Centre for Clinical Practice at NICE (UK)-National Institute for Health and Care Excellence: Clinical Guidelines, 2010, NEUR PAIN PHARM MAN; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Goebel A, 2012, COMPLEX REGIONAL PAI; Harden RN, 2013, PAIN MED, V14, P180, DOI 10.1111/pme.12033; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; International Association for the Study of Pain, CLASSIFICATION CHRON; Marinus Johan, 2011, Lancet Neurol, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; Moseley GL, 2014, J PAIN, V15, P16, DOI 10.1016/j.jpain.2013.08.009; O'Connell NE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009416.pub2; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4	15	8	9	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2014	348								g3683	10.1136/bmj.g3683	http://dx.doi.org/10.1136/bmj.g3683			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UK	24965221	Green Published			2022-12-28	WOS:000338202200001
J	Das, P; Sotomayor, G				Das, Pamela; Sotomayor, Gabriela			WHO and the media: a major impediment to global health?	LANCET			English	Editorial Material									[Das, Pamela] The Lancet, London NW1 7BY, England; [Sotomayor, Gabriela] Assoc Correspondants Aupres Nations Unies, Geneva, Switzerland		Das, P (corresponding author), The Lancet, London NW1 7BY, England.	pamela.das@lancet.com						[Anonymous], 2014, WHO M INT HLTH REG E; Clift C., 2014, WHATS WHO FINAL REPO; Kelland K, 2014, REUTERS         0522; Moghtader M, 2014, REUTERS         0527; Nebehay S, 2014, REUTERS         0528; World Health Organization, 2014, 67 WORLD HLTH ASS PR	6	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2102	2104		10.1016/S0140-6736(14)60854-0	http://dx.doi.org/10.1016/S0140-6736(14)60854-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24928807	Green Published, Bronze			2022-12-28	WOS:000337906600005
J	Feldman, DE				Feldman, D. E.			Electronically erased	SCIENCE			English	Editorial Material							DELAYED-CHOICE EXPERIMENT; QUANTUM ERASER		Brown Univ, Dept Phys, Providence, RI 02912 USA	Brown University	Feldman, DE (corresponding author), Brown Univ, Dept Phys, Providence, RI 02912 USA.	dmitri_feldman@brown.edu						HERZOG TJ, 1995, PHYS REV LETT, V75, P3034, DOI 10.1103/PhysRevLett.75.3034; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Kaiser F, 2012, SCIENCE, V338, P637, DOI 10.1126/science.1226755; Kang K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125326; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; KWIAT PG, 1992, PHYS REV A, V45, P7729, DOI 10.1103/PhysRevA.45.7729; Ma XS, 2013, P NATL ACAD SCI USA, V110, P1221, DOI 10.1073/pnas.1213201110; Peruzzo A, 2012, SCIENCE, V338, P634, DOI 10.1126/science.1226719; SCULLY MO, 1982, PHYS REV A, V25, P2208, DOI 10.1103/PhysRevA.25.2208; Weisz E, 2014, SCIENCE, V344, P1363, DOI 10.1126/science.1248459	10	1	1	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1344	1345		10.1126/science.1255501	http://dx.doi.org/10.1126/science.1255501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948723				2022-12-28	WOS:000337531700020
J	Danser, AHJ; Anand, P				Danser, A. H. Jan; Anand, Praveen			The Angiotensin II Type 2 Receptor for Pain Control	CELL			English	Editorial Material							INHIBITION	All well-known deleterious effects of angiotensin (Ang) II, including vasoconstriction, inflammation, water and salt retention, and vascular remodeling, are mediated via its type 1 (AT(1)) receptor. This explains why AT(1) receptor blockers (ARBs) and inhibitors of Ang II synthesis, such as ACE inhibitors and renin inhibitors, are beneficial for cardiovascular disease. Yet, Ang II has a second receptor, the Ang II type 2 (AT(2)) receptor, the function of which, even after over 20 years of research, remains largely unknown. In this issue, Marion et al. provide a new chapter to the AT(2) receptor story.	[Danser, A. H. Jan] Erasmus MC, Dept Internal Med, Div Pharmacol & Vasc Med, NL-3015 CN Rotterdam, Netherlands; [Anand, Praveen] Imperial Coll London, Ctr Clin Translat, Div Brain Sci, London W12 0NN, England	Erasmus University Rotterdam; Erasmus MC; Imperial College London	Danser, AHJ (corresponding author), Erasmus MC, Dept Internal Med, Div Pharmacol & Vasc Med, NL-3015 CN Rotterdam, Netherlands.	a.danser@erasmusmc.nl	Danser, Jan/GLR-1479-2022					Anand U, 2013, EUR J PAIN, V17, P1012, DOI 10.1002/j.1532-2149.2012.00269.x; Hall BS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004061; Marion E, 2014, CELL, V157, P1565, DOI 10.1016/j.cell.2014.04.040; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Rice ASC, 2014, LANCET, V383, P1637, DOI 10.1016/S0140-6736(13)62337-5; Rompe F, 2010, HYPERTENSION, V55, P924, DOI 10.1161/HYPERTENSIONAHA.109.147843; Verdonk K, 2012, EXPERT OPIN INV DRUG, V21, P501, DOI 10.1517/13543784.2012.664131; Zavattaro E, 2012, HISTOPATHOLOGY, V61, P224, DOI 10.1111/j.1365-2559.2012.04206.x	8	23	25	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1504	1506		10.1016/j.cell.2014.05.030	http://dx.doi.org/10.1016/j.cell.2014.05.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949962	Bronze			2022-12-28	WOS:000340941900005
J	Palmer, JC; Martelli, F; Liu, Y; Car, R; Panagiotopoulos, AZ; Debenedetti, PG				Palmer, Jeremy C.; Martelli, Fausto; Liu, Yang; Car, Roberto; Panagiotopoulos, Athanassios Z.; Debenedetti, Pablo G.			Metastable liquid-liquid transition in a molecular model of water	NATURE			English	Article							SUPERCOOLED WATER; HEAT-CAPACITY; CUBIC ICE; ST2 WATER; ENERGY; SIMULATION; DYNAMICS; BEHAVIOR; SINGULARITY; STABILITY	Liquid water's isothermal compressibility(1) and isobaric heat capacity(2), and the magnitude of its thermal expansion coefficient(3), increase sharply on cooling below the equilibrium freezing point. Many experimental(4-8), theoretical(9-11) and computational(12,13) studies have sought to understand the molecular origin and implications of this anomalous behaviour. Of the different theoretical scenarios(9,14,15) put forward, one posits the existence of a first-order phase transition that involves two forms of liquid water and terminates at a critical point located at deeply supercooled conditions(9,12). Some experimental evidence is consistent with this hypothesis(4,16), but no definitive proof of a liquid-liquid transition in water has been obtained to date: rapid ice crystallization has so far prevented decisive measurements on deeply supercooled water, although this challenge has been overcome recently(16). Computer simulations are therefore crucial for exploring water's structure and behaviour in this regime, and have shown(13,17-21) that some water models exhibit liquid-liquid transitions and others do not. However, recent work(22,23) has argued that the liquid-liquid transition has been mistakenly interpreted, and is in fact a liquid-crystal transition in all atomistic models of water. Here we show, by studying the liquid-liquid transition in the ST2 model of water(24) with the use of six advanced sampling methods to compute the free-energy surface, that two metastable liquid phases and a stable crystal phase exist at the same deeply supercooled thermodynamic condition, and that the transition between the two liquids satisfies the thermodynamic criteria of a first-order transition(25). We follow the rearrangement of water's coordination shell and topological ring structure along a thermodynamically reversible path from the low-density liquid to cubic ice(26). We also show that the system fluctuates freely between the two liquid phases rather than crystallizing. These findings provide unambiguous evidence for a liquid-liquid transition in the ST2 model of water, and point to the separation of time scales between crystallization and relaxation as being crucial for enabling it.	[Palmer, Jeremy C.; Liu, Yang; Panagiotopoulos, Athanassios Z.; Debenedetti, Pablo G.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Martelli, Fausto; Car, Roberto] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Debenedetti, PG (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	pdebene@princeton.edu	Debenedetti, Pablo/ABD-1497-2021; Panagiotopoulos, Athanassios Z/K-2955-2014; Martelli, Fausto/A-6148-2017	Debenedetti, Pablo/0000-0003-1881-1728; Panagiotopoulos, Athanassios Z/0000-0002-8152-6615; Martelli, Fausto/0000-0002-5350-8225	National Science Foundation [CHE 1213343]; US Department of Energy [DE-SC0002128, DE-SC0008626]; Direct For Mathematical & Physical Scien [1213343] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Computations were performed at the Terascale Infrastructure for Groundbreaking Research in Engineering and Science (TIGRESS) facility at Princeton University. P.G.D. acknowledges support from the National Science Foundation (CHE 1213343), A.Z.P. acknowledges support from the US Department of Energy (DE-SC0002128), and R.C. acknowledges support from the US Department of Energy (DE-SC0008626).	Amann-Winkel K, 2013, P NATL ACAD SCI USA, V110, P17720, DOI 10.1073/pnas.1311718110; ANGELL CA, 1982, J PHYS CHEM-US, V86, P998, DOI 10.1021/j100395a032; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Choukroun M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3487520; Choukroun M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768957; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; Frenkel D., 2000, UNDERSTANDING MOL SI; Gee J, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3551576; HANDA YP, 1986, J CHEM PHYS, V84, P7009, DOI 10.1063/1.450622; Handel R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036104; HARE DE, 1986, J CHEM PHYS, V84, P5085, DOI 10.1063/1.450660; Holten V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00713; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; HUNTER JE, 1995, J CHEM PHYS, V103, P8627, DOI 10.1063/1.470121; Kesselring TA, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808355; KING SV, 1967, NATURE, V213, P1112, DOI 10.1038/2131112a0; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEE JY, 1990, PHYS REV LETT, V65, P137, DOI 10.1103/PhysRevLett.65.137; Li YP, 2013, P NATL ACAD SCI USA, V110, P12209, DOI 10.1073/pnas.1309042110; Limmer DT, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4807479; Limmer DT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643333; Liu Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769126; Liu Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3229892; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; MAYER E, 1987, NATURE, V325, P601, DOI 10.1038/325601a0; MCMILLAN JA, 1965, NATURE, V206, P806, DOI 10.1038/206806a0; Miller TF, 2002, J CHEM PHYS, V116, P8649, DOI 10.1063/1.1473654; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; Moore EB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3451112; Overduin SD, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803868; Palmer J. C., 2013, FARADAY DISCUSS, V167, P118; Palmer JC, 2013, FARADAY DISCUSS, V167, P77, DOI 10.1039/c3fd00074e; Poole PH, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4775738; POOLE PH, 1994, PHYS REV LETT, V73, P1632, DOI 10.1103/PhysRevLett.73.1632; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Reinhardt A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4766362; ROSSKY PJ, 1978, J CHEM PHYS, V69, P4628, DOI 10.1063/1.436415; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Shilling JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026671; Shiratani E, 1998, J CHEM PHYS, V108, P3264, DOI 10.1063/1.475723; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P982, DOI 10.1021/j100395a030; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; STILLINGER FH, 1974, J CHEM PHYS, V60, P1545, DOI 10.1063/1.1681229; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tanaka H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064202; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vega C, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715577; WEBER TA, 1984, J CHEM PHYS, V80, P438, DOI 10.1063/1.446468; Winkel K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2830029; YAMAMURO O, 1987, J PHYS CHEM SOLIDS, V48, P935, DOI 10.1016/0022-3697(87)90130-2	57	359	362	16	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					385	+		10.1038/nature13405	http://dx.doi.org/10.1038/nature13405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24943954				2022-12-28	WOS:000337350200032
J	Regot, S; Hughey, JJ; Bajar, BT; Carrasco, S; Covert, MW				Regot, Sergi; Hughey, Jacob J.; Bajar, Bryce T.; Carrasco, Silvia; Covert, Markus W.			High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells	CELL			English	Article							PROTEIN-PHOSPHORYLATION; FRET BIOSENSORS; GROWTH-FACTOR; DYNAMICS; ACTIVATION; REPORTERS; DECISION; PATHWAY; SIGNALS; BRIGHT	Increasing evidence has shown that population dynamics are qualitatively different from single-cell behaviors. Reporters to probe dynamic, single-cell behaviors are desirable yet relatively scarce. Here, we describe an easy-to-implement and generalizable technology to generate reporters of kinase activity for individual cells. Our technology converts phosphorylation into a nucleocytoplasmic shuttling event that can be measured by epifluorescence microscopy. Our reporters reproduce kinase activity for multiple types of kinases and allow for calculation of active kinase concentrations via a mathematical model. Using this technology, we made several experimental observations that had previously been technically-unfeasible, including stimulus-dependent patterns of c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappa B) activation. We also measured JNK, p38, and ERK activities simultaneously, finding that p38 regulates the peak number, but not the intensity, of ERK fluctuations. Our approach opens the possibility of analyzing a wide range of kinase-mediated processes in individual cells.	[Regot, Sergi; Hughey, Jacob J.; Bajar, Bryce T.; Carrasco, Silvia; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Regot, S (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	sregot@stanford.edu; mcovert@stanford.edu		Covert, Markus/0000-0002-5993-8912; Regot, Sergi/0000-0001-9786-3897; Hughey, Jacob/0000-0002-1558-6089; Bajar, Bryce/0000-0002-0169-0870	Human Frontier Science Program (HFSP) postdoctoral fellowship [LT000529/2012-L]; NIH [5R21AI104305-02, 5DP1LM01150-05]; Stanford Center for Systems Biology [NIH P50GM107615]; Allen Distinguished Investigator Award; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R18DP001150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI104305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM011510] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006413] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP) postdoctoral fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Center for Systems Biology; Allen Distinguished Investigator Award; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Collins and members of the Covert lab, in particular D. Macklin, for helpful discussions and comments on the manuscript. We thank Dr. K. Aoki for providing the FRET-based JNKAR plasmid. We also gratefully acknowledge a Human Frontier Science Program (HFSP) postdoctoral fellowship (LT000529/2012-L) to S.R., as well as an NIH R21 (5R21AI104305-02), an NIH Pioneer Award (5DP1LM01150-05), the Stanford Center for Systems Biology (NIH P50GM107615), and an Allen Distinguished Investigator Award to M.W.C. S.R., J.J.H., and M.W.C. are listed as inventors in a patent application for KTR technology.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Jensen KJ, 2013, CELL HOST MICROBE, V13, P67, DOI 10.1016/j.chom.2012.11.009; Joaquin M, 2012, EMBO J, V31, P2952, DOI 10.1038/emboj.2012.122; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	36	286	288	2	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1724	1734		10.1016/j.cell.2014.04.039	http://dx.doi.org/10.1016/j.cell.2014.04.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949979	Green Accepted, Bronze			2022-12-28	WOS:000340941900024
J	Stenhouse, G; Ulbricht, C; Khanna, M				Stenhouse, G.; Ulbricht, C.; Khanna, M.			Spinal injury in ankylosing spondylitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VERTEBRAL FRACTURES; COMPLICATIONS; TRAUMA		[Stenhouse, G.; Ulbricht, C.; Khanna, M.] Imperial Coll Healthcare NHS Trust, Dept Radiol, London W2 1NY, England	Imperial College London	Stenhouse, G (corresponding author), Imperial Coll Healthcare NHS Trust, Dept Radiol, London W2 1NY, England.	gregors45@gmail.com						Anwar F, 2011, EUR SPINE J, V20, P403, DOI 10.1007/s00586-010-1628-y; Caron T, 2010, SPINE, V35, pE458, DOI 10.1097/BRS.0b013e3181cc764f; Clarke A, 2010, ACTA ORTHOP BELG, V76, P413; College of Emergency Medicine, 2010, GUID MAN AL AD PAT P; DENIS F, 1984, CLIN ORTHOP RELAT R, P65; Finkelstein JA, 1999, SPINAL CORD, V37, P444, DOI 10.1038/sj.sc.3100837; Lu GH, 2009, CHIN J TRAUMATOL, V12, P148, DOI 10.3760/cma.j.issn.1008-1275.2009.03.005; Magrey Marina, 2010, Curr Rheumatol Rep, V12, P332, DOI 10.1007/s11926-010-0122-1; Mundwiler ML, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/1/E6; National Institute for Health and Care Excellence, 2014, HEAD INJ CG176; Payer M, 2006, J CLIN NEUROSCI, V13, P73, DOI 10.1016/j.jocn.2005.02.010; Sanchez B, 2005, J TRAUMA, V59, P179, DOI 10.1097/01.TA.0000171449.94650.81; Sapkas G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-96; Vosse D, 2004, J RHEUMATOL, V31, P1981; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0	15	2	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g3849	10.1136/bmj.g3849	http://dx.doi.org/10.1136/bmj.g3849			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24934727				2022-12-28	WOS:000337804300012
J	ten Hoope-Bender, P; de Bernis, L; Campbell, J; Downe, S; Fauveau, V; Fogstad, H; Homer, CSE; Kennedy, HP; Matthews, Z; McFadden, A; Renfrew, MJ; Van Lerberghe, W				ten Hoope-Bender, Petra; de Bernis, Luc; Campbell, James; Downe, Soo; Fauveau, Vincent; Fogstad, Helga; Homer, Caroline S. E.; Kennedy, Holly Powell; Matthews, Zoe; McFadden, Alison; Renfrew, Mary J.; Van Lerberghe, Wim			Improvement of maternal and newborn health through midwifery	LANCET			English	Article							EFFECTIVE COVERAGE; GLOBAL HEALTH; CARE; INTERVENTIONS; AFGHANISTAN; STRENGTHEN; RETENTION; FRAMEWORK; POST-2015; MORTALITY	In the concluding paper of this Series about midwifery, we look at the policy implications from the framework for quality maternal and newborn care, the potential effect of life-saving interventions that fall within the scope of practice of midwives, and the historic sequence of health system changes that made a reduction in maternal mortality possible in countries that have expanded their midwifery workforce. Achievement of better health outcomes for women and newborn infants is possible, but needs improvements in the quality of reproductive, maternal, and newborn care, alongside necessary increases in universal coverage. In this report, we propose three priority research areas and outline how national investment in midwives and in their work environment, education, regulation, and management can improve quality of care. Midwifery and midwives are crucial to the achievement of national and international goals and targets in reproductive, maternal, newborn, and child health; now and beyond 2015.	[ten Hoope-Bender, Petra; Campbell, James] Inst Cooperac Social Integrare, Barcelona 08007, Spain; [de Bernis, Luc] UN Populat Fund, Geneva, Switzerland; [Downe, Soo] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England; [Fauveau, Vincent] Holist Sante, Montpellier, France; [Fogstad, Helga] Norwegian Agcy Dev Cooperat, Oslo, Norway; [Homer, Caroline S. E.] Univ Technol, Fac Hlth, Sydney, NSW, Australia; [Kennedy, Holly Powell] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Matthews, Zoe] Univ Southampton, Southampton, Hants, England; [McFadden, Alison; Renfrew, Mary J.] Univ Dundee, Coll Med Dent & Nursing, Sch Nursing & Midwifery, Mother & Infant Res Unit, Dundee, Scotland; [Van Lerberghe, Wim] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark	United Nations Population Fund; University of Central Lancashire; University of Technology Sydney; Yale University; University of Southampton; University of Dundee; World Health Organization	ten Hoope-Bender, P (corresponding author), Inst Cooperac Social Integrare, Barcelona 08007, Spain.	petra.tenhoope@integrare.es	Matthews, Zoe/HGD-0506-2022; Homer, Caroline/J-2101-2014	Renfrew, Mary/0000-0003-2905-403X; Matthews, Zoe/0000-0003-1533-6618; Homer, Caroline/0000-0002-7454-3011; McFadden, Alison/0000-0002-5164-2025	Bill & Melinda Gates Foundation [OPP1042500]; University of Dundee; Instituto de Cooperacion Social Integrare	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Dundee; Instituto de Cooperacion Social Integrare	The work on this paper was supported partly through a grant from the Bill & Melinda Gates Foundation (grant number OPP1042500). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers or the Bill & Melinda Gates Foundation. MJR's work was supported by the University of Dundee. PtH-B's work was supported by the Instituto de Cooperacion Social Integrare. Maria Guerra Arias managed and checked all the references. Thomson Prentice edited sections of the first draft. Joanne McManus edited the second draft. Administrative support was provided by Jenny Brown and Tracy Sparey, and Natalie Muir provided project support. We thank all series co-authors, dose readers, and the reviewers from ICM, FIGO, WHO, and the Bill & Melinda Gates Foundation for their contributions and support.	Abe Eghe, 2008, Afr J Reprod Health, V12, P17; [Anonymous], 1986, WHO CHRON, V40, P175; [Anonymous], 2012, UNICEF PROGR REPORT; [Anonymous], 2011, GLOB REV KEY INT REL; [Anonymous], 2008, PRIM HLTH CAR NOW MO; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Bhutta Z, 2010, LANCET, V376, P1375; Bowser D, 2010, EXPLORING EVIDENCE D; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Campbell, 2013, UNIVERSAL TRUTH NO H; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Campbell J, 2013, LANCET, V381, P725, DOI 10.1016/S0140-6736(13)60579-6; Colston J., 2011, USE EFFECTIVE COVERA; Ebener S, 2013, 5 INT C HLTH BANGK T; Evans T., 2013, VAL MON ASS COMM BAS; Family Planning 2020, 2012, LOND SUMM FAM PLANN; Gibbons L, 2010, GLOBAL NUMBERS COSTS; Global Alliance for Vaccine and Immunization (GAVI), IMM IS ON MOST COST; Hassan-Bitar S, 2011, MIDWIFERY, V27, P154, DOI 10.1016/j.midw.2009.05.007; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, NEW GLOB PARTN ER PO; Homer CSE, 2014, LANCET; Horton R, 2013, LANCET, V382, P382, DOI 10.1016/S0140-6736(13)61641-4; ICM, 2011, ICM INT DEF MIDW; ILO, 2012, INT STAND CLASS OCC, V1; Independent Expert Review Group (iERG), 2013, EV WOM EV CHILD STRE; Info MME, 2013, MAL MAT MORT EST 201; International Confederation of midwives (ICM), 2013, ESS COMP BAS MIDW PR; Jaffre Y, 2003, B AMADES, V56, P639; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2014, BUSTING MYTHS DO HLT; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; Langer A, 2013, LANCET, V381, P601, DOI 10.1016/S0140-6736(13)60259-7; Lawn JE, 2011, LANCET; Leap N., 2009, BRIT J MIDWIFERY, V17, P12, DOI [10.12968/bjom.2009.17.1.37646, DOI 10.12968/BJOM.2009.17.1.37646]; Lemiere C, 2011, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8599-9; Lemiere C, 2014, PRINC MAH AW C 2014; Mansoor GF, 2013, MIDWIFERY, V29, P1088, DOI 10.1016/j.midw.2013.07.021; Montenegro H, 2012, INT J PERS CENT MED, V2, P93; Ngwenya BN, 2011, HEALTH CARE WOMEN IN, V32, P917, DOI 10.1080/07399332.2011.603860; Rath AD, 2007, REPROD HEALTH MATTER, V15, P72, DOI 10.1016/S0968-8080(07)30329-7; Renfrew MJ, 2014, LANCET; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Schaaf M, 2013, HLTH POLICY PLAN, DOI [10.1093/heapol/czt09, DOI 10.1093/HEAPOL/CZT09]; Scheffler R., 2012, LABOUR MARKET HUMAN; Shaban I, 2012, MIDWIFERY, V28, P106, DOI 10.1016/j.midw.2010.11.012; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Soucat A, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9555-4; Sousa A, 2013, B WORLD HEALTH ORGAN, V91, P892, DOI 10.2471/BLT.13.118927; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; ten Hoope-Bender P, 2011, INT J GYNECOL OBSTET, V114, P211, DOI 10.1016/j.ijgo.2011.06.002; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNFPA, 2011, STAT WORLDS MIDW 201; UNFPA, 2014, STAT WORLDS MIDW 201; United Nations Fund for Population Activities (UNFPA), 2014, FRAM ACT FOLL UP PRO; United Nations Human Rights Council, 2011, PRACT AD HUM RIGHTS; United Nations - Department of Economic and Social Affairs - Population Division, 2012, WORLD POP PROSP 2012; Van Lerberghe W, 2014, LANCET; van Teijlingen E, 2014, MIDWIFERY, V30, P1, DOI 10.1016/j.midw.2013.10.022; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; Vujicic M, 2009, MEASURING HLTH WORKF; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2014, EV NEWB DRAFT ACT PL; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2005, MAK EV MOTH CHILD CO; Wood ME, 2013, MIDWIFERY, V29, P1137, DOI 10.1016/j.midw.2013.07.004; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2000, HLTH SYST IMPR PERF; World Health Organization, 2010, FRAM ACT INT ED COLL; World Health Organization, 2001, BACKGR PAP TECHN CON; World Health Organization, 2010, WORKL IND STAFF NEED; World Health Organization, 2013, WHO GUID 2013; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH; World Health Organization & World Bank, 2013, MON PROGR UN HLTH CO	78	250	251	5	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1226	1235		10.1016/S0140-6736(14)60930-2	http://dx.doi.org/10.1016/S0140-6736(14)60930-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	24965818				2022-12-28	WOS:000343002600029
J	Schapira, AHV; Olanow, CW; Greenamyre, JT; Bezard, E				Schapira, Anthony H. V.; Olanow, C. Warren; Greenamyre, J. Timothy; Bezard, Erwan			Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives	LANCET			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; ALLELE-SELECTIVE INHIBITION; NEURONAL CELL-DEATH; ALPHA-SYNUCLEIN; MUTANT HUNTINGTIN; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; PROTEIN; GLUCOCEREBROSIDASE	Several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease and Huntington's disease. These advances have been informed by both direct analysis of the post-mortem brain and by study of the biological consequences of the genetic causes of these diseases. Some of the pathways that have been implicated so far include mitochondrial dysfunction, oxidative stress, kinase pathways, calcium dysregulation, inflammation, protein handling, and prion-like processes. Intriguingly, these pathways seem to be important in the pathogenesis of both diseases and have led to the identification of molecular targets for candidate interventions designed to slow or reverse their course. We review some recent advances that underlie putative therapies for neuroprotection in Parkinson's disease and Huntington's disease, and potential targets that might be exploited in the future. Although we will need to overcome important hurdles, especially in terms of clinical trial design, we propose several target pathways that merit further study. In Parkinson's disease, these targets include agents that might improve mitochondrial function or increase degradation of defective mitochondria, kinase inhibitors, calcium channel blockers, and approaches that interfere with the misfolding, templating, and transmission of alpha-synuclein. In Huntington's disease, strategies might also be directed at mitochondrial bioenergetics and turnover, the prevention of protein dysregulation, disruption of the interaction between huntingtin and p53 or huntingtin-interacting protein 1 to reduce apoptosis, and interference with expression of mutant huntingtin at both the nucleic acid and protein levels.	[Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London, England; [Olanow, C. Warren] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Olanow, C. Warren] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Greenamyre, J. Timothy] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, F-33000 Bordeaux, France; [Bezard, Erwan] CNRS, Inst Malad Neurodegenerat, F-33000 Bordeaux, France	University of London; University College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS)	Schapira, AHV (corresponding author), UCL, Inst Neurol, Rowland Hill St, London NW3 2PF, England.	a.schapira@ucl.ac.uk	Bezard, Erwan/ABD-5153-2021; Schapira, Anthony H V/A-1245-2010	Schapira, Anthony H V/0000-0002-3018-3966; Bezard, Erwan/0000-0002-0410-4638				Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Alvarez-Fischer D, 2011, NAT NEUROSCI, V14, P1260, DOI 10.1038/nn.2916; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Bano D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.112; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Calamini B, 2013, NEUROTHERAPEUTICS, V10, P400, DOI 10.1007/s13311-013-0195-4; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Choi SA, 2006, FEBS LETT, V580, P5275, DOI 10.1016/j.febslet.2006.08.076; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Cowan CM, 2008, J NEUROSCI, V28, P12725, DOI 10.1523/JNEUROSCI.4619-08.2008; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DeVos SL, 2013, NEUROTHERAPEUTICS, V10, P486, DOI 10.1007/s13311-013-0194-5; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dragalin V, 2011, EUR NEUROPSYCHOPHARM, V21, P153, DOI 10.1016/j.euroneuro.2010.09.004; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hara S, 2013, MOL BIOL CELL, V24, P1649, DOI 10.1091/mbc.E12-12-0903; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hersch SM, 2008, NEUROTHERAPEUTICS, V5, P226, DOI 10.1016/j.nurt.2008.01.003; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Kadkhodaei B, 2013, P NATL ACAD SCI USA, V110, P2360, DOI 10.1073/pnas.1221077110; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kang S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2149; Kaplan A, 2012, PROG NEUROBIOL, V99, P262, DOI 10.1016/j.pneurobio.2012.08.004; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kiechle T, 2002, NEUROMOL MED, V1, P183; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; McNeill A, 2014, BRAIN, V137, P1481, DOI 10.1093/brain/awu020; Messer A, 2013, NEUROTHERAPEUTICS, V10, P447, DOI 10.1007/s13311-013-0193-6; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Okamoto Y, 2009, BIOCHEM BIOPH RES CO, V378, P634, DOI 10.1016/j.bbrc.2008.11.094; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Olanow CW, 2008, ANN NEUROL, V64, pS101, DOI 10.1002/ana.21461; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Paradisi I, 2008, J HUM GENET, V53, P127, DOI 10.1007/s10038-007-0227-1; Peterson AL, 2008, NEUROTHERAPEUTICS, V5, P270, DOI 10.1016/j.nurt.2008.02.003; Popiel HA, 2013, NEUROTHERAPEUTICS, V10, P440, DOI 10.1007/s13311-013-0184-7; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Ramachandran PS, 2013, NEUROTHERAPEUTICS, V10, P473, DOI 10.1007/s13311-013-0183-8; Ramaswamy S, 2009, NEUROBIOL DIS, V34, P40, DOI 10.1016/j.nbd.2008.12.005; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; San Sebastian W, 2013, NEUROTHERAPEUTICS, V10, P498, DOI 10.1007/s13311-013-0191-8; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Schapira AHV, 2004, JAMA-J AM MED ASSOC, V291, P358, DOI 10.1001/jama.291.3.358; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schapira AHV, 2013, CURR OPIN NEUROL, V26, P395, DOI 10.1097/WCO.0b013e3283633741; Schapira AHV, 2013, P NATL ACAD SCI USA, V110, P3214, DOI 10.1073/pnas.1300822110; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Shoulson I, 2007, NEUROLOGY, V69, P1480, DOI 10.1212/01.wnl.0000277648.63931.c0; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Vagner T, 2012, NEUROL RES INT, V2012, P358; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Warby SC, 2011, EUR J HUM GENET, V19, P561, DOI 10.1038/ejhg.2010.229; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	109	278	291	12	163	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					545	555		10.1016/S0140-6736(14)61010-2	http://dx.doi.org/10.1016/S0140-6736(14)61010-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	24954676				2022-12-28	WOS:000340198300033
J	Broer, DJ				Broer, Dirk J.			APPLIED PHYSICS A new view on displays	NATURE			English	Editorial Material							PHASE-CHANGE MEMORY		[Broer, Dirk J.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5612 AZ Eindhoven, Netherlands; [Broer, Dirk J.] Eindhoven Univ Technol, Lab Funct Organ Mat & Devices, NL-5612 AZ Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology	Broer, DJ (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, Den Dolech 2, NL-5612 AZ Eindhoven, Netherlands.	d.broer@tue.nl	Broer, Dirk J/J-2614-2014	Broer, Dirk J/0000-0001-6136-3276				Alfonso C. N., 1992, APPL PHYS LETT, V60, P3123; Fritzsche H, 1972, ANN REV MAT SCI, V2, P697, DOI DOI 10.1146/ANNUREV.MS.02.080172.003405; Hegedus J, 2008, NAT MATER, V7, P399, DOI 10.1038/nmat2157; Hosseini P, 2014, NATURE, V511, P206, DOI 10.1038/nature13487; Simpson RE, 2011, NAT NANOTECHNOL, V6, P501, DOI [10.1038/NNANO.2011.96, 10.1038/nnano.2011.96]; YAMADA N, 1991, J APPL PHYS, V69, P2849, DOI 10.1063/1.348620	6	4	4	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					159	160		10.1038/511159a	http://dx.doi.org/10.1038/511159a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008515				2022-12-28	WOS:000338649800029
J	Kaastra, JS; Kriss, GA; Cappi, M; Mehdipour, M; Petrucci, PO; Steenbrugge, KC; Arav, N; Behar, E; Bianchi, S; Boissay, R; Branduardi-Raymont, G; Chamberlain, C; Costantini, E; Ely, JC; Ebrero, J; Di Gesu, L; Harrison, FA; Kaspi, S; Malzac, J; De Marco, B; Matt, G; Nandra, K; Paltani, S; Person, R; Peterson, BM; Pinto, C; Ponti, G; Nunez, FP; De Rosa, A; Seta, H; Ursini, F; de Vries, CP; Walton, DJ; Whewell, M				Kaastra, J. S.; Kriss, G. A.; Cappi, M.; Mehdipour, M.; Petrucci, P. -O.; Steenbrugge, K. C.; Arav, N.; Behar, E.; Bianchi, S.; Boissay, R.; Branduardi-Raymont, G.; Chamberlain, C.; Costantini, E.; Ely, J. C.; Ebrero, J.; Di Gesu, L.; Harrison, F. A.; Kaspi, S.; Malzac, J.; De Marco, B.; Matt, G.; Nandra, K.; Paltani, S.; Person, R.; Peterson, B. M.; Pinto, C.; Ponti, G.; Nunez, F. Pozo; De Rosa, A.; Seta, H.; Ursini, F.; de Vries, C. P.; Walton, D. J.; Whewell, M.			A fast and long-lived outflow from the supermassive black hole in NGC 5548	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; X-RAY ABSORBER; MULTIWAVELENGTH CAMPAIGN; MASS OUTFLOW; CLUMPY-TORUS; LINE; VARIABILITY; GALAXIES; NGC-5548; WIND	Supermassive black holes in the nuclei of active galaxies expel large amounts of matter through powerful winds of ionized gas. The archetypal active galaxy NGC 5548 has been studied for decades, and high-resolution x-ray and ultraviolet (UV) observations have previously shown a persistent ionized outflow. An observing campaign in 2013 with six space observatories shows the nucleus to be obscured by a long-lasting, clumpy stream of ionized gas not seen before. It blocks 90% of the soft x-ray emission and causes simultaneous deep, broad UV absorption troughs. The outflow velocities of this gas are up to five times faster than those in the persistent outflow, and, at a distance of only a few light days from the nucleus, it may likely originate from the accretion disk.	[Kaastra, J. S.; Mehdipour, M.; Costantini, E.; Ebrero, J.; Di Gesu, L.; de Vries, C. P.] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Kaastra, J. S.] Univ Utrecht, Dept Phys & Astron, NL-3508 TA Utrecht, Netherlands; [Kaastra, J. S.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Kriss, G. A.; Ely, J. C.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Kriss, G. A.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Cappi, M.] Ist Astrofis Spaziale & Fis Cosm IASF Bologna, Ist Nazl Astrofis INAF, I-40129 Bologna, Italy; [Mehdipour, M.; Branduardi-Raymont, G.; Whewell, M.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Petrucci, P. -O.; Ursini, F.] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Petrucci, P. -O.; Ursini, F.] CNRS, IPAG, F-38000 Grenoble, France; [Steenbrugge, K. C.] Univ Catolica Norte, Inst Astron, Casilla 1280, Antofagasta, Chile; [Steenbrugge, K. C.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Arav, N.; Chamberlain, C.] Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA; [Behar, E.; Kaspi, S.] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Bianchi, S.; Matt, G.] Univ Roma Tre, Dipartimento Matemat & Fis, I-00146 Rome, Italy; [Boissay, R.; Paltani, S.] Univ Geneva, Dept Astron, CH-1290 Versoix, Switzerland; [Ebrero, J.] European Space Astron Ctr, E-28691 Madrid, Spain; [Harrison, F. A.; Walton, D. J.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Malzac, J.] Univ Toulouse, UPS, OMP, IRAP, Toulouse, France; [Malzac, J.] CNRS, IRAP, F-31028 Toulouse 4, France; [De Marco, B.; Nandra, K.; Ponti, G.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Peterson, B. M.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Peterson, B. M.] Ohio State Univ, Ctr Cosmol & AstroParticle Phys, Columbus, OH 43210 USA; [Pinto, C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Nunez, F. Pozo] Ruhr Univ Bochum, Inst Astron, D-44801 Bochum, Germany; [De Rosa, A.] INAF, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy; [Seta, H.] Rikkyo Univ, Res Ctr Measurement Adv Sci, Toshima Ku, Tokyo 171, Japan; [Seta, H.] Saitama Univ, Dept Phys, Sakura Ku, Saitama 3388570, Japan	Utrecht University; Leiden University; Leiden University - Excl LUMC; Space Telescope Science Institute; Johns Hopkins University; Istituto Nazionale Astrofisica (INAF); University of London; University College London; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Universidad Catolica del Norte; University of Oxford; Virginia Polytechnic Institute & State University; Technion Israel Institute of Technology; Roma Tre University; University of Geneva; European Space Agency; California Institute of Technology; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Max Planck Society; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Cambridge; Ruhr University Bochum; Istituto Nazionale Astrofisica (INAF); Rikkyo University; Saitama University	Kaastra, JS (corresponding author), SRON Netherlands Inst Space Res, Sorbonnelaan 2, NL-3584 CA Utrecht, Netherlands.	j.kaastra@sron.nl	Costantini, Elisa/AAQ-8122-2020; Cappi, Massimo/F-4813-2015; Ursini, Francesco/AAP-1135-2020; Bianchi, Stefano/B-4804-2010; Pinto, Ciro/CAH-0295-2022; Pozo Nunez, Francisco/AAA-2812-2022; De Marco, Barbara/A-6462-2019	Ursini, Francesco/0000-0001-9442-7897; Bianchi, Stefano/0000-0002-4622-4240; Pinto, Ciro/0000-0003-2532-7379; Pozo Nunez, Francisco/0000-0002-6716-4179; Cappi, Massimo/0000-0001-6966-8920; De Marco, Barbara/0000-0003-2743-6632; Branduardi-Raymont, Graziella/0000-0002-6620-6357; Costantini, Elisa/0000-0001-8470-749X; De Rosa, Alessandra/0000-0001-5668-6863; Ebrero, Jacobo/0000-0001-5924-8818; Peterson, Bradley/0000-0001-6481-5397; Boissay-Malaquin, Rozenn/0000-0003-2704-599X; Kriss, Gerard/0000-0002-2180-8266; Ponti, Gabriele/0000-0003-0293-3608; Mehdipour, Missagh/0000-0002-4992-4664; Matt, Giorgio/0000-0002-2152-0916; Kaastra, Jelle/0000-0001-5540-2822; Malzac, Julien/0000-0003-3334-3424	International Space Science Institute in Bern; Netherlands Organization for Scientific Research; NASA HST program from the Space Telescope Science Institute [13184]; NASA [NAS5-26555]; UK Science and Technology Facilities Council; French Centre National d'Etudes Spatiales; CNRS/Project International de Cooperation Scientific; CNRS/Programme National Hautes Energies; Vicerrectoria de Investigacion y Desarrollo Tecnologico (Chile); Israel's Ministry of Science, Technology, and Space; Israel Science Foundation [1163/10]; Israeli Centers of Research Excellence program [1937/12]; Swiss National Science Foundation; Agenzia Spaziale Italiana [INAF I/037/12/0-011/13]; INAF/Project for International Scientific Cooperation; NSF [AST-1008882]; European Union [FP-PEOPLE-2012-IEF-331095]; Science and Technology Facilities Council [ST/K000977/1, ST/K50239X/1, ST/H00260X/1] Funding Source: researchfish; UK Space Agency [ST/G008868/1] Funding Source: researchfish; STFC [ST/K50239X/1, ST/K000977/1, ST/H00260X/1] Funding Source: UKRI; Division Of Astronomical Sciences [1008882] Funding Source: National Science Foundation	International Space Science Institute in Bern; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NASA HST program from the Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); French Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); CNRS/Project International de Cooperation Scientific; CNRS/Programme National Hautes Energies; Vicerrectoria de Investigacion y Desarrollo Tecnologico (Chile); Israel's Ministry of Science, Technology, and Space; Israel Science Foundation(Israel Science Foundation); Israeli Centers of Research Excellence program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); INAF/Project for International Scientific Cooperation; NSF(National Science Foundation (NSF)); European Union(European Commission); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The data used in this research are stored in the public archives of the international space observatories involved: XMM-Newton, HST, Swift, NuSTAR, INTEGRAL, and Chandra. We acknowledge support by the International Space Science Institute in Bern; the Netherlands Organization for Scientific Research; NASA HST program 13184 from the Space Telescope Science Institute, which is operated by Association of Universities for Research in Astronomy, Incorporated, under NASA contract NAS5-26555; the UK Science and Technology Facilities Council; the French Centre National d'Etudes Spatiales, CNRS/Project International de Cooperation Scientific and CNRS/Programme National Hautes Energies; Vicerrectoria de Investigacion y Desarrollo Tecnologico (Chile); Israel's Ministry of Science, Technology, and Space, Israel Science Foundation (1163/10), and Israeli Centers of Research Excellence program (1937/12); the Swiss National Science Foundation; the Agenzia Spaziale Italiana grant INAF I/037/12/0-011/13 and INAF/Project for International Scientific Cooperation; NSF grant AST-1008882; and European Union Marie Curie contract FP-PEOPLE-2012-IEF-331095. We thank S. Paniagua for help with Fig. 4.	Bianchi S, 2009, ASTROPHYS J, V695, P781, DOI 10.1088/0004-637X/695/1/781; Crenshaw DM, 2007, ASTROPHYS J, V659, P250, DOI 10.1086/511970; Crenshaw DM, 2009, ASTROPHYS J, V698, P281, DOI 10.1088/0004-637X/698/1/281; Crenshaw DM, 1999, ASTROPHYS J, V516, P750, DOI 10.1086/307144; Gallagher SC, 2006, ASTROPHYS J, V644, P709, DOI 10.1086/503762; Kaastra JS, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118161; Kaastra JS, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201116869; KORISTA KT, 1995, ASTROPHYS J SUPPL S, V97, P285, DOI 10.1086/192144; Lamer G, 2003, MON NOT R ASTRON SOC, V342, pL41, DOI 10.1046/j.1365-8711.2003.06759.x; Longinotti AL, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/104; Markowitz AG, 2014, MON NOT R ASTRON SOC, V439, P1403, DOI 10.1093/mnras/stt2492; Miniutti G, 2014, MON NOT R ASTRON SOC, V437, P1776, DOI 10.1093/mnras/stt2005; Proga D, 2004, ASTROPHYS J, V616, P688, DOI 10.1086/425117; Reynolds CS, 1997, MON NOT R ASTRON SOC, V286, P513, DOI 10.1093/mnras/286.3.513; Risaliti G, 2002, ASTROPHYS J, V571, P234, DOI 10.1086/324146; Risaliti G, 2009, ASTROPHYS J, V696, P160, DOI 10.1088/0004-637X/696/1/160; Steenbrugge KC, 2005, ASTRON ASTROPHYS, V434, P569, DOI 10.1051/0004-6361:20047138; Turner TJ, 2008, ASTRON ASTROPHYS, V483, P161, DOI 10.1051/0004-6361:20078808	18	148	148	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					64	68		10.1126/science.1253787	http://dx.doi.org/10.1126/science.1253787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994647	Green Submitted, Green Accepted			2022-12-28	WOS:000338284400049
J	Wilson, TD; Reinhard, DA; Westgate, EC; Gilbert, DT; Ellerbeck, N; Hahn, C; Brown, CL; Shaked, A				Wilson, Timothy D.; Reinhard, David A.; Westgate, Erin C.; Gilbert, Daniel T.; Ellerbeck, Nicole; Hahn, Cheryl; Brown, Casey L.; Shaked, Adi			Just think: The challenges of the disengaged mind	SCIENCE			English	Article							BRAINS DEFAULT NETWORK; METAANALYSIS; MINDFULNESS; DISTRACTION; MODE	In 11 studies, we found that participants typically did not enjoy spending 6 to 15 minutes in a room by themselves with nothing to do but think, that they enjoyed doing mundane external activities much more, and that many preferred to administer electric shocks to themselves instead of being left alone with their thoughts. Most people seem to prefer to be doing something rather than nothing, even if that something is negative.	[Wilson, Timothy D.; Reinhard, David A.; Westgate, Erin C.; Ellerbeck, Nicole; Hahn, Cheryl; Brown, Casey L.; Shaked, Adi] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Gilbert, Daniel T.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Virginia; Harvard University	Wilson, TD (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	tdw@virginia.edu	Westgate, Erin/T-5190-2019	Westgate, Erin/0000-0002-9116-6246	NSF [SES-0951779]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020006] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge the support of NSF grant SES-0951779. The data from all studies can be accessed at https://osf.io/cgwdy/files/. We thank J. Coan for his help with study 10 and E. Winkler, the pastor of Wesley Memorial United Methodist Church, for his help in recruiting participants for study 9.	Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; [Anonymous], 2012, AM TIM US SURV; Baird B, 2012, PSYCHOL SCI, V23, P1117, DOI 10.1177/0956797612446024; Baumeister R.F., 1991, ESCAPING SELF; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Duval S., 1972, THEORY OBJECTIVE SEL; Franklin MS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00583; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Harvey AG, 2002, BEHAV RES THER, V40, P267, DOI 10.1016/S0005-7967(01)00012-2; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Huba G. J., 1982, SHORT IMAGINAL PROCE; Immordino-Yang MH, 2012, PERSPECT PSYCHOL SCI, V7, P352, DOI 10.1177/1745691612447308; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Klinger E., 1990, DAYDREAMING; Leary M. R., 2004, CURSE SELF; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McMillan RL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00626; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Pennebaker J. W., 2007, LIWC2007 LINGUISTIC; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Schooler JW, 2014, PSYCHOL LEARN MOTIV, V60, P1, DOI 10.1016/B978-0-12-800090-8.00001-9; Singer J.L., 1966, DAYDREAMING INTRO EX; SINGER JL, 1975, AM PSYCHOL, V30, P727, DOI 10.1037/h0076928; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34	27	213	218	10	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					75	77		10.1126/science.1250830	http://dx.doi.org/10.1126/science.1250830			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994650	Green Accepted			2022-12-28	WOS:000338284400052
J	Loxterkamp, D				Loxterkamp, David			The torch has passed: G Gayle Stephens	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									Seaport Commun Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Commun Hlth Ctr, Belfast, ME 04915 USA.							Stephens G G, 1989, Fam Med, V21, P103; Stephens G G, 1989, J Am Board Fam Pract, V2, P64; STEPHENS GG, 1992, CAN FAM PHYSICIAN, V38, P2482	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g3714	10.1136/bmj.g3714	http://dx.doi.org/10.1136/bmj.g3714			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24996884				2022-12-28	WOS:000338646100020
J	Mahajan, R; Zachariah, U				Mahajan, Ramit; Zachariah, Uday			Wing-Beating Tremor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mahajan, Ramit; Zachariah, Uday] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Mahajan, R (corresponding author), Christian Med Coll & Hosp, Vellore, Tamil Nadu, India.	mahajan.ramit@gmail.com	Mahajan, Ramit/AAV-4038-2021	Mahajan, Ramit/0000-0001-6726-6151					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					E1	E1		10.1056/NEJMicm1312190	http://dx.doi.org/10.1056/NEJMicm1312190			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988588				2022-12-28	WOS:000338265700012
J	Weeks, JC; Uno, H; Taback, N; Ting, G; Cronin, A; D'Amico, TA; Friedberg, JW; Schrag, D				Weeks, Jane C.; Uno, Hajime; Taback, Nathan; Ting, Gladys; Cronin, Angel; D'Amico, Thomas A.; Friedberg, Jonathan W.; Schrag, Deborah			Interinstitutional Variation in Management Decisions for Treatment of 4 Common Types of Cancer A Multi-institutional Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							REGIONAL-VARIATION; CARE; SURGERY; COMORBIDITY; INTENSITY; REGISTRY; DISEASE; QUALITY; ADULTS; RATES	Background: When clinical practice is governed by evidence-based guidelines and there is consensus about their validity, practice variation should be minimal. For areas in which evidence gaps exist, greater variation is expected. Objective: To systematically assess interinstitutional variation in management decisions for 4 common types of cancer. Design: Multi-institutional, observational cohort study of patients with cancer diagnosed between July 2006 through May 2011 and observed through 31 December 2011. Setting: 18 cancer centers participating in the formulation of treatment guidelines and systematic outcomes assessment through the National Comprehensive Cancer Network. Patients: 25 589 patients with incident breast cancer, colorectal cancer, lung cancer, or non-Hodgkin lymphoma. Measurements: Interinstitutional variation for 171 binary management decisions with varying levels of supporting evidence. For each decision, variation was characterized by the median absolute deviation of the center-specific proportions. Results: Interinstitutional variation was high (median absolute deviation >10%) for 35 of 171 (20%) oncology management decisions, including 9 of 22 (41%) decisions for non-Hodgkin lymphoma, 16 of 76 (21%) for breast cancer, 7 of 47 (15%) for lung cancer, and 3 of 26 (12%) for colorectal cancer. Forty-six percent of high-variance decisions involved imaging or diagnostic procedures and 37% involved choice of chemotherapy regimen. The evidence grade underpinning the 35 high-variance decisions was category 1 for 0%, 2A for 49%, and 2B/other for 51%. Limitation: Physician identifiers were unavailable, and results may not generalize outside of major cancer centers. Conclusion: The substantial variation in institutional practice manifest among cancer centers reveals a lack of consensus about optimal management for common clinical scenarios. For clinicians, awareness of management decisions with high variation should prompt attention to patient preferences. For health systems, high variation can be used to prioritize comparative effectiveness research, patient-provider education, or pathway development.	[Uno, Hajime; Ting, Gladys; Cronin, Angel; Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Taback, Nathan] Univ Toronto, Dept Stat Sci, Toronto, ON M5S 3G3, Canada; [D'Amico, Thomas A.] Duke Univ, Med Ctr, Durham, NC 27710 USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Harvard University; Dana-Farber Cancer Institute; University of Toronto; Duke University; University of Rochester	Schrag, D (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	angelm_cronin@dfci.harvard.edu; deb_schrag@dfci.harvard.edu	Uno, Hajime/W-4099-2019	Uno, Hajime/0000-0003-0622-8471; Taback, Nathan/0000-0001-9497-3951	National Cancer Institute; National Comprehensive Cancer Network; NATIONAL CANCER INSTITUTE [RC1CA146196] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Comprehensive Cancer Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: National Cancer Institute and National Comprehensive Cancer Network.	Arnold SV, 2011, CIRCULATION, V124, P2405, DOI 10.1161/CIRCULATIONAHA.111.038265; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen ME, 2009, ANN SURG, V250, P901, DOI 10.1097/SLA.0b013e3181b2a948; Donohue JM, 2012, NEW ENGL J MED, V366, P530, DOI 10.1056/NEJMsa1104816; Edge S, 2010, AJCC CANC STAGING HD; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kho ME, 2008, CANCER, V113, P3209, DOI 10.1002/cncr.23911; Matlock DD, 2012, ARCH INTERN MED, V172, P634, DOI 10.1001/archinternmed.2012.394; *NAT COMPR CANC NE, 2009, NCCN CLIN PRACT GUID; National Comprehensive Cancer Network, 2007, NCCN CLIN PRACT GUID; National Comprehensive Cancer Network, NCCN CAT EV CONS; NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102, DOI 10.1056/NEJM199204233261702; O'Hare AM, 2010, JAMA-J AM MED ASSOC, V304, P180, DOI 10.1001/jama.2010.924; Poonacha TK, 2011, J CLIN ONCOL, V29, P186, DOI 10.1200/JCO.2010.31.6414; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Stukel TA, 2012, JAMA-J AM MED ASSOC, V307, P1037, DOI 10.1001/jama.2012.265; Subherwal S, 2012, J AM COLL CARDIOL, V59, P1861, DOI 10.1016/j.jacc.2011.12.045; Venkatraman G, 2011, ARCH OTOLARYNGOL, V137, P253, DOI 10.1001/archoto.2011.17; Weeks J C, 1997, Oncology (Williston Park), V11, P137	28	21	21	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					20	+		10.7326/M13-2231	http://dx.doi.org/10.7326/M13-2231			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24979447	Green Accepted			2022-12-28	WOS:000338419700003
J	Jae, LT; Raaben, M; Herbert, AS; Kuehne, AI; Wirchnianski, AS; Soh, TK; Stubbs, SH; Janssen, H; Damme, M; Saftig, P; Whelan, SP; Dye, JM; Brummelkamp, TR				Jae, Lucas T.; Raaben, Matthijs; Herbert, Andrew S.; Kuehne, Ana I.; Wirchnianski, Ariel S.; Soh, Timothy K.; Stubbs, Sarah H.; Janssen, Hans; Damme, Markus; Saftig, Paul; Whelan, Sean P.; Dye, John M.; Brummelkamp, Thijn R.			Lassa virus entry requires a trigger-induced receptor switch	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ALPHA-DYSTROGLYCAN; HUMAN AIRWAY; MEMBRANE; BINDING; SPECIFICITY; INHIBITORS; COMPLEX; FEVER; CELLS	Lassa virus spreads from a rodent to humans and can lead to lethal hemorrhagic fever. Despite its broad tropism, chicken cells were reported 30 years ago to resist infection. We found that Lassa virus readily engaged its cell-surface receptor a-dystroglycan in avian cells, but virus entry in susceptible species involved a pH-dependent switch to an intracellular receptor, the lysosome-resident protein LAMP1. Iterative haploid screens revealed that the sialyltransferase ST3GAL4 was required for the interaction of the virus glycoprotein with LAMP1. A single glycosylated residue in LAMP1, present in susceptible species but absent in birds, was essential for interaction with the Lassa virus envelope protein and subsequent infection. The resistance of Lamp1-deficient mice to Lassa virus highlights the relevance of this receptor switch in vivo.	[Jae, Lucas T.; Raaben, Matthijs; Janssen, Hans; Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Raaben, Matthijs; Soh, Timothy K.; Stubbs, Sarah H.; Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Herbert, Andrew S.; Kuehne, Ana I.; Wirchnianski, Ariel S.; Dye, John M.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Damme, Markus; Saftig, Paul] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Brummelkamp, Thijn R.] Cancer Genom Ctr CGC Nl, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Harvard University; Harvard Medical School; University of Kiel; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Brummelkamp, TR (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sean_whelan@hms.harvard.edu; john.m.dye1.civ@mail.mil; t.brummelkamp@nki.nl	Saftig, Paul/A-7966-2010; Jae, Lucas/AAY-3438-2021; Jae, Lucas/AAH-5342-2020	Jae, Lucas/0000-0002-3531-1760; Raaben, Matthijs/0000-0001-5989-289X; Whelan, Sean/0000-0003-1564-8590; Dye, John/0000-0002-0883-5016; Stubbs, Sarah Hulsey/0000-0002-3261-191X	CGC.nl; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant [91711316]; European Research Council (ERC) Starting Grant [ERC-2012-StG 309634]; Deutsche Forschungsgemeinschaft [DFG SPP1580, GRK1459]; NIH [AI081842, AI109740]; Defense Threat Reduction Agency [CB3947]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081842, R01AI081842, U19AI109740, T32AI007245] Funding Source: NIH RePORTER	CGC.nl; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant; European Research Council (ERC) Starting Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Sixma, A. Perrakis, E. von Castelmur, D. Lefeber, and members of the Brummelkamp group for discussion; M. Rusch for mouse breeding; S. Kunz for a plasmid encoding Lassa-GP; E. Ollmann-Saphire for an Fc-fusion vector; R. Schoepp for GP1 antibodies; and M. Verheije for DF1 cells. This work was supported by CGC.nl, Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant 91711316, and European Research Council (ERC) Starting Grant (ERC-2012-StG 309634) to T. R. B.; Deutsche Forschungsgemeinschaft (DFG SPP1580 and GRK1459) to P. S.; and NIH grants AI081842 and AI109740 to S. P. W. J.M.D was supported by the Defense Threat Reduction Agency (CB3947). The HAP1 cells that were used are distributed under a materials transfer agreement. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Army. T. R. B. is a cofounder and shareholder of Haplogen GmbH, a company involved in haploid genetics. Sequencing data are accessible at www.ncbi.nlm.nih.gov/sra (accession SRP041566).	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Cosset FL, 2009, J VIROL, V83, P3228, DOI 10.1128/JVI.01711-08; de Graaf M, 2014, EMBO J, V33, P823, DOI 10.1002/embj.201387442; DISIMONE C, 1995, VIROLOGY, V209, P3, DOI 10.1006/viro.1995.1225; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; HEFFERNAN M, 1989, CANCER RES, V49, P6077; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; LUKASHEVICH IS, 1983, ACTA VIROL, V27, P282; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nunberg JH, 2012, VIRUSES-BASEL, V4, P83, DOI 10.3390/v4010083; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Saito F, 2005, FEBS LETT, V579, P2359, DOI 10.1016/j.febslet.2005.03.033; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; WANG WC, 1988, J BIOL CHEM, V263, P4576; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; Zhu WY, 2011, BIOMED ENVIRON SCI, V24, P81, DOI 10.3967/0895-3988.2011.01.011	23	170	176	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1506	1510		10.1126/science.1252480	http://dx.doi.org/10.1126/science.1252480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970085	Green Accepted			2022-12-28	WOS:000337889900048
J	Malakoff, D				Malakoff, David			The gas surge	SCIENCE			English	Editorial Material																			0	55	57	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1464	1467		10.1126/science.344.6191.1464	http://dx.doi.org/10.1126/science.344.6191.1464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970074				2022-12-28	WOS:000337889900034
J	Tononi, G				Tononi, Giulio			Gerald M. Edelman (1929-2014)	SCIENCE			English	Biographical-Item									Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu						EDELMAN GM, PUBLICATION LIST	1	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1457	1457		10.1126/science.1257185	http://dx.doi.org/10.1126/science.1257185			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970069				2022-12-28	WOS:000337889900025
J	Schlamminger, S				Schlamminger, Stephan			FUNDAMENTAL CONSTANTS A cool way to measure big G	NATURE			English	Editorial Material									NIST, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	Schlamminger, S (corresponding author), NIST, Gaithersburg, MD 20899 USA.	stephan.schlamminger@nist.gov	Schlamminger, Stephan/J-4982-2012	Schlamminger, Stephan/0000-0002-9270-4018				Armstrong TR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.201101; Bagley CH, 1997, PHYS REV LETT, V78, P3047, DOI 10.1103/PhysRevLett.78.3047; BRANSCOMB LM, 1985, AM SCI, V73, P421; Gundlach JH, 2000, PHYS REV LETT, V85, P2869, DOI 10.1103/PhysRevLett.85.2869; Karagioz O. V., 1996, IZMER TEKH, V10, P3; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; Kleinevoss U., 2002, THESIS U WUPPERTAL; Lamporesi G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050801; LUTHER GG, 1982, PHYS REV LETT, V48, P121, DOI 10.1103/PhysRevLett.48.121; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Parks HV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.110801; Quinn T, 2014, NATURE, V505, P455, DOI 10.1038/505455a; Quinn T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.101102; Quinn TJ, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.111101; Rosi G, 2014, NATURE, V510, P518, DOI 10.1038/nature13433; Schlamminger S, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.082001; Tu LC, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.022001	17	14	14	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					478	480		10.1038/nature13507	http://dx.doi.org/10.1038/nature13507			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965646				2022-12-28	WOS:000337806300033
J	Sridhar, D; Frenk, J; Gostin, L; Moon, S				Sridhar, Devi; Frenk, J.; Gostin, L.; Moon, S.			Global rules for global health: why we need an independent, impartial WHO	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sridhar, Devi] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9LD, Midlothian, Scotland; [Sridhar, Devi] Univ Oxford, Blavatnik Sch Govt, Oxford, England; [Frenk, J.; Moon, S.] Harvard Univ, Sch Publ Hlth, Harvard Global Hlth Inst, Boston, MA 02115 USA; [Gostin, L.] Georgetown Univ, ONeill Inst Global & Natl Hlth Law, Washington, DC USA	University of Edinburgh; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Georgetown University	Sridhar, D (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9LD, Midlothian, Scotland.	devi.sridhar@ed.ac.uk		Moon, Suerie/0000-0001-8504-1212; Gostin, Lawrence/0000-0001-5286-4044				Allen CE, 1950, INT ORGAN, V4, P27; Clift C., 2014, WHATS WHO; da Silva JB, 2014, B WORLD HEALTH ORGAN, V92, P388, DOI 10.2471/BLT.14.141051; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Garrett L., 2013, CNN             0602; Gostin L.O., 2014, GLOBAL HLTH LAW; Kamradt-Scott A, 2011, POLIT STUD-LONDON, V59, P831, DOI 10.1111/j.1467-9248.2011.00926.x; Lundin A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004166; Mackey TK, 2012, GLOB HLTH GOV, pVI; Moon S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001218; Nozaki I, 2013, LANCET, V382, P937, DOI 10.1016/S0140-6736(13)61930-3; Rottingen J, 2012, MULT TECHN M IMPL OP; Sedyaningsih ER, 2008, ANN ACAD MED SINGAP, V37, P482; Sridhar D, 2013, GLOB POLICY, V4, P325, DOI 10.1111/1758-5899.12066; Sridhar D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001312; 't Hoen Ellen F.M., 2009, GLOBAL POLITICS PHAR, P17; WHO, 2014, DIS OUTBREAK NEWS; WHO Consultative Expert Working Group on Research and Development: Financing and Coordination, 2012, RES DEV MEET HLTH NE; Woods N, 2013, TRANSFORMING GLOBAL	19	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2014	348								g3841	10.1136/bmj.g3841	http://dx.doi.org/10.1136/bmj.g3841			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LF	24942299	Green Published			2022-12-28	WOS:000337805600010
J	Wilcox, ME; Chong, CAKY; Stanbrook, MB; Tricco, AC; Wong, C; Straus, SE				Wilcox, M. Elizabeth; Chong, Christopher A. K. Y.; Stanbrook, Matthew B.; Tricco, Andrea C.; Wong, Camilla; Straus, Sharon E.			Does This Patient Have an Exudative Pleural Effusion? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ULTRASOUND-GUIDED THORACENTESIS; BRAIN NATRIURETIC PEPTIDE; CHEST ROENTGENOGRAPHY; THERAPEUTIC THORACENTESIS; BLEEDING COMPLICATIONS; BIOCHEMICAL PARAMETERS; LACTATE-DEHYDROGENASE; PROCEDURAL SKILLS; LIGHTS CRITERIA; FLUID	IMPORTANCE Thoracentesis is performed to identify the cause of a pleural effusion. Although generally safe, thoracentesis may be complicated by transient hypoxemia, bleeding, patient discomfort, reexpansion pulmonary edema, and pneumothorax. OBJECTIVE To identify the best means for differentiating between transudative and exudative effusions and also to identify thoracentesis techniques for minimizing the risk of complications by performing a systematic review the evidence. DATA SOURCES We searched The Cochrane Library, MEDLINE, and Embase from inception to February 2014 to identify relevant studies. STUDY SELECTION We included randomized and observational studies of adult patients undergoing thoracentesis that examined diagnostic tests for differentiating exudates from transudates and evaluated thoracentesis techniques associated with a successful procedure with minimal complications. DATA EXTRACTION AND SYNTHESIS Two investigators independently appraised study quality and extracted data from studies of laboratory diagnosis of pleural effusion for calculation of likelihood ratios (LRs; n = 48 studies) and factors affecting adverse event rates (n = 37 studies). RESULTS The diagnosis of an exudate was most accurate if cholesterol in the pleural fluid was greater than 55mg/dL (LR range, 7.1-250), lactate dehydrogenase (LDH) was greater than 200 U/L (LR, 18; 95% CI, 6.8-46), or the ratio of pleural fluid cholesterol to serum cholesterol was greater than 0.3 (LR, 14; 95% CI, 5.5-38). A diagnosis of exudate was less likely when all Light's criteria (a ratio of pleural fluid protein to serum protein >0.5, a ratio of pleural fluid LDH to serum LDH >0.6, or pleural fluid LDH >two-thirds the upper limit of normal for serum LDH) were absent (LR, 0.04; 95% CI, 0.02-0.11). The most common complication of thoracentesis was pneumothorax, which occurred in 6.0% of cases (95% CI, 4.0%-7.0%). Chest tube placement was required in 2.0% of procedures (95% CI, 0.99%-2.9%) in which a patient was determined to have radiographic evidence of a pneumothorax. With ultrasound, a radiologist's marking the needle insertion site was not associated with decreased pneumothorax events (skin marking vs no skin marking odds ratio [OR], 0.37; 95% CI, 0.08-1.7). Use of ultrasound by any experienced practitioner also was not associated with decreased pneumothorax events (OR, 0.55; 95% CI, 0.06-5.3). CONCLUSIONS AND RELEVANCE Light's criteria, cholesterol and pleural fluid LDH levels, and the pleural fluid cholesterol-to-serum ratio are the most accurate diagnostic indicators for pleural exudates. Ultrasound skin marking by a radiologist or ultrasound-guided thoracentesis were not associated with a decrease in pneumothorax events.	[Wilcox, M. Elizabeth] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada; [Chong, Christopher A. K. Y.] Lakeridge Hlth Oshawa, Gen Internal Med Sect, Oshawa, ON, Canada; [Stanbrook, Matthew B.] Dept Med, Div Respirol, Univ Hlth Network, Toronto, ON, Canada; [Tricco, Andrea C.; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Wong, Camilla; Straus, Sharon E.] Univ Toronto, St Michaels Hosp, Div Geriatr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wilcox, ME (corresponding author), Toronto Western Hosp, Univ Hlth Network, McLaughlin Wing 2-411M,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	elizabeth.wilcox@mail.utoronto.ca	Wong, Camilla/J-6419-2019; Tricco, Andrea/B-9920-2011	Wong, Camilla/0000-0002-4430-2321; Tricco, Andrea/0000-0002-4114-8971				Abunasser Jafar, 2010, Conn Med, V74, P23; Aleman C, 1999, AM J MED, V107, P340, DOI 10.1016/S0002-9343(99)00238-7; *AM COLL SURG, 1998, ULTR EX SURG; American College of Emergency Physicians, 2001, AECP POL STAT EM ULT; Atalay F, 2005, CLIN BIOCHEM, V38, P1066, DOI 10.1016/j.clinbiochem.2005.07.009; Audige L, 2004, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000137558.97346.fb; Barnes TW, 2005, J CLIN ULTRASOUND, V33, P442, DOI 10.1002/jcu.20163; BARTTER T, 1993, CHEST, V103, P1873, DOI 10.1378/chest.103.6.1873; Bass J, 2005, CHEST, V127, P2101, DOI 10.1378/chest.127.6.2101; Berg D, 2013, AM J MED QUAL, V28, P220, DOI 10.1177/1062860612459881; Boland GW, 1998, AM J ROENTGENOL, V170, P943, DOI 10.2214/ajr.170.4.9530040; BRANDSTETTER RD, 1994, HEART LUNG, V23, P67; BRANDSTETTER RD, 1982, HEART LUNG, V11, P216; BRANDSTETTER RD, 1979, JAMA-J AM MED ASSOC, V242, P1060, DOI 10.1001/jama.242.10.1060; BRUCE NC, 1989, ACAD MED, V64, P213, DOI 10.1097/00001888-198904000-00010; Buckley O, 2008, HONG KONG J RADIOL, V11, P72; BUENO CE, 1990, ARCH INTERN MED, V150, P1190, DOI 10.1001/archinte.1990.00390180034005; Candeira SR, 2002, CHEST, V121, P465, DOI 10.1378/chest.121.2.465; Capizzi SA, 1998, MAYO CLIN PROC, V73, P948, DOI 10.4065/73.10.948; CARDOZO PL, 1966, ACTA CYTOL, V10, P455; CARR DT, 1958, NEW ENGL J MED, V259, P926, DOI 10.1056/NEJM195811062591909; Castro DJ, 2005, RESPIRATION, V72, P357, DOI 10.1159/000086248; Cincin A, 2013, RESP CARE, V58, P313, DOI 10.4187/respcare.01818; Clark SJ, 1999, J BRONCHOLOGY, V6, P207, DOI [10.1097/00128594-199907000-00015, DOI 10.1097/00128594-199907000-00015]; COLLINS TR, 1987, CHEST, V91, P817, DOI 10.1378/chest.91.6.817; Colt HG, 1999, CHEST, V116, P134, DOI 10.1378/chest.116.1.134; COSTA M, 1995, CHEST, V108, P1260, DOI 10.1378/chest.108.5.1260; Deeks J J, 2003, Health Technol Assess, V7, piii; Diacon AH, 2003, CHEST, V123, P436, DOI 10.1378/chest.123.2.436; DINES DE, 1975, MAYO CLIN PROC, V50, P571; Doyle JJ, 1996, ANN INTERN MED, V124, P816, DOI 10.7326/0003-4819-124-9-199605010-00005; Duncan DR, 2009, CHEST, V135, P1315, DOI 10.1378/chest.08-1227; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feller-Kopman D, 2007, ANN THORAC SURG, V84, P1656, DOI 10.1016/j.athoracsur.2007.06.038; Feller-Kopman D, 2007, CURR OPIN PULM MED, V13, P312, DOI 10.1097/MCP.0b013e3281214492; Feller-Kopman D, 2006, CHEST, V129, P1709, DOI 10.1378/chest.129.6.1709; Feller-Kopman D, 2006, CHEST, V129, P1556, DOI 10.1378/chest.129.6.1556; Fox RA, 2000, ANN RHEUM DIS, V59, P668, DOI 10.1136/ard.59.9.668; GarciaPachon E, 1996, CHEST, V110, P97, DOI 10.1378/chest.110.1.97; Gazquez I, 1998, RESP MED, V92, P762, DOI 10.1016/S0954-6111(98)90009-9; GODWIN JE, 1990, ANN INTERN MED, V113, P800, DOI 10.7326/0003-4819-113-10-800; Golder S, 2008, J CLIN EPIDEMIOL, V61, P440, DOI 10.1016/j.jclinepi.2007.06.005; Golder Su, 2006, BMC Med Res Methodol, V6, P3, DOI 10.1186/1471-2288-6-3; Goligher EC, 2011, CRIT CARE, V15, DOI 10.1186/cc10009; GOOD JT, 1980, CHEST, V78, P55, DOI 10.1378/chest.78.1.55; Gordon CE, 2010, ARCH INTERN MED, V170, P332, DOI 10.1001/archinternmed.2009.548; Gotsman I, 2001, AM J MED, V111, P375, DOI 10.1016/S0002-9343(01)00881-6; Grodzin CJ, 1997, CHEST, V111, P981, DOI 10.1378/chest.111.4.981; GROGAN DR, 1990, ARCH INTERN MED, V150, P873, DOI 10.1001/archinte.150.4.873; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hackbarth JS, 2010, CLIN BIOCHEM, V43, P1051, DOI 10.1016/j.clinbiochem.2010.05.016; HAMM H, 1987, CHEST, V92, P296, DOI 10.1378/chest.92.2.296; Han CH, 2008, INTERNAL MED, V47, P1669, DOI 10.2169/internalmedicine.47.1276; HEFFNER JE, 1981, ARCH INTERN MED, V141, P1238, DOI 10.1001/archinte.1981.00340090134033; Hibbert RM, 2013, CHEST, V144, P456, DOI 10.1378/chest.12-2374; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iqbal Mobeen, 2002, J Ayub Med Coll Abbottabad, V14, P2; James Prince, 2010, Indian J Tuberc, V57, P19; JENKINS DW, 1983, SOUTHERN MED J, V76, P1383; Jiang GC, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-39; Jones PW, 2003, CHEST, V123, P418, DOI 10.1378/chest.123.2.418; Josephson T, 2009, ACTA RADIOL, V50, P42, DOI 10.1080/02841850802590460; Kiefe CI, 1998, INT J QUAL HEALTH C, V10, P443, DOI 10.1093/intqhc/10.5.443; KOHAN JM, 1986, AM REV RESPIR DIS, V133, P1124; Krenke R, 2009, EUR RESPIR J, V34, P1111, DOI 10.1183/09031936.00197708; Lakhotia M, 1989, Indian J Chest Dis Allied Sci, V31, P259; LEUALLEN EC, 1955, NEW ENGL J MED, V252, P79, DOI 10.1056/NEJM195501202520301; LIGHT RW, 1973, JAMA-J AM MED ASSOC, V225, P257; LIGHT RW, 1973, ARCH INTERN MED, V132, P854, DOI 10.1001/archinte.132.6.854; LIGHT RW, 1973, CHEST, V64, P591, DOI 10.1378/chest.64.5.591; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; LIGHT RW, 1973, AM REV RESPIR DIS, V108, P660; LIGHT RW, 1980, AM REV RESPIR DIS, V121, P799; Lisi M, 2012, INTERACT CARDIOV TH, V15, P596, DOI 10.1093/icvts/ivs223; Manthous CA, 2003, CHEST, V124, P1978, DOI 10.1378/chest.124.5.1978; Marinho FCA, 2011, RESPIROLOGY, V16, P495, DOI 10.1111/j.1440-1843.2011.01930.x; Martinez-Garcia MA, 2000, EUR RESPIR J, V15, P166, DOI 10.1034/j.1399-3003.2000.15a30.x; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; Mayo PH, 2004, CHEST, V125, P1059, DOI 10.1378/chest.125.3.1059; MCCARTNEY JP, 1993, CHEST, V103, P1920, DOI 10.1378/chest.103.6.1920; MCVAY PA, 1991, TRANSFUSION, V31, P164, DOI 10.1046/j.1537-2995.1991.31291142949.x; MEISEL S, 1990, CHEST, V98, P141, DOI 10.1378/chest.98.1.141; Mercaldi CJ, 2013, CHEST, V143, P532, DOI 10.1378/chest.12-0447; Ong K. C., 2000, SMJ, V41, P19; Ozcakar B, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-63; PARADIS IL, 1977, J MAINE MED ASSOC, V68, P378; Patel MD, 2011, AM J ROENTGENOL, V197, pW164, DOI 10.2214/AJR.10.5589; Patel PA, 2012, J CLIN ULTRASOUND, V40, P135, DOI 10.1002/jcu.20884; PETERSEN GW, 1983, CRIT CARE MED, V11, P67, DOI 10.1097/00003246-198302000-00002; Petersen WG, 2000, CHEST, V117, P1038, DOI 10.1378/chest.117.4.1038; Pihlajamaa K, 2004, ACTA RADIOL, V45, P828, DOI 10.1080/02841850410008270; Porcel JM, 2007, RESPIROLOGY, V12, P234, DOI 10.1111/j.1440-1843.2006.01026.x; Porcel JM, 2011, RESPIROLOGY, V16, P44, DOI 10.1111/j.1440-1843.2010.01794.x; Porcel JM, 2010, EUR J INTERN MED, V21, P419, DOI 10.1016/j.ejim.2010.03.011; Puchalski Jonathan T, 2013, Ann Am Thorac Soc, V10, P336, DOI 10.1513/AnnalsATS.201210-088OC; Puchalski JT, 2013, RESP MED, V107, P284, DOI 10.1016/j.rmed.2012.10.004; RAPTOPOULOS V, 1991, AM J ROENTGENOL, V156, P917, DOI 10.2214/ajr.156.5.2017951; RASMUSSEN OS, 1989, EUR J RADIOL, V9, P91; Riantawan P, 2000, RESPIRATION, V67, P24, DOI 10.1159/000029458; ROHLFING BM, 1976, RADIOLOGY, V121, P25, DOI 10.1148/121.1.25; Romero-Candeira S, 2002, CHEST, V122, P1524, DOI 10.1378/chest.122.5.1524; ROTH BJ, 1990, CHEST, V98, P546, DOI 10.1378/chest.98.3.546; Rubins JB, 1996, CHEST, V110, P1271, DOI 10.1378/chest.110.5.1271; Salamonsen M, 2013, CHEST, V144, P930, DOI 10.1378/chest.12-2728; Sangsayunh Piamlarp, 2012, J Med Assoc Thai, V95 Suppl 8, pS6; SCHEURICH JW, 1989, SOUTH MED J, V82, P1487, DOI 10.1097/00007611-198912000-00008; See KC, 2013, RESPIROLOGY, V18, P534, DOI 10.1111/resp.12033; SENEFF MG, 1986, CHEST, V90, P97, DOI 10.1378/chest.90.1.97; Shen Y, 2013, EUR REV MED PHARMACO, V17, P201; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simel DL, 2008, RATIONAL CLIN EXAMIN; Simon RR, 1982, PROCEDURES TECHNIQUE; Soldati G, 2013, MULTIDISCIPLINARY RE, V8; STEWART BN, 1974, CHEST, V66, P456, DOI 10.1378/chest.66.4.456; SUAY VG, 1995, RESPIRATION, V62, P57; SUE DY, 1982, POSTGRAD MED, V72, P101, DOI 10.1080/00325481.1982.11716123; Swiderek J, 2010, CHEST, V137, P68, DOI 10.1378/chest.09-0641; Tavana S., 2009, Research Journal of Medical Sciences, V3, P91; Thomsen Todd W, 2006, N Engl J Med, V355, pe16, DOI 10.1056/NEJMvcm053812; VALDES L, 1991, CHEST, V99, P1097, DOI 10.1378/chest.99.5.1097; Villena V, 2004, CHEST, V125, P156, DOI 10.1378/chest.125.1.156; Villena V, 2000, AM J RESP CRIT CARE, V162, P1534, DOI 10.1164/ajrccm.162.4.9907047; Wayne DB, 2008, J HOSP MED, V3, P48, DOI 10.1002/jhm.268; WEINGARDT JP, 1994, J CLIN ULTRASOUND, V22, P419, DOI 10.1002/jcu.1870220702; WIGTON RS, 1989, ANN INTERN MED, V111, P932, DOI 10.7326/0003-4819-111-11-932; Yetkin O, 2006, RESP MED, V100, P1286, DOI 10.1016/j.rmed.2005.10.010; Zalt MB, 2012, J BRONCHOL INTERN PU, V19, P284, DOI 10.1097/LBR.0b013e3182720428; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zanforlin A, 2013, EUR REV MED PHARMACO, V17, P25; Zimmerman J E, 1975, Crit Care Med, V3, P69	131	26	30	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2422	2431		10.1001/jama.2014.5552	http://dx.doi.org/10.1001/jama.2014.5552			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938565				2022-12-28	WOS:000337301500023
J	Black, MM; Hurley, KM				Black, Maureen M.; Hurley, Kristen M.			Investment in early childhood development	LANCET			English	Editorial Material							ADULT HEALTH; INTERVENTION; STIMULATION; DEPRESSION; BEHAVIOR; PAKISTAN; OUTCOMES; TRIAL		[Black, Maureen M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Hurley, Kristen M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Black, MM (corresponding author), Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA.	mblack@peds.umaryland.edu		Black, Maureen/0000-0002-6427-4639				Black MM, 2014, ANN NY ACAD SCI, V1308, P1, DOI 10.1111/nyas.12351; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Campbell FA, 2012, DEV PSYCHOL, V48, P1033, DOI 10.1037/a0026644; Chan M, 2013, LANCET, V381, P1514, DOI 10.1016/S0140-6736(13)60944-7; Conti G, 2013, PEDIATRICS, V131, pS133, DOI 10.1542/peds.2013-0252d; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Gowani S, 2014, ANN NY ACAD SCI, V1308, P149, DOI 10.1111/nyas.12367; Hurley KM, 2011, J NUTR, V141, P489, DOI 10.3945/jn.110.130070; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rahman A, 2012, BRIT J PSYCHIAT, V201, P451, DOI 10.1192/bjp.bp.112.109207; Vazir S, 2013, MATERN CHILD NUTR, V9, P99, DOI 10.1111/j.1740-8709.2012.00413.x; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231; Yousafzai A. K., 2014, LANCET; Zafar S, 2014, ANN NY ACAD SCI, V1308, P107, DOI 10.1111/nyas.12339	16	18	18	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1244	1245		10.1016/S0140-6736(14)60607-3	http://dx.doi.org/10.1016/S0140-6736(14)60607-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7NB	24947105				2022-12-28	WOS:000343003400009
J	Smith, EA; Jahnke, SA; Poston, WSC; Williams, LN; Haddock, CK; Schroeder, SA; Malone, RE				Smith, Elizabeth A.; Jahnke, Sara A.; Poston, Walker S. C.; Williams, Larry N.; Haddock, Christopher K.; Schroeder, Steven A.; Malone, Ruth E.			Is It Time for a Tobacco-free Military?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							US MILITARY		[Smith, Elizabeth A.; Jahnke, Sara A.; Malone, Ruth E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Jahnke, Sara A.; Poston, Walker S. C.; Haddock, Christopher K.] Natl Dev & Res Inst, Leawood, KS USA; [Jahnke, Sara A.; Poston, Walker S. C.; Haddock, Christopher K.] Natl Dev & Res Inst, New York, NY USA; [Williams, Larry N.] Midwestern Univ, Coll Dent Med, Downers Grove, IL 60515 USA	University of California System; University of California San Francisco; National Development & Research Institutes, Inc; Midwestern University; Midwestern University - College of Dental Medicine - Illinois	Smith, EA (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Smith, Elizabeth/0000-0002-4712-513X	NATIONAL CANCER INSTITUTE [R01CA109153, R01CA157014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036507, R01DA036509] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA109153, R01 CA157014] Funding Source: Medline; NIDA NIH HHS [R01 DA036507, R01 DA036509] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 2009, COMB TOB US MIL VET, P12632, DOI 10.17226/12632; Arvey SR, 2008, MIL MED, V173, P985, DOI 10.7205/MILMED.173.10.985; Haddock CK, 2014, AM J PUBLIC HEALTH, V104, pE82, DOI 10.2105/AJPH.2013.301660; Smith EA, 2013, AM J PUBLIC HEALTH, V103, P599, DOI 10.2105/AJPH.2012.301041; Stein RJ, 2008, MIL MED, V173, P271, DOI 10.7205/MILMED.173.3.271	5	19	19	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					589	591		10.1056/NEJMp1405976	http://dx.doi.org/10.1056/NEJMp1405976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZL	24988299	Green Accepted, Green Published			2022-12-28	WOS:000340819600002
J	Lucas, JS; Zhang, YJ; Dudko, OK; Murre, C				Lucas, Joseph S.; Zhang, Yaojun; Dudko, Olga K.; Murre, Cornelis			3D Trajectories Adopted by Coding and Regulatory DNA Elements: First-Passage Times for Genomic Interactions	CELL			English	Article							IMMUNOGLOBULIN-HEAVY-CHAIN; V(D)J RECOMBINATION; B-CELLS; LYMPHOCYTE DEVELOPMENT; ANOMALOUS DIFFUSION; SEQUENCING REVEALS; ALLELIC EXCLUSION; VARIABLE REGION; MONTE-CARLO; IGH LOCUS	During B lymphocyte development, immunoglobulin heavy-chain variable (V-H), diversity (D-H), and joining (J(H)) segments assemble to generate a diverse antigen receptor repertoire. Here, we have marked the distal V-H and D-H-J(H)-E-mu regions with Tet-operator binding sites and traced their 3D trajectories in proB cells transduced with a retrovirus encoding Tetrepressor-EGFP. We found that these elements displayed fractional Langevin motion (fLm) due to the viscoelastic hindrance from the surrounding network of proteins and chromatin fibers. Using fractional Langevin dynamics modeling, we found that, with high probability, D(H)J(H) elements reach a V-H elementwithin minutes. Spatial confinement emerged as the dominant parameter that determined the frequency of such encounters. We propose that the viscoelastic nature of the nuclear environment causes coding elements and regulatory elements to bounce back and forth in a spring-like fashion until specific genomic interactions are established and that spatial confinement of topological domains largely controls first-passage times for genomic interactions.	[Lucas, Joseph S.; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, San Diego, CA 92093 USA; [Zhang, Yaojun; Dudko, Olga K.] Univ Calif San Diego, Dept Phys, San Diego, CA 92093 USA; [Zhang, Yaojun; Dudko, Olga K.] Univ Calif San Diego, Ctr Theoret Biol Phys, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dudko, OK (corresponding author), Univ Calif San Diego, Dept Phys, San Diego, CA 92093 USA.	dudko@physics.ucsd.edu; murre@biomail.ucsd.edu			National Institutes of Health [AI00880, AI082850]; National Science Foundation Faculty Early Career Development Award [MCB-0845099]; National Science Foundation Center for Theoretical Biological Physics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082850, R01AI100880, Z01AI000880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Faculty Early Career Development Award(National Science Foundation (NSF)); National Science Foundation Center for Theoretical Biological Physics(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Peter Geiduschek, Alex Bortnick, and Roy Riblet for editing the manuscript. We thank John Sedat, Richard Flavell, Cornelia Zorca, and Lena Koslover for stimulating discussions. We thank Claudia Bossen, Joe Pogliano, and Ralf Metzler for advice. We thank James Fitzpatrick and Jamie Kasuboski (Waitt Advanced Biophotonics Center Core Facility) for help with imaging and image analysis. J.S.L. was supported by a training grant from the National Institutes of Health (Cellular and Molecular Genetics). The studies were supported by the National Science Foundation Faculty Early Career Development Award (MCB-0845099) to O.K.D., by the grant from the National Institutes of Health (AI00880 and AI082850) to C.M., and by the National Science Foundation Center for Theoretical Biological Physics.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boveri T., 1909, ARCH ZELLFORSCH, V3, P181; Bronstein I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018102; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dietrich CR, 1997, SIAM J SCI COMPUT, V18, P1088, DOI 10.1137/S1064827592240555; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hawley RG, 1996, ANN NY ACAD SCI, V795, P341, DOI 10.1111/j.1749-6632.1996.tb52687.x; Hewitt SL, 2010, IMMUNOL REV, V237, P43, DOI 10.1111/j.1600-065X.2010.00931.x; Jeon JH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021103; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Lucas JS, 2011, CURR OPIN CELL BIOL, V23, P318, DOI 10.1016/j.ceb.2010.11.007; Lutz E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051106; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; MONTROLL EW, 1965, J MATH PHYS, V6, P167, DOI 10.1063/1.1704269; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; NUSSENZWEIG MC, 1988, J EXP MED, V167, P1969, DOI 10.1084/jem.167.6.1969; Onozawa M, 2012, GENE CHROMOSOME CANC, V51, P525, DOI 10.1002/gcc.21942; Rabl C, 1885, MORPHOL JB, V10, P214; Retter I, 2007, J IMMUNOL, V179, P2419, DOI 10.4049/jimmunol.179.4.2419; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Sedat J., 1978, S QUANT BIOL, V42, P331; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Weber SC, 2012, BIOPHYS J, V102, P2443, DOI 10.1016/j.bpj.2012.03.062; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	54	143	144	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					339	352		10.1016/j.cell.2014.05.036	http://dx.doi.org/10.1016/j.cell.2014.05.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998931	Bronze, Green Accepted			2022-12-28	WOS:000340943600014
J	Putterman, L				Putterman, Louis			BEHAVIOURAL ECONOMICS A caring majority secures the future	NATURE			English	Editorial Material									Brown Univ, Dept Econ, Providence, RI 02912 USA	Brown University	Putterman, L (corresponding author), Brown Univ, Dept Econ, Providence, RI 02912 USA.	louis_putterman@brown.edu						Cooper D., 2002, HDB EXPT EC, V2; Ertan A, 2009, EUR ECON REV, V53, P495, DOI 10.1016/j.euroecorev.2008.09.007; Feldman A. M., 2006, WELFARE EC SOCIAL CH, V2, P253; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Markussen T, 2014, REV ECON STUD, V81, P301, DOI 10.1093/restud/rdt022; Nikiforakis N, 2011, J ECON BEHAV ORGAN, V78, P319, DOI 10.1016/j.jebo.2011.01.017; Ostrom E., 1994, RULES GAMES COMMON P; Tyran J.-R., 2014, EXP EC; Van Lange P.A., 2014, REWARD PUNISHMENT SO	10	2	2	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					165	166		10.1038/nature13510	http://dx.doi.org/10.1038/nature13510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25008520				2022-12-28	WOS:000338649800033
J	Smith, JM				Smith, Jeanette M.			The Ride With A Snap, Venice, California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					114	115		10.1001/jama.2013.279601	http://dx.doi.org/10.1001/jama.2013.279601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005635				2022-12-28	WOS:000338511200001
J	Haegerich, TM; Dahlberg, LL; Simon, TR; Baldwin, GT; Sleet, DA; Greenspan, AI; Degutis, LC				Haegerich, Tamara M.; Dahlberg, Linda L.; Simon, Thomas R.; Baldwin, Grant T.; Sleet, David A.; Greenspan, Arlene I.; Degutis, Linda C.			Prevention of injury and violence in the USA	LANCET			English	Article							ADVERSE CHILDHOOD EXPERIENCES; TRAUMATIC BRAIN-INJURY; PEDIATRIC PRIMARY-CARE; UNITED-STATES; PUBLIC-HEALTH; OLDER-ADULTS; EMERGENCY-DEPARTMENT; INTERVENTIONS; RISK; DEATHS	In the first three decades of life, more individuals in the USA die from injuries and violence than from any other cause. Millions more people survive and are left with physical, emotional, and financial problems. Injuries and violence are not accidents; they are preventable. Prevention has a strong scientific foundation, yet efforts are not fully implemented or integrated into clinical and community settings. In this Series paper, we review the burden of injuries and violence in the USA, note effective interventions, and discuss methods to bring interventions into practice. Alliances between the public health community and medical care organisations, health-care providers, states, and communities can reduce injuries and violence. We encourage partnerships between medical and public health communities to consistently frame injuries and violence as preventable, identify evidence-based interventions, provide scientific information to decision makers, and strengthen the capacity of an integrated health system to prevent injuries and violence.	[Haegerich, Tamara M.; Dahlberg, Linda L.; Simon, Thomas R.; Baldwin, Grant T.; Sleet, David A.; Greenspan, Arlene I.; Degutis, Linda C.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Haegerich, Tamara M.; Dahlberg, Linda L.; Simon, Thomas R.; Baldwin, Grant T.; Sleet, David A.; Greenspan, Arlene I.; Degutis, Linda C.] US Dept HHS, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Haegerich, TM (corresponding author), Ctr Dis Control & Prevent, Div Unint Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA.	thaegerich@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		ACIP, 2012, SOC DET INJ; Adams WG, 2003, PEDIATRICS, V111, P626, DOI 10.1542/peds.111.3.626; [Anonymous], PREVENTING VIOLENCE, DOI DOI 10.1037/11385-004; [Anonymous], CDC INJ RES AG 2009; [Anonymous], MAT INF EARL CHILDH; Bilukha O, 2005, AM J PREV MED, V28, P11, DOI 10.1016/j.amepre.2004.10.004; Black M.C., 2011, NATL INTIMATE PARTNE; Brownson RC, 2012, DISSEMINATION IMPLEM, DOI 10.1093/acprof:oso/9780199751877.001.0001; Carande-Kulis VG, 2010, INJURY PREV, V16, pA249, DOI 10.1136/ip.2010.029215.886; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chorpita Bruce F, 2005, Ment Health Serv Res, V7, P5, DOI 10.1007/s11020-005-1962-6; Cook PJ, 2011, ECON J, V121, P445, DOI 10.1111/j.1468-0297.2011.02419.x; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crosby Alex E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; D'Onofrio G, 2008, ANN EMERG MED, V51, P742, DOI 10.1016/j.annemergmed.2007.11.028; D'Onofrio G, 2010, ACAD EMERG MED, V17, P903, DOI 10.1111/j.1553-2712.2010.00824.x; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Dellinger AM, 2009, FAM COMMUNITY HEALTH, V32, P115, DOI 10.1097/FCH.0b013e31819946e7; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Doll L., 2007, HDB INJURY VIOLENCE; Dubowitz H, 2009, PEDIATRICS, V123, P858, DOI 10.1542/peds.2008-1376; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2005, CHILD MALTREATMENT, V10, P5, DOI 10.1177/1077559504271287; Finkelhor D, 2009, PEDIATRICS, V124, P1411, DOI 10.1542/peds.2009-0467; Florence C, 2014, INJURY PREV, V20, P108, DOI 10.1136/injuryprev-2012-040622; Florence C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3313; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Gielen AC, 2002, ARCH PEDIAT ADOL MED, V156, P33, DOI 10.1001/archpedi.156.1.33; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Girasek DC, 2001, ACCIDENT ANAL PREV, V33, P455, DOI 10.1016/S0001-4575(00)00059-2; Haegerich TM, 2011, AM J LIFESTYLE MED, V5, P392, DOI 10.1177/1559827611409127; Hahn RA, 2005, AM J PREV MED, V28, P72, DOI 10.1016/j.amepre.2004.10.007; Hahn R, 2007, AM J PREV MED, V33, pS114, DOI 10.1016/j.amepre.2007.04.012; Hall JE, 2012, AM J PREV MED, V43, pS60, DOI 10.1016/j.amepre.2012.04.019; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Ikeda RM, 2010, AM J LIFESTYLE MED, V4, P5, DOI 10.1177/1559827609348459; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P619; Lee S., 2012, 12041201 WASH STAT I, P672; Lyons RA, 2010, INT J INJ CONTROL SA, V17, P145, DOI 10.1080/17457300903453104; MacDonald J, 2010, INJURY PREV, V16, P327, DOI 10.1136/ip.2009.024943; McClure R.J., 2004, SCI BASIS INJURY PRE; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller TR, 2006, INJURY PREVENTION CH; Neumann T, 2006, J TRAUMA, V61, P805, DOI 10.1097/01.ta.0000196399.29893.52; Owen N, 2012, DISSEMINATION IMPLEM, P114, DOI DOI 10.1093/ACPROF.OSO/9780199751877.003.0006; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Pollack KM, 2012, EPIDEMIOL REV, V34, P73, DOI 10.1093/epirev/mxr019; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Sachs-Ericsson N, 2009, J TRAUMA DISSOCIATIO, V10, P170, DOI 10.1080/15299730802624585; SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489; Scutchfield FD, 2012, AM J PREV MED, V42, pS1, DOI 10.1016/j.amepre.2012.01.027; Shakur H, 2012, LANCET, V380, P2062, DOI 10.1016/S0140-6736(12)62037-6; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Sleet DA, 2012, J SAFETY RES, V43, P233, DOI 10.1016/j.jsr.2012.09.002; Sleet David A, 2011, MMWR Suppl, V60, P78; Sleet DA, 2009, FAM COMMUNITY HEALTH, V32, P88, DOI 10.1097/01.FCH.0000347985.67681.9d; Sleet David A., 2009, P439, DOI 10.1007/978-3-7643-9923-8_27; Sogolow E. D., 2007, Handbook of injury and violence prevention, P493, DOI 10.1007/978-0-387-29457-5_28; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Stevens JA, 2013, HEALTH PROMOT PRACT, V14, P706, DOI 10.1177/1524839912463576; TENO J, 1990, J AM GERIATR SOC, V38, P1321, DOI 10.1111/j.1532-5415.1990.tb03455.x; The American Geriatrics Society and British Geriatric Society, 2010, AGS ABS CLIN PRACT G; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; TORELL U, 1995, J SAFETY RES, V26, P63, DOI 10.1016/0022-4375(95)00007-D; US Department of Health and Human Services Administration on Children and Families, 2011, DROP; Wandersman A, 2008, AM J COMMUN PSYCHOL, V41, P171, DOI 10.1007/s10464-008-9174-z; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Zaza S, 2001, AM J PREV MED, V21, P31, DOI 10.1016/S0749-3797(01)00377-4; Zaza S, 2005, GUIDE COMMUNITY PREV	81	29	29	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					64	74		10.1016/S0140-6736(14)60074-X	http://dx.doi.org/10.1016/S0140-6736(14)60074-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24996591	Green Accepted			2022-12-28	WOS:000338919600027
J	Lane, R				Lane, Richard			Harold Jaffe: tireless proponent of better health for the USA	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					15	15		10.1016/S0140-6736(14)61094-1	http://dx.doi.org/10.1016/S0140-6736(14)61094-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1XL	24998003				2022-12-28	WOS:000338919600010
J	Lorenzoni, L; Belloni, A; Sassi, F				Lorenzoni, Luca; Belloni, Annalisa; Sassi, Franco			Health-care expenditure and health policy in the USA versus other high-spending OECD countries	LANCET			English	Article							MEDICARE PART D; UNITED-STATES; HOSPITAL PRICES; DRUG COVERAGE; GROWTH; INSURANCE; LESSONS; INCOME; COSTS; IMPLEMENTATION	The USA has exceptional levels of health-care expenditure, but growth has slowed dramatically in recent years, amidst major efforts to close the coverage gap with other countries of the Organisation for Economic Co-operation and Development (OECD). We reviewed expenditure trends and key policies since 2000 in the USA and five other high-spending OECD countries. Higher health-sector prices explain much of the difference between the USA and other high-spending countries, and price dynamics are largely responsible for the slowdown in expenditure growth. Other high-spending countries did not face the same coverage challenges, and could draw from a broader set of policies to keep expenditure under control, but expenditure growth was similar to the USA. Tightening Medicare and Medicaid price controls on plans and providers, and leveraging the scale of the public programmes to increase efficiency in financing and care delivery, might prevent a future economic recovery from off setting the slowdown in health sector prices and expenditure growth.	[Lorenzoni, Luca; Belloni, Annalisa; Sassi, Franco] Org Econ Cooperat & Dev, Hlth Div, F-75016 Paris, France	Organisation for Economic Co-operation & Development (OECD)	Lorenzoni, L (corresponding author), Org Econ Cooperat & Dev, Hlth Div, 2 Rue Andre Pascal, F-75016 Paris, France.	luca.lorenzoni@oecd.org		Sassi, Franco/0000-0001-9773-2117; Belloni, Annalisa/0000-0001-6214-0285				Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; Anis Aslam, 2011, Open Med, V5, pe149; [Anonymous], 2013, REP C MED PAYM POL; Berenson RA, 2012, HEALTH AFFAIR, V31, P973, DOI 10.1377/hlthaff.2011.0920; Boards of Trustees Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, 2013, 2013 ANN REP; Bradford JW, 2011, ACCOUNTING COST US H; Busse R, 2004, HLTH CARE SYSTEMS TR; Centers for Medicare and Medicaid Services, 2013, NAT HLTH STAT; Centers for Medicare & Medicaid Services, 2011, MED MED STAT S; Chandra A, 2013, PAN EC ACT IN PRESS; CHANDRA A., 2011, TECHNOLOGY GROWTH EX; Cohen J, 2013, HEALTH AFFAIR, V32, P762, DOI 10.1377/hlthaff.2012.0707; Commission des Comptes de la Securite sociale, 2010, COMPT SEC SOC RES 20; Congressional Budget Office, CBOS MAY 2013 EST EF; Cutler DM, 2013, HEALTH AFFAIR, V32, P841, DOI 10.1377/hlthaff.2012.0289; DeNavas-Walt C., 2012, INCOME POVERTY HLTH; Department of Health and Human Services, 2011, CONN KIDS COV STEAD; Department of Health and Human Services, 2011, FED REG; Department of Health and Human Services, 2011, HIGH REB BRANDN DRUG; Docteur E., 2004, HLTH SYSTEM REFORM L; Docteur E, 2009, DOES QUALITY US HLTH; Douven R, 2012, 201201 NZA; Eurostat and Organisation for Economic Co-operation and Development, 2012, EUR OECD METH MAN PU; Forde I, 2013, HEALTH POLICY, V112, P4, DOI 10.1016/j.healthpol.2013.01.018; Harper MJ, 2010, MON LABOR REV, V133, P16; Hartman M, 2013, HEALTH AFFAIR, V32, P87, DOI 10.1377/hlthaff.2012.1206; Hartwig J, 2008, J HEALTH ECON, V27, P603, DOI 10.1016/j.jhealeco.2007.05.006; Henry J Kaiser Family Foundation, 2010, EXT COBRA SUBS UPD; Henry J Kaiser Family Foundation, 2013, AFF CAR ACT 3 YEARS; Holahan J, 2013, ACA IMPLEMENTATION M; Holahan J, 2012, NEW ENGL J MED, V367, P393, DOI 10.1056/NEJMp1204899; Iglehart JK, 2011, HEALTH AFFAIR, V30, P1627, DOI 10.1377/hlthaff.2011.0836; Institute of Medicine, 2013, VAR HLTH CAR SPEND T; Kocher R, 2011, NEW ENGL J MED, V365, P1370, DOI 10.1056/NEJMp1109649; Koechlin F, 2010, OECD HLTH WORKING PA; Law MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023030; Leu R. E., 2009, SWISS DUTCH HLTH INS; Levine M., 2013, WHY HAS GROWTH SPEND; Lewis VA, 2013, HEALTH SERV RES, V48, P1840, DOI 10.1111/1475-6773.12102; Marmor T, 2011, SOC SCI MED, V72, P125, DOI 10.1016/j.socscimed.2010.10.016; Martin AB, 2014, HEALTH AFFAIR, V33, P67, DOI 10.1377/hlthaff.2013.1254; Mason A, 2010, J CLIN ONCOL, V28, P3234, DOI 10.1200/JCO.2009.26.2758; McKellar MR, 2013, HLTH SERV RES, DOI 10.1111/1475-6773.12131; McWilliams JM, 2011, JAMA-J AM MED ASSOC, V306, P402, DOI 10.1001/jama.2011.1026; Mechanic R, 2012, NEW ENGL J MED, V367, P1873, DOI 10.1056/NEJMp1210823; Medicare Payment Advisory Commission, 2011, REP C REG VAR MED SE; Melnick GA, 2011, HEALTH AFFAIR, V30, P1728, DOI 10.1377/hlthaff.2010.0406; Mladovsky Philipa, 2012, HLTH POLICY RESPONSE; MORGAN D, 2013, OECD HLTH WORKING PA, V60; Moriya AS, 2010, HEALTH ECON POLICY L, V5, P459, DOI 10.1017/S1744133110000083; Mulcahy A, 2013, NEW ENGL J MED, V368, P2105, DOI 10.1056/NEJMsa1212779; Murray R, 2009, HEALTH AFFAIR, V28, P1395, DOI 10.1377/hlthaff.28.5.1395; National Research Council and Institute of Medicine, 2013, US HLTH INT PERSP SH; Oberlander J, 2011, J HEALTH POLIT POLIC, V36, P477, DOI 10.1215/03616878-1271126; OECD, 2000, SYST HLTH ACC; Ognyanova D., 2011, Eurohealth, V17, P11; Organisation for Economic Co-operation and Development, 2013, HLTH GLANC; Organisation for Economic Co-operation and Development, OECD HLTH STAT; Organisation for Economic Co-operation and Development Health Division, MAN HOSP VOL GERM EX; Paris Valerie, 2010, OECD HLTH WORKING PA; Polinski JM, 2010, J AM GERIATR SOC, V58, P1764, DOI 10.1111/j.1532-5415.2010.03025.x; Quentin W, 2013, HEALTH AFFAIR, V32, P713, DOI 10.1377/hlthaff.2012.0876; Reinhardt UE, 2011, HEALTH AFFAIR, V30, P2125, DOI 10.1377/hlthaff.2011.0813; Robinson JC, 2013, HEALTH AFFAIR, V32, P1392, DOI 10.1377/hlthaff.2013.0188; Rowland D, 2009, NEW ENGL J MED, V360, P1273, DOI 10.1056/NEJMp0901072; Ryu AJ, 2013, HEALTH AFFAIR, V32, P835, DOI 10.1377/hlthaff.2012.1297; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Schoen C, 2010, HEALTH AFFAIR, V29, P2323, DOI 10.1377/hlthaff.2010.0862; Shrank WH, 2011, NEW ENGL J MED, V364, P598, DOI 10.1056/NEJMp1011625; Sinnott SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064914; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; Squires DA`, 2012, EXPLAINING HIGH HLTH; Stabile M, 2013, HEALTH AFFAIR, V32, P643, DOI 10.1377/hlthaff.2012.1252; Sutherland J. M., 2011, HOSP PAYMENT MECH OV; The Patented Medicine Prices Review Board, 2013, AN SNAPSH INT GEN PR; White C, 2007, HEALTH AFFAIR, V26, P154, DOI 10.1377/hlthaff.26.1.154; White J, 2013, HEALTH ECON POLICY L, V8, P289, DOI 10.1017/S1744133112000308; Young K, 2013, ENROLLMENT DRIVEN EX; Zhang YT, 2012, NEW ENGL J MED, V367, P1724, DOI 10.1056/NEJMsa1203980; Zhang Y, 2009, HEALTH AFFAIR, V28, pW317, DOI 10.1377/hlthaff.28.2.w317	80	80	80	2	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					83	92		10.1016/S0140-6736(14)60571-7	http://dx.doi.org/10.1016/S0140-6736(14)60571-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1XL	24993914				2022-12-28	WOS:000338919600029
J	Prejean, SG; Haney, MM				Prejean, Stephanie G.; Haney, Matthew M.			Shaking up volcanoes	SCIENCE			English	Editorial Material									[Prejean, Stephanie G.; Haney, Matthew M.] US Geol Survey, Volcano Sci Ctr, Anchorage, AK 99508 USA	United States Department of the Interior; United States Geological Survey	Prejean, SG (corresponding author), US Geol Survey, Volcano Sci Ctr, Anchorage, AK 99508 USA.	sprejean@usgs.gov; mhaney@usgs.gov		Prejean, Stephanie/0000-0003-0510-1989				Battaglia J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052003; Brenguier F, 2014, SCIENCE, V345, P80, DOI 10.1126/science.1254073; Brodsky EE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002321; Campillo M, 2003, SCIENCE, V299, P547, DOI 10.1126/science.1078551; Hill D. P., 2007, TREATISE GEOPHYS EAR, V4, P257, DOI [10.1016/B978-044452748-6.00070-5, DOI 10.1016/B978-044452748-6.00070-5]; Hill DP, 2002, PHYS TODAY, V55, P41, DOI 10.1063/1.1535006; Manga M, 2006, ANNU REV EARTH PL SC, V34, P263, DOI 10.1146/annurev.earth.34.031405.125125; Miyazawa M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049795; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339	9	4	4	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					39	39		10.1126/science.1256196	http://dx.doi.org/10.1126/science.1256196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994641				2022-12-28	WOS:000338284400040
J	de Boer, VCJ; Houten, SM				de Boer, Vincent C. J.; Houten, Sander M.			A Mitochondrial Expatriate: Nuclear Pyruvate Dehydrogenase	CELL			English	Editorial Material							METABOLISM; PROLIFERATION; ACETYLATION	The pyruvate dehydrogenase complex (PDC) catalyzes the conversion of pyruvate into acetyl-CoA, a critical step in metabolism. Sutendra et al. now demonstrate that PDC can translocate from the mitochondria to the nucleus to provide acetyl-CoA necessary for histone acetylation, suggesting a new pathway for mitochondrial-nuclear communication.	[de Boer, Vincent C. J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [de Boer, Vincent C. J.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Houten, Sander M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Houten, Sander M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	de Boer, VCJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.c.deboer@amc.uva.nl; sander.houten@mssm.edu	de Boer, Vincent C.J./F-4879-2010; Houten, Sander/Y-3599-2019; de Boer, Vincent CJ/L-2196-2016	de Boer, Vincent C.J./0000-0001-9928-1698; Houten, Sander/0000-0002-6167-9147; de Boer, Vincent CJ/0000-0001-9928-1698				Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Pougovkina O., 2014, HUM MOL GENET; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	10	21	21	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					9	10		10.1016/j.cell.2014.06.018	http://dx.doi.org/10.1016/j.cell.2014.06.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995972	Bronze			2022-12-28	WOS:000340943100001
J	Outterson, K				Outterson, Kevin			Clinical Trial Transparency - Antidote to Weaker Off-Label-Promotion Rules?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCESS		Boston Univ, Sch Law, Boston, MA 02215 USA	Boston University	Outterson, K (corresponding author), Boston Univ, Sch Law, Boston, MA 02215 USA.			Outterson, Kevin/0000-0003-2513-3216				Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526	5	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					1	3		10.1056/NEJMp1402969	http://dx.doi.org/10.1056/NEJMp1402969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK2RA	24988551				2022-12-28	WOS:000338265700001
J	McCartney, M				McCartney, Margaret			Jeremy Hunt's bizarre ideas show that he doesn't understand general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Adams Stephen, 2014, DAILY MAIL; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; NHS Choices, GUID NHS WAIT TIM	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2014	349								g4368	10.1136/bmj.g4368	http://dx.doi.org/10.1136/bmj.g4368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YY	24986834	Green Published, hybrid			2022-12-28	WOS:000338645400021
J	Wang, Q				Wang, Qiang			Rural students are being left behind in China	NATURE			English	Editorial Material									Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	qiangwang7@gmail.com	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	7	7	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					445	445		10.1038/510445a	http://dx.doi.org/10.1038/510445a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24965616	Bronze			2022-12-28	WOS:000337806300012
J	Frank, M; Knechtli, C				Frank, Michael; Knechtli, Christopher			Lymphoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelharris681@btinternet.com						Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2014	348								g3736	10.1136/bmj.g3736	http://dx.doi.org/10.1136/bmj.g3736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LH	24934281	Bronze, Green Published			2022-12-28	WOS:000337805800010
J	Cooney, G; Dwan, K; Mead, G				Cooney, Gary; Dwan, Kerry; Mead, Gillian			Exercise for Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cooney, Gary] Royal Edinburgh & Associated Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Dwan, Kerry] Univ Liverpool, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England; [Mead, Gillian] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH8 9YL, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Liverpool; University of Edinburgh	Cooney, G (corresponding author), Royal Edinburgh & Associated Hosp, Div Psychiat, NHS Lothian, Morningside Terrace, Edinburgh EH10 5HF, Midlothian, Scotland.	garycooney@gmail.com	Dwan, Kerry/AFK-6469-2022; Dwan, Kerry/AAG-4726-2022	Dwan, Kerry/0000-0001-6918-1215; Dwan, Kerry/0000-0001-6918-1215	Medical Research Council [MR/K026992/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Chalder M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16100; Chalder M, 2012, HEALTH TECHNOL ASSES, V16, piii; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Deeks JJ, ANAL DATA UNDERTAKIN; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; National Institute for Health and Clinical Excellence, DEPR TREATM MAN DEPR	7	28	28	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2432	2433		10.1001/jama.2014.4930	http://dx.doi.org/10.1001/jama.2014.4930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938566				2022-12-28	WOS:000337301500024
J	Kaunitz, J				Kaunitz, Julius			Landmarks in Simple Pleural Effusions (Reprinted from vol 113, pg 1312, 1939)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Damoiseau H., 1844, RECHERCHES CLIN PLUS, P2; Kaunitz J, 1936, AM J ROENTGENOL RADI, V35, P57; Kaunitz J, 1939, J AMER MED ASSOC, V113, P1312, DOI 10.1001/jama.1939.02800390034009; Kaunitz Julius, 1936, BRIT J RADIOL, V9, P644	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2444	2444		10.1001/jama.2013.279594	http://dx.doi.org/10.1001/jama.2013.279594			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938578				2022-12-28	WOS:000337301500035
J	Moreno-Estrada, A; Gignoux, CR; Fernandez-Lopez, JC; Zakharia, F; Sikora, M; Contreras, AV; Acuna-Alonzo, V; Sandoval, K; Eng, C; Romero-Hidalgo, S; Ortiz-Tello, P; Robles, V; Kenny, EE; Nuno-Arana, I; Barquera-Lozano, R; Macin-Perez, G; Granados-Arriola, J; Huntsman, S; Galanter, JM; Via, M; Ford, JG; Chapela, R; Rodriguez-Cintron, W; Rodriguez-Santana, JR; Romieu, I; Sienra-Monge, JJ; Navarro, BD; London, SJ; Ruiz-Linares, A; Garcia-Herrera, R; Estrada, K; Hidalgo-Miranda, A; Jimenez-Sanchez, G; Carnevale, A; Soberon, X; Canizales-Quinteros, S; Rangel-Villalobos, H; Silva-Zolezzi, I; Burchard, EG; Bustamante, CD				Moreno-Estrada, Andres; Gignoux, Christopher R.; Carlos Fernandez-Lopez, Juan; Zakharia, Fouad; Sikora, Martin; Contreras, Alejandra V.; Acuna-Alonzo, Victor; Sandoval, Karla; Eng, Celeste; Romero-Hidalgo, Sandra; Ortiz-Tello, Patricia; Robles, Victoria; Kenny, Eimear E.; Nuno-Arana, Ismael; Barquera-Lozano, Rodrigo; Macin-Perez, Gaston; Granados-Arriola, Julio; Huntsman, Scott; Galanter, Joshua M.; Via, Marc; Ford, Jean G.; Chapela, Rocio; Rodriguez-Cintron, William; Rodriguez-Santana, Jose R.; Romieu, Isabelle; Jose Sienra-Monge, Juan; del Rio Navarro, Blanca; London, Stephanie J.; Ruiz-Linares, Andres; Garcia-Herrera, Rodrigo; Estrada, Karol; Hidalgo-Miranda, Alfredo; Jimenez-Sanchez, Gerardo; Carnevale, Alessandra; Soberon, Xavier; Canizales-Quinteros, Samuel; Rangel-Villalobos, Hector; Silva-Zolezzi, Irma; Burchard, Esteban Gonzalez; Bustamante, Carlos D.			HUMAN GENETICS The genetics of Mexico recapitulates Native American substructure and affects biomedical traits	SCIENCE			English	Article							ANCESTRY; ADMIXTURE; POPULATIONS; CHROMOSOME; DIVERSITY; SAMPLE; RISK	Mexico harbors great cultural and ethnic diversity, yet fine-scale patterns of human genome-wide variation from this region remain largely uncharacterized. We studied genomic variation within Mexico from over 1000 individuals representing 20 indigenous and 11 mestizo populations. We found striking genetic stratification among indigenous populations within Mexico at varying degrees of geographic isolation. Some groups were as differentiated as Europeans are from East Asians. Pre-Columbian genetic substructure is recapitulated in the indigenous ancestry of admixed mestizo individuals across the country. Furthermore, two independently phenotyped cohorts of Mexicans and Mexican Americans showed a significant association between subcontinental ancestry and lung function. Thus, accounting for fine-scale ancestry patterns is critical for medical and population genetic studies within Mexico, in Mexican-descent populations, and likely in many other populations worldwide.	[Moreno-Estrada, Andres; Zakharia, Fouad; Sikora, Martin; Sandoval, Karla; Ortiz-Tello, Patricia; Robles, Victoria; Kenny, Eimear E.; Rodriguez-Santana, Jose R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Gignoux, Christopher R.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Carlos Fernandez-Lopez, Juan; Contreras, Alejandra V.; Romero-Hidalgo, Sandra; Rodriguez-Santana, Jose R.; Garcia-Herrera, Rodrigo; Estrada, Karol; Hidalgo-Miranda, Alfredo; Jimenez-Sanchez, Gerardo; Carnevale, Alessandra; Soberon, Xavier; Canizales-Quinteros, Samuel; Silva-Zolezzi, Irma] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor; Barquera-Lozano, Rodrigo; Macin-Perez, Gaston] ENAH, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor; Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Eng, Celeste; Huntsman, Scott; Galanter, Joshua M.; Via, Marc; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Nuno-Arana, Ismael; Rangel-Villalobos, Hector] Univ Guadalajara, Inst Invest Genet Mol, Ocotlan, Mexico; [Granados-Arriola, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Galanter, Joshua M.; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ford, Jean G.] Brooklyn Hosp Ctr, Brooklyn, NY USA; [Chapela, Rocio; Romieu, Isabelle] INER, Mexico City, DF, Mexico; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; Ctr Neumol Pediat, San Juan, PR USA; Int Agcy Res Canc, F-69372 Lyon, France; [Jose Sienra-Monge, Juan; del Rio Navarro, Blanca] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [London, Stephanie J.] NIEHS, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico	Stanford University; University of California System; University of California San Francisco; Instituto Nacional de Medicina Genomica; University of London; University College London; University of California System; University of California San Francisco; Universidad de Guadalajara; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of California System; University of California San Francisco; Brooklyn Hospital Center; World Health Organization; International Agency for Research on Cancer (IARC); Hospital Infantil de Mexico Federico Gomez; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Universidad Nacional Autonoma de Mexico	Moreno-Estrada, A (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	morenoe@stanford.edu; esteban.burchard@ucsf.edu; cdbustam@stanford.edu	Hidalgo-Miranda, Alfredo/B-2123-2010; Moreno-Estrada, Andres/R-3950-2017; Ruiz-Linares, Andres/AAR-1104-2021; Moreno-Estrada, Andres/AAP-4657-2021; Via, Marc/L-6511-2014; Sikora, Martin/C-8609-2015; Contreras, Alejandra/E-7815-2013; Fernandez, Juan Carlos/C-4976-2013; London, Stephanie/C-3734-2019; RANGEL-VILLALOBOS, HECTOR/C-5081-2018	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Moreno-Estrada, Andres/0000-0001-8329-8292; Ruiz-Linares, Andres/0000-0001-8372-1011; Moreno-Estrada, Andres/0000-0001-8329-8292; Via, Marc/0000-0002-9966-9921; Sikora, Martin/0000-0003-2818-8319; Contreras, Alejandra/0000-0003-3653-5958; Fernandez, Juan Carlos/0000-0003-3680-4193; London, Stephanie/0000-0003-4911-5290; Bustamante, Carlos D./0000-0002-4187-7920; Romero-Hidalgo, Sandra/0000-0003-3077-7825; Garcia Herrera, Ricardo/0000-0003-2456-4727; Sandoval, Karla/0000-0002-6175-2463; Garcia-Herrera, Rodrigo/0000-0002-7972-5746; Galanter, Joshua/0000-0002-2561-6384; Barquera, Rodrigo/0000-0003-0518-4518; RANGEL-VILLALOBOS, HECTOR/0000-0003-2641-8782	Stanford University; Department of Genetics; Federal Government of Mexico; Ministry of Health; Mexican Health Foundation (FUNSALUD); Gonzalo Rio Arronte Foundation; George Rosenkranz Prize for Health Care Research in Developing Countries; University of California San Francisco (UCSF) Chancellor's Research Fellowship; Dissertation Year Fellowship; NIH Training Grants [T32GM007175, T32HG000044]; Robert Wood Johnson Foundation Amos Medical Faculty Development Award; Sandler Foundation; American Asthma Foundation; CONACYT [129693]; BBSRC grant [BB/I021213/1]; National Institutes of Health (NIH) [R01GM090087, R01HG003229, ES015794, GM007546, GM061390, HL004464, HL078885, HL088133, HL111636, RR000083, P60MD006902, ZIA ES49019]; National Science Foundation [DMS-1201234]; Intramural Research Program of NIH, National Institute of Environmental Health Sciences; BBSRC [BB/I021213/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I021213/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111636, R01HL078885, R01HL088133, K23HL004464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019, ZIAES043012, R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, T32GM007546, U19GM061390, R01GM083606, R01GM090087, T32GM007175] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R13MD008154, P60MD006902] Funding Source: NIH RePORTER	Stanford University(Stanford University); Department of Genetics; Federal Government of Mexico; Ministry of Health; Mexican Health Foundation (FUNSALUD); Gonzalo Rio Arronte Foundation; George Rosenkranz Prize for Health Care Research in Developing Countries; University of California San Francisco (UCSF) Chancellor's Research Fellowship; Dissertation Year Fellowship; NIH Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation Amos Medical Faculty Development Award(Robert Wood Johnson Foundation (RWJF)); Sandler Foundation; American Asthma Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of NIH, National Institute of Environmental Health Sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank all volunteers for generously donating DNA samples and participating in the study. This project was possible with the joint support from multiple Institutions in Mexico and the United States. Stanford University supported C.D.B. with funding from the Department of Genetics. INMEGEN received support from the Federal Government of Mexico, particularly the Ministry of Health, the Mexican Health Foundation (FUNSALUD), and the Gonzalo Rio Arronte Foundation. State governments and universities of Durango, Campeche, Guanajuato, Guerrero, Oaxaca, Sonora, Tamaulipas, Veracruz, Yucatan, and Zacatecas contributed significantly to this work. This research was also supported by the George Rosenkranz Prize for Health Care Research in Developing Countries awarded to A.M.-E.; University of California San Francisco (UCSF) Chancellor's Research Fellowship, Dissertation Year Fellowship, and NIH Training Grants T32GM007175 and T32HG000044 (to C. R. G.); the Robert Wood Johnson Foundation Amos Medical Faculty Development Award; the Sandler Foundation; the American Asthma Foundation (to E. G. B.); CONACYT grant 129693 (to H. R.-V.); BBSRC grant BB/I021213/1 (to A. R.-L.); the National Institutes of Health (NIH) (grants R01GM090087, R01HG003229, ES015794, GM007546, GM061390, HL004464, HL078885, HL088133, HL111636, RR000083, P60MD006902, and ZIA ES49019); and National Science Foundation award DMS-1201234. This work was supported in part by the Intramural Research Program of NIH, National Institute of Environmental Health Sciences (to S.J.L.). Some computations were performed using the UCSF Biostatistics High Performance Computing System. We also thank B. Henn, S. Gravel, and J. Byrnes for helpful discussions; C. Gunter and M. Carpenter for editing the manuscript; and M. Morales for informatics and programming support. C. D. B. is on the advisory board of a project at 23andMe; and on the scientific advisory boards of Personalis, Inc.; InVitae; Etalon, Inc.; and Ancestry.com. The collections and methods for the Population Reference Sample (POPRES) are described by Nelson et al. (2008). The POPRES data sets used for the analyses described here were obtained from dbGaP through accession number phs000145.v1.p1. Access to the MCCAS data set may be obtained under the terms of a data transfer agreement with the National Institute of Environmental Health Sciences; the contact is S.J.L.. Individual-level genotypes for new data presented in this study are available, through a data access agreement to respect the privacy of the participants for the transfer of genetic data, by contacting C.D.B., A.M.-E., and INMEGEN (http://www.inmegen.gob.mx/).	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Brisbin A, 2012, HUM BIOL, V84, P343, DOI 10.3378/027.084.0401; CAMPBELL L, 1985, ANNU REV ANTHROPOL, V14, P187; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Gorostiza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044666; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lisker R, 1996, HUM BIOL, V68, P395; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pascual Soto Arturo, 2006, TAJIN BUSCA ORIGENES; Peralta CA, 2010, AM J NEPHROL, V31, P202, DOI 10.1159/000268955; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Sandoval K, 2012, AM J PHYS ANTHROPOL, V148, P395, DOI 10.1002/ajpa.22062; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	31	305	311	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1280	1285		10.1126/science.1251688	http://dx.doi.org/10.1126/science.1251688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926019	Green Accepted			2022-12-28	WOS:000337077500040
J	El Arifeen, S; Hill, K; Ahsan, KZ; Jamil, K; Nahar, Q; Streatfield, PK				El Arifeen, Shams; Hill, Kenneth; Ahsan, Karar Zunaid; Jamil, Kanta; Nahar, Quamrun; Streatfield, Peter Kim			Maternal mortality in Bangladesh: a Countdown to 2015 country case study	LANCET			English	Article							DECLINE; MATLAB	Background Bangladesh is one of the only nine Countdown countries that are on track to achieve the primary target of Millennium Development Goal (MDG) 5 by 2015. It is also the only low-income or middle-income country with two large, nationally-representative, high-quality household surveys focused on the measurement of maternal mortality and service use. Methods We use data from the 2001 and 2010 Bangladesh Maternal Mortality Surveys to measure change in the maternal mortality ratio (MMR) and from these and six Bangladesh Demographic and Health Surveys to measure changes in factors potentially related to such change. We estimate the changes in risk of maternal death between the two surveys using Poisson regression. Findings The MMR fell from 322 deaths per 100 000 livebirths (95% CI 253-391) in 1998-2001 to 194 deaths per 100 000 livebirths (149-238) in 2007-10, an annual rate of decrease of 5.6%. This decrease rate is slightly higher than that required (5.5%) to achieve the MDG target between 1990 and 2015. The key contribution to this decrease was a drop in mortality risk mainly due to improved access to and use of health facilities. Additionally, a number of favourable changes occurred during this period: fertility decreased and the proportion of births associated with high risk to the mother fell; income per head increased sharply and the poverty rate fell; and the education levels of women of reproductive age improved substantially. We estimate that 52% of maternal deaths that would have occurred in 2010 in view of 2001 rates were averted because of decreases in fertility and risk of maternal death. Interpretation The decrease in MMR in Bangladesh seems to have been the result of factors both within and outside the health sector. This finding holds important lessons for other countries as the world discusses and decides on the post-MDG goals and strategies. For Bangladesh, this case study provides a strong rationale for the pursuit of a broader developmental agenda alongside increased and accelerated investments in improving access to and quality of public and private health-care facilities providing maternal health in Bangladesh.	[El Arifeen, Shams; Nahar, Quamrun; Streatfield, Peter Kim] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Hill, Kenneth] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Ahsan, Karar Zunaid] Univ N Carolina, MEASURE Evaluat, Chapel Hill, NC USA; [Jamil, Kanta] USAID, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; United States Agency for International Development (USAID)	El Arifeen, S (corresponding author), ICDDR B, Ctr Children & Adolescent Hlth, Dhaka 1212, Bangladesh.	shams@icddrb.org	Ahsan, Karar/ABB-2160-2020	Ahsan, Karar/0000-0001-7630-288X	United States Agency for International Development; UK Department for International Development; Bill & Melinda Gates Foundation	United States Agency for International Development(United States Agency for International Development (USAID)); UK Department for International Development; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	United States Agency for International Development, UK Department for International Development, Bill & Melinda Gates Foundation.	Bangladesh Bureau of Statistics (BBS), 2012, REPORT OF THE HOUSEH; Bangladesh Bureau of Statistics (BBS), 2010, REPORT ON MONITORING; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, V91, P914, DOI 10.2471/BLT.13.117598; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; Dieltiens G, 2005, MET NEED FOR LIFE SA; Dubourg D, 2003, THE UNMET OBSTETRIC; Government of Bangladesh (GOB), 2003, HEALTH AND POPULATIO; Government of Bangladesh (GOB), 2010, BANGLADESH ECONOMIC; Government of Bangladesh (GOB), 2013, ANNUAL REPORT 2011 2; Government of Bangladesh (GOB), 2010, NATIONAL HEALTH ACCO; Government of Bangladesh (GOB), 2011, END LINE EVALUATION; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; ICF International, 2012, MEASURE DHS STATCOMP; Jain AK, 2011, STUD FAMILY PLANN, V42, P247, DOI 10.1111/j.1728-4465.2011.00288.x; Khan R, EXAMINING BIRTH PLAN; Lohr Sharon L., 1999, SAMPLING DESIGN AND; Mridha MK, 2009, J HEALTH POPUL NUTR, V27, P124; Mridha MK, 2011, ASSESSMENT OF MATERN; Naripokkho, 2006, GOVERNMENT POLICIES; National Institute of Population Research and Training (NIPORT) MEASURE Evaluation and ICDDR B, 2012, BANGLADESH MATERNAL; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGLADESH DEMOGRAPH; National Institute of Population Research and Training (NIPORT) ORC Macro Johns Hopkins University and ICDDR B, 2003, BANGLADESH MATERNAL; Powers DA, 2011, STATA J, V11, P556, DOI 10.1177/1536867X1101100404; Rahman SA, 2003, MATERNAL HEALTH REVI; Requejo J, 2012, BUILDING A FUTURE FO; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Schurmann AT, 2009, J HEALTH POPUL NUTR, V27, P505; Singh S, 2012, INT PERSPECT SEX R H, V38, P122, DOI 10.1363/3812212; StataCorp, 2011, STATA STATISTICAL SO; Tomkins A, 2001, BRIT J NUTR, V85, pS93, DOI 10.1079/BJN2001358; WHO U. UNFPA The World Bank, 2012, TRENDS MAT MORT 1990; World Data Atlas, 2013, BANGLADESH MOBILE CE; World Health Organisation, 2007, VERBAL AUTOPSY STAND	35	97	97	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1366	1374		10.1016/S0140-6736(14)60955-7	http://dx.doi.org/10.1016/S0140-6736(14)60955-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	24990814				2022-12-28	WOS:000343004000026
J	Viner, RM; Hargreaves, DS; Coffey, C; Patton, GC; Wolfe, I				Viner, Russell M.; Hargreaves, Dougal S.; Coffey, Carolyn; Patton, George C.; Wolfe, Ingrid			Deaths in young people aged 0-24 years in the UK compared with the EU15+countries, 1970-2008: analysis of the WHO Mortality Database	LANCET			English	Article							PRETERM BIRTHS; TRENDS; EUROPE; PREVALENCE; COUNTRIES	Background Concern is growing that mortality and health in children and young people in the UK lags behind that of similar countries. Methods We analysed death registry data provided to the WHO Mortality Database to compare UK mortality for children and young people aged 0-24 years with that of European Union member states (before May, 2004, excluding the UK, plus Australia, Canada, and Norway [the EU15+ countries]) from 1970 to 2008 using the WHO World Mortality Database. We grouped causes of death by Global Burden of Disease classification: communicable, nutritional, or maternal causes; non-communicable disorders; and injury. UK mortality trends were compared with quartiles of mortality in EU15+ countries. We used quasi-likelihood Poisson models to explore differences between intercepts and slopes between the UK and the EU15+ countries. Findings In 1970, UK total mortality was in the best EU15+ quartile (<25th centile) for children and young people aged 1-24 years, with UK infant mortality similar to the EU15+ median. Subsequent mortality reductions in the UK were smaller than were those in the EU15+ countries in all age groups. By 2008, total mortality for neonates, infants, and children aged 1-4 years in the UK was in the worst EU15+ quartile (>75th centile). In 2008, UK annual excess mortality compared with the EU15+ median was 1035 deaths for infants and 134 for children aged 1-9 years. Mortality from non-communicable diseases in the UK fell from being roughly equivalent to the EU15+ median in 1970 to the worst quartile in all age groups by 2008, with 446 annual excess deaths from non-communicable diseases in the UK (280 for young people aged 10-24 years) in 2008. UK mortality from injury remained in the best EU15+ quartile for the study period in all age groups. Interpretation The UK has not matched the gains made in child, adolescent, and young adult mortality by other comparable countries in the 40 years since 1970, particularly for infant deaths and mortality from non-communicable diseases, including neuropsychiatric disorders. The UK needs to identify and address amenable social determinants and health system factors that lead to poor health outcomes for infants and for children and young people with chronic disorders.	[Viner, Russell M.; Hargreaves, Dougal S.] UCL Inst Child Hlth, London WC1N 1EH, England; [Coffey, Carolyn; Patton, George C.] Univ Melbourne, Ctr Adolescent Hlth, Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic 3010, Australia; [Wolfe, Ingrid] Evelina London Childrens Hosp, Kings Coll London, London, England	University of London; University College London; Murdoch Children's Research Institute; University of Melbourne; University of London; King's College London	Viner, RM (corresponding author), UCL Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England.	r.viner@ucl.ac.uk	Ribeiro, Ana Cristina/HHN-7466-2022; Patton, George C/B-5246-2013; Viner, Russell M/A-1441-2009	Ribeiro, Ana Cristina/0000-0002-0493-8376; Patton, George C/0000-0001-5039-8326; Viner, Russell M/0000-0003-3047-2247; Wolfe, Ingrid/0000-0002-4717-7634	Commonwealth Fund	Commonwealth Fund	DSH was supported for this study by The Commonwealth Fund; the views presented here are those of the authors and should not be attributed to The Commonwealth Fund.	Anderson HR, 2008, INT J EPIDEMIOL, V37, P573, DOI 10.1093/ije/dyn039; [Anonymous], 2012, NAT PAED DIAB AUD RE; Armour-Marshall J, 2012, EUR J PUBLIC HEALTH, V22, P61, DOI 10.1093/eurpub/ckr004; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bonett DG, 2002, PSYCHOL METHODS, V7, P370, DOI 10.1037//1082-989X.7.3.370; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Euro-Peristat Project, 2013, EUROPEAN PERINATAL H; Eurostat, 2010, ROAD SAF STAT REG LE; Eurostat, 2013, SHAR FOR RES POP 1 J; Field D, 2008, ARCH DIS CHILD-FETAL, V93, pF212, DOI 10.1136/adc.2007.119271; Field D, 2009, ARCH DIS CHILD-FETAL, V94, pF253, DOI 10.1136/adc.2008.150433; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Germany L, 2013, RES DEV DISABIL, V34, P1669, DOI 10.1016/j.ridd.2013.02.016; Hardelid P, 2013, OVERVIEW CHILD DEATH; Hardelid P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068323; Kurinczuk JJ, 2009, 1 NAT PER EP UN; Lewis I, 2013, REPORT CHILDREN YOUN; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacDorman Marian F, 2009, NCHS Data Brief, P1; Mackenbach JP, 2008, NEW ENGL J MED, V358; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Moser Kath, 2009, Health Stat Q, P78; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; National Research Council and Institute of Medicine, 2013, US HLTH INT PERSP SH; OECD, 2011, OV GROW INC IN OECD; Ovretveit John, 2007, Qual Manag Health Care, V16, P68; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Plug I, 2011, AVOIDABLE MORATALITY, V1; Royal College of Paediatrics & Child Health, 2012, EP 12 UK COLL CLIN A; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Stiller CA, 2006, EUR J CANCER, V42, P1952, DOI 10.1016/j.ejca.2006.05.017; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; Ver Hoff J M, 2007, QUASIPOISSON VS NEGA; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; WHO, 2013, MORT DAT DOC; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6; World Bank, 2007, WORLD DEV REP DEV NE	39	43	44	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					880	892		10.1016/S0140-6736(14)60485-2	http://dx.doi.org/10.1016/S0140-6736(14)60485-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	24929452				2022-12-28	WOS:000341362200030
J	Song, ZR; Sequist, TD; Barnett, ML				Song, Zirui; Sequist, Thomas D.; Barnett, Michael L.			Patient Referrals A Linchpin for Increasing the Value of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICARE; QUALITY		[Song, Zirui] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Song, Zirui; Sequist, Thomas D.; Barnett, Michael L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Song, Zirui] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Sequist, Thomas D.; Barnett, Michael L.] Brigham & Womens Hosp, Dept Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Sequist, Thomas D.] Partners Healthcare Syst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Bureau of Economic Research; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Song, ZR (corresponding author), Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA.	zsong@partners.org	Barnett, Michael/ABA-4159-2021; Barnett, Michael/AAF-4017-2019	Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609	NIA NIH HHS [F30 AG039175] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F30AG039175] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barnett ML, 2014, J GEN INTERN MED, V29, pS241; Barnett ML, 2012, ARCH INTERN MED, V172, P163, DOI 10.1001/archinternmed.2011.722; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Kim-Hwang JE, 2010, J GEN INTERN MED, V25, P1123, DOI 10.1007/s11606-010-1402-1; Mehrotra A, 2011, MILBANK Q, V89, P39, DOI 10.1111/j.1468-0009.2011.00619.x; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416	8	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					597	598		10.1001/jama.2014.7878	http://dx.doi.org/10.1001/jama.2014.7878			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM8OU	24992078	Green Accepted			2022-12-28	WOS:000340136400015
J	Stoessl, AJ; Lehericy, S; Strafella, AP				Stoessl, A. Jon; Lehericy, Stephane; Strafella, Antonio P.			Imaging insights into basal ganglia function, Parkinson's disease, and dystonia	LANCET			English	Article							STRIATAL DOPAMINE RELEASE; IMPULSE CONTROL DISORDERS; LEVODOPA-INDUCED CHANGES; MICROGLIAL ACTIVATION; DEPRESSIVE SYMPTOMS; RESPONSIVE DYSTONIA; SYNAPTIC DOPAMINE; RECEPTOR-BINDING; BRAIN NETWORKS; MOTOR CORTEX	Recent advances in structural and functional imaging have greatly improved our ability to assess normal functions of the basal ganglia, diagnose parkinsonian syndromes, understand the pathophysiology of parkinsonism and other movement disorders, and detect and monitor disease progression. Radionuclide imaging is the best way to detect and monitor dopamine deficiency, and will probably continue to be the best biomarker for assessment of the effects of disease-modifying therapies. However, advances in magnetic resonance enable the separation of patients with Parkinson's disease from healthy controls, and show great promise for differentiation between Parkinson's disease and other akinetic-rigid syndromes. Radionuclide imaging is useful to show the dopaminergic basis for both motor and behavioural complications of Parkinson's disease and its treatment, and alterations in non-dopaminergic systems. Both PET and MRI can be used to study patterns of functional connectivity in the brain, which is disrupted in Parkinson's disease and in association with its complications, and in other basal-ganglia disorders such as dystonia, in which an anatomical substrate is not otherwise apparent. Functional imaging is increasingly used to assess underlying pathological processes such as neuroinflammation and abnormal protein deposition. This imaging is another promising approach to assess the effects of treatments designed to slow disease progression.	[Stoessl, A. Jon] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada; [Stoessl, A. Jon] Univ British Columbia, Natl Parkinson Fdn Ctr Excellence, Vancouver, BC V6T 2B5, Canada; [Stoessl, A. Jon] Vancouver Coastal Hlth, Vancouver, BC, Canada; [Lehericy, Stephane] Inst Natl Sante & Rech Med, U 1127, F-75013 Paris, France; [Lehericy, Stephane] CNRS, Unite Mixte Rech 7225, F-75013 Paris, France; [Lehericy, Stephane] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech S 1127, F-75013 Paris, France; [Lehericy, Stephane] ICM, Ctr NeuroImagerie Rech, CENIR, F-75013 Paris, France; [Lehericy, Stephane] Hop La Pitie Salpetriere, AP HP, Serv Neuroradiol, F-75013 Paris, France; [Strafella, Antonio P.] Univ Hlth Network, Morton & Gloria Shulman Movement Disorder Unit, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Hlth Network, EJ Safra Parkinson Dis Program, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Hlth Network, Div Brain Imaging & Behaviour Syst Neurosci, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Hlth Network, Res Inst, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Toronto, Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Stoessl, AJ (corresponding author), Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada.	jstoessl@mail.ubc.ca	Stoessl, A Jon/J-9661-2015	Stoessl, A Jon/0000-0002-9778-7246	Canadian Institutes of Health Research; Michael J Fox Foundation; Pacific Alzheimer Research Foundation; Canada Research Chairs programme; Investissements d'avenir [ANR-10-IAIHU-06]; Canadian Institutes of Health Research [MOP 110962]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael J Fox Foundation; Pacific Alzheimer Research Foundation; Canada Research Chairs programme(Canada Research Chairs); Investissements d'avenir(French National Research Agency (ANR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	AJS's work was supported by the Canadian Institutes of Health Research, the Michael J Fox Foundation, the Pacific Alzheimer Research Foundation, and the Canada Research Chairs programme, none of whom had any direct involvement in the preparation of or decision to submit this Series paper. SL's work was supported by the "Investissements d'avenir" (grant number ANR-10-IAIHU-06). APS's work was supported by the Canadian Institutes of Health Research (MOP 110962) and Canada Research Chairs programme.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Bagchi DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055031; Bardinet E, 2009, J NEUROSURG, V110, P208, DOI 10.3171/2008.3.17469; Bartels AL, 2010, PARKINSONISM RELAT D, V16, P57, DOI 10.1016/j.parkreldis.2009.05.005; Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Boileau I, 2008, MOVEMENT DISORD, V23, P1776, DOI 10.1002/mds.22212; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Brighina F, 2009, EXP BRAIN RES, V192, P651, DOI 10.1007/s00221-008-1572-9; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Carbon M, 2009, NEUROLOGY, V72, P2097, DOI 10.1212/WNL.0b013e3181aa538f; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Castrop F, 2012, MOVEMENT DISORD, V27, P1432, DOI 10.1002/mds.24944; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; de la Fuente-Fernandez R, 2004, BRAIN, V127, P2747, DOI 10.1093/brain/awh290; de la Fuente-Fernandez R, 2001, ANN NEUROL, V49, P298; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Donaghy P, 2013, AM J GERIATR PSYCHIA; Eidelberg D, 1995, BRAIN, V118, P1473, DOI 10.1093/brain/118.6.1473; Eidelberg D, 1998, ANN NEUROL, V44, P303, DOI 10.1002/ana.410440304; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Fiorio M, 2011, BRAIN, V134, P1428, DOI 10.1093/brain/awr026; Garcia-Lorenzo D, 2013, BRAIN, V136, P2120, DOI 10.1093/brain/awt152; Gerhard A, 2006, MOVEMENT DISORD, V21, P89, DOI 10.1002/mds.20668; Gerhard A, 2004, MOVEMENT DISORD, V19, P1221, DOI 10.1002/mds.20162; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gerhard A, 2003, NEUROLOGY, V61, P686, DOI 10.1212/01.WNL.0000078192.95645.E6; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hamada M, 2012, J PHYSIOL-LONDON, V590, P2365, DOI 10.1113/jphysiol.2012.230540; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Ibarretxe-Bilbao N, 2012, MOVEMENT DISORD, V27, P1746, DOI 10.1002/mds.25240; Ibarretxe-Bilbao N, 2011, J NEUROL SCI, V310, P70, DOI 10.1016/j.jns.2011.07.054; Iranzo A, 2011, LANCET NEUROL, V10, P797, DOI 10.1016/S1474-4422(11)70152-1; Kishore A, 1998, NEUROLOGY, V50, P1028, DOI 10.1212/WNL.50.4.1028; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Lidstone SC, 2010, ARCH GEN PSYCHIAT, V67, P857, DOI 10.1001/archgenpsychiatry.2010.88; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Marjanska M, 2013, MOVEMENT DISORD, V28, P201, DOI 10.1002/mds.25279; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Menke RA, 2009, NEUROIMAGE, V47, P435, DOI 10.1016/j.neuroimage.2009.05.017; Meyer PM, 2009, ARCH GEN PSYCHIAT, V66, P866, DOI 10.1001/archgenpsychiatry.2009.106; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Muller MLTM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0377-9; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Nelson AJ, 2009, ANN NEUROL, V66, P146, DOI 10.1002/ana.21626; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Niethammer M, 2012, ANN NEUROL, V72, P635, DOI 10.1002/ana.23631; Niethammer M, 2011, NEUROBIOL DIS, V42, P202, DOI 10.1016/j.nbd.2010.10.010; O'Sullivan SS, 2011, BRAIN, V134, P969, DOI 10.1093/brain/awr003; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Perlmutter JS, 1997, J NEUROSCI, V17, P843; Piccini P, 1997, ANN NEUROL, V42, P720, DOI 10.1002/ana.410420508; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Popa T, 2013, CEREB CORTEX, V23, P305, DOI 10.1093/cercor/bhs016; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Quartarone A, 2013, MOVEMENT DISORD, V28, P958, DOI 10.1002/mds.25532; Ramlackhansingh AF, 2011, NEUROLOGY, V76, P1811, DOI 10.1212/WNL.0b013e31821ccce4; Ray N, 2010, CLIN EEG NEUROSCI, V41, P87, DOI 10.1177/155005941004100208; Ray NJ, 2012, NEUROBIOL DIS, V48, P519, DOI 10.1016/j.nbd.2012.06.021; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; SNOW BJ, 1993, ANN NEUROL, V34, P733, DOI 10.1002/ana.410340518; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Strafella AP, 2005, EUR J NEUROSCI, V22, P2946, DOI 10.1111/j.1460-9568.2005.04476.x; Tedroff J, 1996, NEUROLOGY, V46, P1430, DOI 10.1212/WNL.46.5.1430; Tinazzi M, 2009, MOVEMENT DISORD, V24, P1427, DOI 10.1002/mds.22490; Trost M, 2002, ANN NEUROL, V52, P853, DOI 10.1002/ana.10418; Ulug AM, 2011, P NATL ACAD SCI USA, V108, P6638, DOI 10.1073/pnas.1016445108; van Eimeren T, 2010, NEUROLOGY, V75, P1711, DOI 10.1212/WNL.0b013e3181fc27fa; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Van Laere K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.009; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zoons E, 2011, NEUROIMAGE, V56, P1011, DOI 10.1016/j.neuroimage.2011.02.045	90	95	101	3	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					532	544		10.1016/S0140-6736(14)60041-6	http://dx.doi.org/10.1016/S0140-6736(14)60041-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	24954673	Green Accepted			2022-12-28	WOS:000340198300032
J	Zwintz, K; Fossati, L; Ryabchikova, T; Guenther, D; Aerts, C; Barnes, TG; Themessl, N; Lorenz, D; Cameron, C; Kuschnig, R; Pollack-Drs, S; Moravveji, E; Baglin, A; Matthews, JM; Moffat, AFJ; Poretti, E; Rainer, M; Rucinski, SM; Sasselov, D; Weiss, WW				Zwintz, K.; Fossati, L.; Ryabchikova, T.; Guenther, D.; Aerts, C.; Barnes, T. G.; Themessl, N.; Lorenz, D.; Cameron, C.; Kuschnig, R.; Pollack-Drs, S.; Moravveji, E.; Baglin, A.; Matthews, J. M.; Moffat, A. F. J.; Poretti, E.; Rainer, M.; Rucinski, S. M.; Sasselov, D.; Weiss, W. W.			Echography of young stars reveals their evolution	SCIENCE			English	Article							MAIN-SEQUENCE STARS; INSTABILITY STRIP; MASS STARS; BIRTHLINE; NGC-2264	We demonstrate that a seismic analysis of stars in their earliest evolutionary phases is a powerful method with which to identify young stars and distinguish their evolutionary states. The early star that is born from the gravitational collapse of a molecular cloud reaches at some point sufficient temperature, mass, and luminosity to be detected. Accretion stops, and the pre-main sequence star that emerges is nearly fully convective and chemically homogeneous. It will continue to contract gravitationally until the density and temperature in the core are high enough to start nuclear burning of hydrogen. We show that there is a relationship for a sample of young stars between detected pulsation properties and their evolutionary status, illustrating the potential of asteroseismology for the early evolutionary phases.	[Zwintz, K.; Aerts, C.; Moravveji, E.] KU, Inst Sterrenkunde, B-3001 Leuven, Belgium; [Fossati, L.] Bond Univ, Argelander Inst Astron, D-53121 Bonn, Germany; [Ryabchikova, T.] Russian Acad Sci, Inst Astron, Moscow 109017, Russia; [Guenther, D.] St Marys Univ, Dept Phys & Astron, Halifax, NS B3H 3C3, Canada; [Aerts, C.] Radboud Univ Nijmegen, Dept Astrophys, Inst Math Astrophys & Particle Phys, NL-6500 GL Nijmegen, Netherlands; [Barnes, T. G.] Univ Texas Austin, McDonald Observ, Mcdonald Observ, TX 79734 USA; [Themessl, N.; Lorenz, D.; Kuschnig, R.; Pollack-Drs, S.; Weiss, W. W.] Univ Vienna, Inst Astrophys, A-1180 Vienna, Austria; [Cameron, C.] Cape Breton Univ, Dept Math Phys & Geol, Sydney, NS B1P 6L2, Canada; [Baglin, A.] Observ Paris, Lab Etud Spatiales & Instrumentat Astrophy, F-92195 Meudon, France; [Matthews, J. M.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Moffat, A. F. J.] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Poretti, E.; Rainer, M.] Osserv Astron Brera, Ist Nazl Astrofis, I-23807 Merate, Italy; [Rucinski, S. M.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Sasselov, D.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	KU Leuven; University of Bonn; Institute of Astronomy of the Russian Academy of Sciences; Russian Academy of Sciences; Saint Marys University - Canada; Radboud University Nijmegen; University of Texas System; University of Texas Austin; University of Vienna; Cape Breton University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of British Columbia; Universite de Montreal; Istituto Nazionale Astrofisica (INAF); University of Toronto; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Zwintz, K (corresponding author), KU, Inst Sterrenkunde, Celestijnenlaan 200D, B-3001 Leuven, Belgium.	konstanze.zwintz@ster.kuleuven.be	Zwintz, Konstanze/HIK-0566-2022; Poretti, Ennio/N-4730-2016	Zwintz, Konstanze/0000-0001-9229-8315; Poretti, Ennio/0000-0003-1200-0473; Rainer, Monica/0000-0002-8786-2572; Themessl, Nathalie/0000-0001-5100-4659; Aerts, Conny/0000-0003-1822-7126; Weiss, Werner/0000-0003-3977-4436	European Research Council (ERC) under the European Community/ERC [227224]; Research Council of the KU Leuven [GOA/2013/012]; Fund for Scientific Research of Flanders (FWO), Belgium [G.0B69.13]; Presidium RAS Program "Nonstationary Phenomena in Objects of the Universe"; Natural Sciences and Engineering Research Council (NSERC) of Canada; Austrian Fonds zur Forderung der wissenschaftlichen Forschung [P22691-N16]; Austrian Research Promotion Agency-ALR; FP7 project "SPACEINN: Exploitation of Space Data for Innovative Helio-and Asteroseismology"; Belgian Federal Science Policy Office by the Marie Curie Actions from the European Commission [246540]; Canadian Space Agency; Funds for Scientific Research of Flanders (FWO), Belgium; Research Council of KU Leuven, Belgium; Fonds National Recherches Scientific (FNRS), Belgium; Royal Observatory of Belgium; Observatoire de Geneve, Switzerland; Thuringer Landessternwarte Tautenburg, Germany; ESO Large Programme [LP185.D-0056]	European Research Council (ERC) under the European Community/ERC(European Research Council (ERC)); Research Council of the KU Leuven(KU Leuven); Fund for Scientific Research of Flanders (FWO), Belgium(FWO); Presidium RAS Program "Nonstationary Phenomena in Objects of the Universe"; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Research Promotion Agency-ALR; FP7 project "SPACEINN: Exploitation of Space Data for Innovative Helio-and Asteroseismology"; Belgian Federal Science Policy Office by the Marie Curie Actions from the European Commission; Canadian Space Agency(Canadian Space Agency); Funds for Scientific Research of Flanders (FWO), Belgium(FWO); Research Council of KU Leuven, Belgium(KU Leuven); Fonds National Recherches Scientific (FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); Royal Observatory of Belgium; Observatoire de Geneve, Switzerland; Thuringer Landessternwarte Tautenburg, Germany; ESO Large Programme	Data obtained with the MOST satellite are available through the MOST Public Data Archive (http://most.astro.ubc.ca//archive.html), and data from CoRoT are available in the CoRoT Archive (http://idoc-corot.ias.u-psud.fr/index.jsp). Spectroscopic data can be obtained at the European Southern Observatory (ESO) archive (http://archive.eso.org) and the Canada-France-Hawaii Telescope (CFHT) archive (http://www3.cadc-ccda.hia-iha.nrc-cnrc.gc.ca/en/cfht). Data are also available from the public Web site: www.ster.kuleuven.be/similar to konstanze/science. We are grateful to the MOST and CoRoT teams for making this work possible. We thank N. Piskunov for his advice on the best usage of the SME software. The research leading to these results has received funding from the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 227224 (PROSPERITY), from the Research Council of the KU Leuven under grant agreement GOA/2013/012, and from the Fund for Scientific Research of Flanders (FWO), Belgium, under grant agreement G.0B69.13. T. R. acknowledges partial financial support from the Presidium RAS Program "Nonstationary Phenomena in Objects of the Universe." D. G., J.M.M., A. F. J.M., and S. M. R. acknowledge the funding support of the Natural Sciences and Engineering Research Council (NSERC) of Canada. R. K. and W. W. W. are supported by the Austrian Fonds zur Forderung der wissenschaftlichen Forschung (P22691-N16) and by the Austrian Research Promotion Agency-ALR. E. P. and M. R. acknowledge financial support from the FP7 project "SPACEINN: Exploitation of Space Data for Innovative Helio-and Asteroseismology." E. M. is beneficiary of a postdoctoral grant from the Belgian Federal Science Policy Office cofunded by the Marie Curie Actions FP7-PEOPLE-COFUND2008 n246540 Mobility Grant from the European Commission. C. C. was supported by the Canadian Space Agency. E. M. is the beneficiary of a postdoctoral grant from the Belgian Federal Science Policy Office cofunded by the Marie Curie Actions FP7-PEOPLE-COFUND2008 n246540 Mobility Grant from the European Commission. Spectroscopic data were obtained with the 2.7-m telescope at McDonald Observatory, Texas; the 3.6m-telescope at La Silla Observatory under the ESO Large Programme LP185.D-0056; the CFHT (proposal CFHT2012AC003); the Cerro Tololo Inter-American Observatory 1.5-m telescope; and the Mercator Telescope (operated on the island of La Palma by the Flemish Community, at the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias) with the HERMES spectrograph, which is supported by the Funds for Scientific Research of Flanders (FWO), Belgium; the Research Council of KU Leuven, Belgium; the Fonds National Recherches Scientific (FNRS), Belgium; the Royal Observatory of Belgium, the Observatoire de Geneve, Switzerland; and the Thuringer Landessternwarte Tautenburg, Germany.	Aerts C., 2010, ASTRON ASTROPHYS LIB; Alecian E, 2013, MON NOT R ASTRON SOC, V429, P1027, DOI 10.1093/mnras/sts384; Baglin A., 2006, ESA SP, VSP-1306; Bedding TR, 2011, NATURE, V471, P608, DOI 10.1038/nature09935; Casey M., 2011, THESIS ST MARYS U CA; Dahm SE, 2005, ASTRON J, V129, P829, DOI 10.1086/426326; Guenther DB, 2009, ASTROPHYS J, V704, P1710, DOI 10.1088/0004-637X/704/2/1710; Hayashi C., 1961, PASJ, V13, P450; HENYEY LG, 1955, PUBL ASTRON SOC PAC, V67, P154, DOI 10.1086/126791; Herbig G. H., 1960, AP J SUPPL, V4, P337, DOI DOI 10.1086/190050; Marconi M, 1998, ASTROPHYS J, V507, pL141, DOI 10.1086/311704; PALLA F, 1990, ASTROPHYS J, V360, pL47, DOI 10.1086/185809; Rebull LM, 2002, ASTRON J, V123, P1528, DOI 10.1086/338904; Stahler S. W., 2006, FORMATION STARS; STAHLER SW, 1983, ASTROPHYS J, V274, P822, DOI 10.1086/161495; STAHLER SW, 1988, ASTROPHYS J, V332, P804, DOI 10.1086/166694; Suran M, 2001, ASTRON ASTROPHYS, V372, P233, DOI 10.1051/0004-6361:20010485; Walker G, 2003, PUBL ASTRON SOC PAC, V115, P1023, DOI 10.1086/377358; Zwintz K, 2008, ASTROPHYS J, V673, P1088, DOI 10.1086/524293; Zwintz K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/20	20	43	43	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					550	553		10.1126/science.1253645	http://dx.doi.org/10.1126/science.1253645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	24993346	Green Submitted			2022-12-28	WOS:000339651300042
J	Manzano, S; Vunda, A; Schneider, F; Vandertuin, L; Lacroix, LE				Manzano, Sergio; Vunda, Aaron; Schneider, Franck; Vandertuin, Lynda; Lacroix, Laurence E.			Catheterization of the Urethra in Girls	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Manzano, Sergio; Vunda, Aaron; Schneider, Franck; Vandertuin, Lynda; Lacroix, Laurence E.] Univ Geneva, Univ Hosp Geneva, Child & Adolescent Dept, Pediat Emergency Med Serv, CH-1211 Geneva 4, Switzerland	University of Geneva	Manzano, S (corresponding author), Univ Hosp Geneva, Pediat Emergency Med Serv, Child & Adolescent Dept, 6 Rue Willy Donze, CH-1211 Geneva, Switzerland.	sergio.manzano@hcuge.ch	Manzano, Sergio/ABG-6281-2020; Lacroix, Laurence/ABF-5052-2021; Lacroix-Ducardonnoy, Laurence/HDN-9583-2022	Manzano, Sergio/0000-0001-9603-5520; Lacroix, Laurence/0000-0002-6636-3344; Lacroix-Ducardonnoy, Laurence/0000-0002-6636-3344				Boenning DA, 2008, TXB PEDIAT EMERGENCY, P888; FOSTER H, 1992, J UROLOGY, V148, P1496, DOI 10.1016/S0022-5347(17)36948-3; Gerard LL, 2003, J UROLOGY, V170, P564, DOI 10.1097/01.ju.0000068720.10881.b3; Robson WLM, 2006, CLIN PEDIATR, V45, P795, DOI 10.1177/0009922806295277	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2								10.1056/NEJMvcm1105612	http://dx.doi.org/10.1056/NEJMvcm1105612			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006742	Green Published			2022-12-28	WOS:000338645500001
J	Anton, SC; Potts, R; Aiello, LC				Anton, Susan C.; Potts, Richard; Aiello, Leslie C.			Evolution of early Homo: An integrated biological perspective	SCIENCE			English	Review							TURKANA BASIN; LIFE-HISTORY; KOOBI-FORA; GENUS HOMO; BODY-SIZE; AUSTRALOPITHECUS-AFARENSIS; PLEISTOCENE HOMINIDS; AFRICAN CLIMATE; EAST-AFRICA; BRAIN SIZE	Integration of evidence over the past decade has revised understandings about the major adaptations underlying the origin and early evolution of the genus Homo. Many features associated with Homo sapiens, including our large linear bodies, elongated hind limbs, large energy-expensive brains, reduced sexual dimorphism, increased carnivory, and unique life history traits, were once thought to have evolved near the origin of the genus in response to heightened aridity and open habitats in Africa. However, recent analyses of fossil, archaeological, and environmental data indicate that such traits did not arise as a single package. Instead, some arose substantially earlier and some later than previously thought. From similar to 2.5 to 1.5 million years ago, three lineages of early Homo evolved in a context of habitat instability and fragmentation on seasonal, intergenerational, and evolutionary time scales. These contexts gave a selective advantage to traits, such as dietary flexibility and larger body size, that facilitated survival in shifting environments.	[Anton, Susan C.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Potts, Richard] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Aiello, Leslie C.] Wenner Gren Fdn, New York, NY 10016 USA	New York University; Smithsonian Institution; Smithsonian National Museum of Natural History	Anton, SC (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, Rufus D Smith Hall,25 Waverly Pl, New York, NY 10003 USA.	susan.anton@nyu.edu; pottsr@si.edu; laiello@wennergren.org			Wenner-Gren Foundation for Anthropological Research; New York University; Peter Buck Fund for Human Origins Research; Human Origins Program (Smithsonian)	Wenner-Gren Foundation for Anthropological Research; New York University; Peter Buck Fund for Human Origins Research; Human Origins Program (Smithsonian)	We thank the participants of the Wenner-Gren Symposium "Human Biology and the Origin of Homo"; our field and laboratory collaborators for contributing stimulating conversation and ideas; J. B. Clark, who assisted in creating the figures; and E. R. Middleton, who provided bibliographic assistance. Funding provided by the Wenner-Gren Foundation for Anthropological Research (S. C. A. and L. C. A.), New York University (S. C. A.), the Peter Buck Fund for Human Origins Research, and the Human Origins Program (Smithsonian) (R. P.). The authors contributed equally to this work.	AIELLO LC, 1994, AM J PHYS ANTHROPOL, V95, P409, DOI 10.1002/ajpa.1330950405; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Aiello LC, 2012, CURR ANTHROPOL, V53, pS269, DOI 10.1086/667693; Aiello LC, 2010, AM J PHYS ANTHROPOL, V142, P167, DOI 10.1002/ajpa.21255; Alexeev V.P., 1986, ORIGIN HUMAN RACE; [Anonymous], 1988, AM ANTHROPOL; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; Anton SC, 2012, CURR ANTHROPOL, V53, pS479, DOI 10.1086/667692; Anton SC, 2012, CURR ANTHROPOL, V53, pS278, DOI 10.1086/667695; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Ashley GM, 2007, GEOLOGY, V35, P1091, DOI 10.1130/G24163A.1; Baab KL, 2008, J HUM EVOL, V54, P827, DOI 10.1016/j.jhevol.2007.11.003; Baab KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069119; Baab KL, 2009, J HUM EVOL, V57, P608, DOI 10.1016/j.jhevol.2008.08.011; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobinson J. T., 1961, South African Journal of Science, V57, P3; Brace CL., 1967, STAGES HUMAN EVOLUTI; Braun DR, 2008, J ARCHAEOL SCI, V35, P2329, DOI 10.1016/j.jas.2008.03.004; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; BROOM R, 1949, NATURE, V164, P322, DOI 10.1038/164322a0; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Curnoe D, 2010, HOMO, V61, P151, DOI 10.1016/j.jchb.2010.04.002; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean M. C., 2009, 1 HUMANS ORIGIN EARL, P101; DEAN MC, 1982, AM J PHYS ANTHROPOL, V59, P157, DOI 10.1002/ajpa.1330590206; Deino AL, 2006, EARTH PLANET SC LETT, V247, P41, DOI 10.1016/j.epsl.2006.04.009; Deino AL, 2012, J HUM EVOL, V63, P251, DOI 10.1016/j.jhevol.2012.05.004; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Feibel C.S., 1991, P321; Feibel CS, 2009, J HUM EVOL, V57, P112, DOI 10.1016/j.jhevol.2009.05.007; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; FEIBEL CS, 1997, GSA TODAY, V7, P1; Ferraro JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062174; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gathogo PN, 2006, J HUM EVOL, V51, P471, DOI 10.1016/j.jhevol.2006.05.005; Gordon AD, 2013, AM J PHYS ANTHROPOL, V151, P77, DOI 10.1002/ajpa.22259; GORDON IJ, 1989, OECOLOGIA, V79, P383, DOI 10.1007/BF00384318; Graves RR, 2010, J HUM EVOL, V59, P542, DOI 10.1016/j.jhevol.2010.06.007; Grine F. E., 2009, VERTEBRATE PALEONTOL, P49; Grine Frederick E., 2001, P107; Grove M, 2011, J HUM EVOL, V61, P306, DOI 10.1016/j.jhevol.2011.04.005; Groves C, 2011, UNGULATE TAXONOMY; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HILL A, 1992, NATURE, V355, P719, DOI 10.1038/355719a0; Holliday TW, 2012, CURR ANTHROPOL, V53, pS330, DOI 10.1086/667360; Holloway Ralph L., 2004, P123; HOLLOWAY RL, 1969, CURR ANTHROPOL, V10, P395, DOI 10.1086/201036; Hrdlicka A, 1927, J R ANTHROPOL INST G, V57, P249, DOI 10.2307/2843704; ISAAC G, 1978, SCI AM, V238, P90, DOI 10.1038/scientificamerican0478-90; ISAAC G, 1971, WORLD ARCHAEOL, V2, P278, DOI 10.1080/00438243.1971.9979481; Isler K, 2012, CURR ANTHROPOL, V53, pS453, DOI 10.1086/667623; Isler K, 2012, J HUM EVOL, V63, P52, DOI 10.1016/j.jhevol.2012.03.009; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; Kimura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069308; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; Kuzawa CW, 2012, CURR ANTHROPOL, V53, pS369, DOI 10.1086/667410; Laland KN, 2001, J EVOLUTION BIOL, V14, P22, DOI 10.1046/j.1420-9101.2001.00262.x; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lehman SM, 2007, INT J PRIMATOL, V28, P183, DOI 10.1007/s10764-006-9114-4; Lemorini C, 2014, J HUM EVOL, V72, P10, DOI 10.1016/j.jhevol.2014.03.002; Leonard WR, 2003, COMP BIOCHEM PHYS A, V136, P5, DOI 10.1016/S1095-6433(03)00132-6; Lepre CJ, 2007, J HUM EVOL, V53, P504, DOI 10.1016/j.jhevol.2007.01.015; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Levin N.E., 2013, **DATA OBJECT**, DOI [10.1594/IEDA/100231, DOI 10.1594/IEDA/100231]; Levin NE, 2011, PALAEOGEOGR PALAEOCL, V307, P75, DOI 10.1016/j.palaeo.2011.04.026; LEVINS RICHARD, 1968; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Mayr E., 1944, NATL RES COUNCIL B, V262, P11; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Meijer HJM, 2010, J BIOGEOGR, V37, P995, DOI 10.1111/j.1365-2699.2010.02308.x; Migliano AB, 2012, CURR ANTHROPOL, V53, pS359, DOI 10.1086/667694; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Neubauer S, 2012, J HUM EVOL, V62, P498, DOI 10.1016/j.jhevol.2012.01.005; Oelze VM, 2014, J HUM EVOL, V66, P95, DOI 10.1016/j.jhevol.2013.10.003; ORourke B., 2012, HUMAN BIOL EVOLUTION, P863; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Plavcan JM, 2012, CURR ANTHROPOL, V53, pS409, DOI 10.1086/667605; Plummer TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007199; Pontzer H, 2012, CURR ANTHROPOL, V53, pS346, DOI 10.1086/667402; Pontzer H, 2010, P NATL ACAD SCI USA, V107, P14048, DOI 10.1073/pnas.1001031107; Pontzer H, 2009, P NATL ACAD SCI USA, V106, P192, DOI 10.1073/pnas.0806105106; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; Potts R, 1996, SCIENCE, V273, P922, DOI 10.1126/science.273.5277.922; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Potts R, 2012, CURR ANTHROPOL, V53, pS299, DOI 10.1086/667704; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Rightmire G.P., 1990, EVOLUTION HOMOERECTU; Rightmire G. Philip, 2009, P39, DOI 10.1007/978-1-4020-9980-9_5; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Ruff C, 2008, J HUM EVOL, V54, P383, DOI 10.1016/j.jhevol.2007.09.001; Ruff C, 2009, AM J PHYS ANTHROPOL, V138, P90, DOI 10.1002/ajpa.20907; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Schroepfer KK, 2012, AM J PHYS ANTHROPOL, V147, P263; Schwartz GT, 2012, CURR ANTHROPOL, V53, pS395, DOI 10.1086/667591; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Seymour R., 2001, THESIS U KENT CANTER; SHIPMAN P, 1989, J HUM EVOL, V18, P373, DOI 10.1016/0047-2484(89)90037-7; Simpson SW, 2008, SCIENCE, V322, P1089, DOI 10.1126/science.1163592; Smith JE, 2012, CURR ANTHROPOL, V53, pS436, DOI 10.1086/667653; Snodgrass JJ, 2009, VERTEBR PALEOBIOL PA, P15, DOI 10.1007/978-1-4020-9699-0_2; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Spoor F, 2013, NATURE, V502, P452, DOI 10.1038/502452a; Stringer C.B., 1986, P266; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Thomassen HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077191; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Trauth MH, 2010, QUATERNARY SCI REV, V29, P2981, DOI 10.1016/j.quascirev.2010.07.007; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Turner TR, 1997, AM J PHYS ANTHROPOL, V103, P19, DOI 10.1002/(SICI)1096-8644(199705)103:1<19::AID-AJPA3>3.0.CO;2-8; Ungar PS, 2012, CURR ANTHROPOL, V53, pS318, DOI 10.1086/666700; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24; Walker A., 1993, NARIOKOTOME HOMO ERE; Wang SW, 2009, J ZOOL, V277, P275, DOI 10.1111/j.1469-7998.2008.00537.x; Ward CV, 2012, J HUM EVOL, V63, P1, DOI 10.1016/j.jhevol.2011.11.012; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; Wells JCK, 2012, CURR ANTHROPOL, V53, pS466, DOI 10.1086/667606; WOLPOFF MH, 1971, MAN, V6, P601, DOI 10.2307/2799185; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2014, NATURE, V508, P31, DOI 10.1038/508031a; Wood B, 2011, ANNU REV ECOL EVOL S, V42, P47, DOI 10.1146/annurev-ecolsys-102209-144653; Wood Bernard A., 2009, P17, DOI 10.1007/978-1-4020-9980-9_3; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Zhu RX, 2008, J HUM EVOL, V55, P1075, DOI 10.1016/j.jhevol.2008.08.005	152	270	278	16	439	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					45	+	1236828	10.1126/science.1236828	http://dx.doi.org/10.1126/science.1236828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK2XU	24994657				2022-12-28	WOS:000338284400043
J	Deane, RP; Paragi, Z; Jarvis, MJ; Coriat, M; Bernardi, G; Fender, RP; Frey, S; Heywood, I; Klockner, HR; Grainge, K; Rumsey, C				Deane, R. P.; Paragi, Z.; Jarvis, M. J.; Coriat, M.; Bernardi, G.; Fender, R. P.; Frey, S.; Heywood, I.; Kloeckner, H-R; Grainge, K.; Rumsey, C.			A close-pair binary in a distant triple supermassive black hole system	NATURE			English	Article							ACTIVE GALACTIC NUCLEUS; RADIO-SOURCES; MINOR MERGER; GALAXIES; DISCOVERY; JETS; SCALE; SKY; EVOLUTION; QUASARS	Galaxies are believed to evolve through merging(1), which should lead to some hosting multiple supermassive black holes(2-4). There are four known triple black hole systems(5-8), with the closest black hole pair being 2.4 kiloparsecs apart (the third component in this system is at 3 kiloparsecs)(7), which is far from the gravitational sphere of influence (about 100 parsecs for a black hole with mass one billion times that of the Sun). Previous searches for compact black hole systems concluded that they were rare(9), with the tightest binary system having a separation of 7 parsecs (ref. 10). Here we report observations of a triple black hole system at redshift z = 0.39, with the closest pair separated by about 140 parsecs and significantly more distant from Earth than any other known binary of comparable orbital separation. The effect of the tight pair is to introduce a rotationally symmetric helical modulation on the structure of the large-scale radio jets, which provides a useful way to search for other tight pairs without needing extremely high resolution observations. As we found this tight pair after searching only six galaxies, we conclude that tight pairs are more common than hitherto believed, which is an important observational constraint for low-frequency gravitational wave experiments(11,12).	[Deane, R. P.; Coriat, M.] Univ Cape Town, Dept Astron, Astrophys Cosmol & Grav Ctr, ZA-7701 Cape Town, South Africa; [Deane, R. P.; Coriat, M.; Bernardi, G.] Sq Kilometre Array South Africa, ZA-7405 Cape Town, South Africa; [Paragi, Z.] Joint Inst VLBI Europe, NL-7990 AA Dwingeloo, Netherlands; [Jarvis, M. J.; Fender, R. P.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Jarvis, M. J.] Univ Western Cape, Dept Phys, ZA-7535 Bellville, South Africa; [Bernardi, G.; Heywood, I.] Rhodes Univ, Dept Phys & Elect, Ctr Radio Astron Tech & Technol, ZA-6140 Grahamstown, South Africa; [Bernardi, G.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Frey, S.] Inst Geodesy Cartog & Remote Sensing, Satellite Geodet Observ, H-1592 Budapest, Hungary; [Heywood, I.] CSIRO Astron & Space Sci, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Kloeckner, H-R] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Grainge, K.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester, Lancs, England; [Rumsey, C.] Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England	University of Cape Town; SKA South Africa; University of Oxford; University of the Western Cape; Rhodes University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; University of Manchester; Jodrell Bank Centre for Astrophysics; University of Cambridge	Deane, RP (corresponding author), Univ Cape Town, Dept Astron, Astrophys Cosmol & Grav Ctr, ZA-7701 Cape Town, South Africa.	roger.deane@ast.uct.ac.za	Frey, Sándor/G-4465-2013; Klöckner, Hans-Rainer/AAW-7015-2021	Frey, Sándor/0000-0003-3079-1889; Klöckner, Hans-Rainer/0000-0002-0648-2704; Deane, Roger/0000-0003-1027-5043; Heywood, Ian/0000-0001-6864-5057; Bernardi, Gianni/0000-0002-0916-7443; Paragi, Zsolt/0000-0002-5195-335X	European Union [RI-261525 NEXPReS]; South African SKA Project (SKA SA); Hungarian Scientific Research Fund [OTKA 104539]; International Space Science Institute; STFC [ST/J001600/1, ST/L000768/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001600/1, ST/L000768/1] Funding Source: researchfish	European Union(European Commission); South African SKA Project (SKA SA); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); International Space Science Institute; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank J. Magorrian, A. Karastergiou, S. Ransom and B. Fanaroff for discussions. The European VLBI Network is a joint facility of European, Chinese, South African and other radio astronomy institutes funded by their national research councils. e-VLBI research infrastructure in Europe was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number RI-261525 NEXPReS. The financial assistance of the South African SKA Project (SKA SA) towards this research is acknowledged. Opinions expressed and conclusions arrived at are those of the authors and are not necessarily to be attributed to the SKA SA. Z.P. and S.F. acknowledge funding from the Hungarian Scientific Research Fund (OTKA 104539). Z.P. is grateful for funding support from the International Space Science Institute.	An T, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/77; Barth AJ, 2008, ASTROPHYS J LETT, V683, pL119, DOI 10.1086/591905; BECKER RH, 1995, ASTROPHYS J, V450, P559, DOI 10.1086/176166; BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Bianchi S, 2013, MON NOT R ASTRON SOC, V435, P2335, DOI 10.1093/mnras/stt1459; BLANDFORD RD, 1979, ASTROPHYS J, V232, P34, DOI 10.1086/157262; Boroson TA, 2009, NATURE, V458, P53, DOI 10.1038/nature07779; Burke-Spolaor S, 2011, MON NOT R ASTRON SOC, V410, P2113, DOI 10.1111/j.1365-2966.2010.17586.x; Djorgovski SG, 2007, ASTROPHYS J, V662, pL1, DOI 10.1086/519162; Fabbiano G, 2011, NATURE, V477, P431, DOI 10.1038/nature10364; Farina EP, 2013, MON NOT R ASTRON SOC, V431, P1019, DOI 10.1093/mnras/stt209; Fu H, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/2/L44; Fu H, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/103; GE JP, 1994, ASTRON J, V108, P1523, DOI 10.1086/117173; Hada K, 2011, NATURE, V477, P185, DOI 10.1038/nature10387; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; HJELLMING RM, 1981, ASTROPHYS J, V246, pL141, DOI 10.1086/183571; Hoffman L, 2007, MON NOT R ASTRON SOC, V377, P957, DOI 10.1111/j.1365-2966.2007.11694.x; Jiang LH, 2007, ASTROPHYS J, V656, P680, DOI 10.1086/510831; KAASTRA JS, 1992, ASTRON ASTROPHYS, V254, P96; Kettenis M., 2006, ASP C SER VOL 351, V351, P497; Komossa S, 2003, ASTROPHYS J, V582, pL15, DOI 10.1086/346145; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581, DOI 10.1146/annurev.aa.33.090195.003053; Koss M, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/2/L22; Kulkarni G, 2012, MON NOT R ASTRON SOC, V422, P1306, DOI 10.1111/j.1365-2966.2012.20699.x; Liu X, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/1/L7; Lobanov AP, 1998, ASTRON ASTROPHYS, V330, P79; Mauch T, 2013, MON NOT R ASTRON SOC, V435, P650, DOI 10.1093/mnras/stt1323; Noordam JE, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015013; O'Dea CP, 1998, PUBL ASTRON SOC PAC, V110, P493, DOI 10.1086/316162; Paragi Z, 1999, ASTRON ASTROPHYS, V348, P910; Perley RA, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/19; Rodriguez C, 2006, ASTROPHYS J, V646, P49, DOI 10.1086/504825; Schawinski K, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/2/L37; Sesana A, 2013, MON NOT R ASTRON SOC, V433, pL1, DOI 10.1093/mnrasl/slt034; Smith KL, 2010, ASTROPHYS J, V716, P866, DOI 10.1088/0004-637X/716/1/866; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; TONRY JL, 1984, ASTROPHYS J, V279, P13, DOI 10.1086/161861; Ulvestad J. S., 2009, VLA OBSERVATIONAL ST; Valtonen MJ, 2008, NATURE, V452, P851, DOI 10.1038/nature06896; Van Wassenhove S, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/1/L7; Volonteri M, 2003, ASTROPHYS J, V582, P559, DOI 10.1086/344675; Wilman RJ, 2008, MON NOT R ASTRON SOC, V388, P1335, DOI 10.1111/J.1365-2966.2008.13486.X; Wyithe JSB, 2003, ASTROPHYS J, V590, P691, DOI 10.1086/375187; Zwart JTL, 2008, MON NOT R ASTRON SOC, V391, P1545, DOI 10.1111/j.1365-2966.2008.13953.x	45	80	80	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					57	U578		10.1038/nature13454	http://dx.doi.org/10.1038/nature13454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990745	Green Submitted			2022-12-28	WOS:000338199400034
J	Rauskolb, C; Sun, SG; Sun, GP; Pan, YW; Irvine, KD				Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.			Cytoskeletal Tension Inhibits Hippo Signaling through an Ajuba-Warts Complex	CELL			English	Article							WING IMAGINAL DISC; F-ACTIN; CELL-PROLIFERATION; ALPHA-CATENIN; SIZE-CONTROL; DROSOPHILA; PATHWAY; GROWTH; MECHANISM; PROTEIN	Mechanical forces have been proposed to modulate organ growth, but a molecular mechanism that links them to growth regulation in vivo has been lacking. We report that increasing tension within the cytoskeleton increases Drosophila wing growth, whereas decreasing cytoskeletal tension decreases wing growth. These changes in growth can be accounted for by changes in the activity of Yorkie, a transcription factor regulated by the Hippo pathway. The influence of myosin activity on Yorkie depends genetically on the Ajuba LIM protein Jub, a negative regulator of Warts within the Hippo pathway. We further show that Jub associates with a-catenin and that its localization to adherens junctions and association with alpha-catenin are promoted by cytoskeletal tension. Jub recruits Warts to junctions in a tension-dependent manner. Our observations delineate a mechanism that links cytoskeletal tension to regulation of Hippo pathway activity, providing a molecular understanding of how mechanical forces can modulate organ growth.	[Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu		Sun, Gongping/0000-0002-0411-2697	Howard Hughes Medical Institute; National Institutes of Health [R01 GM078620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078620] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yongqiang Feng for Wts:V5-expressing flies, Spencer Irvine for initial characterization of rok RNAi phenotypes, and Martha Soto for helpful discussion in suggesting alpha-catenin experiments. We thank R. Basto, C. Bokel, R. Fehon, B. Hay, J. Jiang, D. Kiehart, L. Luo, G. Longmore, T. Lecuit, D. Pan, U. Tepass, J. Zallen, the Developmental Studies Hybridoma Bank, the Gene Disruption Project, the Bloomington Stock Center for antibodies and Drosophila stocks, and the Drosophila Genomics Resource Center for plasmids. This research was supported by the Howard Hughes Medical Institute and the National Institutes of Health (R01 GM078620).	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bertet C, 2009, DEVELOPMENT, V136, P4199, DOI 10.1242/dev.040402; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Degoutin JL, 2013, NAT CELL BIOL, V15, P1176, DOI 10.1038/ncb2829; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Enderle L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004208; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Herranz H, 2008, EMBO J, V27, P1633, DOI 10.1038/emboj.2008.84; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; OBROCHTA DA, 1987, DEV BIOL, V119, P137, DOI 10.1016/0012-1606(87)90215-6; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schluck T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076171; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	57	219	224	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					143	156		10.1016/j.cell.2014.05.035	http://dx.doi.org/10.1016/j.cell.2014.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995985	Bronze, Green Accepted			2022-12-28	WOS:000340943100014
J	Sutendra, G; Kinnaird, A; Dromparis, P; Paulin, R; Stenson, TH; Haromy, A; Hashimoto, K; Zhang, N; Flaim, E; Michelakis, ED				Sutendra, Gopinath; Kinnaird, Adam; Dromparis, Peter; Paulin, Roxane; Stenson, Trevor H.; Haromy, Alois; Hashimoto, Kyoko; Zhang, Nancy; Flaim, Eric; Michelakis, Evangelos D.			A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation	CELL			English	Article							HEAT-SHOCK-PROTEIN; GENE-TRANSCRIPTION; KINASE M2; EXPRESSION; TRANSPORT; HYPOXIA; CANCER; HSP70; PROLIFERATION; REQUIRES	DNA transcription, replication, and repair are regulated by histone acetylation, a process that requires the generation of acetyl-coenzyme A (CoA). Here, we show that all the subunits of the mitochondrial pyruvate dehydrogenase complex (PDC) are also present and functional in the nucleus of mammalian cells. We found that knockdown of nuclear PDC in isolated functional nuclei decreased the de novo synthesis of acetyl-CoA and acetylation of core histones. Nuclear PDC levels increased in a cell-cycle-dependent manner and in response to serum, epidermal growth factor, or mitochondrial stress; this was accompanied by a corresponding decrease in mitochondrial PDC levels, suggesting a translocation from the mitochondria to the nucleus. Inhibition of nuclear PDC decreased acetylation of specific lysine residues on histones important for G1-S phase progression and expression of S phase markers. Dynamic translocation of mitochondrial PDC to the nucleus provides a pathway for nuclear acetyl-CoA synthesis required for histone acetylation and epigenetic regulation.	[Sutendra, Gopinath; Kinnaird, Adam; Dromparis, Peter; Paulin, Roxane; Stenson, Trevor H.; Haromy, Alois; Hashimoto, Kyoko; Michelakis, Evangelos D.] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada; [Zhang, Nancy; Flaim, Eric] Univ Alberta, NanoFAB Fabricat & Characterizat Facil, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta	Sutendra, G (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada.	gopinath.sutendra@ludwig.ox.ac.uk	Kinnaird, Adam/O-3969-2017	Kinnaird, Adam/0000-0002-4115-4327; Stenson, Trevor/0000-0001-7164-1137	Canadian Institutes for Health Research; Alberta Innovation for Health Solutions; Hecht Foundation (Vancouver, Canada)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovation for Health Solutions; Hecht Foundation (Vancouver, Canada)	We would like to thank Dr. Ryan McKay of the Canadian National High Field NMR Centre (NANUC) and Chenomx for the NMR acquisition and data analysis, Dr. Nasser Tahbaz (University of Alberta) for the immunogold labeling and electron microscopy, and Dr. Gregg Semenza (Johns Hopkins University) for the adenoviruses encoding LacZ and CA5. This study was funded by the Canadian Institutes for Health Research, the Alberta Innovation for Health Solutions, and the Hecht Foundation (Vancouver, Canada) to E. D. M.	Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; BEHAL RH, 1993, ANNU REV NUTR, V13, P497, DOI 10.1146/annurev.nu.13.070193.002433; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dhar S, 2009, P NATL ACAD SCI USA, V106, P22199, DOI 10.1073/pnas.0912276106; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kiang JG, 2006, AM J PHYSIOL-GASTR L, V291, pG117, DOI 10.1152/ajpgi.00397.2005; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Koishi M, 2001, CLIN CANCER RES, V7, P215; Lodish H, 2000, MOL CELL BIOL; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rodriguez MA, 1998, MICROB PATHOGENESIS, V25, P1, DOI 10.1006/mpat.1998.0202; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SIEBERT GUNTHER, 1965, ADVANCE ENZYMOL, V27, P239; SUMEGI B, 1987, EUR J BIOCHEM, V169, P223, DOI 10.1111/j.1432-1033.1987.tb13601.x; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; Zhou ZH, 2001, J BIOL CHEM, V276, P21704, DOI 10.1074/jbc.M101765200	39	346	351	4	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					84	97		10.1016/j.cell.2014.04.046	http://dx.doi.org/10.1016/j.cell.2014.04.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995980	Bronze			2022-12-28	WOS:000340943100009
J	Yelagandula, R; Stroud, H; Holec, S; Zhou, K; Feng, SH; Zhong, XH; Muthurajan, UM; Nie, X; Kawashima, T; Groth, M; Luger, K; Jacobsen, SE; Berger, F				Yelagandula, Ramesh; Stroud, Hume; Holec, Sarah; Zhou, Keda; Feng, Suhua; Zhong, Xuehua; Muthurajan, Uma M.; Nie, Xin; Kawashima, Tomokazu; Groth, Martin; Luger, Karolin; Jacobsen, Steven E.; Berger, Frederic			The Histone Variant H2A. W Defines Heterochromatin and Promotes Chromatin Condensation in Arabidopsis	CELL			English	Article							DNA METHYLATION; NUCLEOSOME; GENOME; MAINTENANCE; LINKER; GENES; SPKK; LOCALIZATION; EUCHROMATIN; ASSOCIATION	Histone variants play crucial roles in gene expression, genome integrity, and chromosome segregation. We report that the four H2A variants in Arabidopsis define different genomic features, contributing to overall genomic organization. The histone variant H2A. W marks heterochromatin specifically and acts in synergy with heterochromatic marks H3K9me2 and DNA methylation to maintain transposon silencing. In vitro, H2A. W enhances chromatin condensation by promoting fiber-to-fiber interactions via its conserved C-terminal motif. In vivo, H2A. W is required for heterochromatin condensation, demonstrating that H2A. W plays critical roles in heterochromatin organization. Similarities in conserved motifs between H2A. W and another H2A variant in metazoans suggest that plants and animals share common mechanisms for heterochromatin condensation.	[Yelagandula, Ramesh; Holec, Sarah; Nie, Xin; Kawashima, Tomokazu; Berger, Frederic] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117604, Singapore; [Yelagandula, Ramesh; Nie, Xin; Berger, Frederic] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Stroud, Hume; Feng, Suhua; Zhong, Xuehua; Groth, Martin; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Feng, Suhua; Groth, Martin; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Zhou, Keda; Muthurajan, Uma M.; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA	National University of Singapore; National University of Singapore; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Colorado State University; Colorado State University; Howard Hughes Medical Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; fred@tll.org.sg	Stroud, Hume/ABF-1325-2021; Kawashima, Tomokazu/I-9333-2014; Kawashima, Tomo/AAM-9411-2021; zhou, keda/AAH-9343-2021	Kawashima, Tomokazu/0000-0003-3803-3070; Kawashima, Tomo/0000-0003-3803-3070; Berger, Frederic/0000-0002-3609-8260; Yelagandula, Ramesh/0000-0001-7418-4322; Groth, Martin/0000-0003-0547-5032; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	UCLA; NSF [1121245]; NIH [GM067777]; EMBO ALTF [986-2011]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067777, F32GM096483] Funding Source: NIH RePORTER	UCLA; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO ALTF; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.Y., S. H., X.N., and F. B. were funded by Temasek Life Sciences Laboratory. Sequencing was performed at the UCLA BSCRC BioSequencing Core facility. We thank Meredith Calvert for help with imaging and Mahnaz Akhavan for Illumina sequencing. We thank Dr. Maruyama for his comments and support with the graphical abstract. H. S. was supported by a Dissertation Year Fellowship from UCLA. X.Z. is a research fellow of Ruth L. Kirschstein National Research Service Award (F32GM096483-01). S. F. is a Special Fellow of the Leukemia & Lymphoma Society. Work in the Jacobsen lab was supported by NSF grant 1121245. K. L., U. M., and K.Z. are supported by NIH-GM067777. M. G. is supported by EMBO ALTF 986-2011 and HHMI. S.E.J. and K. L. are Investigators of the Howard Hughes Medical Institute.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bian Q, 2012, CURR OPIN CELL BIOL, V24, P359, DOI 10.1016/j.ceb.2012.03.003; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; BRUTLAG DL, 1980, ANNU REV GENET, V14, P121, DOI 10.1146/annurev.ge.14.120180.001005; Buttinelli M, 1999, GENETICA, V106, P117, DOI 10.1023/A:1003745315540; Chakravarthy S, 2012, NUCLEIC ACIDS RES, V40, P8285, DOI 10.1093/nar/gks645; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; De Rop V, 2012, CHROMOSOMA, V121, P527, DOI 10.1007/s00412-012-0386-5; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fang YD, 2005, MOL BIOL CELL, V16, P5710, DOI 10.1091/mbc.E05-08-0706; Filipescu D, 2013, TRENDS GENET, V29, P630, DOI 10.1016/j.tig.2013.06.002; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Khadake JR, 1997, BIOCHEMISTRY-US, V36, P1041, DOI 10.1021/bi961617p; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; LINDSEY GG, 1991, J MOL BIOL, V218, P805, DOI 10.1016/0022-2836(91)90268-B; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Lysak Martin, 2006, V323, P173; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2013, BIOCHEM J, V449, P567, DOI 10.1042/BJ20121646; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muthurajan UM, 2011, J BIOL CHEM, V286, P23852, DOI 10.1074/jbc.M111.244871; POCCIA DL, 1992, TRENDS BIOCHEM SCI, V17, P223, DOI 10.1016/0968-0004(92)90382-J; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Talbert Paul B., 2009, P193, DOI 10.1007/978-0-387-69076-6_7; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Vaillant I, 2008, PLANT J, V54, P299, DOI 10.1111/j.1365-313X.2008.03413.x; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	62	149	156	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					98	109		10.1016/j.cell.2014.06.006	http://dx.doi.org/10.1016/j.cell.2014.06.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995981	Green Accepted, Bronze			2022-12-28	WOS:000340943100010
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Overprescribing antidepressants: where's the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Gotzsche P., 2014, GUARDIAN; Health and Social Care Information Centre, 2012, PRESCR DISP COMM STA; Health Foundation Nuffield Trust; QualityWatch, 2014, FOC ANT PRESCR; Moberly T., 2011, GP              0705; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Siddique H., 2014, GUARDIAN; Thompson S., 2014, DAILY TELEGRAPH	8	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2014	348								g4218	10.1136/bmj.g4218	http://dx.doi.org/10.1136/bmj.g4218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YU	24982509	Bronze, Green Published			2022-12-28	WOS:000338644600002
J	Owen, J; Hector, A				Owen, John; Hector, Andrew			Phase-transforming electrodes	SCIENCE			English	Editorial Material							LIFEPO4		[Owen, John; Hector, Andrew] Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England	University of Southampton	Owen, J (corresponding author), Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England.	j.r.owen@soton.ac.uk	owen, john/A-8736-2008; Hector, Andrew L/B-8344-2009	owen, john/0000-0002-4938-3693; Hector, Andrew L/0000-0002-9964-2163				Bai P, 2011, NANO LETT, V11, P4890, DOI 10.1021/nl202764f; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; Johns PA, 2009, ELECTROCHEM COMMUN, V11, P2089, DOI 10.1016/j.elecom.2009.09.001; Liu H, 2014, SCIENCE, V344, DOI 10.1126/science.1252817; Malik R, 2011, NAT MATER, V10, P587, DOI [10.1038/NMAT3065, 10.1038/nmat3065]; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Ravet N, 2001, J POWER SOURCES, V97-8, P503, DOI 10.1016/S0378-7753(01)00727-3	7	21	21	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1451	1452		10.1126/science.1255819	http://dx.doi.org/10.1126/science.1255819			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970065				2022-12-28	WOS:000337889900021
J	Gupta, S				Gupta, Sujata			MENTAL HEALTH Ups and downs	NATURE			English	Editorial Material							POSTSTROKE DEPRESSION; CONTROLLED-TRIAL; MOOD DISORDER; COMPLICATION; MORTALITY; STROKE											Carson AJ, 2012, J NEUROL NEUROSUR PS, V83, P859, DOI 10.1136/jnnp-2011-301854; Casal S. L., 2014, STROKE, V45, pANS3; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; El Husseini N, 2012, STROKE, V43, P1609, DOI 10.1161/STROKEAHA.111.643130; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; ROBINSON RG, 1975, NATURE, V255, P332, DOI 10.1038/255332a0; Robinson RG, 2008, JAMA-J AM MED ASSOC, V299, P2391, DOI 10.1001/jama.299.20.2391	9	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S10	S11		10.1038/510S10a	http://dx.doi.org/10.1038/510S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964021	Bronze			2022-12-28	WOS:000337806300007
J	Belluz, J				Belluz, Julia			FEATURE The Truvada wars	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIRETROVIRAL PROPHYLAXIS		MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Belluz, J (corresponding author), MIT, Cambridge, MA 02142 USA.	jbelluz@gmail.com						Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Centers for Disease Control and Prevention, PREEXP PROPH PREP; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Crary DT, 2014, HUFFINGTON POST; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Mascolini M., 2013, 53 ICAAC INT C ANT A; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Public Health England, PROUD STUD EX IMP GA	8	12	12	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2014	348								g3811	10.1136/bmj.g3811	http://dx.doi.org/10.1136/bmj.g3811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UG	24961949				2022-12-28	WOS:000338201800003
J	Austin, J				Austin, Jim			What it takes	SCIENCE			English	Editorial Material																			0	1	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1422	1422		10.1126/science.344.6190.1422	http://dx.doi.org/10.1126/science.344.6190.1422			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ2YQ	24948739				2022-12-28	WOS:000337531700044
J	Poelstra, JW; Vijay, N; Bossu, CM; Lantz, H; Ryll, B; Muller, I; Baglione, V; Unneberg, P; Wikelski, M; Grabherr, MG; Wolf, JBW				Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Lantz, H.; Ryll, B.; Mueller, I.; Baglione, V.; Unneberg, P.; Wikelski, M.; Grabherr, M. G.; Wolf, J. B. W.			The genomic landscape underlying phenotypic integrity in the face of gene flow in crows	SCIENCE			English	Article							HOODED CROWS; HYBRID ZONE; SPECIATION; DIVERGENCE; INVERSIONS; EXPRESSION; EVOLUTION; EXCHANGE	The importance, extent, and mode of interspecific gene flow for the evolution of species has long been debated. Characterization of genomic differentiation in a classic example of hybridization between all-black carrion crows and gray-coated hooded crows identified genome-wide introgression extending far beyond the morphological hybrid zone. Gene expression divergence was concentrated in pigmentation genes expressed in gray versus black feather follicles. Only a small number of narrow genomic islands exhibited resistance to gene flow. One prominent genomic region (<2 megabases) harbored 81 of all 82 fixed differences (of 8.4 million single-nucleotide polymorphisms in total) linking genes involved in pigmentation and in visual perception-a genomic signal reflecting color-mediated prezygotic isolation. Thus, localized genomic selection can cause marked heterogeneity in introgression landscapes while maintaining phenotypic divergence.	[Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Wolf, J. B. W.] Uppsala Univ, Sci Life Lab, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Wolf, J. B. W.] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Lantz, H.] Uppsala Univ, S-75124 Uppsala, Sweden; [Lantz, H.; Grabherr, M. G.] Uppsala Univ, Sci Life Lab, S-75123 Uppsala, Sweden; [Lantz, H.; Grabherr, M. G.] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Ryll, B.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Mueller, I.; Wikelski, M.] Max Planck Inst Ornithol, D-78315 Radolfzell am Bodensee, Germany; [Mueller, I.; Wikelski, M.] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Baglione, V.] Univ Valladolid, Dept Ciencias Agroforestales, Palencia 34004, Spain; [Unneberg, P.] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden; [Unneberg, P.] Stockholm Univ, Dept Biochem & Biophys, S-17121 Solna, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Max Planck Society; University of Konstanz; Universidad de Valladolid; Stockholm University; Stockholm University	Wolf, JBW (corresponding author), Uppsala Univ, Sci Life Lab, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden.	jochen.wolf@ebc.uu.se	Vijay, Nagarjun/AAM-7687-2021; Baglione, Vittorio/D-6456-2014; Wolf, Jochen/U-2243-2017; Vijay, Nagarjun/AAI-9433-2020	Vijay, Nagarjun/0000-0002-8703-6991; Wolf, Jochen/0000-0002-2958-5183; Baglione, Vittorio/0000-0001-8464-7861; Poelstra, Jelmer/0000-0002-3514-7462; Bossu, Christen/0000-0002-0458-9305; Unneberg, Per/0000-0001-5735-3315; Lantz, Henrik/0000-0003-2419-0075; Grabherr, Manfred/0000-0001-8792-6508	VolkswagenStiftung grant [I/83 496]; Swedish Research Council [621-2010-5553]; Wallenberg Advanced Bioinformatics Infrastructure - (Knut and Alice Wallenberg Foundation); Carl Tryggers foundation [CTS11:517, CTS12:543]; European Research Council [ERCStG-336536]; Max Planck Society; SciLifeLab Uppsala; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing; NCBI [PRJNA192205]	VolkswagenStiftung grant(Volkswagen); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Advanced Bioinformatics Infrastructure - (Knut and Alice Wallenberg Foundation); Carl Tryggers foundation; European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); SciLifeLab Uppsala; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing; NCBI	We thank W. Fiedler, K. Temnow, L. Vossen, M. Dopfner, T. Part, K.-H. Siebenrock, and the other staff of the Max Planck Institute for Ornithology for help with field work and animal husbandry. R. Burri assisted in population genetic analyses. Supported by VolkswagenStiftung grant I/83 496, Swedish Research Council grant 621-2010-5553, the Wallenberg Advanced Bioinformatics Infrastructure (funded by the Knut and Alice Wallenberg Foundation), Carl Tryggers foundation grant CTS11:517, CTS12:543, and European Research Council grant ERCStG-336536 (J.B.W.W.); the Max Planck Society (M. W., I. M.); and SciLifeLab Uppsala (M. G. G., H. L.). C. brachyrhynchos samples were provided by courtesy of the American Museum of Natural History, New York; Polish hooded crows by A. Kruszewicz and M. Gajownik, Warsaw Zoo. We thank the UPPMAX Next-Generation Sequencing Cluster and Storage (UPPNEX) project, funded by the Knut and Alice Wallenberg Foundation and the Swedish National Infrastructure for Computing, for access to computational resources. All sequencing data and the genome assembly are available in the NCBI short read archive under project PRJNA192205.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Guerrero RF, 2012, PHILOS T R SOC B, V367, P430, DOI 10.1098/rstb.2011.0246; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hoogduijn MJ, 2006, PIGM CELL RES, V19, P58, DOI 10.1111/j.1600-0749.2005.00284.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; McLean CA, 2014, BIOL REV, V89, P860, DOI 10.1111/brv.12083; MEISE WILHELM, 1928, JOUR ORNITHOL [BERLIN], V76, P1; Moniot B, 2011, DEV DYNAM, V240, P2335, DOI 10.1002/dvdy.22726; Parkin David T, 2003, British Birds, V96, P274; Randler C, 2007, ARDEA, V95, P143, DOI 10.5253/078.095.0116; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; SAINO N, 1991, B ZOOL, V58, P255, DOI 10.1080/11250009109355762; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; THORNEYCROFT HB, 1975, EVOLUTION, V29, P611, DOI 10.1111/j.1558-5646.1975.tb00855.x; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	24	347	357	2	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1410	1414		10.1126/science.1253226	http://dx.doi.org/10.1126/science.1253226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948738	Green Submitted			2022-12-28	WOS:000337531700043
J	Kneussel, M; Triller, A; Choquet, D				Kneussel, Matthias; Triller, Antoine; Choquet, Daniel			SnapShot: Receptor Dynamics at Plastic Synapses	CELL			English	Article									[Kneussel, Matthias] Univ Med Ctr Hamburg Eppendorf, D-20251 Hamburg, Germany; [Triller, Antoine] Ecole Normale Super, Inst Biol IBENS, CNRS UMR 8197, Inserm 1024, F-75005 Paris, France; [Choquet, Daniel] Bordeaux Univ, CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33077 Bordeaux, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Kneussel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Falkenried 94, D-20251 Hamburg, Germany.		Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Kneussel, Matthias/0000-0003-4900-366X; TRILLER, Antoine/0000-0002-7530-1233				Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022	6	18	18	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7							1738.e1	10.1016/j.cell.2014.06.002	http://dx.doi.org/10.1016/j.cell.2014.06.002			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3RL	24949980	Bronze			2022-12-28	WOS:000349545900001
J	Hajdenberg, J				Hajdenberg, Julio			Radical prostatectomy reduced long-term mortality more than watchful waiting in early prostate cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									UF Hlth Canc Ctr Orlando Hlth, Orlando, FL 32806 USA		Hajdenberg, J (corresponding author), UF Hlth Canc Ctr Orlando Hlth, Orlando, FL 32806 USA.			Hajdenberg, Julio/0000-0001-6346-1638				Barry MJ, 2012, J CLIN ONCOL, V30, P513, DOI 10.1200/JCO.2011.36.8621; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC10	10.7326/0003-4819-160-12-201406170-02010	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935504				2022-12-28	WOS:000337374900010
J	Prasad, V				Prasad, Vinay			Statins, Primary Prevention, and Overall Mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LOW-RISK; MEN; DISEASE; PEOPLE		NCI, NIH, 10 Ctr Dr,Bldg 10,Room 12N226, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prasad, V (corresponding author), NCI, NIH, 10 Ctr Dr,Bldg 10,Room 12N226, Bethesda, MD 20892 USA.	vinayak.prasad@nih.gov		Prasad, Vinayak/0000-0002-6110-8221				Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Conference of State Legislatures, 2010, AUT REC; Newman DH, 2012, LANCET, V380, P1814, DOI 10.1016/S0140-6736(12)62020-0; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Robinson JG, 2013, JAMA-J AM MED ASSOC, V310, P2405, DOI 10.1001/jama.2013.281355; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Zomer E, 2012, LANCET, V380, P1817, DOI 10.1016/S0140-6736(12)62026-1	11	4	4	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					867	+		10.7326/M13-2974	http://dx.doi.org/10.7326/M13-2974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935491				2022-12-28	WOS:000337374900025
J	Requejo, JH; Bryce, J; Barros, AJD; Berman, P; Bhutta, ZQ; Chopra, M; Daelmans, B; de Francisco, A; Lawn, J; Maliqi, B; Mason, E; Newby, H; Presern, C; Starrs, A; Victora, CG				Requejo, Jennifer Harris; Bryce, Jennifer; Barros, Aluisio J. D.; Berman, Peter; Bhutta, Zulfi Qar; Chopra, Mickey; Daelmans, Bernadette; de Francisco, Andres; Lawn, Joy; Maliqi, Blerta; Mason, Elizabeth; Newby, Holly; Presern, Carole; Starrs, Ann; Victora, Cesar G.			Countdown to 2015 and beyond: fulfilling the health agenda for women and children	LANCET			English	Review							INTERVENTIONS; NUTRITION; COVERAGE; NEWBORN	The end of 2015 will signal the end of the Millennium Development Goal era, when the world can take stock of what has been achieved. The Countdown to 2015 for Maternal, Newborn, and Child Survival (Countdown) has focused its 2014 report on how much has been achieved in intervention coverage in these groups, and on how best to sustain, focus, and intensify efforts to progress for this and future generations. Our 2014 results show unfinished business in achievement of high, sustained, and equitable coverage of essential interventions. Progress has accelerated in the past decade in most Countdown countries, suggesting that further gains are possible with intensified actions. Some of the greatest coverage gaps are in family planning, interventions addressing newborn mortality, and case management of childhood diseases. Although inequities are pervasive, country successes in reaching of the poorest populations provide lessons for other countries to follow. As we transition to the next set of global goals, we must remember the centrality of data to accountability, and the importance of support of country capacity to collect and use high-quality data on intervention coverage and inequities for decision making. To fulfill the health agenda for women and children both now and beyond 2015 requires continued monitoring of country and global progress; Countdown is committed to playing its part in this effort.	[Requejo, Jennifer Harris; de Francisco, Andres; Presern, Carole] WHO, Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland; [Daelmans, Bernadette; Maliqi, Blerta; Mason, Elizabeth] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva 27, Switzerland; [Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA; [Barros, Aluisio J. D.; Victora, Cesar G.] Univ Fed Pelotas, BR-96001 Pelotas, Brazil; [Berman, Peter] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Bhutta, Zulfi Qar] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfi Qar] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi 74800, Pakistan; [Chopra, Mickey; Newby, Holly] United Nations Childrens Fund, New York, NY USA; [Lawn, Joy] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Starrs, Ann] Family Care Int, New York, NY USA	World Health Organization; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Pelotas; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; UNICEF; University of London; London School of Hygiene & Tropical Medicine	Requejo, JH (corresponding author), WHO, Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland.	requejoj@who.int	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019; Barros, Aluisio JD/A-7417-2008; Lawn, Joy/ABE-6382-2020	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Lawn, Joy/0000-0002-4573-1443	Bill & Melinda Gates Foundation; World Bank; Government of Australia; Government of Canada; Government of Norway; Government of Sweden; Government of USA; Government of UK	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Bank(The World Bank India); Government of Australia; Government of Canada(CGIAR); Government of Norway; Government of Sweden; Government of USA; Government of UK	We thank Lois Park, Monica Fox, Bob Black, Archana Dwivedi, Colleen Murray, Li Liu, Maria Clara Restrepo Mendez, Giovanny Araujo Franca, Fernando Wehrmeister, Kerry Wong, Adam Deixel, Annabel Lim, Laura Laski, Doris Chou, Lale Say, Jocelyn DeJong, Hyam El-Zein, and Nacer Tarif. Our work was supported by the Bill & Melinda Gates Foundation, The World Bank, and the Governments of Australia, Canada, Norway, Sweden, the USA, and the UK. The funders had no role in the conceptualisation of the paper or in the material presented.	Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001422, 10.1371/journal.pmed.1001421]; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gillespie S, 2013, LANCET, V382, P552, DOI 10.1016/S0140-6736(13)60842-9; Global Health Workforce Alliance World Health Organization, 2013, UN TRUTH NO HLTH WOR; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Independent Expert Review Group Commission on Information and Accountability for Women's and Children's Health, 2013, 2 WHO INT EXP REV GR; Kassebaum N.J, 2014, LANCET; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; Partnership for Maternal Newborn & Child Health and WHO, 2014, MULT POL COMP RMNCH; Requejo J, 2014, COUNTDOWN 2015 FULFI, P1; Requejo J, 2014, INT J EPIDEMIOL, V43, P586, DOI 10.1093/ije/dyu034; Requejo JH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001416; Requejo JH, 2012, COUNTDOWN 2012 REPOR; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; UN-IGME, 2013, LEV TRENDS CHILD MOR; UNICEF, 2014, STAT WORLDS CHILDR 2; UNICEF Division of Policy and Strategy, 2013, COMM CHILD SURV PROM; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Wang H, 2014, LANCET; World Health Organization, WORLD STAT REP 2014; World Health Organization, 2013, END PREV DEATHS PNEU; World Health Organization UNICEF UNFPA The World Bank and the United Nations Population Division, 2014, TRENDS MAT MORT EST	34	132	134	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					466	476		10.1016/S0140-6736(14)60925-9	http://dx.doi.org/10.1016/S0140-6736(14)60925-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	24990815	Green Accepted			2022-12-28	WOS:000348509900034
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Is Coca-Cola's antiobesity scheme the real thing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2009, ASA ADJ COC COL GREA; [Anonymous], 2011, ASA ADJ COC COL GREA; [Anonymous], 2014, BIRMINGHAM NEWS 0526; [Anonymous], GLAC; [Anonymous], 2014, INDEPENDENT; Newham London, COC COL ZER PARKLIVE	6	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2014	349								g4340	10.1136/bmj.g4340	http://dx.doi.org/10.1136/bmj.g4340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZD	25007793	Green Published, Bronze			2022-12-28	WOS:000338993500008
J	Andersson, C; Read, D				Andersson, Claes; Read, Dwight			Group size and cultural complexity	NATURE			English	Letter									[Andersson, Claes] Chalmers Univ Technol, Dept Energy & Environm, S-41296 Gothenburg, Sweden; [Read, Dwight] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA	Chalmers University of Technology; University of California System; University of California Los Angeles	Andersson, C (corresponding author), Chalmers Univ Technol, Dept Energy & Environm, S-41296 Gothenburg, Sweden.	dread@anthro.ucla.edu	Read, Dwight/I-2280-2014; Andersson, Claes/F-8354-2011	Read, Dwight/0000-0003-3125-0769; Andersson, Claes/0000-0003-1457-3240				Collard M., 2005, CAN J ARCHAEOL J CAN, V29, P1; Collard M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0412; Collard M, 2013, CURR ANTHROPOL, V54, pS388, DOI 10.1086/673881; Collard Mark, 2011, Biology Theory, V6, P251, DOI 10.1007/s13752-012-0034-6; Derex M, 2013, NATURE, V503, P389, DOI 10.1038/nature12774; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Read D, 2006, AM ANTIQUITY, V71, P164, DOI 10.2307/40035327; Read D., 2012, UCLA HUM COMPLEX SYS, V2012; Read D., 2009, MISUSE MATH MODEL TA; Read D, 2008, AM ANTIQUITY, V73, P599, DOI 10.2307/25470520	10	14	14	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					E1	E1		10.1038/nature13411	http://dx.doi.org/10.1038/nature13411			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990755	Green Published			2022-12-28	WOS:000338199400001
J	George, R				George, Rob			ASSISTED DYING BILL We must not deprive dying people of the most important protection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CROSS-SECTIONAL SURVEY; PREDICTING SURVIVAL; EUTHANASIA; DISEASE; NETHERLANDS; SUICIDE		[George, Rob] Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England; [George, Rob] Guys & St Thomas Hosp NHS Fdn Trust, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	George, R (corresponding author), Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England.	rob.george@kcl.ac.uk						Beckford M., 2008, TELEGRAPH; Butler-Schloss E, 2013, TELEGRAPH; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Ganzini L, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1682; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Goeman JJ, 2004, STAT NEERL, V58, P21, DOI 10.1111/j.1467-9574.2004.00244.x; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; Hendin H, 2008, MICH LAW REV, V106, P1613; House of Lords, 2005, ASS DYING TERM ILL B; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Oregon Health Authority, DEATH DIGN ACT ANN R; Royal College of Physicians, 2014, NAT CAR DYING AUD HO; Tallis R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3532	13	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g4311	10.1136/bmj.g4311	http://dx.doi.org/10.1136/bmj.g4311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24994758				2022-12-28	WOS:000338646100007
J	Kapoor, A; Yao, WT; Ying, HQ; Hua, SJ; Liewen, A; Wang, QY; Zhong, Y; Wu, CJ; Sadanandam, A; Hu, BL; Chang, Q; Chu, GC; Al-Khalil, R; Jiang, S; Xia, HA; Fletcher-Sananikone, E; Lim, C; Horwitz, GI; Viale, A; Pettazzoni, P; Sanchez, N; Wang, HM; Protopopov, A; Zhang, JH; Heffernan, T; Johnson, RL; Chin, LD; Wang, YA; Draetta, G; DePinho, RA				Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang; Hua, Sujun; Liewen, Alison; Wang, Qiuyun; Zhong, Yi; Wu, Chang-Jiun; Sadanandam, Anguraj; Hu, Baoli; Chang, Qing; Chu, Gerald C.; Al-Khalil, Ramsey; Jiang, Shan; Xia, Hongai; Fletcher-Sananikone, Eliot; Lim, Carol; Horwitz, Gillian I.; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Wang, Huamin; Protopopov, Alexei; Zhang, Jianhua; Heffernan, Timothy; Johnson, Randy L.; Chin, Lynda; Wang, Y. Alan; Draetta, Giulio; DePinho, Ronald A.			Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer	CELL			English	Article							HIPPO PATHWAY; GROWTH; ADENOCARCINOMA; PROLIFERATION; INACTIVATION; INHIBITION; RESISTANCE; INDUCTION; TARGET	Activating mutations in KRAS are among the most frequent events in diverse human carcinomas and are particularly prominent in human pancreatic ductal adenocarcinoma (PDAC). An inducible Kras(G12D) driven mouse model of PDAC has established a critical role for sustained Kras(G12D) expression in tumor maintenance, providing a model to determine the potential for and the underlying mechanisms of Kras(G12D)-independent PDAC recurrence. Here, we show that some tumors undergo spontaneous relapse and are devoid of Kras(G12D) expression and downstream canonical MAPK signaling and instead acquire amplification and overexpression of the transcriptional coactivator Yap1. Functional studies established the role of Yap1 and the transcriptional factor Tead2 in driving Kras(G12D)-independent tumor maintenance. The Yap1/Tead2 complex acts cooperatively with E2F transcription factors to activate a cell cycle and DNA replication program. Our studies, along with corroborating evidence from human PDAC models, portend a novel mechanism of escape from oncogenic Kras addiction in PDAC.	[DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang; Hua, Sujun; Liewen, Alison; Wang, Qiuyun; Wu, Chang-Jiun; Hu, Baoli; Al-Khalil, Ramsey; Jiang, Shan; Xia, Hongai; Fletcher-Sananikone, Eliot; Lim, Carol; Horwitz, Gillian I.; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Chin, Lynda; Wang, Y. Alan; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Yao, Wantong; Ying, Haoqiang; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Zhong, Yi; Chang, Qing; Protopopov, Alexei; Zhang, Jianhua; Heffernan, Timothy; Chin, Lynda; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sadanandam, Anguraj] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Sadanandam, Anguraj] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Stn 19, CH-1015 Lausanne, Switzerland; [Chu, Gerald C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of London; Institute of Cancer Research - UK; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Brigham & Women's Hospital	Ying, HQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hying@mdanderson.org; rdepinho@mdanderson.org	Ying, Haoqiang/AAK-4325-2020; Pettazzoni, Piergiorgio/GRJ-3011-2022	DePinho, Ronald/0000-0002-5625-577X; Sadanandam, Anguraj/0000-0001-8485-5150	Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center [CA16672]; National Institutes of Health [5U01CA084313, P01CA117969, R56DK094865]; UT Star Award; American-Italian Cancer Foundation Award; NHS; Department of Defense [W81XWH-12-1-0459]; Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center; Jane Coffin Childs Postdoctoral Fellowship [61-1512]; Damon Runyon Foundation Postdoctoral Fellowship; TRIUMPH Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P01CA117969, U01CA084313, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102611, R56DK094865] Funding Source: NIH RePORTER	Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Star Award; American-Italian Cancer Foundation Award; NHS; Department of Defense(United States Department of Defense); Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center; Jane Coffin Childs Postdoctoral Fellowship; Damon Runyon Foundation Postdoctoral Fellowship; TRIUMPH Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the laboratory of Kun-Liang Guan, William Kaelin, Jiandie D. Lin, Hiroshi Sasaki, and Marius Sudol for sharing various reagents; Mien-Chie Hung and William Hahn for sharing unpublished data; Douglas Hanahan for helpful suggestions and support for PDAC subtype analysis; Shreya Malu for help with the graphical abstract; and Giannicola Genovese, Sharmistha Sarkar, Shruti Malu, Simona Colla, and other members of the DePinho laboratory for helpful suggestions and technical support. We would also like to thank the Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center (Cancer Center Support grant, CA16672).; The project was supported by 5U01CA084313 (R.A.D.), P01CA117969 (R.A.D.), R56DK094865 (R.L.J.) from National Institutes of Health; UT Star Award (R.A.D.); American-Italian Cancer Foundation Award (G.D.); NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer (A.S.); and Discovery Award W81XWH-12-1-0459 from Department of Defense (H.Y.). G.D., H.Y., and T.H. were also supported by funds from the Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center. Additional support was provided by the Jane Coffin Childs Postdoctoral Fellowship to A.K. (61-1512), Damon Runyon Foundation Postdoctoral Fellowship to S.H., and TRIUMPH Postdoctoral Fellowship to N.S.	Adams PD, 1996, CURR TOP MICROBIOL, V208, P79; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Berns K, 2012, DRUG RESIST UPDATE, V15, P268, DOI 10.1016/j.drup.2012.10.002; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gao T, 2013, GASTROENTEROLOGY, V144, P1543, DOI 10.1053/j.gastro.2013.02.037; George NM, 2012, MOL CELL BIOL, V32, P5116, DOI 10.1128/MCB.01034-12; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	45	446	456	0	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					185	197		10.1016/j.cell.2014.06.003	http://dx.doi.org/10.1016/j.cell.2014.06.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24954535	Green Accepted, Bronze			2022-12-28	WOS:000340943100017
J	Keung, AJ; Bashor, CJ; Kiriakov, S; Collins, JJ; Khalil, AS				Keung, Albert J.; Bashor, Caleb J.; Kiriakov, Szilvia; Collins, James J.; Khalil, Ahmad S.			Using Targeted Chromatin Regulators to Engineer Combinatorial and Spatial Transcriptional Regulation	CELL			English	Article							HISTONE MODIFICATIONS; SYNTHETIC BIOLOGY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; ACTIVATION; PROMOTER; CELLS; MAP; ACETYLATION	The transcription of genomic information in eukaryotes is regulated in large part by chromatin. How a diverse array of chromatin regulator (CR) proteins with different functions and genomic localization patterns coordinates chromatin activity to control transcription remains unclear. Here, we take a synthetic biology approach to decipher the complexity of chromatin regulation by studying emergent transcriptional behaviors from engineered combinatorial, spatial, and temporal patterns of individual CRs. We fuse 223 yeast CRs to programmable zinc finger proteins. Site-specific and combinatorial recruitment of CRs to distinct intralocus locations reveals a range of transcriptional logic and behaviors, including synergistic activation, long-range and spatial regulation, and gene expression memory. Comparing these transcriptional behaviors with annotated CR complex and function terms provides design principles for the engineering of transcriptional regulation. This work presents a bottom-up approach to investigating chromatin-mediated transcriptional regulation and introduces chromatin-based components and systems for synthetic biology and cellular engineering.	[Keung, Albert J.; Bashor, Caleb J.; Collins, James J.; Khalil, Ahmad S.] Boston Univ, Dept Biomed Engn & Ctr Synthet Biol, Boston, MA 02215 USA; [Kiriakov, Szilvia] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Keung, Albert J.; Bashor, Caleb J.; Collins, James J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Collins, James J.; Khalil, Ahmad S.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Boston University; Howard Hughes Medical Institute; Harvard University	Khalil, AS (corresponding author), Boston Univ, Dept Biomed Engn & Ctr Synthet Biol, Boston, MA 02215 USA.	akhalil@bu.edu	Keung, Albert/AAU-3870-2021		NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship [1F32GM105272-01A1]; Boehringer Ingelheim Fonds PhD Fellowship; Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; startup funds from the Department of Biomedical Engineering at Boston University; National Science Foundation CAREER Award [MCB-1350949]; Wyss Institute for Biologically Inspired Engineering [PRJ-0329]; Howard Hughes Medical Institute; Direct For Biological Sciences [1350949] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105272] Funding Source: NIH RePORTER	NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); startup funds from the Department of Biomedical Engineering at Boston University; National Science Foundation CAREER Award(National Science Foundation (NSF)); Wyss Institute for Biologically Inspired Engineering; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the J.J.C. and A. S. K. laboratories for helpful discussions. Emily Egan and the Moazed laboratory provided valuable technical advice on ChIP experiments. We thank the Siggers laboratory for use of their sonicator. We thank Sylvain Meylan and Kwan T. Chow for engaging discussions and manuscript feedback. This work was supported by a NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship (1F32GM105272-01A1 to A.J.K.), a Boehringer Ingelheim Fonds PhD Fellowship (to S. K.), a Defense Advanced Research Projects Agency grant (DARPA-BAA-11-23 to A. S. K. and J.J.C.), startup funds from the Department of Biomedical Engineering at Boston University (to A. S. K.), a National Science Foundation CAREER Award (MCB-1350949 to A. S. K.), the Wyss Institute for Biologically Inspired Engineering (PRJ-0329 to J.J.C.), and the Howard Hughes Medical Institute (to J.J.C.).	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Martens C, 2001, MOL MICROBIOL, V40, P1009, DOI 10.1046/j.1365-2958.2001.02445.x; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Weber W, 2010, CURR OPIN BIOTECH, V21, P690, DOI 10.1016/j.copbio.2010.07.006; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	46	88	95	3	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					110	120		10.1016/j.cell.2014.04.047	http://dx.doi.org/10.1016/j.cell.2014.04.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995982	Green Accepted, Bronze			2022-12-28	WOS:000340943100011
J	Rothwell, PE; Fuccillo, MV; Maxeiner, S; Hayton, SJ; Gokce, O; Lim, BK; Fowler, SC; Malenka, RC; Sudhof, TC				Rothwell, Patrick E.; Fuccillo, Marc V.; Maxeiner, Stephan; Hayton, Scott J.; Gokce, Ozgun; Lim, Byung Kook; Fowler, Stephen C.; Malenka, Robert C.; Suedhof, Thomas C.			Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal Circuits to Boost Repetitive Behaviors	CELL			English	Article							NUCLEUS-ACCUMBENS; SYNAPTIC PATHOPHYSIOLOGY; BASAL GANGLIA; SOCIAL REWARD; MOUSE MODEL; DE-NOVO; MICE; PLASTICITY; SKILL; ACQUISITION	In humans, neuroligin-3 mutations are associated with autism, whereas in mice, the corresponding mutations produce robust synaptic and behavioral changes. However, different neuroligin-3 mutations cause largely distinct phenotypes in mice, and no causal relationship links a specific synaptic dysfunction to a behavioral change. Using rotarod motor learning as a proxy for acquired repetitive behaviors in mice, we found that different neuroligin-3 mutations uniformly enhanced formation of repetitive motor routines. Surprisingly, neuroligin-3 mutations caused this phenotype not via changes in the cerebellum or dorsal striatum but via a selective synaptic impairment in the nucleus accumbens/ventral striatum. Here, neuroligin-3 mutations increased rotarod learning by specifically impeding synaptic inhibition onto D1-dopamine receptor-expressing but not D2-dopamine receptor-expressing medium spiny neurons. Our data thus suggest that different autism-associated neuroligin-3 mutations cause a common increase in acquired repetitive behaviors by impairing a specific striatal synapse and thereby provide a plausible circuit substrate for autism pathophysiology.	[Rothwell, Patrick E.; Fuccillo, Marc V.; Maxeiner, Stephan; Gokce, Ozgun; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Rothwell, Patrick E.; Fuccillo, Marc V.; Hayton, Scott J.; Lim, Byung Kook; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Fowler, Stephen C.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Kansas	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA.	malenka@stanford.edu; tcs1@stanford.edu	Maxeiner, Stephan/Y-7692-2019	Maxeiner, Stephan/0000-0002-4472-695X; Lim, Byungkook/0000-0002-3766-5415; gokce, ozgun/0000-0001-6319-404X; Rothwell, Patrick/0000-0003-0514-2510; Fuccillo, Marc/0000-0002-6569-706X	NIMH [P50 MH086403, K99 MH099243, F32 MH096491]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403, K99MH099243, F32MH096491] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Darvishzadeh, A. Afjei, G. Sun, S. Ghosh, and N. Huang for technical assistance, C. Foldy for advice, and all Malenka and Sudhof lab members for helpful discussions. This work was supported by grants from the NIMH (P50 MH086403 to R.C.M. and T.C.S., K99 MH099243 to M.V.F., and F32 MH096491 to P.E.R.); initial stages were also supported by the Simons Foundation (to R.C.M. and T.C.S.).	Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Haber SN, 2000, J NEUROSCI, V20, P2369; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Howes SR, 2000, PSYCHOPHARMACOLOGY, V151, P55, DOI 10.1007/s002130000451; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Presti MF, 2004, PHARMACOL BIOCHEM BE, V77, P501, DOI 10.1016/j.pbb.2003.12.004; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	46	281	286	4	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					198	212		10.1016/j.cell.2014.04.045	http://dx.doi.org/10.1016/j.cell.2014.04.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995986	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000340943100018
J	Sebastian, SE; Harrison, N; Balakirev, FF; Altarawneh, MM; Goddard, PA; Liang, RX; Bonn, DA; Hardy, WN; Lonzarich, GG				Sebastian, Suchitra E.; Harrison, N.; Balakirev, F. F.; Altarawneh, M. M.; Goddard, P. A.; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.; Lonzarich, G. G.			Normal-state nodal electronic structure in underdoped high-T-c copper oxides	NATURE			English	Article							QUANTUM OSCILLATIONS; FERMI-SURFACE; MAGNETIC BREAKDOWN; DENSITY-WAVE; PSEUDOGAP; ORDER; SUPERCONDUCTIVITY; MAGNETORESISTANCE; INTERFERENCE; FLUCTUATIONS	An outstanding problem in the field of high-transition-temperature (high-T-c) superconductivity is the identification of the normal state out of which superconductivity emerges in the mysterious underdoped regime(1). The normal state uncomplicated by thermal fluctuations can be studied using applied magnetic fields that are sufficiently strong to suppress long-range superconductivity at low temperatures(2,3). Proposals in which the normal ground state is characterized by small Fermi surface pockets that exist in the absence of symmetry breaking(1,4-8) have been superseded by models based on the existence of a superlattice that breaks the translational symmetry of the underlying lattice(7-15). Recently, a charge superlattice model that positions a small electron-like Fermi pocket in the vicinity of the nodes (where the superconducting gap is minimum)(8,9,16,17) has been proposed as a replacement for the prevalent superlatticemodels(10-14) that position the Fermi pocket in the vicinity of the pseudogap at the antinodes (where the superconducting gap is maximum)(18). Although some ingredients of symmetry breaking have been recently revealed by crystallographic studies, their relevance to the electronic structure remains unresolved(19-21). Here we report angle-resolved quantum oscillation measurements in the underdoped copper oxide YBa2Cu3O6+x. These measurements reveal a normal ground state comprising electron-like Fermi surface pockets located in the vicinity of the nodes, and also point to an underlying superlattice structure of low frequency and long wavelength with features in common with the charge order identified recently by complementary spectroscopic techniques(14,19-22).	[Sebastian, Suchitra E.; Lonzarich, G. G.] Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England; [Harrison, N.; Balakirev, F. F.; Altarawneh, M. M.] Los Alamos Natl Lab, Natl High Magnet Field Lab, Los Alamos, NM 87504 USA; [Altarawneh, M. M.] Mutah Univ, Dept Phys, Mutah 61710, Karak, Jordan; [Goddard, P. A.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Liang, Ruixing; Bonn, D. A.; Hardy, W. N.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada; [Liang, Ruixing; Bonn, D. A.; Hardy, W. N.] Canadian Inst Adv Res, Quantum Mat Program, Toronto, ON M5G 1Z8, Canada	University of Cambridge; United States Department of Energy (DOE); Los Alamos National Laboratory; Mutah University; University of Warwick; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Sebastian, SE (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 OHE, England.	suchitra@phy.cam.ac.uk; nharrison@lanl.gov	Hardy, Walter Newbold/AAN-7827-2020; Balakirev, Fedor/AAY-2860-2020; Goddard, Paul/S-3177-2019; Goddard, Paul/GSN-5091-2022; Balakirev, Fedor/AAS-6827-2020; Goddard, Paul/A-8638-2015	Balakirev, Fedor/0000-0003-4887-5140; Goddard, Paul/0000-0002-0666-5236; Goddard, Paul/0000-0002-0666-5236; Balakirev, Fedor/0000-0003-4887-5140; Goddard, Paul/0000-0002-0666-5236; Harrison, Neil/0000-0001-5456-7756; Altarawneh, Moaz/0000-0001-9278-9907	Royal Society, King's College Cambridge; Winton Programme for the Physics of Sustainability; European Research Council under the European Union [337425-SUPERCONDUCTINGMOTT]; Engineering and Physical Sciences Research Council (EPSRC) grant [EP/K012894/1]; EPSRC; Canadian Institute for Advanced Research; Natural Science and Engineering Research Council; NSF [DMR-0654118]; state of Florida; DOE; EPSRC [EP/K012894/1, EP/H00324X/1, EP/H00324X/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H00324X/2, EP/K012894/1, EP/H00324X/1] Funding Source: researchfish	Royal Society, King's College Cambridge; Winton Programme for the Physics of Sustainability; European Research Council under the European Union(European Research Council (ERC)); Engineering and Physical Sciences Research Council (EPSRC) grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); state of Florida; DOE(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	S.E.S. acknowledges support from the Royal Society, King's College Cambridge, the Winton Programme for the Physics of Sustainability, and the European Research Council under the European Union's Seventh Framework Programme (grant number FP/2007-2013)/ERC Grant Agreement number 337425-SUPERCONDUCTINGMOTT. N.H. and F.F.B. acknowledge support for high-magnetic-field experiments from the US Department of Energy, Office of Science, BES-MSE 'Science of 100 Tesla' programme. G. G. L. acknowledges support from Engineering and Physical Sciences Research Council (EPSRC) grant EP/K012894/1. P. A. G. is supported by the EPSRC and thanks the University of Oxford for the provision of a Visiting Lectureship. R.L., D.A.B. and W.N.H. acknowledge support from the Canadian Institute for Advanced Research, and the Natural Science and Engineering Research Council. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by NSF co-operative agreement number DMR-0654118, the state of Florida, and the DOE. We acknowledge discussions with many colleagues, including H. Alloul, C. Bergemann, A. Carrington, S. Chakravarty, A. Chubukov, E. M. Forgan, S. R. Julian, B. Keimer, S. A. Kivelson, R. B. Laughlin, M. Le Tacon, L. Taillefer, D.-H. Lee, P. A. Lee, P. B. Littlewood, A. P. Mackenzie, M. R. Norman, C. Pepin, C. Proust, M. Randeria, S. Sachdev, A. Sacuto, T. Senthil, J. P. Sethna, J. Tranquada and C. M. Varma. We are grateful for the experimental support provided by the '100 T' team, including J. B. Betts, Y. Coulter, M. Gordon, C. H. Mielke, A. Parish, D. Rickel and D. Roybal.	Alexandrov AS, 1996, PHYS REV LETT, V76, P1308, DOI 10.1103/PhysRevLett.76.1308; Altarawneh MM, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3152219; Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3; Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Anderson PW, 2009, PHYS REV LETT, V106; Audouard A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.157003; Bangura A. F., 2008, PHYS REV LETT, V100; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; BENNETT AJ, 1964, PHYS REV A-GEN PHYS, V136, pA998, DOI 10.1103/PhysRev.136.A998; Berg E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115004; Bergemann C, 2003, ADV PHYS, V52, P639, DOI 10.1080/00018730310001621737; Carrington A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.140508; Carrington A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124507; CASTELLANI C, 1995, PHYS REV LETT, V75, P4650, DOI 10.1103/PhysRevLett.75.4650; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Chakravarty S, 2008, P NATL ACAD SCI USA, V105, P8835, DOI 10.1073/pnas.0804002105; Chen WQ, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/17004; Choy TP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196405; Chubukov AV, 1997, PHYS REP, V288, P355, DOI 10.1016/S0370-1573(97)00033-1; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Efetov KB, 2013, NAT PHYS, V9, P442, DOI [10.1038/nphys2641, 10.1038/NPHYS2641]; Elfimov IS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.060504; Fazekas P., 1999, LECT NOTES ELECT COR; Garcia-Aldea D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/105005; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Grissonnanche G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4280; Gull E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216405; Harrison N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/095023; Harrison N, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186408; Harrison N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.226402; Harrison N, 1996, J PHYS-CONDENS MAT, V8, P5415, DOI 10.1088/0953-8984/8/29/016; Hayward LE, 2014, SCIENCE, V343, P1336, DOI [10.1126/science.1246310, 10.1126/science.1242862]; Helm T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.157002; Hinton JP, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.060508; Hossain MA, 2008, NAT PHYS, V4, P527, DOI 10.1038/nphys998; Hosur P, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115116; Kartsovnik MV, 2004, CHEM REV, V104, P5737, DOI 10.1021/cr0306891; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kyung D.-B., 2006, PHYS REV B, V73; Laughlin RB, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035134; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; LeBoeuf D, 2013, NAT PHYS, V9, P79, DOI 10.1038/nphys2502; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lee PA, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/012501; Li CH, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.060501; Li JX, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.184515; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Meier H., 2013, PREPRINT; Melikyan A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020502; Millis AJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.220503; Monthoux P, 2007, NATURE, V450, P1177, DOI 10.1038/nature06480; Oh H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.014518; Pereg-Barnea T, 2010, NAT PHYS, V6, P44, DOI 10.1038/NPHYS1431; Pines D., 1989, THEORY QUANTUM LIQUI; PROSHIN JN, 1991, PHYSICA B, V173, P386, DOI 10.1016/0921-4526(91)90465-Q; Ramshaw BJ, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.174501; Ramshaw BJ, 2011, NAT PHYS, V7, P234, DOI [10.1038/nphys1873, 10.1038/NPHYS1873]; Reynoso AA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.115312; Rice TM, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016502; Riggs SC, 2011, NAT PHYS, V7, P332, DOI 10.1038/NPHYS1921; Rourke PMC, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/105009; Rullier-Albenque F, 2013, J PHYS CONF SER, V449, DOI 10.1088/1742-6596/449/1/012010; Sachdev S., 2014, PREPRINT; Sachdev S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027202; Sacuto A, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/2/022502; Sau JD, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075129; Scalapino DJ, 2012, REV MOD PHYS, V84, P1383, DOI 10.1103/RevModPhys.84.1383; Schmalian J, 1998, PHYS REV LETT, V80, P3839, DOI 10.1103/PhysRevLett.80.3839; Sebastian SE, 2008, NATURE, V454, P200, DOI 10.1038/nature07095; Sebastian SE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102501; Sebastian SE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196403; Sebastian SE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1468; Sebastian SE, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214524; Sebastian SE, 2010, P NATL ACAD SCI USA, V107, P6175, DOI 10.1073/pnas.0913711107; Senthil T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245116; Shoenberg D., 1984, MAGNETIC OSCILLATION; Singleton J., 2001, BAND THEORY ELECT PR; Singleton J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.086403; STARK RW, 1977, J LOW TEMP PHYS, V26, P763, DOI 10.1007/BF00654879; Sushkov OP, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094532; SWANSON JA, 1955, PHYS REV, V99, P1799, DOI 10.1103/PhysRev.99.1799; Tewari S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.217004; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Tremblay A.-M. S., 2013, AUT SCH CORR EL EM P; Varma CM, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085110; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323; Vignolle B, 2011, CR PHYS, V12, P446, DOI 10.1016/j.crhy.2011.04.011; Wang Y., 2014, PREPRINT; Wang YX, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.127001; Wang YY, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.257003; WANG ZQ, 1990, PHYS REV B, V42, P8690, DOI 10.1103/PhysRevB.42.8690; WOSNITZA J, 1993, INT J MOD PHYS B, V7, P2707, DOI 10.1142/S0217979293003012; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; YAMAJI K, 1989, J PHYS SOC JPN, V58, P1520, DOI 10.1143/JPSJ.58.1520; Yang KY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174501; Yao H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.012507; Yelland EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047003; Zaanen J, 2006, NAT PHYS, V2, P138; Ziman J.M., 1979, PRINCIPLES THEORY SO, V2nd	107	79	80	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					61	U378		10.1038/nature13326	http://dx.doi.org/10.1038/nature13326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24930767	Green Submitted			2022-12-28	WOS:000338199400035
J	Corbyn, Z				Corbyn, Zoe			A GROWING GLOBAL BURDEN	NATURE			English	Editorial Material																			0	40	48	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S2	S3		10.1038/510S2a	http://dx.doi.org/10.1038/510S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964023	Bronze			2022-12-28	WOS:000337806300002
J	de Knijff, P				de Knijff, Peter			How carrion and hooded crows defeat Linnaeus's curse	SCIENCE			English	Editorial Material							GENOMICS		Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Knijff, P (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, NL-2300 RC Leiden, Netherlands.	knijf@lumc.nl	de Knijff, Peter/Y-2519-2018	de Knijff, Peter/0000-0002-0899-771X				Cramp S., 1994, BIRDS W PALEARCTIC, V8; Darwin Charles, 1859, ORIGIN SPECIES MEANS; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Haring E, 2012, J ZOOL SYST EVOL RES, V50, P230, DOI 10.1111/j.1439-0469.2012.00664.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Linnaeus C., 1758, SYSTEMA NATURAE; Parkin David T, 2003, British Birds, V96, P274; Poelstra JW, 2014, SCIENCE, V344, P1410, DOI 10.1126/science.1253226; Seberg O, 2003, TRENDS ECOL EVOL, V18, P63, DOI 10.1016/S0169-5347(02)00059-9; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Winker Kevin, 2007, Ornithological Monographs, V63, P30, DOI 10.1642/0078-6594(2007)63[30:VBTASD]2.0.CO;2; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	14	7	7	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1345	1346		10.1126/science.1255744	http://dx.doi.org/10.1126/science.1255744			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948724				2022-12-28	WOS:000337531700021
J	Gunaydin, LA; Grosenick, L; Finkelstein, JC; Kauvar, IV; Fenno, LE; Adhikari, A; Lammel, S; Mirzabekov, JJ; Airan, RD; Zalocusky, KA; Tye, KM; Anikeeva, P; Malenka, RC; Deisseroth, K				Gunaydin, Lisa A.; Grosenick, Logan; Finkelstein, Joel C.; Kauvar, Isaac V.; Fenno, Lief E.; Adhikari, Avishek; Lammel, Stephan; Mirzabekov, Julie J.; Airan, Raag D.; Zalocusky, Kelly A.; Tye, Kay M.; Anikeeva, Polina; Malenka, Robert C.; Deisseroth, Karl			Natural Neural Projection Dynamics Underlying Social Behavior	CELL			English	Article							VENTRAL TEGMENTAL AREA; IN-VIVO CONTROL; NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; CALCIUM INDICATOR; NEURONAL-ACTIVITY; INBRED STRAINS; PRAIRIE VOLES; REWARD; MICE	Social interaction is a complex behavior essential for many species and is impaired in major neuropsychiatric disorders. Pharmacological studies have implicated certain neurotransmitter systems in social behavior, but circuit-level understanding of endogenous neural activity during social interaction is lacking. We therefore developed and applied a new methodology, termed fiber photometry, to optically record natural neural activity in genetically and connectivity-defined projections to elucidate the realtime role of specified pathways in mammalian behavior. Fiber photometry revealed that activity dynamics of a ventral tegmental area (VTA)-to-nucleus accumbens (NAc) projection could encode and predict key features of social, but not novel object, interaction. Consistent with this observation, optogenetic control of cells specifically contributing to this projection was sufficient to modulate social behavior, which was mediated by type 1 dopamine receptor signaling downstream in the NAc. Direct observation of deep projection-specific activity in this way captures a fundamental and previously inaccessible dimension of mammalian circuit dynamics.	[Gunaydin, Lisa A.; Grosenick, Logan; Finkelstein, Joel C.; Kauvar, Isaac V.; Fenno, Lief E.; Adhikari, Avishek; Mirzabekov, Julie J.; Airan, Raag D.; Zalocusky, Kelly A.; Tye, Kay M.; Anikeeva, Polina; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Grosenick, Logan; Fenno, Lief E.; Zalocusky, Kelly A.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lammel, Stephan; Malenka, Robert C.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Fenno, Lief/AAF-9638-2019; Adhikari, Avishek/N-1284-2015; Lammel, Stephan/O-8295-2018; Adhikari, Avishek/AAF-4444-2021; Adhikari, Avishek/A-3339-2012; Fenno, Lief/AAK-2924-2020	Adhikari, Avishek/0000-0002-9187-9211; Lammel, Stephan/0000-0002-3350-3208; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Airan, Raag/0000-0001-5259-5606	Stanford Bio-X Fellowship; NSF [0801700]; Stanford Medical Scientist Training Program; Simons Foundation Autism Research Initiative; NIMH; NIDA; DARPA; Gatsby Charitable Foundation; James Doty; CCARE center at Stanford; Stanford Institute for Neuroinnovation and Translational Neurosciences; Wiegers Family Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016, R01MH099647, R01MH086373, R00MH106649, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794, R37DA035377] Funding Source: NIH RePORTER	Stanford Bio-X Fellowship; NSF(National Science Foundation (NSF)); Stanford Medical Scientist Training Program; Simons Foundation Autism Research Initiative; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gatsby Charitable Foundation; James Doty; CCARE center at Stanford; Stanford Institute for Neuroinnovation and Translational Neurosciences; Wiegers Family Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the entire Deisseroth lab for helpful discussions and T. Jardetzky for use of a Biotek Synergy4 plate reader. L.A.G. is supported by a Stanford Bio-X Fellowship. L.G. is supported by NSF 0801700. L.E.F. is supported by the Stanford Medical Scientist Training Program. K.D. is supported by the Simons Foundation Autism Research Initiative, a Conte Center grant from NIMH, and NIDA, DARPA, the Gatsby Charitable Foundation, James Doty and the CCARE center at Stanford, the Stanford Institute for Neuroinnovation and Translational Neurosciences, and the Wiegers Family Fund. R.C.M. and S.L. were supported by a grant from the Simons Foundation Autism Research Initiative and a Conte Center grant from NIMH. All optogenetic tools and methods described are distributed and supported freely (http://www.optogenetics.org).	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Budygin EA, 2012, NEUROSCIENCE, V201, P331, DOI 10.1016/j.neuroscience.2011.10.056; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Curtis JT, 2005, PHYSIOL BEHAV, V86, P338, DOI 10.1016/j.physbeh.2005.08.022; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Dong YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025615; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; PALIJ P, 1990, BRAIN RES, V509, P172, DOI 10.1016/0006-8993(90)90329-A; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Podda MV, 2010, NEUROSCIENCE, V167, P678, DOI 10.1016/j.neuroscience.2010.02.075; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; Robinson DL, 2011, NEUROSCIENCE, V176, P296, DOI 10.1016/j.neuroscience.2010.12.016; Robinson DL, 2002, J NEUROSCI, V22, P10477; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Yuan KX, 2011, J NEUROSCI, V31, P13333, DOI 10.1523/JNEUROSCI.1000-11.2011	50	714	724	9	131	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1535	1551		10.1016/j.cell.2014.05.017	http://dx.doi.org/10.1016/j.cell.2014.05.017			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949967	Bronze, Green Accepted			2022-12-28	WOS:000340941900010
J	Munyi, CW; Jones, KDJ				Munyi, Caroline W.; Jones, Kelsey D. J.			Mondor's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Munyi, Caroline W.] German Doctors Nairobi, Baraka Hlth Ctr, Nairobi, Kenya; [Jones, Kelsey D. J.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya	Kenya Medical Research Institute	Munyi, CW (corresponding author), German Doctors Nairobi, Baraka Hlth Ctr, Nairobi, Kenya.	kjones@kemri-wellcome.org		Jones, Kelsey/0000-0002-1237-0127					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2426	2426		10.1056/NEJMicm1313969	http://dx.doi.org/10.1056/NEJMicm1313969			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24941180				2022-12-28	WOS:000337353000011
J	Chatterjee, S; Chakraborty, A; Weinberg, I; Kadakia, M; Wilensky, RL; Sardar, P; Kumbhani, DJ; Mukherjee, D; Jaff, MR; Giri, J				Chatterjee, Saurav; Chakraborty, Anasua; Weinberg, Ido; Kadakia, Mitul; Wilensky, Robert L.; Sardar, Partha; Kumbhani, Dharam J.; Mukherjee, Debabrata; Jaff, Michael R.; Giri, Jay			Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTROLLED CLINICAL-TRIAL; VENOUS THROMBOEMBOLISM; PLASMINOGEN-ACTIVATOR; SEQUENTIAL-ANALYSIS; INFORMATION SIZE; RANDOMIZED-TRIAL; PROGNOSTIC VALUE; HEPARIN; THERAPY; ALTEPLASE	IMPORTANCE Thrombolytic therapy may be beneficial in the treatment of some patients with pulmonary embolism. To date, no analysis has had adequate statistical power to determine whether thrombolytic therapy is associated with improved survival, compared with conventional anticoagulation. OBJECTIVE To determine mortality benefits and bleeding risks associated with thrombolytic therapy compared with anticoagulation in acute pulmonary embolism, including the subset of hemodynamically stable patients with right ventricular dysfunction (intermediate-risk pulmonary embolism). DATA SOURCES PubMed, the Cochrane Library, EMBASE, EBSCO, Web of Science, and CINAHL databases from inception through April 10, 2014. STUDY SELECTION Eligible studies were randomized clinical trials comparing thrombolytic therapy vs anticoagulant therapy in pulmonary embolism patients. Sixteen trials comprising 2115 individuals were identified. Eight trials comprising 1775 patients specified inclusion of patients with intermediate-risk pulmonary embolism. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted trial-level data including number of patients, patient characteristics, duration of follow-up, and outcomes. MAIN OUTCOMES AND MEASURES The primary outcomes were all-cause mortality and major bleeding. Secondary outcomes were risk of recurrent embolism and intracranial hemorrhage (ICH). Peto odds ratio (OR) estimates and associated 95% CIs were calculated using a fixed-effects model. RESULTS Use of thrombolytics was associated with lower all-cause mortality (OR, 0.53; 95% CI, 0.32-0.88; 2.17%[23/1061] vs 3.89% [41/1054] with anticoagulants; number needed to treat [NNT] = 59) and greater risks of major bleeding (OR, 2.73; 95% CI, 1.91-3.91; 9.24% [98/1061] vs 3.42%[36/1054]; number needed to harm [NNH] = 18) and ICH (OR, 4.63; 95% CI, 1.78-12.04; 1.46%[15/1024] vs 0.19% [2/1019]; NNH = 78). Major bleeding was not significantly increased in patients 65 years and younger (OR, 1.25; 95% CI, 0.50-3.14). Thrombolysis was associated with a lower risk of recurrent pulmonary embolism (OR, 0.40; 95% CI, 0.22-0.74; 1.17%[12/1024] vs 3.04%[31/1019]; NNT = 54). In intermediate-risk pulmonary embolism trials, thrombolysis was associated with lower mortality (OR, 0.48; 95% CI, 0.25-0.92) and more major bleeding events (OR, 3.19; 95% CI, 2.07-4.92). CONCLUSIONS AND RELEVANCE Among patients with pulmonary embolism, including those who were hemodynamically stable with right ventricular dysfunction, thrombolytic therapy was associated with lower rates of all-cause mortality and increased risks of major bleeding and ICH. However, findings may not apply to patients with pulmonary embolism who are hemodynamically stable without right ventricular dysfunction.	[Chatterjee, Saurav] Mt Sinai Hlth Syst, Div Cardiol, St Lukes Roosevelt Hosp Ctr, New York, NY USA; [Chakraborty, Anasua] Thomas Jefferson Univ Hosp, Div Pulmonol & Crit Care, Philadelphia, PA 19107 USA; [Weinberg, Ido; Jaff, Michael R.] Massachusetts Gen Hosp, Inst Heart Vasc & Stroke Care, Boston, MA 02114 USA; [Kadakia, Mitul; Wilensky, Robert L.; Giri, Jay] Univ Penn, Div Cardiovasc Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sardar, Partha; Mukherjee, Debabrata] Texas Tech Univ, Div Cardiol, El Paso, TX USA; [Kumbhani, Dharam J.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's; Mount Sinai West; Jefferson University; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Texas Tech University System; Texas Tech University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Giri, J (corresponding author), Hosp Univ Penn, Div Cardiovasc Med, Gates Pavil,Ninth Floor,3400 Spruce St, Philadelphia, PA 19104 USA.	giri.jay@gmail.com	Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694	EKOS Corporation; Embolitech; Boston Scientific; Cordis Corporation	EKOS Corporation; Embolitech; Boston Scientific(Boston Scientific); Cordis Corporation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Jaff reported having served as a consultant to AstraZeneca; having received support from EKOS Corporation, Embolitech, Boston Scientific, and Cordis Corporation; and being a board member for VIVA Physicians, a 501(c)(3) not-for profit education and research organization. Dr Wilensky reported being a member of the scientific advisor boards of Cardiostem, GenWay, Soteria, and Vascular Magnetics and having equity interest in Johnson & Johnson. No other disclosures were reported.	[Anonymous], 1970, J AMER MED ASSOC, V214, P2163; [Anonymous], 1990, Chest, V97, P528; [Anonymous], VEN THROMB DIS MAN V; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Becattini C, 2010, THROMB RES, V125, pE82, DOI 10.1016/j.thromres.2009.09.017; Beckman MG, 2010, AM J PREV MED, V38, pS495, DOI 10.1016/j.amepre.2009.12.017; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; DALLAVOLTA S, 1992, J AM COLL CARDIOL, V20, P520, DOI 10.1016/0735-1097(92)90002-5; Dong BR, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004437.pub3; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Fasullo S, 2011, AM J MED SCI, V341, P33, DOI 10.1097/MAJ.0b013e3181f1fc3e; GOLDHABER SZ, 1993, LANCET, V341, P507, DOI 10.1016/0140-6736(93)90274-K; Goldhaber SZ, 2001, CIRCULATION, V104, P2876, DOI 10.1161/circ.104.24.2876; Hamel E, 2001, CHEST, V120, P120, DOI 10.1378/chest.120.1.120; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jerjes-Sanchez, 1995, J Thromb Thrombolysis, V2, P227; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kline JA, 2014, J THROMB HAEMOST, V12, P459, DOI 10.1111/jth.12521; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kucher N, 2014, CIRCULATION, V129, P479, DOI 10.1161/CIRCULATIONAHA.113.005544; LEVINE M, 1990, CHEST, V98, P1473, DOI 10.1378/chest.98.6.1473; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LY B, 1978, ACTA MED SCAND, V203, P465; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MARINI C, 1988, RESPIRATION, V54, P162, DOI 10.1159/000195517; MENEVEAU N, 1993, J AM COLL CARDIOL, V22, P1075, DOI 10.1016/0735-1097(93)90418-Z; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; Sharifi M, 2013, AM J CARDIOL, V111, P273, DOI 10.1016/j.amjcard.2012.09.027; Stein PD, 2012, AM J MED, V125, P465, DOI 10.1016/j.amjmed.2011.10.015; Thabut G, 2002, J AM COLL CARDIOL, V40, P1660, DOI 10.1016/S0735-1097(02)02381-1; Thorlund K., 2011, USER MANUAL TRIAL SE, P1, DOI DOI 10.1158/1055-9965.EPI-08-0169; TIBBUTT DA, 1974, BRIT MED J, V1, P343, DOI 10.1136/bmj.1.5904.343; Wan S, 2004, CIRCULATION, V110, P744, DOI 10.1161/01.CIR.0000137826.09715.9C; Weinberg I, 2014, CIRCULATION, V129, P420, DOI 10.1161/CIRCULATIONAHA.113.007132; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	42	447	460	2	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2414	2421		10.1001/jama.2014.5990	http://dx.doi.org/10.1001/jama.2014.5990			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938564	Bronze			2022-12-28	WOS:000337301500022
J	Smith, JM				Smith, Jeanette M.			Black on Red	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2362	2363		10.1001/jama.2013.279558	http://dx.doi.org/10.1001/jama.2013.279558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938547				2022-12-28	WOS:000337301500001
J	Homer, CSE; Friberg, IK; Dias, MAB; Ten Hoope-Bender, P; Sandall, J; Speciale, AM; Bartlett, LA				Homer, Caroline S. E.; Friberg, Ingrid K.; Bastos Dias, Marcos Augusto; Ten Hoope-Bender, Petra; Sandall, Jane; Maria Speciale, Anna; Bartlett, Linda A.			The projected effect of scaling up midwifery	LANCET			English	Article							LIVES SAVED TOOL; CHILD HEALTH INTERVENTIONS; CESAREAN-SECTION RATES; MATERNAL MORTALITY; NEONATAL-MORTALITY; POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; CASELOAD MIDWIFERY; PRETERM BIRTH; BURKINA-FASO	We used the Lives Saved Tool (LiST) to estimate deaths averted if midwifery was scaled up in 78 countries classified into three tertiles using the Human Development Index (HDI). We selected interventions in LiST to encompass the scope of midwifery practice, including prepregnancy, antenatal, labour, birth, and post-partum care, and family planning. Modest (10%), substantial (25%), or universal (95%) scale-up scenarios from present baseline levels were all found to reduce maternal deaths, stillbirths, and neonatal deaths by 2025 in all countries tested. With universal coverage of midwifery interventions for maternal and newborn health, excluding family planning, for the countries with the lowest HDI, 61% of all maternal, fetal, and neonatal deaths could be prevented. Family planning alone could prevent 57% of all deaths because of reduced fertility and fewer pregnancies. Midwifery with both family planning and interventions for maternal and newborn health could avert a total of 83% of all maternal deaths, stillbirths, and neonatal deaths. The inclusion of specialist care in the scenarios resulted in an increased number of deaths being prevented, meaning that midwifery care has the greatest effect when provided within a functional health system with effective referral and transfer mechanisms to specialist care.	[Homer, Caroline S. E.] Univ Technol Sydney, Fac Hlth, Broadway, NSW 2007, Australia; [Friberg, Ingrid K.] Johns Hopkins Bloomberg Sch Publ, Dept Int Hlth, Baltimore, MD USA; [Bastos Dias, Marcos Augusto] Inst Fernandes Figueira FIOCRUZ, Dept Obstet, Rio De Janeiro, Brazil; [Ten Hoope-Bender, Petra] Inst Cooperac Social Integrare, Barcelona, Spain; [Maria Speciale, Anna] Autonomous Univ Barcelona, Barcelona, Spain; [Sandall, Jane] St Thomas Hosp, Kings Coll London, Womens Hlth Acad Ctr Kings Hlth Partners, Div Womens Hlth, London, England	University of Technology Sydney; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fundacao Oswaldo Cruz; Autonomous University of Barcelona; Guy's & St Thomas' NHS Foundation Trust; King's Health Partners; University of London; King's College London	Homer, CSE (corresponding author), Univ Technol Sydney, Fac Hlth, POB 123, Broadway, NSW 2007, Australia.	caroline.homer@uts.edu.au	Sandall, Jane/D-4146-2009; Homer, Caroline/J-2101-2014	Sandall, Jane/0000-0003-2000-743X; Homer, Caroline/0000-0002-7454-3011	Bill & Melinda Gates Foundation [OPP1042500]; University of York, England; University of Dundee, Scotland; Instituto de Cooperacion Social Integrare	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); University of York, England; University of Dundee, Scotland; Instituto de Cooperacion Social Integrare	This work was partly supported by a grant from the Bill & Melinda Gates Foundation (grant number OPP1042500), with additional support from the University of York, England, and the University of Dundee, Scotland. PtH-B's work was supported by the Instituto de Cooperacion Social Integrare. These funding organisations had no role in the analysis or synthesis of the findings of this work. The findings and conclusions of this report are those of the authors and do not necessarily represent the official position of their employers or the Bill & Melinda Gates Foundation. Thomson Prentice was the technical editor for the Lancet Series on Midwifery. Administrative support was provided by Jenny Brown and Tracy Sparey, and Natalie Muir provided project support. We thank the close readers and colleagues who made helpful contributions, namely Yves Bergevin, Dell Horey, Judith Fullerton, Sonia Lansky, Wendy Graham, Ann Starrs, Howard Friedman, Cathy Warwick, Frances Day-Stirk, Fabienne Richard, Jerker Liljestrand, Elizabeth Mason, Fran McConville, Blerta Maliqi, Matthews Mathai, Metin Gulmezoglu, Veronica Walford, Hermen Ormel, Kate Teela, France Donnay, and Mariam Claeson. All coauthors of the Lancet Series on Midwifery commented on drafts of this manuscript. Eugene Declercq and Vincent Fauveau, other members of the Lancet Series on Midwifery Helicopter Group, also made important contributions, along with Mary Renfrew, Luc de Bernis, Zoe Matthews, Helga Fogstad, and Alison McFadden, other members of the Lancet Series on Midwifery Executive Group, who made important contributions throughout the writing of this report.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Amouzou A, 2010, INT J EPIDEMIOL, V39, P186, DOI 10.1093/ije/dyq034; [Anonymous], 2012, HUMAN DEV REPORT GEN; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Bryce J, 2010, INT J EPIDEMIOL, V39, P40, DOI 10.1093/ije/dyq020; Buist A, 1998, AUST NZ J PSYCHIAT, V32, P370, DOI 10.3109/00048679809065529; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Cousens S, 2010, INT J EPIDEMIOL, V39, P134, DOI 10.1093/ije/dyq030; Dahlen HG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001723; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Devane D, 2010, SYSTEMATIC REV META; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; Gibbons L, 2010, 30 WHO; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Hodnett ED, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000012.pub4; Iguiniz-Romero R, 2012, REPROD HEALTH MATTER, V20, P174, DOI 10.1016/S0968-8080(12)39605-5; International Confederation of Midwives, 2010, ESS COMP BAS MIDW PR; International Confederation of Midwives (ICM), 2017, DEF MIDW INT CONF; Johns Hopkins University, 2012, LIST LIV SAV TOOL EV; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kennedy EC, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-30; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Koblinsky M, 2012, J HEALTH POPUL NUTR, V30, P124, DOI 10.3329/jhpn.v30i2.11294; Korenromp EL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-94; Labrique AB, 2012, REPROD HEALTH MATTER, V20, P113, DOI 10.1016/S0968-8080(12)39631-6; Larsen DA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S34; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Levy T. M., 1998, ATTACHMENT TRAUMA HE; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Low LK, 2008, J MIDWIFERY WOM HEAL, V53, P302, DOI 10.1016/j.jmwh.2008.01.009; McLachlan HL, 2012, BJOG-INT J OBSTET GY, V119, P1483, DOI 10.1111/j.1471-0528.2012.03446.x; Milgrom J, 2004, INFANT BEHAV DEV, V27, P443, DOI 10.1016/j.infbeh.2004.03.003; Milgrom J, 2006, STRESS HEALTH, V22, P229, DOI 10.1002/smi.1101; Murphy PA, 2001, J MIDWIFERY WOM HEAL, V46, P274, DOI 10.1016/S1526-9523(01)00158-1; Murray L, 1997, ARCH DIS CHILD, V77, P99, DOI 10.1136/adc.77.2.99; Murray L, 1997, PSYCHOL MED, V27, P253, DOI 10.1017/S0033291796004564; Murray L, 2003, AETIOLOGICAL MECH DE; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Nations United, 2011, WORLD POP PROSP 2010, V1; Noakes TD, 2008, EPIDEMIOL INFECT, V136, P1, DOI 10.1017/S0950268807008746; Osotimehin B, 2012, LANCET, V380, P82, DOI 10.1016/S0140-6736(12)60906-4; Overgaard C, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000262; Overgaard C, 2012, SOC SCI MED, V74, P973, DOI 10.1016/j.socscimed.2011.12.023; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Plosky WD, 2011, LIVES SAVED TOOL COM; Pollard SL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S12; PRECHTL HFR, 1980, EARLY HUM DEV, V4, P201; Renfrew MJ, 2014, LANCET; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Ross JA, 2012, MATERN CHILD HLTH J, V16, P456, DOI 10.1007/s10995-011-0777-x; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Schroeder E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2292; Seng JS, 2008, J MIDWIFERY WOM HEAL, V53, P110, DOI 10.1016/j.jmwh.2007.09.006; Sheridan M, 2010, MIDWIFERY, V26, pE9, DOI 10.1016/j.midw.2009.09.002; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Streatfield PK, 2010, BANGLADESH MATERNAL; The Organisation for Economic Co-operation and Development Development Centre, 2012, 2012 SIGI SOC I GEND; The Partnership for Maternal Newborn and Child Health, 2011, MAT NEWB CHILD HLTH; Tracy SK, 2013, LANCET, V382, P1723, DOI 10.1016/S0140-6736(13)61406-3; UN Population Fund, 2011, STAT WORLDS MIDW REP; UNDP, 2011, HUM DEV REP 2011 SUS; USAid, 2011, SPECTR POL MOD SYST; Van Lerberghe W, 2014, LANCET; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Victora CG, 2010, INT J EPIDEMIOL, V39, P1, DOI 10.1093/ije/dyq044; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; Walsh D, 2004, BIRTH-ISS PERINAT C, V31, P222, DOI 10.1111/j.0730-7659.2004.00309.x; Warriner IK, 2006, LANCET, V368, P1965, DOI 10.1016/S0140-6736(06)69742-0; WHO, 2006, WORK HLTH WORLD HLTH; WHO, 2010, EV WOM EV CHILD ACC; WHO and UNICEF, 2012, COUNTD 2015 MAT NEWB; Wiegers TA, 1996, J CLIN EPIDEMIOL, V49, P319, DOI 10.1016/0895-4356(95)00549-8; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	95	174	176	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1146	1157		10.1016/S0140-6736(14)60790-X	http://dx.doi.org/10.1016/S0140-6736(14)60790-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965814				2022-12-28	WOS:000342630600035
J	Lee, YCG				Lee, Y. C. Gary			Surgical resection of mesothelioma: an evidence-free practice	LANCET			English	Editorial Material							MALIGNANT-PLEURAL-MESOTHELIOMA; PHASE-III; SURGERY; ORGANIZATION; CISPLATIN; THERAPY		[Lee, Y. C. Gary] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Lee, Y. C. Gary] Sir Charles Gairdner Hosp, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Lee, YCG (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.	gary.lee@uwa.edu.au	Lee, Y C Gary/H-5264-2014	Lee, Yun Chor Gary/0000-0002-0036-511X				Bennett M, 2014, LANCET; Datta A, 2014, THORAX, V69, P194, DOI 10.1136/thoraxjnl-2013-203846; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Finn RS, 2012, CHEST, V142, P1267, DOI 10.1378/chest.11-3204; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Jaklitsch MT, 2001, WORLD J SURG, V25, P210, DOI 10.1007/s002680020021; Le GV, 2011, RESPIROLOGY, V16, P767, DOI 10.1111/j.1440-1843.2011.01975.x; Lee Y C, 2000, Curr Opin Pulm Med, V6, P267, DOI 10.1097/00063198-200007000-00003; Sugarbaker DJ, 1999, J THORAC CARDIOV SUR, V117, P54, DOI 10.1016/S0022-5223(99)70469-1; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; WAGNER J C, 1960, Br J Ind Med, V17, P260	13	24	24	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1080	1081		10.1016/S0140-6736(14)60795-9	http://dx.doi.org/10.1016/S0140-6736(14)60795-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	24942632				2022-12-28	WOS:000342630600012
J	Koltov, MK; Damle, NS				Koltov, Michelle K.; Damle, Nitin S.			Health Policy Basics: Physician Quality Reporting System	ANNALS OF INTERNAL MEDICINE			English	Article								The U. S. health care system is in the midst of transforming from a fee-for-service system to a value-based system that delivers high-quality and cost-effective care. Quality reporting programs and increasing transparency of performance are meant to encourage physicians and hospitals to invest in improving the delivery of care. In 2006, the Centers for Medicare & Medicaid Services implemented the Physician Quality Reporting System (PQRS). The PQRS is an incentive and penalty payment program for eligible professionals who report data on quality measures for covered professional services furnished to Medicare beneficiaries. The program gives eligible professionals the opportunity to assess the quality of care they are providing to their patients and compare their performance on a given measure with that of their peers. This article discusses the history of PQRS, the 2014 PQRS, and how it affects other quality programs.	[Koltov, Michelle K.] Amer Coll Physicians, Washington, DC 20001 USA; South Cty Internal Med, Wakefield, RI 02879 USA	American College of Physicians	Koltov, MK (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	mkoltov@mail.acponline.org						American Board of Internal Medicine, 2014, PART MOC REC CMS; Centers for Medicare and Medicaid Services, 2013, PHYS QUAL REP SYST P; Centers for Medicare & Medicaid Services, 2014, CALL MEAS; Centers for Medicare & Medicaid Services, 2014, 2011 REP EXP INCL TR; Centers for Medicare & Medicaid Services, 2013, MED PROGR REV PAYM B; Medicare Learning Network Connects National Provider Call Centers for Medicare & Medicaid Services, 2013, CY 2014 MED PHYS FIN	6	18	18	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					365	U177		10.7326/M14-0786	http://dx.doi.org/10.7326/M14-0786			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO7VT	24957469				2022-12-28	WOS:000341561400008
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							ENDARTERECTOMY; DISEASE; APPROPRIATENESS; ATHEROSCLEROSIS; EFFICACY; SURGERY; TRIAL	Description: Update of the 2007 U. S. Preventive Services Task Force (USPSTF) recommendation on screening for carotid artery stenosis. Methods: The USPSTF commissioned a systematic review to synthesize the evidence on the accuracy of screening tests, externally validated risk-stratification tools, the benefits of treatment of asymptomatic carotid artery stenosis with carotid endarterectomy (CEA) or carotid angioplasty and stenting (CAAS), the benefits from medications added to current standard medical therapy, and the harms of screening and treatment with CEA or CAAS. Population: This recommendation applies to adults without a history of transient ischemic attack, stroke, or other neurologic signs or symptoms. Recommendation: The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (D recommendation)	[LeFevre, Michael L.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		LeFevre, ML (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.							American Academy of Family Physicians, 2014, CLIN PREV SERV; [Anonymous], 1992, Mayo Clin Proc, V67, P513; Baker WH, 2000, STROKE, V31, P2330, DOI 10.1161/01.STR.31.10.2330; Bratzler D W, 1996, J Okla State Med Assoc, V89, P423; Brott TG, 2013, CATHETER CARDIO INTE, V81, pE75, DOI 10.1002/ccd.22983; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Cebul RD, 1998, JAMA-J AM MED ASSOC, V279, P1282, DOI 10.1001/jama.279.16.1282; Cheng SWK, 1999, CARDIOVASC SURG, V7, P303, DOI 10.1016/S0967-2109(98)00115-X; Cournot M, 2007, J VASC SURG, V46, P1215, DOI 10.1016/j.jvs.2007.08.022; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Halm EA, 2003, STROKE, V34, P1464, DOI 10.1161/01.STR.0000072514.79745.7D; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; Hopkins LN, 2010, J STROKE CEREBROVASC, V19, P153, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.001; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Johansson EP, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-23; Jonas DE, 2014, ANN INTERN MED, V161, P336, DOI 10.7326/M14-0530; Jonas DE, 2014, AHRQ PUBLICATION, V14-EHC029-EF; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; Ratchford EV, 2009, NEUROL RES, V31, P748, DOI 10.1179/174313209X382458; Ricotta JJ, 2011, J VASC SURG, V54, pE1, DOI 10.1016/j.jvs.2011.07.031; Sabeti S, 2004, RADIOLOGY, V232, P431, DOI 10.1148/radiol.2321030791; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; 1991, STROKE, V22, P1229	27	68	71	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					356	U170		10.7326/M14-1333	http://dx.doi.org/10.7326/M14-1333			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO7VT	25003392				2022-12-28	WOS:000341561400006
J	Ghesquiere, B; Wong, BW; Kuchnio, A; Carmeliet, P				Ghesquiere, Bart; Wong, Brian W.; Kuchnio, Anna; Carmeliet, Peter			Metabolism of stromal and immune cells in health and disease	NATURE			English	Review							FATTY-ACID OXIDATION; SMALL-MOLECULE INHIBITION; ENDOTHELIAL-CELLS; GLYCOLYTIC METABOLISM; GLUTAMINE-METABOLISM; CANCER METABOLISM; TUMOR-STROMA; GLUCOSE; STRESS; ANGIOGENESIS	Cancer cells have been at the centre of cell metabolism research, but the metabolism of stromal and immune cells has received less attention. Nonetheless, these cells influence the progression of malignant, inflammatory and metabolic disorders. Here we discuss the metabolic adaptations of stromal and immune cells in health and disease, and highlight how metabolism determines their differentiation and function.	[Ghesquiere, Bart; Wong, Brian W.; Kuchnio, Anna; Carmeliet, Peter] Univ Leuven, Dept Oncol, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium; [Ghesquiere, Bart; Wong, Brian W.; Kuchnio, Anna; Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	Carmeliet, P (corresponding author), Univ Leuven, Dept Oncol, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium.	peter.carmeliet@vib-kuleuven.be	Wong, Brian/B-6168-2009; Carmeliet, Peter/AAQ-5140-2020; Ghesquiere, Bart/HGU-8736-2022	Wong, Brian/0000-0001-8447-3064; Carmeliet, Peter/0000-0001-7961-1821; Ghesquiere, Bart/0000-0003-1547-1705	FWO; Marie Curie Fellowship; Flemish Government, FWO [IUAP P7/03]; AXA Research Fund; ERC Advanced Research Grant	FWO(FWO); Marie Curie Fellowship(European Commission); Flemish Government, FWO(FWO); AXA Research Fund(AXA Research Fund); ERC Advanced Research Grant	Supporting fellowships: FWO Fellowships (B. G., B. W. W., A. K.) and Marie Curie Fellowship (B. W. W.). Supporting grants: IUAP P7/03, long-term structural funding - Methusalem funding by the Flemish Government, FWO grants, AXA Research Fund and ERC Advanced Research Grant. We thank P. Agostinis, M. Baes, K. De Bock, S. Fendt, P. Fraisl, B. Lambrecht, A. Liston, M. Mazzone, J. Rathmell, J. Van Ginderachter, P. Verstreken and others for suggestions.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Avraham-Davidi I, 2012, NAT MED, V18, P967, DOI 10.1038/nm.2759; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Becker JC, 2013, CANCER IMMUNOL IMMUN, V62, P1137, DOI 10.1007/s00262-013-1434-6; Beleznai T, 2012, VASC PHARMACOL, V56, P115, DOI 10.1016/j.vph.2011.11.003; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Brandes RP, 2014, J MOL CELL CARDIOL, V73, P70, DOI 10.1016/j.yjmcc.2014.02.006; Byersdorfer CA, 2013, BLOOD, V122, P3230, DOI 10.1182/blood-2013-04-495515; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chaudhri VK, 2013, MOL CANCER RES, V11, P579, DOI 10.1158/1541-7786.MCR-12-0437-T; Chung SJ, 2004, J BIOCHEM MOL BIOL, V37, P239; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Eheim A, 2014, SEMIN IMMUNOPATHOL, V36, P13, DOI 10.1007/s00281-013-0403-7; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hill MF, 2008, CURR CARDIOL REV, V4, P259, DOI 10.2174/157340308786349453; Hotta N, 2012, DIABETIC MED, V29, P1529, DOI 10.1111/j.1464-5491.2012.03684.x; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Leopold JA, 2003, ARTERIOSCL THROM VAS, V23, P411, DOI 10.1161/01.ATV.0000056744.26901.BA; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Lisanti MP, 2010, CANCER BIOL THER, V10, P537, DOI 10.4161/cbt.10.6.13370; Liu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041495; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manigrasso MB, 2014, TRENDS ENDOCRIN MET, V25, P15, DOI 10.1016/j.tem.2013.08.002; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Merchan JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013699; MERTENS S, 1990, AM J PHYSIOL, V258, pH689, DOI 10.1152/ajpheart.1990.258.3.H689; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Obrosova IG, 2011, CURR PHARM BIOTECHNO, V12, P373; Ohashi T, 2013, INT J CANCER, V133, P1107, DOI 10.1002/ijc.28114; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; Popovic PJ, 2007, J NUTR, V137, p1681S, DOI 10.1093/jn/137.6.1681S; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Robichaud PP, 2013, J LIPID RES, V54, P2665, DOI 10.1194/jlr.M037044; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Sena CM, 2012, PHARMACOL RES, V65, P497, DOI 10.1016/j.phrs.2012.03.004; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Shah GN, 2013, J PHARMACOL EXP THER, V344, P637, DOI 10.1124/jpet.112.201400; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; SPOLARICS Z, 1991, AM J PHYSIOL, V261, pG185, DOI 10.1152/ajpgi.1991.261.2.G185; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; Unterluggauer H, 2008, BIOGERONTOLOGY, V9, P247, DOI 10.1007/s10522-008-9134-x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P255, DOI 10.1016/j.cmet.2006.08.006; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wahl DR, 2012, IMMUNOL REV, V249, P104, DOI 10.1111/j.1600-065X.2012.01148.x; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Warren CM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004235; Wei XC, 2011, J BIOL CHEM, V286, P2933, DOI 10.1074/jbc.M110.193037; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wu GY, 2000, COMP BIOCHEM PHYS A, V126, P115, DOI 10.1016/S1095-6433(00)00196-3; Yamanishi S, 2006, AM J PHYSIOL-HEART C, V290, pH925, DOI 10.1152/ajpheart.01012.2005; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212	106	292	301	11	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					167	176		10.1038/nature13312	http://dx.doi.org/10.1038/nature13312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008522				2022-12-28	WOS:000338649800034
J	Howard, DH				Howard, David H.			Drug Companies' Patient-Assistance Programs - Helping Patients or Profits?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Howard, David H.] Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA; [Howard, David H.] Emory Univ, Dept Econ, Atlanta, GA 30322 USA; [Howard, David H.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Howard, DH (corresponding author), Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA.							[Anonymous], 2013, COMMUNICATION, P2; [Anonymous], PROV FIN COV; Department of Health and Human Services Office of Inspector General, 2005, FED REGISTER, V70, P70623; Pavcnik N, 2002, RAND J ECON, V33, P469, DOI 10.2307/3087468; Visante, 2011, COP COUP COULS RAIS	5	36	36	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					97	99		10.1056/NEJMp1401658	http://dx.doi.org/10.1056/NEJMp1401658			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK7YZ	25006717				2022-12-28	WOS:000338645500003
J	Krupalnik, V; Hanna, JH				Krupalnik, Vladislav; Hanna, Jacob H.			STEM CELLS The quest for the perfect reprogrammed cell	NATURE			English	Editorial Material							LINES		[Krupalnik, Vladislav; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Krupalnik, V (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	jacob.hanna@weizmann.ac.il	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974				Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yamada M., 2014, NATURE	11	8	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					160	162		10.1038/nature13515	http://dx.doi.org/10.1038/nature13515			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008516				2022-12-28	WOS:000338649800030
J	McCarthy, M; Rosengart, A; Schuetz, AN; Kontoyiannis, DP; Walsh, TJ				McCarthy, Matthew; Rosengart, Axel; Schuetz, Audrey N.; Kontoyiannis, Dimitrios P.; Walsh, Thomas J.			Mold Infections of the Central Nervous System	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FUNGAL MENINGITIS; CONTAMINATED METHYLPREDNISOLONE; OCHROCONIS-GALLOPAVA; MULTISTATE OUTBREAK; CEREBROSPINAL-FLUID; ANTIFUNGAL ACTIVITY; AMPHOTERICIN-B; MUCORMYCOSIS; DIAGNOSIS; PHEOHYPHOMYCOSIS		[McCarthy, Matthew; Walsh, Thomas J.] Cornell Univ, Weill Cornell Med Ctr, Transplantat Oncol Infect Dis Program, Dept Med, New York, NY 10065 USA; [McCarthy, Matthew; Walsh, Thomas J.] Cornell Univ, Weill Cornell Med Ctr, Transplantat Oncol Infect Dis Program, Dept Pediat, New York, NY 10065 USA; [McCarthy, Matthew; Walsh, Thomas J.] Cornell Univ, Weill Cornell Med Ctr, Transplantat Oncol Infect Dis Program, Dept Microbiol & Immunol, New York, NY 10065 USA; [Rosengart, Axel] Cornell Univ, Weill Cornell Med Ctr, Dept Neurol Neurosci & Neurosurg, New York, NY 10065 USA; [Schuetz, Audrey N.] Cornell Univ, Weill Cornell Med Ctr, Dept Pathol & Lab Med, New York, NY 10065 USA; [Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Houston, TX 77030 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Walsh, TJ (corresponding author), Cornell Univ, Weill Cornell Med Ctr, Transplantat Oncol Infect Dis Program, 1300 York Ave,Rm A-421, New York, NY 10065 USA.	thw2003@med.cornell.edu			Merck; Gilead; Pfizer; Astellas; ContraFect; iCo; Methylgene; Cubist; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007613] Funding Source: NIH RePORTER	Merck(Merck & Company); Gilead(Gilead Sciences); Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals); ContraFect; iCo; Methylgene; Cubist; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Kontoyiannis reports receiving fees for serving on an advisory board from Merck, personal fees from Gilead, and grant support from Merck, Pfizer, and Astellas. Dr. Walsh reports receiving fees for serving on advisory boards from Astellas, ContraFect, Pfizer, and iCo, consulting fees from Astellas, ContraFect, Pfizer, iCo, Methylgene, and grant support from Astellas, Novartis, ContraFect, Merck, and Cubist; he also reports serving as an uncompensated consultant for Drais, SigmaTau, and Trius, and receiving a study drug for laboratory investigation from Pfizer. No other potential conflict of interest relevant to this article was reported.	Al-Tawfiq Jaffar A, 2011, J Infect Public Health, V4, P96, DOI 10.1016/j.jiph.2011.01.001; ANAISSIE E, 1991, EUR J CLIN MICROBIOL, V10, P665, DOI 10.1007/BF01975823; Antinori S, 2013, J INFECTION, V66, P218, DOI 10.1016/j.jinf.2012.11.003; Ben-Ami R, 2009, CLIN INFECT DIS, V48, P1033, DOI 10.1086/597400; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Dignani MC, 2004, CLIN MICROBIOL INFEC, V10, P67, DOI 10.1111/j.1470-9465.2004.00845.x; DIXON DM, 1989, REV INFECT DIS, V11, P515; Gade L, 2013, EUKARYOT CELL, V12, P677, DOI 10.1128/EC.00046-13; Greenberg RN, 2006, ANTIMICROB AGENTS CH, V50, P126, DOI 10.1128/AAC.50.1.126-133.2006; Hammond SP, 2011, ANTIMICROB AGENTS CH, V55, P5018, DOI 10.1128/AAC.00536-11; Herbrecht R, 2002, J CLIN ONCOL, V20, P1898, DOI 10.1200/JCO.2002.07.004; HOPKINS RJ, 1994, CLIN INFECT DIS, V19, P1133, DOI 10.1093/clinids/19.6.1133; Ibrahim AS, 2012, CLIN INFECT DIS, V54, pS16, DOI 10.1093/cid/cir865; IIHARA K, 1990, Neurologia Medico-Chirurgica, V30, P618, DOI 10.2176/nmc.30.618; Johnson EM, 1998, J ANTIMICROB CHEMOTH, V42, P741, DOI 10.1093/jac/42.6.741; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Katragkou A, 2012, CLIN MICROBIOL INFEC, V18, P134, DOI 10.1111/j.1469-0691.2011.03689.x; Kauffman CA, 2013, NEW ENGL J MED, V368, P2495, DOI 10.1056/NEJMra1212617; Kontoyiannis DP, 2013, CLIN INFECT DIS, V57, P853, DOI 10.1093/cid/cit283; Kourkoumpetis TK, 2012, MEDICINE, V91, P328, DOI 10.1097/MD.0b013e318274cd77; Lamaris GA, 2008, EUR J CLIN MICROBIOL, V27, P343, DOI 10.1007/s10096-007-0443-9; Li DM, 2009, LANCET INFECT DIS, V9, P376, DOI 10.1016/S1473-3099(09)70131-8; Litvintseva AP, 2014, CLIN INFECT DIS, V58, P622, DOI 10.1093/cid/cit808; Lyons JL, 2013, J CLIN MICROBIOL, V51, P1285, DOI 10.1128/JCM.00061-13; Lyons MK, 2005, CLIN NEUROL NEUROSUR, V107, P532, DOI 10.1016/j.clineuro.2004.11.020; Mantadakis E, 2009, CLIN MICROBIOL INFEC, V15, P15, DOI 10.1111/j.1469-0691.2009.02974.x; Martino P, 1994, J Infect, V28 Suppl 1, P7, DOI 10.1016/S0163-4453(94)95911-0; McDermott NE, 2010, ORAL SURG ORAL MED O, V109, pE64, DOI 10.1016/j.tripleo.2009.11.012; MCNULTY JS, 1982, LARYNGOSCOPE, V92, P1140; Mikulska M, 2013, CLIN INFECT DIS, V56, P1511, DOI 10.1093/cid/cit073; Montejo M, 2002, MYCOSES, V45, P418, DOI 10.1046/j.1439-0507.2002.00790.x; Perfect JR, 2012, ANN INTERN MED, V157, P825, DOI 10.7326/0003-4819-157-11-201212040-00558; Petrikkos G, 2012, CLIN INFECT DIS, V54, pS23, DOI 10.1093/cid/cir866; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2040, DOI 10.1128/JCM.00248-12; Qureshi ZA, 2012, CLIN TRANSPLANT, V26, pE17, DOI 10.1111/j.1399-0012.2011.01528.x; Rambach G, 2005, MICROBES INFECT, V7, P1285, DOI 10.1016/j.micinf.2005.04.014; Reinwald M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056706; Revankar SG, 2004, CLIN INFECT DIS, V38, P206, DOI 10.1086/380635; Schwartz S, 2009, MED MYCOL, V47, pS387, DOI 10.1080/13693780802537953; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Shoham S, 2008, TRANSPL INFECT DIS, V10, P442, DOI 10.1111/j.1399-3062.2008.00327.x; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; Soeffker G, 2013, PROG TRANSPLANT, V23, P71, DOI 10.7182/pit2013386; Spellberg B, 2012, J ANTIMICROB CHEMOTH, V67, P715, DOI 10.1093/jac/dkr375; Spellberg B, 2012, CLIN INFECT DIS, V54, pS73, DOI 10.1093/cid/cir885; STEINBERG GK, 1983, J NEUROSURG, V58, P598, DOI 10.3171/jns.1983.58.4.0598; Stevens DA, 2013, ANTIMICROB AGENTS CH, V57, P1567, DOI 10.1128/AAC.02242-12; Tortorano AM, 2012, J CLIN MICROBIOL, V50, P1051, DOI 10.1128/JCM.05946-11; Troke P, 2008, ANTIMICROB AGENTS CH, V52, P1743, DOI 10.1128/AAC.01388-07; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; WALSH TJ, 1985, NEUROLOGY, V35, P1654, DOI 10.1212/WNL.35.11.1654; Zhao YN, 2013, J CLIN MICROBIOL, V51, P1034, DOI 10.1128/JCM.03369-12	53	100	112	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					150	160		10.1056/NEJMra1216008	http://dx.doi.org/10.1056/NEJMra1216008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006721	Green Accepted			2022-12-28	WOS:000338645500011
J	Maher, P; Wang, L; Gao, YD; Forsythe, C; Taniguchi, T; Watanabe, K; Abanin, D; Papic, Z; Cadden-Zimansky, P; Hone, J; Kim, P; Dean, CR				Maher, Patrick; Wang, Lei; Gao, Yuanda; Forsythe, Carlos; Taniguchi, Takashi; Watanabe, Kenji; Abanin, Dmitry; Papic, Zlatko; Cadden-Zimansky, Paul; Hone, James; Kim, Philip; Dean, Cory R.			Tunable fractional quantum Hall phases in bilayer graphene	SCIENCE			English	Article							TRANSITION; STATES	Symmetry-breaking in a quantum system often leads to complex emergent behavior. In bilayer graphene (BLG), an electric field applied perpendicular to the basal plane breaks the inversion symmetry of the lattice, opening a band gap at the charge neutrality point. In a quantizing magnetic field, electron interactions can cause spontaneous symmetry-breaking within the spin and valley degrees of freedom, resulting in quantum Hall effect (QHE) states with complex order. Here, we report fractional QHE states in BLG that show phase transitions that can be tuned by a transverse electric field. This result provides a model platform with which to study the role of symmetry-breaking in emergent states with topological order.	[Maher, Patrick; Forsythe, Carlos; Kim, Philip] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Wang, Lei] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Gao, Yuanda; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Abanin, Dmitry; Papic, Zlatko] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Abanin, Dmitry; Papic, Zlatko] Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Cadden-Zimansky, Paul] Bard Coll, Phys Program, Annandale On Hudson, NY 12504 USA; [Dean, Cory R.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	Columbia University; Columbia University; Columbia University; National Institute for Materials Science; Perimeter Institute for Theoretical Physics; University of Waterloo; City University of New York (CUNY) System; City College of New York (CUNY)	Kim, P (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	pk2015@columbia.edu; cdean@ccny.cuny.edu	Kim, Philip/N-1886-2013; Abanin, Dmitry/ABD-6660-2021; Hone, James C/E-1879-2011; Papic, Zlatko/AAE-2499-2020; Wang, Lei/K-1160-2012; TANIGUCHI, Takashi/H-2718-2011; Papic, Zlatko/K-6714-2013; WATANABE, Kenji/H-2825-2011	Kim, Philip/0000-0002-8255-0086; Hone, James C/0000-0002-8084-3301; Papic, Zlatko/0000-0002-8451-2235; Wang, Lei/0000-0002-1919-9107; WATANABE, Kenji/0000-0003-3701-8119	U.S. National Science Foundation [DMR-0654118]; State of Florida; U.S. Department of Energy (DOE); National Science Foundation [DMR-1124894]; FAME under STARnet; Office of Naval Research [N000141310662]; DOE [DE-FG02-05ER46215]	U.S. National Science Foundation(National Science Foundation (NSF)); State of Florida; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); FAME under STARnet; Office of Naval Research(Office of Naval Research); DOE(United States Department of Energy (DOE))	We acknowledge M. Shinn and G. Myers for assistance with measurements. We thank A. Yacoby for helpful discussions. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by U.S. National Science Foundation cooperative agreement DMR-0654118, the State of Florida, and the U.S. Department of Energy (DOE). This work is supported by the National Science Foundation (DMR-1124894) and FAME under STARnet. J.H. acknowledges support from Office of Naval Research N000141310662. P. K. acknowledges support from DOE (DE-FG02-05ER46215).	Apalkov VM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.036801; Bao WZ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246601; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; DU RR, 1995, PHYS REV LETT, V75, P3926, DOI 10.1103/PhysRevLett.75.3926; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; EISENSTEIN JP, 1989, PHYS REV LETT, V62, P1540, DOI 10.1103/PhysRevLett.62.1540; Feldman BE, 2012, SCIENCE, V337, P1196, DOI 10.1126/science.1224784; Gorbar EV, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235449; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Kang W, 1997, PHYS REV B, V56, P12776, DOI 10.1103/PhysRevB.56.R12776; Ki DK, 2014, NANO LETT, V14, P2135, DOI 10.1021/nl5003922; Kim S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016803; Kou A, 2014, SCIENCE, V345, P55, DOI 10.1126/science.1250270; Lai K, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125337; Lambert J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115415; Liu Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195303; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Padmanabhan M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016805; Papic Z, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.046602; Papic Z, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.241306; Roy B., 2012, ARXIV12036340CONDMAT; Snizhko K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.201415; Velasco J, 2014, NANO LETT, V14, P1324, DOI 10.1021/nl4043399; Velasco J, 2012, NAT NANOTECHNOL, V7, P156, DOI [10.1038/nnano.2011.251, 10.1038/NNANO.2011.251]; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776	37	122	125	7	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					61	64		10.1126/science.1252875	http://dx.doi.org/10.1126/science.1252875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994646	Green Submitted, Green Accepted			2022-12-28	WOS:000338284400048
J	Behar, SM; Sassetti, CM				Behar, Samuel M.; Sassetti, Christopher M.			Fixing the odds against tuberculosis	NATURE			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; IMMUNITY		[Behar, Samuel M.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Behar, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA.	samuel.behar@umassmed.edu; christopher.sassetti@umassmed.edu		Behar, Samuel/0000-0002-3374-6699				Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	13	5	7	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					39	40		10.1038/nature13512	http://dx.doi.org/10.1038/nature13512			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990740				2022-12-28	WOS:000338199400028
J	Kfoury, Y; Mercier, F; Scadden, DT				Kfoury, Youmna; Mercier, Francois; Scadden, David T.			SnapShot: The Hematopoietic Stem Cell Niche	CELL			English	Editorial Material							BONE-MARROW NICHE; LEUKEMIA		[Kfoury, Youmna; Mercier, Francois; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst,Dept Stem Cell & Regenerat, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital	Kfoury, Y (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst,Dept Stem Cell & Regenerat, Cambridge, MA 02138 USA.							Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/nchembio.1367, 10.1038/NCHEMBIO.1367]; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Levesque JP, 2013, BIOESSAYS, V35, P183, DOI 10.1002/bies.201200111; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Motabi IH, 2012, BLOOD REV, V26, P267, DOI 10.1016/j.blre.2012.09.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034	10	13	14	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					228	U252		10.1016/j.cell.2014.06.019	http://dx.doi.org/10.1016/j.cell.2014.06.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995988	Bronze			2022-12-28	WOS:000340943100022
J	Lee, J; Tymchenko, M; Argyropoulos, C; Chen, PY; Lu, F; Demmerle, F; Boehm, G; Amann, MC; Alu, A; Belkin, MA				Lee, Jongwon; Tymchenko, Mykhailo; Argyropoulos, Christos; Chen, Pai-Yen; Lu, Feng; Demmerle, Frederic; Boehm, Gerhard; Amann, Markus-Christian; Alu, Andrea; Belkin, Mikhail A.			Giant nonlinear response from plasmonic metasurfaces coupled to intersubband transitions	NATURE			English	Article							OPTIMIZED 2ND-HARMONIC GENERATION; QUANTUM; GAAS	Intersubband transitions in n-doped multi-quantum-well semiconductor heterostructures make it possible to engineer one of the largest known nonlinear optical responses in condensed matter systems-but this nonlinear response is limited to light with electric field polarized normal to the semiconductor layers(1-7). In a different context, plasmonic metasurfaces (thin conductor-dielectric composite materials) have been proposed as a way of strongly enhancing light-matter interaction and realizing ultrathin planarized devices with exotic wave properties(8-11). Here we propose and experimentally realize metasurfaces with a record-high nonlinear response based on the coupling of electromagnetic modes in plasmonic metasurfaces with quantum-engineered electronic intersubband transitions in semiconductor heterostructures. We show that it is possible to engineer almost any element of the nonlinear susceptibility tensor of these structures, and we experimentally verify this concept by realizing a 400-nm-thick metasurface with nonlinear susceptibility of greater than 5 x 10(4) picometres per volt for second harmonic generation at a wavelength of about 8 micrometres under normal incidence. This susceptibility is many orders of magnitude larger than any second-order nonlinear response in optical metasurfaces measured so far(12-15). The proposed structures can act as ultrathin highly nonlinear optical elements that enable efficient frequency mixing with relaxed phase-matching conditions, ideal for realizing broadband frequency up-and down-conversions, phase conjugation and all-optical control and tunability over a surface.	[Lee, Jongwon; Tymchenko, Mykhailo; Argyropoulos, Christos; Chen, Pai-Yen; Lu, Feng; Alu, Andrea; Belkin, Mikhail A.] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Demmerle, Frederic; Boehm, Gerhard; Amann, Markus-Christian] Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany	University of Texas System; University of Texas Austin; Technical University of Munich	Belkin, MA (corresponding author), Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA.	mbelkin@ece.utexas.edu	Lee, Jongwon/AFK-3283-2022; Chen, Pai-Yen/AAR-3291-2020; Lee, Jongwon/AAG-1934-2022; Tymchenko, Mykhailo/A-1503-2017	Lee, Jongwon/0000-0002-3878-0650; Chen, Pai-Yen/0000-0002-8112-8457; Lee, Jongwon/0000-0002-3878-0650; Tymchenko, Mykhailo/0000-0003-4156-3531	NSF EAGER grant [1348049]; AFOSR YIP award [FA9550-10-1-0076]; AFOSR YIP [FA9550-11-1-0009]; ONR MURI grant [N00014-10-1-0942]; Excellence Cluster 'Nano Initiative Munich (NIM)'; Directorate For Engineering [1348049] Funding Source: National Science Foundation	NSF EAGER grant(National Science Foundation (NSF)); AFOSR YIP award; AFOSR YIP(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ONR MURI grant; Excellence Cluster 'Nano Initiative Munich (NIM)'; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by NSF EAGER grant no. 1348049 (to M.A.B. and A.A.), AFOSR YIP award no. FA9550-10-1-0076 (M.A.B.), AFOSR YIP award no. FA9550-11-1-0009 (A.A.), and ONR MURI grant no. N00014-10-1-0942 (A.A.). The Walter Schottky Institute group acknowledges support from the Excellence Cluster 'Nano Initiative Munich (NIM)'. Sample fabrication was carried out in the Microelectronics Research Center at the University of Texas at Austin, which is a member of the National Nanotechnology Infrastructure Network.	Argyropoulos C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.263905; Balanis C.A., 1989, ADV ENG ELECTROMAGNE; Belkin MA, 2007, NAT PHOTONICS, V1, P288, DOI 10.1038/nphoton.2007.70; Benz A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3882; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; CAPASSO F, 1994, IEEE J QUANTUM ELECT, V30, P1313, DOI 10.1109/3.303697; Chen PY, 2012, ADV MATER, V24, pOP281, DOI 10.1002/adma.201202624; Ellenbogen T, 2012, NANO LETT, V12, P1026, DOI 10.1021/nl204257g; Fan WJ, 2006, OPT EXPRESS, V14, P9570, DOI 10.1364/OE.14.009570; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; FEJER MM, 1989, PHYS REV LETT, V62, P1041, DOI 10.1103/PhysRevLett.62.1041; Feth N, 2008, OPT LETT, V33, P1975, DOI 10.1364/OL.33.001975; Gmachl C, 2003, IEEE J QUANTUM ELECT, V39, P1345, DOI 10.1109/JQE.2003.818315; Hugi A, 2012, NATURE, V492, P229, DOI 10.1038/nature11620; Klein MW, 2006, SCIENCE, V313, P502, DOI 10.1126/science.1129198; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Liu XL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.045901; Monticone F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203903; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Niesler FBP, 2009, OPT LETT, V34, P1997, DOI 10.1364/OL.34.001997; Pendry JB, 2008, SCIENCE, V322, P71, DOI 10.1126/science.1162087; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Rose A, 2011, OPT MATER EXPRESS, V1, P1232; Rosencher E, 1996, SCIENCE, V271, P168, DOI 10.1126/science.271.5246.168; ROSENCHER E, 1989, ELECTRON LETT, V25, P1063, DOI 10.1049/el:19890711; Todorov Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.196402; Vijayraghavan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3021; Vodopyanov KL, 1998, APPL PHYS LETT, V72, P2654, DOI 10.1063/1.121088; Vodopyanov KL, 1997, SEMICOND SCI TECH, V12, P708, DOI 10.1088/0268-1242/12/6/011; Vurgaftman I, 1996, IEEE J QUANTUM ELECT, V32, P1334, DOI 10.1109/3.511546; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhao Y, 2013, NANO LETT, V13, P1086, DOI 10.1021/nl304392b	33	463	477	25	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					65	U389		10.1038/nature13455	http://dx.doi.org/10.1038/nature13455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990746				2022-12-28	WOS:000338199400036
J	Sanna, T; Diener, HC; Passman, RS; Di Lazzaro, V; Bernstein, RA; Morillo, CA; Rymer, MM; Thijs, V; Rogers, T; Beckers, F; Lindborg, K; Brachmann, J				Sanna, Tommaso; Diener, Hans-Christoph; Passman, Rod S.; Di Lazzaro, Vincenzo; Bernstein, Richard A.; Morillo, Carlos A.; Rymer, Marilyn Mollman; Thijs, Vincent; Rogers, Tyson; Beckers, Frank; Lindborg, Kate; Brachmann, Johannes		CRYSTAL AF Investigators	Cryptogenic Stroke and Underlying Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; RISK-FACTORS; ECG; SUBTYPES; CLASSIFICATION; GUIDELINES; MANAGEMENT; TELEMETRY; RECORDERS; UPDATE	BACKGROUND Current guidelines recommend at least 24 hours of electrocardiographic (ECG) monitoring after an ischemic stroke to rule out atrial fibrillation. However, the most effective duration and type of monitoring have not been established, and the cause of ischemic stroke remains uncertain despite a complete diagnostic evaluation in 20 to 40% of cases (cryptogenic stroke). Detection of atrial fibrillation after cryptogenic stroke has therapeutic implications. METHODS We conducted a randomized, controlled study of 441 patients to assess whether long-term monitoring with an insertable cardiac monitor (ICM) is more effective than conventional follow-up (control) for detecting atrial fibrillation in patients with cryptogenic stroke. Patients 40 years of age or older with no evidence of atrial fibrillation during at least 24 hours of ECG monitoring underwent randomization within 90 days after the index event. The primary end point was the time to first detection of atrial fibrillation (lasting >30 seconds) within 6 months. Among the secondary end points was the time to first detection of atrial fibrillation within 12 months. Data were analyzed according to the intention-to-treat principle. RESULTS By 6 months, atrial fibrillation had been detected in 8.9% of patients in the ICM group (19 patients) versus 1.4% of patients in the control group (3 patients) (hazard ratio, 6.4; 95% confidence interval [CI], 1.9 to 21.7; P<0.001). By 12 months, atrial fib-rillation had been detected in 12.4% of patients in the ICM group (29 patients) versus 2.0% of patients in the control group (4 patients) (hazard ratio, 7.3; 95% CI, 2.6 to 20.8; P<0.001). CONCLUSIONS ECG monitoring with an ICM was superior to conventional follow-up for detecting atrial fibrillation after cryptogenic stroke.	[Sanna, Tommaso] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00168 Rome, Italy; [Di Lazzaro, Vincenzo] Campus Biomed Univ, Inst Neurol, Rome, Italy; [Diener, Hans-Christoph] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Diener, Hans-Christoph] Univ Hosp Essen, Stroke Ctr, Essen, Germany; [Brachmann, Johannes] Univ Wurzburg, Teaching Hosp, Hosp Klinikum Coburg, Coburg, Germany; [Passman, Rod S.] Northwestern Univ, Feinberg Sch Med, Bluhm Cardiovasc Inst, Chicago, IL 60611 USA; [Bernstein, Richard A.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA; [Morillo, Carlos A.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Rymer, Marilyn Mollman] Univ Kansas, Med Ctr, Kansas City, KS USA; [Thijs, Vincent] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Thijs, Vincent] VIB, Vesalius Res Ctr, Leuven, Belgium; [Thijs, Vincent] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Rogers, Tyson; Lindborg, Kate] Medtronic, Mounds View, MN USA; [Beckers, Frank] Medtronic, Maastricht, Netherlands	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University Campus Bio-Medico - Rome Italy; University of Duisburg Essen; University of Duisburg Essen; Klinikum Coburg; University of Wurzburg; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; McMaster University; Population Health Research Institute; University of Kansas; University of Kansas Medical Center; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Medtronic; Medtronic	Sanna, T (corresponding author), Univ Cattolica Sacro Cuore, Inst Cardiol, Largo A Gemelli 8, I-00168 Rome, Italy.	tommaso.sanna@rm.unicatt.it	Diener, Hans-Christoph/AAF-7275-2019; Thijs, Vincent/C-3647-2009; Sanna, Tommaso/AAC-9487-2021; Brachmann, Johannes/AAD-1499-2021; Di Lazzaro, Vincenzo/L-3731-2018	Thijs, Vincent/0000-0002-6614-8417; Di Lazzaro, Vincenzo/0000-0002-9113-5925; Fernandez Lozano, Ignacio/0000-0002-3092-8761; Pickett, Robert/0000-0002-7764-3800; Platonov, Pyotr/0000-0002-5592-8717; Morillo, Carlos/0000-0002-8739-2099; SANNA, Tommaso/0000-0002-5760-6885	Medtronic	Medtronic(Medtronic)	Funded by Medtronic; CRYSTAL AF ClinicalTrials.gov number, NCT00924638.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amarenco P, 2009, CEREBROVASC DIS, V27, P502, DOI 10.1159/000210433; Barthelemy JC, 2003, ANN NONINVAS ELECTRO, V8, P194, DOI 10.1046/j.1542-474X.2003.08305.x; Bhatt A, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/172074; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Cotter PE, 2013, NEUROLOGY, V80, P1546, DOI 10.1212/WNL.0b013e31828f1828; Dion F, 2010, J INTERV CARD ELECTR, V28, P101, DOI 10.1007/s10840-010-9485-5; Douen AG, 2008, STROKE, V39, P480, DOI 10.1161/STROKEAHA.107.492595; Elijovich L, 2009, J STROKE CEREBROVASC, V18, P185, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.005; Etgen T, 2013, STROKE, V44, P2007, DOI 10.1161/STROKEAHA.113.001340; Flint AC, 2012, STROKE, V43, P2788, DOI 10.1161/STROKEAHA.112.665844; Gaillard N, 2010, NEUROLOGY, V74, P1666, DOI 10.1212/WNL.0b013e3181e0427e; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Go AS, 2013, CIRCULATION, V127, pE841, DOI 10.1161/CIR.0b013e31829ae08c; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Higgins P, 2013, STROKE, V44, P2525, DOI 10.1161/STROKEAHA.113.001927; Hindricks G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P141, DOI 10.1161/CIRCEP.109.877852; Jabaudon D, 2004, STROKE, V35, P1647, DOI 10.1161/01.STR.0000131269.69502.d9; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kamel H, 2013, STROKE, V44, P528, DOI 10.1161/STROKEAHA.112.679100; Kamel H, 2009, J STROKE CEREBROVASC, V18, P453, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.012; Kishore A, 2014, STROKE, V45, P520, DOI 10.1161/STROKEAHA.113.003433; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Manina G, 2014, INTERN EMERG MED, V9, P65, DOI 10.1007/s11739-012-0755-3; Miller DJ, 2013, J NEUROL SCI, V324, P57, DOI 10.1016/j.jns.2012.10.001; Rabinstein AA, 2013, J STROKE CEREBROVASC, V22, P1405, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.013; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Roten L, 2012, HEART, V98, P645, DOI 10.1136/heartjnl-2011-301455; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; Seet RCS, 2011, CIRCULATION, V124, P477, DOI 10.1161/CIRCULATIONAHA.111.029801; Sinha AM, 2010, AM HEART J, V160, P36, DOI 10.1016/j.ahj.2010.03.032; Tayal AH, 2008, NEUROLOGY, V71, P1696, DOI 10.1212/01.wnl.0000325059.86313.31; Ziegler PD, 2012, AM J CARDIOL, V110, P1309, DOI 10.1016/j.amjcard.2012.06.034; Ziegler PD, 2006, HEART RHYTHM, V3, P1445, DOI 10.1016/j.hrthm.2006.07.030	35	1205	1251	4	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2478	2486		10.1056/NEJMoa1313600	http://dx.doi.org/10.1056/NEJMoa1313600			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963567				2022-12-28	WOS:000337804400005
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Is discussing futile treatments really best for dying patients?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Dyer C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4094; Gallo JJ, 2003, J AM GERIATR SOC, V51, P961, DOI 10.1046/j.1365-2389.2003.51309.x; Kjorstad Odd Jarle, 2013, Tidsskr Nor Laegeforen, V133, P417, DOI 10.4045/tidsskr.12.0378	3	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2014	348								g4180	10.1136/bmj.g4180	http://dx.doi.org/10.1136/bmj.g4180			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UG	24962061				2022-12-28	WOS:000338201800020
J	Chiew, AL; Isbister, GRK				Chiew, Angela L.; Isbister, Geoff Rey K.			A coagulopathic dilemma: snakes or genes	LANCET			English	Editorial Material									[Chiew, Angela L.] Univ NSW, Prince Wales Hosp, Sch Clin, Randwick, NSW, Australia; [Chiew, Angela L.; Isbister, Geoff Rey K.] Sydney Childrens Hosp Network, NSW Poisons Informat Ctr, Sydney, NSW, Australia; [Isbister, Geoff Rey K.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia	University of New South Wales Sydney; University of Newcastle	Chiew, AL (corresponding author), Prince Wales Hosp, Dept Emergency Med, Clin & Expt Toxicol Unit, Barker St, Randwick, NSW 2031, Australia.	angela.chiew@sesiahs.health.nsw.gov.au	Isbister, Geoffrey K/G-8052-2015; Chiew, Angela L/V-5544-2019	Isbister, Geoffrey K/0000-0003-1519-7419; Chiew, Angela L/0000-0002-0079-5056				Allen GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053188; Gailani D, 2013, HEMATOLOGY BASIC PRI, P1981; HALBMAYER WM, 1994, THROMB HAEMOSTASIS, V71, P68; Isbister GK, 2010, J THROMB HAEMOST, V8, P2504, DOI 10.1111/j.1538-7836.2010.04050.x; Johnston CI, 2013, CLIN TOXICOL, V51, P417, DOI 10.3109/15563650.2013.787535	5	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2184	2184		10.1016/S0140-6736(14)60690-5	http://dx.doi.org/10.1016/S0140-6736(14)60690-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24953476	Green Submitted			2022-12-28	WOS:000337906600033
J	Hublin, JJ				Hublin, Jean-Jacques			How to build a Neandertal	SCIENCE			English	Editorial Material									Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany	Max Planck Society	Hublin, JJ (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	hublin@eva.mpg.de						Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Gunz P, 2012, J HUM EVOL, V62, P300, DOI 10.1016/j.jhevol.2011.11.013; Holliday TW, 2007, VERTEBR PALEOBIOL PA, P281; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Parfitt SA, 2010, NATURE, V466, P229, DOI 10.1038/nature09117; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001	13	11	11	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1338	1339		10.1126/science.1255554	http://dx.doi.org/10.1126/science.1255554			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ2YQ	24948719				2022-12-28	WOS:000337531700016
J	Fairbrother, WJ; Ashkenazi, A				Fairbrother, Wayne J.; Ashkenazi, Avi			Designer Proteins to Trigger Cell Death	CELL			English	Editorial Material								Efforts to generate biologically active proteins by de novo computational design have been limited to creating functional sites within pre-existing scaffolds. Procko et al. use an innovative computational design approach coupled with in-vitro-targeted evolution to produce a potent polypeptide inhibitor of a viral Bcl-2-like protein. This novel inhibitor triggers apoptosis of virus-infected cells.	[Fairbrother, Wayne J.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Ashkenazi, Avi] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Fairbrother, WJ (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	fairbrother.wayne@gene.com; aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Fleishman SJ, 2011, J MOL BIOL, V413, P1047, DOI 10.1016/j.jmb.2011.09.001; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Procko E, 2014, CELL, V157, P1644, DOI 10.1016/j.cell.2014.04.034; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035	10	3	3	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1506	1508		10.1016/j.cell.2014.06.010	http://dx.doi.org/10.1016/j.cell.2014.06.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949963	Bronze			2022-12-28	WOS:000340941900006
J	Xu, HT; Han, Z; Gao, P; He, SJ; Li, ZZ; Shi, W; Kodish, O; Shao, W; Brown, KN; Huang, K; Shi, SH				Xu, Hua-Tai; Han, Zhi; Gao, Peng; He, Shuijin; Li, Zhizhong; Shi, Wei; Kodish, Oren; Shao, Wei; Brown, Keith N.; Huang, Kun; Shi, Song-Hai			Distinct Lineage-Dependent Structural and Functional Organization of the Hippocampus	CELL			English	Article							RADIAL GLIAL-CELLS; IN-VIVO; EXCITATORY NEURONS; GABAERGIC NEURONS; PYRAMIDAL CELLS; PLACE CELLS; INTERNEURONS; MIGRATION; RAT; SPECIFICATION	The hippocampus, as part of the cerebral cortex, is essential for memory formation and spatial navigation. Although it has been extensively studied, especially as a model system for neurophysiology, the cellular processes involved in constructing and organizing the hippocampus remain largely unclear. Here, we show that clonally related excitatory neurons in the developing hippocampus are progressively organized into discrete horizontal, but not vertical, clusters in the stratum pyramidale, as revealed by both cell-type-specific retroviral labeling and mosaic analysis with double markers (MADM). Moreover, distinct from those in the neocortex, sister excitatory neurons in the cornu ammonis 1 region of the hippocampus rarely develop electrical or chemical synapses with each other. Instead, they preferentially receive common synaptic input from nearby fast-spiking (FS), but not non-FS, interneurons and exhibit synchronous synaptic activity. These results suggest that shared inhibitory input may specify horizontally clustered sister excitatory neurons as functional units in the hippocampus.	[Xu, Hua-Tai; Gao, Peng; He, Shuijin; Li, Zhizhong; Shi, Wei; Kodish, Oren; Shao, Wei; Brown, Keith N.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Han, Zhi] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Gao, Peng; Shi, Wei; Brown, Keith N.; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY 10065 USA; [Shi, Wei; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Biochem & Struct Biol Cell & Dev Bio, New York, NY 10065 USA; [Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	Memorial Sloan Kettering Cancer Center; Nankai University; Cornell University; Cornell University; University System of Ohio; Ohio State University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org	Huang, Kun/E-3272-2011	Han, Zhi/0000-0002-5603-8433	NIH [R01DA024681, R01MH101382, P01NS048120]; Simons Foundation [GC221194]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624, R01MH101382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Nicoletta Tekki-Kessaris and Dieter Saur for providing the Emx1-CreER<SUP>T2</SUP> and R26<SUP>LSLTVA-iLacZ</SUP> mouse lines, Dr. Shaoyu Ge for sharing retroviral vectors, and Dr. Eric Holland for initially supporting our avian retroviral engineering. We are grateful to Drs. Yasunori Hayashi, Alexandra L. Joyner, Mary E. Hatten, and Mu-ming Poo and Ildiko Lily Erdy for critical reading of the manuscript. This work was supported by grants from the NIH (R01DA024681, R01MH101382, and P01NS048120) and the Simons Foundation (GC221194).	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fiala JC, 1998, J NEUROSCI, V18, P8900; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gorski JA, 2002, J NEUROSCI, V22, P6309; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hilscher MM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00120; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KNOWLES WD, 1981, J NEUROSCI, V1, P318; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lee SMK, 2000, DEVELOPMENT, V127, P457; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Martin LA, 2002, J NEUROSCI, V22, P3520; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nauta W., 1986, FUNDAMENTAL NEUROANA; Nielsen JV, 2007, DEVELOPMENT, V134, P1133, DOI 10.1242/dev.000265; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; NOWAKOWSKI RS, 1979, J NEUROCYTOL, V8, P697, DOI 10.1007/BF01206671; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; SIK A, 1995, J NEUROSCI, V15, P6651; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tole S, 1997, DEVELOPMENT, V124, P4959; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	66	46	46	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1552	1564		10.1016/j.cell.2014.03.067	http://dx.doi.org/10.1016/j.cell.2014.03.067			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949968	Green Accepted, Bronze			2022-12-28	WOS:000340941900011
J	Sweet, M				Sweet, Melissa			Beginning of the end for universal healthcare in Australia? Extreme health cuts and a plan to shift more costs on to patients are bad news for Australians, reports Melissa Sweet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												melissa@sweetcommunication.com.au						[Anonymous], 2014, AUSTRALIAN, P4; [Anonymous], 2014, NEWS            0613; [Anonymous], 2014, CONVERSATION    0513; Harvey R., OUT OF POCKET PAYMEN; Lewis Geraint., 2014, CONVERSATION 0923	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g4041	10.1136/bmj.g4041	http://dx.doi.org/10.1136/bmj.g4041			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24939413				2022-12-28	WOS:000337804900020
J	Ziakas, PD; Mylonakis, E				Ziakas, P. D.; Mylonakis, E.			Probiotics did not prevent antibiotic-associated or C. difficile diarrhea in hospitalized older patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ziakas, P. D.; Mylonakis, E.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Ziakas, PD (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.			Ziakas, Panayiotis/0000-0002-5943-8635				Goldenberg JZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub3	1	4	4	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC6	10.7326/0003-4819-160-12-201406170-02006	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935512				2022-12-28	WOS:000337374900006
J	Alcorn, T				Alcorn, Ted			Responding to sexual violence in armed conflict	LANCET			English	Editorial Material								The global community has called for an end to rape in wartime, but the crime is less understood than typically acknowledged, and addressing it will demand local interventions. Ted Alcorn reports.											0	9	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2034	2037		10.1016/S0140-6736(14)60970-3	http://dx.doi.org/10.1016/S0140-6736(14)60970-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24936625				2022-12-28	WOS:000337292400012
J	Berger, PB; Blankenship, JC				Berger, Peter B.; Blankenship, James C.			Is the heat on HEAT-PPCI appropriate?	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; UNFRACTIONATED HEPARIN; MYOCARDIAL-INFARCTION; PRIMARY PCI; BIVALIRUDIN		[Berger, Peter B.; Blankenship, James C.] Geisinger Hlth Syst, Dept Cardiol, Danville, PA 17822 USA	Geisinger Health System	Berger, PB (corresponding author), Geisinger Hlth Syst, Dept Cardiol, Danville, PA 17822 USA.	pbberger@geisinger.edu	Blankenship, James/AAX-4084-2020	Blankenship, James/0000-0003-4966-533X				Fung AY, 2009, J AM COLL CARDIOL, V53, P837, DOI 10.1016/j.jacc.2008.09.060; Karrowni W, 2013, JACC-CARDIOVASC INTE, V6, P814, DOI 10.1016/j.jcin.2013.04.010; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; Schulz S, 2010, EUR HEART J, V31, P2482, DOI 10.1093/eurheartj/ehq330; Shahzad A, 2014, LANCET; Shaw D., 2014, LANCET; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Wood S., 2014, HEAT PPCI HEPARIN BE	9	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1824	1826		10.1016/S0140-6736(14)61041-2	http://dx.doi.org/10.1016/S0140-6736(14)61041-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	25002176				2022-12-28	WOS:000345116800005
J	Reznik, Y; Cohen, O; Aronson, R; Conget, I; Runzis, S; Castaneda, J; Lee, SW				Reznik, Yves; Cohen, Ohad; Aronson, Ronnie; Conget, Ignacio; Runzis, Sarah; Castaneda, Javier; Lee, Scott W.		OpT2mise Study Grp	Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial	LANCET			English	Article							GLYCEMIC CONTROL; INFUSION; THERAPY; MELLITUS; HYPERGLYCEMIA; METFORMIN; REGIMEN; RANGE	Background Many patients with advanced type 2 diabetes do not meet their glycated haemoglobin targets and randomised controlled studies comparing the efficacy of pump treatment and multiple daily injections for lowering glucose in insulin-treated patients have yielded inconclusive results. We aimed to resolve this uncertainty with a randomised controlled trial (OpT2mise). Methods We did this multicentre, controlled trial at 36 hospitals, tertiary care centres, and referal centres in Canada, Europe, Israel, South Africa, and the USA. Patients with type 2 diabetes who had poor glycaemic control despite multiple daily injections with insulin analogues were enrolled into a 2-month dose-optimisation run-in period. After the run-in period, patients with glycated haemoglobin of 8 .0-12.0% (64-108 mmol/mol) were randomly assigned (1: 1) by a computer-generated randomisation sequence (block size 2 with probability 0.75 and size 4 with probability 0.25) to pump treatment or to continue with multiple daily injections. Neither patients nor investigators were masked to treatment allocation. The primary endpoint was change in mean glycated haemoglobin between baseline and end of the randomised phase for the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT01182493. Findings 495 of 590 screened patients entered the run-in phase and 331 were randomised (168 to pump treatment, 163 to multiple daily injections). Mean glycated haemoglobin at baseline was 9% (75 mmol/mol) in both groups. At 6 months, mean glycated haemoglobin had decreased by 1 .1% (SD 1.2; 12 mmol/mol, SD 13) in the pump treatment group and 0.4% (SD 1.1; 4 mmol/mol, SD 12) in the multiple daily injection group, resulting in a between-group treatment difference of -0.7% (95% CI -0.9 to -0.4; -8 mmol/mol, 95% CI -10 to -4, p < 0.0001). At the end of the study, the mean total daily insulin dose was 97 units (SD 56) with pump treatment versus 122 units (SD 68) for multiple daily injections (p < 0.0001), with no significant difference in bodyweight change between the two groups (1.5 kg [SD 3.5] vs 1.1 kg [3.6], p = 0.322). Two diabetes-related serious adverse events (hyperglycaemia or ketosis without acidosis) resulting in hospital admission occurred in the pump treatment group compared with one in the multiple daily injection group. No ketoacidosis occurred in either group and one episode of severe hypoglycaemia occurred in the multiple daily injection group. Interpretation In patients with poorly controlled type 2 diabetes despite using multiple daily injections of insulin, pump treatment can be considered as a safe and valuable treatment option.	[Reznik, Yves] Univ Caen, Cote Nacre Reg Hosp Ctr, Dept Endocrinol, F-14032 Caen, France; [Cohen, Ohad] Chaim Sheba Med Ctr, Inst Endocrinol, IL-52621 Tel Hashomer, Israel; [Aronson, Ronnie] LMC Diabet & Endocrinol, Toronto, ON, Canada; [Conget, Ignacio] Univ Hosp Clin, Endocrinol & Nutr Dept, Diabet Unit, Barcelona, Spain; [Runzis, Sarah] Medtron Int Trading Sarl, Tolochenaz, Switzerland; [Castaneda, Javier] Medtron Bakken Res Ctr, Maastricht, Netherlands; [Lee, Scott W.] Medtron Diabet, Northridge, CA USA	CHU de Caen NORMANDIE; Universite de Caen Normandie; Chaim Sheba Medical Center; Medtronic; Medtronic Bakken Research Center B.V.	Reznik, Y (corresponding author), Univ Caen, Cote Nacre Reg Hosp Ctr, Dept Endocrinol, F-14032 Caen, France.	reznik-y@chu-caen.fr	Giorgino, Francesco/K-7262-2016; Petrovski, Goran/R-9343-2018	Giorgino, Francesco/0000-0001-7372-2678; Petrovski, Goran/0000-0002-8622-2186; Castaneda, Javier/0000-0003-0752-8847; Orszag, Andrej/0000-0002-0027-1607	Medtronic	Medtronic(Medtronic)	Medtronic.	Aronson R, 2014, DIABETES TECHNOL THE, V16, P414, DOI 10.1089/dia.2013.0363; Berthe E, 2007, HORM METAB RES, V39, P224, DOI 10.1055/s-2007-970423; Chen YHJ, 2004, STAT MED, V23, P1023, DOI 10.1002/sim.1688; Edelman SV, 2010, DIABETES TECHNOL THE, V12, P627, DOI 10.1089/dia.2010.0034; Fatourechi MM, 2009, J CLIN ENDOCR METAB, V94, P729, DOI 10.1210/jc.2008-1415; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Herman WH, 2005, DIABETES CARE, V28, P1568, DOI 10.2337/diacare.28.7.1568; Kesavadev J, 2009, DIABETES TECHNOL THE, V11, P517, DOI 10.1089/dia.2008.0128; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pouwels MJJ, 2003, DIABETIC MED, V20, P76, DOI 10.1046/j.1464-5491.2003.00848.x; Raskin P, 2003, DIABETES CARE, V26, P2598, DOI 10.2337/diacare.26.9.2598; Reznik Y, 2013, DIABETES CARE, V36, pS219, DOI 10.2337/dcS13-2027; Reznik Y, 2010, DIABETES TECHNOL THE, V12, P931, DOI 10.1089/dia.2010.0110; Riddle M, 2011, DIABETES CARE, V34, P2508, DOI 10.2337/dc11-0632; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Wainstein J, 2005, DIABETIC MED, V22, P1037, DOI 10.1111/j.1464-5491.2005.01597.x; Wulffele MG, 2002, DIABETES CARE, V25, P2133, DOI 10.2337/diacare.25.12.2133	21	114	120	3	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1265	1272		10.1016/S0140-6736(14)61037-0	http://dx.doi.org/10.1016/S0140-6736(14)61037-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24998009				2022-12-28	WOS:000343003400029
J	Mandal, A; Mathai, A				Mandal, Anil; Mathai, Annie			Bilateral Wandering Lens in an Infant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mandal, Anil; Mathai, Annie] LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Mandal, A (corresponding author), LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India.	mandal@lvpei.org	Mandal, Anil/AAY-4809-2020						0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2								10.1056/NEJMicm1310648	http://dx.doi.org/10.1056/NEJMicm1310648			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006743				2022-12-28	WOS:000338645500002
J	McDonald, RA				McDonald, Robbie A.			ANIMAL HEALTH How to control bovine tuberculosis	NATURE			English	Editorial Material							BADGERS; CATTLE		Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, Cornwall, England	University of Exeter	McDonald, RA (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, Cornwall, England.	r.mcdonald@exeter.ac.uk	McDonald, Robbie A/A-2931-2012; McDonald, Robbie/AAK-2718-2020	McDonald, Robbie A/0000-0002-6922-3195; McDonald, Robbie/0000-0002-6922-3195				Bielby J., 2014, P NATL ACAD SCI US; Brooks-Pollock E, 2014, NATURE, V511, P228, DOI 10.1038/nature13529; Cassidy A, 2012, SOCIOL RURALIS, V52, P192, DOI 10.1111/j.1467-9523.2012.00562.x; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103	7	7	7	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					158	159		10.1038/nature13514	http://dx.doi.org/10.1038/nature13514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008514				2022-12-28	WOS:000338649800028
J	Moore, A; Wiffen, P; Kalso, E				Moore, Andrew; Wiffen, Philip; Kalso, Eija			Antiepileptic Drugs for Neuropathic Pain and Fibromyalgia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Moore, Andrew; Wiffen, Philip] Univ Oxford, Oxford, England; [Moore, Andrew; Wiffen, Philip] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Kalso, Eija] Univ Helsinki, Cent Hosp, Dept Anaesthesia Intens Care Med Emergency Med &, Helsinki, Finland; [Kalso, Eija] Univ Helsinki, Inst Clin Med, Helsinki, Finland	University of Oxford; University of Oxford; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Wiffen, P (corresponding author), Churchill Hosp, Pain Res Unit, Oxford OX3 7LE, England.	phil.wiffen@ndcn.ox.ac.uk	Wiffen, Philip/GNP-1768-2022	Kalso, Eija/0000-0002-4899-605X	Astellas; Eli Lilly; Pfizer; Oxford Systematic review services; Grunenthal; Janssen-Cilag; Mundipharma; Orion Pharma; Pharmaleads	Astellas(Astellas Pharmaceuticals); Eli Lilly(Eli Lilly); Pfizer(Pfizer); Oxford Systematic review services; Grunenthal(HAL Allergy Group); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Mundipharma; Orion Pharma; Pharmaleads	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Moore reports receiving personal fees from Astellas, Eli Lilly, and Pfizer. Mr Wiffen reports receiving personal fees from Oxford Systematic review services. Dr Kalso reports receiving personal fees from Grunenthal, Janssen-Cilag, Mundipharma, Orion Pharma, Pfizer, and Pharmaleads and has patents or stock options with Orion Pharma.	Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Kalso E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7339; Moore A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2690; Moore RA, 2013, ANAESTHESIA, V68, P400, DOI 10.1111/anae.12148; Moore RA, 2012, PAIN, V153, P265, DOI 10.1016/j.pain.2011.10.004; National Institute for Health and Care Excellence, PHARM MAN NEUR PAIN; Wiffen PJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010567.pub2	7	54	56	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					182	183		10.1001/jama.2014.6336	http://dx.doi.org/10.1001/jama.2014.6336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005656				2022-12-28	WOS:000338511200025
J	Nageshwaran, S; Davies, LM; Rafi, I; Radunovic, A				Nageshwaran, Saiji; Davies, Lucy Medina; Rafi, Imran; Radunovic, Aleksandar			EASILY MISSED? Motor neurone disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; DIAGNOSIS		[Nageshwaran, Saiji; Rafi, Imran] Univ London, Dept Populat Hlth Sci & Educ, London SW17 0RE, England; [Davies, Lucy Medina; Rafi, Imran] Royal Coll Gen Practitioners, Clin Innovat & Res Ctr, London, England; [Radunovic, Aleksandar] Royal London Hosp, Barts Motor Neurone Dis Ctr, London E1 1BB, England	University of London; Barts Health NHS Trust; Royal London Hospital	Nageshwaran, S (corresponding author), Univ London, Dept Populat Hlth Sci & Educ, London SW17 0RE, England.	saiji@doctors.org.uk						Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Leigh PN, 2003, J NEUROL NEUROSUR PS, V74, P32; McDermott CJ, 2008, BMJ-BRIT MED J, V336, P658, DOI 10.1136/bmj.39493.511759.BE; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Mitchell JD, 2010, AMYOTROPH LATERAL SC, V11, P537, DOI 10.3109/17482968.2010.495158; National Institute for Health and Care Excellence, 2010, MOT NEUR DIS US NON; National Institute for Health and Care Excellence, 2001, GUID US RIL RIL TREA; Radunovic A, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004427.PUB.3; Radunovic A, 2007, LANCET NEUROL, V6, P913, DOI 10.1016/S1474-4422(07)70244-2; Royal College of General Practitioners, RAR DIS RED FLAGS TO; Turner Martin R, 2013, Pract Neurol, V13, P153, DOI 10.1136/practneurol-2013-000557	11	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2014	349								g4052	10.1136/bmj.g4052	http://dx.doi.org/10.1136/bmj.g4052			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZD	25008100				2022-12-28	WOS:000338993500002
J	Barr, JG; Al-Reefy, H; Fox, AT; Hopkins, C				Barr, James G.; Al-Reefy, Hiba; Fox, Adam T.; Hopkins, Claire			Allergic rhinitis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; NASAL SPRAY; SUBLINGUAL IMMUNOTHERAPY; PEDIATRIC-PATIENTS; OLOPATADINE HYDROCHLORIDE; RECEPTOR ANTAGONISTS; POLLEN IMMUNOTHERAPY; CLINICAL SYMPTOMS; EUROPEAN-ACADEMY; GRASS-POLLEN		[Barr, James G.; Al-Reefy, Hiba; Fox, Adam T.; Hopkins, Claire] Guys & St Thomas Hosp NHS Fdn Trust, Dept ENT Surg, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Barr, JG (corresponding author), Guys & St Thomas Hosp NHS Fdn Trust, Dept ENT Surg, London SE1 9RT, England.	jgbarr85@gmail.com	Fox, Adam/O-3547-2015	Fox, Adam/0000-0002-3533-9798				Ait-Khaled N, 2009, ALLERGY, V64, P123, DOI 10.1111/j.1398-9995.2008.01884.x; Alm B, 2011, PEDIAT ALLERG IMM-UK, V22, P398, DOI 10.1111/j.1399-3038.2011.01153.x; Bhatia S, 2005, ARCH OTOLARYNGOL, V131, P223, DOI 10.1001/archotol.131.3.223; Bisgaard H, 2009, PEDIATR PULM, V44, P568, DOI 10.1002/ppul.21018; Bjornsdottir US, 2003, ANN ALLERG ASTHMA IM, V91, P189; Blaiss MS, 2004, CURR MED RES OPIN, V20, P1937, DOI 10.1185/030079904X13266; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2003, ALLERGY, V58, P192, DOI 10.1034/j.1398-9995.2003.00054.x; Brannan MD, 1997, CLIN THER, V19, P1330, DOI 10.1016/S0149-2918(97)80008-2; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Burbach GJ, 2009, ALLERGY, V64, P1507, DOI 10.1111/j.1398-9995.2009.02089.x; Burgess JA, 2007, J ALLERGY CLIN IMMUN, V120, P863, DOI 10.1016/j.jaci.2007.07.020; Ciprandi G, 2005, ALLERGY, V60, P882, DOI 10.1111/j.1398-9995.2005.00602.x; de Blic J, 2005, PEDIATR ALLERGY IMMU, V16, P267, DOI 10.1111/j.1399-3038.2005.00216.x; de Bot CMA, 2013, PRIM CARE RESP J, V22, P155, DOI 10.4104/pcrj.2013.00015; Demoly P, 2003, ALLERGY, V58, P672, DOI 10.1034/j.1398-9995.2003.t01-1-00202.x; Eng PA, 2002, ALLERGY, V57, P306, DOI 10.1034/j.1398-9995.2002.1o3264.x; Erbas B, 2012, CLIN EXP ALLERGY, V42, P799, DOI 10.1111/j.1365-2222.2012.03995.x; Garavello W, 2003, PEDIATR ALLERGY IMMU, V14, P140, DOI 10.1034/j.1399-3038.2003.00021.x; Ghouri N, 2008, J ROY SOC MED, V101, P466, DOI 10.1258/jrsm.2008.080096; Horak F, 2006, CURR MED RES OPIN, V22, P151, DOI 10.1185/030079906X80305; Horak F, 2004, CLIN EXP ALLERGY, V34, P1220, DOI 10.1111/j.1365-2222.2004.02024.x; Host A, 2003, ALLERGY, V58, P559, DOI 10.1034/j.1398-9995.2003.00238.x; Howarth PH, 2000, ALLERGY, V55, P7, DOI 10.1034/j.1398-9995.2000.00802.x; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; JOHNSON DA, 1993, PHARMACOTHERAPY, V13, pS110; Joint Formulary Committee, 2013, BRIT NAT FORM CHILDR; Lee JH, 2007, CLIN EXP IMMUNOL, V148, P53, DOI 10.1111/j.1365-2249.2007.03329.x; Leynaert Benedicte, 2000, Journal of Allergy and Clinical Immunology, V106, pS201; LINNA O, 1992, ACTA PAEDIATR, V81, P100, DOI 10.1111/j.1651-2227.1992.tb12182.x; Meltzer EO, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-5; Meltzer EO, 2009, CLIN DRUG INVEST, V29, P79, DOI 10.2165/0044011-200929020-00002; Meltzer EO, 2004, PEDIAT ALLERG IMM-UK, V15, P253, DOI 10.1111/j.1399-3038.2004.00167.x; Meltzer EO, 2001, ANN ALLERG ASTHMA IM, V86, P286, DOI 10.1016/S1081-1206(10)63300-5; Meltzer EO, 2001, J ALLERGY CLIN IMMUN, V108, pS45, DOI 10.1067/mai.2001.115566; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Novembre E, 2004, J ALLERGY CLIN IMMUN, V114, P851, DOI 10.1016/j.jaci.2004.07.012; Patel D, 2007, ALLERGY ASTHMA PROC, V28, P592, DOI 10.2500/aap2007.28.3033; Penagos M, 2006, ANN ALLERG ASTHMA IM, V97, P141, DOI 10.1016/S1081-1206(10)60004-X; Potter P, 2013, PEDIAT ALLERG IMM-UK, V24, P144, DOI 10.1111/pai.12036; Radulovic S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002893.pub2; Roberts G, 2013, ALLERGY, V68, P1102, DOI 10.1111/all.12235; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Scadding Glenis, 2008, Paediatr Drugs, V10, P151, DOI 10.2165/00148581-200810030-00004; Scheinmann P, 2012, ARCH PEDIATRIE, V19, P330, DOI 10.1016/j.arcped.2012.01.003; Schenkel EJ, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e22; Shah SR, 2009, CLIN THER, V31, P99, DOI 10.1016/j.clinthera.2009.01.016; Silva Carlos Henrique Martins da, 2009, Braz. j. otorhinolaryngol., V75, P642; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Skoner DP, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.2.e23; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Slapak I, 2008, ARCH OTOLARYNGOL, V134, P67, DOI 10.1001/archoto.2007.19; Tschopp JM, 1998, ALLERGY, V53, P608, DOI 10.1111/j.1398-9995.1998.tb03937.x; VENGE P, 1994, ALLERGY, V49, P1, DOI 10.1111/j.1398-9995.1994.tb00765.x; Walker SM, 2011, CLIN EXP ALLERGY, V41, P1177, DOI 10.1111/j.1365-2222.2011.03794.x; Weiner JM, 1998, BMJ-BRIT MED J, V317, P1624, DOI 10.1136/bmj.317.7173.1624; Wilson AM, 2004, AM J MED, V116, P338, DOI 10.1016/j.amjmed.2003.10.030; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x	58	16	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2014	349								g4153	10.1136/bmj.g4153	http://dx.doi.org/10.1136/bmj.g4153			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YY	24986886				2022-12-28	WOS:000338645400005
J	Hopewell, S; Collins, GS; Boutron, I; Yu, LM; Cook, J; Shanyinde, M; Wharton, R; Shamseer, L; Altman, DG				Hopewell, Sally; Collins, Gary S.; Boutron, Isabelle; Yu, Ly-Mee; Cook, Jonathan; Shanyinde, Milensu; Wharton, Rose; Shamseer, Larissa; Altman, Douglas G.			Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Review							QUALITY; MANUSCRIPTS; GUIDELINES; ARTICLES; IMPROVE	Objective To investigate the effectiveness of open peer review as a mechanism to improve the reporting of randomised trials published in biomedical journals. Design Retrospective before and after study. Setting BioMed Central series medical journals. Sample 93 primary reports of randomised trials published in BMC-series medical journals in 2012. Main outcome measures Changes to the reporting of methodological aspects of randomised trials in manuscripts after peer review, based on the CONSORT checklist, corresponding peer reviewer reports, the type of changes requested, and the extent to which authors adhered to these requests. Results Of the 93 trial reports, 38% (n=35) did not describe the method of random sequence generation, 54% (n=50) concealment of allocation sequence, 50% (n=46) whether the study was blinded, 34% (n=32) the sample size calculation, 35% (n=33) specification of primary and secondary outcomes, 55% (n=51) results for the primary outcome, and 90% (n=84) details of the trial protocol. The number of changes between manuscript versions was relatively small; most involved adding new information or altering existing information. Most changes requested by peer reviewers had a positive impact on the reporting of the final manuscript-for example, adding or clarifying randomisation and blinding (n=27), sample size (n=15), primary and secondary outcomes (n=16), results for primary or secondary outcomes (n=14), and toning down conclusions to reflect the results (n=27). Some changes requested by peer reviewers, however, had a negative impact, such as adding additional unplanned analyses (n=15). Conclusion Peer reviewers fail to detect important deficiencies in reporting of the methods and results of randomised trials. The number of these changes requested by peer reviewers was relatively small. Although most had a positive impact, some were inappropriate and could have a negative impact on reporting in the final publication.	[Hopewell, Sally; Collins, Gary S.; Yu, Ly-Mee; Cook, Jonathan; Shanyinde, Milensu; Wharton, Rose; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX3 7LD, England; [Hopewell, Sally; Boutron, Isabelle] Univ Paris 05, Ctr Epidemiol Clin, INSERM U1153, Paris, France; [Cook, Jonathan] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Shamseer, Larissa] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute	Hopewell, S (corresponding author), Univ Oxford, Ctr Stat Med, Oxford OX3 7LD, England.	sally.hopewell@csm.ox.ac.uk	Cook, Jonathan/D-3648-2015; Shamseer, Larissa/E-9645-2017; Collins, Gary Stephen/A-2258-2014	Cook, Jonathan/0000-0002-4156-6989; Shamseer, Larissa/0000-0003-3690-3378; Collins, Gary Stephen/0000-0002-2772-2316; Hopewell, Sally/0000-0002-6881-6984; Yu, Ly-Mee/0000-0003-0331-7364; Boutron, Isabelle/0000-0002-5263-6241	MRC [MR/J004871/1, G1002292] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J004871/1, G1002292] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alam M, 2011, BRIT J DERMATOL, V165, P563, DOI 10.1111/j.1365-2133.2011.10432.x; [Anonymous], 2014, BMC SERIES J PEER RE; Arnau C, 2003, MED CLIN-BARCELONA, V121, P690, DOI 10.1157/13054597; Black N, 1998, JAMA-J AM MED ASSOC, V280, P231, DOI 10.1001/jama.280.3.231; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Cho MK, 1998, JAMA-J AM MED ASSOC, V280, P243, DOI 10.1001/jama.280.3.243; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Cobo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000332; Dickersin K, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-44; Hames I, 2007, PEER REV MANUSCRIPT, Vxii; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; International Committee of Medical Journal Editors, 2008, BIOMEDICAL J UNPUB; Jefferson T, 2007, Cochrane Database Syst Rev, pMR000016; Kravitz RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010072; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; RENNIE D, 1992, CONTROL CLIN TRIALS, V13, P443, DOI 10.1016/0197-2456(92)90201-A; Schroter S, 2004, BRIT MED J, V328, P673, DOI 10.1136/bmj.38023.700775.AE; Schroter S, 2008, J ROY SOC MED, V101, P507, DOI 10.1258/jrsm.2008.080062; Smith RA, 1999, TEACH PSYCHOL, V26, P4; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60	21	62	63	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2014	349								g4145	10.1136/bmj.g4145	http://dx.doi.org/10.1136/bmj.g4145			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YY	24986891	Green Published, hybrid			2022-12-28	WOS:000338645400004
J	Finney, J				Finney, John			Nuclear blind man's buff	NATURE			English	Editorial Material									[Finney, John] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Finney, John] UCL, London Ctr Nanotechnol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Finney, J (corresponding author), UCL, Dept Phys & Astron, Mortimer St, London WC1E 6BT, England.	john.finney@ucl.ac.uk	Finney, John L/C-2175-2008						0	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					476	476		10.1038/510476a	http://dx.doi.org/10.1038/510476a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965644				2022-12-28	WOS:000337806300030
J	Schulman, KA; Richman, BD; Herzlinger, RE				Schulman, Kevin A.; Richman, Barak D.; Herzlinger, Regina E.			Shifting toward Defined Contributions - Predicting the Effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27708 USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Schulman, Kevin A.; Richman, Barak D.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Richman, Barak D.] Duke Univ, Sch Law, Durham, NC 27706 USA; [Herzlinger, Regina E.] Harvard Univ, Sch Business, Boston, MA 02163 USA	Duke University; Duke University; Duke University; Duke University; Harvard University	Schulman, KA (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27708 USA.							[Anonymous], 2013, HLTH CAR REF HEIGHT, DOI 10.1056/NEJMp1314391; Herzlinger RE, 2013, A HEWITTS PRIVATE HL; Kaiser Family Foundation, PREM WORK CONTR WORK; Mathews Anna Wilde, 2013, WALL STREET J	4	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2462	2465		10.1056/NEJMp1314391	http://dx.doi.org/10.1056/NEJMp1314391			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ6KY	24963565				2022-12-28	WOS:000337804400003
J	Cattaneo, E; Corbellini, G				Cattaneo, Elena; Corbellini, Gilberto			Taking a stand against pseudoscience	NATURE			English	Editorial Material									[Cattaneo, Elena] Univ Milan, Dept Biosci, I-20122 Milan, Italy; [Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, I-20122 Milan, Italy; [Corbellini, Gilberto] Univ Roma La Sapienza, Rome, Italy	University of Milan; University of Milan; Sapienza University Rome	Cattaneo, E (corresponding author), Univ Milan, Dept Biosci, I-20122 Milan, Italy.	elena.cattaneo@unimi.it		CATTANEO, ELENA/0000-0002-0755-4917				Andolina Marino, 2014, International Journal of Stem Cells, V7, P30, DOI 10.15283/ijsc.2014.7.1.30	1	24	24	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					333	335		10.1038/510333a	http://dx.doi.org/10.1038/510333a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24955466	Bronze			2022-12-28	WOS:000337350200012
J	Cohen, RL; Settleman, J				Cohen, Robert L.; Settleman, Jeff			From Cancer Genomics to Precision Oncology-Tissue's Still an Issue	CELL			English	Article							ABL TYROSINE KINASE; CELL LUNG-CANCER; TARGETED THERAPY; INHIBITION; MULTICENTER; SORAFENIB; MELANOMA; SURVIVAL; LABEL	Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy material, thereby facilitating the broader implementation of personalized cancer medicine. However, genomics-based patient stratification across diverse tumor types is unlikely to supplant tissue-of-origin considerations in addressing clinical needs, including the development and application of novel "rationally targeted" cancer therapies.	[Cohen, Robert L.] Calico Life Sci, San Francisco, CA 94080 USA; [Settleman, Jeff] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Settleman, J (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	settleman.jeffrey@gene.com						AACR Cancer Progress Report Writing Committee, 2013, Clin Cancer Res, V19, pS4, DOI 10.1158/1078-0432.CCR-13-2107; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Crowther M, 2013, HEMATOL-AM SOC HEMAT, P15, DOI 10.1182/asheducation-2013.1.15; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eifert C, 2012, NAT REV CANCER, V12, P572, DOI 10.1038/nrc3299; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Figueroa-Magalhaes MC, 2014, BREAST, V23, P128, DOI 10.1016/j.breast.2013.11.011; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Heng DYC, 2008, CURR CANCER DRUG TAR, V8, P676, DOI 10.2174/156800908786733450; Horning SJ, 2013, CLIN CANCER RES, V19, P4297, DOI 10.1158/1078-0432.CCR-13-0523; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Minuti G, 2013, EXPERT OPIN BIOL TH, V13, P1401, DOI 10.1517/14712598.2013.827657; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Mullins CD, 2012, J CLIN ONCOL, V30, P661, DOI 10.1200/JCO.2011.35.5198; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Willyard C, 2013, NAT MED, V19, P655, DOI 10.1038/nm0613-655	28	21	26	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1509	1514		10.1016/j.cell.2014.05.027	http://dx.doi.org/10.1016/j.cell.2014.05.027			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949964	Bronze			2022-12-28	WOS:000340941900007
J	Kirschke, E; Goswami, D; Southworth, D; Griffin, PR; Agard, DA				Kirschke, Elaine; Goswami, Devrishi; Southworth, Daniel; Griffin, Patrick R.; Agard, David A.			Glucocorticoid Receptor Function Regulated by Coordinated Action of the Hsp90 and Hsp70 Chaperone Cycles	CELL			English	Article							LIGAND-BINDING DOMAIN; SHOCK-PROTEIN 90; CONFORMATIONAL DYNAMICS; PROGESTERONE-RECEPTOR; SIGNAL-TRANSDUCTION; ELECTRON-MICROSCOPY; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP HYDROLYSIS	The glucocorticoid receptor (GR), like many signaling proteins, depends on the Hsp90 molecular chaperone for in vivo function. Although Hsp90 is required for ligand binding in vivo, purified apo GR is capable of binding ligand with no enhancement from Hsp90. We reveal that Hsp70, known to facilitate client delivery to Hsp90, inactivates GR through partial unfolding, whereas Hsp90 reverses this inactivation. Full recovery of ligand binding requires ATP hydrolysis on Hsp90 and the Hop and p23 cochaperones. Surprisingly, Hsp90 ATP hydrolysis appears to regulate client transfer from Hsp70, likely through a coupling of the two chaperone's ATP cycles. Such coupling is embodied in contacts between Hsp90 and Hsp70 in the GR: Hsp70: Hsp90: Hop complex imaged by cryoelectron microscopy. Whereas GR released from Hsp70 is aggregation prone, release from Hsp90 protects GR from aggregation and enhances its ligand affinity. Together, this illustrates how coordinated chaperone interactions can enhance stability, function, and regulation.	[Kirschke, Elaine; Southworth, Daniel; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Kirschke, Elaine; Southworth, Daniel; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu			PSI-Biology grant [U01 GM098254]; UCSF Quantitative Biosciences Consortium; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098254, T32GM008284] Funding Source: NIH RePORTER	PSI-Biology grant; UCSF Quantitative Biosciences Consortium; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Liao and Y. Cheng for help with the initial model for EM refinement and members of the D.A.A. lab for helpful discussions. Support for this work was provided by the PSI-Biology grant U01 GM098254 (to D.A.A.), the UCSF Quantitative Biosciences Consortium (to E.K.), and the Howard Hughes Medical Institute.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; KIMURA Y, 1995, SCIENCE, V268, P1362, DOI 10.1126/science.7761857; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLaughlin SH, 2002, PROTEIN SCI, V11, P1926, DOI 10.1110/ps.5000102; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pfaff SJ, 2010, J BIOL CHEM, V285, P15256, DOI 10.1074/jbc.M110.108118; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	51	256	264	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1685	1697		10.1016/j.cell.2014.04.038	http://dx.doi.org/10.1016/j.cell.2014.04.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949977	Bronze, Green Accepted			2022-12-28	WOS:000340941900021
J	Blanpain, C; Fuchs, E				Blanpain, Cedric; Fuchs, Elaine			STEM CELL PLASTICITY Plasticity of epithelial stem cells in tissue regeneration	SCIENCE			English	Review							HAIR-FOLLICLE REGENERATION; TRANSIT-AMPLIFYING CELLS; LABEL-RETAINING CELLS; PROGENITOR CELLS; PROSTATE-CANCER; SMALL-INTESTINE; MAMMARY-GLAND; IN-VITRO; SELF-RENEWAL; WOUND REPAIR	Tissues rely upon stem cells for homeostasis and repair. Recent studies show that the fate and multilineage potential of epithelial stem cells can change depending on whether a stem cell exists within its resident niche and responds to normal tissue homeostasis, whether it is mobilized to repair a wound, or whether it is taken from its niche and challenged to de novo tissue morphogenesis after transplantation. In this Review, we discuss how different populations of naturally lineage-restricted stem cells and committed progenitors can display remarkable plasticity and reversibility and reacquire long-term self-renewing capacities and multilineage differentiation potential during physiological and regenerative conditions. We also discuss the implications of cellular plasticity for regenerative medicine and for cancer.	[Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, Walloon Excellence Life Sci & Biotechnol WELBIO, B-1070 Brussels, Belgium; [Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO; Howard Hughes Medical Institute; Rockefeller University	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be; fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Blanpain, Cedric/ABD-8392-2021		NIH; Empire State Stem Cell Board (NYSTEM); Ellison Foundation; Fond National de la Recherche Scientifique (FNRS); European Research Council (ERC); ULB Foundation; Fondation contre le Cancer; Foundation Bettencourt Schueller; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Board (NYSTEM); Ellison Foundation(Lawrence Ellison Foundation); Fond National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Research Council (ERC)(European Research Council (ERC)); ULB Foundation; Fondation contre le Cancer; Foundation Bettencourt Schueller; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank our colleagues in epithelial stem cell biology for the excitement and major advances they've contributed. We apologize for works not cited because of space constraints. E.F. is a HHMI investigator and supported by grants from the NIH, Empire State Stem Cell Board (NYSTEM), and Ellison Foundation. C.B. is a WELBIO investigator and is supported by the Fond National de la Recherche Scientifique (FNRS), the European Research Council (ERC), the ULB Foundation, the Fondation contre le Cancer, and the Foundation Bettencourt Schueller.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; MERRITT AJ, 1994, CANCER RES, V54, P614; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sale S, 2013, NAT CELL BIOL, V15, P451, DOI 10.1038/ncb2725; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	100	358	369	0	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1243	+	1242281	10.1126/science.1242281	http://dx.doi.org/10.1126/science.1242281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926024	Green Accepted			2022-12-28	WOS:000337077500030
J	Ball, P				Ball, Philip			The art of medicine Unnatural reactions	LANCET			English	Editorial Material																			0	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1964	1965		10.1016/S0140-6736(14)60945-4	http://dx.doi.org/10.1016/S0140-6736(14)60945-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24936628				2022-12-28	WOS:000336848200014
J	Gruener, AM; Jeffries, MAR; El Housseini, Z; Whitefield, L				Gruener, Anna M.; Jeffries, Megan A. R.; El Housseini, Zine; Whitefield, Laurence			Poppers maculopathy	LANCET			English	Editorial Material									[Gruener, Anna M.; Jeffries, Megan A. R.; El Housseini, Zine] Guys & St Thomas NHS Fdn Trust, Dept Ophthalmol, London SE1 7EH, England; [Gruener, Anna M.; Jeffries, Megan A. R.; Whitefield, Laurence] Queen Marys Hosp, Dept Ophthalmol, Sidcup, Kent, England	Guy's & St Thomas' NHS Foundation Trust	Gruener, AM (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Ophthalmol, Westminster Bridge Rd, London SE1 7EH, England.	anna.gruener@nhs.net							0	12	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1606	1606		10.1016/S0140-6736(14)60887-4	http://dx.doi.org/10.1016/S0140-6736(14)60887-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	24954683				2022-12-28	WOS:000343901700029
J	Shamian, J				Shamian, Judith			Interprofessional collaboration, the only way to Save Every Woman and Every Child	LANCET			English	Editorial Material									Int Council Nurses, CH-1201 Geneva, Switzerland		Shamian, J (corresponding author), Int Council Nurses, Pl Jean Marteau, CH-1201 Geneva, Switzerland.	shamianjudith@gmail.com							0	14	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					E41	E42		10.1016/S0140-6736(14)60858-8	http://dx.doi.org/10.1016/S0140-6736(14)60858-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965821				2022-12-28	WOS:000342630600002
J	Pena, LD; Goldstein, SL				Pena, Leopoldo D.; Goldstein, Steven L.			Thermohaline circulation crisis and impacts during the mid-Pleistocene transition	SCIENCE			English	Article							MIDDLE PLEISTOCENE TRANSITION; CARBON-DIOXIDE CONCENTRATION; OCEAN CIRCULATION; DEEP-WATER; ICE; EVOLUTION; CLIMATE; TEMPERATURE; NEODYMIUM; SEA	The mid-Pleistocene transition (MPT) marked a fundamental change in glacial-interglacial periodicity, when it increased from similar to 41-thousand-year to 100-thousand-year cycles and developed higher-amplitude climate variability without substantial changes in the Milankovitch forcing. Here, we document, by using Nd isotopes, a major disruption of the ocean thermohaline circulation (THC) system during the MPT between marine isotope stages (MISs) 25 and 21 at similar to 950 to 860 thousand years ago, which effectively marks the first 100-thousand-year cycle, including an exceptional weakening through a critical interglacial (MIS 23) at similar to 900 thousand years ago. Its recovery into the post-MPT 100-thousand-year world is characterized by continued weak glacial THC. The MPT ocean circulation crisis facilitated the coeval drawdown of atmospheric CO2 and high-latitude ice sheet growth, generating the conditions that stabilized 100-thousand-year cycles.	[Pena, Leopoldo D.; Goldstein, Steven L.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Goldstein, Steven L.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Columbia University; Columbia University	Pena, LD (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W, Palisades, NY 10964 USA.	leopoldo@ldeo.columbia.edu	Pena, Leopoldo/A-7085-2015; Pena, Leopoldo/B-8140-2013	Pena, Leopoldo/0000-0001-6414-6293; Pena, Leopoldo/0000-0001-6414-6293	NSF [OCE-10-31198]; Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University; Directorate For Geosciences [1031198] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge support from NSF grant OCE-10-31198. We also thank two anonymous reviewers for valuable comments. This study was partly supported by the Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University. Samples were provided by the ODP, which is sponsored by the NSF and participating countries under management of Joint Oceanographic Institutions. R. Lupien helped with sample processing. The data in this paper will be available in the supplementary materials and deposited with National Oceanic and Atmospheric Administration-National Climate Data Center at www.ncdc.noaa.gov. This is LDEO contribution number 7809.	Abouchami W, 1997, GEOCHIM COSMOCHIM AC, V61, P3957, DOI 10.1016/S0016-7037(97)00218-4; Berger W.H., 1994, GEOPHYS MONOGR SER, P295, DOI DOI 10.1029/GM085P0295; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Broecker WS, 1992, GLOBAL BIOGEOCHEM CY, V6, P315, DOI 10.1029/92GB01672; Burton KW, 1999, EARTH PLANET SC LETT, V171, P149, DOI 10.1016/S0012-821X(99)00138-7; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Gildor H, 2000, PALEOCEANOGRAPHY, V15, P605, DOI 10.1029/1999PA000461; Goldstein S.L., 2003, TREATISE GEOCHEMISTR, P453, DOI [10.1016/B0-08-043751-6/06179-X, DOI 10.1016/B0-08-043751-6/06179-X]; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Kohler P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001703; Kohler P, 2008, CLIM PAST, V4, P311, DOI 10.5194/cp-4-311-2008; Ling HF, 2005, EARTH PLANET SC LETT, V232, P345, DOI 10.1016/j.epsl.2004.12.009; Lisiecki LE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045109; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MACKENSEN A, 1993, PALEOCEANOGRAPHY, V8, P587, DOI 10.1029/93PA01291; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; McClymont EL, 2013, EARTH-SCI REV, V123, P173, DOI 10.1016/j.earscirev.2013.04.006; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; RAYMO ME, 1990, EARTH PLANET SC LETT, V97, P353, DOI 10.1016/0012-821X(90)90051-X; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Stichel T, 2012, EARTH PLANET SC LETT, V317, P282, DOI 10.1016/j.epsl.2011.11.025; Tachikawa K, 1999, EARTH PLANET SC LETT, V170, P433, DOI 10.1016/S0012-821X(99)00127-2; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Venz KA, 2002, PALAEOGEOGR PALAEOCL, V182, P197, DOI 10.1016/S0031-0182(01)00496-5	36	93	96	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					318	322		10.1126/science.1249770	http://dx.doi.org/10.1126/science.1249770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24968939				2022-12-28	WOS:000339400700049
J	Brown, AJ; Brunelli, NA; Eum, K; Rashidi, F; Johnson, JR; Koros, WJ; Jones, CW; Nair, S				Brown, Andrew J.; Brunelli, Nicholas A.; Eum, Kiwon; Rashidi, Fereshteh; Johnson, J. R.; Koros, William J.; Jones, Christopher W.; Nair, Sankar			Interfacial microfluidic processing of metal-organic framework hollow fiber membranes	SCIENCE			English	Article							ZEOLITIC IMIDAZOLATE FRAMEWORK-8; ZIF-8 MEMBRANES; GAS SEPARATION; MIXTURES; GROWTH	Molecular sieving metal-organic framework (MOF) membranes have great potential for energy-efficient chemical separations, but a major hurdle is the lack of a scalable and inexpensive membrane fabrication mechanism. We describe a route for processing MOF membranes in polymeric hollow fibers, combining a two-solvent interfacial approach for positional control over membrane formation (at inner and outer surfaces, or in the bulk, of the fibers), a microfluidic approach to replenishment or recycling of reactants, and an in situ module for membrane fabrication and permeation. We fabricated continuous molecular sieving ZIF-8 membranes in single and multiple poly(amide-imide) hollow fibers, with H-2/C3H8 and C3H6/C3H8 separation factors as high as 370 and 12, respectively. We also demonstrate positional control of the ZIF-8 films and characterize the contributions of membrane defects and lumen bypass.	[Brown, Andrew J.; Jones, Christopher W.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Brunelli, Nicholas A.; Eum, Kiwon; Rashidi, Fereshteh; Johnson, J. R.; Koros, William J.; Jones, Christopher W.; Nair, Sankar] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Brunelli, Nicholas A.] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Ohio; Ohio State University	Jones, CW (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	christopher.jones@chbe.gatech.edu; sankar.nair@chbe.gatech.edu	Eum, Kiwon/ABF-6760-2020; Brunelli, Nicholas/E-7675-2012	Eum, Kiwon/0000-0003-4316-2301; Nair, Sankar/0000-0001-5339-470X	Phillips 66 Company	Phillips 66 Company	This work was supported by Phillips 66 Company. S.N., A.J.B., and C.W.J. conceived the research. A.J.B. and N.A.B. designed the synthesis reactor. Hollow-fiber fabrication was carried out by J.R.J. and W.J.K. Membrane synthesis, characterization, and permeation measurements were carried out by A.J.B., K.E., and F.R. Permeation modeling was carried out by S.N. and A.J.B. All authors contributed to manuscript writing and editing. We thank W. Qiu, R. P. Lively, and A. Rownaghi (all at Georgia Institute of Technology) for helpful discussions. The Supplementary Materials includes a detailed description of materials and methods, details of the IMMP reactor, time-dependent flow profiles and synthesis cases, SEM images of ZIF-8 membranes, XRD patterns of membranes, schematics of permeation apparatus and gas bypass effects, EDX mapping of the ZIF-8 membrane, permeation modeling equations, and gas permeation data. A patent application related to this work has been filed [U.S. patent application 61/820,489, filed 7 May 2013; S. Nair et al., Flow processing and characterization of metal-organic framework (MOF) membranes in tubular and hollow fiber modules].	Ameloot R, 2011, NAT CHEM, V3, P382, DOI [10.1038/nchem.1026, 10.1038/NCHEM.1026]; Brown AJ, 2012, ANGEW CHEM INT EDIT, V51, P10615, DOI 10.1002/anie.201206640; Buonomenna MG, 2013, RSC ADV, V3, P5694, DOI 10.1039/c2ra22580h; Bux H, 2011, CHEM MATER, V23, P2262, DOI 10.1021/cm200555s; Chiu WV, 2011, J MEMBRANE SCI, V377, P182, DOI 10.1016/j.memsci.2011.04.047; Choi J, 2009, SCIENCE, V325, P590, DOI 10.1126/science.1176095; Gascon J, 2012, CHEM MATER, V24, P2829, DOI 10.1021/cm301435j; Gummalla M, 2004, AICHE J, V50, P684, DOI 10.1002/aic.10062; HENIS JMS, 1983, SCIENCE, V220, P11, DOI 10.1126/science.220.4592.11; Huang AS, 2010, J AM CHEM SOC, V132, P15562, DOI 10.1021/ja108774v; Jang KS, 2011, CHEM MATER, V23, P3025, DOI 10.1021/cm200939d; Kwon HT, 2013, CHEM COMMUN, V49, P3854, DOI 10.1039/c3cc41039k; Li KH, 2009, J AM CHEM SOC, V131, P10368, DOI 10.1021/ja9039983; Lively RP, 2011, ACS APPL MATER INTER, V3, P3568, DOI 10.1021/am200789g; Nakayama K., 2006, Patent, Patent No. [US 7, 014, 680 B2, 7014680, 7,014,680]; Pan YC, 2012, J MEMBRANE SCI, V421, P292, DOI 10.1016/j.memsci.2012.07.028; Pan YC, 2012, J MEMBRANE SCI, V390, P93, DOI 10.1016/j.memsci.2011.11.024; Pan YC, 2011, CHEM COMMUN, V47, P10275, DOI 10.1039/c1cc14051e; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Pera-Titus M, 2006, J MEMBRANE SCI, V278, P401, DOI 10.1016/j.memsci.2005.11.026; Pinnau I, 2004, J MEMBRANE SCI, V244, P227, DOI 10.1016/j.memsci.2004.06.055; Shah M, 2012, IND ENG CHEM RES, V51, P2179, DOI 10.1021/ie202038m; Shi YT, 2006, J MEMBRANE SCI, V282, P115, DOI 10.1016/j.memsci.2006.05.011; Thompson JA, 2012, CHEM MATER, V24, P1930, DOI 10.1021/cm3006953; Tsapatsis M, 2011, SCIENCE, V334, P767, DOI 10.1126/science.1205957; Tung CTP, 2011, SCIENCE, V334, P1533, DOI 10.1126/science.1212472; Varoon K, 2011, SCIENCE, V334, P72, DOI 10.1126/science.1208891; Zhang C, 2012, J PHYS CHEM LETT, V3, P2130, DOI 10.1021/jz300855a	28	473	488	82	1682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					72	75		10.1126/science.1251181	http://dx.doi.org/10.1126/science.1251181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994649				2022-12-28	WOS:000338284400051
J	Hom, EFY; Murray, AW				Hom, Erik F. Y.; Murray, Andrew W.			Niche engineering demonstrates a latent capacity for fungal-algal mutualism	SCIENCE			English	Article							EVOLUTION; TRANSITIONS; SYMBIOSIS; LICHENS	Mutualistic symbioses shape the evolution of species and ecosystems and catalyze the emergence of biological complexity, yet how such symbioses first form is unclear. We show that an obligate mutualism between the yeast Saccharomyces cerevisiae and the alga Chlamydomonas reinhardtii-two model eukaryotes with very different life histories-can arise spontaneously in an environment requiring reciprocal carbon and nitrogen exchange. This capacity for mutualism is phylogenetically broad, extending to other Chlamydomonas and fungal species. Furthermore, we witnessed the spontaneous association of Chlamydomonas algal cells physically interacting with filamentous fungi. These observations demonstrate that under specific conditions, environmental change induces free-living species to become obligate mutualists and establishes a set of experimentally tractable, phylogenetically related, synthetic systems for studying the evolution of symbiosis.	[Hom, Erik F. Y.; Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hom, Erik F. Y.; Murray, Andrew W.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hom, EFY (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	erik@fyhom.com; amurray@mcb.harvard.edu	Hom, Erik/B-3889-2008	Hom, Erik/0000-0003-0964-0031	Jane Coffin Childs postdoctoral fellowship; National Institute of General Medical Sciences Center for Modular Biology (NIH) [P50-GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Jane Coffin Childs postdoctoral fellowship; National Institute of General Medical Sciences Center for Modular Biology (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Justman, B. Stern, A. Pringle, S. Sasso, M. Dayel, N. Collins, J. Hess, M. Mueller, G. Frenkel, S. Kryazhimskiy, M. McDonald, D. Van Dyken, E. Wallace, K. Zimmerman, P. Boynton, J. Calarco, D. Chiang, Y. Eun, K. Foster, R. Losick, W. Tong, Y. Katz, and members of the Murray and Nelson labs for helpful feedback. We thank D. Thompson, M. Dunham, F. Winston, and N. Rhind for yeast strains; T. Schinko and J. Strauss for A. nidulans strains; and the Fungal Genetics Stock Center (Kansas City, MO) for fungal strains. We thank P. Rogers, M. Tam, and B. Tilton (Faculty of Arts and Sciences Center for Systems Biology FACS Core); B. Goetze, C. Kraft, and D. Richardson (Harvard Center for Biological Imaging); M. Yankova and S. King (Central Electron Microscopy Facility, University of Connecticut Health Center) for their resources and assistance; and U. Goodenough for her help in interpreting electron micrographs. Supported in part by a Jane Coffin Childs postdoctoral fellowship to E.F.Y.H. and by the National Institute of General Medical Sciences Center for Modular Biology (NIH grant P50-GM068763). Additional data described in this work can be found in the online supplementary materials. E.F.Y.H. conceived the project, performed the experiments, and analyzed the data. E.F.Y.H. and A.W.M. devised the research and wrote the manuscript. A.W.M. supported and provided input throughout all stages of this work.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; AZUARA MP, 1983, PLANT PHYSIOL, V71, P286, DOI 10.1104/pp.71.2.286; Bronstein J.L., 2009, PRINCETON GUIDE ECOL, P233, DOI DOI 10.1515/9781400833023.233; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Douglas A.E., 2010, SYMBIOTIC HABIT; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; HAWKSWORTH DL, 1988, BOT J LINN SOC, V96, P3, DOI 10.1111/j.1095-8339.1988.tb00623.x; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; HONEGGER R, 1986, NEW PHYTOL, V103, P785, DOI 10.1111/j.1469-8137.1986.tb00853.x; Honegger R, 2012, FUNGAL ASS, P287, DOI [10.1007/978-3-642-30826-0_15, DOI 10.1007/978-3-642-30826-0_15]; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kohlmeyer J, 1979, MARINE MYCOLOGY HIGH, P70; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Momeni B, 2011, CELL MOL LIFE SCI, V68, P1353, DOI 10.1007/s00018-011-0649-y; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Muller MJI, 2014, P NATL ACAD SCI USA, V111, P1037, DOI 10.1073/pnas.1313285111; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031	24	133	136	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					94	98		10.1126/science.1253320	http://dx.doi.org/10.1126/science.1253320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994654	Green Accepted			2022-12-28	WOS:000338284400058
J	Dong, HH; Xiang, QJ; Gu, YH; Wang, ZS; Paterson, NG; Stansfeld, PJ; He, C; Zhang, YZ; Wang, WJ; Dong, CJ				Dong, Haohao; Xiang, Quanju; Gu, Yinghong; Wang, Zhongshan; Paterson, Neil G.; Stansfeld, Phillip J.; He, Chuan; Zhang, Yizheng; Wang, Wenjian; Dong, Changjiang			Structural basis for outer membrane lipopolysaccharide insertion	NATURE			English	Article							TRANSENVELOPE PROTEIN COMPLEX; BETA-BARREL; MOLECULAR SIMULATION; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; CELL-ENVELOPE; TRANSPORT; BIOGENESIS; LPTD; TRANSLOCON	Lipopolysaccharide (LPS) is essential for most Gram-negative bacteria and has crucial roles in protection of the bacteria fromharsh environments and toxic compounds, including antibiotics. Seven LPS transport proteins (that is, LptA-LptG) form a trans-envelope protein complex responsible for the transport of LPS from the inner membrane to the outer membrane, the mechanism for which is poorly understood. Here we report the first crystal structure of the unique integral membrane LPS translocon LptD-LptE complex. LptD forms a novel 26-stranded beta-barrel, which is to our knowledge the largest beta-barrel reported so far. LptE adopts a roll-like structure located inside the barrel of LptD to form an unprecedented two-protein 'barrel and plug' architecture. The structure, molecular dynamics simulations and functional assays suggest that the hydrophilic O-antigen and the core oligosaccharide of the LPS may pass through the barrel and the lipid A of the LPS may be inserted into the outer leaflet of the outer membrane through a lateral opening between strands beta 1 and beta 26 of LptD. These findings not only help us to understand important aspects of bacterial outer membrane biogenesis, but also have significant potential for the development of novel drugs against multi-drug resistant pathogenic bacteria.	[Dong, Haohao; Gu, Yinghong; Wang, Zhongshan; Dong, Changjiang] Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Dong, Haohao; Xiang, Quanju; Wang, Zhongshan; He, Chuan] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Xiang, Quanju] Sichuan Agr Univ, Dept Microbiol, Coll Resource & Environm Sci, Yaan 625000, Peoples R China; [Wang, Zhongshan; Zhang, Yizheng] Sichuan Univ, Coll Life Sci, Chengdu 610065, Peoples R China; [Paterson, Neil G.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [He, Chuan] Wuhan Tech Coll Commun, Sch Elect & Informat, Wuhan 430065, Hubei, Peoples R China; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510080, Guangdong, Peoples R China	University of East Anglia; University of St Andrews; Sichuan Agricultural University; Sichuan University; Diamond Light Source; University of Oxford; Sun Yat Sen University	Dong, CJ (corresponding author), Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	wenjian166@googlemail.com; c.dong@uea.ac.uk	Stansfeld, Phillip James/AAA-9228-2020; GU, Yinghong/D-2433-2010; xiang, quanju/AAI-3042-2020	Stansfeld, Phillip James/0000-0001-8800-7669; GU, Yinghong/0000-0002-9364-1389; Paterson, Neil/0000-0003-4292-6971; Wang, Zhongshan/0000-0002-1321-3916	China Scholarship Council; BBSRC [BB/I019855/1, BB/L002558/1, BB/H000267/1] Funding Source: UKRI; EPSRC [EP/J010421/1] Funding Source: UKRI; MRC [G1100110] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019855/1, BB/H000267/1, BB/L002558/1, BEP17032, B19456, BBS/B/16011] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J010421/1] Funding Source: researchfish; Medical Research Council [G1100110] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. J. Silhavy for providing AM689 and AM661 cells, J. Naismith and C. Whitfield for support, and R. Field, A. Johnston and X. Tang for critical reading of the manuscript. We thank the staff at I24, I02, I03 and I04 of Diamond Light Source UK for beamtime (proposal mx7641) and their assistance with data collection. C.D. is a Wellcome Trust career development fellow (083501/Z/07/Z). Q.X. and Z.W. are the receipts of the Chinese overseas study scholarships of The China Scholarship Council.	Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Colombo G, 2003, BIOPHYS J, V84, P2331, DOI 10.1016/S0006-3495(03)75038-3; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Grabowicz M, 2013, J BACTERIOL, V195, P1327, DOI 10.1128/JB.02142-12; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan MA, 2009, BIOCHEMISTRY-US, V48, P9745, DOI 10.1021/bi9013566; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J CHEM PHYS, V74, P1990, DOI 10.1063/1.441242; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	44	174	177	2	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					52	U569		10.1038/nature13464	http://dx.doi.org/10.1038/nature13464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990744	Green Accepted			2022-12-28	WOS:000338199400033
J	Jorgensen, AB; Frikke-Schmidt, R; Nordestgaard, BG; Tybjaerg-Hansen, A				Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne			Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-C-III; TRIGLYCERIDE-RICH LIPOPROTEINS; HIGH-DENSITY-LIPOPROTEIN; NONFASTING TRIGLYCERIDES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; REMNANT CHOLESTEROL; ARTERIAL INTIMA; IN-VIVO; PLASMA	Background High plasma levels of nonfasting triglycerides are associated with an increased risk of ischemic cardiovascular disease. Whether lifelong low levels of nonfasting triglycerides owing to mutations in the gene encoding apolipoprotein C3 (APOC3) are associated with a reduced risk of ischemic cardiovascular disease in the general population is unknown. Methods Using data from 75,725 participants in two general-population studies, we first tested whether low levels of nonfasting triglycerides were associated with reduced risks of ischemic vascular disease and ischemic heart disease. Second, we tested whether loss-of-function mutations in APOC3, which were associated with reduced levels of nonfasting triglycerides, were also associated with reduced risks of ischemic vascular disease and ischemic heart disease. During follow-up, ischemic vascular disease developed in 10,797 participants, and ischemic heart disease developed in 7557 of these 10,797 participants. Results Participants with nonfasting triglyceride levels of less than 1.00 mmol per liter (90 mg per deciliter) had a significantly lower incidence of cardiovascular disease than those with levels of 4.00 mmol per liter (350 mg per deciliter) or more (hazard ratio for ischemic vascular disease, 0.43; 95% confidence interval [CI], 0.35 to 0.54; hazard ratio for ischemic heart disease, 0.40; 95% CI, 0.31 to 0.52). Heterozygosity for loss-of-function mutations in APOC3, as compared with no APOC3 mutations, was associated with a mean reduction in nonfasting triglyceride levels of 44% (P<0.001). The cumulative incidences of ischemic vascular disease and ischemic heart disease were reduced in heterozygotes as compared with noncarriers of APOC3 mutations (P = 0.009 and P = 0.05, respectively), with corresponding risk reductions of 41% (hazard ratio, 0.59; 95% CI, 0.41 to 0.86; P = 0.007) and 36% (hazard ratio, 0.64; 95% CI, 0.41 to 0.99; P = 0.04). Conclusions Loss-of-function mutations in APOC3 were associated with low levels of triglycerides and a reduced risk of ischemic cardiovascular disease. (Funded by the European Union and others.)	[Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen Hosp, DK-2100 Copenhagen O, Denmark; [Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nordestgaard, Borge G.] Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Tybjaerg-Hansen, A (corresponding author), Univ Copenhagen Hosp, Dept Clin Chem KB 3011, Mol Genet Sect, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	anne.tybjaerg.hansen@regionh.dk	Girelli, Domenico/B-1183-2008; Nordestgaard, Borge Gronne/ABF-1310-2020	Girelli, Domenico/0000-0001-9684-1899; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Nordestgaard, Borge/0000-0002-1954-7220	European Union	European Union(European Commission)	Funded by the European Union and others.	AIM- HIGH Investigators, 2012, NEW ENGL J MED, V367, P189; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bochem AE, 2014, CLIN GENET, V85, P433, DOI 10.1111/cge.12201; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Johannsen TH, 2009, J CLIN ENDOCR METAB, V94, P1264, DOI 10.1210/jc.2008-1342; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Liu HQ, 2000, J LIPID RES, V41, P1760; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Novelli V, 2008, BIOGERONTOLOGY, V9, P85, DOI 10.1007/s10522-007-9116-4; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Varbo A, 2011, ANN NEUROL, V69, P628, DOI 10.1002/ana.22384; Voight BF, 2012, LANCET, V380, P564; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WINDLER E, 1985, J LIPID RES, V26, P556; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70	41	603	645	4	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					32	41		10.1056/NEJMoa1308027	http://dx.doi.org/10.1056/NEJMoa1308027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24941082				2022-12-28	WOS:000338265700007
J	Liu, H; Strobridge, FC; Borkiewicz, OJ; Wiaderek, KM; Chapman, KW; Chupas, PJ; Grey, CP				Liu, Hao; Strobridge, Fiona C.; Borkiewicz, Olaf J.; Wiaderek, Kamila M.; Chapman, Karena W.; Chupas, Peter J.; Grey, Clare P.			Capturing metastable structures during high-rate cycling of LiFePO4 nanoparticle electrodes	SCIENCE			English	Article							X-RAY-ABSORPTION; SOLID-SOLUTION; CATHODE MATERIALS; LITHIUM; PHASE; FEPO4; DIFFRACTION; LIXFEPO4; ENERGY; EXPANSION	The absence of a phase transformation involving substantial structural rearrangements and large volume changes is generally considered to be a key characteristic underpinning the high-rate capability of any battery electrode material. In apparent contradiction, nanoparticulate LiFePO4, a commercially important cathode material, displays exceptionally high rates, whereas its lithium-composition phase diagram indicates that it should react via a kinetically limited, two-phase nucleation and growth process. Knowledge concerning the equilibrium phases is therefore insufficient, and direct investigation of the dynamic process is required. Using time-resolved in situ x-ray powder diffraction, we reveal the existence of a continuous metastable solid solution phase during rapid lithium extraction and insertion. This nonequilibrium facile phase transformation route provides a mechanism for realizing high-rate capability of electrode materials that operate via two-phase reactions.	[Liu, Hao; Strobridge, Fiona C.; Grey, Clare P.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Borkiewicz, Olaf J.; Wiaderek, Kamila M.; Chapman, Karena W.; Chupas, Peter J.] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Grey, Clare P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	University of Cambridge; United States Department of Energy (DOE); Argonne National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Grey, CP (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cpg27@cam.ac.uk	Liu, Hao/B-2416-2016; Grey, Clare P/Q-8860-2017	Liu, Hao/0000-0003-0345-6647; Grey, Clare P/0000-0001-5572-192X	Northeastern Center for Chemical Energy Storage, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-SC0001294]; DOE [DE-AC02-06CH11357]; European Union [FP7-265368]; Cambridge Overseas Trust; Engineering Physical Science Research Council	Northeastern Center for Chemical Energy Storage, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); European Union(European Commission); Cambridge Overseas Trust; Engineering Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported as part of the Northeastern Center for Chemical Energy Storage, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under award no. DE-SC0001294. Work performed at Argonne National Laboratory and use of the Advanced Photon Source, an Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory, were supported by DOE under contract no. DE-AC02-06CH11357. H. L. acknowledges the funding from European Union FP7-265368 via the Eurolion Project and the Cambridge Overseas Trust. F. C. S. acknowledges the funding from the Engineering Physical Science Research Council via a Doctoral Training Partnership Award. We thank B. Orvananos, H. C. Yu, K. Thornton, R. Malik, A. Abdellahi, G. Ceder, and M. S. Whittingham for helpful discussions and comments. H. L., F. C. S., O.J.B. and K. M. W. carried out the experiments; H. L., K. W. C., P.J.C. and C. P. G. performed the analysis; and C. P. G. and H. L. wrote the manuscript with help from all coauthors.	Allen JL, 2008, J SOLID STATE ELECTR, V12, P1031, DOI 10.1007/s10008-007-0459-1; Bai P, 2011, NANO LETT, V11, P4890, DOI 10.1021/nl202764f; BARSCH GR, 1984, PHYS REV LETT, V53, P1069, DOI 10.1103/PhysRevLett.53.1069; Borkiewicz OJ, 2012, J APPL CRYSTALLOGR, V45, P1261, DOI 10.1107/S0021889812042720; Brunetti G, 2011, CHEM MATER, V23, P4515, DOI 10.1021/cm201783z; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; Chen GY, 2006, ELECTROCHEM SOLID ST, V9, pA295, DOI 10.1149/1.2192695; Chueh WC, 2013, NANO LETT, V13, P866, DOI 10.1021/nl3031899; Coelho A., 2007, TOPAS ACAD VERSION 4; Delacourt C, 2005, NAT MATER, V4, P254, DOI 10.1038/nmat1335; Delmas C, 2008, NAT MATER, V7, P665, DOI 10.1038/nmat2230; Dodd JL, 2006, ELECTROCHEM SOLID ST, V9, pA151, DOI 10.1149/1.2164548; Fongy C, 2010, J ELECTROCHEM SOC, V157, pA885, DOI 10.1149/1.3432559; Goodwin AL, 2008, SCIENCE, V319, P794, DOI 10.1126/science.1151442; Gwon H, 2009, ADV FUNCT MATER, V19, P3285, DOI 10.1002/adfm.200900414; JARVINEN M, 1993, J APPL CRYSTALLOGR, V26, P525, DOI 10.1107/S0021889893001219; Kang B, 2009, NATURE, V458, P190, DOI 10.1038/nature07853; Kobayashi G, 2009, ADV FUNCT MATER, V19, P395, DOI 10.1002/adfm.200801522; Kunduraci M, 2006, J ELECTROCHEM SOC, V153, pA1345, DOI 10.1149/1.2198110; Laffont L, 2006, CHEM MATER, V18, P5520, DOI 10.1021/cm0617182; Malik R, 2011, NAT MATER, V10, P587, DOI [10.1038/NMAT3065, 10.1038/nmat3065]; Meethong N, 2007, ELECTROCHEM SOLID ST, V10, pA134, DOI 10.1149/1.2710960; Molenda J, 2007, J POWER SOURCES, V174, P689, DOI 10.1016/j.jpowsour.2007.06.238; Nam KW, 2009, ELECTROCHEM COMMUN, V11, P2023, DOI 10.1016/j.elecom.2009.08.044; Nam KW, 2009, ELECTROCHEM COMMUN, V11, P913, DOI 10.1016/j.elecom.2009.02.031; Orikasa Y, 2013, CHEM MATER, V25, P1032, DOI 10.1021/cm303411t; Orikasa Y, 2013, J AM CHEM SOC, V135, P5497, DOI 10.1021/ja312527x; Orvananos B, 2014, ELECTROCHIM ACTA, V137, P245, DOI 10.1016/j.electacta.2014.06.029; Ouvrard G, 2013, J POWER SOURCES, V229, P16, DOI 10.1016/j.jpowsour.2012.11.057; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Park KY, 2013, J ELECTROCHEM SOC, V160, pA444, DOI 10.1149/2.036303jes; PAWLEY GS, 1981, J APPL CRYSTALLOGR, V14, P357, DOI 10.1107/S0021889881009618; Perea A, 2012, RSC ADV, V2, P2080, DOI 10.1039/c1ra00256b; POPA NC, 1992, J APPL CRYSTALLOGR, V25, P611, DOI 10.1107/S0021889892004795; Ramana CV, 2009, J POWER SOURCES, V187, P555, DOI 10.1016/j.jpowsour.2008.11.042; Ravnsbaek DB, 2014, NANO LETT, V14, P1484, DOI 10.1021/nl404679t; RUDMAN PS, 1960, ACTA CRYSTALLOGR, V13, P905, DOI 10.1107/S0365110X60002211; Sharma N, 2012, J AM CHEM SOC, V134, P7867, DOI 10.1021/ja301187u; Sugar JD, 2014, J POWER SOURCES, V246, P512, DOI 10.1016/j.jpowsour.2013.08.003; Wagemaker M, 2011, J AM CHEM SOC, V133, P10222, DOI 10.1021/ja2026213; WARREN BE, 1969, XRAY DIFFRACTION, pCH13; Xia YY, 2001, J ELECTROCHEM SOC, V148, pA723, DOI 10.1149/1.1376117; Yabuuchi N, 2003, J POWER SOURCES, V119, P171, DOI 10.1016/S0378-7753(03)00173-3; Yamada A, 2001, J ELECTROCHEM SOC, V148, pA1153, DOI 10.1149/1.1401083; Zeng DL, 2007, CHEM MATER, V19, P6277, DOI 10.1021/cm702241a; Zhu YJ, 2013, ADV MATER, V25, P5461, DOI 10.1002/adma.201301374	46	419	429	31	769	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191							1252817	10.1126/science.1252817	http://dx.doi.org/10.1126/science.1252817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970091				2022-12-28	WOS:000337889900040
J	Rodriguez, A; Laio, A				Rodriguez, Alex; Laio, Alessandro			Clustering by fast search and find of density peaks	SCIENCE			English	Article								a Cluster analysis is aimed at classifying elements into categories on the basis of their similarity. Its applications range from astronomy to bioinformatics, bibliometrics, and pattern recognition. We propose an approach based on the idea that cluster centers are characterized by a higher density than their neighbors and by a relatively large distance from points with higher densities. This idea forms the basis of a clustering procedure in which the number of clusters arises intuitively, outliers are automatically spotted and excluded fromthe analysis, and clusters are recognized regardless of their shape and of the dimensionality of the space inwhich they are embedded. We demonstrate the power of the algorithm on several test cases.	[Rodriguez, Alex; Laio, Alessandro] SISSA, I-34136 Trieste, Italy	International School for Advanced Studies (SISSA)	Rodriguez, A (corresponding author), SISSA, Via Bonomea 265, I-34136 Trieste, Italy.	alexrod@sissa.it; laio@sissa.it	Laio, Alessandro/K-2117-2012	Laio, Alessandro/0000-0001-9164-7907; Rodriguez, Alex/0000-0002-0213-6695	grant Associazione Italiana per la Ricerca sul Cancro 5 per mille [12214]; Fondo per gli Investimenti della Ricerca di Base-Accordo di programma [RBAP11ETKA]	grant Associazione Italiana per la Ricerca sul Cancro 5 per mille(Fondazione AIRC per la ricerca sul cancro); Fondo per gli Investimenti della Ricerca di Base-Accordo di programma(Ministry of Education, Universities and Research (MIUR))	We thank E. Tosatti, D. Amati, F. Laio, F. Marinelli, A. Maritan, R. Allen, J. Nasica, and M. d'Errico for stimulating discussion. We acknowledge financial support from the grant Associazione Italiana per la Ricerca sul Cancro 5 per mille, Rif. 12214, and Fondo per gli Investimenti della Ricerca di Base-Accordo di programma, Rif. RBAP11ETKA.	Chang H, 2008, PATTERN RECOGN, V41, P191, DOI 10.1016/j.patcog.2007.04.010; Charytanowicz M, 2010, ADV INTEL SOFT COMPU, V69, P15; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Dueck D, 2007, IEEE I CONF COMP VIS, P198; Ester M., 1996, DENSITY BASED ALGORI, V96, P226; Franti P, 2006, PATTERN RECOGN, V39, P761, DOI 10.1016/j.patcog.2005.09.012; Franti P, 2006, IEEE T PATTERN ANAL, V28, P1875, DOI 10.1109/TPAMI.2006.227; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Hoppner F, 1999, FUZZY CLUSTER ANAL M; Horenko I, 2006, MULTISCALE MODEL SIM, V5, P802, DOI 10.1137/050623310; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kaufman L., 2009, FINDING GROUPS DATA, V344; MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1007/S11665-016-2173-6; Marinelli F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000452; McLachlan G.J., 2007, WILEY SERIES PROBABI, V382; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sampat MP, 2009, IEEE T IMAGE PROCESS, V18, P2385, DOI 10.1109/TIP.2009.2025923; Tsaparas, 2007, ACM T KNOWL DISCOV D, V1, P4, DOI [10.1145/1217299.1217303, DOI 10.1145/1217299.1217303]; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	22	2716	3277	152	1738	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1492	1496		10.1126/science.1242072	http://dx.doi.org/10.1126/science.1242072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970081				2022-12-28	WOS:000337889900044
J	Palen, WJ; Sisk, TD; Ryan, ME; Arvai, JL; Jaccard, M; Salomon, AK; Homer-Dixon, T; Lertzman, KP				Palen, Wendy J.; Sisk, Thomas D.; Ryan, Maureen E.; Arvai, Joseph L.; Jaccard, Mark; Salomon, Anne K.; Homer-Dixon, Thomas; Lertzman, Ken P.			Consider the global impacts of oil pipelines	NATURE			English	Editorial Material									[Palen, Wendy J.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Sisk, Thomas D.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Ryan, Maureen E.; Jaccard, Mark; Salomon, Anne K.; Lertzman, Ken P.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Arvai, Joseph L.] Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada; [Homer-Dixon, Thomas] Univ Waterloo, Balsillie Sch Int Affairs, Waterloo, ON N2L 3G1, Canada	Simon Fraser University; Northern Arizona University; Simon Fraser University; University of Calgary; University of Waterloo	Palen, WJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	wpalen@sfu.ca						[Anonymous], 2013, CAN EM TRENDS; Arvai J., 2014, J ENV PLAN MAGMT; Arvai J, 2012, ISSUES SCI TECHNOL, V28, P43; Canadian Association of Petroleum Producers, 2014, 2014 CAPP CRUD OIL F; Chen, 2009, CANC INCIDENCE FORT; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kurek J, 2013, P NATL ACAD SCI USA, V110, P1761, DOI 10.1073/pnas.1217675110; Office of the Auditor General of Canada, 2012, 2012 SPRING REP COMM; Rooney RC, 2012, P NATL ACAD SCI USA, V109, P4933, DOI 10.1073/pnas.1117693108	9	19	19	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					465	467		10.1038/510465a	http://dx.doi.org/10.1038/510465a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24971438	Bronze			2022-12-28	WOS:000337806300021
J	Windecker, S; Stortecky, S; Stefanini, GG; daCosta, BR; Rutjes, AW; Di Nisio, M; Siletta, MG; Maione, A; Alfonso, F; Clemmensen, PM; Collet, JP; Cremer, J; Falk, V; Filippatos, G; Hamm, C; Head, S; Kappetein, AP; Kastrati, A; Knuuti, J; Landmesser, U; Laufer, G; Neumann, FJ; Richter, D; Schauerte, P; Uva, MS; Taggart, DP; Torracca, L; Valgimigli, M; Wijns, W; Witkowski, A; Kolh, P; Juni, P				Windecker, Stephan; Stortecky, Stefan; Stefanini, Giulio G.; daCosta, Bruno R.; Rutjes, Anne Wilhelmina; Di Nisio, Marcello; Siletta, Maria G.; Maione, Ausilia; Alfonso, Fernando; Clemmensen, Peter M.; Collet, Jean-Philippe; Cremer, Jochen; Falk, Volkmar; Filippatos, Gerasimos; Hamm, Christian; Head, Stuart; Kappetein, Arie Pieter; Kastrati, Adnan; Knuuti, Juhani; Landmesser, Ulf; Laufer, Guenther; Neumann, Franz-Joseph; Richter, Dimitri; Schauerte, Patrick; Uva, Miguel Sousa; Taggart, David P.; Torracca, Lucia; Valgimigli, Marco; Wijns, William; Witkowski, Adam; Kolh, Philippe; Juni, Peter			Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BYPASS GRAFT-SURGERY; BARE-METAL STENTS; MYOCARDIAL-INFARCTION; BALLOON ANGIOPLASTY; ELUTING STENTS; RANDOMIZED-TRIALS; THERAPY; INTERVENTION; IMPLANTATION; HETEROGENEITY	Objective To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease. Design Bayesian network meta-analyses to combine direct within trial comparisons between treatments with indirect evidence from other trials while maintaining randomisation. Eligibility criteria for selecting studies A strategy of initial medical treatment compared with revascularisation by coronary artery bypass grafting or Food and Drug Administration approved techniques for percutaneous revascularization: balloon angioplasty, bare metal stent, early generation paclitaxel eluting stent, sirolimus eluting stent, and zotarolimus eluting (Endeavor) stent, and new generation everolimus eluting stent, and zotarolimus eluting (Resolute) stent among patients with stable coronary artery disease. Data sources Medline and Embase from 1980 to 2013 for randomised trials comparing medical treatment with revascularisation. Main outcome measure All cause mortality. Results 100 trials in 93 553 patients with 262 090 patient years of follow-up were included. Coronary artery bypass grafting was associated with a survival benefit (rate ratio 0.80, 95% credibility interval 0.70 to 0.91) compared with medical treatment. New generation drug eluting stents (everolimus: 0.75, 0.59 to 0.96; zotarolimus (Resolute): 0.65, 0.42 to 1.00) but not balloon angioplasty (0.85, 0.68 to 1.04), bare metal stents (0.92, 0.79 to 1.05), or early generation drug eluting stents (paclitaxel: 0.92, 0.75 to 1.12; sirolimus: 0.91, 0.75 to 1.10; zotarolimus (Endeavor): 0.88, 0.69 to 1.10) were associated with improved survival compared with medical treatment. Coronary artery bypass grafting reduced the risk of myocardial infarction compared with medical treatment (0.79, 0.63 to 0.99), and everolimus eluting stents showed a trend towards a reduced risk of myocardial infarction (0.75, 0.55 to 1.01). The risk of subsequent revascularisation was noticeably reduced by coronary artery bypass grafting (0.16, 0.13 to 0.20) followed by new generation drug eluting stents (zotarolimus (Resolute): 0.26, 0.17 to 0.40; everolimus: 0.27, 0.21 to 0.35), early generation drug eluting stents (zotarolimus (Endeavor): 0.37, 0.28 to 0.50; sirolimus: 0.29, 0.24 to 0.36; paclitaxel: 0.44, 0.35 to 0.54), and bare metal stents (0.69, 0.59 to 0.81) compared with medical treatment. Conclusion Among patients with stable coronary artery disease, coronary artery bypass grafting reduces the risk of death, myocardial infarction, and subsequent revascularisation compared with medical treatment. All stent based coronary revascularisation technologies reduce the need for revascularisation to a variable degree. Our results provide evidence for improved survival with new generation drug eluting stents but no other percutaneous revascularisation technology compared with medical treatment.	[Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Windecker, S (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Filippatos, Gerasimos/ABA-4656-2021; Kolh, Philippe/AAE-7224-2019; Torracca, Lucia/AAB-1973-2022; Richter, Dimitris/AFW-3761-2022; Sousa-Uva, Miguel/AAR-9327-2020; Stefanini, Giulio/GZG-4754-2022; Hamm, Christian W./I-3155-2017; Stortecky, Stefan/AAS-9140-2021; Kappetein, Arie Pieter/B-5534-2008; Juni, Peter/Q-8700-2016; Knuuti, Juhani/AAA-7472-2019; Valgimigli, Marco/AAE-9103-2019; , Kastrati/Y-2389-2019; Stefanini, Giulio G/K-7406-2016; Rutjes, Anne/L-8750-2017	Kolh, Philippe/0000-0001-5464-5515; Torracca, Lucia/0000-0003-2689-9440; Sousa-Uva, Miguel/0000-0001-6353-653X; Stefanini, Giulio/0000-0002-3558-6967; Hamm, Christian W./0000-0001-6763-4161; Kappetein, Arie Pieter/0000-0003-3545-2229; Juni, Peter/0000-0002-5985-0670; Knuuti, Juhani/0000-0003-3156-9593; Valgimigli, Marco/0000-0002-4353-7110; Stefanini, Giulio G/0000-0002-3558-6967; Rutjes, Anne/0000-0001-9782-779X; Stortecky, Stefan/0000-0002-5076-0177; Falk, Volkmar/0000-0002-7911-8620; R. da Costa, Bruno/0000-0002-1786-6332; Wijns, William/0000-0002-7267-4376	Department of Cardiology, Bern University Hospital; Institute of Social and Preventive Medicine, University of Bern, Switzerland	Department of Cardiology, Bern University Hospital; Institute of Social and Preventive Medicine, University of Bern, Switzerland	This study was supported by intramural funds from the Department of Cardiology, Bern University Hospital, and the Institute of Social and Preventive Medicine, University of Bern, Switzerland.	Bangalore S, 2013, CIRCULATION, V127, P769, DOI 10.1161/CIRCULATIONAHA.112.131961; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chamberlain DA, 1997, LANCET, V350, P461; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982; Detre KM, 2000, NEW ENGL J MED, V342, P989, DOI 10.1056/NEJM200004063421401; Dias S., 2011, NICE DSU TECHNICAL S; Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985; Fajadet J, 2006, CIRCULATION, V114, P798, DOI 10.1161/CIRCULATIONAHA.105.591206; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Jeremias A, 2009, AM J MED, V122, P152, DOI 10.1016/j.amjmed.2008.07.027; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kereiakes DJ, 2007, J AM COLL CARDIOL, V50, P1598, DOI 10.1016/j.jacc.2007.07.063; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lytle BW, 2004, NEW ENGL J MED, V351, P2262, DOI 10.1056/NEJMp048238; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pfisterer ME, 2010, LANCET, V375, P763, DOI 10.1016/S0140-6736(10)60168-7; Prasad A, 2011, NEW ENGL J MED, V364, P453, DOI 10.1056/NEJMra0912134; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Simoons ML, 2010, EUR HEART J, V31, P530, DOI 10.1093/eurheartj/ehp605; Stefanini GG, 2013, LANCET, V382, P1879, DOI 10.1016/S0140-6736(13)61782-1; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Thorlund K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-2; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	50	197	203	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2014	348								g3859	10.1136/bmj.g3859	http://dx.doi.org/10.1136/bmj.g3859			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UE	24958153	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000338201400001
J	Gurm, HS; Eagle, K				Gurm, Hitinder S.; Eagle, Kim			Red blood cell transfusion after PCI was associated with increased mortality, MI, and stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORONARY		[Gurm, Hitinder S.; Eagle, Kim] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Gurm, HS (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.			Gurm, Hitinder/0000-0002-1646-0218				Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Silvain J, 2014, J AM COLL CARDIOL, V63, P1289, DOI 10.1016/j.jacc.2013.11.029; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC12	10.7326/0003-4819-160-12-201406170-02012	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935506				2022-12-28	WOS:000337374900012
J	Jensen, A; Sherman, S				Jensen, Ashley; Sherman, Scott			In patients at high CV risk, a Mediterranean diet plus olive oil reduced diabetes more than advising a low-fat diet	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jensen, Ashley] VA New York Harbor Healthcare Syst, New York, NY 11209 USA; NYU, Sch Med, New York, NY USA	New York University	Jensen, A (corresponding author), VA New York Harbor Healthcare Syst, New York, NY 11209 USA.		Jensen, Ashley E/B-6452-2015	Jensen, Ashley E/0000-0002-5702-2978; Sherman, Scott/0000-0003-1752-7303				DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Esposito K, 2010, DIABETES RES CLIN PR, V89, P97, DOI 10.1016/j.diabres.2010.04.019	2	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC2	10.7326/0003-4819-160-12-201406170-02002	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935508				2022-12-28	WOS:000337374900002
J	Kahan, S; Cheskin, LJ				Kahan, Scott; Cheskin, Lawrence J.			Review: Vegetarian diets reduce systolic and diastolic blood pressure more than omnivorous diets	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kahan, Scott; Cheskin, Lawrence J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kahan, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.		Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030; Kahan, Scott/0000-0002-3080-0661				Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Ferdowsian HR, 2010, AM J HEALTH PROMOT, V24, P384, DOI 10.4278/ajhp.081027-QUAN-255	2	0	0	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC3	10.7326/0003-4819-160-12-201406170-02003	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935509				2022-12-28	WOS:000337374900003
J	Krishnan, V				Krishnan, Vidya			MATERNAL HEALTH Safety in childbirth: can India maintain its momentum?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												vidyakrishnan13@gmail.com						Cooke J. G., 2013, MATERNAL HLTH NIGERI; World Health Organization, TRENDS MAT MORT 1990	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g3875	10.1136/bmj.g3875	http://dx.doi.org/10.1136/bmj.g3875			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24934846				2022-12-28	WOS:000337804300014
J	Jewkes, R; Sikweyiya, Y; Jama-Shai, N				Jewkes, Rachel; Sikweyiya, Yandisa; Jama-Shai, Nwabisa			The challenges of research on violence in post-conflict Bougainville	LANCET			English	Editorial Material									[Jewkes, Rachel; Sikweyiya, Yandisa; Jama-Shai, Nwabisa] MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa.	rachel.jewkes@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267; Shai, Nwabisa/0000-0003-4171-9129					0	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2039	2040		10.1016/S0140-6736(14)60969-7	http://dx.doi.org/10.1016/S0140-6736(14)60969-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI9VZ	24936627				2022-12-28	WOS:000337292400014
J	Reese, TA; Wakeman, BS; Choi, HS; Hufford, MM; Huang, SC; Zhang, X; Buck, MD; Jezewski, A; Kambal, A; Liu, CY; Goel, G; Murray, PJ; Xavier, RJ; Kaplan, MH; Renne, R; Speck, SH; Artyomov, MN; Pearce, EJ; Virgin, HW				Reese, T. A.; Wakeman, B. S.; Choi, H. S.; Hufford, M. M.; Huang, S. C.; Zhang, X.; Buck, M. D.; Jezewski, A.; Kambal, A.; Liu, C. Y.; Goel, G.; Murray, P. J.; Xavier, R. J.; Kaplan, M. H.; Renne, R.; Speck, S. H.; Artyomov, M. N.; Pearce, E. J.; Virgin, H. W.			Helminth infection reactivates latent gamma-herpesvirus via cytokine competition at a viral promoter	SCIENCE			English	Article							MURINE GAMMAHERPESVIRUS 68; SWITCH GENE 50; B-CELLS; MACROPHAGES; INTERFERON; VIRUS; TRANSACTIVATOR; PROLIFERATION; ESTABLISHMENT; INFLAMMATION	Mammals are coinfected by multiple pathogens that interact through unknown mechanisms. We found that helminth infection, characterized by the induction of the cytokine interleukin-4 (IL-4) and the activation of the transcription factor Stat6, reactivated murine gamma-herpesvirus infection in vivo. IL-4 promoted viral replication and blocked the antiviral effects of interferon-gamma (IFN gamma) by inducing Stat6 binding to the promoter for an important viral transcriptional transactivator. IL-4 also reactivated human Kaposi's sarcoma-associated herpesvirus from latency in cultured cells. Exogenous IL-4 plus blockade of IFN gamma reactivated latent murine gamma-herpesvirus infection in vivo, suggesting a "two-signal" model for viral reactivation. Thus, chronic herpesvirus infection, a component of the mammalian virome, is regulated by the counterpoised actions of multiple cytokines on viral promoters that have evolved to sense host immune status.	[Reese, T. A.; Huang, S. C.; Zhang, X.; Buck, M. D.; Jezewski, A.; Kambal, A.; Liu, C. Y.; Artyomov, M. N.; Pearce, E. J.; Virgin, H. W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Wakeman, B. S.; Speck, S. H.] Emory Univ, Vaccine Ctr, Atlanta, GA 30322 USA; [Choi, H. S.; Renne, R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Hufford, M. M.; Kaplan, M. H.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hufford, M. M.; Kaplan, M. H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Goel, G.; Xavier, R. J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Goel, G.; Xavier, R. J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Murray, P. J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, P. J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Washington University (WUSTL); Emory University; State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019; Murray, Peter J/K-4725-2018; Speck, Samuel/L-5893-2019	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Murray, Peter J/0000-0001-6329-9802; Virgin, Herbert/0000-0001-8580-7628; Jezewski, Andrew/0000-0002-2004-1278; Reese, Tiffany/0000-0003-2325-6546; Buck, Michael/0000-0002-9611-1199	Damon Runyon Postdoctoral Fellowship; Crohn's and Colitis Foundation [274415, AI032573, CA164062, CA119917, CA52004];  [U54 AI057160];  [AI084887]; NATIONAL CANCER INSTITUTE [R01CA164062, R01CA096511, R01CA052004, R01CA119917, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032573, R01AI084887, U54AI057160, R01AI032573, R01AI095282] Funding Source: NIH RePORTER	Damon Runyon Postdoctoral Fellowship; Crohn's and Colitis Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T. A. R. was supported by a Damon Runyon Postdoctoral Fellowship. This work was supported by grants U54 AI057160 and AI084887 and Crohn's and Colitis Foundation grant 274415 to H. W. V., grants AI032573 and CA164062 to E.J.P., grant CA119917 to R. R., and grant CA52004 to S. H. S. We thank R. Schreiber and K. Sheehan for supplying anti-IFNg and PIP, G. Randolph and E. Gautier for PPAR gamma f/f x LyzMcre mice and helpful discussion, J. Urban for help setting up the H. polygyrus system, D. Kreamalmeyer for animal care and breeding, members of the Virgin lab for manuscript review and discussion, the Genome Technology Access Center at Washington University for sequencing, and the Flow Cytometry Core at Washington University for assistance with sorting. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The GEO accession numbers for RNAseq data on virus-infected cells and for the BMDMs are GSE58116 and GSE21895, respectively. T. A. R. designed the project, performed experiments, and wrote the paper. H. W. V. assisted with project design and paper writing. B. S. W. and S. H. S. defined promoters and performed promoter assays. X.Z. created and characterized MHV68-cre virus and performed limiting dilution PCR and Western blots. H. S. C. and R. R. performed KSHV experiments. M. M. H. and M. H. K. performed ChIP experiments. S. C. H. and E. J. P. helped design helminth experiments and supplied reagents. M. D. B. did RT-PCR for gene 50 and host genes. A. J. did flow cytometry with IL-4 in RAW264.7 cells. A. K. did Western blots. C.Y.L. did plaque assays. G. G. and R. J. X. did initial bioinformatic analysis of gene expression by array, later replaced with RNASeq. P. J. M. provided arginase mice. M.N.A. analyzed sequencing data.	Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Goodwin MM, 2010, J VIROL, V84, P12039, DOI 10.1128/JVI.00396-10; Goodwin MM, 2010, J VIROL, V84, P3711, DOI 10.1128/JVI.02099-09; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gray KS, 2009, J VIROL, V83, P314, DOI 10.1128/JVI.01444-08; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; Hwang S, 2008, J VIROL, V82, P12498, DOI 10.1128/JVI.01152-08; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Moser JM, 2005, J VIROL, V79, P9480, DOI 10.1128/JVI.79.15.9480-9491.2005; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Peacock JW, 2003, EUR J IMMUNOL, V33, P1849, DOI 10.1002/eji.200323148; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Saito F, 2013, INFLAMMATION, V36, P1295, DOI 10.1007/s10753-013-9668-1; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Steed A, 2007, J VIROL, V81, P6134, DOI 10.1128/JVI.00108-07; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wakeham K, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-15; Wakeman BS, 2014, J VIROL, V88, P5474, DOI 10.1128/JVI.03110-13; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999	30	140	143	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					573	577		10.1126/science.1254517	http://dx.doi.org/10.1126/science.1254517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	24968940	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000339651300048
J	Beck, LA; Thaci, D; Hamilton, JD; Graham, NM; Bieber, T; Rocklin, R; Ming, JE; Ren, HB; Kao, R; Simpson, E; Ardeleanu, M; Weinstein, SP; Pirozzi, G; Guttman-Yassky, E; Suarez-Farinas, M; Hager, MD; Stahl, N; Yancopoulos, GD; Radin, AR				Beck, Lisa A.; Thaci, Diamant; Hamilton, Jennifer D.; Graham, Neil M.; Bieber, Thomas; Rocklin, Ross; Ming, Jeffrey E.; Ren, Haobo; Kao, Richard; Simpson, Eric; Ardeleanu, Marius; Weinstein, Steven P.; Pirozzi, Gianluca; Guttman-Yassky, Emma; Suarez-Farinas, Mayte; Hager, Melissa D.; Stahl, Neil; Yancopoulos, George D.; Radin, Allen R.			Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUIDELINES; EPIDEMIOLOGY; RELIABILITY; ACTIVATION; PRURITUS; SCORAD; SCALE; EASI	BACKGROUND Dupilumab, a fully human monoclonal antibody that blocks interleukin-4 and interleukin-13, has shown efficacy in patients with asthma and elevated eosinophil levels. The blockade by dupilumab of these key drivers of type 2 helper T-cell (Th2)-mediated inflammation could help in the treatment of related diseases, including atopic dermatitis. METHODS We performed randomized, double-blind, placebo-controlled trials involving adults who had moderate-to-severe atopic dermatitis despite treatment with topical glucocorticoids and calcineurin inhibitors. Dupilumab was evaluated as monotherapy in two 4-week trials and in one 12-week trial and in combination with topical glucocorticoids in another 4-week study. End points included the Eczema Area and Severity Index (EASI) score, the investigator's global assessment score, pruritus, safety assessments, serum biomarker levels, and disease transcriptome. RESULTS In the 4-week monotherapy studies, dupilumab resulted in rapid and dose-dependent improvements in clinical indexes, biomarker levels, and the transcriptome. The results of the 12-week study of dupilumab monotherapy reproduced and extended the 4-week findings: 85% of patients in the dupilumab group, as compared with 35% of those in the placebo group, had a 50% reduction in the EASI score (EASI-50, with higher scores in the EASI indicating greater severity of eczema) (P<0.001); 40% of patients in the dupilumab group, as compared with 7% in the placebo group, had a score of 0 to 1 (indicating clearing or near-clearing of skin lesions) on the investigator's global assessment (P<0.001); and pruritus scores decreased (indicating a reduction in itch) by 55.7% in the dupilumab group versus 15.1% in the placebo group (P<0.001). In the combination study, 100% of the patients in the dupilumab group, as compared with 50% of those who received topical glucocorticoids with placebo injection, met the criterion for EASI-50 (P = 0.002), despite the fact that patients who received dupilumab plus glucocorticoids used less than half the amount of topical glucocorticoids used by those who received placebo plus the topical medication (P = 0.16). Adverse events, such as skin infection, occurred more frequently with placebo; nasopharyngitis and headache were the most frequent adverse events with dupilumab. CONCLUSIONS Patients treated with dupilumab had marked and rapid improvement in all the evaluated measures of atopic dermatitis disease activity. Side-effect profiles were not doselimiting.	[Beck, Lisa A.] Univ Rochester, Med Ctr, Dept Dermatol, Rochester, NY 14642 USA; [Hamilton, Jennifer D.; Graham, Neil M.; Ren, Haobo; Kao, Richard; Ardeleanu, Marius; Weinstein, Steven P.; Hager, Melissa D.; Stahl, Neil; Yancopoulos, George D.; Radin, Allen R.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Guttman-Yassky, Emma] Rockefeller Univ, Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10021 USA; [Guttman-Yassky, Emma] Rockefeller Univ, Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10021 USA; [Guttman-Yassky, Emma; Suarez-Farinas, Mayte] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Thaci, Diamant] Med Univ Lubeck, Dept Dermatol Allergol & Venereol, D-23538 Lubeck, Germany; [Bieber, Thomas] Univ Bonn, Dept Dermatol & Allergol, Bonn, Germany; [Rocklin, Ross; Ming, Jeffrey E.; Pirozzi, Gianluca] Sanofi, Bridgewater, MA USA; [Simpson, Eric] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	University of Rochester; Regeneron; Icahn School of Medicine at Mount Sinai; Rockefeller University; Icahn School of Medicine at Mount Sinai; Rockefeller University; Rockefeller University; Rockefeller University; University of Lubeck; University of Bonn; Sanofi-Aventis; Oregon Health & Science University	Beck, LA (corresponding author), Univ Rochester, Med Ctr, Dept Dermatol, 601 Elmwood Ave,Box 697, Rochester, NY 14642 USA.		Thaci, Diamant/AAE-7310-2022; Suarez-Farinas, Mayte/I-3558-2012; Thaci, Prof. Dr Diamant/K-5455-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553; Thaci, Diamant/0000-0001-8513-550X	Regeneron Pharmaceuticals; Sanofi	Regeneron Pharmaceuticals(Regeneron); Sanofi	Supported by Regeneron Pharmaceuticals and Sanofi.	DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569; De Benedetto A, 2012, J INVEST DERMATOL, V132, P949, DOI 10.1038/jid.2011.435; Eichenfield LF, 2004, ALLERGY, V59, P86, DOI 10.1111/j.1398-9995.2004.00569.x; Elman S, 2010, BRIT J DERMATOL, V162, P587, DOI 10.1111/j.1365-2133.2009.09586.x; Frankel HC, 2012, AM J CLIN DERMATOL, V13, P113, DOI 10.2165/11597780-000000000-00000; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Hamilton JD, 2013, J INVEST DERMATOL, V133, pS178; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Lubbe J, 2006, AM J CLIN DERMATOL, V7, P121; Phan NQ, 2012, ACTA DERM-VENEREOL, V92, P502, DOI 10.2340/00015555-1246; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x; Schmid P, 2001, ALLERGY, V56, P841, DOI 10.1034/j.1398-9995.2001.00144.x; Schram ME, 2012, ALLERGY, V67, P99, DOI 10.1111/j.1398-9995.2011.02719.x; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048	19	837	881	2	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					130	139		10.1056/NEJMoa1314768	http://dx.doi.org/10.1056/NEJMoa1314768			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006719	Bronze			2022-12-28	WOS:000338645500009
J	Iranmanesh, P; Frossard, JL; Mugnier-Konrad, B; Morel, P; Majno, P; Thai, NT; Berney, T; Mentha, G; Toso, C				Iranmanesh, Pouya; Frossard, Jean-Louis; Mugnier-Konrad, Beatrice; Morel, Philippe; Majno, Pietro; Thai Nguyen-Tang; Berney, Thierry; Mentha, Gilles; Toso, Christian			Initial Cholecystectomy vs Sequential Common Duct Endoscopic Assessment and Subsequent Cholecystectomy for Suspected Gallstone Migration A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RETROGRADE CHOLANGIOPANCREATOGRAPHY; LAPAROSCOPIC CHOLECYSTECTOMY; STONES; CHOLEDOCHOLITHIASIS; MANAGEMENT; METAANALYSIS; GALLBLADDER; ERCP; CHOLANGIOGRAPHY; SPHINCTEROTOMY	IMPORTANCE The optimal management of treatment for patients at intermediate risk of a common duct stone (including increased liver function tests but bilirubin <4mg/dL and no cholangitis) is a matter of debate. Many stones migrate spontaneously into the duodenum, making preoperative common duct investigations unnecessary. OBJECTIVE To compare strategies of cholecystectomy first vs a sequential endoscopic common duct assessment and cholecystectomy for the management of patients with an intermediate risk of a common duct stone. The main objective was to reduce the length of stay and the secondary objectives were to reduce the number of common duct investigations, morbidity, and costs. DESIGN, SETTING, AND PARTICIPANTS Interventional, randomized clinical trial with 2 parallel groups performed between June 2011 and February 2013, with a patient follow-up of 6 months. The trial comprised a random sample of 100 adult patients admitted to Geneva University Hospital, Geneva, Switzerland, for acute gallstone-related conditions with an intermediate risk of a common duct stone. Fifty patients were randomized to each group. INTERVENTIONS Cholecystectomy first with intraoperative cholangiogram for the study group and endoscopic common duct assessment and clearance followed by cholecystectomy for the control group. MAIN OUTCOMES AND MEASURES Length of initial hospital stay (primary end point), number of common duct investigations and morbidity and mortality within 6 months after initial admission, and quality of life at 1 and 6 months after discharge (EQ-5D-5L [EuroQol Group, 5-level] questionnaire). RESULTS Patients who underwent cholecystectomy as a first step had a significantly shorter length of hospital stay (median, 5 days [interquartile range {IQR}, 1-8] vs median, 8 days [IQR, 6-12]; P < .001), with fewer common duct investigations (25 vs 71; P < .001), no significant difference in morbidity or quality of life. CONCLUSIONS AND RELEVANCE Among patients at intermediate risk of a common duct stone, initial cholecystectomy compared with sequential common duct endoscopy assessment and subsequent surgery resulted in a shorter length of stay without increased morbidity. If these findings are confirmed, initial cholecystectomy with intraoperative cholangiogram may be a preferred approach.	[Iranmanesh, Pouya; Mugnier-Konrad, Beatrice; Morel, Philippe; Majno, Pietro; Berney, Thierry; Mentha, Gilles; Toso, Christian] Univ Hosp Geneva, Dept Surg, Div Digest Surg, CH-1205 Geneva, Switzerland; [Iranmanesh, Pouya; Frossard, Jean-Louis; Mugnier-Konrad, Beatrice; Morel, Philippe; Majno, Pietro; Thai Nguyen-Tang; Berney, Thierry; Mentha, Gilles; Toso, Christian] Fac Med, CH-1205 Geneva, Switzerland; [Iranmanesh, Pouya; Mugnier-Konrad, Beatrice; Morel, Philippe; Majno, Pietro; Berney, Thierry; Mentha, Gilles; Toso, Christian] Univ Hosp Geneva, Dept Surg, Div Transplant Surg, CH-1205 Geneva, Switzerland; [Iranmanesh, Pouya; Frossard, Jean-Louis; Morel, Philippe; Majno, Pietro; Thai Nguyen-Tang; Berney, Thierry; Mentha, Gilles; Toso, Christian] Univ Hosp Geneva, Hepatopancreatobiliary Ctr, CH-1205 Geneva, Switzerland; [Frossard, Jean-Louis; Thai Nguyen-Tang] Univ Hosp Geneva, Div Gastroenterol & Hepatol, Dept Med Specialties, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Iranmanesh, P (corresponding author), Univ Hosp Geneva, Dept Surg, Div Digest Surg, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	pouya.iranmanesh@hcuge.ch; christian.toso@hcuge.ch	Berney, Thierry/ABE-9450-2021; Iranmanesh, Pouya/I-6315-2019	Berney, Thierry/0000-0002-4230-9378; Iranmanesh, Pouya/0000-0002-6963-1164	Swiss National Science Foundation [PP00P3139021]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Toso reports receipt of salary support from the Swiss National Science Foundation (PP00P3139021). This grant was not given specifically for the present study and was not used for its conduct. The other authors report no disclosures.	Abboud PAC, 1996, GASTROINTEST ENDOSC, V44, P450, DOI 10.1016/S0016-5107(96)70098-6; Alexakis N, 2012, HPB, V14, P254, DOI 10.1111/j.1477-2574.2012.00439.x; Bingener J, 2006, SURG ENDOSC, V20, P577, DOI 10.1007/s00464-005-0322-3; Boraschi P, 1999, MAGN RESON IMAGING, V17, P1245, DOI 10.1016/S0730-725X(99)00075-2; Chang L, 2000, ANN SURG, V231, P82, DOI 10.1097/00000658-200001000-00012; Clayton ESJ, 2006, BRIT J SURG, V93, P1185, DOI 10.1002/bjs.5568; Costi R, 2010, SURG ENDOSC, V24, P51, DOI 10.1007/s00464-009-0511-6; Cuschieri A, 1999, SURG ENDOSC-ULTRAS, V13, P952, DOI 10.1007/s004649901145; Dasari BVM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003327.pub3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; ElGeidie AA, 2011, SURG ENDOSC, V25, P1230, DOI 10.1007/s00464-010-1348-8; EuroQol Group, EQ 5D 5L LANG VERS; Freeman ML, 2005, GASTROINTEST ENDOSC, V61, P112, DOI 10.1016/S0016-5107(04)02463-0; Frossard JL, 2010, GASTROINTEST ENDOSC, V72, P808, DOI 10.1016/j.gie.2010.06.033; Frossard JL, 2000, GASTROINTEST ENDOSC, V51, P175, DOI 10.1016/S0016-5107(00)70414-7; Gurusamy K, 2011, BRIT J SURG, V98, P908, DOI 10.1002/bjs.7460; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Koc B, 2013, AM J SURG, V206, P457, DOI 10.1016/j.amjsurg.2013.02.004; Maple JT, 2010, GASTROINTEST ENDOSC, V71, P1, DOI 10.1016/j.gie.2009.09.041; Nathanson LK, 2005, ANN SURG, V242, P188, DOI 10.1097/01.sla.0000171035.57236.d7; Pierce RA, 2008, SURG ENDOSC, V22, P2365, DOI 10.1007/s00464-008-9785-3; Poh B, 2014, HPB, V16, P629, DOI 10.1111/hpb.12187; Rogers SJ, 2010, ARCH SURG-CHICAGO, V145, P28, DOI 10.1001/archsurg.2009.226; Shelton J, 2012, J SURG RES, V173, P193, DOI 10.1016/j.jss.2011.05.031; Stromberg C, 2011, BRIT J SURG, V98, P1766, DOI 10.1002/bjs.7690; Tantau M, 2013, J GASTROINTEST LIVER, V22, P141; Verma D, 2006, GASTROINTEST ENDOSC, V64, P248, DOI 10.1016/j.gie.2005.12.038; Wang B, 2013, SURG ENDOSC, V27, P2454, DOI 10.1007/s00464-012-2757-7; Yang MH, 2008, SURG ENDOSC, V22, P1620, DOI 10.1007/s00464-007-9665-2; Zidi SH, 1999, GUT, V44, P118, DOI 10.1136/gut.44.1.118	30	35	37	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					137	144		10.1001/jama.2014.7587	http://dx.doi.org/10.1001/jama.2014.7587			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005650				2022-12-28	WOS:000338511200019
J	Cooper, MA; Hutfless, S; Segev, DL; Ibrahim, A; Lyu, H; Makary, MA				Cooper, Michol A.; Hutfless, Susan; Segev, Dorry L.; Ibrahim, Andrew; Lyu, Heather; Makary, Martin A.			Hospital level under-utilization of minimally invasive surgery in the United States: retrospective review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LAPAROSCOPIC COLORECTAL SURGERY; OPEN APPENDECTOMY; COMPLICATIONS; RATES; URBAN	Objective To determine casemix adjusted hospital level utilization of minimally invasive surgery for four common surgical procedures (appendectomy, colectomy, total abdominal hysterectomy, and lung lobectomy) in the United States. Design Retrospective review. Setting United States. Participants Nationwide inpatient sample database, United States 2010. Methods For each procedure, a propensity score model was used to calculate the predicted proportion of minimally invasive operations for each hospital based on patient characteristics. For each procedure, hospitals were categorized into thirds (low, medium, and high) based on their actual to predicted proportion of utilization of minimally invasive surgery. Main outcome measures The primary outcome measures were the actual and predicted proportion of procedures performed with minimally invasive surgery. Secondary outcome measures included surgical complications and hospital characteristics. Results Mean hospital utilization of minimally invasive surgery was 71.0% (423/596) for appendectomy (range 40.9-93.1% (244-555)), 28.4% (154/541) for colectomy (6.7-49.8% (36/541-269/541)), 13.0% (65/499) for hysterectomy (0.0-33.6% (0/499-168/499)), and 32.0% (67/208) for lung lobectomy (3.6-65.7% (7.5/208-137/208)). Utilization of minimally invasive surgery was highly variable for each procedure type. There was noticeable discordance between actual and predicted utilization of the surgery (range of actual to predicted ratio for appendectomy 0-1.49; colectomy 0-3.88; hysterectomy 0-6.68; lung lobectomy 0-2.51). Surgical complications were less common with minimally invasive surgery compared with open surgery, respectively: overall rate for appendectomy 3.94% (1439/36 513) v 7.90% (958/12 123), P<0.001; for colectomy: 13.8% (1689/12 242) v 35.8% (8837/24 687), P<0.001; for hysterectomy: 4.69% (270/5757) v 6.64% (1988/29 940), P<0.001; and for lung lobectomy: 17.1% (367/2145) v 25.4% (971/3824), P<0.05. High utilization of minimally invasive surgery was associated with urban location (appendectomy: odds ratio 4.66, 95% confidence interval 1.17 to 18.5; colectomy: 4.59, 1.04 to 20.3; hysterectomy: 15.0, 2.98 to 75.0), large hospital size (hysterectomy: 8.70, 1.62 to 46.8), teaching hospital (hysterectomy: 5.41, 1.27 to 23.1), Midwest region (appendectomy: 7.85, 1.26 to 49.1), south region (appendectomy: 21.0, 3.79 to 117; colectomy: 10.0, 1.83 to 54.7), and west region (appendectomy: 9.33, 1.48 to 58.8). Conclusion Hospital utilization of minimally invasive surgery for appendectomy, colectomy, total abdominal hysterectomy, and lung lobectomy varies widely in the United States, representing a disparity in the surgical care delivered nationwide.	[Cooper, Michol A.; Segev, Dorry L.; Ibrahim, Andrew; Lyu, Heather; Makary, Martin A.] Johns Hopkins Univ Hosp, Dept Surg, Sch Med, Baltimore, MD 21287 USA; [Hutfless, Susan; Makary, Martin A.] Johns Hopkins Univ, Dept Hlth Policy, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hutfless, Susan; Makary, Martin A.] Johns Hopkins Univ, Dept Management, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hutfless, Susan; Makary, Martin A.] Johns Hopkins Univ, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Makary, MA (corresponding author), Johns Hopkins Univ Hosp, Dept Surg, Halsted 610,600 N Wolfe St, Baltimore, MD 21287 USA.	mmakary1@jhmi.edu		Hutfless, Susan/0000-0002-6311-2611	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001079] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Aimaq R, 2011, AM SURGEON, V77, P1290; Anania G, 2012, G CHIR, V33, P352; [Anonymous], 2010, OV NAT INP SAMPL NIS; [Anonymous], 2013, OVERVIEW AGENCY HEAL; Cheng D, 2007, INNOVATIONS, V2, P261, DOI 10.1097/IMI.0b013e3181662c6a; De Vivo A, 2010, ACTA OBSTET GYN SCAN, V89, P355, DOI 10.3109/00016340903568175; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Galaal K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006655.pub2; Hardiman K, 2013, SURG ENDOSC; Heneghan SJ, 2005, J AM COLL SURGEONS, V201, P732, DOI 10.1016/j.jamcollsurg.2005.06.262; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Kiran RP, 2010, J AM COLL SURGEONS, V211, P232, DOI 10.1016/j.jamcollsurg.2010.03.028; Kondo W, 2012, J LAPAROENDOSC ADV S, V22, P949, DOI 10.1089/lap.2012.0213; Mangano DT, 2004, J CARDIOTHOR VASC AN, V18, P1, DOI 10.1053/j.jvca.2003.10.002; Martin RCG, 2005, AM J SURG, V190, P244, DOI 10.1016/j.amjsurg.2005.05.020; Moloo H, 2009, CAN J SURG, V52, P455; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Nieboer TE, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003677.pub4, 10.1002/14651858.CD003677.pub5]; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Park JY, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.081; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; Schwenk W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003145.pub2; Southgate E, 2012, ARCH SURG-CHICAGO, V147, P557, DOI 10.1001/archsurg.2012.568; Stovall Dale W, 2006, JSLS, V10, P11; Thompson MJ, 2005, ARCH SURG-CHICAGO, V140, P74, DOI 10.1001/archsurg.140.1.74; VanBibber M, 2006, J AM COLL SURGEONS, V203, P812, DOI 10.1016/j.jamcollsurg.2006.07.019; Whelan T, 2004, JAMA-J AM MED ASSOC, V292, P435, DOI 10.1001/jama.292.4.435; Wick EC, 2011, DIS COLON RECTUM, V54, P1475, DOI 10.1097/DCR.0b013e31822ff8f0; Woodham BL, 2012, SURG ENDOSC, V26, P2566, DOI 10.1007/s00464-012-2233-4	32	48	48	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4198	10.1136/bmj.g4198	http://dx.doi.org/10.1136/bmj.g4198			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005264	Green Published, hybrid			2022-12-28	WOS:000338993300001
J	Clayton, GM; Wang, Y; Crawford, F; Novikov, A; Wimberly, BT; Kieft, JS; Falta, MT; Bowerman, NA; Marrack, P; Fontenot, AP; Dai, SD; Kappler, JW				Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Wimberly, Brian T.; Kieft, Jeffrey S.; Falta, Michael T.; Bowerman, Natalie A.; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.			Structural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and Autoimmunity	CELL			English	Article							CD4(+) T-CELLS; MHC-CLASS-II; RECEPTOR TCR INTERACTION; RHEUMATOID-ARTHRITIS; LUNG-DISEASE; PEPTIDES; BINDING; RECOGNITION; PROTEINS; HLA-DP2	T-cell-mediated hypersensitivity to metal cations is common in humans. How the T cell antigen receptor (TCR) recognizes these cations bound to a major histocompatibility complex (MHC) protein and self-peptide is unknown. Individuals carrying the MHCII allele, HLA-DP2, are at risk for chronic beryllium disease (CBD), a debilitating inflammatory lung condition caused by the reaction of CD4 T cells to inhaled beryllium. Here, we show that the T cell ligand is created when a Be2+ cation becomes buried in an HLA-DP2/peptide complex, where it is coordinated by both MHC and peptide acidic amino acids. Surprisingly, the TCR does not interact with the Be2+ itself, but rather with surface changes induced by the firmly bound Be2+ and an accompanying Na+ cation. Thus, CBD, by creating a new antigen by indirectly modifying the structure of preexisting self MHC-peptide complex, lies on the border between allergic hypersensitivity and autoimmunity.	[Clayton, Gina M.; Crawford, Frances; Marrack, Philippa; Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO 80206 USA; [Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.] Univ Colorado, Denver Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.; Marrack, Philippa] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Falta, Michael T.; Bowerman, Natalie A.; Fontenot, Andrew P.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.; Kappler, John W.] Univ Colorado, Denver Sch Med, Program Struct Biol & Biochem, Aurora, CO 80045 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Dai, SD (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.	dais@njhealth.org; kapplerj@njhealth.org	Marrack, Philippa/AHE-6316-2022; Wang, Yang/D-5344-2016	Wang, Yang/0000-0002-6510-6653; Falta, Michael/0000-0002-0835-6904; Marrack, Philippa/0000-0003-1883-3687	NIH [AI17785, HL62410, HL92997, ES011810, AI17134]; CCTSI [KL2TR000156, KL1TR000155]; Boettcher Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000156, KL2TR001080, TL1TR000155, UL1TR001082, TL1TR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL102245, R01HL062410, R01HL092997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R56AI017134, R37AI017134, R01AI018785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCTSI; Boettcher Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Igor Kurinov for data collection assistance at APS Argonne National Laboratory, Beamline 24 ID-C and Corie Ralston at ALS Lawrence Berkley National Laboratory, Beamline 822. Oliver Smart (Global Phasing) assisted us with beryllium definitions in AUTOBuster, and Mario Santiago made the BIORAD CFX96 RCT-PCR instrument available to us. We also thank Randy Anselment at the Molecular Resource Center, National Jewish Health, for oligonucleotide synthesis and DNA sequencing. This work was supported in part by NIH grant AI17785 (P. C. M.), by NIH grants HL62410, HL92997, and ES011810 (to A. P. F.), by CCTSI KL2TR000156 and KL1TR000155 and the Boettcher Foundation (to S. D.), and NIH grant AI17134 (to J. W. K).	Alerghi L., 1999, POLYHEDRON, V18, P3305; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bill JR, 2005, J IMMUNOL, V175, P7029, DOI 10.4049/jimmunol.175.10.7029; Bowerman NA, 2011, J IMMUNOL, V187, P3694, DOI 10.4049/jimmunol.1101872; Cordova KN, 2013, J IMMUNOL, V190, P1457, DOI 10.4049/jimmunol.1201517; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dai SD, 2013, CURR OPIN IMMUNOL, V25, P775, DOI 10.1016/j.coi.2013.07.012; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Diaz G, 2005, IMMUNOGENETICS, V56, P754, DOI 10.1007/s00251-004-0735-5; Diyabalanage HVK, 2008, ANGEW CHEM INT EDIT, V47, P7332, DOI 10.1002/anie.200801965; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Evans PR, 2007, ACTA CRYSTALLOGR D, V63, P58, DOI 10.1107/S090744490604604X; Everest D.A., 1964, TOPICS INORGANIC GEN, V1; Falta MT, 2013, J EXP MED, V210, P1403, DOI 10.1084/jem.20122426; Fontenot AP, 2006, J IMMUNOL, V177, P3874, DOI 10.4049/jimmunol.177.6.3874; Fontenot AP, 2008, SEMIN RESP CRIT CARE, V29, P662, DOI 10.1055/s-0028-1101276; Fontenot AP, 1999, J IMMUNOL, V163, P1019; Fontenot JD, 2004, SEMIN IMMUNOL, V16, P73, DOI 10.1016/j.smim.2003.12.002; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Illing PT, 2013, CURR OPIN IMMUNOL, V25, P81, DOI 10.1016/j.coi.2012.10.002; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; KALISH RS, 1990, J INVEST DERMATOL, V94, pS108, DOI 10.1111/1523-1747.ep12876061; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Keizer TS, 2005, J INORG BIOCHEM, V99, P1174, DOI 10.1016/j.jinorgbio.2005.02.017; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Louis-Dit-Sully Christine, 2014, Exp Suppl, V104, P25, DOI 10.1007/978-3-0348-0726-5_3; Maier LA, 2003, J IMMUNOL, V171, P6910, DOI 10.4049/jimmunol.171.12.6910; Marrack P, 2008, CURR OPIN IMMUNOL, V20, P203, DOI 10.1016/j.coi.2008.03.008; MARTIN S, 1994, INT ARCH ALLERGY IMM, V104, P10, DOI 10.1159/000236703; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; SALTINI C, 1989, NEW ENGL J MED, V320, P1103, DOI 10.1056/NEJM198904273201702; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Sutton M, 2003, CHEM RES TOXICOL, V16, P1145, DOI 10.1021/tx0256477; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; White J, 2000, METH MOL B, V134, P185; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Yin L, 2012, P NATL ACAD SCI USA, V109, P18517, DOI 10.1073/pnas.1215928109	47	72	75	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					132	142		10.1016/j.cell.2014.04.048	http://dx.doi.org/10.1016/j.cell.2014.04.048			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995984	Bronze, Green Accepted			2022-12-28	WOS:000340943100013
J	Koroshetz, WJ				Koroshetz, Walter J.			PERSPECTIVE Time to tackle blood pressure	NATURE			English	Editorial Material							PREVALENCE; DEMENTIA		US Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Koroshetz, WJ (corresponding author), US Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.	koroshetzw@ninds.nih.gov						Cholerton B, 2013, J ALZHEIMERS DIS, V36, P699, DOI 10.3233/JAD-130281; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P157; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lv JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001293; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Wang J, 2014, AM J HYPERTENS	10	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S4	S4		10.1038/510S4a	http://dx.doi.org/10.1038/510S4a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964024	Bronze			2022-12-28	WOS:000337806300003
J	Rutishauser, U				Rutishauser, Urs			Gerald Edelman (1929-2014) OBITUARY	NATURE			English	Biographical-Item									[Rutishauser, Urs] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10021 USA; [Rutishauser, Urs] Rockefeller Univ, Gerald Edelmans Lab, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Rutishauser, U (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	u-rutishauser@mskcc.org							0	0	0	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					474	474		10.1038/510474a	http://dx.doi.org/10.1038/510474a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965643	Bronze			2022-12-28	WOS:000337806300029
J	Stevens, A; Shamseer, L; Weinstein, E; Yazdi, F; Turner, L; Thielman, J; Altman, DG; Hirst, A; Hoey, J; Palepu, A; Schulz, KF; Moher, D				Stevens, Adrienne; Shamseer, Larissa; Weinstein, Erica; Yazdi, Fatemeh; Turner, Lucy; Thielman, Justin; Altman, Douglas G.; Hirst, Allison; Hoey, John; Palepu, Anita; Schulz, Kenneth F.; Moher, David			Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIALS; EUROPEAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; DIAGNOSTIC-ACCURACY; CONSORT STATEMENT; RECOMMENDED GUIDELINES; CLINICAL-TRIALS; TASK-FORCE; CONSENSUS STATEMENT; MINIMUM INFORMATION	Objective To assess whether the completeness of reporting of health research is related to journals' endorsement of reporting guidelines. Design Systematic review. Data sources Reporting guidelines from a published systematic review and the EQUATOR Network (October 2011). Studies assessing the completeness of reporting by using an included reporting guideline (termed "evaluations") (1990 to October 2011; addendum searches in January 2012) from searches of either Medline, Embase, and the Cochrane Methodology Register or Scopus, depending on reporting guideline name. Study selection English language reporting guidelines that provided explicit guidance for reporting, described the guidance development process, and indicated use of a consensus development process were included. The CONSORT statement was excluded, as evaluations of adherence to CONSORT had previously been reviewed. English or French language evaluations of included reporting guidelines were eligible if they assessed the completeness of reporting of studies as a primary intent and those included studies enabled the comparisons of interest (that is, after versus before journal endorsement and/or endorsing versus non-endorsing journals). Data extraction Potentially eligible evaluations of included guidelines were screened initially by title and abstract and then as full text reports. If eligibility was unclear, authors of evaluations were contacted; journals' websites were consulted for endorsement information where needed. The completeness of reporting of reporting guidelines was analyzed in relation to endorsement by item and, where consistent with the authors' analysis, a mean summed score. Results 101 reporting guidelines were included. Of 15 249 records retrieved from the search for evaluations, 26 evaluations that assessed completeness of reporting in relation to endorsement for nine reporting guidelines were identified. Of those, 13 evaluations assessing seven reporting guidelines (BMJ economic checklist, CONSORT for harms, PRISMA, QUOROM, STARD, STRICTA, and STROBE) could be analyzed. Reporting guideline items were assessed by few evaluations. Conclusions The completeness of reporting of only nine of 101 health research reporting guidelines (excluding CONSORT) has been evaluated in relation to journals' endorsement. Items from seven reporting guidelines were quantitatively analyzed, by few evaluations each. Insufficient evidence exists to determine the relation between journals' endorsement of reporting guidelines and the completeness of reporting of published health research reports. Journal editors and researchers should consider collaborative prospectively designed, controlled studies to provide more robust evidence. Systematic review registration Not registered; no known register currently accepts protocols for methodology systematic reviews.	[Stevens, Adrienne; Shamseer, Larissa; Yazdi, Fatemeh; Turner, Lucy; Thielman, Justin; Moher, David] Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada; [Shamseer, Larissa; Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Weinstein, Erica] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX3 7LD, England; [Hirst, Allison] Univ Oxford, Nuffield Dept Surg Sci, Oxford OX3 9DU, England; [Hoey, John] Queens Univ, Populat & Publ Hlth Initiat, Kingston, ON K7L 3N6, Canada; [Palepu, Anita] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y9, Canada; [Palepu, Anita] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Schulz, Kenneth F.] Int Clin Sci Support Ctr, FHI 360, Durham, NC 27713 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Yeshiva University; Albert Einstein College of Medicine; University of Oxford; University of Oxford; Queens University - Canada; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; FHI 360	Moher, D (corresponding author), Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada.	dmoher@ohri.ca	Shamseer, Larissa/E-9645-2017; Weinstein, Erica/AAL-8384-2020; Moher, David/I-3408-2019	Shamseer, Larissa/0000-0003-3690-3378; Moher, David/0000-0003-2434-4206; Weinstein, Erica/0000-0003-3545-8962; Hirst, Allison/0000-0002-5864-4840	Canadian Institutes of Health Research [KSD-111750]; Cancer Research UK; University of Ottawa research chair; National Health Service National Library of Health; National Health Service National Institute for Health Research; National Health Service National Knowledge service; United Kingdom Medical Research Council; Scottish Chief Scientist Office; Pan American Health Organization;  [FHI360]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J00488X/1] Funding Source: researchfish; MRC [MR/J00488X/1] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); University of Ottawa research chair; National Health Service National Library of Health; National Health Service National Institute for Health Research; National Health Service National Knowledge service; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Chief Scientist Office; Pan American Health Organization; ; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Canadian Institutes of Health Research (funding research number KSD-111750). The Canadian Institutes of Health Research had no role in the design, data collection, analysis, or interpretation of the data; in the writing of the report; or in the decision to submit this work for publication. DGA is supported by Cancer Research UK, DM by a University of Ottawa research chair, and KFS by FHI360. All researchers are independent from their relevant funding agencies. DGA, DM, and KFS are executive members of the EQUATOR network; AH served as an EQUATOR staff member during this project. The EQUATOR Network is funded by the National Health Service National Library of Health, National Health Service National Institute for Health Research, National Health Service National Knowledge service, United Kingdom Medical Research Council, Scottish Chief Scientist Office, and Pan American Health Organization.	Aletaha D, 2008, ARTHRIT RHEUM-ARTHR, V59, P1371, DOI 10.1002/art.24123; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; [Anonymous], 2006, Technol Eval Cent Assess Program Exec Summ, V21, P1; [Anonymous], 2013, COMPR MET COMP PROGR; [Anonymous], 2012, REV MAN COMP PROGR V; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Bastuji-Garin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064733; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Berger ML, 2009, VALUE HEALTH, V12, P1044, DOI 10.1111/j.1524-4733.2009.00600.x; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bousquet PJ, 2009, ALLERGY, V64, P1737, DOI 10.1111/j.1398-9995.2009.02232.x; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brown P, 2006, BRIT MED J, V333, P804, DOI 10.1136/bmj.38987.492014.94; Bruns DE, 2000, CLIN CHEM, V46, P893; Campbell Marion K, 2004, BMC Med Res Methodol, V4, P9, DOI 10.1186/1471-2288-4-9; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Canadian Institutes of Health Research, 2014, KNOWL TRANSL; Castren M, 2008, RESUSCITATION, V79, P193, DOI 10.1016/j.resuscitation.2008.07.007; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan S, 2007, J BONE JOINT SURG AM, V89A, P1970, DOI 10.2106/JBJS.F.01591; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839; Coppus SFPJ, 2006, FERTIL STERIL, V86, P1321, DOI 10.1016/j.fertnstert.2006.03.050; Cornelius VR, 2013, PAIN, V154, P213, DOI 10.1016/j.pain.2012.08.012; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Cummins RO, 1997, ACAD EMERG MED, V4, P603; Davidoff F, 2008, J GEN INTERN MED, V23, P2125, DOI 10.1007/s11606-008-0797-4; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Dean ME, 2007, HOMEOPATHY, V96, P42, DOI 10.1016/j.homp.2006.11.006; Delaney M, 2010, TRANSFUSION, V50, P2135, DOI 10.1111/j.1537-2995.2010.02691.x; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Deutsch EW, 2008, NAT BIOTECHNOL, V26, P305, DOI 10.1038/nbt1391; DeVivo MJ, 2011, SPINAL CORD, V49, P596, DOI 10.1038/sc.2010.172; Diehm N, 2007, EUR HEART J, V28, P798, DOI 10.1093/eurheartj/ehl545; Dixon WG, 2010, ANN RHEUM DIS, V69, P1596, DOI 10.1136/ard.2009.125526; Donahue SP, 2003, J AAPOS, V7, P314, DOI 10.1016/S1091-8531(03)00182-4; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Ernst E, 2011, PERFUSION, V24, P89; Fackler ML, 1996, ANN INTERN MED, V124, P741, DOI 10.7326/0003-4819-124-8-199604150-00007; Faggion CM, 2013, J CLIN PERIODONTOL, V40, P889, DOI 10.1111/jcpe.12140; Fleming PS, 2013, EUR J ORTHODONT, V35, P244, DOI 10.1093/ejo/cjs016; Fleming PS, 2013, ANGLE ORTHOD, V83, P158, DOI 10.2319/032612-251.1; Freeman K, 2009, EUR J OBSTET GYN R B, V142, P91, DOI 10.1016/j.ejogrb.2008.10.010; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Gallo V, 2012, EUR J CLIN INVEST, V42, P1, DOI 10.1111/j.1365-2362.2011.02561.x; Gardner IA, 2011, PREV VET MED, V101, P18, DOI 10.1016/j.prevetmed.2011.04.002; Ghimire S, 2014, J CLIN EPIDEMIOL, V67, P658, DOI 10.1016/j.jclinepi.2013.10.012; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; GNEKOW AK, 1995, MED PEDIATR ONCOL, V24, P104, DOI 10.1002/mpo.2950240209; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; Haidich AB, 2011, J CLIN EPIDEMIOL, V64, P124, DOI 10.1016/j.jclinepi.2010.03.005; Hammerschlag R, 2011, EVID BASED COMPLEMEN, V2011; Harris RK, 2008, SOLID STATE NUCL MAG, V33, P41, DOI 10.1016/j.ssnmr.2008.02.004; Helmhout PH, 2008, SPINE, V33, P1782, DOI 10.1097/BRS.0b013e31817b8fd6; Herman PM, 2005, BMC COMPLEMENT ALTER, V5; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Hind D, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-49; Hirst A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035621; Hodkinson A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003436; Hollander JE, 2004, ANN EMERG MED, V44, P589, DOI 10.1016/j.annemergmed.2004.08.009; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Horstkotte D, 2005, J HEART VALVE DIS, V14, P1; Howley L, 2008, MED EDUC, V42, P350, DOI 10.1111/j.1365-2923.2007.02999.x; Idris AH, 1996, CIRCULATION, V94, P2324, DOI 10.1161/01.CIR.94.9.2324; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Jefferson T, 1998, JAMA-J AM MED ASSOC, V280, P275, DOI 10.1001/jama.280.3.275; Johnson ZK, 2007, OPHTHALMOLOGY, V114, P1607, DOI 10.1016/j.ophtha.2006.11.036; Kelly WN, 2007, PHARMACOEPIDEM DR S, V16, P581, DOI 10.1002/pds.1399; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim KH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004136; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Krzych LJ, 2009, MED SCI MONITOR, V15, pSR5; Krzyzanowska MK, 2004, J CLIN ONCOL, V22, P1993, DOI 10.1200/JCO.2004.07.199; Landis RC, 2010, HEART SURG FORUM, V13, pE116, DOI 10.1532/HSF98.20101022; Langhelle A, 2005, RESUSCITATION, V66, P271, DOI 10.1016/j.resuscitation.2005.06.005; Lee PE, 2008, J CLIN EPIDEMIOL, V61, P1152, DOI 10.1016/j.jclinepi.2007.09.012; Lindon JC, 2005, NAT BIOTECHNOL, V23, P833, DOI 10.1038/nbt0705-833; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x; MacPherson Hugh, 2010, J Evid Based Med, V3, P140, DOI 10.1111/j.1756-5391.2010.01086.x; MacPherson Hugh, 2002, Acupunct Med, V20, P22; Mahoney J, 2007, CLIN CHEM, V53, P1122, DOI 10.1373/clinchem.2006.083493; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MASON EE, 1994, OBES SURG, V4, P56; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Meerpohl JJ, 2010, ARCH PEDIAT ADOL MED, V164, P268, DOI 10.1001/archpediatrics.2009.287; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moore HM, 2011, BIOPRESERV BIOBANK, V9, P57, DOI 10.1089/bio.2010.0036; Morton D, 2006, TOXICOL PATHOL, V34, P806, DOI 10.1080/01926230601034624; Nedeltchev K, 2010, CATHETER CARDIO INTE, V76, P333, DOI 10.1002/ccd.22560; Nicholson A, 2008, HAEMOPHILIA, V14, P127, DOI 10.1111/j.1365-2516.2007.01562.x; O'Connor AM, 2010, J VET INTERN MED, V24, P57, DOI 10.1111/j.1939-1676.2009.0441.x; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; Oria HE, 1997, OBES SURG, V7, P521; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Paranjothy B, 2007, J GLAUCOMA, V16, P670, DOI 10.1097/IJG.0b013e3180457c6d; Parsons NR, 2011, J BONE JOINT SURG BR, V93B, P1154, DOI 10.1302/0301-620X.93B9.27193; Peron J, 2013, J CLIN ONCOL, V31, P3957, DOI 10.1200/JCO.2013.49.3981; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; PIZZO PA, 1990, J INFECT DIS, V161, P397, DOI 10.1093/infdis/161.3.397; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P1542, DOI 10.2106/JBJS.F.01292; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Rao SV, 2009, AM HEART J, V158, P881, DOI 10.1016/j.ahj.2009.10.008; Research Information Network, 2008, ACKN FUND SCHOL J AR; Robinson TN, 1998, JAMA-J AM MED ASSOC, V280, P1264, DOI 10.1001/jama.280.14.1264; Rochon Paula A, 2010, Open Med, V4, pe69; Rundback JH, 2002, CIRCULATION, V106, P1572, DOI 10.1161/01.CIR.0000029805.87199.45; RUTHERFORD RB, 1986, J VASC SURG, V4, P80; Scher HI, 2004, J CLIN ONCOL, V22, P537, DOI 10.1200/JCO.2004.07.099; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Selman TJ, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-8; Shamseer L, 2013, 7 INT C PEER REV BIO; Shamseer L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-24; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smidt N, 2006, NEUROLOGY, V67, P792, DOI 10.1212/01.wnl.0000238386.41398.30; Smidt N, 2007, CLIN CHEM, V53, P1983, DOI 10.1373/clinchem.2007.090167; Smith BA, 2008, NURS OUTLOOK, V56, P31, DOI 10.1016/j.outlook.2007.09.002; Smith L, 2010, COUNS PSYCHOL, V38, P1115, DOI 10.1177/0011000010376416; Stephenson EL, 2007, REGEN MED, V2, P349, DOI 10.2217/17460751.2.4.349; Stock-Schroer B, 2009, HOMEOPATHY, V98, P287, DOI 10.1016/j.homp.2009.09.006; Stone SP, 2007, J ANTIMICROB CHEMOTH, V59, P833, DOI 10.1093/jac/dkm055; Strevel EL, 2008, CLIN CANCER RES, V14, P1782, DOI 10.1158/1078-0432.CCR-07-4886; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sung L, 2005, J CLIN EPIDEMIOL, V58, P261, DOI 10.1016/j.jclinepi.2004.08.010; Talmon J, 2009, INT J MED INFORM, V78, P1, DOI 10.1016/j.ijmedinf.2008.09.002; Taylor CF, 2008, NAT BIOTECHNOL, V26, P860, DOI 10.1038/nbt0808-860; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Tunis AS, 2013, RADIOLOGY, V269, P413, DOI 10.1148/radiol.13130273; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Turner LA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-67; Vitek JL, 2010, MOVEMENT DISORD, V25, P1530, DOI 10.1002/mds.23151; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wolfe F, 1999, J RHEUMATOL, V26, P484; [WU Taixiang 吴泰相], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P625; Yesupriya A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-31; Zakrzewska JM, 2003, NEUROSURGERY, V53, P110, DOI 10.1227/01.NEU.0000068862.78930.EE; ZARITSKY A, 1995, ANN EMERG MED, V26, P487, DOI 10.1016/S0196-0644(95)70119-2; Zhang DL, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-22; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	161	136	140	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2014	348								g3804	10.1136/bmj.g3804	http://dx.doi.org/10.1136/bmj.g3804			29	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK1UK	24965222	Green Published, hybrid			2022-12-28	WOS:000338202200002
J	Lee, K; Zhong, XF; Gu, SY; Kruel, AM; Dorner, MB; Perry, K; Rummel, A; Dong, M; Jin, RS				Lee, Kwangkook; Zhong, Xiaofen; Gu, Shenyan; Kruel, Anna Magdalena; Dorner, Martin B.; Perry, Kay; Rummel, Andreas; Dong, Min; Jin, Rongsheng			Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex	SCIENCE			English	Article							CLOSTRIDIUM-BOTULINUM; ADHERENS JUNCTIONS; CRYSTAL-STRUCTURE; ORAL TOXICITIES; BINDING; CELL; TOXINS; TRANSCYTOSIS; DOMAINS	How botulinum neurotoxins (BoNTs) cross the host intestinal epithelial barrier in foodborne botulism is poorly understood. Here, we present the crystal structure of a clostridial hemagglutinin (HA) complex of serotype BoNT/A bound to the cell adhesion protein E-cadherin at 2.4 angstroms. The HA complex recognizes E-cadherin with high specificity involving extensive intermolecular interactions and also binds to carbohydrates on the cell surface. Binding of the HA complex sequesters E-cadherin in the monomeric state, compromising the E-cadherin-mediated intercellular barrier and facilitating paracellular absorption of BoNT/A. We reconstituted the complete 14-subunit BoNT/A complex using recombinantly produced components and demonstrated that abolishing either E-cadherin- or carbohydrate-binding of the HA complex drastically reduces oral toxicity of BoNT/A complex in vivo. Together, these studies establish the molecular mechanism of how HAs contribute to the oral toxicity of BoNT/A.	[Lee, Kwangkook; Gu, Shenyan; Jin, Rongsheng] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Zhong, Xiaofen; Dong, Min] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Neurosci,New England Primate Res Ctr, Southborough, MA 01772 USA; [Kruel, Anna Magdalena; Rummel, Andreas] Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany; [Dorner, Martin B.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens Biol Toxins, D-13353 Berlin, Germany; [Perry, Kay] Cornell Univ, Northeastern Collaborat Access Team NE CAT, Argonne Natl Lab, Argonne, IL 60439 USA; [Perry, Kay] Cornell Univ, Dept Chem & Chem Biol, Argonne Natl Lab, Argonne, IL 60439 USA	University of California System; University of California Irvine; Harvard University; Hannover Medical School; Robert Koch Institute; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Jin, RS (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	r.jin@uci.edu	Dorner, Martin B/C-5703-2013; Jin, Rongsheng/M-7797-2013	Dorner, Martin B/0000-0002-8176-797X; Jin, Rongsheng/0000-0003-0348-7363; Rummel, Andreas/0000-0002-0645-1641; Lipton, Stuart/0000-0002-3490-1259	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI091823]; NIH [8P51OD011103-51, 1R56AI097834-01, 1R01NS080833-01]; Swiss Federal Office for Civil Protection BABS [353003325]; National Institute of General Medical Sciences [P41 GM103403]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097834, R01AI091823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411, R01NS080833] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Federal Office for Civil Protection BABS; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Bobkov for technical assistance. This work was partly supported by National Institute of Allergy and Infectious Diseases (NIAID) grant R01AI091823 to R.J.; by the NIH grant 8P51OD011103-51 (to the New England Primate Research Center), 1R56AI097834-01, and 1R01NS080833-01 to M. D.; and by the Swiss Federal Office for Civil Protection BABS #353003325 to A. R. NE-CAT at the Advanced Photon Source (APS) is supported by a grant from the National Institute of General Medical Sciences (P41 GM103403). Use of the APS, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract DE-AC02-06CH11357. The atomic coordinates and structure factors of the mini-HA-EC1-EC2 complex have been deposited in the Protein Data Bank under the accession code 4QD2. BoNT availability is subject to the restrictions that apply to Centers for Disease Control and Prevention select agents and NIAID Category A pathogens. R.J. is named as an inventor on a U.S. patent application applied for by University of California, Irvine related to oral drug delivery systems.	Amatsu S, 2013, J BIOL CHEM, V288, P35617, DOI 10.1074/jbc.M113.521179; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Cheng LW, 2008, TOXICOLOGY, V249, P123, DOI 10.1016/j.tox.2008.04.018; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Couesnon A, 2008, CELL MICROBIOL, V10, P375, DOI 10.1111/j.1462-5822.2007.01051.x; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Lin GY, 2010, APPL ENVIRON MICROB, V76, P40, DOI 10.1128/AEM.01882-09; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Maksymowych AB, 2004, J PHARMACOL EXP THER, V310, P633, DOI 10.1124/jpet.104.066845; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; OHISHI I, 1984, INFECT IMMUN, V43, P487, DOI 10.1128/IAI.43.2.487-490.1984; OHISHI I, 1977, INFECT IMMUN, V16, P107, DOI 10.1128/IAI.16.1.107-109.1977; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051	28	79	84	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1405	1410		10.1126/science.1253823	http://dx.doi.org/10.1126/science.1253823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948737	Green Accepted			2022-12-28	WOS:000337531700042
J	Mahroo, OA; Graham, EM				Mahroo, Omar A.; Graham, Elizabeth M.			Roth Spots in Infective Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mahroo, Omar A.; Graham, Elizabeth M.] St Thomas Hosp, London, England	Guy's & St Thomas' NHS Foundation Trust	Mahroo, OA (corresponding author), St Thomas Hosp, London, England.	oarm2@cam.ac.uk		Mahroo, Omar/0000-0003-1254-0832	National Institute for Health Research [CL-2011-17-501] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					E38	E38		10.1056/NEJMicm1312093	http://dx.doi.org/10.1056/NEJMicm1312093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24941198				2022-12-28	WOS:000337353000001
J	Tejeda, HA; Bonci, A				Tejeda, Hugo A.; Bonci, Antonello			Shedding "UV" Light on Endogenous Opioid Dependence	CELL			English	Editorial Material							SYSTEM; DRUGS	Excessive sun tanning can result in addictive behavior. In this issue of Cell, Fell et al. utilize a combination of behavioral pharmacology and transgenic mice to demonstrate that chronic UV light exposure recruits p53 signaling in keratinocytes, subsequently increasing beta-endorphin signaling at opioid receptors, and produces an endogenous opioid-dependent state.	[Tejeda, Hugo A.; Bonci, Antonello] Natl Inst Drug Abuse, Cellular Neurobiol Res Branch, Synapt Plast Sect, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Bonci, A (corresponding author), Natl Inst Drug Abuse, Cellular Neurobiol Res Branch, Synapt Plast Sect, Baltimore, MD 21224 USA.	antonello.bonci@nih.gov	Tejeda, Hugo/AAX-2529-2021		NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000601] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Fell GL, 2014, CELL, V157, P1527, DOI 10.1016/j.cell.2014.04.032; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Kaur M, 2006, J AM ACAD DERMATOL, V54, P709, DOI 10.1016/j.jaad.2005.11.1059; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Nolan BV, 2009, DERMATOL CLIN, V27, P109, DOI 10.1016/j.det.2008.11.007; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7	8	7	7	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1500	1501		10.1016/j.cell.2014.06.009	http://dx.doi.org/10.1016/j.cell.2014.06.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949960	Bronze			2022-12-28	WOS:000340941900003
J	Carvajal, RD; Sosman, JA; Quevedo, JF; Milhem, MM; Joshua, AM; Kudchadkar, RR; Linette, GP; Gajewski, TF; Lutzky, J; Lawson, DH; Lao, CD; Flynn, PJ; Albertini, MR; Sato, T; Lewis, K; Doyle, A; Ancell, K; Panageas, KS; Bluth, M; Hedvat, C; Erinjeri, J; Ambrosini, G; Marr, B; Abramson, DH; Dickson, MA; Wolchok, JD; Chapman, PB; Schwartz, GK				Carvajal, Richard D.; Sosman, Jeffrey A.; Quevedo, Jorge Fernando; Milhem, Mohammed M.; Joshua, Anthony M.; Kudchadkar, Ragini R.; Linette, Gerald P.; Gajewski, Thomas F.; Lutzky, Jose; Lawson, David H.; Lao, Christopher D.; Flynn, Patrick J.; Albertini, Mark R.; Sato, Takami; Lewis, Karl; Doyle, Austin; Ancell, Kristin; Panageas, Katherine S.; Bluth, Mark; Hedvat, Cyrus; Erinjeri, Joseph; Ambrosini, Grazia; Marr, Brian; Abramson, David H.; Dickson, Mark Andrew; Wolchok, Jedd D.; Chapman, Paul B.; Schwartz, Gary K.			Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLLABORATIVE OCULAR MELANOMA; CHOROIDAL MELANOMA; METASTATIC-DISEASE; MEK INHIBITOR; GROWTH-FACTOR; SOLID TUMORS; LUNG-CANCER; MUTANT GNAQ; CELL-DEATH; MUTATIONS	IMPORTANCE Uveal melanoma is characterized by mutations in GNAQ and GNA11, resulting in mitogen-activated protein kinase pathway activation. OBJECTIVE To assess the efficacy of selumetinib, a selective, non-adenosine triphosphate competitive inhibitor of MEK1 and MEK2, in uveal melanoma. DESIGN, SETTING, AND PARTICIPANTS Randomized, open-label, phase 2 clinical trial comparing selumetinib vs chemotherapy conducted from August 2010 through December 2013 among 120 patients with metastatic uveal melanoma at 15 academic oncology centers in the United States and Canada. INTERVENTIONS One hundred one patients were randomized in a 1:1 ratio to receive selumetinib, 75mg orally twice daily on a continual basis (n = 50), or chemotherapy (temozolomide, 150mg/m(2) orally daily for 5 of every 28 days, or dacarbazine, 1000mg/m(2) intravenously every 21 days [investigator choice]; n = 51) until disease progression, death, intolerable adverse effects, or withdrawal of consent. After primary outcome analysis, 19 patients were registered and 18 treated with selumetinib without randomization to complete the planned 120-patient enrollment. Patients in the chemotherapy group could receive selumetinib at the time of radiographic progression. MAIN OUTCOMES AND MEASURES Progression-free survival, the primary end point, was assessed as of April 22, 2013. Additional end points, including overall survival, response rate, and safety/toxicity, were assessed as of December 31, 2013. RESULTS Median progression-free survival among patients randomized to chemotherapy was 7 weeks (95% CI, 4.3-8.4weeks; median treatment duration, 8weeks; interquartile range [IQR], 4.3-16weeks) and among those randomized to selumetinib was 15.9 weeks (95% CI, 8.4-21.1 weeks; median treatment duration, 16.1 weeks; IQR, 8.1-25.3weeks) (hazard ratio, 0.46; 95% CI, 0.30-0.71; P < .001). Median overall survival time was 9.1 months (95% CI, 6.1-11.1 months) with chemotherapy and 11.8 months (95% CI, 9.8-15.7 months) with selumetinib (hazard ratio, 0.66; 95% CI, 0.41-1.06; P = .09). No objective responses were observed with chemotherapy. Forty-nine percent of patients treated with selumetinib achieved tumor regression, with 14% achieving an objective radiographic response to therapy. Treatment-related adverse events were observed in 97% of patients treated with selumetinib, with 37% requiring at least 1 dose reduction. CONCLUSIONS AND RELEVANCE In this hypothesis-generating study of patients with advanced uveal melanoma, selumetinib compared with chemotherapy resulted in a modestly improved progression-free survival and response rate; however, no improvement in overall survivalwas observed. Improvement in clinical outcomeswas accompanied by a high rate of adverse events.	[Carvajal, Richard D.; Panageas, Katherine S.; Bluth, Mark; Hedvat, Cyrus; Erinjeri, Joseph; Ambrosini, Grazia; Marr, Brian; Abramson, David H.; Dickson, Mark Andrew; Wolchok, Jedd D.; Chapman, Paul B.; Schwartz, Gary K.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Carvajal, Richard D.; Abramson, David H.; Dickson, Mark Andrew; Wolchok, Jedd D.; Chapman, Paul B.; Schwartz, Gary K.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Sosman, Jeffrey A.; Ancell, Kristin] Vanderbilt Univ, Med Ctr, Dept Hematol Oncol, Nashville, TN USA; [Quevedo, Jorge Fernando] Mayo Clin, Rochester, MN USA; [Milhem, Mohammed M.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Joshua, Anthony M.] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Kudchadkar, Ragini R.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Linette, Gerald P.] Washington Univ, St Louis, MO USA; [Gajewski, Thomas F.] Univ Chicago, Chicago, IL 60637 USA; [Lutzky, Jose] Mt Sinai Comprehens Canc Ctr, Miami Beach, FL USA; [Lawson, David H.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Lao, Christopher D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Flynn, Patrick J.] Metro Minnesota Community Clin Oncol Program, St Louis Pk, MN USA; [Albertini, Mark R.] Univ Wisconsin, Madison, WI 53706 USA; [Sato, Takami] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Lewis, Karl] Univ Colorado, Aurora, CO USA; [Doyle, Austin] NCI, Invest Drug Branch, Rockville, MD USA	Memorial Sloan Kettering Cancer Center; Cornell University; Vanderbilt University; Mayo Clinic; University of Iowa; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Washington University (WUSTL); University of Chicago; Emory University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; Jefferson University; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Carvajal, RD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 300 E 66th St, New York, NY 10065 USA.	carvajar@mskcc.org	Carvajal, Richard/ABA-3285-2021	HEDVAT, CYRUS/0000-0003-0045-3491; Joshua, Anthony/0000-0001-5159-4580; Lutzky, Jose/0000-0002-9503-2130; Milhem, Mohammed/0000-0003-4663-6824; Erinjeri, Joseph/0000-0003-1876-727X	Cancer Therapy Evaluation Program; National Cancer Institute; Conquer Cancer Foundation; Cycle for Survival; Fund for Ophthalmic Knowledge; NATIONAL CANCER INSTITUTE [P30CA008748, UM1CA186644, P30CA056036] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Cancer Therapy Evaluation Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Conquer Cancer Foundation; Cycle for Survival; Fund for Ophthalmic Knowledge; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was sponsored by the Cancer Therapy Evaluation Program. Financial support for this trial was provided by the National Cancer Institute, the Conquer Cancer Foundation, Cycle for Survival, and the Fund for Ophthalmic Knowledge. The Division of Cancer Treatment and Diagnosis at the National Cancer Institute provided selumetinib for this clinical trial.	Ambrosini G, 2013, MOL CANCER THER, V12, P768, DOI 10.1158/1535-7163.MCT-12-1020; Ambrosini G, 2012, CLIN CANCER RES, V18, P3552, DOI 10.1158/1078-0432.CCR-11-3086; Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Banerji U, 2010, CLIN CANCER RES, V16, P1613, DOI 10.1158/1078-0432.CCR-09-2483; Bedikian AY, 2003, MELANOMA RES, V13, P303, DOI 10.1097/00008390-200306000-00013; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Chen X, 2012, NEUROLOGY, V79, P1929, DOI 10.1212/WNL.0b013e318271f87e; Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Huang MH, 2013, MOL ONCOL, V7, P112, DOI 10.1016/j.molonc.2012.09.002; Infante JR, 2013, EUR J CANCER, V49, P2077, DOI 10.1016/j.ejca.2013.03.020; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Khalili JS, 2012, CLIN CANCER RES, V18, P4345, DOI 10.1158/1078-0432.CCR-11-3227; Lev DC, 2003, MOL CANCER THER, V2, P753; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Patel M, 2011, CLIN CANCER RES, V17, P2087, DOI 10.1158/1078-0432.CCR-10-3169; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Robert C, 2013, LANCET ONCOL, V14, P733, DOI 10.1016/S1470-2045(13)70237-7; Singh AD, 2003, OPHTHALMOLOGY, V110, P956, DOI 10.1016/S0161-6420(03)00078-2; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Willson JKV, 2001, ARCH OPHTHALMOL-CHIC, V119, P670; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	26	274	284	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2397	2405		10.1001/jama.2014.6096	http://dx.doi.org/10.1001/jama.2014.6096			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938562	Green Accepted, Bronze			2022-12-28	WOS:000337301500020
J	Ataya, N; Aluttis, C; Flahault, A; Atun, R; Haines, A				Ataya, Nour; Aluttis, Christoph; Flahault, Antoine; Atun, Rifat; Haines, Andy			Improving the assessment and attribution of effects of development assistance for health	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; INITIATIVES; IMPACT		[Ataya, Nour] Sorbonne Paris Cite, Sch Publ Hlth, Ecole Hautes Etud Sante Publ, Paris, France; [Aluttis, Christoph] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Int Hlth, Maastricht, Netherlands; [Flahault, Antoine] Sorbonne Paris Cite, Ctr Virchow Villerme, Paris, France; [Flahault, Antoine] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Atun, Rifat] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Haines, Andy] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Haines, Andy] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England	Maastricht University; University of Geneva; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Keppel St, London WC1E 7HT, England.	andy.haines@lshtm.ac.uk	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Haines, Andy/0000-0002-8053-4605				Akachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021309; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS72, DOI 10.1097/QAI.0b013e318221842a; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Baeza C, 2011, ACCOUNTABILITY IMPAC; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Buse K, 2011, INT DENT J, V61, P2, DOI 10.1111/j.1875-595X.2011.00034.x; Car Josip, 2012, JRSM Short Rep, V3, P70, DOI 10.1258/shorts.2012.012062; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; Chee G, 2007, EVALUATION 1 5 YEARS; Department for International Development, 2012, BROAD RANG DES METH; Development Impact Evaluation Initiative (DIME), AB US; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Institute for Health Metrics and Evaluation, 2012, FIN GLOB HLTH END GL; International Health Partnership Plus, JOINT ASS NAT HLTH S; International Initiative for Impact Evaluation, 2010, IMPR LIV IMP EV STRA; Jongh TE, 2013, HLTH POLICY PLAN, DOI [10.1093/heapol/czt0511-13, DOI 10.1093/HEAPOL/CZT0511-13]; Korenromp EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038816; Leeuw F., 2009, IMPACT EVALUATIONS D, VNo. 57490; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Martinez J, 2009, RFP000608; McCoy D, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001522; ONE, 2013, 2013 DAT REP SPEC RE; Rabkin M, 2009, JAIDS-J ACQ IMM DEF, V52, pS6, DOI 10.1097/QAI.0b013e3181bbcd69; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Shakarishvili G, 2011, HEALTH POLICY PLANN, V26, P316, DOI 10.1093/heapol/czq053; Shorten T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-13; Stover J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021048; The Global Fund, MAK DIFF GLOB FUND R; The United Nations Children's Fund (UNICEF), 2008, DATA ANAL; Towards shared principles for reporting health impacts of development aid, 2012, EUR AID LANC WORKSH; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; World Health Organization, 2008, ASS NAT HLTH INF SYS; World Health Organization ed., 2009, TB IMPACT MEASUREMEN	35	8	9	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2256	2259		10.1016/S0140-6736(14)60791-1	http://dx.doi.org/10.1016/S0140-6736(14)60791-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX0QC	24973810				2022-12-28	WOS:000346655700030
J	Shaw, D				Shaw, David			HEAT-PPCI sheds light on consent in pragmatic trials	LANCET			English	Editorial Material									Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland	University of Basel	Shaw, D (corresponding author), Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland.	david.shaw@unibas.ch						Edwards P, 2005, LANCET, V365, P1957; Faden RR, 2014, NEW ENGL J MED, V370, P766, DOI 10.1056/NEJMhle1313674; Goldacre B, 2013, BAD PHARM, P231; Mundy A, 2009, WALL STREET J; Pear Robert, 2009, NY TIMES; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Shahzad A, 2014, LANCET; WMA, 2013, DECL HELS; Wood S., 2014, HEAT PPCI HEPARIN BE	9	22	22	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1826	1827		10.1016/S0140-6736(14)61040-0	http://dx.doi.org/10.1016/S0140-6736(14)61040-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	25002175				2022-12-28	WOS:000345116800006
J	Wiener, RS				Wiener, Renda Soylemez			Balancing the Benefits and Harms of Low-Dose Computed Tomography Screening for Lung Cancer: Medicare's Options for Coverage	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY; NODULE; RISK		Boston Univ, Sch Med, Boston, MA 02118 USA; Edith Nourse Rogers Mem Vet Hosp, Bedford, MA USA	Boston University	Wiener, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 East Concord St,R-304, Boston, MA 02118 USA.	rwiener@bu.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135	NATIONAL CANCER INSTITUTE [K07CA138772] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA138772] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Arenberg D, 2012, J NATL COMPR CANC NE, V10, P277, DOI 10.6004/jnccn.2012.0024; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Kozower BD, 2010, ANN THORAC SURG, V90, P875, DOI 10.1016/j.athoracsur.2010.03.115; Mazzone P, 2012, CLEV CLIN J MED, V79, P337, DOI 10.3949/ccjm.79a.12018; Mckee BJ, 2013, J AM COLL RADIOL, V10, P586, DOI 10.1016/j.jacr.2013.02.015; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Pinsky PF, 2013, RADIOLOGY, V268, P865, DOI 10.1148/radiol.13121530; Roth JA, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.7_suppl.77; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	10	13	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					445	U107		10.7326/M14-1352	http://dx.doi.org/10.7326/M14-1352			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	24957566				2022-12-28	WOS:000343894400021
J	Manning, KD				Manning, Kimberly D.			The Nod	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University	Manning, KD (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.	kdmanni@emory.edu							0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					133	134		10.1001/jama.2014.7502	http://dx.doi.org/10.1001/jama.2014.7502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005648				2022-12-28	WOS:000338511200017
J	Regimbeau, JM; Fuks, D; Pautrat, K; Mauvais, F; Haccart, V; Msika, S; Mathonnet, M; Scotte, M; Paquet, JC; Vons, C; Sielezneff, I; Millat, B; Chiche, L; Dupont, H; Duhaut, P; Cosse, C; Diouf, M; Pocard, M				Regimbeau, Jean Marc; Fuks, David; Pautrat, Karine; Mauvais, Francois; Haccart, Vincent; Msika, Simon; Mathonnet, Muriel; Scotte, Michel; Paquet, Jean Christophe; Vons, Corinne; Sielezneff, Igor; Millat, Bertrand; Chiche, Laurence; Dupont, Herve; Duhaut, Pierre; Cosse, Cyril; Diouf, Momar; Pocard, Marc		FRENCH Study Grp	Effect of Postoperative Antibiotic Administration on Postoperative Infection Following Cholecystectomy for Acute Calculous Cholecystitis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAABDOMINAL INFECTIONS; TOKYO GUIDELINES; THERAPY; SURGERY; PROPHYLAXIS; MANAGEMENT	IMPORTANCE Ninety percent of cases of acute calculous cholecystitis are of mild (grade I) or moderate (grade II) severity. Although the preoperative and intraoperative antibiotic management of acute calculous cholecystitis has been standardized, few data exist on the utility of postoperative antibiotic treatment. OBJECTIVE To determine the effect of postoperative amoxicillin plus clavulanic acid on infection rates after cholecystectomy. DESIGN, SETTING, AND PATIENTS A total of 414 patients treated at 17 medical centers for grade I or II acute calculous cholecystitis and who received 2 g of amoxicillin plus clavulanic acid 3 times a day while in the hospital before and once at the time of surgery were randomized after surgery to an open-label, noninferiority, randomized clinical trial between May 2010 and August 2012. INTERVENTIONS After surgery, no antibiotics or continue with the preoperative antibiotic regimen 3 times daily for 5 days. MAIN OUTCOMES AND MEASURES The proportion of postoperative surgical site or distant infections recorded before or at the 4-week follow-up visit. RESULTS An imputed intention-to-treat analysis of 414 patients showed that the postoperative infection rates were 17%(35 of 207) in the nontreatment group and 15%(31 of 207) in the antibiotic group (absolute difference, 1.93%; 95% CI, -8.98% to 5.12%). In the per-protocol analysis, which involved 338 patients, the corresponding rates were both 13%(absolute difference, 0.3%; 95% CI, -5.0% to 6.3%). Based on a noninferiority margin of 11%, the lack of postoperative antibiotic treatment was not associated with worse outcomes than antibiotic treatment. Bile cultures showed that 60.9% were pathogen free. Both groups had similar Clavien complication severity outcomes: 195 patients (94.2%) in the nontreatment group had a score of 0 to I and 2 patients (0.97%) had a score of III to V, and 182 patients (87.8%) in the antibiotic group had a score of 0 to I and 4 patients (1.93%) had a score of III to V. CONCLUSIONS AND RELEVANCE Among patients with mild or moderate calculous cholecystitis who received preoperative and intraoperative antibiotics, lack of postoperative treatment with amoxicillin plus clavulanic acid did not result in a greater incidence of postoperative infections.	[Regimbeau, Jean Marc; Fuks, David; Cosse, Cyril] Amiens Univ, Med Ctr, Div Digest Surg, Amiens, France; [Regimbeau, Jean Marc] Jules Verne Univ Picardie, Unit EA4294, Amiens, France; [Regimbeau, Jean Marc] Amiens Univ, Med Ctr, Clin Res Ctr, Amiens, France; [Pautrat, Karine; Pocard, Marc] Paris Lariboisiere Hosp, Div Digest Dis, Paris, France; [Mauvais, Francois] Beauvais Hosp, Div Digest Surg, Beauvais, France; [Haccart, Vincent] Montreuil Sur Mer Hosp, Div Digest Surg, Montreuil Sur Mer, France; [Msika, Simon] Louis Mourier Univ Hosp, Div Digest Surg, Colombes, France; [Mathonnet, Muriel] Limoges Univ Hosp, Div Digest Surg, Limoges, France; [Scotte, Michel] Rouen Univ Hosp, Div Digest Surg, Rouen, France; [Paquet, Jean Christophe] Longjumeau Hosp, Div Digest Surg, Longjumeau, France; [Vons, Corinne] Jean Verdier Univ Hosp, Div Digest Surg, Bondy, France; [Sielezneff, Igor] Marseille Univ, Hosp La Timone, Div Digest Surg, Marseille, France; [Millat, Bertrand] Montpellier Univ Hosp, Div Digest Surg, Montpellier, France; [Chiche, Laurence] Caen Univ Hosp, Div Digest Surg, Caen, France; [Dupont, Herve] Amiens Univ, Med Ctr, Div Anesthesia & Intens Care, Amiens, France; [Duhaut, Pierre] Amiens Univ, Med Ctr, Div Internal Med & System Dis, Amiens, France; [Diouf, Momar] Amiens Univ, Med Ctr, Div Clin Res & Innovat, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; CHU Limoges; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; CHU de Caen NORMANDIE; Universite de Caen Normandie; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Regimbeau, JM (corresponding author), CHU Nord Amiens, Dept Digest & Oncol Surg, Pl Victor Pauchet, F-80054 Amiens 01, France.	regimbeau.jean-marc@chu-amiens.fr	Dupont, Herve/D-1259-2010; Mathonnet, Muriel/ABD-3021-2020; Fuks, David/Y-9410-2019	Mathonnet, Muriel/0000-0002-9127-3068; CHICHE, LAURENCE/0000-0001-9081-4750; scotte, michel/0000-0001-9519-7632	French Ministry of Health; National Clinical Research Protocol	French Ministry of Health; National Clinical Research Protocol	This study was funded by the French Ministry of Health's Programme Hospitalier de Recherche Clinique 2009 program. This study was supported with cooperative agreements from the National Clinical Research Protocol.	BJORVATN B, 1984, SCAND J GASTROENTERO, V19, P65; CLAESSON B, 1984, ACTA CHIR SCAND, V150, P229; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fuks D, 2013, J VISC SURG, V150, P3, DOI 10.1016/j.jviscsurg.2013.01.004; Fuks D, 2012, RADIOLOGY, V263, P128, DOI 10.1148/radiol.12110460; Groezinger K H, 1987, Chemioterapia, V6, P590; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Haute autorite de sante, NOT PROBL PERT CHOL; HAVIG O, 1973, SCAND J GASTROENTERO, V8, P55; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Jaafar G, 2014, BRIT J SURG, V101, P69, DOI 10.1002/bjs.9369; Kanafani ZA, 2005, J INFECTION, V51, P128, DOI 10.1016/j.jinf.2004.11.007; Kapoor V K, 1994, Indian J Gastroenterol, V13, P49; KUNE GA, 1975, MED J AUSTRALIA, V2, P627, DOI 10.5694/j.1326-5377.1975.tb106155.x; LAU WY, 1990, AUST NZ J SURG, V60, P539, DOI 10.1111/j.1445-2197.1990.tb07422.x; Mazeh H, 2012, WORLD J SURG, V36, P1750, DOI 10.1007/s00268-012-1572-6; MEIJER WS, 1990, NETH J SURG, V42, P96; Payen JL, 2011, PRESSE MED, V40, P567, DOI 10.1016/j.lpm.2011.01.024; Piantadosi S, 2005, WILEY SER PROBAB ST, P29; Rodriguez-Sanjuan JC, 2013, J GASTROINTEST SURG, V17, P1947, DOI 10.1007/s11605-013-2321-3; Sartelli M, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-2; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Solomkin JS, 2003, CLIN INFECT DIS, V37, P997, DOI 10.1086/378702; Sozener U, 2011, DIS COLON RECTUM, V54, P923, DOI 10.1097/DCR.0b013e31821cc1f9; THOMPSON JE, 1990, ARCH SURG-CHICAGO, V125, P261; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8; Weigand K, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-29; Yoshida M, 2007, J HEPATO-BILIARY-PAN, V14, P83, DOI 10.1007/s00534-006-1160-y	29	84	87	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					145	154		10.1001/jama.2014.7586	http://dx.doi.org/10.1001/jama.2014.7586			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005651				2022-12-28	WOS:000338511200020
J	Feeney, ER; Chung, RT				Feeney, Eoin R.; Chung, Raymond T.			Antiviral treatment of hepatitis C	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GENOTYPE 1 INFECTION; TREATMENT-NAIVE PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; PEGYLATED INTERFERON ALPHA-2A; PREVIOUSLY TREATED PATIENTS; PEGINTERFERON ALPHA-2A; VIRUS-INFECTION; PHASE-2 TRIAL; RANDOMIZED-TRIAL; LIVER-TRANSPLANTATION	Hepatitis C virus (HCV) infection is a substantial health problem worldwide. Most patients infected with HCV remain chronically infected, with an increased risk of cirrhosis and hepatocellular carcinoma. Although they are associated with toxicities and low sustained viral response rates, interferon alfa and ribavirin have been the mainstay of treatment until recently. New direct acting antivirals, specifically designed to inhibit three viral proteins (the NS3/4A protease, the NS5A protein, and the NS5B RNA dependent RNA polymerase) are now becoming available. The NS3/4A inhibitor simeprevir and NS5B inhibitor sofosbuvir have recently been licensed and can reduce the length of antiviral treatment, improve response rates, and allow for interferon-free regimens for some HCV genotypes. Several other newer direct acting antivirals have shown promise in clinical studies and are likely to be licensed soon. These agents seem to facilitate the use of shortened courses of combination interferon-free therapy, which are associated with high (>95%) sustained response rates and relatively few toxicities. These regimens have also been successful in patients who were previously difficult to treat, including those with cirrhosis, HIV coinfection, and those who have undergone liver transplantation. The high cost of these agents may be the biggest challenge to their implementation worldwide.	[Feeney, Eoin R.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Chung, Raymond T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Chung, RT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.	RTCHUNG@partners.org		Feeney, Eoin/0000-0003-4118-4945	Harvard University Center for AIDS Research (NIH/NIAID) [5P30AI060354-09]; Abbvie; Gilead Sciences; Mass Biologics; Vertex; NIH [DK098079, DA033541, AI082630]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, U19AI082630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK098079, R01DK098079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033541] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research (NIH/NIAID); Abbvie(AbbVie); Gilead Sciences(Gilead Sciences); Mass Biologics; Vertex(Vertex Pharmaceuticals); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	ERF: grant support-Harvard University Center for AIDS Research (NIH/NIAID fund 5P30AI060354-09). RTC has received consultancy fees from Abbvie and payment for clinical trials from Gilead Sciences, Mass Biologics, and Vertex; grant support: NIH DK098079, DA033541, and AI082630.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; [Anonymous], 2006, HEPATITIS C VIRUSES; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Berger KL, 2014, ANTIMICROB AGENTS CH, V58, P698, DOI 10.1128/AAC.01976-13; Bronowicki JP, 2013, ANTIVIR THER, V18, P885, DOI 10.3851/IMP2660; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Camma C, 2013, J HEPATOL, V59, P658, DOI 10.1016/j.jhep.2013.05.019; Charlton MR, 2013, 64 ANN M AM ASS STUD; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Curry MP, 2013, 64 ANN M AM ASS STUD; Datta PJ, 2014, HINDU; Dietrich D, 2013, 14 EUR AIDS C EACS 2; Dore GJ, 2013, J HEPATOL, V58, pS570, DOI 10.1016/S0168-8278(13)61417-8; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fierer DS, 2014, CLIN INFECT DIS, V58, P873, DOI 10.1093/cid/cit799; Ford N, 2012, B WORLD HEALTH ORGAN, V90, P540, DOI 10.2471/BLT.11.097147; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Forns X, 2013, 64 ANN M AM ASS STUD; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Gane EJ, 2014, GASTROENTEROLOGY, V146; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2012, HEPATOLOGY, V56, p553A; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Jacobson I., 2013, 64 ANN M AM ASS STUD; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Jensen D, 2013, 64 ANN M AM ASS STUD; Kohli A., 2014, 21 C RETR OPP INF BO; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kwo PY, 2014, 49 ANN M EUR ASS STU; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lawitz E., 2013, 64 ANN M AM ASS STUD; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, GASTROENTEROLOGY, V144, pS151; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Lehmann M, 2004, J MED VIROL, V73, P387, DOI 10.1002/jmv.20103; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns MP, 2012, HEPATOLOGY, V56, P884, DOI 10.1002/hep.25743; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 1999, J HEPATOL, V31, P9, DOI 10.1016/S0168-8278(99)80368-7; Marcellin P, 2013, GASTROENTEROLOGY, V145, P790, DOI 10.1053/j.gastro.2013.06.051; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Piroth L, 2010, HEPATOLOGY, V52, P1915, DOI 10.1002/hep.23959; Pol S, 2013, J HEPATOL, V58, P883, DOI 10.1016/j.jhep.2012.12.023; Pollack A., 2013, NY TIMES; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Pungpapong S, 2013, LIVER TRANSPLANT, V19, P690, DOI 10.1002/lt.23669; Rockstroh J, 2013, 64 ANN M AM ASS STUD; Rodriguez-Torres M, 2013, ID WEEK SAN FRANC 2; Rubbia-Brandt L, 2004, GUT, V53, P406, DOI 10.1136/gut.2003.018770; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sulkowski M, 2013, 64 ANN M AM ASS STUD; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tilg H, 1997, GASTROENTEROLOGY, V112, P1017, DOI 10.1053/gast.1997.v112.pm9041265; Wang CS, 2006, AM J TRANSPLANT, V6, P1586, DOI 10.1111/j.1600-6143.2006.01362.x; Wang CF, 2012, ANTIMICROB AGENTS CH, V56, P1350, DOI 10.1128/AAC.05977-11; World Health Organization, 2014, HEP C; WRIGHT TL, 1992, GASTROENTEROLOGY, V103, P317, DOI 10.1016/0016-5085(92)91129-R; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	86	149	151	0	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2014	349								g3308	10.1136/bmj.g3308	http://dx.doi.org/10.1136/bmj.g3308			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2YY	25002352	Green Published			2022-12-28	WOS:000338993000001
J	Islamian, AP; Polemikos, M; Krauss, JK				Islamian, Ariyan Pirayesh; Polemikos, Manolis; Krauss, Joachim K.			Chronic subdural haematoma secondary to headbanging	LANCET			English	Editorial Material							HEMORRHAGE		[Islamian, Ariyan Pirayesh; Polemikos, Manolis; Krauss, Joachim K.] Hannover Med Sch, Dept Neurosurg, D-30625 Hannover, Germany	Hannover Medical School	Islamian, AP (corresponding author), Hannover Med Sch, Dept Neurosurg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	pirayesh03@web.de						MACKENZIE JM, 1991, LANCET, V338, P1457, DOI 10.1016/0140-6736(91)92757-S; Matsuzaki S, 2012, ANN THORAC SURG, V94, P2113, DOI 10.1016/j.athoracsur.2012.05.054; Neyaz Z, 2006, NEUROL INDIA, V54, P319; Scheel M, 2011, NEUROLOGY, V76, pE60, DOI 10.1212/WNL.0b013e318211c389; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937	5	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2014	384	9937					102	102		10.1016/S0140-6736(14)60923-5	http://dx.doi.org/10.1016/S0140-6736(14)60923-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1XL	24998813				2022-12-28	WOS:000338919600032
J	Tian, XY; Hu, TY; Zhang, H; He, LJ; Huang, XZ; Liu, QZ; Yu, W; He, L; Yang, Z; Yan, Y; Yang, X; Zhong, TP; Pu, WT; Zhou, B				Tian, Xueying; Hu, Tianyuan; Zhang, Hui; He, Lingjuan; Huang, Xiuzhen; Liu, Qiaozhen; Yu, Wei; He, Liang; Yang, Zhen; Yan, Yan; Yang, Xiao; Zhong, Tao P.; Pu, William T.; Zhou, Bin			De novo formation of a distinct coronary vascular population in neonatal heart	SCIENCE			English	Article							ENDOTHELIAL-CELLS; ENDOCARDIAL CELLS; ARTERIES; FORM; BIOLOGY	The postnatal coronary vessels have been viewed as developing through expansion of vessels formed during the fetal period. Using genetic lineage tracing, we found that a substantial portion of postnatal coronary vessels arise de novo in the neonatal mouse heart, rather than expanding from preexisting embryonic vasculature. Our data show that lineage conversion of neonatal endocardial cells during trabecular compaction generates a distinct compartment of the coronary circulation located within the inner half of the ventricular wall. This lineage conversion occurs within a brief period after birth and provides an efficient means of rapidly augmenting the coronary vasculature. This mechanism of postnatal coronary vascular growth provides avenues for understanding and stimulating cardiovascular regeneration following injury and disease.	[Tian, Xueying; Hu, Tianyuan; Zhang, Hui; He, Lingjuan; Huang, Xiuzhen; Liu, Qiaozhen; Yu, Wei; He, Liang; Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai 200031, Peoples R China; [Yang, Zhen; Yan, Yan] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Beijing 100071, Peoples R China; [Zhong, Tao P.] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Pu, William T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Harvard University; Harvard University; Boston Children's Hospital	Zhou, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn	Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079; Zhou, Bin/0000-0001-5278-5522	National Basic Research Program of China [2012CB945102, 2013CB945302]; National Natural Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Chinese Academy of Sciences [KSCX2-EW-R-09]; Shanghai Pujiang Program [11PJ1411400]; Basic Research Key Project [14JC1407400]; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; NIH [2 R01 HL094683]; American Heart Association Established Investigator Award;  [SIBS-2013KIP311];  [2013M541561]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116461, R01HL094683] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Basic Research Key Project; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca(AstraZeneca); Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Red-Horse, Y. Chen, and N. Jin for insightful discussions and R. Adams, H. Zeng, Z. Yang, T. Quertermous, J. Rossant, and A. Nagy for mouse strains. This work was supported by National Basic Research Program of China (2012CB945102 and 2013CB945302), National Natural Science Foundation of China (91339104, 31271552, 31222038, 31301188), Chinese Academy of Sciences (Hundred Talents Program and KSCX2-EW-R-09), Shanghai Pujiang Program (11PJ1411400) and Basic Research Key Project (14JC1407400), Organization Department of the CPC Central Committee Bajian Talents Program, AstraZeneca, Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship, Postdoc Fund (SIBS-2013KIP311, China-2013M541561), NIH (2 R01 HL094683), and American Heart Association Established Investigator Award to W.T.P.	Bennett HS, 1936, AM J ANAT, V60, P27, DOI 10.1002/aja.1000600103; del Monte G, 2012, CELL, V151, P932, DOI 10.1016/j.cell.2012.11.004; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Riley P, 2010, NATURE, V464, P498, DOI 10.1038/464498a; Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Yi BA, 2010, J CLIN INVEST, V120, P20, DOI 10.1172/JCI40820; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640	14	131	142	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					90	94		10.1126/science.1251487	http://dx.doi.org/10.1126/science.1251487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994653	Green Accepted			2022-12-28	WOS:000338284400057
J	Victor, DG; Gerlagh, R; Baiocchi, G				Victor, David G.; Gerlagh, Reyer; Baiocchi, Giovanni			Getting serious about categorizing countries	SCIENCE			English	Editorial Material									[Victor, David G.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Gerlagh, Reyer] Tilburg Univ, NL-5037 AB Tilburg, Netherlands; [Baiocchi, Giovanni] Univ Maryland, College Pk, MD 20742 USA; Ctr Policy Res, New Delhi 110021, DL, India; Princeton Univ, Princeton, NJ 08544 USA; Stockholm Environm Inst, S-10451 Stockholm, Sweden; Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany	University of California System; University of California San Diego; Tilburg University; University System of Maryland; University of Maryland College Park; Princeton University; Stockholm Environment Institute; Potsdam Institut fur Klimafolgenforschung	Victor, DG (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.		baiocchi, giovanni/AAN-4104-2021	baiocchi, giovanni/0000-0002-0319-7561; Gerlagh, Reyer/0000-0001-9781-9212					0	28	28	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					34	36		10.1126/science.1255302	http://dx.doi.org/10.1126/science.1255302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994638				2022-12-28	WOS:000338284400037
J	Chawla, LS; Eggers, PW; Star, RA; Kimmel, PL				Chawla, Lakhmir S.; Eggers, Paul W.; Star, Robert A.; Kimmel, Paul L.			Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE-RENAL-FAILURE; LONG-TERM; RISK; PROGRESSION; FIBROSIS; AKI; ALBUMINURIA; DYSFUNCTION; INCREASES; MORTALITY		Dept Med, Div Intens Care Med, Washington, DC USA; Div Nephrol, Washington, DC USA; [Chawla, Lakhmir S.] George Washington Univ, Med Ctr, Vet Affairs Med Ctr, Washington, DC 20037 USA; [Chawla, Lakhmir S.] George Washington Univ, Med Ctr, Dept Anesthesiol & Crit Care Med, Washington, DC 20037 USA; [Chawla, Lakhmir S.; Kimmel, Paul L.] George Washington Univ, Med Ctr, Dept Med, Div Renal Dis & Hypertens, Washington, DC 20037 USA; [Eggers, Paul W.; Star, Robert A.; Kimmel, Paul L.] Natl Inst Diabet & Digest & Kidney Dis NIDDK, NIH, Bethesda, MD 20892 USA	George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); George Washington University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kimmel, PL (corresponding author), NIDDK, NIH, 6707 Democracy Blvd, Bethesda, MD 20892 USA.	kimmelp@extra.niddk.nih.gov			AbbVie; AM-Pharma; Alere; Covidien; Gambro; Bard Medical; NxStage Medical; Astute Medical; Ikaria; Eli Lilly; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043403] Funding Source: NIH RePORTER	AbbVie(AbbVie); AM-Pharma; Alere; Covidien; Gambro; Bard Medical; NxStage Medical; Astute Medical; Ikaria; Eli Lilly(Eli Lilly); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Chawla reports receiving fees for serving on steering committees from AbbVie and AM-Pharma, fees for serving as an adjudicator for a clinical end-point study from Alere, fees for device development from Covidien, Gambro, Bard Medical, and NxStage Medical, fees for serving as a principal investigator for trials sponsored by Astute Medical, fees for clinical-trial development and planning from Ikaria, and grant support from Eli Lilly. He also reports providing expert testimony in a case of a patient with severe rhabdomyolysis and in a case of a patient who died after intubation. No other potential conflict of interest relevant to this article was reported.	Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; BALDWIN DS, 1977, AM J MED, V62, P1, DOI 10.1016/0002-9343(77)90344-8; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bonventre JV, 2013, CLIN J AM SOC NEPHRO, V8, P1606, DOI 10.2215/CJN.06040613; Chang A, 2011, NEPHRON CLIN PRACT, V119, pC171, DOI 10.1159/000325669; Chawla LS, 2014, CLIN J AM SOC NEPHRO, V9, P448, DOI 10.2215/CJN.02440213; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Clermont G, 2002, KIDNEY INT, V62, P986, DOI 10.1046/j.1523-1755.2002.00509.x; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Cohen SD, 2012, CURR OPIN CRIT CARE, V18, P623, DOI 10.1097/MCC.0b013e328358d3f5; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eddy AA, 2013, NAT MED, V19, P964, DOI 10.1038/nm.3299; Geng H, 2009, AM J PATHOL, V174, P1291, DOI 10.2353/ajpath.2009.080295; Go AS, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-22; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldstein SL, 2012, BLOOD PURIFICAT, V33, P131, DOI 10.1159/000334143; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Ishani A, 2011, ARCH INTERN MED, V171, P226, DOI 10.1001/archinternmed.2010.514; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Johnson ACM, 2010, AM J PHYSIOL-RENAL, V299, pF426, DOI 10.1152/ajprenal.00248.2010; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Leelahavanichkul A, 2011, KIDNEY INT, V80, P1198, DOI 10.1038/ki.2011.261; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; McMahon GM, 2013, AM J KIDNEY DIS, V62, P165, DOI 10.1053/j.ajkd.2012.12.022; Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x; Palevsky PM, 2012, KIDNEY INT, V81, P430, DOI 10.1038/ki.2011.435; Palmer BF, 2002, NEW ENGL J MED, V347, P1256, DOI 10.1056/NEJMra020676; Ratliff BB, 2013, J AM SOC NEPHROL, V24, P529, DOI 10.1681/ASN.2012060633; Schrimpf C, 2011, CURR OPIN NEPHROL HY, V20, P297, DOI 10.1097/MNH.0b013e328344c3d4; Spurgeon-Pechman KR, 2007, AM J PHYSIOL-RENAL, V293, pF269, DOI 10.1152/ajprenal.00279.2006; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; System USRD, 2016, AM J KIDNEY DIS; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Tsagalis G, 2009, NEPHROL DIAL TRANSPL, V24, P194, DOI 10.1093/ndt/gfn471; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zarjou A, 2012, CTS-CLIN TRANSL SCI, V5, P93, DOI 10.1111/j.1752-8062.2011.00302.x; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484	57	1088	1123	20	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					58	66		10.1056/NEJMra1214243	http://dx.doi.org/10.1056/NEJMra1214243			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988558	Green Accepted			2022-12-28	WOS:000338265700010
J	Jais, A; Einwallner, E; Sharif, O; Gossens, K; Lu, TTH; Soyal, SM; Medgyesi, D; Neureiter, D; Paier-Pourani, J; Dalgaard, K; Duvigneau, JC; Lindroos-Christensen, J; Zapf, TC; Amann, S; Saluzzo, S; Jantscher, F; Stiedl, P; Todoric, J; Martins, R; Oberkofler, H; Muller, S; Hauser-Kronberger, C; Kenner, L; Casanova, E; Sutterluty-Fall, H; Bilban, M; Miller, K; Kozlov, AV; Krempler, F; Knapp, S; Lumeng, CN; Patsch, W; Wagner, O; Pospisilik, JA; Esterbauer, H				Jais, Alexander; Einwallner, Elisa; Sharif, Omar; Gossens, Klaus; Lu, Tess Tsai-Hsiu; Soyal, Selma M.; Medgyesi, David; Neureiter, Daniel; Paier-Pourani, Jamile; Dalgaard, Kevin; Duvigneau, J. Catharina; Lindroos-Christensen, Josefine; Zapf, Thea-Christin; Amann, Sabine; Saluzzo, Simona; Jantscher, Florian; Stiedl, Patricia; Todoric, Jelena; Martins, Rui; Oberkofler, Hannes; Mueller, Simone; Hauser-Kronberger, Cornelia; Kenner, Lukas; Casanova, Emilio; Sutterluety-Fall, Hedwig; Bilban, Martin; Miller, Karl; Kozlov, Andrey V.; Krempler, Franz; Knapp, Sylvia; Lumeng, Carey N.; Patsch, Wolfgang; Wagner, Oswald; Pospisilik, J. Andrew; Esterbauer, Harald			Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man	CELL			English	Article							ADIPOSE-TISSUE; UP-REGULATION; IKK-BETA; MACROPHAGE POLARIZATION; MITOCHONDRIAL-FUNCTION; COBALT PROTOPORPHYRIN; METABOLIC HOMEOSTASIS; GENE-EXPRESSION; OBESITY; INFLAMMATION	Obesity and diabetes affect more than half a billion individuals worldwide. Interestingly, the two conditions do not always coincide and the molecular determinants of "healthy" versus "unhealthy" obesity remain ill-defined. Chronic metabolic inflammation (metaflammation) is believed to be pivotal. Here, we tested a hypothesized anti-inflammatory role for heme oxygenase-1 (HO-1) in the development of metabolic disease. Surprisingly, in matched biopsies from "healthy" versus insulin-resistant obese subjects we find HO-1 to be among the strongest positive predictors of metabolic disease in humans. We find that hepatocyte and macrophage conditional HO-1 deletion in mice evokes resistance to diet-induced insulin resistance and inflammation, dramatically reducing secondary disease such as steatosis and liver toxicity. Intriguingly, cellular assays show that HO-1 defines prestimulation thresholds for inflammatory skewing and NF-kappa B amplification in macrophages and for insulin signaling in hepatocytes. These findings identify HO-1 inhibition as a potential therapeutic strategy for metabolic disease.	[Jais, Alexander; Einwallner, Elisa; Sharif, Omar; Lindroos-Christensen, Josefine; Zapf, Thea-Christin; Amann, Sabine; Saluzzo, Simona; Jantscher, Florian; Todoric, Jelena; Martins, Rui; Kenner, Lukas; Casanova, Emilio; Sutterluety-Fall, Hedwig; Bilban, Martin; Knapp, Sylvia; Wagner, Oswald; Esterbauer, Harald] Med Univ Vienna, A-1090 Vienna, Austria; [Sharif, Omar; Saluzzo, Simona; Martins, Rui; Knapp, Sylvia] Austrian Acad Sci, Res Ctr Mol Med, CeMM, A-1090 Vienna, Austria; [Gossens, Klaus; Lu, Tess Tsai-Hsiu; Medgyesi, David; Dalgaard, Kevin; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Soyal, Selma M.; Neureiter, Daniel; Oberkofler, Hannes; Hauser-Kronberger, Cornelia; Patsch, Wolfgang] Paracelsus Med Univ, A-5020 Salzburg, Austria; [Medgyesi, David] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Paier-Pourani, Jamile; Kozlov, Andrey V.] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria; [Duvigneau, J. Catharina; Mueller, Simone; Kenner, Lukas] Univ Vet Med Vienna, A-1210 Vienna, Austria; [Stiedl, Patricia; Kenner, Lukas; Casanova, Emilio] Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria; [Miller, Karl; Krempler, Franz] Gen Hosp Hallein, A-5400 Hallein, Austria; [Lumeng, Carey N.] Univ Michigan, Ann Arbor, MI 48109 USA	Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society; Paracelsus Private Medical University; University of Freiburg; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute; University of Michigan System; University of Michigan	Pospisilik, JA (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	pospisilik@ie-freiburg.mpg.de; harald.esterbauer@meduniwien.ac.at	Casanova, Emilio/Y-6553-2019; Knapp, Sylvia/J-3973-2013; Jais, Alexander/AAQ-9102-2021; Duvigneau, J. Catharina/AAE-6992-2019; Martins, Rui/M-9606-2016	Casanova, Emilio/0000-0001-7992-5361; Knapp, Sylvia/0000-0001-9016-5244; Jais, Alexander/0000-0002-9897-4983; Martins, Rui/0000-0001-8106-6324; Kenner, Lukas/0000-0003-2184-1338; Esterbauer, Harald/0000-0001-7343-7455; Kozlov, Andrey/0000-0002-0834-4997; Saluzzo, Simona/0000-0003-2675-4014; Duvigneau, Johanna Catharina/0000-0002-2433-3120; Bilban, Martin/0000-0001-7043-7142; Sharif, Omar/0000-0001-7899-2343; Sutterluty-Fall, Hedwig/0000-0001-9249-9299	Vienna Science and Technology Fund; Max-Planck Society; Austrian Diabetes Association; Medical Scientific Fund of the Mayor of the City of Vienna; Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie; National Institutes of Health [DK090262]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090262] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [V 344] Funding Source: researchfish	Vienna Science and Technology Fund; Max-Planck Society(Max Planck Society); Austrian Diabetes Association; Medical Scientific Fund of the Mayor of the City of Vienna; Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Vienna Science and Technology Fund (J.A.P. and H.E.), the Max-Planck Society (J.A.P.), the Austrian Diabetes Association (H.E.), the Medical Scientific Fund of the Mayor of the City of Vienna (E.E.), the Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie (E.E.), and a grant from the National Institutes of Health (DK090262, C.N.L.). The authors are grateful to J. Husa, J. Kacerovsky, I. Miller, G. Mitterer, M. Ozsvar Kozma, and M. Ruf for critical technical and theoretical help.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Calay ES, 2013, NAT MED, V19, P265, DOI 10.1038/nm.3114; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055369; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Koliaraki V, 2011, ADV EXP MED BIOL, V780, P101, DOI 10.1007/978-1-4419-5632-3_9; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Qatanani M, 2013, DIABETES, V62, P855, DOI 10.2337/db12-0399; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shakeri-Manesch S, 2009, INT J OBESITY, V33, P1257, DOI 10.1038/ijo.2009.160; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zheng JY, 2008, MOL CELL BIOCHEM, V319, P153, DOI 10.1007/s11010-008-9888-0	59	190	194	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					25	40		10.1016/j.cell.2014.04.043	http://dx.doi.org/10.1016/j.cell.2014.04.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995976	Green Accepted, Bronze			2022-12-28	WOS:000340943100005
J	Boles, MA; Talapin, DV				Boles, Michael A.; Talapin, Dmitri V.			Connecting the dots	SCIENCE			English	Editorial Material							ORIENTED ATTACHMENT; NANOPARTICLES; NANOWIRES		[Boles, Michael A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Boles, MA (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	dvtalapin@uchicago.edu						Boneschanscher MP, 2014, SCIENCE, V344, P1377, DOI 10.1126/science.1252642; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Kalesaki E, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011010; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Moreels I, 2009, ACS NANO, V3, P3023, DOI 10.1021/nn900863a; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Schliehe C, 2010, SCIENCE, V329, P550, DOI 10.1126/science.1188035; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Vogt P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155501; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zherebetskyy D, 2014, SCIENCE, V344, P1380, DOI 10.1126/science.1252727	12	19	20	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1340	1341		10.1126/science.1256197	http://dx.doi.org/10.1126/science.1256197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948720				2022-12-28	WOS:000337531700017
J	Tetienne, JP; Hingant, T; Kim, JV; Diez, LH; Adam, JP; Garcia, K; Roch, JF; Rohart, S; Thiaville, A; Ravelosona, D; Jacques, V				Tetienne, J-P.; Hingant, T.; Kim, J. -V.; Diez, L. Herrera; Adam, J. -P.; Garcia, K.; Roch, J. -F.; Rohart, S.; Thiaville, A.; Ravelosona, D.; Jacques, V.			Nanoscale imaging and control of domain- wall hopping with a nitrogen- vacancy center microscope	SCIENCE			English	Article							AMBIENT CONDITIONS; DIAMOND; SPIN	The control of domain walls in magnetic wires underpins an emerging class of spintronic devices. Propagation of these walls in imperfect media requires defects that pin them to be characterized on the nanoscale. Using a magnetic microscope based on a single nitrogen-vacancy (NV) center in diamond, we report domain-wall imaging on a 1-nanometer-thick ferromagnetic nanowire and directly observe Barkhausen jumps between two pinning sites spaced 50 nanometers apart. We further demonstrate in situ laser control of these jumps, which allows us to drag the domain wall along the wire and map the pinning landscape. Our work demonstrates the potential of NV microscopy to study magnetic nano-objects in complex media, whereas controlling domain walls with laser light may find an application in spintronic devices.	[Tetienne, J-P.; Hingant, T.; Roch, J. -F.; Jacques, V.] Univ Paris Sud, CNRS, Aime Cotton Lab, F-91405 Orsay, France; [Tetienne, J-P.; Hingant, T.; Roch, J. -F.; Jacques, V.] CNRS, ENS Cachan, UPR 3321, F-91405 Orsay, France; [Tetienne, J-P.; Hingant, T.; Jacques, V.] ENS Cachan, Lab Photon Quant & Mol, F-94235 Cachan, France; [Tetienne, J-P.; Hingant, T.; Jacques, V.] CNRS, UMR 8537, F-94235 Cachan, France; [Kim, J. -V.; Diez, L. Herrera; Adam, J. -P.; Garcia, K.; Ravelosona, D.] Univ Paris Sud, Inst Elect Fondamentale, F-91405 Orsay, France; [Kim, J. -V.; Diez, L. Herrera; Adam, J. -P.; Garcia, K.; Ravelosona, D.] CNRS, UMR 8622, F-91405 Orsay, France; [Rohart, S.; Thiaville, A.] Univ Paris Sud, Phys Solides Lab, F-91405 Orsay, France; [Rohart, S.; Thiaville, A.] CNRS, UMR 8502, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Jacques, V (corresponding author), Univ Paris Sud, CNRS, Aime Cotton Lab, F-91405 Orsay, France.	vjacques@ens-cachan.fr	Jacques, Vincent/D-3881-2014; Tetienne, Jean-Philippe/H-4896-2014; Adam, Jean-Paul/G-5705-2013; TETIENNE, Jean-Philippe/Q-4171-2019; ravelosona, dafine/A-5066-2016; Kim, Joo-Von/B-3672-2008; Rohart, Stanislas/H-3814-2017; Garcia, Karin/A-6039-2013	Tetienne, Jean-Philippe/0000-0001-5796-2508; Adam, Jean-Paul/0000-0003-2025-7105; TETIENNE, Jean-Philippe/0000-0001-5796-2508; ravelosona, dafine/0000-0002-4072-1457; Kim, Joo-Von/0000-0002-3849-649X; Rohart, Stanislas/0000-0001-7772-1306; Herrera Diez, Liza/0000-0002-2058-4272; Garcia, Karin/0000-0002-4528-8592	European Community's Seventh Framework Programme (FP7) [611143, 257707]; French Agence Nationale de la Recherche through the project DIAMAG; French Agence Nationale de la Recherche through the project FRIENDS; French Agence Nationale de la Recherche through the project ELECMADE; C'Nano Ile-de-France (NANOMAG)	European Community's Seventh Framework Programme (FP7); French Agence Nationale de la Recherche through the project DIAMAG(French National Research Agency (ANR)); French Agence Nationale de la Recherche through the project FRIENDS(French National Research Agency (ANR)); French Agence Nationale de la Recherche through the project ELECMADE(French National Research Agency (ANR)); C'Nano Ile-de-France (NANOMAG)	We thank L. Rondin, O. Boulle, G. Gaudin, L. Vila, and B. Ocker for experimental assistance and fruitful discussions. The research has been partially funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements 611143 (DIADEMS) and 257707 (MAGWIRE); the French Agence Nationale de la Recherche through the projects DIAMAG, FRIENDS, and ELECMADE; and C'Nano Ile-de-France (NANOMAG).	Astakhov GV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037204; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Burgess JAJ, 2013, SCIENCE, V339, P1051, DOI 10.1126/science.1231390; Burrowes C, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826439; Chanthbouala A, 2011, NAT PHYS, V7, P626, DOI [10.1038/nphys1968, 10.1038/NPHYS1968]; Chen G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177204; Chernobrod BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1829373; Chizhik A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3460292; Degen CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2943282; Devolder T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4775684; Grinolds MS, 2013, NAT PHYS, V9, P215, DOI [10.1038/NPHYS2543, 10.1038/nphys2543]; Hayashi M, 2008, SCIENCE, V320, P209, DOI 10.1126/science.1154587; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/NMAT2804, 10.1038/nmat2804]; Im MY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147204; Klaui M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.026601; Lemerle S, 1998, PHYS REV LETT, V80, P849, DOI 10.1103/PhysRevLett.80.849; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Meckler S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.157201; Metaxas PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217208; Mohrke P, 2010, SOLID STATE COMMUN, V150, P489, DOI 10.1016/j.ssc.2009.11.040; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Rondin L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3279; Rondin L, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3703128; Schwarz A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077206; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Tetienne JP, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.214408; Toyli DM, 2013, P NATL ACAD SCI USA, V110, P8417, DOI 10.1073/pnas.1306825110; Yamanouchi M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4808033	29	137	141	4	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1366	1369		10.1126/science.1250113	http://dx.doi.org/10.1126/science.1250113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948732				2022-12-28	WOS:000337531700032
J	Biesecker, LG; Green, RC				Biesecker, Leslie G.; Green, Robert C.			Diagnostic Clinical Genome and Exome Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INCIDENTAL FINDINGS; VARIANTS; DISEASE; IMPACT		[Biesecker, Leslie G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Green, Robert C.] Harvard Univ, Sch Med, Boston, MA USA; [Green, Robert C.] Partners Healthcare Personalized Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System	Biesecker, LG (corresponding author), 49 Convent Dr,Rm 4A56, Bethesda, MD 20892 USA.	lesb@mail.nih.gov	Biesecker, Leslie/AAG-2526-2021	Virani, Alice/0000-0003-1374-3172; Visseren, Frank/0000-0003-3951-5223	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328, ZIAHG200388, ZIAHG200359] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ACMG Board of Directors, 2013, Genet Med, V15, P748, DOI 10.1038/gim.2013.94; Altmuller J, 2014, BIOL CHEM, V395, P231, DOI 10.1515/hsz-2013-0199; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Biesecker L, 2012, HUM MUTAT, V33, P1501, DOI 10.1002/humu.22131; Blue Cross and Blue Shield Association, 2013, Technol Eval Cent Assess Program Exec Summ, V28, P1; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Green RC, 2013, GENOMIC AND PERSONALIZED MEDICINE, VOL 1-2, 2ND EDITION, P102, DOI 10.1016/B978-0-12-382227-7.00009-4; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; Johnston JJ, 2013, HUM MOL GENET, V22, pR27, DOI 10.1093/hmg/ddt384; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Pyeritz RE, 2012, GENET MED, V14, P171, DOI [10.1038/gim.2012.74, 10.1038/gim.2011.48]; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Stein LD, 2011, CURR PROTOC BIOINFOR; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Vassy JL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-85; Wallace AJ, 2004, GENET TEST, V8, P368, DOI 10.1089/gte.2004.8.368; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	23	375	379	0	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2418	2425		10.1056/NEJMra1312543	http://dx.doi.org/10.1056/NEJMra1312543			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24941179				2022-12-28	WOS:000337353000010
J	Lu, CY; Zhang, F; Lakoma, MD; Madden, JM; Rusinak, D; Penfold, RB; Simon, G; Ahmedani, BK; Clarke, G; Hunkeler, EM; Waitzfelder, B; Owen-Smith, A; Raebel, MA; Rossom, R; Coleman, KJ; Copeland, LA; Soumerai, SB				Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Rusinak, Donna; Penfold, Robert B.; Simon, Gregory; Ahmedani, Brian K.; Clarke, Gregory; Hunkeler, Enid M.; Waitzfelder, Beth; Owen-Smith, Ashli; Raebel, Marsha A.; Rossom, Rebecca; Coleman, Karen J.; Copeland, Laurel A.; Soumerai, Stephen B.			Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERRUPTED TIME-SERIES; PEDIATRIC SUICIDALITY; E-CODES; RISK; DEPRESSION; ADOLESCENTS; FLUOXETINE; CHILDREN; DECLINE; TRENDS	Objective To investigate if the widely publicized warnings in 2003 from the US Food and Drug Administration about a possible increased risk of suicidality with antidepressant use in young people were associated with changes in antidepressant use, suicide attempts, and completed suicides among young people. Design Quasi-experimental study assessing changes in outcomes after the warnings, controlling for pre-existing trends. Setting Automated healthcare claims data (2000-10) derived from the virtual data warehouse of 11 health plans in the US Mental Health Research Network. Participants Study cohorts included adolescents (around 1.1 million), young adults (around 1.4 million), and adults (around 5 million). Main outcome measures Rates of antidepressant dispensings, psychotropic drug poisonings (a validated proxy for suicide attempts), and completed suicides. Results Trends in antidepressant use and poisonings changed abruptly after the warnings. In the second year after the warnings, relative changes in antidepressant use were -31.0% (95% confidence interval -33.0% to -29.0%) among adolescents, -24.3% (-25.4% to -23.2%) among young adults, and -14.5% (-16.0% to -12.9%) among adults. These reflected absolute reductions of 696, 1216, and 1621 dispensings per 100 000 people among adolescents, young adults, and adults, respectively. Simultaneously, there were significant, relative increases in psychotropic drug poisonings in adolescents (21.7%, 95% confidence interval 4.9% to 38.5%) and young adults (33.7%, 26.9% to 40.4%) but not among adults (5.2%, -6.5% to 16.9%). These reflected absolute increases of 2 and 4 poisonings per 100 000 people among adolescents and young adults, respectively (approximately 77 additional poisonings in our cohort of 2.5 million young people). Completed suicides did not change for any age group. Conclusions Safety warnings about antidepressants and widespread media coverage decreased antidepressant use, and there were simultaneous increases in suicide attempts among young people. It is essential to monitor and reduce possible unintended consequences of FDA warnings and media reporting.	[Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Soumerai, Stephen B.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Soumerai, Stephen B.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Penfold, Robert B.; Simon, Gregory] Grp Hlth Res Inst, Seattle, WA USA; [Penfold, Robert B.] Univ Washington, Dept Hlth Serv Res, Seattle, WA 98195 USA; [Simon, Gregory] Mental Hlth Res Network, Detroit, MI USA; [Ahmedani, Brian K.] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Clarke, Gregory] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Hunkeler, Enid M.] Kaiser Permanente Med Care Program Northern Calif, Div Res, Oakland, CA USA; [Waitzfelder, Beth] Kaiser Permanente Ctr Hlth Res Hawaii, Honolulu, HI USA; [Owen-Smith, Ashli] Kaiser Permanente Georgia, Ctr Hlth Res Southeast, Atlanta, GA USA; [Raebel, Marsha A.] Kaiser Permanente Colorado Inst Hlth Res, Denver, CO USA; [Rossom, Rebecca] HealthPartners Inst Educ & Res, Bloomington, MN USA; [Coleman, Karen J.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst Jointly Scott & Whi, Ctr Appl Hlth Res, Temple, TX USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Washington; University of Washington Seattle; Henry Ford Health System; Henry Ford Hospital; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; HealthPartners Institute for Education & Research; Kaiser Permanente	Lu, CY (corresponding author), 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	christine_lu@harvardpilgrim.org	Rossom, Rebecca/R-7103-2019; Copeland, Laurel A/C-3763-2017; Zhang, Fang/HHN-2153-2022	Copeland, Laurel A/0000-0002-9478-0209; Rossom, Rebecca/0000-0002-9531-914X	US National Institute of Mental Health [U19MH092201]; Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK) [1P30-DK092924]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH092201] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This research was supported by a cooperative agreement (U19MH092201; principal investigator, GS) with the US National Institute of Mental Health; SBS was the study principal investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The sponsor had no role in the design and conduct of the study; analysis, and interpretation of the data; the preparation of the manuscript; and the decision to submit the manuscript for publication. SBS was supported in part by the Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK grant 1P30-DK092924).	Baldessarini RJ, 2006, ARCH GEN PSYCHIAT, V63, P246, DOI 10.1001/archpsyc.63.3.246; Barry CL, 2010, PEDIATRICS, V125, P88, DOI 10.1542/peds.2009-0792; Busch SH, 2010, PSYCHIAT SERV, V61, P11, DOI 10.1176/appi.ps.61.1.11; Centers for Disease Control and Prevention, 2011, STRATEGIES PREVENT O, P60; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P321; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; FDA, 2007, QUEST ANSW ANT US CH; FDA, 2004, JOINT M PSYCH DRUGS; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P580, DOI 10.1001/archgenpsychiatry.2011.2048; Gibbons RD, 2011, DRUG SAFETY, V34, P375, DOI 10.2165/11589350-000000000-00000; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harris G, 2004, NY TIMES; Hornbrook Mark C, 2005, J Natl Cancer Inst Monogr, P12; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kaizar EE, 2006, CLIN TRIALS, V3, P96; Kaizar EE, 2006, CLIN TRIALS, V3, P73, DOI 10.1191/1740774506cn139oa; Klein DF, 2006, NEUROPSYCHOPHARMACOL, V31, P689, DOI 10.1038/sj.npp.1300996; Leckman JF, 2007, AM J PSYCHIAT, V164, P1304, DOI 10.1176/appi.ajp.2007.07050880; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lu CY, 2014, PHARMACOEPIDEM DR S, V23, P218, DOI 10.1002/pds.3551; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; March JS, 2007, ARCH GEN PSYCHIAT, V64, P1132; Morrato EH, 2008, AM J PSYCHIAT, V165, P42, DOI 10.1176/appi.ajp.2007.07010205; National Institute of Mental Health, 2013, SUIC US STAT PREV; Olfson M, 2008, J CLIN PSYCHIAT, V69, P425, DOI 10.4088/JCP.v69n0313; Pamer CA, 2010, PHARMACOEPIDEM DR S, V19, P158, DOI 10.1002/pds.1886; Patrick AR, 2010, PHARMACOEPIDEM DR S, V19, P1263, DOI 10.1002/pds.2037; Schneeweiss S, 2010, ARCH GEN PSYCHIAT, V67, P497, DOI 10.1001/archgenpsychiatry.2010.39; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; Simon GE, 2006, NEW ENGL J MED, V355, P2722, DOI 10.1056/NEJMp068270; SOUMERAI SB, 1992, MILBANK Q, V70, P155, DOI 10.2307/3350088; Spettell CM, 2003, HEALTH SERV RES, V38, P1081, DOI 10.1111/1475-6773.00164; Spiller HA, 2010, LEGAL MED, V12, P177, DOI 10.1016/j.legalmed.2010.04.005; Strom BL, 2012, PHARMACOEPIDEMIOLOGY, V5th, P163; Ting SA, 2012, GEN HOSP PSYCHIAT, V34, P557, DOI 10.1016/j.genhosppsych.2012.03.020; Townsend L, 2012, PHARMACOEPIDEM DR S, V21, P163, DOI 10.1002/pds.2310; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007; Vedantam S, 2004, WASHINGTON POST; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wagner Edward H, 2005, J Natl Cancer Inst Monogr, P3, DOI 10.1093/jncimonographs/lgi032; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	43	119	120	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2014	348								g3596	10.1136/bmj.g3596	http://dx.doi.org/10.1136/bmj.g3596			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LF	24942789	Green Published, hybrid			2022-12-28	WOS:000337805600001
J	Bushnell, C; McCullough, L				Bushnell, Cheryl; McCullough, Louise			Stroke Prevention in Women: Synopsis of the 2014 American Heart Association/American Stroke Association Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; HEALTH-CARE PROFESSIONALS; SEX-DIFFERENCES; ISCHEMIC-STROKE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; GENDER-DIFFERENCES; OUTCOMES	Description: In February 2014, the American Heart Association/American Stroke Association released their first guideline focused on stroke prevention in women. This new guideline highlights unique risk factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associated disorders, such as preeclampsia, that may have long-lasting consequences on a woman's health. It also addresses hypertension; atrial fibrillation; migraine headache with aura; and the epidemiology of types of stroke, such as aneurysmal subarachnoid hemorrhage and cerebral vein thrombosis, that are predominant in women. Methods: Members of a multidisciplinary expert panel searched, reviewed, and critiqued relevant English-language literature published between 1990 and May 2013. The panel devised evidence tables and developed recommendations using American Heart Association guideline procedures and levels of evidence. Recommendations: This synopsis of the guideline summarizes the evidence about risk factors for stroke in women and suggests prevention strategies. It also describes the new recommendations relevant to identifying and treating hypertensive disorders in pregnancy that increase risk for stroke.	[Bushnell, Cheryl] Wake Forest Baptist Med Ctr, Winston Salem, NC 27157 USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA; Hartford Hosp, Stroke Ctr, Hartford, CT 06115 USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Connecticut; Hartford Hospital	Bushnell, C (corresponding author), Wake Forest Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cbushnel@wakehealth.edu	McCullough, Louise/R-2824-2019		Hazel K. Goddess Fund for Stroke Research in Women; World Federation of Neurology; National Institutes of Health [RO1 NS055215, RO1 NS077769, R21 NS082906]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077769, R21NS082906, R01NS055215] Funding Source: NIH RePORTER	Hazel K. Goddess Fund for Stroke Research in Women; World Federation of Neurology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Bushnell is supported the Hazel K. Goddess Fund for Stroke Research in Women and the World Federation of Neurology. Dr. McCullough is supported by grants RO1 NS055215, RO1 NS077769, and R21 NS082906 from the National Institutes of Health.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Berry JD, 2014, CIRCULATION, V129, P399, DOI DOI 10.1161/01.CIR.0000442015.53336.12; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Bushnell CD, 2014, NEUROLOGY, V82, P922, DOI 10.1212/WNL.0000000000000208; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gall SL, 2012, STROKE, V43, P1982, DOI 10.1161/STROKEAHA.111.632547; Gargano JW, 2007, STROKE, V38, P2541, DOI 10.1161/STROKEAHA.107.485482; Giralt D, 2012, ACTA NEUROL SCAND, V125, P83, DOI 10.1111/j.1600-0404.2011.01514.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gray LJ, 2007, STROKE, V38, P2960, DOI 10.1161/STROKEAHA.107.488304; Howard VJ, 2011, LANCET NEUROL, V10, P530, DOI 10.1016/S1474-4422(11)70080-1; Jacobs AK, 2013, CIRCULATION, V127, P268, DOI 10.1161/CIR.0b013e31827e8e5f; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2009, NEUROLOGY, V73, P581, DOI 10.1212/WNL.0b013e3181ab2c20; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Merikangas KR, 2013, HEADACHE, V53, P230, DOI 10.1111/head.12038; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pan A, 2011, STROKE, V42, P2770, DOI 10.1161/STROKEAHA.111.617043; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Peters SA, 2014, LANCET; Poisson SN, 2010, STROKE, V41, P1891, DOI 10.1161/STROKEAHA.110.580977; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Sturm JW, 2004, STROKE, V35, P2340, DOI 10.1161/01.STR.0000141977.18520.3b; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	35	35	37	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					853	U71		10.7326/M14-0762	http://dx.doi.org/10.7326/M14-0762			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935489	Green Accepted			2022-12-28	WOS:000337374900020
J	Van Lerberghe, W; Matthews, Z; Achadi, E; Ancona, C; Campbell, J; Channon, A; de Bernis, L; De Brouwere, V; Fauveau, V; Fogstad, H; Koblinsky, M; Liljestrand, J; Mechbal, A; Murray, SF; Rathavay, T; Rehr, H; Richard, F; ten Hoope-Bender, P; Turkmani, S				Van Lerberghe, Wim; Matthews, Zoe; Achadi, Endang; Ancona, Chiara; Campbell, James; Channon, Amos; de Bernis, Luc; De Brouwere, Vincent; Fauveau, Vincent; Fogstad, Helga; Koblinsky, Marge; Liljestrand, Jerker; Mechbal, Abdelhay; Murray, Susan F.; Rathavay, Tung; Rehr, Helen; Richard, Fabienne; ten Hoope-Bender, Petra; Turkmani, Sabera			Country experience with strengthening of health systems and deployment of midwives in countries with high maternal mortality	LANCET			English	Article							OBSTETRIC COMPLICATIONS; CESAREAN-SECTION; BURKINA-FASO; CARE; BIRTH; MANAGEMENT; SERVICES; DISTRICT; PROGRESS; MOROCCO	This paper complements the other papers in the Lancet Series on midwifery by documenting the experience of low-income and middle-income countries that deployed midwives as one of the core constituents of their strategy to improve maternal and newborn health. It examines the constellation of various diverse health-system strengthening interventions deployed by Burkina Faso, Cambodia, Indonesia, and Morocco, among which the scaling up of the pre-service education of midwives was only one element. Efforts in health system strengthening in these countries have been characterised by: expansion of the network of health facilities with increased uptake of facility birthing, scaling up of the production of midwives, reduction of financial barriers, and late attention for improving the quality of care. Overmedicalisation and respectful woman-centred care have received little or no attention.	[Achadi, Endang] Univ Indonesia, Fac Publ Hlth, Ctr Family Welf, Depok, West Java, Indonesia; [Campbell, James; ten Hoope-Bender, Petra] Inst Cooperac Social Integrare, Barcelona, Spain; [Channon, Amos] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Van Lerberghe, Wim; de Bernis, Luc] UN Populat Fund, Geneva, Switzerland; [Fauveau, Vincent] Holist Sante, Montpellier, France; [De Brouwere, Vincent] Woman & Child Hlth Res Ctr, Inst Trop Med, Antwerp, Belgium; [Koblinsky, Marge] US Agcy Int Dev, Washington, DC 20523 USA; [Liljestrand, Jerker] Lund Univ, S-22100 Lund, Sweden; [Matthews, Zoe] Univ Southampton, Evidence Act, Southampton, Hants, England; [Murray, Susan F.] Kings Coll London, Inst Int Dev, London WC2R 2LS, England; [Rehr, Helen] Evidence Act, London, England; [Richard, Fabienne] Inst Trop Med, B-2000 Antwerp, Belgium; [Rathavay, Tung] Natl Reprod Hlth Program, Phnom Penh, Cambodia; [Turkmani, Sabera] Jhpiego, Afghan Midw Assoc, Kabul, Afghanistan; [Van Lerberghe, Wim] WHO, Reg Off Europe, Athens 11521, Greece	University of Indonesia; University of Southampton; United Nations Population Fund; Institute of Tropical Medicine (ITM); United States Agency for International Development (USAID); Lund University; University of Southampton; University of London; King's College London; Institute of Tropical Medicine (ITM); Jhpiego; World Health Organization	Van Lerberghe, W (corresponding author), WHO, Reg Off Europe, Athens 11521, Greece.	wvl@euro.who.int	Matthews, Zoe/HGD-0506-2022; Turkmani, Sabera/G-2037-2015; Turkmani, Sabera/AAS-9438-2020	Turkmani, Sabera/0000-0001-7819-5061; Turkmani, Sabera/0000-0001-7819-5061; Channon, Andrew/0000-0003-4855-0418; Matthews, Zoe/0000-0003-1533-6618	Bill & Melinda Gates Foundation [OPP1042500]; ICS Integrare; University of York; University of Dundee	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); ICS Integrare; University of York(European Commission); University of Dundee	The work on this paper was supported partly through a grant from the Bill & Melinda Gates Foundation (OPP1042500) and additional support from ICS Integrare, the University of York, and the University of Dundee. Julie Glanville from the York Health Economics Consortium contributed to the literature searches, and the Midwives Information and Resource Service (MIDIRS) supported the search work. PtH-B's work was supported by the Institut de Cooperacion Social Integrare. The funding organisations had no role in the undertaking of the analysis and synthesis of the findings of this report. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers. Jenny Brown and Tracy Sparey provided administrative support, and Natalie Muir provided project support. We thank the close readers and colleagues who made helpful contributions: Hamid Ashwal, Hilda Bonilla, Mickey Chopra, Bernadette Daelmans; Frances Day-Stirk, Eugene Declerc, France Donnay, Soo Downe; Elizabeth Goodburn, Wendy Graham, Isaline Greindl, Caroline Homer, Louise Hulton, Peter Johnson, Fran McConville, Blerta Maliqi, Liz Mason, Matthews Mathai, Remo Meloni, Nester Moyo; Mary Renfrew, Arul Sabaratum, Kate Somers, Kate Teela, and Veronica Walford.	Abouchadi S, 2013, TROP MED INT HEALTH, V18, P444, DOI 10.1111/tmi.12065; AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; Abouzahr C., 2010, MAKING SENSE MATERNA; Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; Annear Peter Leslie, 2008, STUDIES HSO P, V23, P189; [Anonymous], 2011, MON MAT NEWB CHILD H; [Anonymous], 2011, HLTH FAC SURV; [Anonymous], 1996, KINGD CAMB HLTH COV; Australia Indonesia Partnership for Maternal and Neonatal Health, 2008, SURV MIDW 3 DISTR NU; Bachelet M., 2012, COMMUNICATION; Badan Pusat Statistik-Statistics Indonesia (BPS) and ORC Macro, 2003, IND DEM HLTH SURV 20; Bailey P, 2006, INT J GYNECOL OBSTET, V93, P292, DOI 10.1016/j.ijgo.2006.01.029; Barber S, 2004, HEALTH POLICY PLANN, V19, P199, DOI 10.1093/heapol/czh025; Beaglehole R., 2003, WORLD HLTH REPORT 20; Bennis I, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-3; Berer M, 2012, REPROD HEALTH MATTER, V20, P5, DOI 10.1016/S0968-8080(12)39632-8; Bowser D, 2010, EXPLORING EVIDENCE D; Bulatao A, 2001, RATINGS MATERNAL NEO; Burkina Faso Ministere de la Sante, 2000, PLAN NAT DEV SAN 200; Burkina Faso Ministere de la Sante, 2001, POL NORM PROT SERV S; Burkina Faso Ministere de la Sante Publique, 2004, ANN STAT 2003; Burkina Faso. Ministere de la Sante Publique, 2013, ANN STAT 2012; Cambodia Ministry of Health, 2008, HLTH STRAT PLAN 2008; Central Bureau of Statistics Indonesia National Family Planning Coordinating Board Ministry of Health Indonesia Macro International, 1992, IND DEM HLTH SURV 19; De Brouwere V, 2001, STUDIES HLTH SERVICE, V17, P1; De Silva A, 2002, INVESTING MATERNAL H; DEBROUWERE V, 1998, BESOINS OBSTET NONCO; Drhimeur A., 2013, INT C NAT SANT 1 3 J; Edmond J, 2002, MATERNAL HLTH FINANC; Eng S, 2014, QUALITY MAT IN PRESS; Ensor T, 2008, EUR J HEALTH ECON, V9, P385, DOI 10.1007/s10198-007-0094-x; Ergo A, 2011, STRENGTHENING HLTH S; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; Fort C, PRIVATE SECTOR ASSES; Fujita N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002685; Goodburn E, 2001, BRIT MED J, V322, P917, DOI 10.1136/bmj.322.7291.917; Homer CSE, 2014, LANCET, V384, P1146, DOI 10.1016/S0140-6736(14)60790-X; Hort K, 2011, HLTH POLICY HLTH FIN, V12, P1; Hounton SH, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-34; IBI Indonesian Midwives Association, 2012, MON ARCH         OCT; Institut National de la Statistique et de la Demographie et Macro International Inc, 1994, ENQ DEM SANT BURK FA; Institut National de la Statistique et de la Demographie (INSD) et ICF International, 2012, ENQ DEM SANT IND MUL; Institut National de la Statistique et de la Demographie (INSD) Ministere de l'Economie et des Finances et ICF International, 2011, ENQ DEM SANT IND MUL; Jaffre Y., 2003, MED INHOSPITALIERE D; Jahn A, 2001, SAFE MOTHERHOOD STRA; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kingdom of Morocco Ministry of Health UNFPA, 2011, RED MAT MORT MOR SHA; Koblinsky M., 2003, REDUCING MATERNAL MO; Koblinsky MA, 2003, REDUCING MATERNAL MO, P1; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kremer M, 2006, CONTRACTING HLTH EVI; Lassi ZS, 2013, B WORLD HEALTH ORGAN, V91, P824, DOI 10.2471/BLT.13.118786; Liljestrand J, 2010, INT J GYNECOL OBSTET, V111, P188, DOI 10.1016/j.ijgo.2010.06.002; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Malqvist M, 2013, B WORLD HEALTH ORGAN, V91, P254, DOI 10.2471/BLT.12.112425; Marouani Y.`, 2019, PUBLICATIONS MINISTE; McDonagh M, 2001, SAFE MOTHERHOOD STRA, P367; Ministry of Health Cambodia, 2007, JOINT ANN PERF REV; Ministry of Health Cambodia, 2006, MIDT REV REP 2003 JU; Ministry of Health Cambodia, 2008, HLTH STRAT PLAN 2008; Ministry of Health Kingdom of Cambodia, 2009, IMPL HLTH EQ FUNDS G; Ministry of National Development Planning/National Development Planning Agency (BAPPENAS), 2010, ROADM ACC ACH MDGS I; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; Muffler N, 2007, TROP MED INT HEALTH, V12, P1248, DOI 10.1111/j.1365-3156.2007.01911.x; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; National Institute of Statistics Directorate General for Health and ICF Macro, 2011, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health [Cambodia] and ORC Macro, 2006, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health ORC Macro, 2001, CAMB DEM HLTH SURV 2; Ooms G, 2012, FACTS VIEWS VIS OBGY, V4, P11; Ouedraogo L T, 2003, Sante, V13, P17; Pujiyanto, 2009, SAKIT PEMISKINAN MDG; RACHA, 1999, TRAIN EMPL ACT LEV C; RACHA, 1999, TRAIL STUD CAMB MIDW; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Richard F, 2007, TROP MED INT HEALTH, V12, P972, DOI 10.1111/j.1365-3156.2007.01877.x; Richard F, 2003, PROGRAMME AMELIORATI; Ridde V, 2011, HEALTH POLICY PLANN, V26, P1, DOI 10.1093/heapol/czq021; Rokx C, 2010, FINANCING INDONESIA; Royaume du Maroc Ministere de la Sante, 2012, ENQ NAT POP SANT FAM; Royaume du Maroc Ministere de la Sante, 2013, LIVR BLANC NOUV GOUV; Royaume du Maroc Ministere de la Sante, 2012, SANT MAR CHIFFR 2011; Royaume du Maroc Ministere de la Sante, 2010, PLAN NAT 2008 2012 A; Royaume du Maroc Ministere de la Sante et Ministere de la Sante Publique. Division de la Planification de la Statistique et de l'Informatique Service & Macro International DHS, 2011, RED MORT MAT MAR PAR; Royaume du Maroc Ministere de la Sante et Ministere de la Sante Publique. Division de la Planification de la Statistique et de l'Informatique Service & Macro International DHS, 1992, ENPS21992 SEIS ROYAU; Satriyo HA, 2008, 10 YEARS REFORMASI W; Secretariat General-Direction General de la Sante, 2006, PLAN MIS OEUVR STRAT; Sherratt DR., 2006, FINAL REPORT COMPREH; Soeters R, 2003, HEALTH POLICY PLANN, V18, P74, DOI 10.1093/heapol/18.1.74; Soura Y, 2005, RAPPORT MISSION ATEL; Statistics Indonesia (Badan Pusat Statistik-BPS) and Macro International, 2008, IND DEM HLTH SURV 20; Statistics Indonesia (Badan Pusat Statistik-BPS) National Population and Family Planning Board (BKKBN) International Kementerian Kesehatan (Kemenkes-MOH) ICF, 2013, IND DEM HLTH SURV 20; Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011; Temmar F, 2006, REPROD HEALTH MATTER, V14, P83, DOI 10.1016/S0968-8080(06)27245-8; UNFPA, 2011, STAT WORLDS MIDW 201; UNFPA UNICEF WHO World Bank, 2012, TRENDS MAT MORT 1990; UNICEF, 2014, BURK FAS COUNTR STAT; Utz B, 2013, ACTA OBSTET GYN SCAN, V92, P1063, DOI 10.1111/aogs.12166; Van Lerberghe W., 2001, SAFER MOTHERHOOD COM; Von Schreeb S., 2000, SURVEY ESSENTIAL OBS; Walford V, 1999, MIDTERM REV HLTH SEC; Walt G, 2004, BRIT MED J, V328, P6, DOI 10.1136/bmj.328.7430.6; WHO, 2006, US HUM RIGHTS MAT NE; WHO UNICEF, 2013, ACC MAT NEWB CHILD S; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Wilkinson D, 2001, IMPACT USER FEES ACC; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2014, WORLD BANK DAT PROF; World Bank, 2010, THEN SHE DIED IND MA; World Health Organization, 2005, WORLD HLTH REP 2005	111	131	132	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1215	1225		10.1016/S0140-6736(14)60919-3	http://dx.doi.org/10.1016/S0140-6736(14)60919-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7MT	24965819				2022-12-28	WOS:000343002600028
J	Horton, R; Astudillo, O				Horton, Richard; Astudillo, Olaya			The power of midwifery	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Homer CSE, 2014, LANCET; Renfrew MJ, 2014, LANCET; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; Van Lerberghe W, 2014, LANCET	4	39	42	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1075	+		10.1016/S0140-6736(14)60855-2	http://dx.doi.org/10.1016/S0140-6736(14)60855-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965820				2022-12-28	WOS:000342630600009
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Screening for Abdominal Aortic Aneurysm: U.S. Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VASCULAR-SURGERY; ENDOVASCULAR REPAIR; PRACTICE GUIDELINES; COST-EFFECTIVENESS; CLINICAL-TRIAL; MORTALITY; SOCIETY; SURVEILLANCE; OUTCOMES	Description: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for abdominal aortic aneurysm (AAA). Methods: The USPSTF commissioned a systematic review that assessed the evidence on the benefits and harms of screening for AAA and strategies for managing small (3.0 to 5.4 cm) screen-detected AAAs. Population: These recommendations apply to asymptomatic adults aged 50 years or older. Recommendation: The USPSTF recommends 1-time screening for AAA with ultrasonography in men aged 65 to 75 years who have ever smoked. (B recommendation) The USPSTF recommends that clinicians selectively offer screening for AAA in men aged 65 to 75 years who have never smoked. (C recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for AAA in women aged 65 to 75 years who have ever smoked. (I statement) The USPSTF recommends against routine screening for AAA in women who have never smoked. (D recommendation)							Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Owens reports support from the Agency for Healthcare Research and Quality during the conduct of the study. Authors not named here have disclosed no conflicts of interest. Authors followed the policy regarding conflicts of interest described at www.uspreventive servicestaskforce.org/methods.htm. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-1204.	[Anonymous], RAND PREV VASC SCREE; [Anonymous], 2013, CONSUMER REPORTS; Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Blois B, 2012, CAN FAM PHYSICIAN, V58, pE172; Cao P, 2011, EUR J VASC ENDOVASC, V41, P13, DOI 10.1016/j.ejvs.2010.08.026; Centers for Medicare & Medicaid Services, 2014, YOUR MED COV ABD AOR; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Chun KC, 2013, J VASC SURG, V57, P376, DOI 10.1016/j.jvs.2012.08.038; DARLING RC, 1977, CIRCULATION, V56, P161; Dua A, 2014, J VASC SURG, V59, P1512, DOI 10.1016/j.jvs.2014.01.007; Greco G, 2010, ANN SURG, V252, P675, DOI 10.1097/SLA.0b013e3181f621c8; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Guirguis-Blake JM, 2014, AHRQ PUBLICATION; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; Lederle FA, 2012, EUR J VASC ENDOVASC, V44, P543, DOI 10.1016/j.ejvs.2012.10.002; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Lim LS, 2011, AM J PREV MED, V40, DOI 10.1016/j.amepre.2010.11.021; Lin PH, 2003, AM J SURG, V186, P455, DOI 10.1016/j.amjsurg.2003.07.018; Lindholt JS, 2010, BRIT J SURG, V97, P826, DOI 10.1002/bjs.7001; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lo RC, 2013, J VASC SURG, V57, P1261, DOI 10.1016/j.jvs.2012.11.039; Mastracci TM, 2007, J VASC SURG, V45, P1268, DOI 10.1016/j.jvs.2007.02.041; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Ouriel K, 2010, J VASC SURG, V51, P1081, DOI 10.1016/j.jvs.2009.10.113; Powell JT, 1998, LANCET, V352, P1649; Schermerhorn ML, 2012, ANN SURG, V256, P651, DOI 10.1097/SLA.0b013e31826b4f91; SCOTT RAP, 1995, BRIT J SURG, V82, P1066, DOI 10.1002/bjs.1800820821; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Svensjo S, 2013, BRIT J SURG, V100, P367, DOI 10.1002/bjs.8984; Sweeting MJ, 2012, BRIT J SURG, V99, P655, DOI 10.1002/bjs.8707; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Wanhainen A, 2004, ANN VASC SURG, V18, P287, DOI 10.1007/s10016-004-0021-x	40	169	180	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					281	+		10.7326/M14-1204	http://dx.doi.org/10.7326/M14-1204			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	24957320				2022-12-28	WOS:000342347300018
J	Cohen, IG; Lynch, HF; Curfman, GD				Cohen, I. Glenn; Lynch, Holly Fernandez; Curfman, Gregory D.			When Religious Freedom Clashes with Access to Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, I. Glenn; Lynch, Holly Fernandez] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	14	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					596	599		10.1056/NEJMp1407965	http://dx.doi.org/10.1056/NEJMp1407965			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZL	24988298				2022-12-28	WOS:000340819600005
J	Budkevich, TV; Giesebrecht, J; Behrmann, E; Loerke, J; Ramrath, DJF; Mielke, T; Ismer, J; Hildebrand, PW; Tung, CS; Nierhaus, KH; Sanbonmatsu, KY; Spahn, CMT				Budkevich, Tatyana V.; Giesebrecht, Jan; Behrmann, Elmar; Loerke, Justus; Ramrath, David J. F.; Mielke, Thorsten; Ismer, Jochen; Hildebrand, Peter W.; Tung, Chang-Shung; Nierhaus, Knud H.; Sanbonmatsu, Karissa Y.; Spahn, Christian M. T.			Regulation of the Mammalian Elongation Cycle by Subunit Rolling: A Eukaryotic-Specific Ribosome Rearrangement	CELL			English	Article							AMINOACYL-TRANSFER-RNA; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; EF-TU; GTP HYDROLYSIS; CRYO-EM; COMPLEX; TRANSLOCATION; MECHANISM; SELECTION	The extent to which bacterial ribosomes and the significantly larger eukaryotic ribosomes share the same mechanisms of ribosomal elongation is unknown. Here, we present subnanometer resolution cryoelectron microscopy maps of the mammalian 80S ribosome in the posttranslocational state and in complex with the eukaryotic eEF1A, Val-tRNA, GMPPNP ternary complex, revealing significant differences in the elongation mechanism between bacteria and mammals. Surprisingly, and in contrast to bacterial ribosomes, a rotation of the small subunit around its long axis and orthogonal to the well-known intersubunit rotation distinguishes the posttranslocational state from the classical pre-translocational state ribosome. We term this motion "subunit rolling.'' Correspondingly, a mammalian decoding complex visualized in substates before and after codon recognition reveals structural distinctions from the bacterial system. These findings suggest how codon recognition leads to GTPase activation in the mammalian system and demonstrate that in mammalia subunit rolling occurs during tRNA selection.	[Budkevich, Tatyana V.; Giesebrecht, Jan; Behrmann, Elmar; Loerke, Justus; Ramrath, David J. F.; Mielke, Thorsten; Ismer, Jochen; Hildebrand, Peter W.; Nierhaus, Knud H.; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Budkevich, Tatyana V.; Nierhaus, Knud H.] Max Planck Inst Mol Genet, Abt Vingron, D-14195 Berlin, Germany; [Budkevich, Tatyana V.] Inst Mol Biol & Genet, Grp Prot Biosynthesis, UA-03143 Kiev, Ukraine; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Tung, Chang-Shung; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Sanbonmatsu, Karissa Y.] New Mexico Consortium, Los Alamos, NM 87544 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, CharitePl 1, D-10117 Berlin, Germany.	christian.spahn@charite.de	Behrmann, Elmar/I-5808-2015	Behrmann, Elmar/0000-0001-6794-3669; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft DFG [SFB 740, 436 UKR 113/64/1-1, HI 1502]; HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); HFSP, NIH [R01-GM072686]; Los Alamos Institutional Computing; North-German Supercomputing Alliance (HLRN) [beb00001, bec00085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072686] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); HFSP, NIH; Los Alamos Institutional Computing; North-German Supercomputing Alliance (HLRN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Scott Blanchard for helpful discussion. The present work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB 740 to C. M. T. S., P. W. H., and T. M.; 436 UKR 113/64/1-1 to T. B. and HI 1502 to P. W. H.), HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum). K.Y.S. was supported by HFSP, NIH Grant R01-GM072686 and Los Alamos Institutional Computing. We acknowledge the use of computational resources supplied by the North-German Supercomputing Alliance (HLRN; project beb00001 to C. M. T. S and bec00085 to P. W. H.).	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bommer U, 1997, SUBCELLULAR FRACTION, P271; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Fagan CE, 2013, P NATL ACAD SCI USA, V110, P9716, DOI 10.1073/pnas.1301585110; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P9319, DOI 10.1093/nar/gks660; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; STEITZ JA, 1969, COLD SPRING HARB SYM, V34, P621, DOI 10.1101/SQB.1969.034.01.072; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311	38	82	83	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					121	131		10.1016/j.cell.2014.04.044	http://dx.doi.org/10.1016/j.cell.2014.04.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995983	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000340943100012
J	Hurley, R				Hurley, Richard			SHARED DECISION MAKING Can doctors reduce harmful medical overuse worldwide?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE		BMJ, London, England		Hurley, R (corresponding author), BMJ, London, England.	rhurley@bmj.com						Allan GM, 2012, CAN FAM PHYSICIAN, V58, P275; American Academy of Family Physicians, 15 THINGS PHYS PAT S; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Choosing Wisely, PAR P WILL SONG HAPP; Choosing Wisely, 2014, UNN TESTS PROC HLTH; Choosing Wisely, 5 QUEST ASK YOUR DOC; Choosing Wisely, IM TESTS LOW BACK PA; Choosing Wisely Canada. Campaign videos, CAMP VID; Dunn J., 2012, VOGUE            NOV; Lenzer J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6230; National Institute for Health and Care Excellence, SAV PROD COLL; NHS Wales, 2014, ACH PRUD HEALTHC NHS; Smith R., 2012, CASE SLOW MED; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V310, P380, DOI 10.1001/jama.2013.8278; van 't Hooft Janneke, 2013, Ned Tijdschr Geneeskd, V157, pA6287	16	17	19	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g4289	10.1136/bmj.g4289	http://dx.doi.org/10.1136/bmj.g4289			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24993249				2022-12-28	WOS:000338646100006
J	Kim, D; Shi, Z; Simmons, CB; Ward, DR; Prance, JR; Koh, TS; Gamble, JK; Savage, DE; Lagally, MG; Friesen, M; Coppersmith, SN; Eriksson, MA				Kim, Dohun; Shi, Zhan; Simmons, C. B.; Ward, D. R.; Prance, J. R.; Koh, Teck Seng; Gamble, John King; Savage, D. E.; Lagally, M. G.; Friesen, Mark; Coppersmith, S. N.; Eriksson, Mark A.			Quantum control and process tomography of a semiconductor quantum dot hybrid qubit	NATURE			English	Article							SINGLE-ELECTRON SPIN; OSCILLATIONS; COMPUTATION	The similarities between gated quantum dots and the transistors in modern microelectronics(1,2)-in fabrication methods, physical structure and voltage scales for manipulation-have led to great interest in the development of quantum bits (qubits) in semiconductor quantum dots(3-18). Although quantum dot spin qubits have demonstrated long coherence times, their manipulation is often slower than desired for important future applications, such as factoring(19). Furthermore, scalability and manufacturability are enhanced when qubits are as simple as possible. Previous work has increased the speed of spin qubit rotations by making use of integrated micromagnets(11), dynamic pumping of nuclear spins(12) or the addition of a third quantum dot(17). Here we demonstrate a qubit that is a hybrid of spin and charge. It is simple, requiring neither nuclear-state preparation nor micromagnets. Unlike previous double-dot qubits, the hybrid qubit enables fast rotations about two axes of the Bloch sphere. We demonstrate full control on the Bloch sphere with pi-rotation times of less than 100 picoseconds in two orthogonal directions, which is more than an order of magnitude faster than any other double-dot qubit. The speed arises from the qubit's charge-like characteristics, and its spin-like features result in resistance to decoherence over a wide range of gate voltages. We achieve full process tomography in our electrically controlled semiconductor quantum dot qubit, extracting high fidelities of 85 per cent for X rotations (transitions between qubit states) and 94 per cent for Z rotations (phase accumulation between qubit states).	[Kim, Dohun; Shi, Zhan; Simmons, C. B.; Ward, D. R.; Prance, J. R.; Koh, Teck Seng; Friesen, Mark; Coppersmith, S. N.; Eriksson, Mark A.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Gamble, John King] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Savage, D. E.; Lagally, M. G.] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Sandia National Laboratories; University of Wisconsin System; University of Wisconsin Madison	Eriksson, MA (corresponding author), Univ Wisconsin, Dept Phys, 1150 Univ Ave, Madison, WI 53706 USA.	maeriksson@wisc.edu	Coppersmith, Susan N/I-9685-2018; Prance, Jonathan R/B-3536-2013; Koh, Teck Seng/J-7142-2016; Kim, Dohun/AAR-3741-2021	Coppersmith, Susan N/0000-0002-5630-4893; Prance, Jonathan R/0000-0001-5009-383X; Koh, Teck Seng/0000-0002-4030-8232; Kim, Dohun/0000-0001-9687-2089; Friesen, Mark/0000-0003-2878-2844; Eriksson, Mark/0000-0002-3130-9735; Gamble, John/0000-0001-7897-5420; Savage, Donald/0000-0001-8515-4196; Ward, Daniel/0000-0002-9263-5542	ARO [W911NF-12-0607]; NSF [PHY-1104660]; Laboratory Directed Research and Development programme at Sandia National Laboratories; US Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]; Division Of Physics [1104660] Funding Source: National Science Foundation	ARO; NSF(National Science Foundation (NSF)); Laboratory Directed Research and Development programme at Sandia National Laboratories; US Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by ARO (W911NF-12-0607), the NSF (PHY-1104660) and by the Laboratory Directed Research and Development programme at Sandia National Laboratories. Sandia National Laboratories is a multi-programme laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the US Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. Development and maintenance of the growth facilities used for fabricating samples is supported by the US Department of Energy (DE-FG02-03ER46028). This research used US National Science Foundation-supported shared facilities at the University of Wisconsin-Madison. D.K. acknowledges conversations with X. Wu and K. Rudinger.	Chow JM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.090502; Dial OE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146804; DiVincenzo DP, 2000, NATURE, V408, P339, DOI 10.1038/35042541; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Gaudreau L, 2012, NAT PHYS, V8, P54, DOI 10.1038/nphys2149; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hayashi T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226804; Koh TS, 2013, P NATL ACAD SCI USA, V110, P19695, DOI 10.1073/pnas.1319875110; Koh TS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.250503; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Kouwenhoven LP, 2006, PHYS STATUS SOLIDI B, V243, P3682, DOI 10.1002/pssb.200642228; Laird EA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075403; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Maune BM, 2012, NATURE, V481, P344, DOI 10.1038/nature10707; Medford J, 2013, NAT NANOTECHNOL, V8, P654, DOI [10.1038/nnano.2013.168, 10.1038/NNANO.2013.168]; Medford J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.050501; NIELSEN MA, 2000, QUANTUM COMPUTATION, P389; Petersson KD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246804; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Petta JR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.186802; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Shi Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4020; Shi Z, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075416; Shi Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140503; Simmons CB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156804; Taylor JM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035315; Thalakulam M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3425892; Van Meter R, 2008, CONTROLLABLE QUANTUM STATES: MESOSCOPIC SUPERCONDUCTIVITY AND SPRINTRONICS, P183, DOI 10.1142/9789812814623_0029; Zwanenburg FA, 2013, REV MOD PHYS, V85, P961, DOI 10.1103/RevModPhys.85.961	30	210	212	3	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					70	74		10.1038/nature13407	http://dx.doi.org/10.1038/nature13407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990747	Green Submitted			2022-12-28	WOS:000338199400037
J	Georgalas, I; Pagoulatos, D; Koutsandrea, C; Pavlidis, M				Georgalas, Ilias; Pagoulatos, Dionisis; Koutsandrea, Chryssanthi; Pavlidis, Mitrofanis			Sudden unilateral painless loss of vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RETINAL ARTERY-OCCLUSION; OCULAR NEOVASCULARIZATION; CILIORETINAL ARTERIES; THROMBOLYSIS; DISEASE; BRANCH		[Georgalas, Ilias; Pagoulatos, Dionisis; Koutsandrea, Chryssanthi] Univ Athens, Dept Ophthalmol, Athens 15452, Greece; [Pavlidis, Mitrofanis] Univ Munster, Dept Ophthalmol, Munster, Germany	National & Kapodistrian University of Athens; University of Munster	Georgalas, I (corresponding author), Univ Athens, Dept Ophthalmol, Athens 15452, Greece.	igeorgalas@yahoo.com	Georgalas, Ilias/AAD-5946-2019	Georgalas, Ilias/0000-0002-6171-5865				[Anonymous], PEDIAT OPHTHALMOLOGY; ARRUGA J, 1982, OPHTHALMOLOGY, V89, P1336; Atebara NH, 1995, OPHTHALMOLOGY, V102, P2029, DOI 10.1016/S0161-6420(95)30758-0; AUGSBURGER JJ, 1980, BRIT J OPHTHALMOL, V64, P913, DOI 10.1136/bjo.64.12.913; Beatty S, 2000, J ACCID EMERG MED, V17, P324; Biousse V, 2003, J NEURO-OPHTHALMOL, V23, P50, DOI 10.1097/00041327-200303000-00011; Braat A, 2001, VASC ENDOVASC SURG, V35, P141; BROWN GC, 1981, OPHTHALMOLOGY, V88, P18; BROWN GC, 1979, ARCH OPHTHALMOL-CHIC, V97, P84; CHAWLUK JB, 1988, NEUROLOGY, V38, P858, DOI 10.1212/WNL.38.6.858; Cohen JE, 2012, J CLIN NEUROSCI, V19, P462, DOI 10.1016/j.jocn.2011.06.010; Flynn JT., 1983, PEDIATRIC OPHTHALMOL, P1; Fraser S, 2002, COCHRANE DB SYST REV, V1; Hattenrach LO, 2008, AM J OPHTHALMOL, V146, P700, DOI 10.1016/j.ajo.2008.06.016; Hayreh SS, 2006, EYE, V20, P1130, DOI 10.1038/sj.eye.6702377; HAYREH S S, 1963, Br J Ophthalmol, V47, P71, DOI 10.1136/bjo.47.2.71; Hayreh SS, 2007, RETINA-J RET VIT DIS, V27, P276, DOI 10.1097/01.iae.0000238095.97104.9b; Hayreh SS, 2011, PROG RETIN EYE RES, V30, P359, DOI 10.1016/j.preteyeres.2011.05.001; Hayreh SS, 2009, OPHTHALMOLOGY, V116, P1928, DOI 10.1016/j.ophtha.2009.03.006; HAYREH SS, 1980, OPHTHALMOLOGY, V87, P75, DOI 10.1016/s0161-6420(80)35283-4; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; HAYREH SS, 1980, BRIT J OPHTHALMOL, V64, P818, DOI 10.1136/bjo.64.11.818; HAYREH SS, 1982, ARCH OPHTHALMOL-CHIC, V100, P1585, DOI 10.1001/archopht.1982.01030040563002; JONAS J, 1986, AM J OPHTHALMOL, V102, P37, DOI 10.1016/0002-9394(86)90206-0; JUSTICE J, 1976, ARCH OPHTHALMOL-CHIC, V94, P1355, DOI 10.1001/archopht.1976.03910040227015; Martyn LJ, 1983, PEDIAT OPHTHALMOLOGY, P767; Mueller AJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1377, DOI 10.1001/archopht.121.10.1377; Nowak RJ, 2012, J STROKE CEREBROVASC, V21, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.003; PAKOLA SJ, 1993, INVEST OPHTH VIS SCI, V34, P2866; Rudkin AK, 2010, EUR J OPHTHALMOL, V20, P1042, DOI 10.1177/112067211002000603; Rudkin AK, 2010, CLIN EXP OPHTHALMOL, V38, P496, DOI 10.1111/j.1442-9071.2010.02280.x; Rumclt S., 2003, CURR OPIN OPHTHALMOL, V14, P139; Schmidt D, 2007, EUR J MED RES, V12, P595; Von Graefe A., 1859, ARCH OPHTHALMOL-CHIC, V5, P136, DOI [10.1007/BF02720764, DOI 10.1007/BF02720764]	34	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2014	349								g4117	10.1136/bmj.g4117	http://dx.doi.org/10.1136/bmj.g4117			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YY	24986885				2022-12-28	WOS:000338645400003
J	Qaseem, A; Humphrey, LL; Harris, R; Starkey, M; Denberg, TD				Qaseem, Amir; Humphrey, Linda L.; Harris, Russell; Starkey, Melissa; Denberg, Thomas D.		Amer Coll Phys	Screening Pelvic Examination in Adult Women: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GYNECOLOGIC EXAMINATION; OVARIAN-CANCER; PAP-SMEAR; ATTITUDES; EXPERIENCES; CHLAMYDIA; BELIEFS; TRAUMA; SAMPLE	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the utility of screening pelvic examination for the detection of pathology in asymptomatic, nonpregnant, adult women. Methods: This guideline is based on a systematic review of the published literature in the English language from 1946 through January 2014 identified using MEDLINE and hand-searching. Evaluated outcomes include morbidity; mortality; and harms, including overdiagnosis, overtreatment, diagnostic procedure-related harms, fear, anxiety, embarrassment, pain, and discomfort. The target audience for this guideline includes all clinicians, and the target patient population includes asymptomatic, nonpregnant, adult women. This guideline grades the evidence and recommendations using the ACP's clinical practice guidelines grading system. Recommendation: ACP recommends against performing screening pelvic examination in asymptomatic, nonpregnant, adult women (strong recommendation, moderate-quality evidence).	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Carilion Clin, Roanoke, VA USA	American College of Physicians; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Chahchahi, Sarah/Q-6499-2016	Starkey, Melissa/0000-0002-5818-0265	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	ADAMS CH, 1993, WOMEN HEALTH, V20, P45, DOI 10.1300/J013v20n02_04; Adonakis GL, 1996, EUR J OBSTET GYN R B, V65, P221, DOI 10.1016/0301-2115(95)02369-0; American Academy of Family Physicians, 2013, CHOOS WIS 15 THINGS; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Armstrong L, 2012, EUR J CONTRACEP REPR, V17, P307, DOI 10.3109/13625187.2012.672665; Berkowitz Z, 2013, JAMA INTERN MED, V173, P922, DOI 10.1001/jamainternmed.2013.368; Bloomfield H, 2013, SCREENING PELVIC EXA; Bloomfield HE, 2014, ANN INTERN MED, V161, P46, DOI 10.7326/M13-2881; Bourne PA, 2010, N AM J MED SCI, V2, P478, DOI 10.4297/najms.2010.2478; BROADMORE J, 1986, NEW ZEAL MED J, V99, P8; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Centers for Medicare & Medicaid Services, OV PHYS FEE SCHED; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Farley MS, 2002, J FAM PRACTICE, V51, P827; Fiddes P, 2003, CONTRACEPTION, V67, P313, DOI 10.1016/S0010-7824(02)00540-1; Goldshore M, 2013, AM J OBSTET GYNECOL, V208, pS166, DOI 10.1016/j.ajog.2012.10.543; Golomb D, 1983, R I Med J, V66, P281; GROVER SR, 1995, MED J AUSTRALIA, V162, P408, DOI 10.5694/j.1326-5377.1995.tb139967.x; Gutman RE, 2005, OBSTET GYNECOL, V105, P551, DOI 10.1097/01.AOG.0000145752.97999.67; HAAR E, 1977, MED CARE, V15, P787, DOI 10.1097/00005650-197709000-00006; Harper C, 2001, FAM PLANN PERSPECT, V33, P13, DOI 10.2307/2673737; Henderson JT, 2010, OBSTET GYNECOL, V116, P1257, DOI 10.1097/AOG.0b013e3181fb540f; HESSELIUS I, 1975, SCAND J SOC MED, V3, P129, DOI 10.1177/140349487500300304; Hilden M, 2003, ACTA OBSTET GYN SCAN, V82, P1030; Hoyo C, 2005, PREV MED, V41, P439, DOI 10.1016/j.ypmed.2004.11.021; JACOBS I, 1988, LANCET, V1, P268; Kahn JA, 2003, OBSTET GYNECOL, V101, P490, DOI 10.1016/S0029-7844(02)02592-9; Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrheae, 2009, EXP CONS M SUMM REP; Lang AJ, 2003, BEHAV MED, V28, P150, DOI 10.1080/08964280309596053; Mehrotra A, 2007, ARCH INTERN MED, V167, P1876, DOI 10.1001/archinte.167.17.1876; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Moyer VA, 2012, ANN INTERN MED, V157, P567, DOI 10.7326/0003-4819-157-8-201210160-00533; OSOFSKY HJ, 1967, OBSTET GYNECOL, V30, P146; PETRAVAGE JB, 1979, J FAM PRACTICE, V9, P1039; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Reitsma JB, 2009, COCHRANE HDB SYSTEMA; Robohm JS, 1996, WOMEN HEALTH, V24, P59; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; Stormo AR, 2011, ARCH INTERN MED, V171, P2053, DOI 10.1001/archinternmed.2011.575; Stormo AR, 2012, PREV MED, V54, P415, DOI 10.1016/j.ypmed.2012.03.012; Taylor VM, 2004, CANCER EPIDEM BIOMAR, V13, P613; Weitlauf JC, 2010, J WOMENS HEALTH, V19, P1271, DOI 10.1089/jwh.2009.1673; Weitlauf JC, 2008, OBSTET GYNECOL, V112, P1343, DOI 10.1097/AOG.0b013e31818e4678; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wijma B, 1998, ACTA OBSTET GYN SCAN, V77, P422, DOI 10.1034/j.1600-0412.1998.770411.x; Yu CKH, 1998, BRIT J FAM PLAN, V23, P127	47	71	72	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					67	+		10.7326/M14-0701	http://dx.doi.org/10.7326/M14-0701			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24979451				2022-12-28	WOS:000338419700007
J	Fang, Y				Fang, Yu			PERSONAL VIEW China should curb non-prescription use of antibiotics in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATTITUDES; KNOWLEDGE		Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian, Shaanxi, Peoples R China.	yufang@mail.xjtu.edu.cn						China Food and Drug Administration, PROV SUP DRUG DISTR; China Food and Drug Administration, 2013, 2013 ANN REP NAT ADV; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Jiang MH, 2013, CHINESE J HLTH POLIC, V1, P40; Li YF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-995; Liu ZJ, 2011, EVALUATION ANAL DRUG, V11, P853; Lv B, 2014, TROP MED INT HEALTH, V19, P769, DOI 10.1111/tmi.12322; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; The State Council, 12 5 YEAR PLAN DRUG; Xiao Y., 2010, CHINESE HLTH EC, V29, P94, DOI [10.3969/j.issn.1003-0743.2010.05.034, DOI 10.3969/J.ISSN.1003-0743.2010.05.034]; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Xiao YH, 2013, LANCET INFECT DIS, V13, P189, DOI 10.1016/S1473-3099(13)70011-2; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Yu M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-112; SHANGHAI DAILY	17	30	30	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2014	348								g4233	10.1136/bmj.g4233	http://dx.doi.org/10.1136/bmj.g4233			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YU	24982508				2022-12-28	WOS:000338644600003
J	Hare, T				Hare, Todd			Exploiting and exploring the options	SCIENCE			English	Editorial Material							SIGNALS; CORTEX		Univ Zurich, SNS Lab, Zurich, Switzerland	University of Zurich	Hare, T (corresponding author), Univ Zurich, SNS Lab, Zurich, Switzerland.	todd.hare@econ.uzh.ch	Hare, Todd/AAE-8574-2019; Hare, Todd A/E-7091-2017	Hare, Todd/0000-0002-0260-2772; Hare, Todd A/0000-0002-0260-2772				Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Cowan N, 2005, HUMAN LEARING AND MEMORY: ADVANCES IN THEORY AND APPLICATION, P155; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Donoso M, 2014, SCIENCE, V344, P1481, DOI 10.1126/science.1252254; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007	10	2	2	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1446	1447		10.1126/science.1256862	http://dx.doi.org/10.1126/science.1256862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970062				2022-12-28	WOS:000337889900018
J	Kelly, RP; Port, JA; Yamahara, KM; Martone, RG; Lowell, N; Thomsen, PF; Mach, ME; Bennett, M; Prahler, E; Caldwell, MR; Crowder, LB				Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Martone, Rebecca G.; Lowell, Natalie; Thomsen, Philip Francis; Mach, Megan E.; Bennett, Meredith; Prahler, Erin; Caldwell, Margaret R.; Crowder, Larry B.			Harnessing DNA to improve environmental management	SCIENCE			English	Editorial Material							FUTURE		[Kelly, Ryan P.; Lowell, Natalie] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98103 USA; [Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Martone, Rebecca G.; Mach, Megan E.; Bennett, Meredith; Prahler, Erin; Caldwell, Margaret R.; Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Thomsen, Philip Francis] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	University of Washington; University of Washington Seattle; Stanford University; University of Copenhagen	Kelly, RP (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98103 USA.	rpkelly@uw.edu	Thomsen, Philip Francis/AAE-9354-2019	Thomsen, Philip Francis/0000-0002-9867-4366; Mach, Megan/0000-0003-2697-1254; Kelly, Ryan/0000-0001-5037-2441				BAKER CS, 1994, SCIENCE, V265, P1538, DOI 10.1126/science.265.5178.1538; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Gooding JJ, 2006, ANAL CHIM ACTA, V559, P137, DOI 10.1016/j.aca.2005.12.020; Griffith J.F., 2013, CALIFORNIA MICROBIAL; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wood SA, 2013, NEW ZEAL J MAR FRESH, V47, P90, DOI 10.1080/00288330.2012.745885	14	132	141	7	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1455	1456		10.1126/science.1251156	http://dx.doi.org/10.1126/science.1251156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970068				2022-12-28	WOS:000337889900024
J	Arsuaga, JL; Martinez, I; Arnold, LJ; Aranburu, A; Gracia-Tellez, A; Sharp, WD; Quam, RM; Falgueres, C; Pantoja-Perez, A; Bischoff, J; Poza-Rey, E; Pares, JM; Carretero, JM; Demuro, M; Lorenzo, C; Sala, N; Martinon-Torres, M; Garcia, N; de Velasco, AA; Cuenca-Bescos, G; Gomez-Olivencia, A; Moreno, D; Pablos, A; Shen, CC; Rodriguez, L; Ortega, AI; Garcia, R; Bonmati, A; de Castro, JMB; Carbonell, E				Arsuaga, J. L.; Martinez, I.; Arnold, L. J.; Aranburu, A.; Gracia-Tellez, A.; Sharp, W. D.; Quam, R. M.; Falgueres, C.; Pantoja-Perez, A.; Bischoff, J.; Poza-Rey, E.; Pares, J. M.; Carretero, J. M.; Demuro, M.; Lorenzo, C.; Sala, N.; Martinon-Torres, M.; Garcia, N.; Alcazar de Velasco, A.; Cuenca-Bescos, G.; Gomez-Olivencia, A.; Moreno, D.; Pablos, A.; Shen, C. -C.; Rodriguez, L.; Ortega, A. I.; Garcia, R.; Bonmati, A.; Bermudez de Castro, J. M.; Carbonell, E.			Neandertal roots: Cranial and chronological evidence from Sima de los Huesos	SCIENCE			English	Article							MIDDLE-PLEISTOCENE SITE; SIERRA-DE-ATAPUERCA; MORPHOMETRIC-ANALYSIS; DENTAL REMAINS; HOMO; HOMINIDS; AGE; EVOLUTION; (SIERRA; SPAIN).	Seventeen Middle Pleistocene crania from the Sima de los Huesos site (Atapuerca, Spain) are analyzed, including seven new specimens. This sample makes it possible to thoroughly characterize a Middle Pleistocene hominin paleodeme and to address hypotheses about the origin and evolution of the Neandertals. Using a variety of techniques, the hominin-bearing layer could be reassigned to a period around 430,000 years ago. The sample shows a consistent morphological pattern with derived Neandertal features present in the face and anterior vault, many of which are related to the masticatory apparatus. This suggests that facial modification was the first step in the evolution of the Neandertal lineage, pointing to a mosaic pattern of evolution, with different anatomical and functional modules evolving at different rates.	[Arsuaga, J. L.; Martinez, I.; Gracia-Tellez, A.; Quam, R. M.; Pantoja-Perez, A.; Poza-Rey, E.; Lorenzo, C.; Sala, N.; Garcia, N.; Alcazar de Velasco, A.; Gomez-Olivencia, A.; Pablos, A.; Bonmati, A.] Ctr Mixto UCM ISCIII Evoluc & Comportamiento Huma, Madrid, Spain; [Arsuaga, J. L.; Pantoja-Perez, A.; Poza-Rey, E.; Garcia, N.; Bonmati, A.] Univ Complutense Madrid, Dept Paleontol, Fac Ciencias Geol, E-28040 Madrid, Spain; [Martinez, I.; Gracia-Tellez, A.] Univ Alcala, Area Paleontol, Dept Geol Geog & Medio Ambiente, Madrid, Spain; [Arnold, L. J.; Pares, J. M.; Demuro, M.; Martinon-Torres, M.; Pablos, A.; Ortega, A. I.; Bermudez de Castro, J. M.] Ctr Nacl Invest Evoluc Humana Burgo, Burgos, Spain; [Arnold, L. J.] Univ Adelaide, Sch Earth & Environm Sci, Inst Environm, Adelaide, SA 5005, Australia; [Arnold, L. J.] Univ Adelaide, IPAS, Adelaide, SA 5005, Australia; [Aranburu, A.] Univ Basque Country, Dept Mineral & Petrol, Fac Ciencia & Tecnol, E-48080 Bilbao, Spain; [Sharp, W. D.] Berkeley Geochronol Ctr, Berkeley, CA USA; [Quam, R. M.] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Quam, R. M.] Amer Museum Nat Hist, Div Anthropol, New York, NY 10024 USA; [Falgueres, C.; Moreno, D.] Museum Natl Hist Nat, Dept Prehist, F-75231 Paris, France; [Bischoff, J.] US Geol Survey, Menlo Pk, CA 94025 USA; [Carretero, J. M.; Moreno, D.; Pablos, A.; Rodriguez, L.; Garcia, R.] Univ Burgos, Lab Evoluc Humana, Dept Ciencias Hist & Geog, Burgos, Spain; [Demuro, M.] Univ Adelaide, IPAS, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Lorenzo, C.; Carbonell, E.] URV, Area Prehist, Dept Hist & Hist Art, Tarragona, Spain; [Lorenzo, C.; Carbonell, E.] Inst Catal Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Cuenca-Bescos, G.] Univ Zaragoza, Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Cuenca-Bescos, G.] Univ Zaragoza, Fac Ciencias, E-50009 Zaragoza, Spain; [Gomez-Olivencia, A.] Div Biol Anthropol, PAVE Res Grp, Cambridge, England; [Shen, C. -C.] Natl Taiwan Univ, High Precis Mass Spectrometry & Environm Change L, Dept Geosci, Taipei, Taiwan; [Carbonell, E.] Inst Vertebrate Paleontol & Paleoanthropol Beijin, Beijing, Peoples R China	Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Complutense University of Madrid; Universidad de Alcala; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of Adelaide; University of Adelaide; University of Basque Country; Berkeley Geochronolgy Center; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; American Museum of Natural History (AMNH); Museum National d'Histoire Naturelle (MNHN); United States Department of the Interior; United States Geological Survey; Universidad de Burgos; University of Adelaide; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); University of Zaragoza; University of Zaragoza; National Taiwan University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Arsuaga, JL (corresponding author), Ctr Mixto UCM ISCIII Evoluc & Comportamiento Huma, Madrid, Spain.	jlarsuaga@isciii.es	Garcia, Rebeca/GRJ-1228-2022; Shen, Chuan-Chou/H-9642-2013; Sala, Nohemi/N-9961-2014; Rodriguez, Laura/H-4774-2015; Pérez, Ana Pantoja/AAG-7145-2019; Sala, Nohemi/AAA-8881-2020; Pablos, Adrián/N-7531-2019; DAVINIA, MORENO/J-6433-2019; Carbonell, Eudald/G-3003-2015; Lorenzo, Carlos/E-4290-2015; lin, ke/GZM-8300-2022; Rodriguez, Laura/AAO-4864-2020; Carretero, José-Miguel/AAN-1926-2020; Aranburu, Arantza/L-9502-2014; Arnold, Lee J/J-4356-2018; Demuro, Martina/AAD-9985-2019; Díaz, José-Miguel Carretero/L-1703-2018; Gloria, Cuenca-Bescós/A-3616-2013; Gómez-Olivencia, Asier/D-6531-2015; Demuro, Martina/AAV-9757-2021; Pablos, Adrián/H-4751-2015; Ortega, Ana Isabel/B-2498-2017	Shen, Chuan-Chou/0000-0003-2833-2771; Rodriguez, Laura/0000-0002-5090-1582; Pérez, Ana Pantoja/0000-0001-9302-1756; Sala, Nohemi/0000-0002-0896-1493; Pablos, Adrián/0000-0003-1630-4941; DAVINIA, MORENO/0000-0001-8470-6825; Lorenzo, Carlos/0000-0001-5706-293X; Rodriguez, Laura/0000-0002-5090-1582; Carretero, José-Miguel/0000-0003-0409-8087; Arnold, Lee J/0000-0001-9603-3824; Demuro, Martina/0000-0002-5799-4216; Díaz, José-Miguel Carretero/0000-0003-0409-8087; Gloria, Cuenca-Bescós/0000-0001-5125-9651; Gómez-Olivencia, Asier/0000-0001-7831-3902; Demuro, Martina/0000-0002-5799-4216; Pablos, Adrián/0000-0003-1630-4941; GARCIA-GONZALEZ, REBECA/0000-0002-1035-6655; FALGUERES, christophe/0000-0003-0644-4852; Aranburu, Arantza/0000-0002-0493-085X; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Martinon-Torres, Maria/0000-0002-2750-4554; martinez, ignacio/0000-0002-1835-9199; Ortega, Ana Isabel/0000-0002-4034-0128; Quam, Rolf/0000-0002-1140-5615; Arsuaga, Juan Luis/0000-0001-5361-2295	Ramon y Cajal Program [RYC-2010-06152]; BU-SUNY; AMNH; MECD [AP-2009-4096]; CAM [S2010/BMD-2330]; MINECO [BES-2010-039961, CGL2012-38434-C03-01, 03]; Marie Curie-IEF contract [PIRG8-GA-2010-276810]; Marie Curie-IRG contract [PIRG8-GA-2010-276810]; Fundacion Atapuerca grants; ARCFF [FT130100195]; Taiwan ROC MOST grant [100-2116-M-002-009, 101-2116-M-002-009, 101R7625]; NTU grant [100-2116-M-002-009, 101-2116-M-002-009, 101R7625]; JCyL [BU005A09, DGR 2009 SGR-324]; Fundacion Atapuerca	Ramon y Cajal Program(Spanish Government); BU-SUNY; AMNH; MECD; CAM; MINECO(Spanish Government); Marie Curie-IEF contract; Marie Curie-IRG contract; Fundacion Atapuerca grants; ARCFF(Australian Research Council); Taiwan ROC MOST grant; NTU grant; JCyL(Junta de Castilla y Leon); Fundacion Atapuerca	We are grateful to the Atapuerca team, especially A. Esquivel for work in SH and M. C. Ortega for restoration of the SH fossils, and to K. Ludwig, J. Rofes, and J. M. Lopez-Garcia for constructive discussions. E. Santos assisted with computed tomography scanning and J. Trueba provided the photos. For access to the comparative materials, we thank P. Mennecier, A. Froment, H. de Lumley, D. Grimaud-Herve, C. B. Stringer, R. Kruszynski, G. D. Koufous, D. Mania, D. Lieberman, and J. Haas. A.G.-T. has a contract from the Ramon y Cajal Program (RYC-2010-06152). R. M. Q. received financial support from BU-SUNY and the AMNH. A. P.-P. has a MECD grant (AP-2009-4096). E.P.-R. has a CAM grant (S2010/BMD-2330). A. A. V. has a MINECO grant (BES-2010-039961). A.G.-O. and M. D. have a Marie Curie-IEF and a Marie Curie-IRG (PIRG8-GA-2010-276810) contracts. N.S., A. B., L. R., A. P.-P., A. A. V., and R. G. received Fundacion Atapuerca grants. L. J. A. has an ARCFF grant (FT130100195). Dating at the Berkeley Geochronology Center was supported by the Ann and Gordon Getty Foundation. U-Th isotopic analysis at the HISPEC was supported by Taiwan ROC MOST and NTU grants (100-2116-M-002-009, 101-2116-M-002-009, 101R7625). Thanks to SGIker-UPV/EHU for their research facilities. This research was supported by the MINECO (CGL2012-38434-C03-01 and 03) and the JCyL (BU005A09, DGR 2009 SGR-324) projects. Fieldwork was funded by the JCyL and the Fundacion Atapuerca. Junta de Castilla y Leon is the repository of the fossils.	Andrews P., 1984, Courier Forschungsinstitut Senckenberg, V69, P167; Arnold LJ, 2009, QUAT GEOCHRONOL, V4, P306, DOI 10.1016/j.quageo.2009.02.017; Arnold LJ, 2014, J HUM EVOL, V67, P85, DOI 10.1016/j.jhevol.2013.12.001; ARSUAGA JL, 1991, J HUM EVOL, V20, P191, DOI 10.1016/0047-2484(91)90073-5; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; Arsuaga JL, 2001, ANTHROPOLOGIE, V105, P161; ARSUAGA JL, 1993, NATURE, V362, P534, DOI 10.1038/362534a0; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Condemi S., 1988, HOMME NEANDERTAL, V3, P49; Daura J, 2005, J HUM EVOL, V49, P56, DOI 10.1016/j.jhevol.2005.03.004; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; DECASTRO JMB, 1986, J HUM EVOL, V15, P265; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P335, DOI 10.1002/ajpa.1330960403; Demuro M, 2013, QUAT GEOCHRONOL, V15, P67, DOI 10.1016/j.quageo.2012.11.003; Elyatqine M., 1995, THESIS; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Franciscus RG, 2003, J HUM EVOL, V44, P701, DOI 10.1016/S0047-2484(03)00062-9; Gliganic LA, 2012, ARCHAEOL ANTHROP SCI, V4, P115, DOI 10.1007/s12520-011-0085-9; Gomez-Robles A, 2013, P NATL ACAD SCI USA, V110, P18196, DOI 10.1073/pnas.1302653110; Gomez-Robles A, 2012, J HUM EVOL, V63, P512, DOI 10.1016/j.jhevol.2012.06.002; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hublin J.-J., 1982, GEOBIOS S1, V15, P345; HUBLIN JJ, 1978, CR ACAD SCI D NAT, V287, P923; Jacobs Z, 2011, QUAT GEOCHRONOL, V6, P491, DOI 10.1016/j.quageo.2011.04.003; Martinez I, 1997, J HUM EVOL, V33, P283, DOI 10.1006/jhev.1997.0155; Martinez I, 2006, PERIOD BIOL, V108, P309; Martinon-Torres M, 2013, J ANAT, V223, P353, DOI 10.1111/joa.12090; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Pares JM, 2000, AM J PHYS ANTHROPOL, V111, P451, DOI 10.1002/(SICI)1096-8644(200004)111:4<451::AID-AJPA2>3.3.CO;2-A; Rak Y, 2002, AM J PHYS ANTHROPOL, V119, P199, DOI 10.1002/ajpa.10131; Rak Y, 2011, AM J PHYS ANTHROPOL, V144, P247; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Schwartz JH, 2008, ANAT REC, V291, P1517, DOI 10.1002/ar.20776; Schwartz JH, 2010, AM J PHYS ANTHROPOL, P94, DOI 10.1002/ajpa.21443; Schwartz JH, 1996, P NATL ACAD SCI USA, V93, P10852, DOI 10.1073/pnas.93.20.10852; Stringer C.B., 1984, P51; Stringer C. B., 1985, ANCESTORS HARD EVIDE, P285; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Tattersall I, 2011, VERTEBR PALEOBIOL PA, P47, DOI 10.1007/978-94-007-0492-3_4; Tattersall I, 2009, P NATL ACAD SCI USA, V106, P16018, DOI 10.1073/pnas.0903207106; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; Wood B., 1984, Courier Forschungsinstitut Senckenberg, V69, P99	48	289	298	3	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1358	1363		10.1126/science.1253958	http://dx.doi.org/10.1126/science.1253958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948730	Green Submitted			2022-12-28	WOS:000337531700030
J	Boneschanscher, MP; Evers, WH; Geuchies, JJ; Altantzis, T; Goris, B; Rabouw, FT; van Rossum, SAP; van der Zant, HSJ; Siebbeles, LDA; Van Tendeloo, G; Swart, I; Hilhorst, J; Petukhov, AV; Bals, S; Vanmaekelbergh, D				Boneschanscher, M. P.; Evers, W. H.; Geuchies, J. J.; Altantzis, T.; Goris, B.; Rabouw, F. T.; van Rossum, S. A. P.; van der Zant, H. S. J.; Siebbeles, L. D. A.; Van Tendeloo, G.; Swart, I.; Hilhorst, J.; Petukhov, A. V.; Bals, S.; Vanmaekelbergh, D.			Long-range orientation and atomic attachment of nanocrystals in 2D honeycomb superlattices	SCIENCE			English	Article							ORIENTED ATTACHMENT; ELECTRON TOMOGRAPHY; CATION-EXCHANGE; DIRAC FERMIONS; GRAPHENE; NANOPARTICLES; MICROSCOPY; NANORODS; GROWTH	Oriented attachment of synthetic semiconductor nanocrystals is emerging as a route for obtaining new semiconductors that can have Dirac-type electronic bands such as graphene, but also strong spin-orbit coupling. The two-dimensional (2D) assembly geometry will require both atomic coherence and long-range periodicity of the superlattices. We show how the interfacial self-assembly and oriented attachment of nanocrystals results in 2D metal chalcogenide semiconductors with a honeycomb superlattice. We present an extensive atomic and nanoscale characterization of these systems using direct imaging and wave scattering methods. The honeycomb superlattices are atomically coherent and have an octahedral symmetry that is buckled; the nanocrystals occupy two parallel planes. Considerable necking and large-scale atomic motion occurred during the attachment process.	[Boneschanscher, M. P.; Geuchies, J. J.; Rabouw, F. T.; van Rossum, S. A. P.; Swart, I.; Petukhov, A. V.; Vanmaekelbergh, D.] Univ Utrecht, Debye Inst Nanomat Sci, NL-3508 TA Utrecht, Netherlands; [Evers, W. H.; Siebbeles, L. D. A.] Delft Univ Technol, Optoelect Mat Sect, NL-2628 BL Delft, Netherlands; [Evers, W. H.; van der Zant, H. S. J.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Altantzis, T.; Goris, B.; Van Tendeloo, G.; Bals, S.] Univ Antwerp, Electron Microscopy Mat Sci EMAT, B-2020 Antwerp, Belgium; [Hilhorst, J.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Utrecht University; Delft University of Technology; Delft University of Technology; University of Antwerp; European Synchrotron Radiation Facility (ESRF)	Vanmaekelbergh, D (corresponding author), Univ Utrecht, Debye Inst Nanomat Sci, POB 80-000, NL-3508 TA Utrecht, Netherlands.	d.vanmaekelbergh@uu.nl	Swart, Ingmar/E-6977-2012; Petukhov, Andrei V./B-8235-2009; Rabouw, Frederik/GSE-2644-2022; Vanmaekelbergh, Daniël/G-2104-2010; DA Siebbeles, Laurens/I-2401-2012; Hilhorst, Jan/D-7790-2015; Bals, Sara/F-6963-2016; boneschanscher, mark/A-4862-2012; Rabouw, Freddy T./O-9458-2017; van der Zant, Herre S.J./J-9467-2016	Swart, Ingmar/0000-0003-3201-7301; Petukhov, Andrei V./0000-0001-9840-6014; Rabouw, Frederik/0000-0002-4775-0859; DA Siebbeles, Laurens/0000-0002-4812-7495; Bals, Sara/0000-0002-4249-8017; Rabouw, Freddy T./0000-0002-4775-0859; van der Zant, Herre S.J./0000-0002-5385-0282; Boneschanscher, Mark/0000-0002-7172-6410; Evers, Wiel/0000-0002-3413-5128	Foundation of Fundamental Research on Matter (FOM), Dutch Research Council (NWO); European Research Council (ERC) [24691-COUNTATOMS, 335078-COLOURATOM]; European Union under the Seventh Framework Program [Integrated Infrastructure Initiative 262348 European Soft Matter Infrastructure (ESMI)]; Flemish Fund for Scientific Research (FWO Vlaanderen) through a Ph.D. research grant	Foundation of Fundamental Research on Matter (FOM), Dutch Research Council (NWO); European Research Council (ERC)(European Research Council (ERC)); European Union under the Seventh Framework Program [Integrated Infrastructure Initiative 262348 European Soft Matter Infrastructure (ESMI)]; Flemish Fund for Scientific Research (FWO Vlaanderen) through a Ph.D. research grant	We thank ESRF (Grenoble, France) for providing the synchrotron beamtime and the staff of ESRF beamline ID-01 for their support. We thank C. van Overbeek for his help on the PbS sample. This research is part of the programs "Control over Functional Nanoparticle Solids (FNS)" and "Designing Dirac Carriers in semiconductor honeycomb superlattices (DDC)," which are supported by the Foundation of Fundamental Research on Matter (FOM), which is part of the Dutch Research Council (NWO). The authors also acknowledge financial support from the European Research Council (ERC Advanced Grant 24691-COUNTATOMS and ERC Starting Grant #335078-COLOURATOM). The authors also appreciate financial support from the European Union under the Seventh Framework Program [Integrated Infrastructure Initiative 262348 European Soft Matter Infrastructure (ESMI)]. This work was supported by the Flemish Fund for Scientific Research (FWO Vlaanderen) through a Ph.D. research grant to B.G.	Bals S, 2011, NANO LETT, V11, P3420, DOI 10.1021/nl201826e; Beberwyck BJ, 2013, J PHYS CHEM C, V117, P19759, DOI 10.1021/jp405989z; Boneschanscher MP, 2013, NANO LETT, V13, P1312, DOI 10.1021/nl400100c; Casavola M, 2012, CHEM MATER, V24, P294, DOI 10.1021/cm202796s; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; De Simoni G, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3493189; Evers WH, 2013, NANO LETT, V13, P2317, DOI 10.1021/nl303322k; Friedrich H, 2009, NANO LETT, V9, P2719, DOI 10.1021/nl901212m; Gibertini M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.241406; Gomes KK, 2012, NATURE, V483, P306, DOI 10.1038/nature10941; Kalesaki E, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011010; Koh WK, 2010, J AM CHEM SOC, V132, P3909, DOI 10.1021/ja9105682; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Luther JM, 2009, J AM CHEM SOC, V131, P16851, DOI 10.1021/ja906503w; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Pacholski C, 2002, ANGEW CHEM INT EDIT, V41, P1188, DOI 10.1002/1521-3773(20020402)41:7<1188::AID-ANIE1188>3.0.CO;2-5; Park CH, 2009, NANO LETT, V9, P1793, DOI 10.1021/nl803706c; Schliehe C, 2010, SCIENCE, V329, P550, DOI 10.1126/science.1188035; Singha A, 2011, SCIENCE, V332, P1176, DOI 10.1126/science.1204333; van Huis MA, 2008, NANO LETT, V8, P3959, DOI 10.1021/nl8024467; van Huis MA, 2009, ADV MATER, V21, P4992, DOI 10.1002/adma.200902561; Yuk JM, 2013, CHEM COMMUN, V49, P11479, DOI 10.1039/c3cc46545d; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654	25	280	282	25	491	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1377	1380		10.1126/science.1252642	http://dx.doi.org/10.1126/science.1252642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948734	Green Accepted			2022-12-28	WOS:000337531700035
J	Caliskan, N; Katunin, VI; Belardinelli, R; Peske, F; Rodnina, MV				Caliskan, Neva; Katunin, Vladimir I.; Belardinelli, Riccardo; Peske, Frank; Rodnina, Marina V.			Programmed-1 Frameshifting by Kinetic Partitioning during Impeded Translocation	CELL			English	Article							MESSENGER-RNA TRANSLOCATION; E-SITE; HYBRID STATE; P-SITE; RIBOSOMAL FRAMESHIFT; ESCHERICHIA-COLI; SINGLE RIBOSOMES; A-SITE; TRANSLATION; SIGNAL	Programmed -1 ribosomal frameshifting (-1PRF) is an mRNA recoding event utilized by cells to enhance the information content of the genome and to regulate gene expression. The mechanism of -1PRF and its timing during translation elongation are unclear. Here, we identified the steps that govern -1PRF by following the stepwise movement of the ribosome through the frameshifting site of a model mRNA derived from the IBV 1a/1b gene in a reconstituted in vitro translation system from Escherichia coli. Frameshifting occurs at a late stage of translocation when the two tRNAs are bound to adjacent slippery sequence codons of the mRNA. The downstream pseudoknot in the mRNA impairs the closing movement of the 30S subunit head, the dissociation of EF-G, and the release of tRNA from the ribosome. The slippage of the ribosome into the -1 frame accelerates the completion of translocation, thereby further favoring translation in the new reading frame.	[Caliskan, Neva; Belardinelli, Riccardo; Peske, Frank; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Katunin, Vladimir I.] BP Konstantinov Petersburg Nucl Phys Inst, Dept Mol & Radiat Biophys, Gatchina 188300, Russia	Max Planck Society; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Belardinelli, Riccardo/I-4363-2013; Rodnina, Marina V./AAD-4667-2019; Caliskan, Neva/N-5537-2017	Belardinelli, Riccardo/0000-0002-3333-0466; Rodnina, Marina V./0000-0003-0105-3879; Caliskan, Neva/0000-0003-0435-4757	Deutsche Forschungsgemeinschaft [RO 2004/9-1, SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This paper is dedicated to the memory of Vladimir Katunin, who sadly passed away before submission of the manuscript. We thank Anja Lehwess-Litzmann and Carlos da Cunha for sharing their L12-EF-G FRET reporter system prior to publication. We thank Anna Bursy, Olaf Geintzer, Sandra Kappler, Christina Kothe, Theresia Uhlendorf, Tanja Wiles, and Michael Zimmermann for expert technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 2004/9-1 and SFB860 to M.V.R.).	Bekaert M, 2005, MOL CELL, V17, P61, DOI 10.1016/j.molcel.2004.12.009; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Brierley I, 1997, J MOL BIOL, V270, P360, DOI 10.1006/jmbi.1997.1134; Brierley I, 2010, NUCLEIC ACIDS MOL BI, V24, P149, DOI 10.1007/978-0-387-89382-2_7; Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Fayet O, 2010, NUCLEIC ACIDS MOL BI, V24, P259, DOI 10.1007/978-0-387-89382-2_12; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Holtkamp W, 2014, EMBO J, V33, P1073, DOI 10.1002/embj.201387465; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2004, RNA, V10, P1225, DOI 10.1261/rna.7670704; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; LILL R, 1987, J MOL BIOL, V196, P137, DOI 10.1016/0022-2836(87)90516-X; Lin ZR, 2012, NUCLEIC ACIDS RES, V40, P8674, DOI 10.1093/nar/gks629; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; Mittelstaet J, 2013, J AM CHEM SOC, V135, P17031, DOI 10.1021/ja407511q; Mouzakis KD, 2013, NUCLEIC ACIDS RES, V41, P1901, DOI 10.1093/nar/gks1254; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Napthine S, 2003, EMBO J, V22, P3941, DOI 10.1093/emboj/cdg365; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SEMENKOV Y, 1992, FEBS LETT, V296, P207, DOI 10.1016/0014-5793(92)80380-Y; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; WEISS R B, 1989, New Biologist, V1, P159; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; YELVERTON E, 1994, MOL MICROBIOL, V11, P303, DOI 10.1111/j.1365-2958.1994.tb00310.x	42	107	109	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1619	1631		10.1016/j.cell.2014.04.041	http://dx.doi.org/10.1016/j.cell.2014.04.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949973	Green Published, Bronze			2022-12-28	WOS:000340941900016
J	de Cabo, R; Carmona-Gutierrez, D; Bernier, M; Hall, MN; Madeo, F				de Cabo, Rafael; Carmona-Gutierrez, Didac; Bernier, Michel; Hall, Michael N.; Madeo, Frank			The Search for Antiaging Interventions: From Elixirs to Fasting Regimens	CELL			English	Review							EXTENDS LIFE-SPAN; ALL-CAUSE MORTALITY; CALORIC RESTRICTION; SACCHAROMYCES-CEREVISIAE; OXIDATIVE-STRESS; CAENORHABDITIS-ELEGANS; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; RHESUS-MONKEYS; C-ELEGANS	The phenomenon of aging is an intrinsic feature of life. Accordingly, the possibility to manipulate it has fascinated humans likely since time immemorial. Recent evidence is shaping a picture where low caloric regimes and exercise may improve healthy senescence, and several pharmacological strategies have been suggested to counteract aging. Surprisingly, the most effective interventions proposed to date converge on only a few cellular processes, in particular nutrient signaling, mitochondrial efficiency, proteostasis, and autophagy. Here, we critically examine drugs and behaviors to which life- or healthspan-extending properties have been ascribed and discuss the underlying molecular mechanisms.	[de Cabo, Rafael; Bernier, Michel] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Hall, Michael N.] Univ Basel, CH-4056 Basel, Switzerland; [Carmona-Gutierrez, Didac; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Basel; University of Graz	de Cabo, R (corresponding author), NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.	decabora@mail.nih.gov; frank.madeo@uni-graz.at	Bernier, Michel/AAO-3983-2021; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/E-7996-2010; Bernier, Michel/Y-7139-2019; de Cabo, Rafael/J-5230-2016	Bernier, Michel/0000-0002-5948-368X; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Hall, Michael N/0000-0002-2998-0757; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Madeo, Frank/0000-0002-5070-1329	Austrian Science Fund FWF [SFB-LIPO-TOX F3007, F3012, P23490-B12, P24381-B20, W1226-B18]; European Commission for project APOSYS; Intramural Research Program of the National Institute on Aging; National Institutes of Health; Swiss National Science Foundation; NATIONAL INSTITUTE ON AGING [ZIAAG000368, ZIAAG000363] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 24381, P 23490] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); European Commission for project APOSYS; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	F.M. and D.C.-G. are grateful to the Austrian Science Fund FWF (SFB-LIPO-TOX F3007, F3012, P23490-B12, P24381-B20, W1226-B18) and the European Commission for project APOSYS. R.d.C. and M.B. were funded by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. M.N.H. acknowledges the Swiss National Science Foundation. We are thankful to Luigi Ferrucci, Donald K. Ingram, Mark Mattson, and Steven Sollott for their insightful comments and suggestions for this Review. We apologize to those authors whose work could not be included due to space limitations.	Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Berstein LM, 2012, AGING-US, V4, P320, DOI 10.18632/aging.100455; Bjedov I, 2011, BIOCHEM SOC T, V39, P460, DOI 10.1042/BST0390460; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; CALABRESE EJ, 1987, HEALTH PHYS, V52, P531, DOI 10.1097/00004032-198705000-00002; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; DORMAN JB, 1995, GENETICS, V141, P1399; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266; Fleg JL, 2012, DISCOV MED, V13, P223; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FRIEDMAN DB, 1988, GENETICS, V118, P75; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Goldhamer AC, 2002, J ALTERN COMPLEM MED, V8, P643, DOI 10.1089/107555302320825165; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Heilbronn LK, 2005, AM J CLIN NUTR, V81, P69; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hirano Y, 2013, SCIENCE, V339, P443, DOI 10.1126/science.1227170; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOLLOSZY JO, 1991, J APPL PHYSIOL, V70, P1529, DOI 10.1152/jappl.1991.70.4.1529; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huffman KM, 2011, DIABETES CARE, V34, P174, DOI 10.2337/dc10-0709; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; LARON Z, 1993, HORM RES, V40, P16, DOI 10.1159/000183762; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Martins I, 2011, AGING-US, V3, P821, DOI 10.18632/aging.100380; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Mattison J.A., 2014, CELL METAB; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mercken EM, 2013, AGING CELL, V12, P645, DOI 10.1111/acel.12088; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Mizushima S, 1997, J Cardiovasc Risk, V4, P191, DOI 10.1097/00043798-199706000-00006; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; National Center for Health Statistics (NCHS), 2012, HLTH US 2011 SPEC FE; Nicklas BJ, 2009, EXERC SPORT SCI REV, V37, P165, DOI 10.1097/JES.0b013e3181b7b3d9; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pedersen SB, 2008, INT J OBESITY, V32, P1250, DOI 10.1038/ijo.2008.78; PEKKANEN J, 1987, LANCET, V1, P1473, DOI 10.1016/S0140-6736(87)92218-5; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pucciarelli S, 2012, REJUV RES, V15, P590, DOI 10.1089/rej.2012.1349; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; SAKAMOTO K, 1987, J NUTR, V117, P390, DOI 10.1093/jn/117.2.390; SAMORAJSKI T, 1985, NEUROBIOL AGING, V6, P17, DOI 10.1016/0197-4580(85)90066-1; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sharma PK, 2011, AGE, V33, P143, DOI 10.1007/s11357-010-9169-1; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Solomon TPJ, 2010, AM J CLIN NUTR, V92, P1359, DOI 10.3945/ajcn.2010.29771; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Teng NIMF, 2011, PHYSIOL BEHAV, V104, P1059, DOI 10.1016/j.physbeh.2011.07.007; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Varady KA, 2009, AM J CLIN NUTR, V90, P1138, DOI 10.3945/ajcn.2009.28380; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Wang FM, 2011, EXP HEMATOL, V39, P999, DOI 10.1016/j.exphem.2011.06.007; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; Willcox BJ, 2014, CURR OPIN CLIN NUTR, V17, P51, DOI 10.1097/MCO.0000000000000019; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	115	220	222	4	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1515	1526		10.1016/j.cell.2014.05.031	http://dx.doi.org/10.1016/j.cell.2014.05.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949965	Green Accepted, Bronze			2022-12-28	WOS:000340941900008
J	Soleimanpour, SA; Gupta, A; Bakay, M; Ferrari, AM; Groff, DN; Fadista, J; Spruce, LA; Kushner, JA; Groop, L; Seeholzer, SH; Kaufman, BA; Hakonarson, H; Stoffers, DA				Soleimanpour, Scott A.; Gupta, Aditi; Bakay, Marina; Ferrari, Alana M.; Groff, David N.; Fadista, Joao; Spruce, Lynn A.; Kushner, Jake A.; Groop, Leif; Seeholzer, Steven H.; Kaufman, Brett A.; Hakonarson, Hakon; Stoffers, Doris A.			The Diabetes Susceptibility Gene Clec16a Regulates Mitophagy	CELL			English	Article							PANCREATIC BETA-CELL; MITOFUSIN 2; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL DYNAMICS; PARKIN OVEREXPRESSION; STRESS; MORPHOLOGY; INSULITIS; PROTEINS; PRECEDES	Clec16a has been identified as a disease susceptibility gene for type 1 diabetes, multiple sclerosis, and adrenal dysfunction, but its function is unknown. Here we report that Clec16a is a membrane-associated endosomal protein that interacts with E3 ubiquitin ligase Nrdp1. Loss of Clec16a leads to an increase in the Nrdp1 target Parkin, a master regulator of mitophagy. Islets from mice with pancreas-specific deletion of Clec16a have abnormal mitochondria with reduced oxygen consumption and ATP concentration, both of which are required for normal beta cell function. Indeed, pancreatic Clec16a is required for normal glucose-stimulated insulin release. Moreover, patients harboring a diabetogenic SNP in the Clec16a gene have reduced islet Clec16a expression and reduced insulin secretion. Thus, Clec16a controls beta cell function and prevents diabetes by controlling mitophagy. This pathway could be targeted for prevention and control of diabetes and may extend to the pathogenesis of other Clec16a- and Parkin-associated diseases.	[Soleimanpour, Scott A.; Gupta, Aditi; Ferrari, Alana M.; Groff, David N.; Stoffers, Doris A.] Univ Penn Perelman, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endrocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Soleimanpour, Scott A.] Univ Michigan, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48105 USA; [Bakay, Marina; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Fadista, Joao; Groop, Leif] Lund Univ, Skane Univ Hosp, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Spruce, Lynn A.; Seeholzer, Steven H.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Kushner, Jake A.] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA; [Kaufman, Brett A.] Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn Perelman, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; Skane University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; University of Pennsylvania; University of Pennsylvania	Stoffers, DA (corresponding author), Univ Penn Perelman, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endrocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	stoffers@mail.med.upenn.edu	Fadista, Joao/AAM-4870-2020; Ferrari, Alana/S-4566-2019; Kushner, Jake A/AFJ-8198-2022; Kushner, Jake A/AAF-5049-2022; Gupta, Aditi/HGD-9632-2022	Fadista, Joao/0000-0003-2539-634X; Ferrari, Alana/0000-0002-9058-8041; Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; fadista, joao/0000-0001-7558-7043; Soleimanpour, Scott/0000-0001-6777-4498	Margaret Q. Landenberger Foundation; Charles H. Humpton, Jr. Endowment; JDRF; NIH [K08-DK089117, 5-P01-DK049210-15, 1DP3DK085708-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK089117, P30DK020572, P30DK019525, DP3DK085708, P01DK049210] Funding Source: NIH RePORTER	Margaret Q. Landenberger Foundation; Charles H. Humpton, Jr. Endowment; JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge Dr. N. Doliba and Q. Wei of the Penn Islet Cell Biology Core of the University of Pennsylvania DRC (P30DK19525) for assistance with islet oxygen consumption studies, Dr. D. Williams of the Penn EM Resource Laboratory for imaging assistance, Dr. J. Florez for access to and assistance with MAGIC data, Drs. B. Keith and S. Reiner for immune cell samples, and Dr. P. Herrera for Pdx1-Cre mice. We thank Drs. M. Lazar, M. Birnbaum, M. Marks, J. Raum, and J. Baur for helpful advice. We acknowledge funding support from the Margaret Q. Landenberger Foundation, the Charles H. Humpton, Jr. Endowment, the JDRF, and the NIH (K08-DK089117, 5-P01-DK049210-15, and 1DP3DK085708-01).	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Herrera PL, 2000, DEVELOPMENT, V127, P2317; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kim S, 2012, P NATL ACAD SCI USA, V109, pE1072, DOI 10.1073/pnas.1120320109; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Soleimanpour SA, 2013, TRENDS ENDOCRIN MET, V24, P324, DOI 10.1016/j.tem.2013.03.005; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; 't Hart LM, 2013, DIABETES, V62, P3275, DOI 10.2337/db13-0227; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002; Zouk H, 2014, CLIN EXP IMMUNOL, V175, P485, DOI 10.1111/cei.12240	49	123	133	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1577	1590		10.1016/j.cell.2014.05.016	http://dx.doi.org/10.1016/j.cell.2014.05.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949970	Bronze, Green Accepted			2022-12-28	WOS:000340941900013
J	Teo, WY; Dulman, RY; Vinh, T				Teo, Wan-Yee; Dulman, Robin Y.; Tuyethoa Vinh			Lung Opacification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OSTEOSARCOMA		[Teo, Wan-Yee; Dulman, Robin Y.] Inova Childrens Hosp, Dept Pediat, Falls Church, VA 22042 USA; [Tuyethoa Vinh] Inova Childrens Hosp, Dept Pathol, Falls Church, VA 22042 USA	Inova Fairfax Hospital; Inova Fairfax Hospital	Teo, WY (corresponding author), Inova Childrens Hosp, Dept Pediat, Inova Fairfax Med Campus,3300 Gallows Rd, Falls Church, VA 22042 USA.	wywlzl@singnet.com.sg						Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; GURNEY JG, 1999, CANC INCIDENCE SURVI, P99; Meyers PA, 1997, PEDIATR CLIN N AM, V44, P973, DOI 10.1016/S0031-3955(05)70540-X; Papagelopoulos PJ, 2000, ORTHOPEDICS, V23, P858; Papagelopoulos PJ, 2000, ORTHOPEDICS, V23, P868	5	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2434	2435		10.1001/jama.2013.286226	http://dx.doi.org/10.1001/jama.2013.286226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938567				2022-12-28	WOS:000337301500025
J	Pearl, RG				Pearl, Ronald G.			Review: Noninvasive vs invasive weaning from mechanical ventilation reduces mortality in respiratory failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Pearl, RG (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Burns KEA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1574; Glossop AJ, 2012, BRIT J ANAESTH, V109, P305, DOI 10.1093/bja/aes270; Keenan SP, 2011, CAN MED ASSOC J, V183, pE195, DOI 10.1503/cmaj.100071	3	0	0	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12							JC8	10.7326/0003-4819-160-12-201406170-02008	http://dx.doi.org/10.7326/0003-4819-160-12-201406170-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935514				2022-12-28	WOS:000337374900008
J	Greenhalgh, T; Howick, J; Maskrey, N				Greenhalgh, Trisha; Howick, Jeremy; Maskrey, Neal		Evidence Based Med Renaissance Grp	ESSAY Evidence based medicine: a movement in crisis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES; HEALTH; MANAGEMENT; MORBIDITY; MORTALITY; OUTCOMES; THERAPY; ENGLAND; WOMEN; CARE		[Greenhalgh, Trisha] Barts & London Queen Marys Sch Med & Dent, London E1 2AB, England; [Howick, Jeremy] Univ Oxford, Ctr Evidence Based Med, Oxford OX2 6NW, England; [Maskrey, Neal] Keele Univ, Keele ST5 5BG, Staffs, England	University of London; Queen Mary University London; University of Oxford; Keele University	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, London E1 2AB, England.	p.greenhalgh@qmul.ac.uk	Howick, Jeremy/ADP-7644-2022; Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088; Howick, Jeremy/0000-0003-0280-7206; McCartney, Margaret/0000-0002-7238-6358	National Institute for Health Research [NF-SI-0512-10031] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Allen D, 2005, LANCET, V365, P1768, DOI 10.1016/S0140-6736(05)66578-6; [Anonymous], 1990, BRIT MED J, V301, P651; [Anonymous], 2011, MEREC B, V22, P2; Basson R, 2002, J WOMEN HEALTH GEN-B, V11, P367, DOI 10.1089/152460902317586001; Bone HG, 2000, J CLIN ENDOCR METAB, V85, P720, DOI 10.1210/jc.85.2.720; Chanchlani N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3689; Cohen D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6980; Cooke M, 2010, ED PHYS CALL REFORM; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Dreyfus HL., 1987, IEEE INTELL SYST APP, V2, P110, DOI DOI 10.1109/MEX.1987.4307079; Elwyn G, 2013, PATIENT EDUC COUNS, V90, P207, DOI 10.1016/j.pec.2012.06.036; Every-Palmer S, 2014, J EVAL CLIN PRACT; Eysenbach G, 2004, BMJ-BRIT MED J, V328, P1166, DOI 10.1136/bmj.328.7449.1166; Frank A.W., 1998, FAM SYST HEALTH, V16, P197, DOI [https://doi.org/10.1037/h0089849, DOI 10.1037/H0089849, 10.1037/h0089849]; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Garcia-Retamero R, 2010, SOC SCI MED, V70, P1019, DOI 10.1016/j.socscimed.2009.11.031; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gatta L, 2013, GASTROENTEROLOGY, V144, pS332; Gierisch JM, 2014, ANN INTERN MED, V160, P836, DOI 10.7326/M14-0318; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gillam S, 2011, EXPERT COMMENTARY PA; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Goff Jr DC, 2013, J AM COLL CARDIOL; Gray JAM, 2011, NHS ATLAS VARIATION; Green ML, 2000, J EVAL CLIN PRACT, V6, P121, DOI 10.1046/j.1365-2753.2000.00239.x; Greenhalgh T, 2012, J PRIM HEALTH CARE, V4, P92, DOI 10.1071/HC12092; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Harrison S, 2009, EVIDENCE BASED PRACT; Hart JE, 2010, JAIDS-J ACQ IMM DEF, V54, P167, DOI 10.1097/QAI.0b013e3181d9a330; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hill J, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00007; Hinder S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-83; Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001270.pub2; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kelly MP, 2004, RELATIVE CONTRIBUTIO; Krogsboll LT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009009.pub2; Lau BD, 2014, BMJ QUAL SAF, V23, P187, DOI 10.1136/bmjqs-2012-001782; Lavis John N, 2006, Healthc Policy, V1, P21; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; Lenzer J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3830; Levin A, 2001, ANN INTERN MED, V135, P309, DOI 10.7326/0003-4819-135-4-200108210-00035; Leyden J, 1999, J AM ACAD DERMATOL, V40, P930, DOI 10.1016/S0190-9622(99)70081-2; Llewelyn H., 2014, OXFORD HDB CLIN DIAG, V3rd; Majeed A, 1999, J PUBLIC HEALTH MED, V21, P395, DOI 10.1093/pubmed/21.4.395; McCormack L, 2013, EVIDENCE REPORTS TEC; McNutt R, 2013, CLIN GUIDELINES FAIL; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Montgomery K, 2006, DOCTORS THINK CLIN J; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; National Institute for Health and Clinical Excellence, 2012, CG153 NICE; NICE, 2004, DYS MAN DYSP AD PRIM; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pope C, 2003, HEALTH-LONDON, V7, P267, DOI 10.1177/1363459303007003002; Richards T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2614; Rosling H, 2011, J EPIDEMIOL GLOB HEA, V1, P11, DOI 10.1016/j.jegh.2011.07.001; Schei E, 2006, PERSPECT BIOL MED, V49, P393, DOI 10.1353/pbm.2006.0048; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Swinglehurst D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001754; Timmermans S, 2003, GOLD STANDARD CHALLE; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Volk R, 2013, BMC MED INF DECIS MA, pS1; West CP, 2014, JAMA INTERN MED, V174, P527, DOI 10.1001/jamainternmed.2013.14387	69	918	942	5	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2014	348								g3725	10.1136/bmj.g3725	http://dx.doi.org/10.1136/bmj.g3725			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1IW	24927763	Green Published, Bronze			2022-12-28	WOS:000337410400001
J	Weyand, CM; Goronzy, JJ				Weyand, Cornelia M.; Goronzy, Jorg J.			Giant-Cell Arteritis and Polymyalgia Rheumatica Reply	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Weyand, Cornelia M.; Goronzy, Jorg J.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Weyand, CM (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	cweyand@stanford.edu	Weyand, Cornelia/AAH-3343-2021	Goronzy, Jorg/0000-0001-7670-1856	NEI NIH HHS [R01 EY011916] Funding Source: Medline; NHLBI NIH HHS [P01 HL058000, R01 HL117913] Funding Source: Medline; NHLBI NIH HHS [R01 HL117913] Funding Source: Medline; NIAID NIH HHS [R01 AI108906, R56 AI044142, R01 AI044142] Funding Source: Medline; NIAID NIH HHS [R01 AI108906] Funding Source: Medline; NIAMS NIH HHS [R01 AR042527] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Weyand CM, 2012, J NEURO-OPHTHALMOL, V32, P259, DOI 10.1097/WNO.0b013e318268aa9b	1	236	242	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1653	1653		10.1056/NEJMcp1214825	http://dx.doi.org/10.1056/NEJMcp1214825			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337759	Green Accepted			2022-12-28	WOS:000343648500020
J	Weyand, CM; Goronzy, JJ				Weyand, Cornelia M.; Goronzy, Joerg J.			Giant-Cell Arteritis and Polymyalgia Rheumatica	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE-VESSEL VASCULITIS; CORTICOSTEROID TREATMENT; CLASSIFICATION CRITERIA; TEMPORAL ARTERITIS; TAKAYASU ARTERITIS; RANDOMIZED-TRIAL; DISEASE-ACTIVITY; BHPR GUIDELINES; DOUBLE-BLIND; COLLEGE	A 79-year-old woman presents with new-onset pain in her neck and both shoulders. She takes 7.5 mg of prednisone per day for giant-cell arteritis. Occipital tenderness and diplopia developed 11 months before presentation. At that time, her erythrocyte sedimentation rate was elevated, at 78 mm per hour, and a temporal-artery biopsy revealed granulomatous arteritis. The diplopia resolved after 6 days of treatment with 60 mg of prednisone daily. Neither headache nor visual symptoms developed when the glucocorticoids were tapered. How should this patient's care be managed?	[Weyand, Cornelia M.; Goronzy, Joerg J.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Stanford University	Weyand, CM (corresponding author), Stanford Univ, Sch Med, Dept Med Immunol & Rheumatol, CCSR Bldg Rm 2225,269 Campus Dr W, Stanford, CA 94305 USA.	cweyand@stanford.edu	Weyand, Cornelia/AAH-3343-2021	Goronzy, Jorg/0000-0001-7670-1856	NEI NIH HHS [R01 EY011916] Funding Source: Medline; NHLBI NIH HHS [P01 HL058000, R01 HL117913] Funding Source: Medline; NHLBI NIH HHS [R01 HL117913] Funding Source: Medline; NIAID NIH HHS [R01 AI108906, R56 AI044142, R01 AI044142] Funding Source: Medline; NIAID NIH HHS [R01 AI108906] Funding Source: Medline; NIAMS NIH HHS [R01 AR042527] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Achkar AA, 1998, ANN INTERN MED, V128, P410, DOI 10.7326/0003-4819-128-5-199803010-00016; AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550; Ball EL, 2010, BRIT J SURG, V97, P1765, DOI 10.1002/bjs.7252; Besson FL, 2011, EUR J NUCL MED MOL I, V38, P1764, DOI 10.1007/s00259-011-1830-0; Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; DASGUPTA B, 1990, BRIT J RHEUMATOL, V29, P456; Dasgupta B, 2012, ARTHRITIS RHEUM-US, V64, P943, DOI 10.1002/art.34356; Dasgupta B, 2010, RHEUMATOLOGY, V49, P1594, DOI 10.1093/rheumatology/keq039a; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; Deng JS, 2010, CIRCULATION, V121, P906, DOI 10.1161/CIRCULATIONAHA.109.872903; DESILVA M, 1986, ANN RHEUM DIS, V45, P136, DOI 10.1136/ard.45.2.136; Forster S, 2011, VASA, V40, P219, DOI 10.1024/0301-1526/a000096; Gonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459; Gran JT, 2001, RHEUMATOLOGY, V40, P1238, DOI 10.1093/rheumatology/40.11.1238; Grossman JM, 2012, ARTHRIT CARE RES, V64, P464, DOI 10.1002/acr.21634; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; Hauenstein C, 2012, RHEUMATOLOGY, V51, P1999, DOI 10.1093/rheumatology/kes153; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Kermani TA, 2013, LANCET, V381, P28; Kermani TA, 2013, ANN RHEUM DIS, V72, P1989, DOI 10.1136/annrheumdis-2012-202408; Kermani TA, 2013, LANCET, V381, P63, DOI 10.1016/S0140-6736(12)60680-1; Kermani TA, 2012, SEMIN ARTHRITIS RHEU, V41, P866, DOI 10.1016/j.semarthrit.2011.10.005; Kermani TA, 2011, ARTHRIT CARE RES, V63, P761, DOI 10.1002/acr.20435; Kotter I, 2012, CLIN EXP RHEUMATOL, V30, pS114; Kreiner F, 2011, PAIN, V152, P1127, DOI 10.1016/j.pain.2011.01.032; Kreiner F, 2010, ARTHRITIS RHEUM-US, V62, P3768, DOI 10.1002/art.27728; Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754; Maldini C, 2010, J RHEUMATOL, V37, P2326, DOI 10.3899/jrheum.100353; Matteson EL, 1996, AM J MED, V100, P193, DOI 10.1016/S0002-9343(97)89458-2; Mazlumzadeh M, 2006, ARTHRITIS RHEUM, V54, P3310, DOI 10.1002/art.22163; Miller DV, 2006, AM J SURG PATHOL, V30, P1150, DOI 10.1097/01.pas.0000213293.04026.ec; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; ROCHE NE, 1993, ARTHRITIS RHEUM, V36, P1286, DOI 10.1002/art.1780360913; Saedon Habiba, 2012, JRSM Short Rep, V3, P73, DOI 10.1258/shorts.2012.012069; Salvarani C, 2007, ANN INTERN MED, V146, P631, DOI 10.7326/0003-4819-146-9-200705010-00005; Salvarani C, 2012, NAT REV RHEUMATOL, V8, P509, DOI 10.1038/nrrheum.2012.97; Schmidt J, 2013, J RHEUMATOL, V40, P910, DOI 10.3899/jrheum.121150; Seitz M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13156; Unizony S, 2012, ARTHRIT CARE RES, V64, P1720, DOI 10.1002/acr.21750; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Weyand CM, 2000, ARTHRITIS RHEUM, V43, P1041, DOI 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7; Weyand CM, 2013, NAT REV RHEUMATOL, V9, P731, DOI 10.1038/nrrheum.2013.161; Weyand CM, 2012, J NEURO-OPHTHALMOL, V32, P259, DOI 10.1097/WNO.0b013e318268aa9b; Weyand CM, 2011, CURR OPIN RHEUMATOL, V23, P43, DOI 10.1097/BOR.0b013e32833ee946; Yates M, 2014, CLIN RHEUMATOL, V33, P227, DOI 10.1007/s10067-013-2384-2; Zoller B, 2013, SCAND J RHEUMATOL, V42, P487, DOI 10.3109/03009742.2013.793777	50	236	242	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					50	57		10.1056/NEJMcp1214825	http://dx.doi.org/10.1056/NEJMcp1214825			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	25337759	Green Accepted			2022-12-28	WOS:000338265700009
J	Abdel-Kader, K				Abdel-Kader, Khaled			Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease	ANNALS OF INTERNAL MEDICINE			English	Letter							CONVERTING ENZYME-INHIBITORS		Vanderbilt Univ, Nashville, TN 37235 USA	Vanderbilt University	Abdel-Kader, K (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.		abdel-kader, khaled/AAF-3925-2020; Abdel-Kader, Khaled/ABE-7370-2021	Abdel-Kader, Khaled/0000-0002-6412-8498	NIDDK NIH HHS [K23 DK090304] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; O'Hare AM, 2009, ANN INTERN MED, V150, P717, DOI 10.7326/0003-4819-150-10-200905190-00010; Patel SS, 2013, J CACHEXIA SARCOPENI, V4, P19, DOI 10.1007/s13539-012-0079-1; Qaseem A, 2013, ANN INTERN MED, V159, P835, DOI 10.7326/0003-4819-159-12-201312170-00726	6	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					83	83		10.7326/L14-5013-4	http://dx.doi.org/10.7326/L14-5013-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24979458				2022-12-28	WOS:000338419700014
J	Qaseem, A; Wilt, T; Denberg, TD				Qaseem, Amir; Wilt, Timothy; Denberg, Thomas D.			Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Wilt, Timothy] Minneapolis VA Ctr Epidemiol & Clin Res, Minneapolis, MN USA; [Denberg, Thomas D.] Carilion Clin, Roanoke, VA USA	American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, Philadelphia, PA 19106 USA.		abdel-kader, khaled/AAF-3925-2020; Abdel-Kader, Khaled/ABE-7370-2021	Abdel-Kader, Khaled/0000-0002-6412-8498	NIDDK NIH HHS [K23 DK090304] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Harris R, 2011, EPIDEMIOL REV, V33, P1, DOI 10.1093/epirev/mxr006; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Wilson JMG, 1968, PRINCIPLES PRACTICE	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					83	84		10.7326/L14-5013-5	http://dx.doi.org/10.7326/L14-5013-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24979458				2022-12-28	WOS:000338419700015
